data_2kjw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kjw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.195 0.522 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 52' ' ' LEU . 1.6 mm? -104.67 124.32 49.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.16 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.489 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 1.7 t90 -115.79 119.63 36.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.741 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CA ' ' HD2' ' A' ' 81' ' ' LYS . 27.0 m-85 -126.84 137.37 53.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.761 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.54 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 10.7 tt0 -122.82 159.46 28.08 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.376 -0.827 . . . . 0.0 109.42 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 11.4 m -136.03 -177.51 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.003 -1.061 . . . . 0.0 110.667 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 14.0 tt0 -146.54 56.22 1.15 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.481 0.657 . . . . 0.0 109.651 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.527 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 10.2 mmt -131.12 149.05 72.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.402 -0.811 . . . . 0.0 109.209 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 35.2 Cg_endo -68.63 -168.4 0.22 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.774 1.408 . . . . 0.0 112.823 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.57 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -61.12 -46.55 90.13 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.527 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.0 -28.73 20.0 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.275 -0.89 . . . . 0.0 110.214 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.611 HG22 ' CZ ' ' A' ' 46' ' ' TYR . 43.0 t -47.99 -37.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.571 -0.706 . . . . 0.0 110.791 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -53.64 -29.0 36.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.984 -1.073 . . . . 0.0 109.739 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.573 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 24.6 t0 -59.99 -36.58 77.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 110.655 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.481 HD11 ' O ' ' A' ' 19' ' ' VAL . 6.8 mp -57.97 -39.35 77.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.54 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -61.37 -52.82 63.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.838 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.36 -42.39 75.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.246 -0.909 . . . . 0.0 110.383 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -56.02 -49.05 74.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 110.407 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.38 -36.98 85.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.504 -0.748 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.6 -38.63 88.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.151 -0.968 . . . . 0.0 110.781 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.589 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 55.8 mt -61.6 -47.44 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 120.927 -1.108 . . . . 0.0 110.567 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.9 ptt180 -72.66 67.47 0.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.94 -25.48 29.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -57.9 -14.98 7.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.102 -0.999 . . . . 0.0 110.154 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.592 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 1.7 p -80.35 132.08 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 110.311 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -80.04 -46.49 16.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.513 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttp85 -152.7 123.3 7.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.9 -1.125 . . . . 0.0 111.135 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG13 ' HB2' ' A' ' 26' ' ' LEU . 7.2 p -127.18 136.18 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.465 -0.772 . . . . 0.0 109.75 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.97 120.72 17.38 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.04 -1.038 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 20.0 t -114.94 130.41 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.736 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.485 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 18.9 t -104.43 161.15 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.049 -1.032 . . . . 0.0 110.862 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.11 154.59 23.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.545 -0.722 . . . . 0.0 110.317 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 7.7 p -73.2 -172.58 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -94.66 -1.91 52.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.11 -64.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.043 -1.036 . . . . 0.0 110.786 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.5 Cg_endo -69.18 -160.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.556 1.292 . . . . 0.0 111.226 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.1 37.37 3.85 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.7 mtp180 -93.95 146.89 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.477 -1.014 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.611 ' CZ ' HG22 ' A' ' 19' ' ' VAL . 41.2 m-85 -131.7 154.73 48.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.147 -0.971 . . . . 0.0 110.942 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' CG ' ' HB ' ' A' ' 38' ' ' VAL . 2.6 pt-20 -101.64 104.48 15.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 48.5 t -83.71 116.9 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 111.642 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -131.17 100.53 5.24 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.592 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -117.25 144.85 24.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.903 -178.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' HD13 ' A' ' 50' ' ' ILE . 9.4 p -96.18 147.39 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 109.429 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 8' ' ' LEU . 19.8 mt -107.25 -178.28 3.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.711 -1.243 . . . . 0.0 111.625 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.535 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -64.86 179.32 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.767 -0.583 . . . . 0.0 110.523 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -63.97 -15.99 52.31 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.861 1.453 . . . . 0.0 110.788 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -141.07 87.35 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.533 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.33 173.76 7.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.02 -1.05 . . . . 0.0 111.162 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 173.72 -167.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.527 -0.733 . . . . 0.0 110.133 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.554 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.69 76.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 1.9 mm100 -67.86 -45.11 75.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 79.4 mt -64.61 -35.11 79.94 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 109.811 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.74 -33.89 50.2 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.048 . . . . 0.0 108.342 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' ILE . 15.2 mt -70.94 -49.39 46.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 38.5 mt-10 -68.51 -43.36 77.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 109.316 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.7 mmtp -60.73 -36.2 78.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 110.408 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.6 mm-40 -65.75 -48.84 70.53 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.841 -1.162 . . . . 0.0 110.061 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.589 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 4.6 mt -77.77 -41.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.392 -0.817 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 27.4 mt -59.46 -50.49 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 87.0 mt-30 -64.36 -47.06 80.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.2 -0.938 . . . . 0.0 108.897 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -58.13 -47.11 84.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.509 -0.745 . . . . 0.0 110.81 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -68.76 -48.51 63.53 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.864 -1.148 . . . . 0.0 110.449 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 76.1 mt -65.7 -35.55 81.09 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.326 -0.858 . . . . 0.0 110.455 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 1.4 mm-40 -71.33 -44.91 64.21 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 109.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.9 m-80 -64.29 -36.6 84.64 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.011 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.03 -37.65 61.67 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.628 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.27 23.95 4.32 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' A' ' 14' ' ' MET . . . -108.31 131.32 54.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.26 -1.141 . . . . 0.0 109.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 146.19 46.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.9 t -87.85 122.24 39.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.046 -1.034 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.01 -7.46 59.56 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.077 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.54 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -137.55 152.98 50.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 111.525 -178.738 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.628 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' C ' ' CD1' ' A' ' 8' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.332 0.587 . . . . 0.0 109.643 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.528 ' N ' HD13 ' A' ' 8' ' ' LEU . 6.7 mp -138.46 125.28 21.06 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.825 . . . . 0.0 110.847 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.562 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -99.57 132.41 44.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE1' ' CG1' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -128.12 128.51 44.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.45 157.33 29.57 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.833 -1.167 . . . . 0.0 110.519 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.623 ' CG1' ' CE1' ' A' ' 10' ' ' TYR . 26.6 m -130.36 179.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.75 51.54 2.12 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.58 -0.7 . . . . 0.0 109.84 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.563 ' CB ' ' HB3' ' A' ' 18' ' ' ARG . 70.4 mmm -133.96 151.82 77.46 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 109.535 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 36.0 Cg_endo -71.15 -167.57 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.835 1.44 . . . . 0.0 113.24 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -53.23 -25.51 14.41 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 26.9 t0 -57.58 -23.34 50.23 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.576 ' HD3' ' CE1' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -88.09 -13.49 41.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.3 t -48.26 -44.6 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.508 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -57.9 -29.07 64.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.764 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.594 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.2 t0 -59.64 -45.33 92.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' CD2' ' CZ ' ' A' ' 18' ' ' ARG . 2.0 mm? -59.71 -36.65 76.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.26 74.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.173 -0.954 . . . . 0.0 110.533 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.3 mmt-85 -60.05 -46.64 88.87 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 tm-20 -68.67 -40.99 79.89 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 0.0 109.65 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.536 ' CD2' ' HB ' ' A' ' 35' ' ' VAL . 18.2 mt -55.28 -38.03 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.997 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 9.0 tpt180 -70.64 -40.94 72.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.468 -0.77 . . . . 0.0 110.596 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.61 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 56.5 mt -67.51 -44.94 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.989 -1.07 . . . . 0.0 110.743 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.525 ' CZ ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.51 57.44 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -25.67 60.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 110.569 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -66.36 -20.46 66.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.098 -1.001 . . . . 0.0 110.427 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.538 HG11 ' CG2' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -80.5 154.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.913 . . . . 0.0 110.271 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -79.51 -47.02 16.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 111.41 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.457 ' C ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -153.96 146.27 23.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.764 -1.21 . . . . 0.0 111.939 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' HG11 ' A' ' 32' ' ' VAL . 2.1 t -135.56 135.96 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.459 -0.776 . . . . 0.0 109.11 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.468 ' HB3' ' OD1' ' A' ' 49' ' ' ASN . 2.5 tpt -131.71 117.42 18.6 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.968 -1.083 . . . . 0.0 110.692 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' CG2' HG23 ' A' ' 48' ' ' VAL . 4.4 t -114.59 129.8 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.307 -0.87 . . . . 0.0 109.849 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 3.2 m -115.54 135.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 110.402 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -78.28 154.03 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.467 -0.77 . . . . 0.0 110.503 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 161.23 30.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -83.08 6.49 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 110.648 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.91 -65.07 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.334 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 44.0 Cg_endo -70.95 -176.68 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.562 1.296 . . . . 0.0 110.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.97 28.02 17.81 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 14.8 mtt180 -93.92 138.93 31.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.387 -1.066 . . . . 0.0 109.972 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 7.0 m-85 -119.22 153.89 34.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.056 0.931 . . . . 0.0 110.949 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 4.0 mt-10 -104.31 95.83 6.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 10' ' ' TYR . 5.1 t -88.1 122.72 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.852 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 36' ' ' MET . 0.8 OUTLIER -130.68 101.14 5.56 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.538 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -117.78 149.8 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.447 0.641 . . . . 0.0 111.262 -178.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 50' ' ' ILE . 5.5 p -112.86 152.86 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.71 -0.619 . . . . 0.0 109.786 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.453 HD13 ' HG ' ' A' ' 61' ' ' LEU . 3.4 mt -100.36 -165.03 1.17 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.054 -1.029 . . . . 0.0 110.924 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.539 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -68.69 -178.83 0.45 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.641 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -63.87 -15.04 46.72 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.758 1.399 . . . . 0.0 110.486 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.06 77.71 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.544 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.65 173.2 6.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.73 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 11.9 t70 178.81 171.05 0.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 5.1 mt-30 -57.8 -38.14 75.0 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.707 . . . . 0.0 110.294 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 -31.59 69.02 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.334 -0.854 . . . . 0.0 109.95 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.9 mm100 -74.3 -45.77 45.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 57' ' ' ASP . 1.6 mp -67.69 -36.0 79.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.993 -1.067 . . . . 0.0 109.514 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.84 -33.7 57.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 67' ' ' ILE . 20.2 mt -69.14 -50.31 49.05 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.271 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 29' ' ' ARG . 78.7 mm-40 -71.54 -42.06 68.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -67.34 -30.5 70.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.472 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.8 mm-40 -69.14 -48.34 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.761 -1.212 . . . . 0.0 109.91 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.61 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 6.3 mt -77.38 -42.4 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.4 -0.812 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.518 ' CG2' HD11 ' A' ' 72' ' ' LEU . 85.6 mt -59.47 -46.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.104 -0.998 . . . . 0.0 109.91 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 5.2 mt-30 -64.16 -44.13 93.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -68.41 -43.44 77.23 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.403 -0.811 . . . . 0.0 111.147 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.07 -48.48 73.6 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.886 -1.134 . . . . 0.0 110.499 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 10' ' ' TYR . 96.6 mt -63.92 -35.19 79.84 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 69' ' ' GLN 0.258 2.0 tt0 -69.93 -45.85 66.63 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 108.988 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -58.24 -37.07 74.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.15 -26.53 60.36 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.893 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.24 28.74 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.61 121.92 41.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.24 . . . . 0.0 110.282 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.35 162.57 18.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 1.5 t -87.6 118.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -12.88 58.26 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.876 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.562 ' CE ' ' O ' ' A' ' 9' ' ' TRP 0.254 0.0 OUTLIER -131.57 157.24 44.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.494 -0.754 . . . . 0.0 111.015 -178.78 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 81' ' ' LYS . 32.6 t . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.641 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.437 0.637 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.15 132.35 41.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.262 -0.899 . . . . 0.0 110.523 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -122.86 118.24 27.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.095 -1.003 . . . . 0.0 109.892 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.419 ' HB2' ' CG2' ' A' ' 48' ' ' VAL . 36.2 m-85 -127.78 119.15 25.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 0.0 110.906 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.553 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 34.7 tt0 -107.27 155.6 19.77 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.2 -0.937 . . . . 0.0 109.689 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.528 ' CG2' ' CD2' ' A' ' 46' ' ' TYR . 4.0 m -129.53 -178.38 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.865 -1.147 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' SD ' ' A' ' 14' ' ' MET . 3.5 pt-20 -133.06 48.87 2.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.537 0.684 . . . . 0.0 109.866 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.481 ' HB2' ' HB3' ' A' ' 18' ' ' ARG . 78.3 mmm -126.01 155.0 73.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 109.485 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.3 Cg_endo -72.67 -166.83 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.811 1.427 . . . . 0.0 113.014 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.465 ' O ' HG11 ' A' ' 19' ' ' VAL . 42.4 tt0 -56.38 -26.85 54.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.48 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 29.8 t0 -58.13 -16.13 12.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.059 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.572 ' CD ' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -75.09 -16.57 60.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 110.18 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 20' ' ' ASN . 8.0 p -49.31 -43.68 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.416 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.479 ' N ' HG13 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -64.72 -30.05 71.05 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.594 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 41.1 t0 -65.6 -53.48 41.21 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.556 -0.715 . . . . 0.0 110.07 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 4.7 mp -58.86 -37.11 75.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.136 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.11 -52.71 63.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.158 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -63.32 -46.26 87.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.533 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -56.91 -44.51 82.47 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.454 -0.779 . . . . 0.0 110.17 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' CD2' ' HB ' ' A' ' 35' ' ' VAL . 1.7 mt -66.94 -40.07 87.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.506 -0.746 . . . . 0.0 111.221 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.69 -37.36 83.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.915 -1.116 . . . . 0.0 110.355 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.533 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 14.8 mt -68.18 -44.56 84.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' CD ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -81.4 69.26 8.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.403 -0.81 . . . . 0.0 110.297 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 37.7 p-10 -73.49 -25.96 60.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 6.1 t30 -58.82 -13.88 7.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.407 -0.808 . . . . 0.0 110.575 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.612 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 8.0 p -79.63 141.41 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 111.037 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -46.64 15.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 111.253 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttt180 -152.98 123.79 7.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 111.201 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HB ' ' CD2' ' A' ' 26' ' ' LEU . 11.3 t -108.5 135.46 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 110.035 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 115.76 19.98 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.176 -0.953 . . . . 0.0 110.335 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.478 ' CG1' HD22 ' A' ' 22' ' ' LEU . 48.7 t -114.82 132.04 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.558 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 47' ' ' GLU . 3.9 m -113.22 130.79 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.371 -0.831 . . . . 0.0 110.018 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.619 ' HA ' ' CD1' ' A' ' 46' ' ' TYR . . . -77.62 153.67 32.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.519 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -73.59 166.33 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 109.445 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -83.51 2.83 35.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 0.0 110.848 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.42 -64.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.009 -1.057 . . . . 0.0 110.458 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.6 Cg_endo -70.55 -171.06 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.568 1.299 . . . . 0.0 111.072 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.24 26.42 18.8 Favored Glycine 0 N--CA 1.479 1.563 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -93.45 135.7 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 108.64 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.619 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 11.1 m-85 -128.73 151.29 49.71 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.763 -1.211 . . . . 0.0 112.379 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 mt-10 -105.03 90.63 3.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.098 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 16.0 m -86.92 125.24 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -123.63 100.74 6.94 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.612 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.13 147.77 16.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.447 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.468 ' O ' HD12 ' A' ' 50' ' ' ILE . 2.7 p -102.82 129.76 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.12 -0.988 . . . . 0.0 111.296 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.587 ' CD2' ' CD1' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -93.58 -168.29 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.904 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.53 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.2 m-80 -50.93 172.91 0.12 Allowed Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.0 109.505 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.8 Cg_endo -63.22 -14.66 43.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.548 1.289 . . . . 0.0 110.849 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 4.2 t30 -146.19 86.77 1.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.106 -0.996 . . . . 0.0 110.696 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 52' ' ' LEU . 8.7 mt -61.17 -171.41 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 111.068 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.8 t70 172.94 172.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.483 0.659 . . . . 0.0 110.103 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 11.7 mt-30 -56.37 -34.31 66.55 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -34.22 75.15 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.468 ' CB ' HD22 ' A' ' 56' ' ' LEU . 29.1 mm100 -72.05 -44.32 63.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 110.099 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 55.5 mt -63.37 -34.26 77.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 109.935 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.75 -40.36 63.03 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.613 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.1 mt -71.54 -49.99 35.5 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 79.1 mm-40 -58.34 -41.94 85.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.737 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -70.79 -46.9 62.03 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.263 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -71.4 -37.66 71.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.85 -1.156 . . . . 0.0 109.834 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 63' ' ' LEU . 11.0 mm -76.49 -41.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 56.2 mt -70.26 -49.73 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.714 -1.242 . . . . 0.0 109.786 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 25.7 mm-40 -59.17 -38.74 80.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.883 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -57.74 -48.08 80.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.264 -0.898 . . . . 0.0 111.128 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 25' ' ' GLU . . . -70.95 -48.52 52.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.907 -1.121 . . . . 0.0 110.099 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 20.3 mt -63.71 -35.41 80.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.604 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 4.8 mm-40 -69.57 -45.08 69.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.427 -0.795 . . . . 0.0 109.283 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.48 -40.24 90.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.74 -29.17 58.78 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.528 -0.733 . . . . 0.0 110.0 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . 101.06 18.34 20.11 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -93.6 127.12 39.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -1.086 . . . . 0.0 110.483 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.8 141.32 48.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 109.874 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 2.9 t -94.17 125.37 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.66 -10.29 58.29 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -131.56 133.4 44.99 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 82' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.321 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 121.438 0.637 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.522 HD22 ' CD2' ' A' ' 61' ' ' LEU . 10.9 mt -126.04 125.01 41.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.468 -0.77 . . . . 0.0 110.35 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.481 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -116.54 119.16 34.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.823 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.485 ' HB2' ' HB ' ' A' ' 48' ' ' VAL . 22.0 m-85 -124.19 118.11 26.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.607 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.532 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 31.6 tt0 -110.82 147.14 35.15 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.405 -0.809 . . . . 0.0 109.452 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 m -126.65 -179.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.837 -1.164 . . . . 0.0 111.433 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -129.65 45.3 2.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.737 0.779 . . . . 0.0 109.033 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.535 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 60.6 mmm -120.29 145.99 41.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.77 -0.581 . . . . 0.0 109.563 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 33.4 Cg_endo -67.99 -166.57 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.77 1.405 . . . . 0.0 113.518 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.479 ' HG2' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -59.13 -27.57 65.75 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.237 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -59.53 -22.27 61.42 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.021 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.614 ' NH1' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -83.54 -13.47 54.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.227 -0.921 . . . . 0.0 110.378 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 16' ' ' GLU . 51.8 t -48.0 -46.62 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.585 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -57.8 -29.96 65.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.4 t0 -61.15 -50.77 71.82 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.435 -0.791 . . . . 0.0 109.928 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.9 mm? -59.62 -41.45 90.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.116 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.21 -52.37 64.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.179 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.18 -42.35 89.01 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.33 -0.856 . . . . 0.0 109.608 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 19.0 tt0 -56.89 -48.77 77.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 110.903 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -69.02 -37.56 78.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 110.812 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.447 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.94 -36.11 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.01 -1.056 . . . . 0.0 111.395 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' CG2' HG22 ' A' ' 67' ' ' ILE . 73.1 mt -62.93 -44.83 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.951 -1.093 . . . . 0.0 111.378 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 29' ' ' ARG . 5.9 ptt180 -83.83 93.15 7.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.061 . . . . 0.0 110.788 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -73.43 -24.82 60.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.477 ' OD1' HD23 ' A' ' 52' ' ' LEU . 23.6 p30 -58.56 -15.12 9.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.613 ' CG2' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.61 134.36 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.399 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -79.47 -45.65 18.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 111.043 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -152.7 134.54 14.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.805 -1.184 . . . . 0.0 111.087 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.616 ' HA ' HG13 ' A' ' 50' ' ' ILE . 2.2 p -125.86 131.31 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.339 -0.851 . . . . 0.0 110.547 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.3 ttt -140.42 116.02 10.14 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.611 -0.68 . . . . 0.0 109.538 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 33.2 t -111.88 131.93 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 110.829 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 38' ' ' VAL . 33.5 m -105.59 142.11 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.458 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.03 154.67 23.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.357 -0.839 . . . . 0.0 110.517 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.441 ' HB3' ' NH2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -74.04 -176.12 2.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.089 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -103.06 9.89 38.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.169 -0.957 . . . . 0.0 110.82 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -155.93 -65.1 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.15 -0.969 . . . . 0.0 109.797 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.1 Cg_endo -71.43 -178.94 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.536 1.282 . . . . 0.0 110.334 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -105.13 30.17 10.42 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 3.0 ptt-85 -93.49 160.6 14.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.02 -1.282 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.614 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 78.6 m-85 -134.42 154.38 51.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.089 0.947 . . . . 0.0 111.358 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.55 95.05 7.02 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 15.2 t -78.18 112.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 111.07 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.426 ' O ' HD12 ' A' ' 50' ' ' ILE . 69.1 m-80 -131.29 100.81 5.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.616 HG13 ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -116.11 146.2 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 51' ' ' VAL . 8.4 p -105.85 122.83 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.13 -168.5 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.5 m120 -41.77 165.17 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.46 -0.775 . . . . 0.0 110.07 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -64.4 -27.06 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.762 1.401 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 12.7 t-20 -127.75 78.36 1.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 10.8 mt -62.28 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.226 -0.921 . . . . 0.0 111.011 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 58' ' ' GLN . 5.4 t0 174.59 172.09 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.441 0.638 . . . . 0.0 109.829 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.472 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.3 mm-40 -60.38 -31.4 70.32 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 110.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -70.05 -40.75 74.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.323 -0.861 . . . . 0.0 110.113 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 4.6 mm-40 -66.44 -42.77 87.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 109.942 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.522 ' CD2' HD22 ' A' ' 8' ' ' LEU . 15.1 mt -63.92 -33.5 75.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 109.732 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 59' ' ' SER . . . -51.74 -37.05 49.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 67' ' ' ILE . 62.5 mt -72.19 -51.36 21.5 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.486 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.3 mm-40 -61.64 -36.75 81.68 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.813 -1.179 . . . . 0.0 110.205 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.505 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -72.21 -47.05 53.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.976 -1.078 . . . . 0.0 110.232 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.45 ' OE2' HD23 ' A' ' 63' ' ' LEU . 23.7 pt-20 -71.21 -34.65 71.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.1 -1.0 . . . . 0.0 109.318 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.635 HG12 ' O ' ' A' ' 63' ' ' LEU . 21.4 mm -77.03 -43.51 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.544 -0.722 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 64' ' ' GLU . 49.6 mt -69.75 -46.01 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 110.259 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.09 -34.08 77.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.183 -0.948 . . . . 0.0 110.157 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 2.0 ttt-85 -64.42 -46.21 84.23 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.136 -0.978 . . . . 0.0 110.328 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 25' ' ' GLU . . . -67.69 -48.61 66.11 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 110.21 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.458 HD21 ' HB1' ' A' ' 77' ' ' ALA . 86.9 mt -64.63 -36.07 83.07 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 38.3 mm-40 -70.05 -45.05 67.93 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.623 0.725 . . . . 0.0 109.247 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.51 -37.12 84.83 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.606 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.87 -41.08 60.48 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.564 -0.71 . . . . 0.0 110.049 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.15 23.6 4.48 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -98.7 138.23 36.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.218 . . . . 0.0 110.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -119.32 121.95 40.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.142 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 2.1 t -83.25 126.68 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.185 -0.947 . . . . 0.0 110.037 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.12 -15.01 54.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.63 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.499 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -130.66 129.65 42.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.682 -0.636 . . . . 0.0 110.454 -179.264 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.489 1.49 0 O-C-N 120.906 -1.121 . . . . 0.0 110.887 179.8 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.409 ' C ' ' HG ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.409 ' HG ' ' C ' ' A' ' 7' ' ' PHE . 1.4 mp -129.02 136.73 50.69 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.774 0.797 . . . . 0.0 111.886 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.444 ' C ' ' HE3' ' A' ' 81' ' ' LYS . 3.7 t90 -125.59 119.01 26.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.555 ' CD2' HG22 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -123.59 140.36 53.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 111.383 -178.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.542 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 38.8 tt0 -122.76 158.14 30.82 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.506 -0.746 . . . . 0.0 109.513 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.449 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 13.6 m -130.76 177.59 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.046 . . . . 0.0 110.507 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -131.2 51.99 2.1 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.513 0.673 . . . . 0.0 109.979 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.533 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 54.2 mmm -132.98 153.54 81.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.303 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -71.02 -167.54 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.703 1.37 . . . . 0.0 113.487 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 19' ' ' VAL . 2.6 tt0 -58.27 -27.27 63.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.709 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -59.16 -21.71 59.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.319 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.549 ' NH2' ' CB ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -87.78 -16.87 32.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.788 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.474 ' N ' ' HG3' ' A' ' 18' ' ' ARG . 40.5 t -48.76 -45.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 109.934 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.468 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.2 t-20 -54.96 -29.24 56.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.769 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.58 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 38.3 t0 -60.34 -48.88 79.84 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.422 -0.799 . . . . 0.0 110.017 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.464 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.9 mm? -58.84 -36.74 75.04 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.475 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.8 -52.77 63.78 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.316 -0.865 . . . . 0.0 109.237 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 42.1 mtt180 -66.09 -44.09 85.43 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.429 -0.795 . . . . 0.0 109.331 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.535 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.7 -44.19 77.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.525 ' CD2' HG11 ' A' ' 35' ' ' VAL . 16.0 mt -65.44 -38.96 91.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.668 -0.645 . . . . 0.0 110.46 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -66.14 -36.24 82.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.207 -0.933 . . . . 0.0 111.756 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.557 ' N ' ' HG3' ' A' ' 27' ' ' ARG . 49.0 mt -65.1 -45.7 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.609 -1.307 . . . . 0.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.5 ' NH1' HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.29 79.56 9.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.042 . . . . 0.0 110.679 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.28 -25.47 62.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.998 . . . . 0.0 110.245 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.19 -14.47 10.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 50' ' ' ILE . 2.2 p -79.68 133.65 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.197 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -80.09 -45.87 17.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 111.765 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.474 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.2 mtt85 -152.34 130.39 11.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.738 -1.226 . . . . 0.0 111.598 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 26' ' ' LEU . 2.8 t -122.85 135.68 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.725 . . . . 0.0 109.209 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 115.71 23.01 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.019 -1.051 . . . . 0.0 110.715 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.41 HG12 ' HG ' ' A' ' 22' ' ' LEU . 15.7 t -114.87 129.09 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.298 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 3.6 m -119.81 125.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -82.36 153.99 25.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 p -74.31 -178.93 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.001 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -105.09 5.98 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -149.43 -66.34 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.963 . . . . 0.0 110.21 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.0 Cg_endo -71.59 -164.54 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.334 1.176 . . . . 0.0 110.13 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.29 34.36 4.32 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.1 mtt180 -97.33 134.71 40.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -1.101 . . . . 0.0 110.331 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.572 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 8.1 m-85 -117.88 155.44 30.15 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.288 -0.882 . . . . 0.0 110.438 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.8 mp0 -102.52 98.32 8.41 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 10' ' ' TYR . 66.9 t -78.45 111.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 111.356 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -131.13 101.94 5.8 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.555 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.16 146.91 17.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.728 -177.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.47 ' O ' HD12 ' A' ' 50' ' ' ILE . 11.7 p -119.36 146.92 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.432 -0.792 . . . . 0.0 110.2 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 1.5 mp -135.06 -160.94 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.615 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' LEU . 26.8 m-80 -38.88 161.14 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.92 -0.488 . . . . 0.0 110.351 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 39.4 Cg_endo -64.91 -20.39 64.35 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.91 1.479 . . . . 0.0 110.878 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -143.66 84.4 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 52' ' ' LEU . 18.3 mt -68.37 -162.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 9.0 t70 -161.7 172.2 16.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 0.0 110.464 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 69.2 mt-30 -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.728 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 t -64.49 -28.31 69.57 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.233 -0.917 . . . . 0.0 110.062 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 39.1 mm-40 -65.33 -40.68 94.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 91.6 mt -65.29 -35.25 80.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.048 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.17 -36.39 51.51 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.569 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.9 mt -72.52 -50.67 24.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.179 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' OE1' ' HB2' ' A' ' 29' ' ' ARG . 5.8 mm-40 -63.72 -33.87 76.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.846 -1.159 . . . . 0.0 110.437 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -72.24 -46.73 54.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.394 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 32.2 mm-40 -66.55 -35.38 80.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.121 -0.987 . . . . 0.0 109.85 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 63' ' ' LEU . 11.5 mm -76.71 -47.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.42 -0.8 . . . . 0.0 111.498 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.535 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 45.8 mt -67.78 -48.19 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.937 -1.102 . . . . 0.0 110.125 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.8 mm100 -62.16 -32.93 73.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.329 -0.857 . . . . 0.0 109.956 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -65.81 -46.93 76.78 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.207 -0.933 . . . . 0.0 110.97 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.3 -48.93 47.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.969 -1.082 . . . . 0.0 111.589 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 38.2 mt -58.3 -39.13 78.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 111.293 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 5.3 tt0 -71.28 -46.8 60.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.112 0.958 . . . . 0.0 109.411 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 8.6 t-20 -59.21 -36.89 76.2 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.58 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -74.94 -34.76 62.12 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.873 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.431 ' O ' ' HE3' ' A' ' 14' ' ' MET . . . 113.21 13.81 10.46 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.505 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -102.73 125.69 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 110.2 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -111.99 134.86 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 109.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 10' ' ' TYR . 3.0 t -66.54 124.93 22.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.066 -1.021 . . . . 0.0 109.785 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.2 -11.7 59.35 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.427 -0.796 . . . . 0.0 109.109 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.269 0.0 OUTLIER -138.16 145.37 41.45 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.633 -0.667 . . . . 0.0 110.74 -178.923 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.562 178.58 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.465 0.65 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.599 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 7.8 mp -90.63 129.38 36.76 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 110.243 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 1.6 t90 -124.57 123.56 40.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.524 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 26.3 m-85 -126.79 138.01 53.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.412 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.52 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 1.9 tp60 -121.99 159.99 25.84 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.221 -0.924 . . . . 0.0 110.224 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.477 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 m -133.36 -176.94 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.02 . . . . 0.0 110.609 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' SD ' ' A' ' 14' ' ' MET . 5.6 pt-20 -138.41 56.04 1.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.537 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 4.5 mmt -137.05 149.49 66.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.553 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.484 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -70.84 -167.21 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.035 1.545 . . . . 0.0 113.13 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HA ' HG22 ' A' ' 19' ' ' VAL . 1.4 tt0 -65.22 -25.76 67.83 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.8 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.83 -45.54 89.77 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.264 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 2.8 mtp180 -89.76 -23.65 21.71 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.944 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.505 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 24.4 t -47.95 -38.41 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.525 -0.734 . . . . 0.0 110.012 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 25.1 t-20 -53.36 -29.12 32.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.166 -0.959 . . . . 0.0 109.066 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.588 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 32.9 t0 -59.89 -42.39 93.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.0 mp -58.32 -38.65 77.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.615 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.32 58.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -46.77 82.16 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.216 -0.927 . . . . 0.0 109.292 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' OE1' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -59.29 -48.12 82.82 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.85 0.833 . . . . 0.0 109.454 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 13.3 mt -53.95 -36.92 63.34 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.455 0.645 . . . . 0.0 110.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -35.6 74.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.602 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 15.9 mt -59.48 -32.52 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.041 . . . . 0.0 110.979 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.546 ' O ' ' CG ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -69.4 48.64 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.067 -1.021 . . . . 0.0 111.661 -178.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -25.59 25.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.435 -1.416 . . . . 0.0 109.851 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.384 -0.823 . . . . 0.0 111.14 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.586 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.5 OUTLIER -83.46 142.78 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.12 . . . . 0.0 110.54 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.85 22.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 111.598 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.79 150.34 30.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.619 -1.301 . . . . 0.0 111.822 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.524 ' CB ' HG13 ' A' ' 50' ' ' ILE . 9.7 p -140.03 134.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.4 mtm -122.81 114.12 20.08 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.843 -1.16 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -116.43 132.15 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 109.925 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' HB ' ' CD ' ' A' ' 47' ' ' GLU . 11.2 t -118.81 157.08 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.607 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.11 154.95 21.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -73.91 -170.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.05 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -103.1 -2.13 27.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 111.031 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.578 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -152.25 -66.38 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -70.15 -158.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.469 1.247 . . . . 0.0 110.699 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.79 34.95 4.51 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 2.2 mtt180 -94.52 136.69 34.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -1.13 . . . . 0.0 109.815 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 32.7 m-85 -117.21 153.97 31.95 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.099 -1.0 . . . . 0.0 111.256 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' CD ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -103.67 110.82 23.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 67.5 t -89.41 124.66 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 111.686 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.476 ' ND2' ' N ' ' A' ' 49' ' ' ASN . 1.4 m-80 -131.01 101.18 5.5 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.586 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -124.05 148.27 28.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 111.689 -178.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.476 HG21 ' N ' ' A' ' 52' ' ' LEU . 7.2 p -105.68 151.28 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.695 -0.628 . . . . 0.0 109.758 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 4.9 mp -132.88 -170.62 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.053 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.473 ' N ' HD22 ' A' ' 56' ' ' LEU . 39.2 m-80 -43.44 161.3 0.2 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 110.456 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.42 -31.75 51.24 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.099 1.579 . . . . 0.0 110.838 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -113.3 70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 9.1 mt -62.85 -168.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 110.984 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 168.18 -175.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.62 0.724 . . . . 0.0 110.031 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.556 ' HA ' ' CD2' ' A' ' 61' ' ' LEU . 74.4 mt-30 -65.54 -32.44 74.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.06 -30.37 63.66 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 110.29 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.431 ' HG3' ' HA ' ' A' ' 56' ' ' LEU . 15.2 mm100 -73.84 -46.12 47.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 58' ' ' GLN . 3.7 pp -68.0 -34.98 77.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 109.267 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.67 -35.6 55.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.656 ' O ' HG12 ' A' ' 67' ' ' ILE . 15.2 mt -70.92 -50.83 30.52 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.005 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.519 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 28.3 mm-40 -65.0 -41.84 95.02 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.37 -1.456 . . . . 0.0 109.397 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.22 -46.33 64.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.896 -1.127 . . . . 0.0 110.326 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 52.9 mm-40 -70.05 -39.75 75.52 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.891 -1.131 . . . . 0.0 110.106 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 63' ' ' LEU . 18.9 mm -77.54 -41.55 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.319 -0.863 . . . . 0.0 111.562 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CG2' ' OE1' ' A' ' 25' ' ' GLU . 24.0 mt -70.74 -49.7 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.53 -1.356 . . . . 0.0 110.047 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.556 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 2.7 mt-30 -58.74 -34.09 70.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.243 -0.91 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' NH1' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -56.49 -47.63 78.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.84 -1.162 . . . . 0.0 109.868 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -71.93 -48.46 45.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 110.654 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 93.1 mt -58.2 -43.9 87.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 111.472 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.556 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.08 -44.26 69.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.163 -0.96 . . . . 0.0 109.468 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -59.67 -37.07 77.76 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.588 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -75.14 -26.18 58.97 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.644 -0.66 . . . . 0.0 110.117 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 14' ' ' MET . . . 109.92 -0.51 30.19 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -90.62 127.58 36.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.253 -1.145 . . . . 0.0 110.13 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.31 147.65 44.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 110.596 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 3.6 t -86.31 125.81 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -9.82 59.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.357 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.499 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -133.58 150.0 51.63 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.615 -0.678 . . . . 0.0 110.776 -179.022 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.856 178.497 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 121.512 0.672 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 2.9 mm? -103.47 126.19 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.395 -0.815 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CE2' ' OD1' ' A' ' 49' ' ' ASN . 1.6 t90 -124.15 130.94 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.178 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -126.24 134.87 51.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.208 -0.932 . . . . 0.0 110.744 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.507 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 54.8 tt0 -123.02 159.05 29.2 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 5.2 m -138.56 -176.74 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 110.643 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 5.0 tt0 -140.72 54.28 1.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 110.249 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.545 ' CB ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -130.43 161.17 62.2 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.168 -0.958 . . . . 0.0 110.347 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' O ' HG22 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -75.44 -178.42 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.934 1.492 . . . . 0.0 113.009 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.545 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -67.6 -24.6 65.5 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.409 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -59.72 -45.53 91.87 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.718 -0.614 . . . . 0.0 111.5 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.545 ' HD2' ' CB ' ' A' ' 14' ' ' MET . 1.1 ptp180 -89.71 -10.22 46.54 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 111.466 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.546 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 18.2 t -45.16 -36.16 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.115 -0.991 . . . . 0.0 110.42 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -51.53 -26.86 9.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.598 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 33.0 t0 -58.84 -45.76 89.29 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.498 -0.751 . . . . 0.0 110.046 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 1.3 mp -57.92 -41.52 82.9 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.41 63.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.15 -0.969 . . . . 0.0 109.587 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -60.73 -46.77 89.14 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 2.7 tm-20 -60.98 -48.89 79.75 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 109.946 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.527 HD23 ' CG2' ' A' ' 35' ' ' VAL . 41.4 mt -54.28 -37.57 64.9 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.357 0.599 . . . . 0.0 110.268 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.063 -1.023 . . . . 0.0 110.357 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.608 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 7.7 mt -59.49 -44.77 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 121.013 -1.054 . . . . 0.0 110.374 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.525 ' NH2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -80.72 65.46 5.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -53.95 -24.54 16.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.815 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -57.99 -13.12 4.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 110.16 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 1.8 p -78.54 126.65 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.147 -0.971 . . . . 0.0 110.1 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HG2' ' HB2' ' A' ' 34' ' ' ARG . 26.9 ttt180 -79.69 -44.95 19.89 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -151.71 122.97 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.733 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 ' CG2' HD23 ' A' ' 26' ' ' LEU . 11.5 p -132.6 136.02 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.2 122.63 20.7 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.104 -0.997 . . . . 0.0 110.688 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 48' ' ' VAL . 60.0 t -114.38 130.55 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 0.0 110.149 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.87 146.22 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.538 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.41 154.17 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.556 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -74.17 -170.22 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.3 p -103.31 -2.05 27.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 110.994 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -144.84 -67.15 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.0 110.616 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.0 Cg_endo -72.56 -168.29 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.353 1.186 . . . . 0.0 110.705 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -108.02 35.32 5.06 Favored Glycine 0 N--CA 1.479 1.5 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.472 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 4.3 mtp-105 -93.54 134.87 35.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.54 -0.977 . . . . 0.0 110.139 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.583 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 9.5 m-85 -119.31 154.3 33.74 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.876 0.846 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -103.93 99.04 8.79 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 37' ' ' VAL . 47.0 t -79.15 124.41 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.773 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 71.4 m-80 -131.29 100.92 5.35 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.584 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -119.19 138.91 48.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.515 -0.74 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 52' ' ' LEU . 4.0 p -96.59 151.14 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 109.324 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.528 ' N ' HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -114.11 173.91 6.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 111.503 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 65.2 m-80 -58.45 167.11 1.87 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.67 -0.644 . . . . 0.0 109.693 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.67 -15.17 44.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.6 1.316 . . . . 0.0 110.78 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -125.93 66.15 1.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.063 -1.023 . . . . 0.0 110.148 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.46 177.23 6.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.962 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 6.0 t70 -177.08 171.89 2.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.977 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -60.23 -33.23 71.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.597 -0.69 . . . . 0.0 110.037 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -65.04 -45.01 87.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 8.5 mm-40 -64.46 -44.32 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.855 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.524 ' CD2' ' OE1' ' A' ' 64' ' ' GLU . 74.3 mt -64.82 -37.32 87.22 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.729 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.46 55.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.864 -1.148 . . . . 0.0 108.065 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.531 ' O ' ' CG1' ' A' ' 67' ' ' ILE 0.256 0.1 OUTLIER -70.49 -51.28 30.03 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.666 0.746 . . . . 0.0 108.987 178.564 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' OE1' ' CD2' ' A' ' 61' ' ' LEU . 3.7 pt-20 -66.94 -43.16 83.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.316 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.38 -41.45 93.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.327 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -34.71 73.71 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.608 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -75.25 -50.41 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.569 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 17.8 mt -59.71 -46.71 93.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 43.5 mt-30 -61.04 -47.28 87.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 109.749 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.68 -47.22 85.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 0.0 110.772 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB2' ' CG ' ' A' ' 25' ' ' GLU . . . -69.91 -48.81 57.14 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.975 -1.078 . . . . 0.0 110.307 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.49 HD21 ' CB ' ' A' ' 77' ' ' ALA . 44.4 mt -64.06 -35.07 79.54 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.38 -0.825 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 2.1 mm-40 -69.37 -45.24 69.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.53 -0.731 . . . . 0.0 109.176 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -62.6 -39.19 92.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.598 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.23 -37.34 61.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.267 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 115.52 20.8 5.32 Favored Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.49 ' CB ' HD21 ' A' ' 72' ' ' LEU . . . -95.22 123.4 38.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.241 . . . . 0.0 110.123 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.12 134.11 55.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.524 HG22 ' CE2' ' A' ' 10' ' ' TYR . 2.2 t -89.73 123.13 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.41 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -81.78 -10.75 59.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.61 140.6 52.0 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.425 -0.797 . . . . 0.0 110.9 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 109.939 178.59 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.486 0.66 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.08 132.44 50.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.447 -0.783 . . . . 0.0 110.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -124.12 118.37 26.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.956 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.442 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 25.6 m-85 -126.93 134.66 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.493 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 45' ' ' ARG . 3.7 tt0 -117.44 158.29 24.74 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.472 HG23 ' HA ' ' A' ' 45' ' ' ARG . 17.2 m -134.29 -177.43 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.97 -1.081 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -134.51 51.07 2.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.501 ' SD ' ' CB ' ' A' ' 18' ' ' ARG . 1.5 ptp -130.22 152.74 80.66 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.423 -0.798 . . . . 0.0 109.74 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -70.73 -165.69 0.19 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.755 1.397 . . . . 0.0 113.202 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.53 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 19.6 tt0 -52.1 -24.83 7.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.865 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.453 ' O ' ' OH ' ' A' ' 75' ' ' TYR . 12.0 t70 -56.78 -23.76 45.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.044 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' CZ ' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -70.04 -14.1 62.53 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.386 -0.821 . . . . 0.0 110.83 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 16' ' ' GLU . 98.0 t -51.82 -48.79 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.144 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.553 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -59.24 -30.9 68.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.812 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.587 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 27.1 t0 -68.21 -54.91 14.45 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 22' ' ' LEU . 4.5 mm? -62.63 -36.88 84.2 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.967 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -62.73 -52.41 63.34 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.619 -0.676 . . . . 0.0 109.851 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.8 tpp85 -69.84 -41.4 74.94 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.007 -1.058 . . . . 0.0 109.447 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -56.29 -48.82 75.88 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.525 -0.734 . . . . 0.0 110.6 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -66.52 -37.04 84.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 110.411 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.45 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.28 -40.15 93.07 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.174 -0.954 . . . . 0.0 110.903 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.521 ' CG2' HG23 ' A' ' 67' ' ' ILE . 87.1 mt -61.13 -44.13 97.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.002 -1.061 . . . . 0.0 110.994 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 26' ' ' LEU . 13.7 ptt180 -84.88 68.39 10.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.803 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -56.05 -27.3 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 109.875 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -59.09 -14.1 8.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.538 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -80.13 128.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.948 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -79.32 -45.69 19.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 111.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.71 123.8 7.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.607 -1.308 . . . . 0.0 111.915 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.482 ' HB ' HG13 ' A' ' 50' ' ' ILE . 5.9 p -126.0 133.98 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.549 -0.719 . . . . 0.0 109.358 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.3 mtp -128.74 114.84 17.1 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.933 -1.104 . . . . 0.0 110.84 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.51 131.63 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.545 HG22 ' CG ' ' A' ' 47' ' ' GLU . 3.5 m -119.79 152.9 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -83.82 153.65 23.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.87 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -166.47 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.365 -0.834 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -104.94 0.27 27.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 0.0 111.161 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.539 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.4 m -148.83 -65.88 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.865 -1.147 . . . . 0.0 110.801 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 47.2 Cg_endo -71.72 -169.13 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.214 1.113 . . . . 0.0 110.577 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -108.74 32.17 7.16 Favored Glycine 0 N--CA 1.477 1.371 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.526 ' C ' ' CD1' ' A' ' 46' ' ' TYR . 6.2 ptm180 -93.9 160.43 14.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.923 -1.34 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.583 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 35.1 m-85 -138.28 155.44 48.6 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.888 0.851 . . . . 0.0 111.059 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.545 ' CG ' HG22 ' A' ' 38' ' ' VAL . 2.9 pt-20 -100.71 96.07 7.08 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.1 t -78.15 116.47 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 111.484 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -131.58 100.74 5.24 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.538 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -123.69 140.25 47.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.591 -0.693 . . . . 0.0 110.603 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.47 ' O ' HD12 ' A' ' 50' ' ' ILE . 5.3 p -100.13 144.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.882 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.555 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -122.87 -166.54 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 110.9 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 52' ' ' LEU . 40.3 m-80 -39.46 159.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.725 -0.609 . . . . 0.0 110.774 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.17 -15.52 50.63 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.126 1.593 . . . . 0.0 111.289 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -140.11 73.11 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.813 -1.179 . . . . 0.0 111.162 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.555 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 13.0 mt -66.32 -164.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.853 -1.155 . . . . 0.0 110.354 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.9 t70 177.92 172.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.522 -0.736 . . . . 0.0 109.721 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.412 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.4 mm-40 -62.58 -34.89 77.88 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -71.29 -28.78 64.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.341 -0.85 . . . . 0.0 110.575 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -73.82 -39.99 63.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.065 -1.022 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 35.2 mt -66.32 -37.07 84.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.112 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.62 -38.07 59.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.541 ' O ' ' CG1' ' A' ' 67' ' ' ILE 0.259 0.2 OUTLIER -71.93 -51.42 22.2 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.893 0.854 . . . . 0.0 108.81 178.013 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 60.7 mm-40 -61.9 -38.5 88.59 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 -47.22 78.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.207 -0.933 . . . . 0.0 111.308 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 6.3 pt-20 -62.88 -27.21 69.2 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 120.573 -1.329 . . . . 0.0 109.261 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.541 ' CG1' ' O ' ' A' ' 63' ' ' LEU . 2.8 mm -76.81 -55.77 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.627 -0.67 . . . . 0.0 110.061 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 8.8 mt -62.27 -42.69 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.339 -0.85 . . . . 0.0 109.891 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 38.2 mm-40 -63.12 -40.82 98.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -57.97 -47.3 83.37 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.237 -0.914 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.69 -48.45 59.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.147 -0.971 . . . . 0.0 109.81 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.517 ' CD1' HG21 ' A' ' 68' ' ' ILE . 83.1 mt -64.01 -36.19 83.16 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.458 -0.776 . . . . 0.0 110.108 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 6.7 mm-40 -70.49 -45.89 64.8 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.552 -0.717 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -61.82 -38.71 89.17 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.587 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -75.65 -17.9 59.83 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.92 51.9 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -87.63 129.2 35.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.147 -1.208 . . . . 0.0 110.055 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 119.6 34.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 110.342 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.7 t -77.19 120.77 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 109.932 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.19 -8.79 59.66 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -130.0 134.27 47.31 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.402 -0.811 . . . . 0.0 110.482 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.464 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 120.812 -1.18 . . . . 0.0 110.651 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 121.26 0.552 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 1.7 mm? -84.67 138.99 32.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.237 -0.915 . . . . 0.0 109.915 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.424 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -108.75 118.96 38.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 0.0 110.585 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.447 ' HB2' ' HB ' ' A' ' 48' ' ' VAL . 28.6 m-85 -127.23 115.45 19.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.161 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 3.1 tt0 -95.35 160.37 14.57 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.183 -0.948 . . . . 0.0 110.402 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 30.7 m -130.41 179.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.517 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -135.55 53.0 1.98 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.414 -0.804 . . . . 0.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.519 ' SD ' ' CB ' ' A' ' 77' ' ' ALA . 4.2 ptt? -133.33 153.32 80.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.91 -163.96 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.13 1.595 . . . . 0.0 112.417 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.512 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 3.9 tm-20 -50.27 -26.75 5.09 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.98 -17.33 16.53 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.772 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.512 ' CB ' ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -63.76 -13.85 47.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 16' ' ' GLU . 93.3 t -53.1 -42.92 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.48 -0.763 . . . . 0.0 110.239 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.45 -34.98 76.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.946 . . . . 0.0 109.826 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.618 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 9.2 t0 -70.71 -54.43 11.82 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.2 mm? -64.17 -36.25 83.45 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 19' ' ' VAL . . . -60.5 -52.75 63.86 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.356 -0.84 . . . . 0.0 109.286 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' ILE . 5.6 mtt180 -70.08 -46.71 64.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 2.7 tm-20 -56.33 -45.73 80.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.808 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' CG ' ' O ' ' A' ' 22' ' ' LEU . 74.1 mt -62.81 -38.65 91.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.862 . . . . 0.0 110.302 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -45.66 93.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.532 ' CG2' HG22 ' A' ' 67' ' ' ILE . 13.4 mt -65.18 -42.96 95.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.526 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 0.7 OUTLIER -70.43 55.22 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 110.67 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 15.4 p-10 -72.14 -30.07 64.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -61.24 -12.9 14.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.59 -0.694 . . . . 0.0 109.978 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.598 ' CG2' ' CG2' ' A' ' 50' ' ' ILE . 3.9 p -79.09 137.55 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.361 -0.837 . . . . 0.0 110.437 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -42.68 25.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 110.813 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -148.06 122.71 9.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.043 -1.035 . . . . 0.0 111.06 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.628 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 22.5 m -117.67 135.16 58.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.328 -0.858 . . . . 0.0 110.423 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.66 116.12 10.09 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t -111.27 131.92 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.38 152.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.558 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.03 154.6 21.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.195 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -73.19 172.77 10.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.74 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 t -89.73 1.08 56.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.937 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.564 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.67 -64.61 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.028 -1.045 . . . . 0.0 110.48 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.9 Cg_endo -70.84 -159.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.532 1.28 . . . . 0.0 110.77 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.16 36.53 4.16 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 5.7 mtt180 -93.13 135.19 34.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.53 -0.982 . . . . 0.0 110.397 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 25.5 m-85 -119.76 154.86 33.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.353 -0.842 . . . . 0.0 110.397 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -102.99 116.53 32.71 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -94.47 112.21 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 110.515 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.481 ' O ' HD13 ' A' ' 50' ' ' ILE . 64.3 m-80 -131.04 100.7 5.32 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 35' ' ' VAL . 1.1 mp -115.28 140.04 38.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 121.738 0.78 . . . . 0.0 111.24 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.61 149.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 53' ' ' ASN . 6.3 mt -118.7 -170.23 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.627 -1.296 . . . . 0.0 112.062 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.6 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.8 m120 -42.34 170.74 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.635 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 36.3 Cg_endo -59.66 -12.72 18.73 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.648 1.341 . . . . 0.0 111.04 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -142.11 87.43 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.087 . . . . 0.0 110.436 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -60.74 -178.09 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.744 -1.222 . . . . 0.0 109.942 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 12.4 t70 -175.24 171.67 2.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.047 . . . . 0.0 110.764 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.432 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 65.8 mt-30 -61.71 -40.55 95.42 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.549 -0.719 . . . . 0.0 110.514 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -29.57 68.81 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.222 -0.924 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.52 -45.11 69.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 110.158 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 0.5 OUTLIER -66.19 -34.37 77.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.98 -38.8 62.55 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 67' ' ' ILE . 40.9 mt -71.64 -51.01 25.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 29' ' ' ARG . 3.5 mt-10 -60.06 -40.9 91.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.887 -1.133 . . . . 0.0 110.061 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -72.66 -46.46 53.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.045 -1.034 . . . . 0.0 109.634 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 6.8 mm-40 -69.58 -38.86 77.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 110.016 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 63' ' ' LEU . 16.0 mm -76.43 -38.17 31.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.296 -0.878 . . . . 0.0 111.257 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 57.7 mt -69.53 -48.28 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.778 -1.201 . . . . 0.0 110.053 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 4.9 pt20 -61.52 -38.86 88.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.184 -0.948 . . . . 0.0 110.02 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.485 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.17 -45.98 86.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.14 -0.975 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . . . -69.92 -48.3 59.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.081 -1.012 . . . . 0.0 110.836 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.483 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 79.2 mt -58.76 -43.03 90.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.267 -0.896 . . . . 0.0 110.661 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.44 -45.4 62.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 0.0 109.622 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 62.8 m-20 -62.61 -36.89 84.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.35 -35.29 58.78 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.312 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.29 18.28 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . . . -109.66 136.87 48.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.29 . . . . 0.0 110.224 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.434 ' NH1' ' HG2' ' A' ' 73' ' ' GLU . 2.1 tpt180 -119.69 133.53 55.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 110.326 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 4.6 t -75.73 124.87 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.011 -1.055 . . . . 0.0 109.533 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.76 -8.0 59.62 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.73 156.31 47.27 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.501 -0.749 . . . . 0.0 111.608 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 7.1 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.437 -0.789 . . . . 0.0 109.416 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.511 ' C ' ' CD2' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.24 0.543 . . . . 0.0 110.029 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.511 ' CD2' ' C ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -138.41 131.86 30.5 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.344 -0.847 . . . . 0.0 109.78 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.505 ' HB3' ' NZ ' ' A' ' 81' ' ' LYS . 1.2 t90 -126.81 127.44 45.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.479 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 28.9 m-85 -126.24 115.08 19.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.537 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 4.4 tt0 -107.5 149.23 28.2 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.544 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.6 m -126.75 -176.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 111.026 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 1.9 tt0 -146.72 59.91 1.2 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.343 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.516 ' HB2' ' HB2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.75 148.69 66.04 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 37.3 Cg_endo -71.78 -165.82 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.135 1.597 . . . . 0.0 113.573 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -62.98 -23.06 67.26 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.039 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.69 -48.15 67.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.738 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 14' ' ' MET . 0.5 OUTLIER -90.86 -14.22 32.2 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.116 -0.99 . . . . 0.0 111.219 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 16' ' ' GLU . 14.5 p -45.88 -37.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.261 -0.899 . . . . 0.0 109.784 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.459 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 62.1 m-80 -53.32 -28.31 27.78 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.474 -0.767 . . . . 0.0 109.304 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 28.7 t0 -58.36 -32.5 68.61 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.545 -0.722 . . . . 0.0 110.129 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.3 mm? -59.0 -37.32 76.6 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.17 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -58.54 -51.22 70.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.28 -46.95 65.97 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.18 -0.95 . . . . 0.0 110.089 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -56.32 -48.38 76.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -67.22 -37.22 83.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.854 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.36 -38.78 78.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.737 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.526 HG21 ' CG2' ' A' ' 67' ' ' ILE . 9.5 mt -59.06 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.148 -0.97 . . . . 0.0 110.703 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 13.1 ptm180 -74.4 56.53 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.12 -25.47 62.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.0 110.296 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -58.66 -17.18 20.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.545 ' CG2' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.88 162.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -0.824 . . . . 0.0 109.965 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -44.18 22.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.976 . . . . 0.0 111.945 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.82 146.58 26.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.741 -1.224 . . . . 0.0 111.655 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.643 ' HA ' HG13 ' A' ' 50' ' ' ILE . 6.9 t -132.32 127.48 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 tpt -140.41 115.55 9.83 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.488 -0.758 . . . . 0.0 109.69 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 88.9 t -114.81 131.9 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.0 110.981 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 7.8 m -101.97 140.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 110.035 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -81.46 153.07 27.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -74.19 152.73 39.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.848 . . . . 0.0 110.014 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.2 p -75.34 -11.56 60.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -0.926 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -141.41 -67.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.117 -0.99 . . . . 0.0 110.496 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.3 Cg_endo -70.68 -176.11 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.323 1.17 . . . . 0.0 110.562 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 33.29 6.65 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.9 mtt180 -93.2 135.44 34.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.008 . . . . 0.0 110.021 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.58 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 30.0 m-85 -117.93 154.93 31.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.296 -0.878 . . . . 0.0 110.568 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 33.9 mt-10 -103.5 95.08 5.83 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.748 -0.595 . . . . 0.0 109.683 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 10' ' ' TYR . 89.4 t -78.77 115.13 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.461 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 70.7 m-80 -131.65 102.0 5.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.643 HG13 ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -111.82 142.26 24.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.749 0.785 . . . . 0.0 110.691 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -92.32 133.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.415 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 56' ' ' LEU . 30.5 mt -90.04 174.37 7.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 0.0 110.549 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 2.1 m120 -62.24 -153.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.74 -35.4 28.16 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 CA-C-N 119.122 0.722 . . . . 0.0 111.439 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 55' ' ' ASN . 8.1 t30 -162.87 76.25 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.802 -1.186 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD1' ' OD1' ' A' ' 53' ' ' ASN . 16.8 mt -74.7 -161.04 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 110.419 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 11.1 t0 -171.92 -164.09 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.496 -0.752 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -64.77 -32.87 74.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.557 -0.715 . . . . 0.0 111.177 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -35.06 78.74 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.4 mm-40 -73.72 -42.9 60.54 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.414 -0.804 . . . . 0.0 109.954 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 1.2 mt -64.87 -34.46 78.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.39 -33.65 44.48 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.555 ' O ' HG13 ' A' ' 67' ' ' ILE . 18.3 mt -64.38 -51.05 65.23 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.461 -0.895 . . . . 0.0 108.618 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 2.5 mt-10 -72.19 -43.09 65.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.232 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -62.51 -34.86 77.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.533 -0.729 . . . . 0.0 110.443 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 32.0 mm-40 -65.7 -48.9 70.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.826 -1.171 . . . . 0.0 109.687 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 63' ' ' LEU . 4.3 mt -78.98 -41.17 23.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.493 -0.754 . . . . 0.0 111.155 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 40.9 mt -59.01 -49.5 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.049 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.8 mt-30 -58.61 -48.91 79.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.393 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -66.15 -47.21 74.79 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 110.877 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 67' ' ' ILE . . . -65.01 -48.25 74.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.907 -1.121 . . . . 0.0 110.182 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.435 HD22 ' HB1' ' A' ' 77' ' ' ALA . 32.8 mt -65.57 -35.33 80.52 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 110.026 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 1.0 OUTLIER -70.34 -45.31 66.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.44 -0.788 . . . . 0.0 109.487 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -63.16 -36.31 83.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.57 -38.9 62.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.562 -0.712 . . . . 0.0 110.604 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.3 21.65 5.12 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 72' ' ' LEU . . . -102.13 123.76 46.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -1.221 . . . . 0.0 109.797 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -119.77 122.41 41.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 110.581 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 2.3 t -81.34 128.99 38.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.079 -1.013 . . . . 0.0 109.59 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.34 -17.68 48.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 108.467 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 9' ' ' TRP 0.255 0.0 OUTLIER -128.78 129.42 45.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.806 -0.559 . . . . 0.0 110.171 -179.533 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.489 1.51 0 O-C-N 120.677 -1.264 . . . . 0.0 110.692 179.335 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.485 ' O ' HD23 ' A' ' 8' ' ' LEU . 26.2 t80 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.11 0.481 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -141.93 124.75 16.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.767 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -127.77 119.86 26.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.118 -0.989 . . . . 0.0 109.972 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.506 ' O ' ' CG2' ' A' ' 48' ' ' VAL . 76.9 m-85 -126.54 137.79 53.4 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.152 -0.968 . . . . 0.0 111.104 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.549 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 1.2 tp60 -120.43 160.66 22.65 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.348 -0.845 . . . . 0.0 109.228 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 21.0 m -130.57 -178.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.03 -1.044 . . . . 0.0 110.687 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.39 57.17 1.59 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.638 -0.664 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.555 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -135.35 155.28 78.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.42 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 37.2 Cg_endo -73.0 -167.79 0.37 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.925 1.487 . . . . 0.0 113.05 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.555 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 15.3 tt0 -66.09 -25.53 67.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.038 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 13.3 t0 -59.87 -40.71 89.55 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.364 0.602 . . . . 0.0 111.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.555 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.1 OUTLIER -88.95 -14.56 36.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.271 -0.893 . . . . 0.0 110.125 -179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.566 ' CG2' ' OH ' ' A' ' 46' ' ' TYR . 15.1 t -47.19 -37.47 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -29.36 22.05 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.589 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 33.1 t0 -59.87 -39.57 85.71 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.481 -0.762 . . . . 0.0 109.199 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.4 mm? -58.94 -42.75 90.54 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.92 -51.77 66.45 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -46.68 78.69 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.575 -0.703 . . . . 0.0 109.257 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.4 -48.53 76.72 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.43 -0.794 . . . . 0.0 109.306 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' ' CG2' ' A' ' 35' ' ' VAL . 89.4 mt -60.33 -39.53 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -70.24 -38.64 75.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.528 -0.732 . . . . 0.0 109.274 179.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.474 HG22 HG23 ' A' ' 67' ' ' ILE . 1.2 mm -58.96 -37.77 69.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.827 0.822 . . . . 0.0 108.855 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.533 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 10.5 mtp180 -69.68 64.05 0.19 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.75 -0.594 . . . . 0.0 110.228 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -37.52 70.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.32 -14.01 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 110.021 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -79.93 138.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.374 -0.829 . . . . 0.0 110.384 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.432 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.7 mmt-85 -79.25 -45.49 19.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.068 -1.02 . . . . 0.0 110.913 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.63 123.15 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.204 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.48 ' CG2' ' CD2' ' A' ' 26' ' ' LEU . 2.8 p -130.12 133.61 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.517 -0.74 . . . . 0.0 109.605 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -128.04 118.25 23.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.124 -0.985 . . . . 0.0 110.75 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.52 ' CG1' HG12 ' A' ' 48' ' ' VAL . 19.4 t -115.06 131.98 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.616 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 47' ' ' GLU . 4.1 m -121.28 159.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HA ' ' CE2' ' A' ' 46' ' ' TYR . . . -84.59 154.17 22.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.401 -0.812 . . . . 0.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.36 176.74 5.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.292 -0.88 . . . . 0.0 109.57 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.4 p -93.34 -3.98 52.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 110.73 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -148.02 -67.77 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.023 -1.048 . . . . 0.0 110.467 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 49.7 Cg_endo -72.53 -168.94 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.303 1.159 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.8 32.88 6.84 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.0 mtt180 -94.26 134.88 36.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -1.068 . . . . 0.0 109.323 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' A' ' 39' ' ' ALA . 7.8 m-85 -116.81 150.18 38.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.871 -1.143 . . . . 0.0 111.427 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.483 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -106.41 90.53 3.37 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.166 178.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.52 HG12 ' CG1' ' A' ' 37' ' ' VAL . 22.0 m -82.42 125.28 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.549 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -122.51 101.62 7.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.584 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -111.96 142.38 24.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 121.561 0.696 . . . . 0.0 111.437 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' HG11 ' A' ' 51' ' ' VAL . 7.3 p -108.61 119.94 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.685 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 53' ' ' ASN . 4.6 mt -86.81 177.21 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.967 . . . . 0.0 110.581 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.2 m-80 -42.96 167.19 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.9 Cg_endo -63.84 -15.0 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.673 1.354 . . . . 0.0 110.24 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 24.2 t-20 -133.28 63.54 1.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.893 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.539 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 3.1 pp -61.78 176.55 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.041 -1.037 . . . . 0.0 110.414 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' O ' HD13 ' A' ' 61' ' ' LEU . 2.5 m-20 -168.29 178.31 4.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 110.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.73 -36.32 83.25 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.537 -0.727 . . . . 0.0 110.461 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 t -69.29 -30.6 68.71 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.255 -0.903 . . . . 0.0 110.3 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -73.12 -45.91 54.22 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' A' ' 8' ' ' LEU . 1.6 mp -66.86 -36.14 81.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 109.366 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.45 -33.87 55.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.542 ' O ' HG13 ' A' ' 67' ' ' ILE . 13.7 mt -69.46 -50.38 46.13 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.248 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HB3' HD12 ' A' ' 68' ' ' ILE . 4.4 mm-40 -71.53 -42.75 67.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -65.55 -30.84 71.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.186 -0.946 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 2.0 mm-40 -69.43 -48.92 59.45 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.865 -1.147 . . . . 0.0 110.355 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 63' ' ' LEU . 4.7 mt -78.6 -38.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.302 -0.873 . . . . 0.0 111.063 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.456 HD11 ' HE3' ' A' ' 65' ' ' LYS . 53.4 mt -60.37 -48.95 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.993 -1.067 . . . . 0.0 110.391 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 1.6 pp0? -63.55 -41.63 98.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.0 109.809 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.55 -46.52 66.25 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.37 -0.832 . . . . 0.0 110.388 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.88 83.39 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.08 -1.013 . . . . 0.0 109.777 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.452 HD21 ' OD2' ' A' ' 21' ' ' ASP . 97.3 mt -65.5 -35.46 80.95 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.8 OUTLIER -67.0 -45.27 78.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.457 -0.777 . . . . 0.0 109.005 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -61.12 -36.55 80.03 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -74.88 -41.87 58.94 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.74 -0.6 . . . . 0.0 110.327 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.45 23.35 4.47 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.54 125.23 54.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.262 -1.14 . . . . 0.0 109.762 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.47 148.91 42.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 110.757 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 1.9 t -95.79 114.59 32.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 108.773 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -82.07 -5.47 58.42 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.774 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.549 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -138.41 150.32 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.274 -0.891 . . . . 0.0 111.736 -178.354 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 178.355 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 4.4 p90 . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 121.164 0.507 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.599 HD13 ' CD2' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -119.52 125.06 47.95 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.227 -0.92 . . . . 0.0 111.245 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -126.58 116.55 21.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.529 ' HB2' ' CG2' ' A' ' 48' ' ' VAL . 1.4 m-85 -126.96 139.48 53.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 111.062 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.46 159.86 24.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 26.5 m -133.8 173.97 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.946 -1.096 . . . . 0.0 111.239 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.98 54.25 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.736 -0.603 . . . . 0.0 109.961 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.51 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 50.3 mmm -129.83 156.74 78.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.64 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.85 -167.02 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.825 1.434 . . . . 0.0 113.124 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -63.79 -28.38 69.83 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.407 -1.269 . . . . 0.0 107.796 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -18.6 40.59 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.539 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.578 ' NH1' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -87.57 -23.71 24.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.593 -0.692 . . . . 0.0 110.095 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.466 ' N ' ' HG3' ' A' ' 18' ' ' ARG . 77.3 t -48.3 -42.71 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.469 -0.77 . . . . 0.0 110.309 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -58.92 -29.97 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.15 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.507 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.7 t0 -61.71 -50.84 70.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.144 -0.972 . . . . 0.0 109.964 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.533 HD12 ' NH1' ' A' ' 18' ' ' ARG . 8.3 mp -59.89 -43.11 94.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.666 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.5 79.64 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.229 -0.92 . . . . 0.0 109.656 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -68.73 -46.42 68.95 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.393 -0.817 . . . . 0.0 109.266 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' OE1' ' CB ' ' A' ' 71' ' ' ALA . 9.7 tp10 -60.38 -47.64 85.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.418 -0.801 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 ' CG ' ' O ' ' A' ' 22' ' ' LEU . 29.6 mt -53.08 -38.66 62.73 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.579 0.704 . . . . 0.0 109.512 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 4.4 tpt180 -64.11 -34.5 78.18 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 110.549 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.519 ' CG2' HG23 ' A' ' 67' ' ' ILE . 5.4 mt -62.12 -44.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.898 -1.126 . . . . 0.0 109.808 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 26' ' ' LEU . 11.6 mtp180 -70.05 76.45 0.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.697 -0.627 . . . . 0.0 110.311 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.62 -36.61 84.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.251 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -61.75 -12.89 18.98 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.977 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.622 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -79.03 123.73 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.719 . . . . 0.0 110.141 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -47.32 15.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 112.186 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.539 ' CG ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -153.55 139.18 17.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.562 -1.336 . . . . 0.0 110.851 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 13.3 p -135.63 135.85 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.455 -0.778 . . . . 0.0 110.002 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.488 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 42.0 mtp -117.44 115.48 25.28 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.227 -0.921 . . . . 0.0 109.846 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG12 ' CD2' ' A' ' 22' ' ' LEU . 95.9 t -114.67 128.55 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 110.572 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.09 134.41 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.14 153.72 23.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.534 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.452 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.1 m -73.86 150.64 40.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.885 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.2 p -76.5 3.0 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.589 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -148.99 -66.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -72.37 178.59 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.366 1.193 . . . . 0.0 110.541 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -101.31 33.01 6.82 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 4.8 mtt180 -93.78 134.74 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.439 -1.036 . . . . 0.0 110.275 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 34.4 m-85 -120.56 151.51 39.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -106.51 99.03 8.63 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.911 -0.493 . . . . 0.0 110.186 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 16.9 m -86.53 122.17 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.01 -1.056 . . . . 0.0 110.686 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 36' ' ' MET . 2.4 p30 -131.16 102.71 6.12 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.622 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.19 140.76 30.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 O-C-N 121.433 -0.792 . . . . 0.0 111.552 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.618 ' N ' HD11 ' A' ' 50' ' ' ILE . 7.4 p -114.87 150.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.572 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.3 mp -139.48 -157.41 0.76 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.769 -1.207 . . . . 0.0 111.928 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 52' ' ' LEU . 27.6 m-80 -37.86 161.47 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.561 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -64.67 -17.4 59.4 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.012 1.533 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -146.78 79.78 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.764 -1.21 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 16.2 mt -67.64 -164.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 110.586 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 3.3 t70 -177.08 171.6 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 110.68 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.1 mt-30 -54.63 -35.53 63.56 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.573 -0.704 . . . . 0.0 110.433 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 m -67.85 -40.6 83.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.177 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -70.77 -44.56 66.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.321 -0.862 . . . . 0.0 109.989 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.5 mm? -66.44 -34.83 78.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.91 -35.3 45.07 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.3 mt -72.12 -49.67 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.215 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 8.2 mt-10 -67.31 -35.88 80.34 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.533 -1.354 . . . . 0.0 109.915 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.24 -45.27 56.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 75.2 mt-10 -70.2 -38.5 75.34 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.096 -1.002 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 63' ' ' LEU . 43.9 mm -76.9 -38.75 29.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.329 -0.857 . . . . 0.0 111.192 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 62.4 mt -69.39 -46.88 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.884 -1.135 . . . . 0.0 110.125 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 20.0 mt-30 -59.71 -38.8 82.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.901 . . . . 0.0 110.165 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -44.66 91.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.196 -0.94 . . . . 0.0 110.894 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.524 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . . . -68.27 -48.64 64.51 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.997 -1.064 . . . . 0.0 110.522 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' CD2' ' NH1' ' A' ' 18' ' ' ARG . 20.3 mt -58.71 -39.93 82.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.39 -0.819 . . . . 0.0 110.547 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -71.2 -45.56 63.13 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.445 -0.784 . . . . 0.0 109.61 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.3 -38.47 86.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -75.79 -32.13 59.75 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.064 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.418 ' C ' ' HE3' ' A' ' 14' ' ' MET . . . 109.11 17.55 10.04 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HB3' ' NH2' ' A' ' 18' ' ' ARG . . . -102.36 124.36 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.0 110.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -119.0 124.1 46.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 3.8 t -67.6 125.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.983 -1.073 . . . . 0.0 109.884 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -10.28 59.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.499 ' HG2' ' HB2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.69 152.99 52.02 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.315 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.633 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 23.2 t80 . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 121.143 0.497 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.627 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.32 123.25 25.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.314 -1.491 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 1.4 t90 -128.69 118.42 22.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.667 -0.645 . . . . 0.0 109.481 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -127.2 137.45 52.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.018 -1.051 . . . . 0.0 110.995 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.552 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 3.8 tt0 -109.32 160.27 16.29 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.282 -0.886 . . . . 0.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.516 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 15.9 m -129.02 -177.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.923 -1.111 . . . . 0.0 111.024 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 1.2 tp10 -140.22 59.68 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.833 0.825 . . . . 0.0 108.971 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.559 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 4.0 tpt -137.07 146.13 53.28 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.601 -0.687 . . . . 0.0 109.216 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HD2' ' HG3' ' A' ' 14' ' ' MET . 33.2 Cg_endo -65.39 -166.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.651 1.342 . . . . 0.0 113.361 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -62.07 -27.02 68.61 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.272 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.65 -20.86 36.37 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.139 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.618 ' CZ ' ' CG ' ' A' ' 46' ' ' TYR . 4.4 ppt_? -88.41 -12.69 42.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 111.063 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -46.78 -44.52 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.403 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.526 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.6 m-20 -57.19 -30.45 64.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 109.536 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 36.0 t0 -62.95 -46.75 86.27 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.299 -0.875 . . . . 0.0 110.221 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.3 mm? -59.02 -43.02 91.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.08 -48.78 80.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -40.85 84.87 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.529 ' O ' ' CD ' ' A' ' 29' ' ' ARG . 28.6 tt0 -56.37 -49.28 74.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.484 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -69.16 -37.08 78.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.138 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.2 tmm_? -65.66 -37.66 87.13 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.284 -0.885 . . . . 0.0 111.489 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.555 ' CG2' ' N ' ' A' ' 29' ' ' ARG . 3.5 tt -58.61 -45.03 90.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.014 -1.054 . . . . 0.0 111.728 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.555 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -86.36 109.21 18.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.984 -1.073 . . . . 0.0 111.206 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -30.65 62.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.893 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 33.9 p30 -59.21 -13.42 7.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.78 . . . . 0.0 110.386 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.551 ' CG2' HD13 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -78.88 122.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.824 . . . . 0.0 110.485 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -79.76 -45.69 18.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 111.01 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -153.38 139.98 18.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.815 -1.178 . . . . 0.0 110.963 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.516 ' CA ' HG12 ' A' ' 50' ' ' ILE . 7.8 p -137.1 132.21 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 0.0 110.409 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.9 tpt -140.88 113.46 8.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.056 -1.027 . . . . 0.0 110.122 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.542 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 23.3 t -116.92 132.25 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -0.821 . . . . 0.0 110.53 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' ' CD ' ' A' ' 47' ' ' GLU . 32.7 m -105.26 148.83 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.003 -1.06 . . . . 0.0 110.43 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -77.61 154.82 31.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.368 -0.832 . . . . 0.0 110.704 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 p -72.64 -176.68 2.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -101.57 5.71 41.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.086 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -153.11 -66.5 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.4 Cg_endo -72.78 -165.34 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.425 1.224 . . . . 0.0 110.567 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.29 35.4 4.77 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.4 mtt180 -94.04 138.5 32.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.456 -1.026 . . . . 0.0 110.216 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.618 ' CG ' ' CZ ' ' A' ' 18' ' ' ARG . 10.0 m-85 -125.52 154.82 41.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 110.307 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 47' ' ' GLU . 10.0 pt-20 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.435 0.636 . . . . 0.0 109.566 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.494 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 44.6 t -88.04 115.92 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 110.836 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.92 101.33 5.59 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.576 HD11 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -117.87 131.64 70.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.593 -178.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.576 ' N ' HD11 ' A' ' 50' ' ' ILE . 9.8 p -95.55 151.25 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 4.4 mp -138.6 -157.11 0.74 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 110.923 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 52' ' ' LEU . 28.2 m-80 -34.85 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 121.056 0.455 . . . . 0.0 111.115 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.83 -27.94 59.22 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.144 1.602 . . . . 0.0 111.15 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -131.11 81.32 1.98 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 110.161 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.564 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 13.8 mt -74.03 -165.36 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 172.63 -171.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.597 0.713 . . . . 0.0 110.371 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -65.36 -33.13 75.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 110.852 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.9 t -68.27 -34.46 76.23 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.501 ' CB ' HD22 ' A' ' 56' ' ' LEU . 21.5 mm-40 -71.19 -42.13 69.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 110.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD2' ' OE2' ' A' ' 64' ' ' GLU . 9.3 mt -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.07 -36.59 60.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.928 -1.107 . . . . 0.0 108.086 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.7 mt -71.5 -49.87 36.98 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.807 0.813 . . . . 0.0 109.272 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.552 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 8.6 pt-20 -67.1 -39.76 86.78 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.585 -1.322 . . . . 0.0 109.94 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -71.87 -41.51 67.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.864 -1.148 . . . . 0.0 110.488 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.5 mt-10 -75.38 -41.07 57.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.701 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 63' ' ' LEU . 17.9 mm -78.92 -36.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 112.219 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 96.7 mt -70.41 -44.58 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.329 -1.482 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.1 mm100 -55.79 -39.2 70.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -57.61 -48.12 80.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 111.374 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -72.23 -48.77 40.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.971 -1.08 . . . . 0.0 111.578 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 25.1 mt -60.1 -42.71 95.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 111.331 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.17 -43.39 70.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.014 -1.053 . . . . 0.0 109.182 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 34.1 t-20 -59.65 -37.12 77.85 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.579 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -74.49 -29.27 61.36 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.259 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.59 5.28 27.91 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -99.66 118.45 36.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -1.149 . . . . 0.0 110.462 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -118.6 137.18 53.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.647 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.3 t -75.98 119.52 24.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.88 -5.63 59.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.571 -0.706 . . . . 0.0 109.213 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.552 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.69 160.81 35.66 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.282 -0.886 . . . . 0.0 111.591 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.032 178.533 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.494 ' C ' ' CD1' ' A' ' 8' ' ' LEU . 57.6 m-85 . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 121.101 0.477 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.3 mp -135.51 127.86 30.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 110.543 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.482 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -97.14 127.86 43.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.7 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.643 ' CE1' ' CG1' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -127.14 120.62 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 9.4 tt0 -112.35 159.7 18.42 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 10' ' ' TYR . 16.4 m -135.73 178.36 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.073 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -132.45 56.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.547 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.91 152.4 72.14 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 110.595 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.507 ' O ' HG21 ' A' ' 19' ' ' VAL . 36.4 Cg_endo -72.23 -167.67 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.977 1.514 . . . . 0.0 112.809 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 2.4 tt0 -65.52 -25.37 67.42 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.854 178.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.92 -41.46 91.81 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.873 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.62 -16.3 30.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.278 -0.889 . . . . 0.0 110.688 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.528 ' CG2' ' OH ' ' A' ' 46' ' ' TYR . 20.6 t -47.36 -37.75 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.43 -0.794 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -53.59 -29.34 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.553 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 36.5 t0 -59.74 -39.47 84.86 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.399 -0.813 . . . . 0.0 110.338 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.4 mm? -59.07 -41.42 87.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 110.088 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.53 63.75 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' O ' HG13 ' A' ' 28' ' ' ILE . 2.1 ttp180 -68.93 -41.72 77.71 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' HG12 ' A' ' 68' ' ' ILE . 3.9 tt0 -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.196 -0.94 . . . . 0.0 109.946 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 14.1 mt -66.09 -38.63 88.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.772 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.81 -37.47 82.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.179 -0.95 . . . . 0.0 111.176 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.516 ' N ' ' HG3' ' A' ' 27' ' ' ARG . 55.1 mt -61.75 -44.23 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.82 -1.175 . . . . 0.0 110.56 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.515 ' CZ ' HG12 ' A' ' 68' ' ' ILE . 9.4 ptp85 -75.06 59.6 0.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.124 -0.985 . . . . 0.0 110.282 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.49 -25.32 16.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.187 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -58.41 -17.08 17.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.3 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.586 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 4.3 p -80.68 137.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 110.302 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -79.18 -46.05 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.978 . . . . 0.0 110.758 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 50' ' ' ILE . 4.8 tpt180 -152.79 121.96 6.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.832 -1.167 . . . . 0.0 110.987 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 50' ' ' ILE . 3.1 m -109.74 135.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.9 ttp -124.77 116.13 21.82 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.059 -1.026 . . . . 0.0 110.802 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 48' ' ' VAL . 19.4 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.078 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 12.0 m -114.29 135.11 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.659 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.66 154.28 22.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -172.56 1.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -101.53 8.41 41.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.173 -0.954 . . . . 0.0 110.595 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.56 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.74 -63.75 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.978 . . . . 0.0 110.421 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.8 Cg_endo -69.56 -176.51 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.537 1.283 . . . . 0.0 110.845 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.36 32.74 6.9 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 17.5 mtt180 -96.21 143.12 27.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.395 -1.062 . . . . 0.0 109.92 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.588 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 12.1 m-85 -125.51 152.99 44.26 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.05 -1.031 . . . . 0.0 111.529 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.3 mp0 -105.05 92.83 4.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 37' ' ' VAL . 21.7 t -80.69 125.41 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 111.84 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 47' ' ' GLU . 1.5 m-80 -130.31 101.08 5.61 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.586 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.98 146.38 33.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 119.746 -0.781 . . . . 0.0 111.876 -177.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.465 ' O ' HD12 ' A' ' 50' ' ' ILE . 14.3 p -111.79 151.66 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 3.9 mp -118.17 -158.69 0.72 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.515 -1.366 . . . . 0.0 111.83 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' O ' ' O ' ' A' ' 52' ' ' LEU . 47.2 m-80 -37.36 163.52 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.737 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.9 Cg_endo -63.73 -15.95 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.934 1.492 . . . . 0.0 110.759 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.434 ' C ' ' OD1' ' A' ' 55' ' ' ASN . 8.9 t-20 -151.84 90.54 1.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 110.201 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.584 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 10.7 mt -76.83 -173.54 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.822 -1.173 . . . . 0.0 111.81 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.73 179.04 6.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.404 0.621 . . . . 0.0 109.536 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -66.13 -43.17 87.88 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.425 -0.797 . . . . 0.0 111.009 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -65.41 -33.22 75.44 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.284 -0.885 . . . . 0.0 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 11.0 mm-40 -62.28 -38.28 88.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 110.359 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.99 -33.18 71.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.01 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.82 -34.48 40.53 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.1 mt -71.18 -51.8 22.74 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.957 0.884 . . . . 0.0 108.706 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -61.7 -41.39 97.53 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.859 -1.151 . . . . 0.0 109.735 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.522 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -72.72 -46.37 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 110.573 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 72.5 mt-10 -68.85 -37.57 79.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.87 -1.144 . . . . 0.0 109.686 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.635 HG12 ' O ' ' A' ' 63' ' ' LEU . 19.2 mm -77.74 -45.5 28.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 111.84 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.515 HG12 ' CZ ' ' A' ' 29' ' ' ARG . 58.2 mt -70.04 -42.01 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.76 -1.213 . . . . 0.0 110.214 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.9 pt20 -64.37 -40.74 96.43 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 11.2 ttt180 -58.38 -46.16 86.88 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.366 -0.834 . . . . 0.0 110.989 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.87 -48.76 57.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.902 -1.124 . . . . 0.0 110.636 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.599 ' CD1' ' CE2' ' A' ' 10' ' ' TYR . 83.8 mt -63.98 -36.24 83.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.336 -0.852 . . . . 0.0 110.641 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -69.82 -44.88 69.09 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.39 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 70' ' ' ARG . 72.5 m-20 -65.44 -37.04 85.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -75.72 -39.82 56.65 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.485 -0.759 . . . . 0.0 110.459 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.41 29.63 2.67 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.37 130.23 55.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.356 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.34 134.98 54.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.105 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.546 HG22 ' CD2' ' A' ' 10' ' ' TYR . 2.1 t -79.4 122.4 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.831 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.95 -10.98 59.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.63 145.03 50.33 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.537 -0.727 . . . . 0.0 111.023 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.034 179.172 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.445 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -148.88 124.54 10.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.15 -0.969 . . . . 0.0 111.413 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.455 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 1.3 t-105 -114.26 119.67 37.79 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.494 ' CD2' HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -125.09 129.86 51.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.053 -1.029 . . . . 0.0 111.023 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.523 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 14.2 tt0 -122.66 151.15 41.79 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.336 -0.852 . . . . 0.0 109.27 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.686 ' CG2' ' CE2' ' A' ' 46' ' ' TYR . 2.0 m -126.18 -174.98 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' O ' ' SD ' ' A' ' 14' ' ' MET . 4.3 pt-20 -138.78 49.93 1.86 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.286 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.492 ' HE2' ' HD2' ' A' ' 18' ' ' ARG . 30.3 mmm -123.46 155.63 65.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 35.5 Cg_endo -70.52 -172.4 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.045 1.55 . . . . 0.0 112.82 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.03 -27.04 68.84 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.536 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.36 -45.89 87.33 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.54 0.686 . . . . 0.0 109.82 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.492 ' HD2' ' HE2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.81 -33.1 16.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.555 -0.715 . . . . 0.0 110.197 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 15' ' ' PRO . 77.5 t -48.05 -40.56 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -54.88 -28.42 50.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.843 . . . . 0.0 109.019 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.581 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 26.0 t0 -58.92 -35.4 73.03 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.357 0.598 . . . . 0.0 110.609 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.529 ' O ' ' CG ' ' A' ' 26' ' ' LEU . 4.2 mm? -55.87 -41.94 75.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.288 -0.965 . . . . 0.0 108.931 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.76 72.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -68.54 -46.05 70.56 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.365 -0.835 . . . . 0.0 109.511 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.565 ' O ' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -65.0 -33.52 76.26 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.521 -0.737 . . . . 0.0 110.235 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 35' ' ' VAL . 27.2 mt -69.42 -37.14 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 110.783 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.529 ' CD ' ' HA ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -68.09 -35.31 77.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.935 -1.103 . . . . 0.0 112.736 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.565 ' CG2' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -61.41 -35.52 67.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 120.423 -1.423 . . . . 0.0 111.43 -178.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.591 ' NE ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -79.9 61.58 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.751 -1.218 . . . . 0.0 109.873 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.94 -23.08 42.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.451 -0.781 . . . . 0.0 111.494 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -56.62 -28.1 59.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.085 -1.009 . . . . 0.0 111.526 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.591 ' CG1' ' NE ' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -82.36 155.98 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.693 -1.254 . . . . 0.0 110.523 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -47.13 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 112.259 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 50' ' ' ILE . 1.2 ttt180 -154.28 156.95 37.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.65 -1.282 . . . . 0.0 112.149 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.59 ' CG2' ' CD2' ' A' ' 26' ' ' LEU . 9.9 p -141.22 135.82 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.4 117.84 23.77 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -115.16 132.01 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 110.966 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 5.4 m -114.3 126.32 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.185 -0.947 . . . . 0.0 110.0 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -80.65 152.58 28.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.287 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 13.6 p -76.42 -168.27 0.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.523 -0.736 . . . . 0.0 110.02 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 t -107.85 -32.61 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.774 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.553 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.4 m -110.09 -67.12 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.078 -1.014 . . . . 0.0 111.136 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.2 Cg_endo -72.19 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.177 1.093 . . . . 0.0 110.628 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.36 31.83 5.28 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.556 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 6.7 mtt180 -94.68 135.71 35.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.997 . . . . 0.0 110.389 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.686 ' CE2' ' CG2' ' A' ' 12' ' ' VAL . 9.4 p90 -135.65 154.01 51.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.738 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -91.88 96.24 10.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.891 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 24.2 t -77.06 124.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.405 -0.81 . . . . 0.0 110.261 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -130.73 102.3 6.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.583 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.7 138.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.176 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' VAL . 7.6 p -94.55 151.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.562 -0.712 . . . . 0.0 110.202 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.525 ' CB ' ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -97.41 179.67 4.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 110.844 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.559 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -49.26 -178.01 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.068 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.0 Cg_endo -63.92 -15.07 46.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.585 1.308 . . . . 0.0 110.068 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -143.7 84.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.297 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -66.23 -176.99 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.074 -1.016 . . . . 0.0 111.389 -178.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 5.7 t70 174.61 172.28 0.22 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.416 0.627 . . . . 0.0 109.417 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.539 ' HA ' ' CD2' ' A' ' 61' ' ' LEU . 9.0 mt-30 -63.21 -41.02 99.09 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.158 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 -31.92 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' ' HB3' ' A' ' 57' ' ' ASP . 3.6 mm100 -74.15 -46.16 44.11 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 110.397 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 58' ' ' GLN . 4.4 pp -68.03 -35.19 77.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.817 -1.177 . . . . 0.0 109.368 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.493 ' N ' ' CD1' ' A' ' 61' ' ' LEU . . . -51.8 -33.4 35.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.626 ' O ' HG12 ' A' ' 67' ' ' ILE . 17.7 mt -71.27 -50.9 27.93 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.628 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HG2' ' CG2' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -71.39 -35.49 71.06 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.401 -1.437 . . . . 0.0 109.885 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -74.15 -39.68 63.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CG ' HG12 ' A' ' 67' ' ' ILE . 13.3 pt-20 -73.81 -37.85 64.76 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.753 -1.217 . . . . 0.0 109.982 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 63' ' ' LEU . 24.0 mm -77.89 -38.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.348 -0.845 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 46.1 mt -68.35 -42.03 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.9 -1.125 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 22.9 mt-30 -64.33 -48.16 76.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -40.41 95.35 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.22 -0.925 . . . . 0.0 110.593 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.53 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -66.47 -48.55 69.52 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.193 -0.942 . . . . 0.0 109.962 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 47.9 mt -66.17 -35.53 80.7 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.313 -0.867 . . . . 0.0 110.017 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 9.0 mm-40 -70.03 -42.86 72.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -0.818 . . . . 0.0 109.086 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -58.78 -36.02 73.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.581 ' CE2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.18 -31.47 62.69 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.581 -0.699 . . . . 0.0 110.559 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.467 ' O ' ' HE1' ' A' ' 14' ' ' MET . . . 115.41 1.5 21.75 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.3 124.77 39.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -1.188 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 5.0 ttm180 -120.37 150.89 40.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 3.1 t -92.67 118.83 39.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.134 -0.979 . . . . 0.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -4.9 57.91 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.79 144.46 51.09 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.388 -0.82 . . . . 0.0 110.894 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 109.087 178.76 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.426 ' C ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.124 0.488 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 3.1 mm? -116.79 144.71 44.15 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 110.616 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.57 ' CE2' ' HE3' ' A' ' 81' ' ' LYS . 5.8 t90 -124.52 118.41 26.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.559 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CE2' HG13 ' A' ' 82' ' ' VAL . 9.1 m-85 -127.61 131.11 49.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.9 tt0 -101.96 159.58 15.23 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.673 ' CG2' ' CE1' ' A' ' 46' ' ' TYR . 3.6 m -129.74 -175.34 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.39 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' SD ' ' A' ' 14' ' ' MET . 0.6 OUTLIER -141.13 54.2 1.56 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.755 -0.591 . . . . 0.0 109.843 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.459 ' SD ' ' HA ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -121.32 152.19 57.19 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.427 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.6 Cg_endo -70.88 -162.9 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.207 1.635 . . . . 0.0 112.385 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.4 ' O ' HG21 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -48.83 -26.45 2.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 15' ' ' PRO . 41.8 t0 -57.73 -15.38 7.79 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.957 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' HD3' ' CE1' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -71.74 -17.07 62.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.411 -0.805 . . . . 0.0 110.552 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 16' ' ' GLU . 94.0 t -65.19 -48.59 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.549 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 20.0 m-80 -64.82 -30.32 71.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.094 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 26.4 t0 -65.16 -54.66 26.38 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 22' ' ' LEU . 3.9 mm? -59.16 -36.87 76.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.173 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.48 -52.24 65.46 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.589 -0.695 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -47.12 80.25 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.378 -0.826 . . . . 0.0 109.585 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.65 -43.79 95.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.487 -0.758 . . . . 0.0 110.007 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' O ' ' CG ' ' A' ' 29' ' ' ARG . 19.2 mt -54.94 -40.16 69.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 109.968 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -37.71 68.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.535 HG23 ' CG2' ' A' ' 67' ' ' ILE . 2.5 mt -59.64 -44.53 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.265 -0.897 . . . . 0.0 110.617 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.54 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 13.8 ptt85 -69.52 62.99 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.457 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.44 -39.76 62.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -62.83 -15.01 52.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.212 -0.93 . . . . 0.0 111.112 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.598 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 6.1 p -80.76 151.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.901 -1.124 . . . . 0.0 111.424 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -45.39 17.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 111.254 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.433 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.22 155.7 38.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.926 -1.109 . . . . 0.0 111.313 -179.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.528 ' CA ' HG13 ' A' ' 50' ' ' ILE . 14.9 p -137.67 136.15 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 110.061 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.14 118.25 26.46 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 131.92 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.823 . . . . 0.0 110.574 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 4.6 m -117.75 127.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.136 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -79.86 153.56 28.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.333 -0.854 . . . . 0.0 110.631 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -74.75 179.41 4.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.205 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -103.5 12.96 34.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.28 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 110.014 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.6 Cg_endo -70.24 -170.69 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.687 1.362 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 21.68 26.22 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HG3' ' OG ' ' A' ' 40' ' ' SER . 8.2 ptp180 -94.79 162.54 13.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.544 -0.974 . . . . 0.0 110.32 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.673 ' CE1' ' CG2' ' A' ' 12' ' ' VAL . 2.1 p90 -152.8 154.7 35.7 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.797 0.808 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HG3' ' CD1' ' A' ' 9' ' ' TRP . 2.4 tt0 -92.71 97.33 10.71 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.351 0.596 . . . . 0.0 109.662 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.42 119.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.419 -0.801 . . . . 0.0 110.059 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.22 100.96 5.58 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.598 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -121.06 147.62 24.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 121.427 0.632 . . . . 0.0 110.602 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.48 ' O ' HG21 ' A' ' 32' ' ' VAL . 12.0 p -126.09 148.22 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 2.1 mp -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.13 -0.981 . . . . 0.0 110.174 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.527 ' N ' HD23 ' A' ' 56' ' ' LEU . 41.5 m-80 -36.75 159.48 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.812 -0.555 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.52 -20.75 66.04 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.983 1.517 . . . . 0.0 111.498 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -127.98 77.67 1.78 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.057 . . . . 0.0 109.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.566 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 6.4 mt -73.3 -173.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.384 1.088 . . . . 0.0 112.531 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.488 ' OD1' ' HG3' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -168.43 170.63 9.67 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.606 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.58 -32.22 73.17 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.958 -1.088 . . . . 0.0 110.813 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -38.39 76.05 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 8.7 mm-40 -68.57 -43.9 75.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 21.2 mt -65.15 -35.36 80.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.018 -1.051 . . . . 0.0 109.702 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 66' ' ' GLU . . . -52.83 -33.25 48.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 24.9 mt -66.17 -50.48 63.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 18.0 pt-20 -74.84 -41.14 60.44 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.847 -1.158 . . . . 0.0 109.513 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 4.0 mptp? -67.98 -32.92 73.66 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.41 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 11.1 pt-20 -69.88 -46.35 65.66 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.41 -1.431 . . . . 0.0 109.945 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.535 ' CG2' HG23 ' A' ' 28' ' ' ILE . 4.4 mt -78.3 -40.72 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.066 . . . . 0.0 111.136 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 68.1 mt -60.49 -49.85 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 70' ' ' ARG . 2.9 pt20 -60.85 -44.12 97.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 17.2 mtp-105 -68.6 -47.11 67.54 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.503 -0.748 . . . . 0.0 110.765 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -62.28 -47.83 82.6 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.053 -1.03 . . . . 0.0 110.077 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD2' ' OD2' ' A' ' 21' ' ' ASP . 91.3 mt -63.13 -38.01 89.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.354 -0.842 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.02 -45.34 64.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.398 -0.814 . . . . 0.0 109.595 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -61.63 -36.47 80.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.47 -17.94 60.0 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.467 -0.771 . . . . 0.0 110.406 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' O ' ' HE1' ' A' ' 14' ' ' MET . . . 103.15 2.86 48.38 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' CB ' ' OD2' ' A' ' 21' ' ' ASP . . . -98.36 111.78 24.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -1.187 . . . . 0.0 110.099 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -118.05 144.75 45.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 3.1 t -88.95 125.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 120.922 -1.111 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 -5.63 58.76 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HE3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -130.38 149.96 51.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 111.579 -178.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 10' ' ' TYR . 1.2 m . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 109.125 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.325 0.584 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 52' ' ' LEU . 4.1 mp -144.34 124.17 13.44 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.34 -0.85 . . . . 0.0 110.645 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -123.15 118.21 27.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.476 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 3.1 m-85 -126.57 135.08 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 110.89 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.55 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 2.3 tt0 -119.42 159.57 23.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 18.9 m -130.27 179.88 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 110.747 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -137.04 60.41 1.66 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.555 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 1.3 ptm -134.48 147.91 65.36 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.501 -0.749 . . . . 0.0 110.999 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 Cg_endo -73.37 -166.73 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.216 1.64 . . . . 0.0 112.452 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 22.7 tt0 -65.24 -25.42 67.66 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.203 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.01 -42.19 93.77 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.836 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.555 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -90.23 -14.34 33.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.33 -0.856 . . . . 0.0 110.322 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 7.2 t -46.52 -36.74 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.8 t30 -52.25 -27.89 16.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.364 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 42.3 t0 -59.14 -44.43 92.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.0 mm? -59.04 -39.62 82.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.84 . . . . 0.0 109.171 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.61 -53.12 61.32 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.439 -0.788 . . . . 0.0 109.292 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -42.89 93.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 29' ' ' ARG . 1.1 tt0 -57.69 -47.57 81.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 35' ' ' VAL . 6.7 mt -54.69 -40.14 68.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -36.13 74.24 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.461 HG23 ' HG3' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -63.28 -43.93 98.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.511 ' CZ ' ' HG2' ' A' ' 25' ' ' GLU . 8.7 mtm180 -70.47 54.82 0.15 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.563 -0.71 . . . . 0.0 110.359 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -74.09 -40.66 62.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.03 -16.18 40.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.573 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.591 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -81.31 158.49 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 110.093 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HD2' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -79.15 -46.81 17.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 111.229 -179.366 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.66 149.93 28.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 111.097 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.54 ' CG1' HD21 ' A' ' 26' ' ' LEU . 7.4 p -139.85 133.79 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.9 mtm -129.91 115.16 16.79 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.059 -1.026 . . . . 0.0 110.968 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.1 t -115.19 130.32 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 109.816 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -116.76 156.51 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.002 -1.061 . . . . 0.0 110.944 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.92 153.42 22.21 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.384 0.611 . . . . 0.0 110.456 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -76.83 -177.35 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.427 179.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -98.37 -47.85 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.303 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -100.59 -66.99 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 110.803 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.9 Cg_endo -72.1 -161.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.335 1.176 . . . . 0.0 110.776 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -116.19 40.49 2.39 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.6 mtt180 -93.3 135.41 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -1.081 . . . . 0.0 110.258 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.599 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 32.7 m-85 -115.05 154.98 27.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 111.034 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 5.3 mm-40 -100.52 114.99 29.06 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.925 -0.484 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 72.4 t -92.46 111.54 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 110.39 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.81 101.07 5.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.591 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.7 OUTLIER -124.83 149.07 29.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 121.681 0.753 . . . . 0.0 111.553 -178.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.435 ' N ' HG12 ' A' ' 50' ' ' ILE . 6.5 p -98.72 151.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.739 -0.601 . . . . 0.0 109.682 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -95.49 176.26 6.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.368 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -48.48 179.23 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.403 -0.811 . . . . 0.0 109.794 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.8 -19.74 69.34 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.458 1.241 . . . . 0.0 109.266 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -142.1 84.92 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 57' ' ' ASP . 3.8 pp -71.13 -172.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.004 . . . . 0.0 110.812 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.579 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 10.8 t70 173.07 171.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.386 0.612 . . . . 0.0 109.782 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.426 ' HG3' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -53.86 -54.39 39.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -0.819 . . . . 0.0 110.868 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -32.48 72.24 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.918 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.0 mm-40 -67.17 -44.77 78.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.848 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 57' ' ' ASP . 5.8 mp -65.05 -34.36 78.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.014 -1.054 . . . . 0.0 109.676 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 66' ' ' GLU . . . -52.28 -33.85 43.88 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.626 ' O ' HG12 ' A' ' 67' ' ' ILE . 32.9 mt -68.16 -50.03 57.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.87 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 90.8 mt-10 -70.62 -35.6 73.04 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.243 -1.536 . . . . 0.0 109.381 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.48 -43.87 59.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 110.646 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 10.0 pt-20 -72.62 -37.82 67.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.891 -1.13 . . . . 0.0 109.893 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 63' ' ' LEU . 40.1 mm -77.25 -39.73 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 111.154 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 87.8 mt -70.28 -47.0 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.867 -1.146 . . . . 0.0 110.043 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 12.0 mm-40 -61.49 -33.83 74.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 110.541 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -67.42 -41.9 84.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.098 -1.002 . . . . 0.0 111.235 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.44 -48.41 56.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 111.323 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.48 ' HG ' ' OE1' ' A' ' 25' ' ' GLU . 29.3 mt -58.59 -36.47 74.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 111.211 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.252 4.0 tt0 -71.53 -47.57 54.35 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.147 0.975 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -61.54 -39.38 90.89 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.116 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.68 -35.73 60.26 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.65 24.82 4.2 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB1' ' CE ' ' A' ' 14' ' ' MET . . . -107.3 127.05 53.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.861 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -118.77 137.69 53.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 110.426 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 1.7 t -90.29 117.16 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -82.42 -6.82 59.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 109.452 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -134.94 136.13 42.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.302 -0.874 . . . . 0.0 111.525 -178.767 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 178.599 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.169 0.509 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.605 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 6.4 mp -105.27 125.33 50.86 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.543 ' CE2' ' OD1' ' A' ' 49' ' ' ASN . 1.1 t90 -124.48 126.72 46.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.356 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.464 ' OH ' HD21 ' A' ' 8' ' ' LEU . 80.1 m-85 -122.94 122.1 37.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.921 . . . . 0.0 110.689 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.538 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 11.8 tt0 -111.29 159.84 17.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.303 -0.873 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.8 m -136.86 -176.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.832 -1.168 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 15.1 tt0 -145.76 53.38 1.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.574 -0.704 . . . . 0.0 110.338 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.51 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -128.77 153.01 79.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.73 -166.53 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.952 1.501 . . . . 0.0 113.574 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' A' ' 19' ' ' VAL . 3.0 tm-20 -60.72 -26.61 67.3 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.918 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.33 -27.28 62.09 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.908 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.616 ' NH1' ' CZ ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -88.44 -13.74 39.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.999 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 79.2 t -47.76 -40.99 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.0 109.968 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.8 m-20 -61.77 -29.68 70.29 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.772 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.591 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 39.5 t0 -60.85 -47.54 85.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.341 -0.85 . . . . 0.0 110.386 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.513 ' HG ' ' NH2' ' A' ' 18' ' ' ARG . 4.4 mm? -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.847 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.01 -47.29 78.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.06 -44.14 73.2 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.386 -0.821 . . . . 0.0 110.003 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.07 -47.95 82.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.546 ' O ' ' NE ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.06 -37.25 86.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.044 -1.035 . . . . 0.0 110.593 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -73.01 -42.38 63.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.849 -1.157 . . . . 0.0 110.454 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -61.93 -43.22 97.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.376 -0.828 . . . . 0.0 111.761 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.549 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -70.63 67.42 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.087 -1.008 . . . . 0.0 110.812 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.7 m-20 -64.59 -25.08 67.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.516 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 24.5 p30 -64.86 -25.79 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.299 -0.875 . . . . 0.0 111.57 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.549 ' CG1' ' HD2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -80.62 148.9 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.808 -1.182 . . . . 0.0 110.162 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -47.4 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 111.994 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -154.46 138.52 16.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.193 . . . . 0.0 111.243 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 32' ' ' VAL . 2.1 t -125.83 132.54 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.335 -0.853 . . . . 0.0 110.131 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 ttm -119.92 115.49 23.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.219 -0.926 . . . . 0.0 109.96 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.89 130.68 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.811 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 1.4 m -123.25 129.07 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -76.66 153.92 34.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -168.2 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.505 -0.747 . . . . 0.0 109.826 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.0 t -109.21 11.82 25.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.977 . . . . 0.0 110.79 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.574 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.36 -65.11 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 50.5 Cg_endo -72.62 -170.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.465 1.245 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -110.37 34.03 5.63 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.9 mtt180 -94.14 141.19 28.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -1.012 . . . . 0.0 110.04 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.616 ' CZ ' ' NH1' ' A' ' 18' ' ' ARG . 17.4 m-85 -124.91 154.19 41.49 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.976 0.893 . . . . 0.0 110.729 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 24.8 mt-10 -103.05 92.5 4.57 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 80.7 t -77.49 124.74 36.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.543 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 74.9 m-20 -128.32 100.83 5.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -113.49 130.03 68.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 121.216 0.531 . . . . 0.0 110.408 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' N ' HD11 ' A' ' 50' ' ' ILE . 8.4 p -91.97 150.25 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.558 ' HB3' ' CG ' ' A' ' 56' ' ' LEU . 12.5 mt -92.94 167.67 11.66 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 111.217 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.662 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 1.7 m-20 -65.1 -147.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.56 -35.14 30.71 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 CA-C-N 119.426 0.831 . . . . 0.0 111.64 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -162.97 79.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.74 -1.225 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' CG ' ' HB3' ' A' ' 52' ' ' LEU . 16.8 mt -80.4 -165.82 0.94 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.134 -0.979 . . . . 0.0 111.3 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.505 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER 177.72 -162.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.664 -0.647 . . . . 0.0 110.273 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.462 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 24.3 mt-30 -64.67 -30.16 71.17 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 111.132 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -71.25 -44.23 65.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.4 mm100 -73.64 -44.09 57.81 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.487 -0.758 . . . . 0.0 109.682 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.605 ' CD2' ' CD2' ' A' ' 8' ' ' LEU . 30.7 mt -66.58 -33.28 75.32 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.76 -32.91 32.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.574 ' O ' ' CG1' ' A' ' 67' ' ' ILE . 88.6 mt -71.18 -50.4 33.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.634 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -70.49 -32.21 69.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.453 -1.404 . . . . 0.0 109.56 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.543 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -73.37 -45.19 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 44.8 mt-10 -64.84 -38.3 90.53 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.121 -0.987 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.574 ' CG1' ' O ' ' A' ' 63' ' ' LEU . 7.1 mm -78.39 -43.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.538 -0.727 . . . . 0.0 111.458 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 64' ' ' GLU . 10.4 mt -64.29 -41.3 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.0 110.7 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -60.91 -37.44 82.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.097 -1.002 . . . . 0.0 110.429 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -69.31 -45.43 69.55 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.222 -0.923 . . . . 0.0 111.103 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -48.82 72.27 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.008 -1.058 . . . . 0.0 110.253 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.48 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 36.1 mt -63.8 -35.68 81.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.958 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -70.35 -45.55 65.91 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.543 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -60.3 -37.23 79.88 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.36 -25.72 57.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.495 -0.753 . . . . 0.0 110.326 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.11 11.32 32.23 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -95.05 126.58 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -1.106 . . . . 0.0 110.2 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -119.49 131.71 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 3.4 t -85.84 124.6 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.01 -9.11 59.66 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -131.57 130.82 42.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.368 -0.832 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 8.9 p . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.094 . . . . 0.0 110.57 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.587 ' CD2' ' O ' ' A' ' 7' ' ' PHE . 85.6 t80 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.221 0.534 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -153.51 123.97 7.12 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 120.962 -1.086 . . . . 0.0 111.939 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.407 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 7.3 t90 -128.11 118.83 24.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.479 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 62.0 m-85 -127.54 145.19 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.874 -1.141 . . . . 0.0 111.753 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.542 ' HB3' ' HG2' ' A' ' 81' ' ' LYS . 23.2 tt0 -122.91 159.6 27.91 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.367 -0.833 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.54 -177.43 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.938 -1.102 . . . . 0.0 110.726 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 6.7 tt0 -135.58 50.18 2.12 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.693 0.759 . . . . 0.0 109.748 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' GLY . 16.6 mmt -128.59 148.7 69.42 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.81 -166.58 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.768 1.404 . . . . 0.0 113.412 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -52.58 -24.84 9.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.713 178.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.445 ' C ' ' OH ' ' A' ' 75' ' ' TYR . 35.8 t0 -58.22 -13.1 4.34 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.329 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.618 ' HA ' ' CZ ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -71.42 -13.3 61.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.234 -0.916 . . . . 0.0 111.027 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 16' ' ' GLU . 54.7 t -49.76 -46.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.34 -0.85 . . . . 0.0 110.068 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -30.87 69.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.168 -0.958 . . . . 0.0 109.58 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.602 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 16.3 t0 -69.48 -54.93 11.83 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.334 -0.854 . . . . 0.0 109.931 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.3 mm? -61.64 -38.13 86.55 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.85 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.49 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.81 -52.02 66.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.433 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -70.35 -46.83 63.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.187 -0.946 . . . . 0.0 109.769 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HA ' ' CB ' ' A' ' 71' ' ' ALA . 50.5 tt0 -56.51 -49.63 74.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 110.919 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -63.76 -36.4 83.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.504 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.95 -41.98 97.35 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.194 -0.942 . . . . 0.0 111.313 -179.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.508 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 23.2 mt -67.57 -40.96 85.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.782 -1.199 . . . . 0.0 109.834 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 32' ' ' VAL . 36.7 mtp180 -74.39 64.53 1.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.546 -0.721 . . . . 0.0 110.373 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -29.62 70.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.942 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -62.14 -13.75 30.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.439 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' A' ' 50' ' ' ILE . 1.8 p -79.91 126.2 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.108 -0.995 . . . . 0.0 110.597 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -80.38 -44.59 19.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 110.69 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -151.72 123.72 8.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 0.0 111.486 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 3.7 p -129.94 128.16 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.708 . . . . 0.0 109.155 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.4 tpp -116.26 115.79 26.6 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.069 -1.02 . . . . 0.0 111.065 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.479 HG21 HG23 ' A' ' 48' ' ' VAL . 16.8 t -115.25 125.23 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.78 160.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.069 -1.019 . . . . 0.0 110.734 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -79.69 154.4 28.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.411 -0.806 . . . . 0.0 110.364 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.414 ' CB ' ' HG2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -74.11 -170.69 0.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.927 . . . . 0.0 110.105 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -98.69 1.71 46.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.629 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -160.53 -64.55 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.012 -1.055 . . . . 0.0 110.625 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 41.2 Cg_endo -67.66 -168.79 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.596 1.314 . . . . 0.0 110.782 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -107.11 29.17 11.04 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HD3' ' CG ' ' A' ' 43' ' ' PRO . 8.6 ptt180 -94.19 160.61 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.845 -1.386 . . . . 0.0 110.393 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.573 ' CE1' ' HG2' ' A' ' 18' ' ' ARG . 60.3 m-85 -132.48 155.26 48.87 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 121.956 0.884 . . . . 0.0 111.018 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.94 96.87 8.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.479 HG23 HG21 ' A' ' 37' ' ' VAL . 43.5 t -79.61 118.99 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.883 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -131.19 101.16 5.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.543 ' CD1' HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -117.36 146.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.912 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.7 p -107.05 120.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.53 ' CD1' HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.52 179.74 6.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 111.175 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.571 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.0 OUTLIER -45.33 174.04 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.766 -0.584 . . . . 0.0 110.359 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.2 Cg_endo -63.23 -15.13 46.19 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.594 1.313 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -140.36 73.71 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.96 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.524 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -63.03 165.19 7.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -165.42 168.67 16.45 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 110.82 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -54.68 -38.2 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.316 -0.865 . . . . 0.0 110.111 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -45.4 87.5 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm100 -69.7 -41.48 75.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.386 -0.822 . . . . 0.0 109.255 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 10.5 mt -63.26 -35.01 78.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.787 . . . . 0.0 109.957 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.561 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . . . -52.22 -43.9 64.51 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.647 ' O ' HG12 ' A' ' 67' ' ' ILE . 66.9 mt -64.75 -48.38 74.77 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.702 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -65.26 -44.74 87.11 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.356 -1.465 . . . . 0.0 110.819 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.561 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 5.0 ptmt -74.52 -35.16 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.471 -1.393 . . . . 0.0 110.433 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 86.9 mt-10 -77.23 -40.41 45.01 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.892 -1.13 . . . . 0.0 109.881 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 63' ' ' LEU . 8.7 mm -76.99 -35.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.173 -0.954 . . . . 0.0 110.946 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 69.1 mt -69.09 -45.27 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 0.0 109.48 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 32.0 mt-30 -60.3 -48.52 81.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.285 -0.885 . . . . 0.0 110.005 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -60.36 -44.24 95.77 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.435 -0.791 . . . . 0.0 111.082 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.533 ' CB ' ' HA ' ' A' ' 25' ' ' GLU . . . -65.5 -48.76 71.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.875 -1.14 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 77' ' ' ALA . 32.0 mt -65.49 -38.15 88.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 12.9 mm-40 -70.88 -44.85 65.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 31.2 t-20 -60.75 -37.02 80.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.618 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 t80 -75.71 -33.47 60.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.241 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.49 11.35 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -103.84 129.41 51.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.24 . . . . 0.0 109.802 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.15 137.57 52.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.131 -0.981 . . . . 0.0 110.547 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.1 t -79.29 115.65 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.596 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.78 -4.67 58.28 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.527 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -130.28 155.01 47.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.226 -0.922 . . . . 0.0 111.889 -178.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.967 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 3.7 mm? -90.79 148.45 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.155 -0.966 . . . . 0.0 111.521 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 3.5 t90 -127.36 119.61 26.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.787 . . . . 0.0 109.356 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -123.27 143.74 49.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.93 -1.106 . . . . 0.0 111.163 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.539 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 5.9 tt0 -121.05 160.33 23.84 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.406 -0.809 . . . . 0.0 109.597 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.85 -177.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 110.515 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 33.7 tt0 -143.32 53.47 1.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.234 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.533 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -122.1 148.93 53.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.256 -0.903 . . . . 0.0 109.876 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 36.2 Cg_endo -69.36 -167.31 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.992 1.522 . . . . 0.0 113.491 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' HG13 ' A' ' 19' ' ' VAL . 3.0 tm-20 -65.52 -23.72 66.95 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.267 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.83 -39.49 79.97 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.615 -0.678 . . . . 0.0 111.966 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.3 OUTLIER -90.69 -16.76 27.98 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.056 -1.027 . . . . 0.0 110.869 -178.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 16' ' ' GLU . 7.4 p -46.54 -36.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.514 -0.741 . . . . 0.0 110.413 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 2.2 t30 -52.21 -28.16 17.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.454 -0.779 . . . . 0.0 109.682 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 39.7 t0 -58.8 -38.12 77.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.365 -0.834 . . . . 0.0 109.834 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.586 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 2.9 mp -58.52 -41.66 85.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.526 -0.734 . . . . 0.0 109.349 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.38 -50.6 71.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.403 -0.811 . . . . 0.0 109.517 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -68.55 -41.03 80.39 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.83 . . . . 0.0 109.694 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 28' ' ' ILE . 1.1 tp10 -59.78 -48.8 80.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.348 -0.845 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -60.89 -37.26 81.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.051 . . . . 0.0 109.055 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.481 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.38 -38.96 81.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.436 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.532 HG22 ' CG2' ' A' ' 67' ' ' ILE . 0.5 OUTLIER -58.86 -44.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.273 -0.892 . . . . 0.0 110.534 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 11.6 ptp180 -78.61 52.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.71 -27.91 69.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.107 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 29.8 p-10 -58.88 -17.85 27.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 109.94 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.575 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 3.4 p -80.9 154.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.45 -0.781 . . . . 0.0 110.522 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -79.17 -45.53 19.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 111.058 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.47 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.5 mtt-85 -152.14 135.62 16.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.992 -1.067 . . . . 0.0 110.899 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.511 ' CA ' HG13 ' A' ' 50' ' ' ILE . 8.8 p -133.87 133.67 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.82 119.26 12.24 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.189 -0.945 . . . . 0.0 110.793 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 46' ' ' TYR . 58.5 t -114.54 130.67 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.984 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 16.2 m -111.28 145.13 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.685 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.547 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.09 153.87 23.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.422 -0.799 . . . . 0.0 110.687 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.53 -173.82 1.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -105.24 -16.91 14.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.087 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -124.31 -67.95 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -71.52 -168.79 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.105 1.055 . . . . 0.0 110.791 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -110.48 31.62 7.23 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.503 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 1.4 ptm180 -94.54 160.74 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -1.183 . . . . 0.0 110.486 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.547 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 19.9 m-85 -132.2 154.35 49.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.846 0.831 . . . . 0.0 110.836 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 20.2 mt-10 -103.85 93.19 4.75 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.574 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 65.4 t -79.5 123.13 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.0 111.603 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 77.6 m-20 -130.91 100.76 5.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.575 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -136.52 147.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.634 0.731 . . . . 0.0 111.432 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.503 ' N ' HG12 ' A' ' 50' ' ' ILE . 9.9 p -124.81 149.92 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.617 -0.677 . . . . 0.0 109.232 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.577 ' HB2' ' CG ' ' A' ' 56' ' ' LEU . 6.1 mp -105.41 -158.56 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 52' ' ' LEU . 1.2 m-80 -39.44 163.8 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.85 -0.531 . . . . 0.0 110.425 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.13 -15.71 50.9 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.0 1.526 . . . . 0.0 110.877 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -139.05 75.88 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 110.117 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.577 ' CG ' ' HB2' ' A' ' 52' ' ' LEU . 8.7 mt -61.76 -174.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.975 -1.078 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.79 -174.25 0.35 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.465 0.65 . . . . 0.0 109.724 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -65.82 -40.01 91.42 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 111.119 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.1 m -66.19 -36.12 82.24 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 0.0 110.56 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' CB ' HD22 ' A' ' 56' ' ' LEU . 16.6 mm100 -70.26 -44.53 68.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 110.45 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.458 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 71.4 mt -64.67 -33.18 75.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.529 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.42 -35.66 52.52 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.64 ' O ' HG12 ' A' ' 67' ' ' ILE . 47.4 mt -71.55 -49.72 38.03 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.873 0.844 . . . . 0.0 109.145 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.529 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 4.6 mt-10 -67.32 -38.39 84.85 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.624 -1.297 . . . . 0.0 109.987 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.458 ' CE ' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.881 -1.137 . . . . 0.0 110.756 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 10.9 mm-40 -75.48 -39.41 58.65 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.725 -1.234 . . . . 0.0 109.628 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 63' ' ' LEU . 23.6 mm -78.17 -40.87 26.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.496 -0.753 . . . . 0.0 111.868 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 89.0 mt -71.32 -41.66 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.322 -1.487 . . . . 0.0 110.294 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 1.4 pp0? -64.35 -34.64 78.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -0.847 . . . . 0.0 110.761 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.06 -41.52 77.48 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.01 -1.056 . . . . 0.0 110.977 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.02 -48.55 62.67 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.09 -1.006 . . . . 0.0 110.709 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' A' ' 77' ' ' ALA . 61.6 mt -60.71 -38.2 84.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.192 -0.943 . . . . 0.0 110.606 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -72.04 -45.9 59.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.367 -0.833 . . . . 0.0 109.563 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -60.9 -40.46 93.18 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.32 -43.75 39.89 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.574 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.72 34.23 1.44 Allowed Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -113.01 127.3 56.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -1.155 . . . . 0.0 109.534 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -120.7 129.29 53.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 110.612 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.3 t -75.13 119.66 23.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.087 -1.008 . . . . 0.0 109.407 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -82.32 -7.06 59.63 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.9 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.539 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -132.98 149.71 52.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.329 -0.857 . . . . 0.0 111.559 -178.397 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 81' ' ' LYS . 9.8 t . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 11.6 mtt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.372 0.606 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.654 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 3.0 t70 -76.4 -37.1 1.92 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 0.0 111.574 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.8 Cg_endo -83.04 8.67 4.47 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.314 1.165 . . . . 0.0 110.339 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 52' ' ' LEU . 2.9 pt20 -165.21 -167.31 1.15 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.887 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.503 ' O ' ' HA3' ' A' ' 86' ' ' GLY . . . -140.66 54.55 0.64 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . 3.3 p90 -63.28 130.82 46.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.59 -1.535 . . . . 0.0 109.402 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 1.7 m-85 -164.68 47.85 0.1 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.979 -1.076 . . . . 0.0 110.531 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 52' ' ' LEU . 1.6 mm? -104.67 124.32 49.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.16 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.489 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 1.7 t90 -115.79 119.63 36.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.741 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CA ' ' HD2' ' A' ' 81' ' ' LYS . 27.0 m-85 -126.84 137.37 53.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.761 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.54 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 10.7 tt0 -122.82 159.46 28.08 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.376 -0.827 . . . . 0.0 109.42 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 11.4 m -136.03 -177.51 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.003 -1.061 . . . . 0.0 110.667 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 14.0 tt0 -146.54 56.22 1.15 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.481 0.657 . . . . 0.0 109.651 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.527 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 10.2 mmt -131.12 149.05 72.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.402 -0.811 . . . . 0.0 109.209 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 35.2 Cg_endo -68.63 -168.4 0.22 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.774 1.408 . . . . 0.0 112.823 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.57 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -61.12 -46.55 90.13 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.527 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.0 -28.73 20.0 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.275 -0.89 . . . . 0.0 110.214 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.611 HG22 ' CZ ' ' A' ' 46' ' ' TYR . 43.0 t -47.99 -37.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.571 -0.706 . . . . 0.0 110.791 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -53.64 -29.0 36.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.984 -1.073 . . . . 0.0 109.739 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 24.6 t0 -59.99 -36.58 77.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 110.655 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.481 HD11 ' O ' ' A' ' 19' ' ' VAL . 6.8 mp -57.97 -39.35 77.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.54 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -61.37 -52.82 63.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.838 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.36 -42.39 75.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.246 -0.909 . . . . 0.0 110.383 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -56.02 -49.05 74.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 110.407 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.38 -36.98 85.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.504 -0.748 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.6 -38.63 88.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.151 -0.968 . . . . 0.0 110.781 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.589 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 55.8 mt -61.6 -47.44 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 120.927 -1.108 . . . . 0.0 110.567 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.9 ptt180 -72.66 67.47 0.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.94 -25.48 29.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -57.9 -14.98 7.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.102 -0.999 . . . . 0.0 110.154 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.592 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 1.7 p -80.35 132.08 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 110.311 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -80.04 -46.49 16.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.513 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttp85 -152.7 123.3 7.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.9 -1.125 . . . . 0.0 111.135 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG13 ' HB2' ' A' ' 26' ' ' LEU . 7.2 p -127.18 136.18 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.465 -0.772 . . . . 0.0 109.75 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.97 120.72 17.38 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.04 -1.038 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 20.0 t -114.94 130.41 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.736 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.485 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 18.9 t -104.43 161.15 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.049 -1.032 . . . . 0.0 110.862 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.11 154.59 23.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.545 -0.722 . . . . 0.0 110.317 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 7.7 p -73.2 -172.58 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -94.66 -1.91 52.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.11 -64.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.043 -1.036 . . . . 0.0 110.786 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.5 Cg_endo -69.18 -160.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.556 1.292 . . . . 0.0 111.226 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.1 37.37 3.85 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.7 mtp180 -93.95 146.89 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.477 -1.014 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.611 ' CZ ' HG22 ' A' ' 19' ' ' VAL . 41.2 m-85 -131.7 154.73 48.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.147 -0.971 . . . . 0.0 110.942 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' CG ' ' HB ' ' A' ' 38' ' ' VAL . 2.6 pt-20 -101.64 104.48 15.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 48.5 t -83.71 116.9 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 111.642 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -131.17 100.53 5.24 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.592 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -117.25 144.85 24.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.903 -178.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.528 ' HA ' ' HB2' ' A' ' 6' ' ' TYR . 9.4 p -96.18 147.39 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 109.429 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 8' ' ' LEU . 19.8 mt -107.25 -178.28 3.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.711 -1.243 . . . . 0.0 111.625 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.535 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -64.86 179.32 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.767 -0.583 . . . . 0.0 110.523 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -63.97 -15.99 52.31 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.861 1.453 . . . . 0.0 110.788 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -141.07 87.35 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.533 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.33 173.76 7.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.02 -1.05 . . . . 0.0 111.162 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 173.72 -167.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.527 -0.733 . . . . 0.0 110.133 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.554 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.69 76.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 1.9 mm100 -67.86 -45.11 75.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 79.4 mt -64.61 -35.11 79.94 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 109.811 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.74 -33.89 50.2 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.048 . . . . 0.0 108.342 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' ILE . 15.2 mt -70.94 -49.39 46.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.465 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 38.5 mt-10 -68.51 -43.36 77.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 109.316 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.7 mmtp -60.73 -36.2 78.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 110.408 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.6 mm-40 -65.75 -48.84 70.53 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.841 -1.162 . . . . 0.0 110.061 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.589 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 4.6 mt -77.77 -41.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.392 -0.817 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 27.4 mt -59.46 -50.49 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 87.0 mt-30 -64.36 -47.06 80.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.2 -0.938 . . . . 0.0 108.897 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -58.13 -47.11 84.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.509 -0.745 . . . . 0.0 110.81 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -68.76 -48.51 63.53 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.864 -1.148 . . . . 0.0 110.449 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 76.1 mt -65.7 -35.55 81.09 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.326 -0.858 . . . . 0.0 110.455 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 1.4 mm-40 -71.33 -44.91 64.21 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 109.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.9 m-80 -64.29 -36.6 84.64 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.011 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.03 -37.65 61.67 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.628 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.27 23.95 4.32 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' A' ' 14' ' ' MET . . . -108.31 131.32 54.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.26 -1.141 . . . . 0.0 109.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 146.19 46.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.9 t -87.85 122.24 39.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.046 -1.034 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.01 -7.46 59.56 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.077 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.54 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -137.55 152.98 50.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 111.525 -178.738 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.94 108.36 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.628 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.28 107.79 10.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.072 -1.017 . . . . 0.0 111.068 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 1.2 tt0 -99.55 110.27 22.73 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.364 -0.835 . . . . 0.0 109.978 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 85' ' ' LEU . 5.0 mp -145.29 176.26 9.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.059 -1.026 . . . . 0.0 110.95 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 5' ' ' GLY . . . 74.63 56.36 5.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.43 67.43 9.43 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.123 -1.222 . . . . 0.0 110.55 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.485 ' HB2' ' HA3' ' A' ' 5' ' ' GLY . 15.2 mmt180 -100.66 151.49 21.57 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.112 -0.993 . . . . 0.0 110.547 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HG3' ' C ' ' A' ' 88' ' ' ARG . 14.1 mtm180 -141.58 39.6 1.7 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.904 0.859 . . . . 0.0 109.763 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.24 119.47 20.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.329 0.585 . . . . 0.0 110.566 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.72 83.86 1.95 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.377 -0.827 . . . . 0.0 110.027 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.62 168.78 7.46 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.234 -0.916 . . . . 0.0 110.37 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.24 58.11 4.24 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.974 1.512 . . . . 0.0 110.569 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.89 117.99 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.046 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.67 135.83 33.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.307 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 pttm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.153 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' CE2' ' A' ' 7' ' ' PHE . 3.5 tpp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.276 0.56 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.649 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 37.3 t70 -62.37 -38.08 42.89 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.386 -0.821 . . . . 0.0 111.116 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.2 Cg_endo -83.02 2.94 8.17 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.467 1.246 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' HB3' ' C ' ' A' ' 54' ' ' PRO . 6.7 pt20 -148.46 -149.48 0.3 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.539 ' HA3' ' CB ' ' A' ' 88' ' ' ARG . . . -169.08 45.06 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.241 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.606 ' CD1' ' O ' ' A' ' 50' ' ' ILE . 25.6 t80 -81.67 135.05 35.53 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.93 -1.335 . . . . 0.0 110.224 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' C ' ' CD1' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -160.8 100.94 1.29 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.547 -0.72 . . . . 0.0 109.643 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.567 HD13 ' CE1' ' A' ' 6' ' ' TYR . 6.7 mp -138.46 125.28 21.06 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.825 . . . . 0.0 110.847 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.562 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -99.57 132.41 44.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.623 ' CE1' ' CG1' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -128.12 128.51 44.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.45 157.33 29.57 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.833 -1.167 . . . . 0.0 110.519 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.623 ' CG1' ' CE1' ' A' ' 10' ' ' TYR . 26.6 m -130.36 179.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.75 51.54 2.12 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.58 -0.7 . . . . 0.0 109.84 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.563 ' CB ' ' HB3' ' A' ' 18' ' ' ARG . 70.4 mmm -133.96 151.82 77.46 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 109.535 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 36.0 Cg_endo -71.15 -167.57 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.835 1.44 . . . . 0.0 113.24 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -53.23 -25.51 14.41 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 26.9 t0 -57.58 -23.34 50.23 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.576 ' HD3' ' CE1' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -88.09 -13.49 41.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.3 t -48.26 -44.6 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.508 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -57.9 -29.07 64.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.764 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.594 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.2 t0 -59.64 -45.33 92.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' CD2' ' CZ ' ' A' ' 18' ' ' ARG . 2.0 mm? -59.71 -36.65 76.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.26 74.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.173 -0.954 . . . . 0.0 110.533 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.3 mmt-85 -60.05 -46.64 88.87 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 tm-20 -68.67 -40.99 79.89 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 0.0 109.65 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.536 ' CD2' ' HB ' ' A' ' 35' ' ' VAL . 18.2 mt -55.28 -38.03 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.997 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 9.0 tpt180 -70.64 -40.94 72.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.468 -0.77 . . . . 0.0 110.596 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.61 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 56.5 mt -67.51 -44.94 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.989 -1.07 . . . . 0.0 110.743 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' CZ ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.51 57.44 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -25.67 60.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 110.569 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -66.36 -20.46 66.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.098 -1.001 . . . . 0.0 110.427 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.538 HG11 ' CG2' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -80.5 154.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.913 . . . . 0.0 110.271 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -79.51 -47.02 16.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 111.41 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.457 ' C ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -153.96 146.27 23.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.764 -1.21 . . . . 0.0 111.939 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' HG11 ' A' ' 32' ' ' VAL . 2.1 t -135.56 135.96 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.459 -0.776 . . . . 0.0 109.11 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.468 ' HB3' ' OD1' ' A' ' 49' ' ' ASN . 2.5 tpt -131.71 117.42 18.6 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.968 -1.083 . . . . 0.0 110.692 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' CG2' HG23 ' A' ' 48' ' ' VAL . 4.4 t -114.59 129.8 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.307 -0.87 . . . . 0.0 109.849 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 3.2 m -115.54 135.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 110.402 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -78.28 154.03 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.467 -0.77 . . . . 0.0 110.503 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 161.23 30.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -83.08 6.49 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 110.648 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.91 -65.07 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.334 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 44.0 Cg_endo -70.95 -176.68 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.562 1.296 . . . . 0.0 110.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.97 28.02 17.81 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 14.8 mtt180 -93.92 138.93 31.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.387 -1.066 . . . . 0.0 109.972 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 7.0 m-85 -119.22 153.89 34.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.056 0.931 . . . . 0.0 110.949 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 4.0 mt-10 -104.31 95.83 6.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 10' ' ' TYR . 5.1 t -88.1 122.72 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.852 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 36' ' ' MET . 0.8 OUTLIER -130.68 101.14 5.56 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.606 ' O ' ' CD1' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -117.78 149.8 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.447 0.641 . . . . 0.0 111.262 -178.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 50' ' ' ILE . 5.5 p -112.86 152.86 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.71 -0.619 . . . . 0.0 109.786 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HB2' ' CD2' ' A' ' 6' ' ' TYR . 3.4 mt -100.36 -165.03 1.17 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.054 -1.029 . . . . 0.0 110.924 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.539 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -68.69 -178.83 0.45 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.641 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -63.87 -15.04 46.72 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.758 1.399 . . . . 0.0 110.486 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.06 77.71 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.563 HD21 ' CA ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -69.65 173.2 6.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.73 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 11.9 t70 178.81 171.05 0.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 5.1 mt-30 -57.8 -38.14 75.0 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.707 . . . . 0.0 110.294 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 -31.59 69.02 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.334 -0.854 . . . . 0.0 109.95 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.9 mm100 -74.3 -45.77 45.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.547 HD21 ' CE2' ' A' ' 6' ' ' TYR . 1.6 mp -67.69 -36.0 79.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.993 -1.067 . . . . 0.0 109.514 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.84 -33.7 57.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 67' ' ' ILE . 20.2 mt -69.14 -50.31 49.05 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.271 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 29' ' ' ARG . 78.7 mm-40 -71.54 -42.06 68.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -67.34 -30.5 70.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.472 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.8 mm-40 -69.14 -48.34 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.761 -1.212 . . . . 0.0 109.91 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.61 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 6.3 mt -77.38 -42.4 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.4 -0.812 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.518 ' CG2' HD11 ' A' ' 72' ' ' LEU . 85.6 mt -59.47 -46.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.104 -0.998 . . . . 0.0 109.91 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 5.2 mt-30 -64.16 -44.13 93.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -68.41 -43.44 77.23 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.403 -0.811 . . . . 0.0 111.147 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.07 -48.48 73.6 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.886 -1.134 . . . . 0.0 110.499 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 10' ' ' TYR . 96.6 mt -63.92 -35.19 79.84 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 69' ' ' GLN 0.258 2.0 tt0 -69.93 -45.85 66.63 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 108.988 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -58.24 -37.07 74.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.15 -26.53 60.36 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.893 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.24 28.74 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.61 121.92 41.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.24 . . . . 0.0 110.282 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.35 162.57 18.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 1.5 t -87.6 118.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -12.88 58.26 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.876 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.562 ' CE ' ' O ' ' A' ' 9' ' ' TRP 0.254 0.0 OUTLIER -131.57 157.24 44.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.494 -0.754 . . . . 0.0 111.015 -178.78 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 81' ' ' LYS . 32.6 t -141.3 108.62 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.641 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' HG2' ' C ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -127.11 109.49 11.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.995 -1.065 . . . . 0.0 111.076 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -97.72 121.18 39.33 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.282 -0.886 . . . . 0.0 109.873 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 7' ' ' PHE . 1.9 mp -81.03 -9.41 59.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 0.0 110.18 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.47 105.45 0.44 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -50.16 154.02 1.29 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.245 -1.15 . . . . 0.0 110.311 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.539 ' CB ' ' HA3' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -105.64 158.97 16.33 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 110.429 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 8.5 ptm180 -105.94 109.33 21.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.675 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 pp -61.92 128.37 35.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 110.474 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.08 -51.14 5.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.34 131.15 83.26 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.288 -0.883 . . . . 0.0 110.171 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.52 154.18 44.79 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.959 1.505 . . . . 0.0 110.267 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 94' ' ' ILE . 9.1 tp -78.69 114.32 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.25 78.15 1.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -0.878 . . . . 0.0 110.254 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.114 -0.991 . . . . 0.0 110.228 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' GLN . 1.9 tmt? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.319 0.581 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.62 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 5.3 t70 -76.62 -39.5 2.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 111.476 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.5 Cg_endo -79.5 4.94 6.2 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.297 1.156 . . . . 0.0 110.777 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 5.1 pt20 179.7 -155.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.534 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.56 -79.16 0.06 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.545 ' HB2' ' CB ' ' A' ' 51' ' ' VAL . 1.1 t80 -64.81 98.25 0.26 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.412 -1.052 . . . . 0.0 111.225 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.569 ' CG ' HD11 ' A' ' 85' ' ' LEU . 1.5 m-85 -165.77 25.42 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.095 -1.003 . . . . 0.0 110.257 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.15 132.35 41.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.262 -0.899 . . . . 0.0 110.523 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -122.86 118.24 27.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.095 -1.003 . . . . 0.0 109.892 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.419 ' HB2' ' CG2' ' A' ' 48' ' ' VAL . 36.2 m-85 -127.78 119.15 25.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 0.0 110.906 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.553 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 34.7 tt0 -107.27 155.6 19.77 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.2 -0.937 . . . . 0.0 109.689 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' CG2' ' CD2' ' A' ' 46' ' ' TYR . 4.0 m -129.53 -178.38 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.865 -1.147 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' SD ' ' A' ' 14' ' ' MET . 3.5 pt-20 -133.06 48.87 2.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.537 0.684 . . . . 0.0 109.866 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.481 ' HB2' ' HB3' ' A' ' 18' ' ' ARG . 78.3 mmm -126.01 155.0 73.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 109.485 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.3 Cg_endo -72.67 -166.83 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.811 1.427 . . . . 0.0 113.014 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' O ' HG11 ' A' ' 19' ' ' VAL . 42.4 tt0 -56.38 -26.85 54.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.48 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 29.8 t0 -58.13 -16.13 12.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.059 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.572 ' CD ' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -75.09 -16.57 60.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 110.18 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 20' ' ' ASN . 8.0 p -49.31 -43.68 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.416 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.479 ' N ' HG13 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -64.72 -30.05 71.05 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.594 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 41.1 t0 -65.6 -53.48 41.21 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.556 -0.715 . . . . 0.0 110.07 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 4.7 mp -58.86 -37.11 75.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.136 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.11 -52.71 63.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.158 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -63.32 -46.26 87.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.533 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -56.91 -44.51 82.47 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.454 -0.779 . . . . 0.0 110.17 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' CD2' ' HB ' ' A' ' 35' ' ' VAL . 1.7 mt -66.94 -40.07 87.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.506 -0.746 . . . . 0.0 111.221 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.69 -37.36 83.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.915 -1.116 . . . . 0.0 110.355 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.533 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 14.8 mt -68.18 -44.56 84.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' CD ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -81.4 69.26 8.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.403 -0.81 . . . . 0.0 110.297 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 37.7 p-10 -73.49 -25.96 60.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 6.1 t30 -58.82 -13.88 7.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.407 -0.808 . . . . 0.0 110.575 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.612 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 8.0 p -79.63 141.41 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 111.037 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -46.64 15.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 111.253 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttt180 -152.98 123.79 7.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 111.201 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HB ' ' CD2' ' A' ' 26' ' ' LEU . 11.3 t -108.5 135.46 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 110.035 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 115.76 19.98 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.176 -0.953 . . . . 0.0 110.335 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.478 ' CG1' HD22 ' A' ' 22' ' ' LEU . 48.7 t -114.82 132.04 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.558 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 47' ' ' GLU . 3.9 m -113.22 130.79 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.371 -0.831 . . . . 0.0 110.018 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.619 ' HA ' ' CD1' ' A' ' 46' ' ' TYR . . . -77.62 153.67 32.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.519 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -73.59 166.33 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 109.445 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -83.51 2.83 35.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 0.0 110.848 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.42 -64.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.009 -1.057 . . . . 0.0 110.458 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.6 Cg_endo -70.55 -171.06 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.568 1.299 . . . . 0.0 111.072 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.24 26.42 18.8 Favored Glycine 0 N--CA 1.479 1.563 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -93.45 135.7 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 108.64 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.619 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 11.1 m-85 -128.73 151.29 49.71 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.763 -1.211 . . . . 0.0 112.379 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 mt-10 -105.03 90.63 3.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.098 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 16.0 m -86.92 125.24 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' HB3' ' OH ' ' A' ' 6' ' ' TYR . 21.6 m-80 -123.63 100.74 6.94 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.612 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.13 147.77 16.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.447 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.545 ' CB ' ' HB2' ' A' ' 6' ' ' TYR . 2.7 p -102.82 129.76 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.12 -0.988 . . . . 0.0 111.296 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.587 ' CD2' ' CD1' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -93.58 -168.29 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.904 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.53 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.2 m-80 -50.93 172.91 0.12 Allowed Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.0 109.505 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.8 Cg_endo -63.22 -14.66 43.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.548 1.289 . . . . 0.0 110.849 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 4.2 t30 -146.19 86.77 1.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.106 -0.996 . . . . 0.0 110.696 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 52' ' ' LEU . 8.7 mt -61.17 -171.41 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 111.068 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.8 t70 172.94 172.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.483 0.659 . . . . 0.0 110.103 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 11.7 mt-30 -56.37 -34.31 66.55 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -34.22 75.15 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.468 ' CB ' HD22 ' A' ' 56' ' ' LEU . 29.1 mm100 -72.05 -44.32 63.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 110.099 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.469 HD23 ' HG2' ' A' ' 84' ' ' GLU . 55.5 mt -63.37 -34.26 77.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 109.935 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.75 -40.36 63.03 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.613 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.1 mt -71.54 -49.99 35.5 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 79.1 mm-40 -58.34 -41.94 85.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.737 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' CE ' ' OE1' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -70.79 -46.9 62.03 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.263 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -71.4 -37.66 71.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.85 -1.156 . . . . 0.0 109.834 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 63' ' ' LEU . 11.0 mm -76.49 -41.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 56.2 mt -70.26 -49.73 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.714 -1.242 . . . . 0.0 109.786 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 25.7 mm-40 -59.17 -38.74 80.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.883 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -57.74 -48.08 80.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.264 -0.898 . . . . 0.0 111.128 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 25' ' ' GLU . . . -70.95 -48.52 52.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.907 -1.121 . . . . 0.0 110.099 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 20.3 mt -63.71 -35.41 80.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.604 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 4.8 mm-40 -69.57 -45.08 69.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.427 -0.795 . . . . 0.0 109.283 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.48 -40.24 90.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.74 -29.17 58.78 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.528 -0.733 . . . . 0.0 110.0 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . 101.06 18.34 20.11 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -93.6 127.12 39.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -1.086 . . . . 0.0 110.483 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.8 141.32 48.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 109.874 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 2.9 t -94.17 125.37 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.66 -10.29 58.29 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -131.56 133.4 44.99 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 82' ' ' VAL . 2.1 p -141.34 106.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.321 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -128.45 105.87 8.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.96 -1.087 . . . . 0.0 110.548 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HG2' HD23 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -101.84 122.84 44.74 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.768 179.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.569 HD11 ' CG ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -76.65 -26.16 54.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.858 -1.151 . . . . 0.0 109.736 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . 65.81 -168.68 31.84 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 ' HG ' ' OD1' ' A' ' 55' ' ' ASN . 1.6 tt -60.47 73.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.25 -1.147 . . . . 0.0 110.224 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 86' ' ' GLY . 51.3 ttt85 -117.46 143.3 46.18 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.172 -0.955 . . . . 0.0 110.377 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 12.7 mtt85 -103.0 133.95 47.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 110.081 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -171.88 91.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.657 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.88 -176.5 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.139 -0.976 . . . . 0.0 109.891 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -103.73 139.02 19.71 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.538 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.66 -3.06 12.82 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.186 1.624 . . . . 0.0 110.636 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.15 114.32 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.101 -0.999 . . . . 0.0 110.286 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 96' ' ' LYS . . . -132.63 153.8 50.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.207 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.499 ' CA ' ' HA ' ' A' ' 54' ' ' PRO . 1.2 tmm? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.395 0.617 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 15.9 t0 -76.65 -43.7 3.13 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.908 . . . . 0.0 110.579 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.5 Cg_endo -77.3 4.25 6.04 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.512 1.27 . . . . 0.0 110.429 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' TYR . 9.7 pt20 -178.68 -139.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.896 . . . . 0.0 110.083 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.462 ' O ' HD13 ' A' ' 56' ' ' LEU . . . 59.32 -80.8 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 6' ' ' TYR . 1.4 p90 -66.38 121.55 15.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -1.166 . . . . 0.0 110.772 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -169.49 42.9 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.522 HD22 ' CD2' ' A' ' 61' ' ' LEU . 10.9 mt -126.04 125.01 41.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.468 -0.77 . . . . 0.0 110.35 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.481 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -116.54 119.16 34.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.823 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' OH ' ' CG ' ' A' ' 84' ' ' GLU . 22.0 m-85 -124.19 118.11 26.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.607 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.532 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 31.6 tt0 -110.82 147.14 35.15 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.405 -0.809 . . . . 0.0 109.452 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 m -126.65 -179.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.837 -1.164 . . . . 0.0 111.433 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -129.65 45.3 2.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.737 0.779 . . . . 0.0 109.033 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.535 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 60.6 mmm -120.29 145.99 41.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.77 -0.581 . . . . 0.0 109.563 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 33.4 Cg_endo -67.99 -166.57 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.77 1.405 . . . . 0.0 113.518 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.479 ' HG2' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -59.13 -27.57 65.75 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.237 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -59.53 -22.27 61.42 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.021 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.614 ' NH1' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -83.54 -13.47 54.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.227 -0.921 . . . . 0.0 110.378 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 16' ' ' GLU . 51.8 t -48.0 -46.62 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.585 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -57.8 -29.96 65.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.4 t0 -61.15 -50.77 71.82 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.435 -0.791 . . . . 0.0 109.928 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.9 mm? -59.62 -41.45 90.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.116 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.21 -52.37 64.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.179 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.18 -42.35 89.01 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.33 -0.856 . . . . 0.0 109.608 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 19.0 tt0 -56.89 -48.77 77.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 110.903 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -69.02 -37.56 78.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 110.812 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.447 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.94 -36.11 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.01 -1.056 . . . . 0.0 111.395 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' CG2' HG22 ' A' ' 67' ' ' ILE . 73.1 mt -62.93 -44.83 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.951 -1.093 . . . . 0.0 111.378 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 29' ' ' ARG . 5.9 ptt180 -83.83 93.15 7.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.061 . . . . 0.0 110.788 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -73.43 -24.82 60.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.477 ' OD1' HD23 ' A' ' 52' ' ' LEU . 23.6 p30 -58.56 -15.12 9.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.613 ' CG2' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.61 134.36 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.399 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.462 ' HD2' ' HE2' ' A' ' 1' ' ' MET . 3.1 ttm-85 -79.47 -45.65 18.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 111.043 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -152.7 134.54 14.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.805 -1.184 . . . . 0.0 111.087 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.616 ' HA ' HG13 ' A' ' 50' ' ' ILE . 2.2 p -125.86 131.31 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.339 -0.851 . . . . 0.0 110.547 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.3 ttt -140.42 116.02 10.14 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.611 -0.68 . . . . 0.0 109.538 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 33.2 t -111.88 131.93 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 110.829 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 38' ' ' VAL . 33.5 m -105.59 142.11 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.458 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.03 154.67 23.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.357 -0.839 . . . . 0.0 110.517 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.441 ' HB3' ' NH2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -74.04 -176.12 2.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.089 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -103.06 9.89 38.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.169 -0.957 . . . . 0.0 110.82 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -155.93 -65.1 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.15 -0.969 . . . . 0.0 109.797 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.1 Cg_endo -71.43 -178.94 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.536 1.282 . . . . 0.0 110.334 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -105.13 30.17 10.42 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 3.0 ptt-85 -93.49 160.6 14.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.02 -1.282 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.614 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 78.6 m-85 -134.42 154.38 51.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.089 0.947 . . . . 0.0 111.358 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.55 95.05 7.02 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 15.2 t -78.18 112.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 111.07 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.426 ' O ' HD12 ' A' ' 50' ' ' ILE . 69.1 m-80 -131.29 100.81 5.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.616 HG13 ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -116.11 146.2 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.561 ' HA ' ' CB ' ' A' ' 6' ' ' TYR . 8.4 p -105.85 122.83 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.13 -168.5 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.5 m120 -41.77 165.17 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.46 -0.775 . . . . 0.0 110.07 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.499 ' HA ' ' CA ' ' A' ' 1' ' ' MET . 38.3 Cg_endo -64.4 -27.06 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.762 1.401 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 12.7 t-20 -127.75 78.36 1.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 10.8 mt -62.28 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.226 -0.921 . . . . 0.0 111.011 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 58' ' ' GLN . 5.4 t0 174.59 172.09 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.441 0.638 . . . . 0.0 109.829 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.472 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.3 mm-40 -60.38 -31.4 70.32 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 110.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -70.05 -40.75 74.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.323 -0.861 . . . . 0.0 110.113 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 4.6 mm-40 -66.44 -42.77 87.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 109.942 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.522 ' CD2' HD22 ' A' ' 8' ' ' LEU . 15.1 mt -63.92 -33.5 75.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 109.732 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 59' ' ' SER . . . -51.74 -37.05 49.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 67' ' ' ILE . 62.5 mt -72.19 -51.36 21.5 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.486 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.3 mm-40 -61.64 -36.75 81.68 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.813 -1.179 . . . . 0.0 110.205 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.505 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -72.21 -47.05 53.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.976 -1.078 . . . . 0.0 110.232 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.45 ' OE2' HD23 ' A' ' 63' ' ' LEU . 23.7 pt-20 -71.21 -34.65 71.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.1 -1.0 . . . . 0.0 109.318 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.635 HG12 ' O ' ' A' ' 63' ' ' LEU . 21.4 mm -77.03 -43.51 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.544 -0.722 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 64' ' ' GLU . 49.6 mt -69.75 -46.01 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 110.259 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.09 -34.08 77.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.183 -0.948 . . . . 0.0 110.157 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 2.0 ttt-85 -64.42 -46.21 84.23 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.136 -0.978 . . . . 0.0 110.328 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 25' ' ' GLU . . . -67.69 -48.61 66.11 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 110.21 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.458 HD21 ' HB1' ' A' ' 77' ' ' ALA . 86.9 mt -64.63 -36.07 83.07 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 38.3 mm-40 -70.05 -45.05 67.93 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.623 0.725 . . . . 0.0 109.247 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.51 -37.12 84.83 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.606 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.87 -41.08 60.48 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.564 -0.71 . . . . 0.0 110.049 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.15 23.6 4.48 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -98.7 138.23 36.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.218 . . . . 0.0 110.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -119.32 121.95 40.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.142 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 2.1 t -83.25 126.68 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.185 -0.947 . . . . 0.0 110.037 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.12 -15.01 54.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.63 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.499 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -130.66 129.65 42.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.682 -0.636 . . . . 0.0 110.454 -179.264 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.65 108.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.906 -1.121 . . . . 0.0 110.887 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 34.2 mp0 -127.45 105.7 8.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.982 . . . . 0.0 110.117 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.512 ' CG ' ' OH ' ' A' ' 10' ' ' TYR . 2.1 mp0 -101.88 104.9 15.66 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.263 -0.898 . . . . 0.0 110.353 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 16.6 mt -105.74 -67.82 0.9 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.051 -1.03 . . . . 0.0 109.812 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 87' ' ' LEU . . . 55.15 46.57 78.11 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' A' ' 87' ' ' LEU . 3.5 pp 179.65 45.19 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.422 -1.046 . . . . 0.0 110.059 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.557 ' HB2' ' CD2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -121.36 121.16 37.01 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.503 -0.748 . . . . 0.0 110.241 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -93.52 109.51 21.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 110.508 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.472 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 3.7 pp -85.12 150.96 24.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 110.01 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.1 -92.36 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 110.334 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -92.03 154.95 43.42 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.206 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.07 83.98 1.37 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.962 1.506 . . . . 0.0 110.384 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -103.34 122.19 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.027 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.04 167.6 9.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 110.152 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 pptp? . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.104 179.909 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.537 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 6.6 mtm . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.12 0.486 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.614 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -62.59 -38.02 41.05 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.32 -0.863 . . . . 0.0 111.543 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 46.7 Cg_endo -78.58 1.84 8.68 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.289 1.152 . . . . 0.0 110.181 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 179.75 116.99 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 110.198 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.475 ' O ' HD13 ' A' ' 56' ' ' LEU . . . 122.28 -82.42 0.35 Allowed Glycine 0 N--CA 1.487 2.076 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.612 ' CG ' ' HA ' ' A' ' 51' ' ' VAL . 10.2 p90 -110.92 147.97 33.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -1.173 . . . . 0.0 111.879 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -158.0 51.49 0.43 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.421 HD23 ' HG3' ' A' ' 84' ' ' GLU . 1.4 mp -129.02 136.73 50.69 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.774 0.797 . . . . 0.0 111.886 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.444 ' C ' ' HE3' ' A' ' 81' ' ' LYS . 3.7 t90 -125.59 119.01 26.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' CD2' HG22 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -123.59 140.36 53.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 111.383 -178.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.542 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 38.8 tt0 -122.76 158.14 30.82 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.506 -0.746 . . . . 0.0 109.513 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.449 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 13.6 m -130.76 177.59 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.046 . . . . 0.0 110.507 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -131.2 51.99 2.1 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.513 0.673 . . . . 0.0 109.979 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.533 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 54.2 mmm -132.98 153.54 81.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.303 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -71.02 -167.54 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.703 1.37 . . . . 0.0 113.487 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 19' ' ' VAL . 2.6 tt0 -58.27 -27.27 63.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.709 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -59.16 -21.71 59.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.319 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.549 ' NH2' ' CB ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -87.78 -16.87 32.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.788 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.474 ' N ' ' HG3' ' A' ' 18' ' ' ARG . 40.5 t -48.76 -45.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 109.934 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.468 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.2 t-20 -54.96 -29.24 56.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.769 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.58 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 38.3 t0 -60.34 -48.88 79.84 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.422 -0.799 . . . . 0.0 110.017 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.464 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.9 mm? -58.84 -36.74 75.04 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.475 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.8 -52.77 63.78 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.316 -0.865 . . . . 0.0 109.237 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 42.1 mtt180 -66.09 -44.09 85.43 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.429 -0.795 . . . . 0.0 109.331 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.535 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.7 -44.19 77.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.525 ' CD2' HG11 ' A' ' 35' ' ' VAL . 16.0 mt -65.44 -38.96 91.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.668 -0.645 . . . . 0.0 110.46 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -66.14 -36.24 82.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.207 -0.933 . . . . 0.0 111.756 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.557 ' N ' ' HG3' ' A' ' 27' ' ' ARG . 49.0 mt -65.1 -45.7 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.609 -1.307 . . . . 0.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.5 ' NH1' HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.29 79.56 9.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.042 . . . . 0.0 110.679 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.28 -25.47 62.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.998 . . . . 0.0 110.245 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.19 -14.47 10.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 50' ' ' ILE . 2.2 p -79.68 133.65 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.197 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -80.09 -45.87 17.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 111.765 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.474 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.2 mtt85 -152.34 130.39 11.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.738 -1.226 . . . . 0.0 111.598 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 26' ' ' LEU . 2.8 t -122.85 135.68 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.725 . . . . 0.0 109.209 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 115.71 23.01 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.019 -1.051 . . . . 0.0 110.715 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.41 HG12 ' HG ' ' A' ' 22' ' ' LEU . 15.7 t -114.87 129.09 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.298 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 3.6 m -119.81 125.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -82.36 153.99 25.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 p -74.31 -178.93 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.001 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -105.09 5.98 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -149.43 -66.34 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.963 . . . . 0.0 110.21 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.0 Cg_endo -71.59 -164.54 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.334 1.176 . . . . 0.0 110.13 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.29 34.36 4.32 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.1 mtt180 -97.33 134.71 40.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -1.101 . . . . 0.0 110.331 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.572 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 8.1 m-85 -117.88 155.44 30.15 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.288 -0.882 . . . . 0.0 110.438 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.8 mp0 -102.52 98.32 8.41 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 10' ' ' TYR . 66.9 t -78.45 111.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 111.356 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -131.13 101.94 5.8 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.555 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.16 146.91 17.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.728 -177.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.612 ' HA ' ' CG ' ' A' ' 6' ' ' TYR . 11.7 p -119.36 146.92 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.432 -0.792 . . . . 0.0 110.2 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 1.5 mp -135.06 -160.94 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.615 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' LEU . 26.8 m-80 -38.88 161.14 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.92 -0.488 . . . . 0.0 110.351 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 4' ' ' GLN . 39.4 Cg_endo -64.91 -20.39 64.35 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.91 1.479 . . . . 0.0 110.878 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -143.66 84.4 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 52' ' ' LEU . 18.3 mt -68.37 -162.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' CA ' HD21 ' A' ' 87' ' ' LEU . 9.0 t70 -161.7 172.2 16.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 0.0 110.464 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 69.2 mt-30 -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.728 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 t -64.49 -28.31 69.57 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.233 -0.917 . . . . 0.0 110.062 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 39.1 mm-40 -65.33 -40.68 94.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 91.6 mt -65.29 -35.25 80.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.048 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.17 -36.39 51.51 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.569 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.9 mt -72.52 -50.67 24.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.179 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' OE1' ' HB2' ' A' ' 29' ' ' ARG . 5.8 mm-40 -63.72 -33.87 76.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.846 -1.159 . . . . 0.0 110.437 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -72.24 -46.73 54.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.394 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 32.2 mm-40 -66.55 -35.38 80.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.121 -0.987 . . . . 0.0 109.85 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 63' ' ' LEU . 11.5 mm -76.71 -47.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.42 -0.8 . . . . 0.0 111.498 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.535 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 45.8 mt -67.78 -48.19 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.937 -1.102 . . . . 0.0 110.125 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.8 mm100 -62.16 -32.93 73.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.329 -0.857 . . . . 0.0 109.956 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -65.81 -46.93 76.78 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.207 -0.933 . . . . 0.0 110.97 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.3 -48.93 47.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.969 -1.082 . . . . 0.0 111.589 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 38.2 mt -58.3 -39.13 78.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 111.293 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 5.3 tt0 -71.28 -46.8 60.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.112 0.958 . . . . 0.0 109.411 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 8.6 t-20 -59.21 -36.89 76.2 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.58 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -74.94 -34.76 62.12 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.873 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.431 ' O ' ' HE3' ' A' ' 14' ' ' MET . . . 113.21 13.81 10.46 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.505 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -102.73 125.69 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 110.2 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -111.99 134.86 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 109.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 10' ' ' TYR . 3.0 t -66.54 124.93 22.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.066 -1.021 . . . . 0.0 109.785 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.2 -11.7 59.35 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.427 -0.796 . . . . 0.0 109.109 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.269 0.0 OUTLIER -138.16 145.37 41.45 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.633 -0.667 . . . . 0.0 110.74 -178.923 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.67 105.26 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.562 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -130.06 108.13 9.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 111.046 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HG3' HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -99.38 100.78 11.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 109.578 178.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' CB ' ' CD2' ' A' ' 7' ' ' PHE . 13.6 mt -75.32 -0.53 20.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.045 -1.034 . . . . 0.0 110.304 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.18 119.94 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.469 HD21 ' CA ' ' A' ' 57' ' ' ASP . 1.5 pp -44.79 134.93 5.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 110.421 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.4 OUTLIER -93.34 164.41 13.23 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.191 -0.943 . . . . 0.0 110.691 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 6.0 ptm180 -126.32 111.71 14.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.172 -0.955 . . . . 0.0 109.986 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 90' ' ' LEU . 26.0 tp -94.79 72.28 3.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -0.982 . . . . 0.0 109.968 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.72 97.42 4.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.247 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -97.92 137.53 20.92 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 110.204 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 154.24 54.07 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.043 1.549 . . . . 0.0 110.457 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.84 114.71 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.394 -0.816 . . . . 0.0 110.019 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.53 131.84 34.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.928 . . . . 0.0 110.55 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.141 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.342 0.591 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.63 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 36.2 t0 -65.17 -37.79 23.26 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.3 -0.875 . . . . 0.0 111.394 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 47.5 Cg_endo -90.7 24.0 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.342 1.18 . . . . 0.0 109.981 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 26.1 mt-30 -125.77 -157.02 0.77 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.351 -0.843 . . . . 0.0 110.665 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.477 ' O ' HD11 ' A' ' 56' ' ' LEU . . . -102.87 0.85 48.29 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.601 ' CD1' ' O ' ' A' ' 50' ' ' ILE . 0.5 OUTLIER -61.61 98.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.928 -1.337 . . . . 0.0 110.526 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HB2' ' HA3' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -163.42 25.18 0.08 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.512 -0.743 . . . . 0.0 109.594 178.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.599 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 7.8 mp -90.63 129.38 36.76 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 110.243 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 1.6 t90 -124.57 123.56 40.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.524 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 26.3 m-85 -126.79 138.01 53.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.412 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.52 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 1.9 tp60 -121.99 159.99 25.84 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.221 -0.924 . . . . 0.0 110.224 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.477 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 m -133.36 -176.94 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.02 . . . . 0.0 110.609 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' SD ' ' A' ' 14' ' ' MET . 5.6 pt-20 -138.41 56.04 1.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.537 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 4.5 mmt -137.05 149.49 66.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.553 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.484 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -70.84 -167.21 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.035 1.545 . . . . 0.0 113.13 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HA ' HG22 ' A' ' 19' ' ' VAL . 1.4 tt0 -65.22 -25.76 67.83 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.8 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.83 -45.54 89.77 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.264 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 2.8 mtp180 -89.76 -23.65 21.71 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.944 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.505 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 24.4 t -47.95 -38.41 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.525 -0.734 . . . . 0.0 110.012 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 25.1 t-20 -53.36 -29.12 32.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.166 -0.959 . . . . 0.0 109.066 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.588 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 32.9 t0 -59.89 -42.39 93.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.0 mp -58.32 -38.65 77.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.615 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.32 58.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -46.77 82.16 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.216 -0.927 . . . . 0.0 109.292 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' OE1' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -59.29 -48.12 82.82 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.85 0.833 . . . . 0.0 109.454 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 13.3 mt -53.95 -36.92 63.34 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.455 0.645 . . . . 0.0 110.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -35.6 74.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.602 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 15.9 mt -59.48 -32.52 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.041 . . . . 0.0 110.979 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.546 ' O ' ' CG ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -69.4 48.64 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.067 -1.021 . . . . 0.0 111.661 -178.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -25.59 25.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.435 -1.416 . . . . 0.0 109.851 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.384 -0.823 . . . . 0.0 111.14 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.586 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.5 OUTLIER -83.46 142.78 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.12 . . . . 0.0 110.54 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.85 22.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 111.598 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.79 150.34 30.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.619 -1.301 . . . . 0.0 111.822 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.524 ' CB ' HG13 ' A' ' 50' ' ' ILE . 9.7 p -140.03 134.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.4 mtm -122.81 114.12 20.08 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.843 -1.16 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -116.43 132.15 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 109.925 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' HB ' ' CD ' ' A' ' 47' ' ' GLU . 11.2 t -118.81 157.08 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.607 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.11 154.95 21.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -73.91 -170.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.05 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -103.1 -2.13 27.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 111.031 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.578 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -152.25 -66.38 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -70.15 -158.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.469 1.247 . . . . 0.0 110.699 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.79 34.95 4.51 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 2.2 mtt180 -94.52 136.69 34.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -1.13 . . . . 0.0 109.815 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 32.7 m-85 -117.21 153.97 31.95 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.099 -1.0 . . . . 0.0 111.256 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' CD ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -103.67 110.82 23.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 67.5 t -89.41 124.66 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 111.686 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.476 ' ND2' ' N ' ' A' ' 49' ' ' ASN . 1.4 m-80 -131.01 101.18 5.5 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.601 ' O ' ' CD1' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -124.05 148.27 28.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 111.689 -178.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' CD1' ' A' ' 6' ' ' TYR . 7.2 p -105.68 151.28 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.695 -0.628 . . . . 0.0 109.758 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 4.9 mp -132.88 -170.62 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.053 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.473 ' N ' HD22 ' A' ' 56' ' ' LEU . 39.2 m-80 -43.44 161.3 0.2 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 110.456 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.401 ' CB ' ' O ' ' A' ' 90' ' ' LEU . 39.7 Cg_endo -65.42 -31.75 51.24 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.099 1.579 . . . . 0.0 110.838 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 35.8 t-20 -113.3 70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 9.1 mt -62.85 -168.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 110.984 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 168.18 -175.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.62 0.724 . . . . 0.0 110.031 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.556 ' HA ' ' CD2' ' A' ' 61' ' ' LEU . 74.4 mt-30 -65.54 -32.44 74.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.06 -30.37 63.66 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 110.29 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.431 ' HG3' ' HA ' ' A' ' 56' ' ' LEU . 15.2 mm100 -73.84 -46.12 47.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 58' ' ' GLN . 3.7 pp -68.0 -34.98 77.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 109.267 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.67 -35.6 55.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.656 ' O ' HG12 ' A' ' 67' ' ' ILE . 15.2 mt -70.92 -50.83 30.52 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.005 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 28.3 mm-40 -65.0 -41.84 95.02 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.37 -1.456 . . . . 0.0 109.397 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.22 -46.33 64.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.896 -1.127 . . . . 0.0 110.326 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 52.9 mm-40 -70.05 -39.75 75.52 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.891 -1.131 . . . . 0.0 110.106 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.656 HG12 ' O ' ' A' ' 63' ' ' LEU . 18.9 mm -77.54 -41.55 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.319 -0.863 . . . . 0.0 111.562 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CG2' ' OE1' ' A' ' 25' ' ' GLU . 24.0 mt -70.74 -49.7 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.53 -1.356 . . . . 0.0 110.047 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.556 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 2.7 mt-30 -58.74 -34.09 70.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.243 -0.91 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' NH1' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -56.49 -47.63 78.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.84 -1.162 . . . . 0.0 109.868 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -71.93 -48.46 45.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 110.654 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 93.1 mt -58.2 -43.9 87.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 111.472 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.556 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.08 -44.26 69.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.163 -0.96 . . . . 0.0 109.468 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -59.67 -37.07 77.76 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.588 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -75.14 -26.18 58.97 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.644 -0.66 . . . . 0.0 110.117 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 14' ' ' MET . . . 109.92 -0.51 30.19 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -90.62 127.58 36.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.253 -1.145 . . . . 0.0 110.13 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.31 147.65 44.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 110.596 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 3.6 t -86.31 125.81 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -9.82 59.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.357 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.499 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -133.58 150.0 51.63 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.615 -0.678 . . . . 0.0 110.776 -179.022 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.68 107.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.856 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -128.4 106.86 9.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.996 -1.065 . . . . 0.0 111.118 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -100.22 90.23 4.28 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 8' ' ' LEU . 4.4 mt -111.79 177.99 4.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.959 . . . . 0.0 110.191 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 7' ' ' PHE . . . 76.01 137.08 0.66 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 87' ' ' LEU . 2.5 pp 179.8 41.92 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.552 -0.969 . . . . 0.0 109.315 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -82.17 176.11 9.76 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.723 -0.611 . . . . 0.0 110.257 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -128.7 99.62 5.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 110.32 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -120.34 92.9 3.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.046 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.24 175.78 8.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.847 . . . . 0.0 110.198 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -90.81 154.46 45.59 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.038 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.84 54.79 2.64 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.002 1.527 . . . . 0.0 110.672 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -125.28 121.99 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.892 . . . . 0.0 110.424 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.509 ' N ' HD12 ' A' ' 94' ' ' ILE . . . -43.63 -70.13 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.469 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.287 -179.883 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' GLN . 4.8 tmm? . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.221 0.534 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.596 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 13.9 t0 -73.58 -43.53 6.92 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.007 . . . . 0.0 110.466 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.2 Cg_endo -82.18 10.12 3.68 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.61 1.321 . . . . 0.0 110.193 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -170.73 -160.35 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.632 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 56' ' ' LEU . . . -120.42 43.15 1.59 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -62.94 98.71 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -1.23 . . . . 0.0 110.262 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.44 ' HB3' ' C ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.15 34.51 0.99 Allowed 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.27 -0.894 . . . . 0.0 109.831 179.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 2.9 mm? -103.47 126.19 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.395 -0.815 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CE2' ' OD1' ' A' ' 49' ' ' ASN . 1.6 t90 -124.15 130.94 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.178 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -126.24 134.87 51.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.208 -0.932 . . . . 0.0 110.744 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.507 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 54.8 tt0 -123.02 159.05 29.2 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 5.2 m -138.56 -176.74 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 110.643 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 5.0 tt0 -140.72 54.28 1.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 110.249 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.545 ' CB ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -130.43 161.17 62.2 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.168 -0.958 . . . . 0.0 110.347 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' O ' HG22 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -75.44 -178.42 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.934 1.492 . . . . 0.0 113.009 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.545 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -67.6 -24.6 65.5 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.409 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -59.72 -45.53 91.87 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.718 -0.614 . . . . 0.0 111.5 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.545 ' HD2' ' CB ' ' A' ' 14' ' ' MET . 1.1 ptp180 -89.71 -10.22 46.54 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 111.466 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.546 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 18.2 t -45.16 -36.16 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.115 -0.991 . . . . 0.0 110.42 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -51.53 -26.86 9.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.598 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 33.0 t0 -58.84 -45.76 89.29 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.498 -0.751 . . . . 0.0 110.046 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 1.3 mp -57.92 -41.52 82.9 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.41 63.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.15 -0.969 . . . . 0.0 109.587 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -60.73 -46.77 89.14 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 2.7 tm-20 -60.98 -48.89 79.75 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 109.946 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.527 HD23 ' CG2' ' A' ' 35' ' ' VAL . 41.4 mt -54.28 -37.57 64.9 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.357 0.599 . . . . 0.0 110.268 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.063 -1.023 . . . . 0.0 110.357 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.608 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 7.7 mt -59.49 -44.77 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 121.013 -1.054 . . . . 0.0 110.374 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' NH2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -80.72 65.46 5.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -53.95 -24.54 16.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.815 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -57.99 -13.12 4.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 110.16 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 1.8 p -78.54 126.65 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.147 -0.971 . . . . 0.0 110.1 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HG2' ' HB2' ' A' ' 34' ' ' ARG . 26.9 ttt180 -79.69 -44.95 19.89 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -151.71 122.97 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.733 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' CG2' HD23 ' A' ' 26' ' ' LEU . 11.5 p -132.6 136.02 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.2 122.63 20.7 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.104 -0.997 . . . . 0.0 110.688 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 48' ' ' VAL . 60.0 t -114.38 130.55 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 0.0 110.149 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.87 146.22 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.538 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.41 154.17 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.556 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -74.17 -170.22 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.3 p -103.31 -2.05 27.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 110.994 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -144.84 -67.15 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.0 110.616 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.0 Cg_endo -72.56 -168.29 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.353 1.186 . . . . 0.0 110.705 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -108.02 35.32 5.06 Favored Glycine 0 N--CA 1.479 1.5 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.472 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 4.3 mtp-105 -93.54 134.87 35.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.54 -0.977 . . . . 0.0 110.139 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.583 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 9.5 m-85 -119.31 154.3 33.74 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.876 0.846 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -103.93 99.04 8.79 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 37' ' ' VAL . 47.0 t -79.15 124.41 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.773 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 71.4 m-80 -131.29 100.92 5.35 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.588 ' O ' ' CD1' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -119.19 138.91 48.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.515 -0.74 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.586 ' HA ' ' CD1' ' A' ' 6' ' ' TYR . 4.0 p -96.59 151.14 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 109.324 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.528 ' N ' HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -114.11 173.91 6.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 111.503 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 65.2 m-80 -58.45 167.11 1.87 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.67 -0.644 . . . . 0.0 109.693 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.67 -15.17 44.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.6 1.316 . . . . 0.0 110.78 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -125.93 66.15 1.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.063 -1.023 . . . . 0.0 110.148 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.46 177.23 6.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.962 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.519 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.0 t70 -177.08 171.89 2.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.977 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -60.23 -33.23 71.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.597 -0.69 . . . . 0.0 110.037 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -65.04 -45.01 87.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 8.5 mm-40 -64.46 -44.32 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.855 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.524 ' CD2' ' OE1' ' A' ' 64' ' ' GLU . 74.3 mt -64.82 -37.32 87.22 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.729 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.46 55.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.864 -1.148 . . . . 0.0 108.065 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.531 ' O ' ' CG1' ' A' ' 67' ' ' ILE 0.256 0.1 OUTLIER -70.49 -51.28 30.03 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.666 0.746 . . . . 0.0 108.987 178.564 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' OE1' ' CD2' ' A' ' 61' ' ' LEU . 3.7 pt-20 -66.94 -43.16 83.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.316 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.38 -41.45 93.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.327 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -34.71 73.71 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.608 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -75.25 -50.41 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.569 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 17.8 mt -59.71 -46.71 93.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 43.5 mt-30 -61.04 -47.28 87.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 109.749 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.68 -47.22 85.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 0.0 110.772 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB2' ' CG ' ' A' ' 25' ' ' GLU . . . -69.91 -48.81 57.14 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.975 -1.078 . . . . 0.0 110.307 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.49 HD21 ' CB ' ' A' ' 77' ' ' ALA . 44.4 mt -64.06 -35.07 79.54 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.38 -0.825 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 2.1 mm-40 -69.37 -45.24 69.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.53 -0.731 . . . . 0.0 109.176 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -62.6 -39.19 92.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.598 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.23 -37.34 61.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.267 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 115.52 20.8 5.32 Favored Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.49 ' CB ' HD21 ' A' ' 72' ' ' LEU . . . -95.22 123.4 38.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.241 . . . . 0.0 110.123 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.12 134.11 55.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.524 HG22 ' CE2' ' A' ' 10' ' ' TYR . 2.2 t -89.73 123.13 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.41 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -81.78 -10.75 59.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.61 140.6 52.0 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.425 -0.797 . . . . 0.0 110.9 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -140.86 105.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 109.939 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.12 107.42 9.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 0.0 110.462 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.542 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 39.2 mt-10 -100.3 90.89 4.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.997 -1.065 . . . . 0.0 110.389 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.44 ' C ' ' HB3' ' A' ' 7' ' ' PHE . 5.0 mt -116.7 178.77 4.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 109.928 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.444 ' O ' HD22 ' A' ' 87' ' ' LEU . . . 90.6 143.08 10.51 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' CD2' ' HA ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER 179.84 46.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.462 -1.022 . . . . 0.0 109.511 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -84.09 170.02 14.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.552 -0.717 . . . . 0.0 111.071 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mtp-105 -144.62 39.81 1.28 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.942 0.877 . . . . 0.0 109.582 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.46 115.05 27.57 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.267 0.556 . . . . 0.0 110.446 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.97 52.74 0.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 109.986 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -92.39 160.41 34.99 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 110.411 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.12 166.84 28.92 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.009 1.531 . . . . 0.0 110.261 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 84.6 mt -91.25 129.97 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.93 9.12 7.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.899 . . . . 0.0 110.028 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.1 tptp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.224 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.559 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.163 0.506 . . . . 0.0 110.197 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.637 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.9 t70 -77.49 -38.14 1.76 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.493 -0.755 . . . . 0.0 111.715 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 52.8 Cg_endo -90.15 11.71 2.69 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.412 1.217 . . . . 0.0 109.142 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.559 ' NE2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -58.27 -139.6 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.426 0.632 . . . . 0.0 111.086 -179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 56' ' ' LEU . . . -34.95 -27.01 0.01 OUTLIER Glycine 0 N--CA 1.494 2.503 0 O-C-N 121.744 -0.598 . . . . 0.0 111.834 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.6 ' CG ' ' HA ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -61.22 97.16 0.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.288 -1.713 . . . . 0.0 109.674 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -167.96 42.57 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.736 179.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.08 132.44 50.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.447 -0.783 . . . . 0.0 110.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -124.12 118.37 26.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.956 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.442 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 25.6 m-85 -126.93 134.66 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.493 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 45' ' ' ARG . 3.7 tt0 -117.44 158.29 24.74 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 HG23 ' HA ' ' A' ' 45' ' ' ARG . 17.2 m -134.29 -177.43 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.97 -1.081 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -134.51 51.07 2.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.501 ' SD ' ' CB ' ' A' ' 18' ' ' ARG . 1.5 ptp -130.22 152.74 80.66 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.423 -0.798 . . . . 0.0 109.74 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -70.73 -165.69 0.19 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.755 1.397 . . . . 0.0 113.202 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.53 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 19.6 tt0 -52.1 -24.83 7.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.865 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.453 ' O ' ' OH ' ' A' ' 75' ' ' TYR . 12.0 t70 -56.78 -23.76 45.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.044 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' CZ ' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -70.04 -14.1 62.53 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.386 -0.821 . . . . 0.0 110.83 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 16' ' ' GLU . 98.0 t -51.82 -48.79 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.144 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.553 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -59.24 -30.9 68.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.812 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.587 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 27.1 t0 -68.21 -54.91 14.45 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 22' ' ' LEU . 4.5 mm? -62.63 -36.88 84.2 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.967 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -62.73 -52.41 63.34 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.619 -0.676 . . . . 0.0 109.851 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.8 tpp85 -69.84 -41.4 74.94 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.007 -1.058 . . . . 0.0 109.447 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -56.29 -48.82 75.88 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.525 -0.734 . . . . 0.0 110.6 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -66.52 -37.04 84.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 110.411 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.28 -40.15 93.07 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.174 -0.954 . . . . 0.0 110.903 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.521 ' CG2' HG23 ' A' ' 67' ' ' ILE . 87.1 mt -61.13 -44.13 97.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.002 -1.061 . . . . 0.0 110.994 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 26' ' ' LEU . 13.7 ptt180 -84.88 68.39 10.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.803 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -56.05 -27.3 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 109.875 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -59.09 -14.1 8.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.538 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -80.13 128.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.948 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -79.32 -45.69 19.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 111.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.71 123.8 7.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.607 -1.308 . . . . 0.0 111.915 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.482 ' HB ' HG13 ' A' ' 50' ' ' ILE . 5.9 p -126.0 133.98 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.549 -0.719 . . . . 0.0 109.358 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.3 mtp -128.74 114.84 17.1 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.933 -1.104 . . . . 0.0 110.84 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.51 131.63 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.545 HG22 ' CG ' ' A' ' 47' ' ' GLU . 3.5 m -119.79 152.9 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -83.82 153.65 23.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.87 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -166.47 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.365 -0.834 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -104.94 0.27 27.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 0.0 111.161 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.539 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.4 m -148.83 -65.88 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.865 -1.147 . . . . 0.0 110.801 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 47.2 Cg_endo -71.72 -169.13 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.214 1.113 . . . . 0.0 110.577 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -108.74 32.17 7.16 Favored Glycine 0 N--CA 1.477 1.371 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.526 ' C ' ' CD1' ' A' ' 46' ' ' TYR . 6.2 ptm180 -93.9 160.43 14.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.923 -1.34 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.583 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 35.1 m-85 -138.28 155.44 48.6 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.888 0.851 . . . . 0.0 111.059 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' CG ' HG22 ' A' ' 38' ' ' VAL . 2.9 pt-20 -100.71 96.07 7.08 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.1 t -78.15 116.47 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 111.484 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -131.58 100.74 5.24 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.538 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -123.69 140.25 47.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.591 -0.693 . . . . 0.0 110.603 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.6 ' HA ' ' CG ' ' A' ' 6' ' ' TYR . 5.3 p -100.13 144.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.882 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.555 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -122.87 -166.54 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 110.9 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 52' ' ' LEU . 40.3 m-80 -39.46 159.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.725 -0.609 . . . . 0.0 110.774 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.48 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 39.7 Cg_endo -65.17 -15.52 50.63 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.126 1.593 . . . . 0.0 111.289 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.498 ' OD1' HD21 ' A' ' 87' ' ' LEU . 43.4 t30 -140.11 73.11 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.813 -1.179 . . . . 0.0 111.162 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.555 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 13.0 mt -66.32 -164.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.853 -1.155 . . . . 0.0 110.354 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.9 t70 177.92 172.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.522 -0.736 . . . . 0.0 109.721 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.412 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.4 mm-40 -62.58 -34.89 77.88 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -71.29 -28.78 64.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.341 -0.85 . . . . 0.0 110.575 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -73.82 -39.99 63.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.065 -1.022 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 35.2 mt -66.32 -37.07 84.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.112 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.62 -38.07 59.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.541 ' O ' ' CG1' ' A' ' 67' ' ' ILE 0.259 0.2 OUTLIER -71.93 -51.42 22.2 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.893 0.854 . . . . 0.0 108.81 178.013 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 60.7 mm-40 -61.9 -38.5 88.59 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 -47.22 78.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.207 -0.933 . . . . 0.0 111.308 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 6.3 pt-20 -62.88 -27.21 69.2 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 120.573 -1.329 . . . . 0.0 109.261 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.541 ' CG1' ' O ' ' A' ' 63' ' ' LEU . 2.8 mm -76.81 -55.77 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.627 -0.67 . . . . 0.0 110.061 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 8.8 mt -62.27 -42.69 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.339 -0.85 . . . . 0.0 109.891 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 38.2 mm-40 -63.12 -40.82 98.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -57.97 -47.3 83.37 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.237 -0.914 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.69 -48.45 59.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.147 -0.971 . . . . 0.0 109.81 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.517 ' CD1' HG21 ' A' ' 68' ' ' ILE . 83.1 mt -64.01 -36.19 83.16 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.458 -0.776 . . . . 0.0 110.108 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 6.7 mm-40 -70.49 -45.89 64.8 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.552 -0.717 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -61.82 -38.71 89.17 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.587 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -75.65 -17.9 59.83 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.92 51.9 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -87.63 129.2 35.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.147 -1.208 . . . . 0.0 110.055 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 119.6 34.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 110.342 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.7 t -77.19 120.77 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 109.932 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.19 -8.79 59.66 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -130.0 134.27 47.31 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.402 -0.811 . . . . 0.0 110.482 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.464 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 9.9 p -141.07 107.68 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.812 -1.18 . . . . 0.0 110.651 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -127.96 106.94 9.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.164 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.402 ' OE2' ' CG2' ' A' ' 82' ' ' VAL . 3.4 mt-10 -100.25 110.09 22.32 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.266 -0.896 . . . . 0.0 110.546 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 85' ' ' LEU . 3.7 mm? -75.55 -16.37 60.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 110.044 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . 61.41 -172.09 7.89 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.498 HD21 ' OD1' ' A' ' 55' ' ' ASN . 24.1 tp -55.44 79.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.657 -0.908 . . . . 0.0 111.036 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 86' ' ' GLY . 19.1 tpt180 -80.52 157.13 26.21 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.185 -0.947 . . . . 0.0 110.022 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 2.5 ptm180 -127.78 116.14 19.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.091 -1.006 . . . . 0.0 110.168 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 90' ' ' LEU . 2.4 tp -71.91 104.5 3.51 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.247 -0.908 . . . . 0.0 110.021 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -168.69 -39.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 109.914 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -105.79 162.33 20.06 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 109.989 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.45 176.54 8.56 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.906 1.477 . . . . 0.0 110.551 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.08 119.52 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.181 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.65 56.99 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 0.0 110.19 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.2 tptt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.269 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.223 0.535 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.575 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 10.9 t70 -58.48 -49.75 91.83 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.902 . . . . 0.0 110.763 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 2' ' ' ASP . 44.3 Cg_endo -69.87 60.09 1.72 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 N-CA-C 109.221 -1.107 . . . . 0.0 109.221 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 3' ' ' PRO . 3.4 pm0 -13.52 -53.52 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 3' ' ' PRO . . . -172.98 32.27 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 118.191 -1.957 . . . . 0.0 112.04 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 52' ' ' LEU . 3.4 t80 -86.49 118.05 25.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.214 -1.756 . . . . 0.0 109.504 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 6' ' ' TYR . 15.9 m-85 -163.21 64.5 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.203 -0.936 . . . . 0.0 110.489 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 84' ' ' GLU . 1.7 mm? -84.67 138.99 32.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.237 -0.915 . . . . 0.0 109.915 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.424 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -108.75 118.96 38.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 0.0 110.585 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.447 ' HB2' ' HB ' ' A' ' 48' ' ' VAL . 28.6 m-85 -127.23 115.45 19.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.161 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 3.1 tt0 -95.35 160.37 14.57 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.183 -0.948 . . . . 0.0 110.402 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 30.7 m -130.41 179.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.517 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -135.55 53.0 1.98 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.414 -0.804 . . . . 0.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.519 ' SD ' ' CB ' ' A' ' 77' ' ' ALA . 4.2 ptt? -133.33 153.32 80.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.91 -163.96 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.13 1.595 . . . . 0.0 112.417 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.512 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 3.9 tm-20 -50.27 -26.75 5.09 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.98 -17.33 16.53 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.772 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.512 ' CB ' ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -63.76 -13.85 47.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 16' ' ' GLU . 93.3 t -53.1 -42.92 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.48 -0.763 . . . . 0.0 110.239 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.45 -34.98 76.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.946 . . . . 0.0 109.826 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.618 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 9.2 t0 -70.71 -54.43 11.82 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.2 mm? -64.17 -36.25 83.45 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 19' ' ' VAL . . . -60.5 -52.75 63.86 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.356 -0.84 . . . . 0.0 109.286 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' ILE . 5.6 mtt180 -70.08 -46.71 64.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 2.7 tm-20 -56.33 -45.73 80.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.808 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' CG ' ' O ' ' A' ' 22' ' ' LEU . 74.1 mt -62.81 -38.65 91.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.862 . . . . 0.0 110.302 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -45.66 93.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.532 ' CG2' HG22 ' A' ' 67' ' ' ILE . 13.4 mt -65.18 -42.96 95.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 0.7 OUTLIER -70.43 55.22 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 110.67 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 15.4 p-10 -72.14 -30.07 64.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -61.24 -12.9 14.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.59 -0.694 . . . . 0.0 109.978 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.598 ' CG2' ' CG2' ' A' ' 50' ' ' ILE . 3.9 p -79.09 137.55 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.361 -0.837 . . . . 0.0 110.437 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -42.68 25.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 110.813 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -148.06 122.71 9.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.043 -1.035 . . . . 0.0 111.06 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.628 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 22.5 m -117.67 135.16 58.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.328 -0.858 . . . . 0.0 110.423 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.66 116.12 10.09 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.4 t -111.27 131.92 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.38 152.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.558 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.03 154.6 21.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.195 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -73.19 172.77 10.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.74 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 t -89.73 1.08 56.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.937 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.564 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.67 -64.61 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.028 -1.045 . . . . 0.0 110.48 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.9 Cg_endo -70.84 -159.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.532 1.28 . . . . 0.0 110.77 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.16 36.53 4.16 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 5.7 mtt180 -93.13 135.19 34.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.53 -0.982 . . . . 0.0 110.397 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 25.5 m-85 -119.76 154.86 33.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.353 -0.842 . . . . 0.0 110.397 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -102.99 116.53 32.71 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -94.47 112.21 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 110.515 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.481 ' O ' HD13 ' A' ' 50' ' ' ILE . 64.3 m-80 -131.04 100.7 5.32 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 35' ' ' VAL . 1.1 mp -115.28 140.04 38.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 121.738 0.78 . . . . 0.0 111.24 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' CG1' ' HB3' ' A' ' 3' ' ' PRO . 0.9 OUTLIER -101.61 149.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 6.3 mt -118.7 -170.23 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.627 -1.296 . . . . 0.0 112.062 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.6 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.8 m120 -42.34 170.74 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.635 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 36.3 Cg_endo -59.66 -12.72 18.73 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.648 1.341 . . . . 0.0 111.04 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.463 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 3.3 t-20 -142.11 87.43 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.087 . . . . 0.0 110.436 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -60.74 -178.09 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.744 -1.222 . . . . 0.0 109.942 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 12.4 t70 -175.24 171.67 2.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.047 . . . . 0.0 110.764 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.432 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 65.8 mt-30 -61.71 -40.55 95.42 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.549 -0.719 . . . . 0.0 110.514 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -29.57 68.81 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.222 -0.924 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.52 -45.11 69.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 110.158 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 0.5 OUTLIER -66.19 -34.37 77.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.98 -38.8 62.55 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 67' ' ' ILE . 40.9 mt -71.64 -51.01 25.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 29' ' ' ARG . 3.5 mt-10 -60.06 -40.9 91.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.887 -1.133 . . . . 0.0 110.061 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -72.66 -46.46 53.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.045 -1.034 . . . . 0.0 109.634 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 6.8 mm-40 -69.58 -38.86 77.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 110.016 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 63' ' ' LEU . 16.0 mm -76.43 -38.17 31.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.296 -0.878 . . . . 0.0 111.257 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 57.7 mt -69.53 -48.28 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.778 -1.201 . . . . 0.0 110.053 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 4.9 pt20 -61.52 -38.86 88.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.184 -0.948 . . . . 0.0 110.02 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.485 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.17 -45.98 86.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.14 -0.975 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . . . -69.92 -48.3 59.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.081 -1.012 . . . . 0.0 110.836 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.483 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 79.2 mt -58.76 -43.03 90.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.267 -0.896 . . . . 0.0 110.661 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.44 -45.4 62.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 0.0 109.622 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 62.8 m-20 -62.61 -36.89 84.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.35 -35.29 58.78 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.312 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.29 18.28 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . . . -109.66 136.87 48.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.29 . . . . 0.0 110.224 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' NH1' ' HG2' ' A' ' 73' ' ' GLU . 2.1 tpt180 -119.69 133.53 55.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 110.326 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 4.6 t -75.73 124.87 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.011 -1.055 . . . . 0.0 109.533 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.76 -8.0 59.62 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.73 156.31 47.27 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.501 -0.749 . . . . 0.0 111.608 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 7.1 p -141.56 106.62 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.437 -0.789 . . . . 0.0 109.416 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.67 108.84 10.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.078 -1.014 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 8' ' ' LEU . 16.4 tt0 -99.02 89.87 4.42 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.187 -0.945 . . . . 0.0 109.858 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -112.61 177.39 4.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.2 -0.937 . . . . 0.0 109.794 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 87' ' ' LEU . . . 62.13 119.24 0.01 OUTLIER Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -168.49 66.09 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.502 -0.999 . . . . 0.0 109.137 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 12.2 mmt180 -117.04 -178.89 3.54 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.429 -0.794 . . . . 0.0 110.659 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 5.8 mtt180 -146.8 113.6 6.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.887 . . . . 0.0 110.408 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.03 127.97 31.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 109.88 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.09 -67.07 0.05 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 110.591 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.435 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . 19.0 m-85 -108.12 167.32 9.45 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.128 -0.983 . . . . 0.0 110.471 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 92' ' ' TYR . 46.9 Cg_endo -74.16 93.51 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.046 1.551 . . . . 0.0 110.276 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -106.92 123.67 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.104 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.483 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -163.8 157.54 19.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.176 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.201 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 20.0 mtp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.119 0.485 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.639 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 24.5 t0 -58.24 -37.66 57.54 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 111.012 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 51.2 Cg_endo -88.9 18.09 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.415 1.218 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 88' ' ' ARG . 14.2 mt-30 -118.76 -155.42 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.854 . . . . 0.0 110.621 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.504 ' O ' ' HA2' ' A' ' 86' ' ' GLY . . . -74.17 8.74 11.44 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.112 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -70.39 98.86 1.48 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.593 -1.534 . . . . 0.0 109.656 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.511 ' C ' ' CD2' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -163.61 59.08 0.17 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.118 -0.989 . . . . 0.0 110.029 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.511 ' CD2' ' C ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -138.41 131.86 30.5 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.344 -0.847 . . . . 0.0 109.78 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.505 ' HB3' ' NZ ' ' A' ' 81' ' ' LYS . 1.2 t90 -126.81 127.44 45.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.479 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 28.9 m-85 -126.24 115.08 19.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.537 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 4.4 tt0 -107.5 149.23 28.2 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.544 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.6 m -126.75 -176.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 111.026 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 1.9 tt0 -146.72 59.91 1.2 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.343 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.516 ' HB2' ' HB2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.75 148.69 66.04 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 37.3 Cg_endo -71.78 -165.82 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.135 1.597 . . . . 0.0 113.573 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -62.98 -23.06 67.26 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.039 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.69 -48.15 67.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.738 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 14' ' ' MET . 0.5 OUTLIER -90.86 -14.22 32.2 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.116 -0.99 . . . . 0.0 111.219 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 16' ' ' GLU . 14.5 p -45.88 -37.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.261 -0.899 . . . . 0.0 109.784 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.459 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 62.1 m-80 -53.32 -28.31 27.78 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.474 -0.767 . . . . 0.0 109.304 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 28.7 t0 -58.36 -32.5 68.61 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.545 -0.722 . . . . 0.0 110.129 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.3 mm? -59.0 -37.32 76.6 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.17 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -58.54 -51.22 70.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.28 -46.95 65.97 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.18 -0.95 . . . . 0.0 110.089 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -56.32 -48.38 76.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -67.22 -37.22 83.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.854 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.36 -38.78 78.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.737 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.526 HG21 ' CG2' ' A' ' 67' ' ' ILE . 9.5 mt -59.06 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.148 -0.97 . . . . 0.0 110.703 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 13.1 ptm180 -74.4 56.53 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.12 -25.47 62.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.0 110.296 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -58.66 -17.18 20.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.545 ' CG2' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.88 162.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -0.824 . . . . 0.0 109.965 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -44.18 22.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.976 . . . . 0.0 111.945 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.82 146.58 26.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.741 -1.224 . . . . 0.0 111.655 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.643 ' HA ' HG13 ' A' ' 50' ' ' ILE . 6.9 t -132.32 127.48 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 tpt -140.41 115.55 9.83 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.488 -0.758 . . . . 0.0 109.69 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 88.9 t -114.81 131.9 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.0 110.981 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 7.8 m -101.97 140.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 110.035 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -81.46 153.07 27.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -74.19 152.73 39.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.848 . . . . 0.0 110.014 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.2 p -75.34 -11.56 60.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -0.926 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -141.41 -67.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.117 -0.99 . . . . 0.0 110.496 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.3 Cg_endo -70.68 -176.11 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.323 1.17 . . . . 0.0 110.562 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 33.29 6.65 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.9 mtt180 -93.2 135.44 34.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.008 . . . . 0.0 110.021 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.58 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 30.0 m-85 -117.93 154.93 31.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.296 -0.878 . . . . 0.0 110.568 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 33.9 mt-10 -103.5 95.08 5.83 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.748 -0.595 . . . . 0.0 109.683 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 10' ' ' TYR . 89.4 t -78.77 115.13 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.461 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 70.7 m-80 -131.65 102.0 5.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.643 HG13 ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -111.82 142.26 24.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.749 0.785 . . . . 0.0 110.691 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.544 ' HA ' ' CG ' ' A' ' 6' ' ' TYR . 7.8 p -92.32 133.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.415 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 56' ' ' LEU . 30.5 mt -90.04 174.37 7.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 0.0 110.549 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 2.1 m120 -62.24 -153.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.74 -35.4 28.16 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 CA-C-N 119.122 0.722 . . . . 0.0 111.439 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.442 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 8.1 t30 -162.87 76.25 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.802 -1.186 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD1' ' OD1' ' A' ' 53' ' ' ASN . 16.8 mt -74.7 -161.04 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 110.419 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 11.1 t0 -171.92 -164.09 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.496 -0.752 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.457 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 2.4 mm-40 -64.77 -32.87 74.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.557 -0.715 . . . . 0.0 111.177 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -35.06 78.74 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.4 mm-40 -73.72 -42.9 60.54 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.414 -0.804 . . . . 0.0 109.954 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 1.2 mt -64.87 -34.46 78.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.39 -33.65 44.48 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.555 ' O ' HG13 ' A' ' 67' ' ' ILE . 18.3 mt -64.38 -51.05 65.23 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.461 -0.895 . . . . 0.0 108.618 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 2.5 mt-10 -72.19 -43.09 65.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.232 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -62.51 -34.86 77.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.533 -0.729 . . . . 0.0 110.443 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 32.0 mm-40 -65.7 -48.9 70.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.826 -1.171 . . . . 0.0 109.687 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 63' ' ' LEU . 4.3 mt -78.98 -41.17 23.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.493 -0.754 . . . . 0.0 111.155 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 40.9 mt -59.01 -49.5 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.049 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.8 mt-30 -58.61 -48.91 79.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.393 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -66.15 -47.21 74.79 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 110.877 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 67' ' ' ILE . . . -65.01 -48.25 74.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.907 -1.121 . . . . 0.0 110.182 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.435 HD22 ' HB1' ' A' ' 77' ' ' ALA . 32.8 mt -65.57 -35.33 80.52 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 110.026 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 1.0 OUTLIER -70.34 -45.31 66.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.44 -0.788 . . . . 0.0 109.487 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -63.16 -36.31 83.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.57 -38.9 62.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.562 -0.712 . . . . 0.0 110.604 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.3 21.65 5.12 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 72' ' ' LEU . . . -102.13 123.76 46.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -1.221 . . . . 0.0 109.797 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -119.77 122.41 41.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 110.581 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 2.3 t -81.34 128.99 38.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.079 -1.013 . . . . 0.0 109.59 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.34 -17.68 48.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 108.467 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 9' ' ' TRP 0.255 0.0 OUTLIER -128.78 129.42 45.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.806 -0.559 . . . . 0.0 110.171 -179.533 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 t -141.86 106.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.677 -1.264 . . . . 0.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.95 106.8 8.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 110.055 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.457 ' OE2' ' NE2' ' A' ' 58' ' ' GLN . 1.4 pt-20 -100.46 90.57 4.34 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 5.8 mp -97.1 -83.97 0.38 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.21 -0.931 . . . . 0.0 109.888 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 5' ' ' GLY . . . 47.05 100.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -170.07 47.38 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.256 -1.143 . . . . 0.0 109.966 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' CB ' ' O ' ' A' ' 4' ' ' GLN . 12.7 ttt180 -115.16 159.92 20.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.461 -0.774 . . . . 0.0 110.371 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 12.6 mtm180 -143.45 110.05 5.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 0.0 110.517 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 18.0 tp -178.97 81.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.354 -0.841 . . . . 0.0 110.161 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.49 -167.09 2.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -72.13 140.41 82.89 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 110.145 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.67 92.75 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.078 1.567 . . . . 0.0 110.441 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.429 HG21 ' O ' ' A' ' 96' ' ' LYS . 8.1 mm -101.14 118.55 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 109.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.6 -11.25 43.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.32 -0.862 . . . . 0.0 110.141 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' O ' HG21 ' A' ' 94' ' ' ILE . 2.3 tttt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.245 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' O ' ' O ' ' A' ' 4' ' ' GLN . 23.7 mtt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.194 0.521 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.647 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 49.9 t0 -74.5 -36.7 2.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.023 -1.048 . . . . 0.0 111.393 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.9 Cg_endo -91.15 13.65 2.08 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.329 1.173 . . . . 0.0 109.674 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 5.2 pt20 -175.16 156.17 2.06 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.317 -0.864 . . . . 0.0 110.464 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.544 ' O ' ' CD2' ' A' ' 56' ' ' LEU . . . 84.61 -57.67 5.01 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.886 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -63.61 98.94 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.711 -1.464 . . . . 0.0 111.073 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.572 ' CE1' ' O ' ' A' ' 84' ' ' GLU . 26.2 t80 -153.33 36.34 0.47 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.843 -1.16 . . . . 0.0 109.828 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -141.93 124.75 16.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.767 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 83' ' ' GLU . 6.2 t90 -127.77 119.86 26.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.118 -0.989 . . . . 0.0 109.972 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.506 ' O ' ' CG2' ' A' ' 48' ' ' VAL . 76.9 m-85 -126.54 137.79 53.4 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.152 -0.968 . . . . 0.0 111.104 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.549 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 1.2 tp60 -120.43 160.66 22.65 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.348 -0.845 . . . . 0.0 109.228 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 21.0 m -130.57 -178.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.03 -1.044 . . . . 0.0 110.687 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.39 57.17 1.59 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.638 -0.664 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.555 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -135.35 155.28 78.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.42 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 37.2 Cg_endo -73.0 -167.79 0.37 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.925 1.487 . . . . 0.0 113.05 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.555 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 15.3 tt0 -66.09 -25.53 67.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.038 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 13.3 t0 -59.87 -40.71 89.55 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.364 0.602 . . . . 0.0 111.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.1 OUTLIER -88.95 -14.56 36.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.271 -0.893 . . . . 0.0 110.125 -179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.566 ' CG2' ' OH ' ' A' ' 46' ' ' TYR . 15.1 t -47.19 -37.47 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -29.36 22.05 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.589 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 33.1 t0 -59.87 -39.57 85.71 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.481 -0.762 . . . . 0.0 109.199 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.4 mm? -58.94 -42.75 90.54 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.92 -51.77 66.45 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -46.68 78.69 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.575 -0.703 . . . . 0.0 109.257 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.4 -48.53 76.72 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.43 -0.794 . . . . 0.0 109.306 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' ' CG2' ' A' ' 35' ' ' VAL . 89.4 mt -60.33 -39.53 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -70.24 -38.64 75.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.528 -0.732 . . . . 0.0 109.274 179.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.474 HG22 HG23 ' A' ' 67' ' ' ILE . 1.2 mm -58.96 -37.77 69.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.827 0.822 . . . . 0.0 108.855 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 10.5 mtp180 -69.68 64.05 0.19 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.75 -0.594 . . . . 0.0 110.228 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -37.52 70.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.32 -14.01 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 110.021 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.7 OUTLIER -79.93 138.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.374 -0.829 . . . . 0.0 110.384 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.432 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.7 mmt-85 -79.25 -45.49 19.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.068 -1.02 . . . . 0.0 110.913 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.63 123.15 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.204 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.48 ' CG2' ' CD2' ' A' ' 26' ' ' LEU . 2.8 p -130.12 133.61 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.517 -0.74 . . . . 0.0 109.605 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -128.04 118.25 23.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.124 -0.985 . . . . 0.0 110.75 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.52 ' CG1' HG12 ' A' ' 48' ' ' VAL . 19.4 t -115.06 131.98 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.616 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 47' ' ' GLU . 4.1 m -121.28 159.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HA ' ' CE2' ' A' ' 46' ' ' TYR . . . -84.59 154.17 22.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.401 -0.812 . . . . 0.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.36 176.74 5.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.292 -0.88 . . . . 0.0 109.57 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.4 p -93.34 -3.98 52.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 110.73 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -148.02 -67.77 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.023 -1.048 . . . . 0.0 110.467 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 49.7 Cg_endo -72.53 -168.94 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.303 1.159 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.8 32.88 6.84 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.0 mtt180 -94.26 134.88 36.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -1.068 . . . . 0.0 109.323 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' A' ' 39' ' ' ALA . 7.8 m-85 -116.81 150.18 38.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.871 -1.143 . . . . 0.0 111.427 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.483 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -106.41 90.53 3.37 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.166 178.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.52 HG12 ' CG1' ' A' ' 37' ' ' VAL . 22.0 m -82.42 125.28 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.549 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -122.51 101.62 7.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.584 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -111.96 142.38 24.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 121.561 0.696 . . . . 0.0 111.437 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' HG11 ' A' ' 51' ' ' VAL . 7.3 p -108.61 119.94 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.685 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 53' ' ' ASN . 4.6 mt -86.81 177.21 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.967 . . . . 0.0 110.581 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.2 m-80 -42.96 167.19 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.9 Cg_endo -63.84 -15.0 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.673 1.354 . . . . 0.0 110.24 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 24.2 t-20 -133.28 63.54 1.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.893 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 5' ' ' GLY . 3.1 pp -61.78 176.55 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.041 -1.037 . . . . 0.0 110.414 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' O ' HD13 ' A' ' 61' ' ' LEU . 2.5 m-20 -168.29 178.31 4.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 110.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.73 -36.32 83.25 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.537 -0.727 . . . . 0.0 110.461 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 t -69.29 -30.6 68.71 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.255 -0.903 . . . . 0.0 110.3 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -73.12 -45.91 54.22 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' A' ' 8' ' ' LEU . 1.6 mp -66.86 -36.14 81.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 109.366 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.45 -33.87 55.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.542 ' O ' HG13 ' A' ' 67' ' ' ILE . 13.7 mt -69.46 -50.38 46.13 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.248 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HB3' HD12 ' A' ' 68' ' ' ILE . 4.4 mm-40 -71.53 -42.75 67.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -65.55 -30.84 71.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.186 -0.946 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 2.0 mm-40 -69.43 -48.92 59.45 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.865 -1.147 . . . . 0.0 110.355 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 63' ' ' LEU . 4.7 mt -78.6 -38.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.302 -0.873 . . . . 0.0 111.063 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.456 HD11 ' HE3' ' A' ' 65' ' ' LYS . 53.4 mt -60.37 -48.95 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.993 -1.067 . . . . 0.0 110.391 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 1.6 pp0? -63.55 -41.63 98.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.0 109.809 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.55 -46.52 66.25 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.37 -0.832 . . . . 0.0 110.388 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.88 83.39 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.08 -1.013 . . . . 0.0 109.777 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.452 HD21 ' OD2' ' A' ' 21' ' ' ASP . 97.3 mt -65.5 -35.46 80.95 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.8 OUTLIER -67.0 -45.27 78.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.457 -0.777 . . . . 0.0 109.005 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -61.12 -36.55 80.03 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -74.88 -41.87 58.94 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.74 -0.6 . . . . 0.0 110.327 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.45 23.35 4.47 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.54 125.23 54.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.262 -1.14 . . . . 0.0 109.762 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.47 148.91 42.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 110.757 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 1.9 t -95.79 114.59 32.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 108.773 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -82.07 -5.47 58.42 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.774 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.549 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -138.41 150.32 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.274 -0.891 . . . . 0.0 111.736 -178.354 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 p -141.56 107.15 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' TRP . 6.8 tp10 -128.6 122.48 31.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.125 -0.985 . . . . 0.0 111.062 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.572 ' O ' ' CE1' ' A' ' 7' ' ' PHE . 42.3 mt-10 -94.21 115.25 27.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.493 ' C ' ' HA ' ' A' ' 7' ' ' PHE . 2.8 pp -124.33 121.22 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.92 -1.112 . . . . 0.0 112.129 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.583 ' HA3' ' CZ ' ' A' ' 6' ' ' TYR . . . 98.76 45.83 2.21 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 88' ' ' ARG . 19.2 tp -45.91 165.78 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.282 -1.128 . . . . 0.0 109.516 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.534 ' O ' ' NE ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -79.02 121.07 24.49 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.962 -1.086 . . . . 0.0 110.477 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -157.89 28.59 0.27 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.013 . . . . 0.0 110.27 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -77.78 128.25 33.72 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.836 179.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.5 ' N ' HD23 ' A' ' 90' ' ' LEU . . . -122.52 -135.95 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 18.5 p90 -100.99 148.51 35.18 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 110.814 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.43 -90.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.012 1.533 . . . . 0.0 110.472 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 tt -99.65 128.41 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.873 . . . . 0.0 110.265 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -165.89 -38.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 110.061 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.267 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.239 0.542 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.616 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 16.7 t70 -68.66 -40.31 17.75 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 111.199 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 53.8 Cg_endo -84.16 41.52 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.432 1.227 . . . . 0.0 110.334 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' C ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -23.65 140.9 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.213 0.53 . . . . 0.0 111.146 -179.197 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' O ' ' CE1' ' A' ' 7' ' ' PHE . . . 85.46 -25.93 6.07 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.483 ' HB3' ' HB2' ' A' ' 3' ' ' PRO . 2.1 t80 -90.47 98.25 11.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.913 -1.345 . . . . 0.0 111.582 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 4.4 p90 -149.94 31.55 0.7 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.169 -0.957 . . . . 0.0 109.734 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.599 HD13 ' CD2' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -119.52 125.06 47.95 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.227 -0.92 . . . . 0.0 111.245 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -126.58 116.55 21.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.529 ' HB2' ' CG2' ' A' ' 48' ' ' VAL . 1.4 m-85 -126.96 139.48 53.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 111.062 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.46 159.86 24.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 26.5 m -133.8 173.97 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.946 -1.096 . . . . 0.0 111.239 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.98 54.25 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.736 -0.603 . . . . 0.0 109.961 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.51 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 50.3 mmm -129.83 156.74 78.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.64 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.85 -167.02 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.825 1.434 . . . . 0.0 113.124 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -63.79 -28.38 69.83 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.407 -1.269 . . . . 0.0 107.796 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -18.6 40.59 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.539 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.578 ' NH1' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -87.57 -23.71 24.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.593 -0.692 . . . . 0.0 110.095 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.466 ' N ' ' HG3' ' A' ' 18' ' ' ARG . 77.3 t -48.3 -42.71 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.469 -0.77 . . . . 0.0 110.309 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -58.92 -29.97 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.15 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.507 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.7 t0 -61.71 -50.84 70.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.144 -0.972 . . . . 0.0 109.964 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.533 HD12 ' NH1' ' A' ' 18' ' ' ARG . 8.3 mp -59.89 -43.11 94.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.666 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.5 79.64 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.229 -0.92 . . . . 0.0 109.656 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -68.73 -46.42 68.95 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.393 -0.817 . . . . 0.0 109.266 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' OE1' ' CB ' ' A' ' 71' ' ' ALA . 9.7 tp10 -60.38 -47.64 85.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.418 -0.801 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 ' CG ' ' O ' ' A' ' 22' ' ' LEU . 29.6 mt -53.08 -38.66 62.73 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.579 0.704 . . . . 0.0 109.512 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 4.4 tpt180 -64.11 -34.5 78.18 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 110.549 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.519 ' CG2' HG23 ' A' ' 67' ' ' ILE . 5.4 mt -62.12 -44.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.898 -1.126 . . . . 0.0 109.808 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 26' ' ' LEU . 11.6 mtp180 -70.05 76.45 0.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.697 -0.627 . . . . 0.0 110.311 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.62 -36.61 84.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.251 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -61.75 -12.89 18.98 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.977 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.622 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -79.03 123.73 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.719 . . . . 0.0 110.141 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -47.32 15.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 112.186 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.539 ' CG ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -153.55 139.18 17.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.562 -1.336 . . . . 0.0 110.851 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 13.3 p -135.63 135.85 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.455 -0.778 . . . . 0.0 110.002 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.488 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 42.0 mtp -117.44 115.48 25.28 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.227 -0.921 . . . . 0.0 109.846 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG12 ' CD2' ' A' ' 22' ' ' LEU . 95.9 t -114.67 128.55 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 110.572 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.09 134.41 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.14 153.72 23.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.534 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.452 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.1 m -73.86 150.64 40.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.885 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.2 p -76.5 3.0 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.589 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -148.99 -66.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -72.37 178.59 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.366 1.193 . . . . 0.0 110.541 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -101.31 33.01 6.82 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 4.8 mtt180 -93.78 134.74 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.439 -1.036 . . . . 0.0 110.275 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 34.4 m-85 -120.56 151.51 39.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -106.51 99.03 8.63 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.911 -0.493 . . . . 0.0 110.186 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 10' ' ' TYR . 16.9 m -86.53 122.17 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.01 -1.056 . . . . 0.0 110.686 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 36' ' ' MET . 2.4 p30 -131.16 102.71 6.12 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.622 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.19 140.76 30.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 O-C-N 121.433 -0.792 . . . . 0.0 111.552 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.618 ' N ' HD11 ' A' ' 50' ' ' ILE . 7.4 p -114.87 150.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.572 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.3 mp -139.48 -157.41 0.76 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.769 -1.207 . . . . 0.0 111.928 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 52' ' ' LEU . 27.6 m-80 -37.86 161.47 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.561 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 4' ' ' GLN . 38.4 Cg_endo -64.67 -17.4 59.4 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.012 1.533 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -146.78 79.78 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.764 -1.21 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 16.2 mt -67.64 -164.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 110.586 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 3.3 t70 -177.08 171.6 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 110.68 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.1 mt-30 -54.63 -35.53 63.56 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.573 -0.704 . . . . 0.0 110.433 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 m -67.85 -40.6 83.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.177 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -70.77 -44.56 66.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.321 -0.862 . . . . 0.0 109.989 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.5 mm? -66.44 -34.83 78.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.91 -35.3 45.07 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.3 mt -72.12 -49.67 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.215 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 8.2 mt-10 -67.31 -35.88 80.34 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.533 -1.354 . . . . 0.0 109.915 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.24 -45.27 56.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 75.2 mt-10 -70.2 -38.5 75.34 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.096 -1.002 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 63' ' ' LEU . 43.9 mm -76.9 -38.75 29.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.329 -0.857 . . . . 0.0 111.192 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 62.4 mt -69.39 -46.88 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.884 -1.135 . . . . 0.0 110.125 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 20.0 mt-30 -59.71 -38.8 82.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.901 . . . . 0.0 110.165 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -44.66 91.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.196 -0.94 . . . . 0.0 110.894 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.524 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . . . -68.27 -48.64 64.51 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.997 -1.064 . . . . 0.0 110.522 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' CD2' ' NH1' ' A' ' 18' ' ' ARG . 20.3 mt -58.71 -39.93 82.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.39 -0.819 . . . . 0.0 110.547 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -71.2 -45.56 63.13 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.445 -0.784 . . . . 0.0 109.61 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.3 -38.47 86.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -75.79 -32.13 59.75 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.064 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.418 ' C ' ' HE3' ' A' ' 14' ' ' MET . . . 109.11 17.55 10.04 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HB3' ' NH2' ' A' ' 18' ' ' ARG . . . -102.36 124.36 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.0 110.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -119.0 124.1 46.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 3.8 t -67.6 125.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.983 -1.073 . . . . 0.0 109.884 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -10.28 59.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.499 ' HG2' ' HB2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.69 152.99 52.02 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 t -141.76 106.82 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -128.28 109.54 11.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.065 -1.022 . . . . 0.0 111.305 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 1.0 OUTLIER -93.65 120.13 33.53 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.168 -0.958 . . . . 0.0 109.496 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 7' ' ' PHE . 64.4 mt -75.28 0.56 16.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.997 -1.064 . . . . 0.0 110.491 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.16 116.57 0.24 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.523 ' CD1' ' HB2' ' A' ' 56' ' ' LEU . 18.2 tp -52.44 114.39 1.35 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.386 -1.067 . . . . 0.0 109.986 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -114.54 151.3 33.58 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.004 -1.06 . . . . 0.0 110.233 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.26 103.61 8.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.917 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.509 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -131.4 81.48 1.99 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.437 -0.79 . . . . 0.0 110.066 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -161.53 -156.55 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.898 . . . . 0.0 110.056 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -105.13 153.9 39.18 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.108 -0.995 . . . . 0.0 110.377 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.8 102.16 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.091 1.574 . . . . 0.0 110.317 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.7 mt -87.31 133.19 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.395 -0.816 . . . . 0.0 110.342 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.42 -14.68 10.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.075 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.153 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.523 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 4.0 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.291 0.567 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.662 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 8.7 t70 -75.76 -34.67 1.57 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 111.496 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.4 Cg_endo -89.28 11.02 3.05 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.281 1.148 . . . . 0.0 109.634 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.544 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -175.68 147.62 0.83 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.481 -0.762 . . . . 0.0 110.054 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.561 ' O ' ' CD1' ' A' ' 56' ' ' LEU . . . 94.47 -56.99 1.99 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.572 ' CE1' ' O ' ' A' ' 2' ' ' ASP . 3.9 p90 -61.85 129.96 43.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.997 -1.296 . . . . 0.0 109.706 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.633 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 23.2 t80 -170.07 21.09 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.242 -0.911 . . . . 0.0 110.846 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.627 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.32 123.25 25.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.314 -1.491 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.563 ' CE3' HD23 ' A' ' 85' ' ' LEU . 1.4 t90 -128.69 118.42 22.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.667 -0.645 . . . . 0.0 109.481 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -127.2 137.45 52.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.018 -1.051 . . . . 0.0 110.995 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.552 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 3.8 tt0 -109.32 160.27 16.29 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.282 -0.886 . . . . 0.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.516 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 15.9 m -129.02 -177.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.923 -1.111 . . . . 0.0 111.024 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 1.2 tp10 -140.22 59.68 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.833 0.825 . . . . 0.0 108.971 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.559 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 4.0 tpt -137.07 146.13 53.28 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.601 -0.687 . . . . 0.0 109.216 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HD2' ' HG3' ' A' ' 14' ' ' MET . 33.2 Cg_endo -65.39 -166.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.651 1.342 . . . . 0.0 113.361 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -62.07 -27.02 68.61 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.272 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.65 -20.86 36.37 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.139 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.618 ' CZ ' ' CG ' ' A' ' 46' ' ' TYR . 4.4 ppt_? -88.41 -12.69 42.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 111.063 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -46.78 -44.52 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.403 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.526 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.6 m-20 -57.19 -30.45 64.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 109.536 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 36.0 t0 -62.95 -46.75 86.27 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.299 -0.875 . . . . 0.0 110.221 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.3 mm? -59.02 -43.02 91.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.08 -48.78 80.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -40.85 84.87 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.529 ' O ' ' CD ' ' A' ' 29' ' ' ARG . 28.6 tt0 -56.37 -49.28 74.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.484 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -69.16 -37.08 78.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.138 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.2 tmm_? -65.66 -37.66 87.13 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.284 -0.885 . . . . 0.0 111.489 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.555 ' CG2' ' N ' ' A' ' 29' ' ' ARG . 3.5 tt -58.61 -45.03 90.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.014 -1.054 . . . . 0.0 111.728 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.555 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -86.36 109.21 18.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.984 -1.073 . . . . 0.0 111.206 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -30.65 62.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.893 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 33.9 p30 -59.21 -13.42 7.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.78 . . . . 0.0 110.386 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.551 ' CG2' HD13 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -78.88 122.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.824 . . . . 0.0 110.485 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -79.76 -45.69 18.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 111.01 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -153.38 139.98 18.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.815 -1.178 . . . . 0.0 110.963 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.516 ' CA ' HG12 ' A' ' 50' ' ' ILE . 7.8 p -137.1 132.21 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 0.0 110.409 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.9 tpt -140.88 113.46 8.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.056 -1.027 . . . . 0.0 110.122 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.542 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 23.3 t -116.92 132.25 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -0.821 . . . . 0.0 110.53 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' ' CD ' ' A' ' 47' ' ' GLU . 32.7 m -105.26 148.83 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.003 -1.06 . . . . 0.0 110.43 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -77.61 154.82 31.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.368 -0.832 . . . . 0.0 110.704 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 p -72.64 -176.68 2.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -101.57 5.71 41.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.086 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -153.11 -66.5 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.4 Cg_endo -72.78 -165.34 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.425 1.224 . . . . 0.0 110.567 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.29 35.4 4.77 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.4 mtt180 -94.04 138.5 32.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.456 -1.026 . . . . 0.0 110.216 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.618 ' CG ' ' CZ ' ' A' ' 18' ' ' ARG . 10.0 m-85 -125.52 154.82 41.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 110.307 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 47' ' ' GLU . 10.0 pt-20 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.435 0.636 . . . . 0.0 109.566 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.494 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 44.6 t -88.04 115.92 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 110.836 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' CB ' HD11 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -130.92 101.33 5.59 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.576 HD11 ' N ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -117.87 131.64 70.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.593 -178.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.576 ' N ' HD11 ' A' ' 50' ' ' ILE . 9.8 p -95.55 151.25 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 4.4 mp -138.6 -157.11 0.74 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 110.923 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 52' ' ' LEU . 28.2 m-80 -34.85 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 121.056 0.455 . . . . 0.0 111.115 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 39.4 Cg_endo -64.83 -27.94 59.22 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.144 1.602 . . . . 0.0 111.15 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.46 ' OD1' ' NH2' ' A' ' 88' ' ' ARG . 8.0 t30 -131.11 81.32 1.98 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 110.161 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.564 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 13.8 mt -74.03 -165.36 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 172.63 -171.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.597 0.713 . . . . 0.0 110.371 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -65.36 -33.13 75.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 110.852 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.9 t -68.27 -34.46 76.23 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.501 ' CB ' HD22 ' A' ' 56' ' ' LEU . 21.5 mm-40 -71.19 -42.13 69.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 110.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD2' ' OE2' ' A' ' 64' ' ' GLU . 9.3 mt -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.07 -36.59 60.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.928 -1.107 . . . . 0.0 108.086 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.7 mt -71.5 -49.87 36.98 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.807 0.813 . . . . 0.0 109.272 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.552 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 8.6 pt-20 -67.1 -39.76 86.78 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.585 -1.322 . . . . 0.0 109.94 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -71.87 -41.51 67.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.864 -1.148 . . . . 0.0 110.488 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.5 mt-10 -75.38 -41.07 57.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.701 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 63' ' ' LEU . 17.9 mm -78.92 -36.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 112.219 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 96.7 mt -70.41 -44.58 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.329 -1.482 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.1 mm100 -55.79 -39.2 70.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -57.61 -48.12 80.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 111.374 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -72.23 -48.77 40.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.971 -1.08 . . . . 0.0 111.578 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 25.1 mt -60.1 -42.71 95.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 111.331 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.17 -43.39 70.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.014 -1.053 . . . . 0.0 109.182 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 34.1 t-20 -59.65 -37.12 77.85 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.579 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -74.49 -29.27 61.36 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.259 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.59 5.28 27.91 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -99.66 118.45 36.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -1.149 . . . . 0.0 110.462 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -118.6 137.18 53.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.647 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.3 t -75.98 119.52 24.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.88 -5.63 59.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.571 -0.706 . . . . 0.0 109.213 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.552 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.69 160.81 35.66 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.282 -0.886 . . . . 0.0 111.591 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.06 107.6 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.032 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.77 132.06 49.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.098 -1.001 . . . . 0.0 111.276 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.567 ' HB3' ' CE1' ' A' ' 7' ' ' PHE . 1.9 mp0 -85.92 124.81 32.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.528 -0.733 . . . . 0.0 109.881 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 2.3 mt -76.3 29.79 0.12 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.084 -1.01 . . . . 0.0 111.671 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' TYR . . . 80.41 111.98 0.29 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.493 ' O ' ' O ' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -51.81 -170.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -1.104 . . . . 0.0 110.286 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -78.44 131.09 36.76 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.941 -1.099 . . . . 0.0 110.212 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -115.43 37.88 3.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -43.78 116.34 0.96 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.305 0.574 . . . . 0.0 110.487 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.42 -44.26 4.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 109.556 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.4 ' O ' HD22 ' A' ' 90' ' ' LEU . 67.8 m-85 -105.65 144.65 29.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.63 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.53 -56.76 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.919 1.484 . . . . 0.0 111.093 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.2 mt -119.86 120.73 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.032 -1.043 . . . . 0.0 110.585 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.12 -63.02 1.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.139 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HG3' ' OXT' ' A' ' 96' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.185 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.576 ' HG2' ' CA ' ' A' ' 5' ' ' GLY . 2.5 ptp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.477 0.656 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.641 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 26.3 t0 -78.09 -26.53 0.51 Allowed Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 45.9 Cg_endo -85.5 -5.67 9.13 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 N-CA-C 109.844 -0.868 . . . . 0.0 109.844 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.52 ' NE2' HD12 ' A' ' 87' ' ' LEU . 1.0 OUTLIER 178.15 -100.54 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.476 -0.765 . . . . 0.0 109.989 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.576 ' CA ' ' HG2' ' A' ' 1' ' ' MET . . . 121.2 94.03 1.32 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.639 ' CE1' ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -84.66 145.98 27.7 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.095 -1.239 . . . . 0.0 110.499 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 57.6 m-85 -145.98 124.71 12.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.541 -0.725 . . . . 0.0 109.733 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.3 mp -135.51 127.86 30.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 110.543 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.482 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -97.14 127.86 43.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.7 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.643 ' CE1' ' CG1' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -127.14 120.62 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 9.4 tt0 -112.35 159.7 18.42 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 10' ' ' TYR . 16.4 m -135.73 178.36 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.073 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -132.45 56.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.547 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.91 152.4 72.14 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 110.595 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.507 ' O ' HG21 ' A' ' 19' ' ' VAL . 36.4 Cg_endo -72.23 -167.67 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.977 1.514 . . . . 0.0 112.809 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 2.4 tt0 -65.52 -25.37 67.42 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.854 178.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.92 -41.46 91.81 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.873 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.62 -16.3 30.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.278 -0.889 . . . . 0.0 110.688 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.528 ' CG2' ' OH ' ' A' ' 46' ' ' TYR . 20.6 t -47.36 -37.75 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.43 -0.794 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -53.59 -29.34 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 36.5 t0 -59.74 -39.47 84.86 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.399 -0.813 . . . . 0.0 110.338 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.4 mm? -59.07 -41.42 87.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 110.088 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.53 63.75 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' O ' HG13 ' A' ' 28' ' ' ILE . 2.1 ttp180 -68.93 -41.72 77.71 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' HG12 ' A' ' 68' ' ' ILE . 3.9 tt0 -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.196 -0.94 . . . . 0.0 109.946 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 14.1 mt -66.09 -38.63 88.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.772 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.81 -37.47 82.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.179 -0.95 . . . . 0.0 111.176 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.516 ' N ' ' HG3' ' A' ' 27' ' ' ARG . 55.1 mt -61.75 -44.23 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.82 -1.175 . . . . 0.0 110.56 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' CZ ' HG12 ' A' ' 68' ' ' ILE . 9.4 ptp85 -75.06 59.6 0.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.124 -0.985 . . . . 0.0 110.282 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.49 -25.32 16.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.187 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -58.41 -17.08 17.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.3 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.586 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 4.3 p -80.68 137.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 110.302 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -79.18 -46.05 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.978 . . . . 0.0 110.758 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 50' ' ' ILE . 4.8 tpt180 -152.79 121.96 6.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.832 -1.167 . . . . 0.0 110.987 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 50' ' ' ILE . 3.1 m -109.74 135.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.9 ttp -124.77 116.13 21.82 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.059 -1.026 . . . . 0.0 110.802 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 48' ' ' VAL . 19.4 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.078 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 12.0 m -114.29 135.11 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.659 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.66 154.28 22.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -172.56 1.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -101.53 8.41 41.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.173 -0.954 . . . . 0.0 110.595 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.56 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.74 -63.75 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.978 . . . . 0.0 110.421 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.8 Cg_endo -69.56 -176.51 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.537 1.283 . . . . 0.0 110.845 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.36 32.74 6.9 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 17.5 mtt180 -96.21 143.12 27.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.395 -1.062 . . . . 0.0 109.92 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.588 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 12.1 m-85 -125.51 152.99 44.26 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.05 -1.031 . . . . 0.0 111.529 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.3 mp0 -105.05 92.83 4.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 37' ' ' VAL . 21.7 t -80.69 125.41 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 111.84 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 47' ' ' GLU . 1.5 m-80 -130.31 101.08 5.61 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.586 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.98 146.38 33.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 119.746 -0.781 . . . . 0.0 111.876 -177.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.465 ' O ' HD12 ' A' ' 50' ' ' ILE . 14.3 p -111.79 151.66 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 3.9 mp -118.17 -158.69 0.72 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.515 -1.366 . . . . 0.0 111.83 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.52 ' O ' ' O ' ' A' ' 52' ' ' LEU . 47.2 m-80 -37.36 163.52 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.737 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' O ' ' CG ' ' A' ' 1' ' ' MET . 37.9 Cg_endo -63.73 -15.95 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.934 1.492 . . . . 0.0 110.759 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.512 ' OD1' ' NE2' ' A' ' 4' ' ' GLN . 8.9 t-20 -151.84 90.54 1.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 110.201 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 10.7 mt -76.83 -173.54 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.822 -1.173 . . . . 0.0 111.81 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.73 179.04 6.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.404 0.621 . . . . 0.0 109.536 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -66.13 -43.17 87.88 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.425 -0.797 . . . . 0.0 111.009 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -65.41 -33.22 75.44 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.284 -0.885 . . . . 0.0 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 11.0 mm-40 -62.28 -38.28 88.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 110.359 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.99 -33.18 71.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.01 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.82 -34.48 40.53 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.635 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.1 mt -71.18 -51.8 22.74 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.957 0.884 . . . . 0.0 108.706 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -61.7 -41.39 97.53 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.859 -1.151 . . . . 0.0 109.735 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.522 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -72.72 -46.37 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 110.573 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 72.5 mt-10 -68.85 -37.57 79.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.87 -1.144 . . . . 0.0 109.686 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.635 HG12 ' O ' ' A' ' 63' ' ' LEU . 19.2 mm -77.74 -45.5 28.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 111.84 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.515 HG12 ' CZ ' ' A' ' 29' ' ' ARG . 58.2 mt -70.04 -42.01 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.76 -1.213 . . . . 0.0 110.214 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.9 pt20 -64.37 -40.74 96.43 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 11.2 ttt180 -58.38 -46.16 86.88 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.366 -0.834 . . . . 0.0 110.989 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.87 -48.76 57.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.902 -1.124 . . . . 0.0 110.636 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.599 ' CD1' ' CE2' ' A' ' 10' ' ' TYR . 83.8 mt -63.98 -36.24 83.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.336 -0.852 . . . . 0.0 110.641 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -69.82 -44.88 69.09 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.39 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 70' ' ' ARG . 72.5 m-20 -65.44 -37.04 85.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -75.72 -39.82 56.65 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.485 -0.759 . . . . 0.0 110.459 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.41 29.63 2.67 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.37 130.23 55.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.356 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.34 134.98 54.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.105 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.546 HG22 ' CD2' ' A' ' 10' ' ' TYR . 2.1 t -79.4 122.4 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.831 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.95 -10.98 59.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.63 145.03 50.33 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.537 -0.727 . . . . 0.0 111.023 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t -141.7 108.28 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.034 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.15 109.09 11.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.013 -1.054 . . . . 0.0 110.586 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' OE2' ' NZ ' ' A' ' 65' ' ' LYS . 29.8 mm-40 -98.61 104.45 16.49 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.214 -0.929 . . . . 0.0 110.508 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 7' ' ' PHE . 2.0 mp -74.95 -24.54 58.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.999 -1.063 . . . . 0.0 110.22 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 6' ' ' TYR . . . 64.64 169.3 1.91 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.639 ' N ' ' CE1' ' A' ' 6' ' ' TYR . 7.6 tt -42.64 110.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -1.07 . . . . 0.0 110.661 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 14.9 mmm180 -88.57 178.2 6.58 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.224 -0.923 . . . . 0.0 110.283 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 124.37 36.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 0.0 110.089 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.72 140.97 9.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 110.446 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.82 -90.45 0.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -112.76 155.33 44.16 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.0 110.138 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.93 -92.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.073 1.565 . . . . 0.0 110.749 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.486 ' CG2' ' O ' ' A' ' 94' ' ' ILE . 4.4 tt -107.24 121.11 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.052 -1.03 . . . . 0.0 110.372 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.11 -76.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.162 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.23 0.538 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.612 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 6.7 t70 -75.95 -42.13 3.52 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 49.8 Cg_endo -82.96 8.82 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.612 1.322 . . . . 0.0 109.803 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 53' ' ' ASN . 1.5 pt20 -178.4 -132.88 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 88' ' ' ARG . . . 168.79 80.43 0.04 OUTLIER Glycine 0 N--CA 1.485 1.938 0 C-N-CA 119.172 -1.49 . . . . 0.0 110.136 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.595 ' CG ' ' HA ' ' A' ' 51' ' ' VAL . 16.2 p90 -62.12 138.48 58.4 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.146 -1.208 . . . . 0.0 109.794 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -145.86 86.06 1.71 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.287 -0.883 . . . . 0.0 109.646 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -148.88 124.54 10.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.15 -0.969 . . . . 0.0 111.413 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.455 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 1.3 t-105 -114.26 119.67 37.79 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.494 ' CD2' HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -125.09 129.86 51.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.053 -1.029 . . . . 0.0 111.023 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.523 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 14.2 tt0 -122.66 151.15 41.79 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.336 -0.852 . . . . 0.0 109.27 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.686 ' CG2' ' CE2' ' A' ' 46' ' ' TYR . 2.0 m -126.18 -174.98 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' O ' ' SD ' ' A' ' 14' ' ' MET . 4.3 pt-20 -138.78 49.93 1.86 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.286 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.492 ' HE2' ' HD2' ' A' ' 18' ' ' ARG . 30.3 mmm -123.46 155.63 65.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 35.5 Cg_endo -70.52 -172.4 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.045 1.55 . . . . 0.0 112.82 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.03 -27.04 68.84 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.536 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.36 -45.89 87.33 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.54 0.686 . . . . 0.0 109.82 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.492 ' HD2' ' HE2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.81 -33.1 16.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.555 -0.715 . . . . 0.0 110.197 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 15' ' ' PRO . 77.5 t -48.05 -40.56 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -54.88 -28.42 50.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.843 . . . . 0.0 109.019 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.581 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 26.0 t0 -58.92 -35.4 73.03 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.357 0.598 . . . . 0.0 110.609 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.529 ' O ' ' CG ' ' A' ' 26' ' ' LEU . 4.2 mm? -55.87 -41.94 75.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.288 -0.965 . . . . 0.0 108.931 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.76 72.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -68.54 -46.05 70.56 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.365 -0.835 . . . . 0.0 109.511 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.565 ' O ' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -65.0 -33.52 76.26 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.521 -0.737 . . . . 0.0 110.235 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 35' ' ' VAL . 27.2 mt -69.42 -37.14 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 110.783 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.529 ' CD ' ' HA ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -68.09 -35.31 77.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.935 -1.103 . . . . 0.0 112.736 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.565 ' CG2' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -61.41 -35.52 67.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 120.423 -1.423 . . . . 0.0 111.43 -178.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.591 ' NE ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -79.9 61.58 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.751 -1.218 . . . . 0.0 109.873 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.94 -23.08 42.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.451 -0.781 . . . . 0.0 111.494 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -56.62 -28.1 59.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.085 -1.009 . . . . 0.0 111.526 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.591 ' CG1' ' NE ' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -82.36 155.98 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.693 -1.254 . . . . 0.0 110.523 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -47.13 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 112.259 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 50' ' ' ILE . 1.2 ttt180 -154.28 156.95 37.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.65 -1.282 . . . . 0.0 112.149 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.59 ' CG2' ' CD2' ' A' ' 26' ' ' LEU . 9.9 p -141.22 135.82 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.4 117.84 23.77 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -115.16 132.01 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 110.966 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 5.4 m -114.3 126.32 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.185 -0.947 . . . . 0.0 110.0 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -80.65 152.58 28.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.287 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 13.6 p -76.42 -168.27 0.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.523 -0.736 . . . . 0.0 110.02 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 t -107.85 -32.61 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.774 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.553 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.4 m -110.09 -67.12 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.078 -1.014 . . . . 0.0 111.136 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.2 Cg_endo -72.19 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.177 1.093 . . . . 0.0 110.628 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.36 31.83 5.28 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.556 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 6.7 mtt180 -94.68 135.71 35.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.997 . . . . 0.0 110.389 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.686 ' CE2' ' CG2' ' A' ' 12' ' ' VAL . 9.4 p90 -135.65 154.01 51.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.738 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -91.88 96.24 10.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.891 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 24.2 t -77.06 124.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.405 -0.81 . . . . 0.0 110.261 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -130.73 102.3 6.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.583 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.7 138.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.176 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.595 ' HA ' ' CG ' ' A' ' 6' ' ' TYR . 7.6 p -94.55 151.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.562 -0.712 . . . . 0.0 110.202 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.525 ' CB ' ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -97.41 179.67 4.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 110.844 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.559 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -49.26 -178.01 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.068 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.0 Cg_endo -63.92 -15.07 46.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.585 1.308 . . . . 0.0 110.068 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 31.1 t-20 -143.7 84.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.297 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -66.23 -176.99 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.074 -1.016 . . . . 0.0 111.389 -178.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 5.7 t70 174.61 172.28 0.22 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.416 0.627 . . . . 0.0 109.417 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.539 ' HA ' ' CD2' ' A' ' 61' ' ' LEU . 9.0 mt-30 -63.21 -41.02 99.09 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.158 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 -31.92 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' ' HB3' ' A' ' 57' ' ' ASP . 3.6 mm100 -74.15 -46.16 44.11 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 110.397 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 58' ' ' GLN . 4.4 pp -68.03 -35.19 77.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.817 -1.177 . . . . 0.0 109.368 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.493 ' N ' ' CD1' ' A' ' 61' ' ' LEU . . . -51.8 -33.4 35.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.626 ' O ' HG12 ' A' ' 67' ' ' ILE . 17.7 mt -71.27 -50.9 27.93 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.628 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HG2' ' CG2' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -71.39 -35.49 71.06 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.401 -1.437 . . . . 0.0 109.885 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -74.15 -39.68 63.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CG ' HG12 ' A' ' 67' ' ' ILE . 13.3 pt-20 -73.81 -37.85 64.76 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.753 -1.217 . . . . 0.0 109.982 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 63' ' ' LEU . 24.0 mm -77.89 -38.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.348 -0.845 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 46.1 mt -68.35 -42.03 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.9 -1.125 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 22.9 mt-30 -64.33 -48.16 76.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -40.41 95.35 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.22 -0.925 . . . . 0.0 110.593 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.53 ' HB1' ' CG ' ' A' ' 25' ' ' GLU . . . -66.47 -48.55 69.52 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.193 -0.942 . . . . 0.0 109.962 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 47.9 mt -66.17 -35.53 80.7 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.313 -0.867 . . . . 0.0 110.017 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 9.0 mm-40 -70.03 -42.86 72.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -0.818 . . . . 0.0 109.086 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -58.78 -36.02 73.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.581 ' CE2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.18 -31.47 62.69 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.581 -0.699 . . . . 0.0 110.559 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.467 ' O ' ' HE1' ' A' ' 14' ' ' MET . . . 115.41 1.5 21.75 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.3 124.77 39.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -1.188 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 5.0 ttm180 -120.37 150.89 40.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 3.1 t -92.67 118.83 39.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.134 -0.979 . . . . 0.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -4.9 57.91 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.79 144.46 51.09 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.388 -0.82 . . . . 0.0 110.894 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.0 t -139.32 106.68 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 109.087 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.26 108.42 10.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 111.315 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -99.07 111.02 23.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -80.08 12.74 2.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.036 -1.04 . . . . 0.0 110.578 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.34 121.09 0.08 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.86 159.94 15.65 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.262 -1.14 . . . . 0.0 109.912 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HB2' ' HA3' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -124.72 153.28 42.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.148 -0.97 . . . . 0.0 110.766 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -142.12 110.66 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 109.785 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.02 146.52 49.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.146 -0.972 . . . . 0.0 110.149 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.02 -140.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.95 . . . . 0.0 110.19 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -80.94 152.71 72.03 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.29 179.21 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.059 1.557 . . . . 0.0 110.301 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.36 114.53 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.37 179.95 4.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.927 . . . . 0.0 110.357 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.137 180.0 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.713 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 6.3 t0 -74.3 -22.72 0.48 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.081 . . . . 0.0 112.676 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 43.8 Cg_endo -86.79 -10.81 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 N-CA-C 109.302 -1.076 . . . . 0.0 109.302 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 87' ' ' LEU . 1.5 pm0 178.89 173.82 0.72 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.664 -0.648 . . . . 0.0 109.616 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.571 ' HA2' ' HG ' ' A' ' 56' ' ' LEU . . . -44.01 142.16 2.73 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.64 ' CD2' ' CD1' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -105.04 108.03 19.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.39 -1.065 . . . . 0.0 110.26 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -90.94 122.36 33.55 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.256 -0.903 . . . . 0.0 110.228 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 3.1 mm? -116.79 144.71 44.15 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 110.616 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.57 ' CE2' ' HE3' ' A' ' 81' ' ' LYS . 5.8 t90 -124.52 118.41 26.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.559 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CE2' HG13 ' A' ' 82' ' ' VAL . 9.1 m-85 -127.61 131.11 49.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.9 tt0 -101.96 159.58 15.23 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.673 ' CG2' ' CE1' ' A' ' 46' ' ' TYR . 3.6 m -129.74 -175.34 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.39 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' SD ' ' A' ' 14' ' ' MET . 0.6 OUTLIER -141.13 54.2 1.56 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.755 -0.591 . . . . 0.0 109.843 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.459 ' SD ' ' HA ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -121.32 152.19 57.19 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.427 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.6 Cg_endo -70.88 -162.9 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.207 1.635 . . . . 0.0 112.385 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.4 ' O ' HG21 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -48.83 -26.45 2.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 15' ' ' PRO . 41.8 t0 -57.73 -15.38 7.79 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.957 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' HD3' ' CE1' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -71.74 -17.07 62.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.411 -0.805 . . . . 0.0 110.552 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 16' ' ' GLU . 94.0 t -65.19 -48.59 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.549 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 20.0 m-80 -64.82 -30.32 71.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.094 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 26.4 t0 -65.16 -54.66 26.38 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 22' ' ' LEU . 3.9 mm? -59.16 -36.87 76.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.173 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.48 -52.24 65.46 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.589 -0.695 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -47.12 80.25 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.378 -0.826 . . . . 0.0 109.585 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.65 -43.79 95.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.487 -0.758 . . . . 0.0 110.007 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.485 ' O ' ' CG ' ' A' ' 29' ' ' ARG . 19.2 mt -54.94 -40.16 69.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 109.968 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -37.71 68.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.535 HG23 ' CG2' ' A' ' 67' ' ' ILE . 2.5 mt -59.64 -44.53 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.265 -0.897 . . . . 0.0 110.617 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.54 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 13.8 ptt85 -69.52 62.99 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.457 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -74.44 -39.76 62.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -62.83 -15.01 52.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.212 -0.93 . . . . 0.0 111.112 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.598 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 6.1 p -80.76 151.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.901 -1.124 . . . . 0.0 111.424 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -45.39 17.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 111.254 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.433 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.22 155.7 38.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.926 -1.109 . . . . 0.0 111.313 -179.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.528 ' CA ' HG13 ' A' ' 50' ' ' ILE . 14.9 p -137.67 136.15 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 110.061 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.14 118.25 26.46 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 131.92 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.823 . . . . 0.0 110.574 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 4.6 m -117.75 127.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.136 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -79.86 153.56 28.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.333 -0.854 . . . . 0.0 110.631 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -74.75 179.41 4.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.205 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -103.5 12.96 34.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.28 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 110.014 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.6 Cg_endo -70.24 -170.69 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.687 1.362 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 21.68 26.22 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HG3' ' OG ' ' A' ' 40' ' ' SER . 8.2 ptp180 -94.79 162.54 13.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.544 -0.974 . . . . 0.0 110.32 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.673 ' CE1' ' CG2' ' A' ' 12' ' ' VAL . 2.1 p90 -152.8 154.7 35.7 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.797 0.808 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HG3' ' CD1' ' A' ' 9' ' ' TRP . 2.4 tt0 -92.71 97.33 10.71 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.351 0.596 . . . . 0.0 109.662 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.42 119.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.419 -0.801 . . . . 0.0 110.059 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.22 100.96 5.58 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.598 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -121.06 147.62 24.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 121.427 0.632 . . . . 0.0 110.602 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.48 ' O ' HG21 ' A' ' 32' ' ' VAL . 12.0 p -126.09 148.22 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 56' ' ' LEU . 2.1 mp -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.13 -0.981 . . . . 0.0 110.174 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.527 ' N ' HD23 ' A' ' 56' ' ' LEU . 41.5 m-80 -36.75 159.48 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.812 -0.555 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 38.9 Cg_endo -64.52 -20.75 66.04 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.983 1.517 . . . . 0.0 111.498 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -127.98 77.67 1.78 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.057 . . . . 0.0 109.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.571 ' HG ' ' HA2' ' A' ' 5' ' ' GLY . 6.4 mt -73.3 -173.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.384 1.088 . . . . 0.0 112.531 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.488 ' OD1' ' HG3' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -168.43 170.63 9.67 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.606 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.58 -32.22 73.17 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.958 -1.088 . . . . 0.0 110.813 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -38.39 76.05 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 8.7 mm-40 -68.57 -43.9 75.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 21.2 mt -65.15 -35.36 80.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.018 -1.051 . . . . 0.0 109.702 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 66' ' ' GLU . . . -52.83 -33.25 48.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 24.9 mt -66.17 -50.48 63.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 18.0 pt-20 -74.84 -41.14 60.44 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.847 -1.158 . . . . 0.0 109.513 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 4.0 mptp? -67.98 -32.92 73.66 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.41 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 11.1 pt-20 -69.88 -46.35 65.66 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.41 -1.431 . . . . 0.0 109.945 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.535 ' CG2' HG23 ' A' ' 28' ' ' ILE . 4.4 mt -78.3 -40.72 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.066 . . . . 0.0 111.136 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 68.1 mt -60.49 -49.85 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 70' ' ' ARG . 2.9 pt20 -60.85 -44.12 97.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 17.2 mtp-105 -68.6 -47.11 67.54 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.503 -0.748 . . . . 0.0 110.765 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -62.28 -47.83 82.6 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.053 -1.03 . . . . 0.0 110.077 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD2' ' OD2' ' A' ' 21' ' ' ASP . 91.3 mt -63.13 -38.01 89.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.354 -0.842 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.02 -45.34 64.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.398 -0.814 . . . . 0.0 109.595 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -61.63 -36.47 80.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.47 -17.94 60.0 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.467 -0.771 . . . . 0.0 110.406 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' O ' ' HE1' ' A' ' 14' ' ' MET . . . 103.15 2.86 48.38 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' CB ' ' OD2' ' A' ' 21' ' ' ASP . . . -98.36 111.78 24.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -1.187 . . . . 0.0 110.099 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -118.05 144.75 45.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 3.1 t -88.95 125.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 120.922 -1.111 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 -5.63 58.76 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HE3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -130.38 149.96 51.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 111.579 -178.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 10' ' ' TYR . 1.2 m -137.5 106.92 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 109.125 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -128.87 123.04 31.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.446 -0.784 . . . . 0.0 111.109 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -97.33 90.45 5.09 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.297 -0.877 . . . . 0.0 109.251 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 86' ' ' GLY . 12.9 mt -125.66 -172.76 2.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.932 . . . . 0.0 110.476 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 87' ' ' LEU . . . 56.53 162.44 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.52 ' HB2' ' NE2' ' A' ' 4' ' ' GLN . 3.7 pp -179.8 130.65 0.1 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.19 -1.182 . . . . 0.0 110.848 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.462 ' HB3' ' HA3' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -83.46 120.91 26.49 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.349 -0.844 . . . . 0.0 109.659 179.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.456 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 6.5 mtp180 -94.09 128.85 40.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.112 -0.992 . . . . 0.0 110.736 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -178.38 80.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 110.266 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -104.03 91.57 4.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 110.037 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.95 160.99 59.43 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -76.7 -74.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.064 1.56 . . . . 0.0 110.773 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.54 138.16 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 110.178 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.86 114.33 24.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.9 tttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.222 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.23 0.538 . . . . 0.0 110.094 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.588 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 30.9 t0 -77.67 -43.12 2.42 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 111.173 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.5 Cg_endo -79.18 0.37 10.08 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.439 1.231 . . . . 0.0 110.059 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.498 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 pt20 -174.43 -149.79 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.342 -0.848 . . . . 0.0 110.064 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.61 76.66 0.18 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 118.951 -1.595 . . . . 0.0 111.033 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.582 ' CG ' ' HA ' ' A' ' 51' ' ' VAL . 2.7 p90 -63.4 134.72 56.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.915 -1.344 . . . . 0.0 109.725 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 17.5 m-85 -152.44 82.74 1.24 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 110.14 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 52' ' ' LEU . 4.1 mp -144.34 124.17 13.44 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.34 -0.85 . . . . 0.0 110.645 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -123.15 118.21 27.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.476 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 3.1 m-85 -126.57 135.08 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 110.89 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.55 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 2.3 tt0 -119.42 159.57 23.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 18.9 m -130.27 179.88 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 110.747 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -137.04 60.41 1.66 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.555 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 1.3 ptm -134.48 147.91 65.36 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.501 -0.749 . . . . 0.0 110.999 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 Cg_endo -73.37 -166.73 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.216 1.64 . . . . 0.0 112.452 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.538 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 22.7 tt0 -65.24 -25.42 67.66 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.203 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.01 -42.19 93.77 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.836 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -90.23 -14.34 33.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.33 -0.856 . . . . 0.0 110.322 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 7.2 t -46.52 -36.74 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.8 t30 -52.25 -27.89 16.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.364 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 42.3 t0 -59.14 -44.43 92.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.0 mm? -59.04 -39.62 82.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.84 . . . . 0.0 109.171 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.61 -53.12 61.32 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.439 -0.788 . . . . 0.0 109.292 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -42.89 93.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 29' ' ' ARG . 1.1 tt0 -57.69 -47.57 81.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 35' ' ' VAL . 6.7 mt -54.69 -40.14 68.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -36.13 74.24 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.461 HG23 ' HG3' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -63.28 -43.93 98.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.511 ' CZ ' ' HG2' ' A' ' 25' ' ' GLU . 8.7 mtm180 -70.47 54.82 0.15 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.563 -0.71 . . . . 0.0 110.359 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -74.09 -40.66 62.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.03 -16.18 40.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.573 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.591 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -81.31 158.49 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 110.093 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HD2' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -79.15 -46.81 17.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 111.229 -179.366 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.66 149.93 28.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 111.097 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.54 ' CG1' HD21 ' A' ' 26' ' ' LEU . 7.4 p -139.85 133.79 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.9 mtm -129.91 115.16 16.79 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.059 -1.026 . . . . 0.0 110.968 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.1 t -115.19 130.32 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 109.816 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' CG1' ' HB2' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -116.76 156.51 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.002 -1.061 . . . . 0.0 110.944 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.92 153.42 22.21 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.384 0.611 . . . . 0.0 110.456 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -76.83 -177.35 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.427 179.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -98.37 -47.85 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.303 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -100.59 -66.99 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 110.803 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.9 Cg_endo -72.1 -161.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.335 1.176 . . . . 0.0 110.776 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -116.19 40.49 2.39 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.6 mtt180 -93.3 135.41 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -1.081 . . . . 0.0 110.258 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.599 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 32.7 m-85 -115.05 154.98 27.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 111.034 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 5.3 mm-40 -100.52 114.99 29.06 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.925 -0.484 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 72.4 t -92.46 111.54 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 110.39 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.81 101.07 5.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.591 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.7 OUTLIER -124.83 149.07 29.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 121.681 0.753 . . . . 0.0 111.553 -178.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.582 ' HA ' ' CG ' ' A' ' 6' ' ' TYR . 6.5 p -98.72 151.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.739 -0.601 . . . . 0.0 109.682 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -95.49 176.26 6.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.368 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -48.48 179.23 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.403 -0.811 . . . . 0.0 109.794 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.8 -19.74 69.34 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.458 1.241 . . . . 0.0 109.266 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 9.6 t-20 -142.1 84.92 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 57' ' ' ASP . 3.8 pp -71.13 -172.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.004 . . . . 0.0 110.812 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.579 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 10.8 t70 173.07 171.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.386 0.612 . . . . 0.0 109.782 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' HG3' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -53.86 -54.39 39.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -0.819 . . . . 0.0 110.868 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -32.48 72.24 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.918 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.0 mm-40 -67.17 -44.77 78.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.848 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 57' ' ' ASP . 5.8 mp -65.05 -34.36 78.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.014 -1.054 . . . . 0.0 109.676 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 66' ' ' GLU . . . -52.28 -33.85 43.88 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.626 ' O ' HG12 ' A' ' 67' ' ' ILE . 32.9 mt -68.16 -50.03 57.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.87 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 90.8 mt-10 -70.62 -35.6 73.04 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.243 -1.536 . . . . 0.0 109.381 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.48 -43.87 59.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 110.646 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 62' ' ' ALA . 10.0 pt-20 -72.62 -37.82 67.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.891 -1.13 . . . . 0.0 109.893 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 63' ' ' LEU . 40.1 mm -77.25 -39.73 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 111.154 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 87.8 mt -70.28 -47.0 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.867 -1.146 . . . . 0.0 110.043 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 12.0 mm-40 -61.49 -33.83 74.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 110.541 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -67.42 -41.9 84.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.098 -1.002 . . . . 0.0 111.235 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.44 -48.41 56.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 111.323 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.48 ' HG ' ' OE1' ' A' ' 25' ' ' GLU . 29.3 mt -58.59 -36.47 74.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 111.211 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.252 4.0 tt0 -71.53 -47.57 54.35 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.147 0.975 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -61.54 -39.38 90.89 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.116 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.68 -35.73 60.26 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.65 24.82 4.2 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB1' ' CE ' ' A' ' 14' ' ' MET . . . -107.3 127.05 53.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.861 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -118.77 137.69 53.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 110.426 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 1.7 t -90.29 117.16 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -82.42 -6.82 59.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 109.452 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -134.94 136.13 42.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.302 -0.874 . . . . 0.0 111.525 -178.767 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.7 p -141.2 108.5 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -127.35 109.63 11.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.005 -1.059 . . . . 0.0 111.656 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.79 113.1 17.69 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.189 -0.945 . . . . 0.0 109.171 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 2.3 mp -85.92 30.76 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.988 -1.07 . . . . 0.0 111.385 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 7' ' ' PHE . . . 96.15 -168.63 25.92 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.811 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.06 -161.79 1.25 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.61 -0.936 . . . . 0.0 110.387 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 3.6 ppt_? -78.57 135.48 37.29 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.514 -0.742 . . . . 0.0 110.776 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -135.09 40.21 2.9 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.947 0.879 . . . . 0.0 109.731 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 tt -44.86 106.93 0.08 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.184 0.516 . . . . 0.0 110.395 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.88 158.87 43.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.158 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.77 131.21 26.12 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.23 88.3 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.924 1.486 . . . . 0.0 110.412 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 94' ' ' ILE . 40.2 pt -93.26 138.51 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.915 . . . . 0.0 110.111 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.15 107.14 10.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.201 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.531 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 19.8 ttm . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.142 0.496 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.714 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.0 p30 -75.18 -22.81 0.46 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 112.065 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.9 Cg_endo -88.41 44.32 0.87 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 122.769 0.878 . . . . 0.0 110.148 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.556 ' CG ' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -42.54 -69.12 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.508 -179.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 88' ' ' ARG . . . -105.42 24.85 26.42 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.604 ' CD1' ' HA ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -63.26 97.3 0.12 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.835 -1.391 . . . . 0.0 108.944 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.472 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -156.5 31.47 0.32 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.906 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.605 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 6.4 mp -105.27 125.33 50.86 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.543 ' CE2' ' OD1' ' A' ' 49' ' ' ASN . 1.1 t90 -124.48 126.72 46.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.356 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.464 ' OH ' HD21 ' A' ' 8' ' ' LEU . 80.1 m-85 -122.94 122.1 37.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.921 . . . . 0.0 110.689 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.538 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 11.8 tt0 -111.29 159.84 17.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.303 -0.873 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.8 m -136.86 -176.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.832 -1.168 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 15.1 tt0 -145.76 53.38 1.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.574 -0.704 . . . . 0.0 110.338 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.51 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -128.77 153.01 79.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.73 -166.53 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.952 1.501 . . . . 0.0 113.574 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' A' ' 19' ' ' VAL . 3.0 tm-20 -60.72 -26.61 67.3 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.918 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.33 -27.28 62.09 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.908 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.616 ' NH1' ' CZ ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -88.44 -13.74 39.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.999 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 79.2 t -47.76 -40.99 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.0 109.968 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.8 m-20 -61.77 -29.68 70.29 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.772 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.591 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 39.5 t0 -60.85 -47.54 85.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.341 -0.85 . . . . 0.0 110.386 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.513 ' HG ' ' NH2' ' A' ' 18' ' ' ARG . 4.4 mm? -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.847 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.01 -47.29 78.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.06 -44.14 73.2 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.386 -0.821 . . . . 0.0 110.003 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.07 -47.95 82.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.546 ' O ' ' NE ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.06 -37.25 86.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.044 -1.035 . . . . 0.0 110.593 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -73.01 -42.38 63.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.849 -1.157 . . . . 0.0 110.454 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -61.93 -43.22 97.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.376 -0.828 . . . . 0.0 111.761 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.549 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -70.63 67.42 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.087 -1.008 . . . . 0.0 110.812 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.7 m-20 -64.59 -25.08 67.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.516 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 24.5 p30 -64.86 -25.79 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.299 -0.875 . . . . 0.0 111.57 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' CG1' ' HD2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -80.62 148.9 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.808 -1.182 . . . . 0.0 110.162 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -47.4 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 111.994 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -154.46 138.52 16.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.193 . . . . 0.0 111.243 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 32' ' ' VAL . 2.1 t -125.83 132.54 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.335 -0.853 . . . . 0.0 110.131 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 ttm -119.92 115.49 23.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.219 -0.926 . . . . 0.0 109.96 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.89 130.68 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.811 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 1.4 m -123.25 129.07 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -76.66 153.92 34.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -168.2 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.505 -0.747 . . . . 0.0 109.826 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.0 t -109.21 11.82 25.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.977 . . . . 0.0 110.79 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.574 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.36 -65.11 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 50.5 Cg_endo -72.62 -170.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.465 1.245 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -110.37 34.03 5.63 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.9 mtt180 -94.14 141.19 28.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -1.012 . . . . 0.0 110.04 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.616 ' CZ ' ' NH1' ' A' ' 18' ' ' ARG . 17.4 m-85 -124.91 154.19 41.49 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.976 0.893 . . . . 0.0 110.729 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.528 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 24.8 mt-10 -103.05 92.5 4.57 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 80.7 t -77.49 124.74 36.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.543 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 74.9 m-20 -128.32 100.83 5.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -113.49 130.03 68.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 121.216 0.531 . . . . 0.0 110.408 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.604 ' HA ' ' CD1' ' A' ' 6' ' ' TYR . 8.4 p -91.97 150.25 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.558 ' HB3' ' CG ' ' A' ' 56' ' ' LEU . 12.5 mt -92.94 167.67 11.66 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 111.217 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.662 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 1.7 m-20 -65.1 -147.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.56 -35.14 30.71 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 CA-C-N 119.426 0.831 . . . . 0.0 111.64 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -162.97 79.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.74 -1.225 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' CG ' ' HB3' ' A' ' 52' ' ' LEU . 16.8 mt -80.4 -165.82 0.94 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.134 -0.979 . . . . 0.0 111.3 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.505 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER 177.72 -162.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.664 -0.647 . . . . 0.0 110.273 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.462 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 24.3 mt-30 -64.67 -30.16 71.17 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 111.132 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -71.25 -44.23 65.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.4 mm100 -73.64 -44.09 57.81 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.487 -0.758 . . . . 0.0 109.682 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.605 ' CD2' ' CD2' ' A' ' 8' ' ' LEU . 30.7 mt -66.58 -33.28 75.32 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.76 -32.91 32.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.574 ' O ' ' CG1' ' A' ' 67' ' ' ILE . 88.6 mt -71.18 -50.4 33.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.634 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -70.49 -32.21 69.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.453 -1.404 . . . . 0.0 109.56 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.543 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -73.37 -45.19 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 44.8 mt-10 -64.84 -38.3 90.53 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.121 -0.987 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.574 ' CG1' ' O ' ' A' ' 63' ' ' LEU . 7.1 mm -78.39 -43.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.538 -0.727 . . . . 0.0 111.458 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 64' ' ' GLU . 10.4 mt -64.29 -41.3 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.0 110.7 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -60.91 -37.44 82.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.097 -1.002 . . . . 0.0 110.429 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -69.31 -45.43 69.55 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.222 -0.923 . . . . 0.0 111.103 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -48.82 72.27 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.008 -1.058 . . . . 0.0 110.253 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.48 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 36.1 mt -63.8 -35.68 81.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.958 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -70.35 -45.55 65.91 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.543 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -60.3 -37.23 79.88 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.36 -25.72 57.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.495 -0.753 . . . . 0.0 110.326 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.11 11.32 32.23 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -95.05 126.58 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -1.106 . . . . 0.0 110.2 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -119.49 131.71 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 11' ' ' GLN . 3.4 t -85.84 124.6 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.01 -9.11 59.66 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -131.57 130.82 42.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.368 -0.832 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 8.9 p -141.2 108.63 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.094 . . . . 0.0 110.57 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' HG3' HD13 ' A' ' 85' ' ' LEU . 3.5 tp10 -127.38 107.91 10.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.994 -1.067 . . . . 0.0 109.876 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.515 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 10.4 pt-20 -99.56 118.22 35.64 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.312 -0.868 . . . . 0.0 111.319 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 6.0 mp -113.64 -69.81 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.487 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 85' ' ' LEU . . . 38.73 72.42 0.2 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 87' ' ' LEU . 3.2 pp 179.55 45.58 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.211 -1.17 . . . . 0.0 110.287 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -121.78 140.49 52.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 110.494 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -130.85 121.46 25.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.878 . . . . 0.0 109.965 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.45 88.27 2.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.428 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.24 -32.77 3.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 110.075 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.545 ' CG ' ' HD2' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -101.03 149.55 36.33 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.096 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 92' ' ' TYR . 48.2 Cg_endo -74.89 55.26 3.83 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.983 1.517 . . . . 0.0 110.741 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 92' ' ' TYR . 25.6 mm -82.05 124.9 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.042 -1.036 . . . . 0.0 110.067 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.71 -156.74 0.75 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 110.316 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.192 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' O ' ' CD2' ' A' ' 90' ' ' LEU . 1.4 mpp? . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.31 0.576 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.607 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 30.4 t0 -62.74 -40.3 62.57 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 111.301 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 47.7 Cg_endo -84.93 15.76 2.13 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.423 1.223 . . . . 0.0 110.373 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.673 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -44.04 123.37 3.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.462 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.523 ' HA2' ' CG ' ' A' ' 56' ' ' LEU . . . 104.19 -37.58 3.7 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.15 -1.5 . . . . 0.0 109.902 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.558 ' CE2' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -66.79 117.42 8.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.062 -1.257 . . . . 0.0 109.701 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.587 ' CD2' ' O ' ' A' ' 7' ' ' PHE . 85.6 t80 -168.08 27.55 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.34 -0.85 . . . . 0.0 109.786 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -153.51 123.97 7.12 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 120.962 -1.086 . . . . 0.0 111.939 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.502 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . 7.3 t90 -128.11 118.83 24.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.479 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 62.0 m-85 -127.54 145.19 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.874 -1.141 . . . . 0.0 111.753 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.542 ' HB3' ' HG2' ' A' ' 81' ' ' LYS . 23.2 tt0 -122.91 159.6 27.91 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.367 -0.833 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.54 -177.43 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.938 -1.102 . . . . 0.0 110.726 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 6.7 tt0 -135.58 50.18 2.12 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.693 0.759 . . . . 0.0 109.748 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' GLY . 16.6 mmt -128.59 148.7 69.42 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.81 -166.58 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.768 1.404 . . . . 0.0 113.412 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -52.58 -24.84 9.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.713 178.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.445 ' C ' ' OH ' ' A' ' 75' ' ' TYR . 35.8 t0 -58.22 -13.1 4.34 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.329 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.618 ' HA ' ' CZ ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -71.42 -13.3 61.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.234 -0.916 . . . . 0.0 111.027 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 16' ' ' GLU . 54.7 t -49.76 -46.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.34 -0.85 . . . . 0.0 110.068 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -30.87 69.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.168 -0.958 . . . . 0.0 109.58 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.602 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 16.3 t0 -69.48 -54.93 11.83 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.334 -0.854 . . . . 0.0 109.931 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.3 mm? -61.64 -38.13 86.55 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.85 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.49 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.81 -52.02 66.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.433 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -70.35 -46.83 63.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.187 -0.946 . . . . 0.0 109.769 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HA ' ' CB ' ' A' ' 71' ' ' ALA . 50.5 tt0 -56.51 -49.63 74.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 110.919 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -63.76 -36.4 83.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.504 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.95 -41.98 97.35 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.194 -0.942 . . . . 0.0 111.313 -179.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.508 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 23.2 mt -67.57 -40.96 85.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.782 -1.199 . . . . 0.0 109.834 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 32' ' ' VAL . 36.7 mtp180 -74.39 64.53 1.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.546 -0.721 . . . . 0.0 110.373 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -29.62 70.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.942 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -62.14 -13.75 30.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.439 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' A' ' 50' ' ' ILE . 1.8 p -79.91 126.2 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.108 -0.995 . . . . 0.0 110.597 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -80.38 -44.59 19.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 110.69 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -151.72 123.72 8.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 0.0 111.486 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 3.7 p -129.94 128.16 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.708 . . . . 0.0 109.155 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.4 tpp -116.26 115.79 26.6 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.069 -1.02 . . . . 0.0 111.065 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.479 HG21 HG23 ' A' ' 48' ' ' VAL . 16.8 t -115.25 125.23 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.78 160.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.069 -1.019 . . . . 0.0 110.734 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -79.69 154.4 28.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.411 -0.806 . . . . 0.0 110.364 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.414 ' CB ' ' HG2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -74.11 -170.69 0.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.927 . . . . 0.0 110.105 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -98.69 1.71 46.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.629 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -160.53 -64.55 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.012 -1.055 . . . . 0.0 110.625 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 41.2 Cg_endo -67.66 -168.79 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.596 1.314 . . . . 0.0 110.782 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -107.11 29.17 11.04 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HD3' ' CG ' ' A' ' 43' ' ' PRO . 8.6 ptt180 -94.19 160.61 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.845 -1.386 . . . . 0.0 110.393 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.573 ' CE1' ' HG2' ' A' ' 18' ' ' ARG . 60.3 m-85 -132.48 155.26 48.87 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 121.956 0.884 . . . . 0.0 111.018 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.94 96.87 8.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.479 HG23 HG21 ' A' ' 37' ' ' VAL . 43.5 t -79.61 118.99 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.883 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -131.19 101.16 5.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.543 ' CD1' HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -117.36 146.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.912 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' HB ' ' CE2' ' A' ' 6' ' ' TYR . 2.7 p -107.05 120.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.53 ' CD1' HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.52 179.74 6.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 111.175 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.571 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.0 OUTLIER -45.33 174.04 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.766 -0.584 . . . . 0.0 110.359 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.2 Cg_endo -63.23 -15.13 46.19 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.594 1.313 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' OD1' ' NH1' ' A' ' 88' ' ' ARG . 19.0 t-20 -140.36 73.71 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.96 . . . . 0.0 110.449 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -63.03 165.19 7.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -165.42 168.67 16.45 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 110.82 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -54.68 -38.2 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.316 -0.865 . . . . 0.0 110.111 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -45.4 87.5 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm100 -69.7 -41.48 75.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.386 -0.822 . . . . 0.0 109.255 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 10.5 mt -63.26 -35.01 78.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.787 . . . . 0.0 109.957 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.561 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . . . -52.22 -43.9 64.51 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.647 ' O ' HG12 ' A' ' 67' ' ' ILE . 66.9 mt -64.75 -48.38 74.77 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.702 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -65.26 -44.74 87.11 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.356 -1.465 . . . . 0.0 110.819 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.561 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 5.0 ptmt -74.52 -35.16 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.471 -1.393 . . . . 0.0 110.433 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 86.9 mt-10 -77.23 -40.41 45.01 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.892 -1.13 . . . . 0.0 109.881 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 63' ' ' LEU . 8.7 mm -76.99 -35.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.173 -0.954 . . . . 0.0 110.946 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 69.1 mt -69.09 -45.27 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 0.0 109.48 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 32.0 mt-30 -60.3 -48.52 81.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.285 -0.885 . . . . 0.0 110.005 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -60.36 -44.24 95.77 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.435 -0.791 . . . . 0.0 111.082 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.533 ' CB ' ' HA ' ' A' ' 25' ' ' GLU . . . -65.5 -48.76 71.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.875 -1.14 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 77' ' ' ALA . 32.0 mt -65.49 -38.15 88.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 12.9 mm-40 -70.88 -44.85 65.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 31.2 t-20 -60.75 -37.02 80.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.618 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 t80 -75.71 -33.47 60.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.241 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.49 11.35 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -103.84 129.41 51.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.24 . . . . 0.0 109.802 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.15 137.57 52.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.131 -0.981 . . . . 0.0 110.547 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.1 t -79.29 115.65 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.596 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.78 -4.67 58.28 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.527 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -130.28 155.01 47.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.226 -0.922 . . . . 0.0 111.889 -178.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -140.99 107.82 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -127.62 111.07 13.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.096 -1.003 . . . . 0.0 111.367 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 6.9 pm0 -95.54 89.49 5.4 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.269 -0.894 . . . . 0.0 109.153 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.571 ' O ' ' CD1' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -107.94 -135.78 0.36 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.178 -0.951 . . . . 0.0 109.977 -179.601 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 85' ' ' LEU . . . 43.99 -171.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.5 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 2.7 pp 179.68 124.3 0.07 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.239 -1.154 . . . . 0.0 110.482 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -77.84 128.94 34.78 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.312 -0.868 . . . . 0.0 110.545 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.442 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -141.25 26.64 1.98 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 110.045 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.504 ' CD2' ' O ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -82.33 51.18 1.76 Allowed 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.15 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.96 165.26 24.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 110.288 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.33 165.63 37.38 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 0.0 110.431 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.22 151.74 49.4 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.106 1.582 . . . . 0.0 110.495 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 87.6 mt -122.52 115.24 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.195 -0.94 . . . . 0.0 110.131 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.28 47.21 0.88 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.373 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.297 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.608 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.257 0.551 . . . . 0.0 110.026 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.692 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 26.6 t0 -77.61 -23.86 0.44 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 113.0 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 49.3 Cg_endo -82.57 -5.33 11.68 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 122.699 0.842 . . . . 0.0 110.106 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER 179.57 -170.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.818 . . . . 0.0 110.828 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.553 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -68.18 126.23 22.62 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.608 ' CD2' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -80.48 132.27 35.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.611 -0.935 . . . . 0.0 110.591 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -101.84 93.92 5.55 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.271 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 3.7 mm? -90.79 148.45 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.155 -0.966 . . . . 0.0 111.521 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 3.5 t90 -127.36 119.61 26.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.787 . . . . 0.0 109.356 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -123.27 143.74 49.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.93 -1.106 . . . . 0.0 111.163 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.539 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 5.9 tt0 -121.05 160.33 23.84 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.406 -0.809 . . . . 0.0 109.597 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.85 -177.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 110.515 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 33.7 tt0 -143.32 53.47 1.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.234 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.533 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -122.1 148.93 53.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.256 -0.903 . . . . 0.0 109.876 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 36.2 Cg_endo -69.36 -167.31 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.992 1.522 . . . . 0.0 113.491 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' HG13 ' A' ' 19' ' ' VAL . 3.0 tm-20 -65.52 -23.72 66.95 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.267 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.83 -39.49 79.97 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.615 -0.678 . . . . 0.0 111.966 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.3 OUTLIER -90.69 -16.76 27.98 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.056 -1.027 . . . . 0.0 110.869 -178.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 16' ' ' GLU . 7.4 p -46.54 -36.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.514 -0.741 . . . . 0.0 110.413 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 2.2 t30 -52.21 -28.16 17.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.454 -0.779 . . . . 0.0 109.682 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 39.7 t0 -58.8 -38.12 77.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.365 -0.834 . . . . 0.0 109.834 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.586 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 2.9 mp -58.52 -41.66 85.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.526 -0.734 . . . . 0.0 109.349 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.38 -50.6 71.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.403 -0.811 . . . . 0.0 109.517 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -68.55 -41.03 80.39 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.83 . . . . 0.0 109.694 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 28' ' ' ILE . 1.1 tp10 -59.78 -48.8 80.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.348 -0.845 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -60.89 -37.26 81.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.051 . . . . 0.0 109.055 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.481 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.38 -38.96 81.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.436 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.532 HG22 ' CG2' ' A' ' 67' ' ' ILE . 0.5 OUTLIER -58.86 -44.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.273 -0.892 . . . . 0.0 110.534 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 11.6 ptp180 -78.61 52.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.71 -27.91 69.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.107 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 29.8 p-10 -58.88 -17.85 27.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 109.94 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.575 ' CG2' ' CD1' ' A' ' 50' ' ' ILE . 3.4 p -80.9 154.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.45 -0.781 . . . . 0.0 110.522 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -79.17 -45.53 19.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 111.058 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.47 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.5 mtt-85 -152.14 135.62 16.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.992 -1.067 . . . . 0.0 110.899 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.511 ' CA ' HG13 ' A' ' 50' ' ' ILE . 8.8 p -133.87 133.67 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.82 119.26 12.24 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.189 -0.945 . . . . 0.0 110.793 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 46' ' ' TYR . 58.5 t -114.54 130.67 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.984 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 16.2 m -111.28 145.13 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.685 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.547 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.09 153.87 23.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.422 -0.799 . . . . 0.0 110.687 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.53 -173.82 1.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -105.24 -16.91 14.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.087 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -124.31 -67.95 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -71.52 -168.79 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.105 1.055 . . . . 0.0 110.791 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -110.48 31.62 7.23 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.503 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 1.4 ptm180 -94.54 160.74 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -1.183 . . . . 0.0 110.486 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.547 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 19.9 m-85 -132.2 154.35 49.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.846 0.831 . . . . 0.0 110.836 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 20.2 mt-10 -103.85 93.19 4.75 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.574 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 65.4 t -79.5 123.13 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.0 111.603 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 77.6 m-20 -130.91 100.76 5.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.575 ' CD1' ' CG2' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -136.52 147.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.634 0.731 . . . . 0.0 111.432 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.503 ' N ' HG12 ' A' ' 50' ' ' ILE . 9.9 p -124.81 149.92 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.617 -0.677 . . . . 0.0 109.232 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.577 ' HB2' ' CG ' ' A' ' 56' ' ' LEU . 6.1 mp -105.41 -158.56 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 52' ' ' LEU . 1.2 m-80 -39.44 163.8 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.85 -0.531 . . . . 0.0 110.425 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' GLY . 38.5 Cg_endo -64.13 -15.71 50.9 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.0 1.526 . . . . 0.0 110.877 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.494 ' HA ' ' CA ' ' A' ' 4' ' ' GLN . 66.9 t30 -139.05 75.88 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 110.117 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.577 ' CG ' ' HB2' ' A' ' 52' ' ' LEU . 8.7 mt -61.76 -174.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.975 -1.078 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD2' ' OD1' ' A' ' 2' ' ' ASP . 0.5 OUTLIER -178.79 -174.25 0.35 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.465 0.65 . . . . 0.0 109.724 179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -65.82 -40.01 91.42 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 111.119 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.1 m -66.19 -36.12 82.24 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 0.0 110.56 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' CB ' HD22 ' A' ' 56' ' ' LEU . 16.6 mm100 -70.26 -44.53 68.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 110.45 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.458 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 71.4 mt -64.67 -33.18 75.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.529 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.42 -35.66 52.52 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.64 ' O ' HG12 ' A' ' 67' ' ' ILE . 47.4 mt -71.55 -49.72 38.03 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.873 0.844 . . . . 0.0 109.145 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.529 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 4.6 mt-10 -67.32 -38.39 84.85 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.624 -1.297 . . . . 0.0 109.987 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' CE ' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.881 -1.137 . . . . 0.0 110.756 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 10.9 mm-40 -75.48 -39.41 58.65 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.725 -1.234 . . . . 0.0 109.628 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 63' ' ' LEU . 23.6 mm -78.17 -40.87 26.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.496 -0.753 . . . . 0.0 111.868 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 89.0 mt -71.32 -41.66 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.322 -1.487 . . . . 0.0 110.294 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 1.4 pp0? -64.35 -34.64 78.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -0.847 . . . . 0.0 110.761 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.06 -41.52 77.48 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.01 -1.056 . . . . 0.0 110.977 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.02 -48.55 62.67 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.09 -1.006 . . . . 0.0 110.709 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' A' ' 77' ' ' ALA . 61.6 mt -60.71 -38.2 84.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.192 -0.943 . . . . 0.0 110.606 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -72.04 -45.9 59.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.367 -0.833 . . . . 0.0 109.563 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -60.9 -40.46 93.18 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.32 -43.75 39.89 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.574 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.72 34.23 1.44 Allowed Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -113.01 127.3 56.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -1.155 . . . . 0.0 109.534 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -120.7 129.29 53.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 110.612 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.3 t -75.13 119.66 23.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.087 -1.008 . . . . 0.0 109.407 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -82.32 -7.06 59.63 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.9 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.539 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -132.98 149.71 52.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.329 -0.857 . . . . 0.0 111.559 -178.397 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 81' ' ' LYS . 9.8 t -141.51 105.21 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -129.95 115.81 17.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 110.652 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.439 ' HB3' ' OH ' ' A' ' 6' ' ' TYR . 10.0 mt-10 -98.18 89.7 4.6 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.979 -1.076 . . . . 0.0 109.974 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -131.77 -165.24 1.55 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.389 -0.819 . . . . 0.0 110.06 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 87' ' ' LEU . . . 61.12 163.34 0.19 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 3.5 pp -178.41 137.43 0.17 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.311 -1.111 . . . . 0.0 110.258 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 20.2 mmm-85 -80.12 171.33 15.22 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.178 -0.951 . . . . 0.0 110.197 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -113.57 102.57 10.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.274 -0.891 . . . . 0.0 110.598 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -77.69 138.36 39.02 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.93 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.13 -36.22 4.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.221 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.91 144.27 47.61 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 110.309 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.79 -90.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.055 1.555 . . . . 0.0 110.296 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.43 HD11 HG21 ' A' ' 94' ' ' ILE . 24.9 mt -107.83 117.24 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 110.102 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.96 149.39 28.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.384 -0.822 . . . . 0.0 110.282 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.276 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.412 ' N ' HD22 ' A' ' 8' ' ' LEU . 1.7 m-85 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.195 0.522 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 8' ' ' LEU . 1.6 mm? -104.67 124.32 49.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.16 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.502 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 1.7 t90 -115.79 119.63 36.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.741 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CA ' ' HD2' ' A' ' 81' ' ' LYS . 27.0 m-85 -126.84 137.37 53.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.761 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.553 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 10.7 tt0 -122.82 159.46 28.08 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.376 -0.827 . . . . 0.0 109.42 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 11.4 m -136.03 -177.51 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.003 -1.061 . . . . 0.0 110.667 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -146.54 56.22 1.15 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.481 0.657 . . . . 0.0 109.651 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.543 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 10.2 mmt -131.12 149.05 72.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.402 -0.811 . . . . 0.0 109.209 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.95 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.2 Cg_endo -68.63 -168.4 0.22 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.774 1.408 . . . . 0.0 112.823 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.57 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -61.12 -46.55 90.13 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.543 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.0 -28.73 20.0 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.275 -0.89 . . . . 0.0 110.214 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 15' ' ' PRO . 43.0 t -47.99 -37.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.571 -0.706 . . . . 0.0 110.791 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -53.64 -29.0 36.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.984 -1.073 . . . . 0.0 109.739 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.573 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 24.6 t0 -59.99 -36.58 77.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 110.655 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.628 HD13 ' HA ' ' A' ' 19' ' ' VAL . 6.8 mp -57.97 -39.35 77.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.54 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -61.37 -52.82 63.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.838 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.36 -42.39 75.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.246 -0.909 . . . . 0.0 110.383 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.588 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -56.02 -49.05 74.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 110.407 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.38 -36.98 85.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.504 -0.748 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.6 -38.63 88.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.151 -0.968 . . . . 0.0 110.781 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.802 ' CG2' HG21 ' A' ' 67' ' ' ILE . 55.8 mt -61.6 -47.44 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 120.927 -1.108 . . . . 0.0 110.567 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 2.9 ptt180 -72.66 67.47 0.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.94 -25.48 29.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -57.9 -14.98 7.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.102 -0.999 . . . . 0.0 110.154 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.9 ' CG2' HD11 ' A' ' 50' ' ' ILE . 1.7 p -80.35 132.08 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 110.311 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -80.04 -46.49 16.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.518 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttp85 -152.7 123.3 7.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.9 -1.125 . . . . 0.0 111.135 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 26' ' ' LEU . 7.2 p -127.18 136.18 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.465 -0.772 . . . . 0.0 109.75 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.97 120.72 17.38 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.04 -1.038 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.735 HG12 ' HB3' ' A' ' 46' ' ' TYR . 20.0 t -114.94 130.41 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.736 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 18.9 t -104.43 161.15 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.049 -1.032 . . . . 0.0 110.862 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.11 154.59 23.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.545 -0.722 . . . . 0.0 110.317 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 7.7 p -73.2 -172.58 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 41' ' ' THR . 8.5 t -94.66 -1.91 52.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.11 -64.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.043 -1.036 . . . . 0.0 110.786 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.5 Cg_endo -69.18 -160.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.556 1.292 . . . . 0.0 111.226 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.1 37.37 3.85 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.7 mtp180 -93.95 146.89 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.477 -1.014 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.735 ' HB3' HG12 ' A' ' 37' ' ' VAL . 41.2 m-85 -131.7 154.73 48.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.147 -0.971 . . . . 0.0 110.942 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.495 ' CG ' ' HB ' ' A' ' 38' ' ' VAL . 2.6 pt-20 -101.64 104.48 15.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 48.5 t -83.71 116.9 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 111.642 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -131.17 100.53 5.24 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.9 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -117.25 144.85 24.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.903 -178.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 50' ' ' ILE . 9.4 p -96.18 147.39 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 109.429 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.615 ' HB2' HD23 ' A' ' 56' ' ' LEU . 19.8 mt -107.25 -178.28 3.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.711 -1.243 . . . . 0.0 111.625 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.545 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -64.86 179.32 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.767 -0.583 . . . . 0.0 110.523 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -63.97 -15.99 52.31 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.861 1.453 . . . . 0.0 110.788 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -141.07 87.35 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.33 173.76 7.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.02 -1.05 . . . . 0.0 111.162 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 173.72 -167.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.527 -0.733 . . . . 0.0 110.133 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.554 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.69 76.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 7.7 mm-40 -67.86 -45.11 75.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 52' ' ' LEU . 79.4 mt -64.61 -35.11 79.94 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 109.811 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.74 -33.89 50.2 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.048 . . . . 0.0 108.342 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.558 ' O ' HG13 ' A' ' 67' ' ' ILE . 15.2 mt -70.94 -49.39 46.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' OE1' HD21 ' A' ' 52' ' ' LEU . 38.5 mt-10 -68.51 -43.36 77.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 109.316 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.7 mmtp -60.73 -36.2 78.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 110.408 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.6 mm-40 -65.75 -48.84 70.53 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.841 -1.162 . . . . 0.0 110.061 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.802 HG21 ' CG2' ' A' ' 28' ' ' ILE . 4.6 mt -77.77 -41.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.392 -0.817 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 27.4 mt -59.46 -50.49 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 30.0 mt-30 -64.36 -47.06 80.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.2 -0.938 . . . . 0.0 108.897 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -58.13 -47.11 84.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.509 -0.745 . . . . 0.0 110.81 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -68.76 -48.51 63.53 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.864 -1.148 . . . . 0.0 110.449 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.496 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 76.1 mt -65.7 -35.55 81.09 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.326 -0.858 . . . . 0.0 110.455 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 69' ' ' GLN . 1.4 mm-40 -71.33 -44.91 64.21 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 109.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.9 m-80 -64.29 -36.6 84.64 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.011 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.03 -37.65 61.67 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.628 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.27 23.95 4.32 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HA ' ' HG3' ' A' ' 14' ' ' MET . . . -108.31 131.32 54.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.26 -1.141 . . . . 0.0 109.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 146.19 46.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.9 t -87.85 122.24 39.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.046 -1.034 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.01 -7.46 59.56 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.077 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -137.55 152.98 50.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 111.525 -178.738 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.628 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.971 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.332 0.587 . . . . 0.0 109.643 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.971 HD12 ' C ' ' A' ' 7' ' ' PHE . 6.7 mp -138.46 125.28 21.06 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.825 . . . . 0.0 110.847 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.562 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -99.57 132.41 44.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.975 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -128.12 128.51 44.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.45 157.33 29.57 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.833 -1.167 . . . . 0.0 110.519 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.743 HG21 ' CD ' ' A' ' 18' ' ' ARG . 26.6 m -130.36 179.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.75 51.54 2.12 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.58 -0.7 . . . . 0.0 109.84 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.586 ' CB ' ' HB3' ' A' ' 18' ' ' ARG . 70.4 mmm -133.96 151.82 77.46 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 109.535 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 36.0 Cg_endo -71.15 -167.57 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.835 1.44 . . . . 0.0 113.24 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 19' ' ' VAL . 37.7 tt0 -53.23 -25.51 14.41 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.528 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 26.9 t0 -57.58 -23.34 50.23 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.864 ' NH1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -88.09 -13.49 41.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 16' ' ' GLU . 70.3 t -48.26 -44.6 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.52 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 4.6 m-20 -57.9 -29.07 64.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.764 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.2 t0 -59.64 -45.33 92.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.864 HD21 ' NH1' ' A' ' 18' ' ' ARG . 2.0 mm? -59.71 -36.65 76.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.26 74.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.173 -0.954 . . . . 0.0 110.533 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.3 mmt-85 -60.05 -46.64 88.87 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.5 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 tm-20 -68.67 -40.99 79.89 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 0.0 109.65 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.537 ' CD2' ' HB ' ' A' ' 35' ' ' VAL . 18.2 mt -55.28 -38.03 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.997 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 9.0 tpt180 -70.64 -40.94 72.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.468 -0.77 . . . . 0.0 110.596 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.974 ' CG2' HG21 ' A' ' 67' ' ' ILE . 56.5 mt -67.51 -44.94 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.989 -1.07 . . . . 0.0 110.743 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.912 ' HD3' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.51 57.44 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -73.75 -25.67 60.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 110.569 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -66.36 -20.46 66.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.098 -1.001 . . . . 0.0 110.427 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.034 HG21 HD11 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.5 154.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.913 . . . . 0.0 110.271 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -79.51 -47.02 16.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 111.41 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.446 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.96 146.27 23.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.764 -1.21 . . . . 0.0 111.939 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.912 HG21 ' HD3' ' A' ' 29' ' ' ARG . 2.1 t -135.56 135.96 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.459 -0.776 . . . . 0.0 109.11 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.472 ' HB3' ' OD1' ' A' ' 49' ' ' ASN . 2.5 tpt -131.71 117.42 18.6 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.968 -1.083 . . . . 0.0 110.692 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.798 HG13 ' CG2' ' A' ' 48' ' ' VAL . 4.4 t -114.59 129.8 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.307 -0.87 . . . . 0.0 109.849 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 47' ' ' GLU . 3.2 m -115.54 135.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 110.402 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.551 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -78.28 154.03 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.467 -0.77 . . . . 0.0 110.503 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 161.23 30.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -83.08 6.49 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 110.648 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.91 -65.07 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.334 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 44.0 Cg_endo -70.95 -176.68 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.562 1.296 . . . . 0.0 110.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.97 28.02 17.81 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 14.8 mtt180 -93.92 138.93 31.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.387 -1.066 . . . . 0.0 109.972 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 18' ' ' ARG . 7.0 m-85 -119.22 153.89 34.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.056 0.931 . . . . 0.0 110.949 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.686 ' HB2' HG23 ' A' ' 38' ' ' VAL . 4.0 mt-10 -104.31 95.83 6.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.798 ' CG2' HG13 ' A' ' 37' ' ' VAL . 5.1 t -88.1 122.72 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.852 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 36' ' ' MET . 0.8 OUTLIER -130.68 101.14 5.56 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.288 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.034 HD11 HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -117.78 149.8 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.447 0.641 . . . . 0.0 111.262 -178.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.418 ' N ' HG12 ' A' ' 50' ' ' ILE . 5.5 p -112.86 152.86 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.71 -0.619 . . . . 0.0 109.786 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 52' ' ' LEU . 3.4 mt -100.36 -165.03 1.17 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.054 -1.029 . . . . 0.0 110.924 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -68.69 -178.83 0.45 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.641 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -63.87 -15.04 46.72 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.758 1.399 . . . . 0.0 110.486 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.06 77.71 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.65 173.2 6.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.73 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.983 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.9 t70 178.81 171.05 0.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 5.1 mt-30 -57.8 -38.14 75.0 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.707 . . . . 0.0 110.294 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 -31.59 69.02 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.334 -0.854 . . . . 0.0 109.95 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.9 mm100 -74.3 -45.77 45.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.983 HD12 ' O ' ' A' ' 57' ' ' ASP . 1.6 mp -67.69 -36.0 79.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.993 -1.067 . . . . 0.0 109.514 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.84 -33.7 57.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' ILE . 20.2 mt -69.14 -50.31 49.05 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.271 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 29' ' ' ARG . 78.7 mm-40 -71.54 -42.06 68.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -67.34 -30.5 70.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.472 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 1.8 mm-40 -69.14 -48.34 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.761 -1.212 . . . . 0.0 109.91 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.974 HG21 ' CG2' ' A' ' 28' ' ' ILE . 6.3 mt -77.38 -42.4 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.4 -0.812 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.5 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 85.6 mt -59.47 -46.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.104 -0.998 . . . . 0.0 109.91 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 5.2 mt-30 -64.16 -44.13 93.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -68.41 -43.44 77.23 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.403 -0.811 . . . . 0.0 111.147 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 25' ' ' GLU . . . -65.07 -48.48 73.6 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.886 -1.134 . . . . 0.0 110.499 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.975 HD13 ' CZ ' ' A' ' 10' ' ' TYR . 96.6 mt -63.92 -35.19 79.84 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 69' ' ' GLN 0.258 2.0 tt0 -69.93 -45.85 66.63 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 108.988 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -58.24 -37.07 74.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.15 -26.53 60.36 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.893 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.24 28.74 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.61 121.92 41.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.24 . . . . 0.0 110.282 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.35 162.57 18.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.908 HG22 ' CE2' ' A' ' 10' ' ' TYR . 1.5 t -87.6 118.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -12.88 58.26 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.876 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.562 ' CE ' ' O ' ' A' ' 9' ' ' TRP 0.254 0.0 OUTLIER -131.57 157.24 44.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.494 -0.754 . . . . 0.0 111.015 -178.78 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.641 179.186 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.437 0.637 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 61' ' ' LEU . 9.6 mp -96.15 132.35 41.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.262 -0.899 . . . . 0.0 110.523 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -122.86 118.24 27.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.095 -1.003 . . . . 0.0 109.892 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.662 ' O ' HG22 ' A' ' 48' ' ' VAL . 36.2 m-85 -127.78 119.15 25.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 0.0 110.906 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.944 ' O ' HG13 ' A' ' 79' ' ' VAL . 34.7 tt0 -107.27 155.6 19.77 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.2 -0.937 . . . . 0.0 109.689 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.528 ' CG2' ' CD2' ' A' ' 46' ' ' TYR . 4.0 m -129.53 -178.38 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.865 -1.147 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' SD ' ' A' ' 14' ' ' MET . 3.5 pt-20 -133.06 48.87 2.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.537 0.684 . . . . 0.0 109.866 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.536 ' HB2' ' HB3' ' A' ' 18' ' ' ARG . 78.3 mmm -126.01 155.0 73.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 109.485 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.3 Cg_endo -72.67 -166.83 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.811 1.427 . . . . 0.0 113.014 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' HG12 ' A' ' 19' ' ' VAL . 42.4 tt0 -56.38 -26.85 54.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.48 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 29.8 t0 -58.13 -16.13 12.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.059 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.572 ' CD ' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -75.09 -16.57 60.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 110.18 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.588 HG13 ' N ' ' A' ' 20' ' ' ASN . 8.0 p -49.31 -43.68 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.416 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.588 ' N ' HG13 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -64.72 -30.05 71.05 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.104 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 41.1 t0 -65.6 -53.48 41.21 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.556 -0.715 . . . . 0.0 110.07 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.91 ' O ' HD12 ' A' ' 26' ' ' LEU . 4.7 mp -58.86 -37.11 75.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.136 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.11 -52.71 63.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.158 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -63.32 -46.26 87.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -56.91 -44.51 82.47 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.454 -0.779 . . . . 0.0 110.17 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.91 HD12 ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -66.94 -40.07 87.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.506 -0.746 . . . . 0.0 111.221 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.552 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.69 -37.36 83.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.915 -1.116 . . . . 0.0 110.355 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.955 ' CG2' HG23 ' A' ' 67' ' ' ILE . 14.8 mt -68.18 -44.56 84.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.727 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -81.4 69.26 8.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.403 -0.81 . . . . 0.0 110.297 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 37.7 p-10 -73.49 -25.96 60.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 6.1 t30 -58.82 -13.88 7.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.407 -0.808 . . . . 0.0 110.575 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.038 HG23 HD11 ' A' ' 50' ' ' ILE . 8.0 p -79.63 141.41 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 111.037 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -46.64 15.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 111.253 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttt180 -152.98 123.79 7.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 111.201 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.847 HG22 HG13 ' A' ' 50' ' ' ILE . 11.3 t -108.5 135.46 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 110.035 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 115.76 19.98 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.176 -0.953 . . . . 0.0 110.335 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.076 HG13 HG12 ' A' ' 48' ' ' VAL . 48.7 t -114.82 132.04 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.558 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 47' ' ' GLU . 3.9 m -113.22 130.79 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.371 -0.831 . . . . 0.0 110.018 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.654 ' HA ' ' CD1' ' A' ' 46' ' ' TYR . . . -77.62 153.67 32.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.519 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.59 166.33 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 109.445 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -83.51 2.83 35.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 0.0 110.848 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.42 -64.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.009 -1.057 . . . . 0.0 110.458 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.6 Cg_endo -70.55 -171.06 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.568 1.299 . . . . 0.0 111.072 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.24 26.42 18.8 Favored Glycine 0 N--CA 1.479 1.563 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -93.45 135.7 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 108.64 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.654 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 11.1 m-85 -128.73 151.29 49.71 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.763 -1.211 . . . . 0.0 112.379 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 mt-10 -105.03 90.63 3.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.098 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.076 HG12 HG13 ' A' ' 37' ' ' VAL . 16.0 m -86.92 125.24 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -123.63 100.74 6.94 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.038 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.13 147.77 16.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.447 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.76 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.7 p -102.82 129.76 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.12 -0.988 . . . . 0.0 111.296 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.781 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -93.58 -168.29 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.904 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 2.8 m120 -50.93 172.91 0.12 Allowed Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.0 109.505 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.8 Cg_endo -63.22 -14.66 43.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.548 1.289 . . . . 0.0 110.849 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -146.19 86.77 1.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.106 -0.996 . . . . 0.0 110.696 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.781 HD21 ' CB ' ' A' ' 52' ' ' LEU . 8.7 mt -61.17 -171.41 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 111.068 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.8 t70 172.94 172.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.483 0.659 . . . . 0.0 110.103 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 11.7 mt-30 -56.37 -34.31 66.55 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -34.22 75.15 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -72.05 -44.32 63.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 110.099 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 8' ' ' LEU . 55.5 mt -63.37 -34.26 77.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 109.935 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.75 -40.36 63.03 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.62 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.1 mt -71.54 -49.99 35.5 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 79.1 mm-40 -58.34 -41.94 85.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.737 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -70.79 -46.9 62.03 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.263 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -71.4 -37.66 71.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.85 -1.156 . . . . 0.0 109.834 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.955 HG23 ' CG2' ' A' ' 28' ' ' ILE . 11.0 mm -76.49 -41.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 56.2 mt -70.26 -49.73 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.714 -1.242 . . . . 0.0 109.786 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 25.7 mm-40 -59.17 -38.74 80.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.883 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -57.74 -48.08 80.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.264 -0.898 . . . . 0.0 111.128 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 25' ' ' GLU . . . -70.95 -48.52 52.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.907 -1.121 . . . . 0.0 110.099 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 20.3 mt -63.71 -35.41 80.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.604 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 4.8 mm-40 -69.57 -45.08 69.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.427 -0.795 . . . . 0.0 109.283 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.48 -40.24 90.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.74 -29.17 58.78 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.528 -0.733 . . . . 0.0 110.0 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . 101.06 18.34 20.11 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -93.6 127.12 39.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -1.086 . . . . 0.0 110.483 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.8 141.32 48.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 109.874 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.9 t -94.17 125.37 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.66 -10.29 58.29 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -131.56 133.4 44.99 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 82' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.321 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 121.438 0.637 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 7' ' ' PHE . 10.9 mt -126.04 125.01 41.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.468 -0.77 . . . . 0.0 110.35 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.481 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -116.54 119.16 34.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.823 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB2' ' HB ' ' A' ' 48' ' ' VAL . 22.0 m-85 -124.19 118.11 26.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.607 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.805 ' O ' HG13 ' A' ' 79' ' ' VAL . 7.4 tt0 -110.82 147.14 35.15 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.405 -0.809 . . . . 0.0 109.452 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.506 HG21 ' HD3' ' A' ' 18' ' ' ARG . 8.4 m -126.65 -179.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.837 -1.164 . . . . 0.0 111.433 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -129.65 45.3 2.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.737 0.779 . . . . 0.0 109.033 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.561 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 60.6 mmm -120.29 145.99 41.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.77 -0.581 . . . . 0.0 109.563 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 33.4 Cg_endo -67.99 -166.57 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.77 1.405 . . . . 0.0 113.518 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -27.57 65.75 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.237 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.527 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -59.53 -22.27 61.42 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.021 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.614 ' NH1' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -83.54 -13.47 54.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.227 -0.921 . . . . 0.0 110.378 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -48.0 -46.62 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.585 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -57.8 -29.96 65.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.604 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.4 t0 -61.15 -50.77 71.82 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.435 -0.791 . . . . 0.0 109.928 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.678 HD12 HG21 ' A' ' 37' ' ' VAL . 3.9 mm? -59.62 -41.45 90.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.116 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.21 -52.37 64.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.179 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.18 -42.35 89.01 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.33 -0.856 . . . . 0.0 109.608 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.813 ' OE2' HG23 ' A' ' 68' ' ' ILE . 19.0 tt0 -56.89 -48.77 77.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 110.903 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.72 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -69.02 -37.56 78.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 110.812 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.94 -36.11 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.01 -1.056 . . . . 0.0 111.395 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.85 ' CG2' HG23 ' A' ' 67' ' ' ILE . 73.1 mt -62.93 -44.83 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.951 -1.093 . . . . 0.0 111.378 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HB3' HG21 ' A' ' 67' ' ' ILE . 5.9 ptt180 -83.83 93.15 7.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.061 . . . . 0.0 110.788 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -73.43 -24.82 60.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 23.6 p30 -58.56 -15.12 9.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.645 HG21 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.61 134.36 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.399 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -79.47 -45.65 18.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 111.043 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -152.7 134.54 14.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.805 -1.184 . . . . 0.0 111.087 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.872 HG23 HD11 ' A' ' 50' ' ' ILE . 2.2 p -125.86 131.31 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.339 -0.851 . . . . 0.0 110.547 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.3 ttt -140.42 116.02 10.14 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.611 -0.68 . . . . 0.0 109.538 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.678 HG21 HD12 ' A' ' 22' ' ' LEU . 33.2 t -111.88 131.93 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 110.829 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 38' ' ' VAL . 33.5 m -105.59 142.11 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.458 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.03 154.67 23.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.357 -0.839 . . . . 0.0 110.517 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' NH2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -74.04 -176.12 2.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.089 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -103.06 9.89 38.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.169 -0.957 . . . . 0.0 110.82 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -155.93 -65.1 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.15 -0.969 . . . . 0.0 109.797 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.1 Cg_endo -71.43 -178.94 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.536 1.282 . . . . 0.0 110.334 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -105.13 30.17 10.42 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 3.0 ptt-85 -93.49 160.6 14.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.02 -1.282 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.614 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 78.6 m-85 -134.42 154.38 51.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.089 0.947 . . . . 0.0 111.358 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.55 95.05 7.02 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 15.2 t -78.18 112.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 111.07 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.624 ' O ' HD12 ' A' ' 50' ' ' ILE . 35.8 m120 -131.29 100.81 5.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -116.11 146.2 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.4 p -105.85 122.83 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.95 ' HB2' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.13 -168.5 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.5 m120 -41.77 165.17 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.46 -0.775 . . . . 0.0 110.07 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -64.4 -27.06 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.762 1.401 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 12.7 t-20 -127.75 78.36 1.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 52' ' ' LEU . 10.8 mt -62.28 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.226 -0.921 . . . . 0.0 111.011 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 58' ' ' GLN . 5.4 t0 174.59 172.09 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.441 0.638 . . . . 0.0 109.829 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.472 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.3 mm-40 -60.38 -31.4 70.32 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 110.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.422 ' HB2' ' OD2' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -70.05 -40.75 74.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.323 -0.861 . . . . 0.0 110.113 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 4.6 mm-40 -66.44 -42.77 87.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 109.942 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.524 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 15.1 mt -63.92 -33.5 75.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 109.732 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.74 -37.05 49.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.658 ' O ' HG12 ' A' ' 67' ' ' ILE . 62.5 mt -72.19 -51.36 21.5 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.3 mm-40 -61.64 -36.75 81.68 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.813 -1.179 . . . . 0.0 110.205 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.524 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -72.21 -47.05 53.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.976 -1.078 . . . . 0.0 110.232 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.488 ' OE2' HD23 ' A' ' 63' ' ' LEU . 23.7 pt-20 -71.21 -34.65 71.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.1 -1.0 . . . . 0.0 109.318 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.85 HG23 ' CG2' ' A' ' 28' ' ' ILE . 21.4 mm -77.03 -43.51 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.544 -0.722 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.813 HG23 ' OE2' ' A' ' 25' ' ' GLU . 49.6 mt -69.75 -46.01 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 110.259 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.09 -34.08 77.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.183 -0.948 . . . . 0.0 110.157 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 2.0 ttt-85 -64.42 -46.21 84.23 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.136 -0.978 . . . . 0.0 110.328 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -67.69 -48.61 66.11 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 110.21 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.506 HD23 ' OD2' ' A' ' 21' ' ' ASP . 86.9 mt -64.63 -36.07 83.07 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 38.3 mm-40 -70.05 -45.05 67.93 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.623 0.725 . . . . 0.0 109.247 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.51 -37.12 84.83 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.87 -41.08 60.48 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.564 -0.71 . . . . 0.0 110.049 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.15 23.6 4.48 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.52 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -98.7 138.23 36.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.218 . . . . 0.0 110.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -119.32 121.95 40.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.142 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.1 t -83.25 126.68 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.185 -0.947 . . . . 0.0 110.037 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.12 -15.01 54.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.63 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -130.66 129.65 42.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.682 -0.636 . . . . 0.0 110.454 -179.264 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.489 1.49 0 O-C-N 120.906 -1.121 . . . . 0.0 110.887 179.8 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.414 ' C ' ' HG ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HG ' ' C ' ' A' ' 7' ' ' PHE . 1.4 mp -129.02 136.73 50.69 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.774 0.797 . . . . 0.0 111.886 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 3.7 t90 -125.59 119.01 26.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.554 ' CE2' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -123.59 140.36 53.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 111.383 -178.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.563 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 38.8 tt0 -122.76 158.14 30.82 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.506 -0.746 . . . . 0.0 109.513 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.586 HG11 HH11 ' A' ' 18' ' ' ARG . 13.6 m -130.76 177.59 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.046 . . . . 0.0 110.507 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -131.2 51.99 2.1 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.513 0.673 . . . . 0.0 109.979 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.56 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 54.2 mmm -132.98 153.54 81.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.303 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -71.02 -167.54 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.703 1.37 . . . . 0.0 113.487 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.6 tt0 -58.27 -27.27 63.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.709 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -59.16 -21.71 59.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.319 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.586 HH11 HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -87.78 -16.87 32.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.788 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 16' ' ' GLU . 40.5 t -48.76 -45.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 109.934 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.496 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.2 t-20 -54.96 -29.24 56.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.769 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 38.3 t0 -60.34 -48.88 79.84 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.422 -0.799 . . . . 0.0 110.017 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 22' ' ' LEU . 3.9 mm? -58.84 -36.74 75.04 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.475 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -56.8 -52.77 63.78 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.316 -0.865 . . . . 0.0 109.237 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 42.1 mtt180 -66.09 -44.09 85.43 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.429 -0.795 . . . . 0.0 109.331 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.642 ' OE2' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.7 -44.19 77.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.535 ' CD2' HG11 ' A' ' 35' ' ' VAL . 16.0 mt -65.44 -38.96 91.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.668 -0.645 . . . . 0.0 110.46 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.55 ' HG3' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -66.14 -36.24 82.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.207 -0.933 . . . . 0.0 111.756 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.967 ' CG2' HG23 ' A' ' 67' ' ' ILE . 49.0 mt -65.1 -45.7 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.609 -1.307 . . . . 0.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.901 ' NH1' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.29 79.56 9.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.042 . . . . 0.0 110.679 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.28 -25.47 62.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.998 . . . . 0.0 110.245 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.19 -14.47 10.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.748 ' CG2' HD11 ' A' ' 50' ' ' ILE . 2.2 p -79.68 133.65 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.197 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -80.09 -45.87 17.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 111.765 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.2 mtt85 -152.34 130.39 11.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.738 -1.226 . . . . 0.0 111.598 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.898 HG13 ' HB ' ' A' ' 50' ' ' ILE . 2.8 t -122.85 135.68 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.725 . . . . 0.0 109.209 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 115.71 23.01 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.019 -1.051 . . . . 0.0 110.715 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.498 HG11 ' HG ' ' A' ' 22' ' ' LEU . 15.7 t -114.87 129.09 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.298 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 3.6 m -119.81 125.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -82.36 153.99 25.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 p -74.31 -178.93 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.001 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -105.09 5.98 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -149.43 -66.34 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.963 . . . . 0.0 110.21 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.0 Cg_endo -71.59 -164.54 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.334 1.176 . . . . 0.0 110.13 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.29 34.36 4.32 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.1 mtt180 -97.33 134.71 40.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -1.101 . . . . 0.0 110.331 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.628 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 8.1 m-85 -117.88 155.44 30.15 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.288 -0.882 . . . . 0.0 110.438 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.8 mp0 -102.52 98.32 8.41 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 10' ' ' TYR . 66.9 t -78.45 111.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 111.356 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -131.13 101.94 5.8 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.898 ' HB ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.16 146.91 17.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.728 -177.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.765 ' N ' HD13 ' A' ' 50' ' ' ILE . 11.7 p -119.36 146.92 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.432 -0.792 . . . . 0.0 110.2 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.026 HD13 HD11 ' A' ' 56' ' ' LEU . 1.5 mp -135.06 -160.94 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.615 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' LEU . 14.2 m120 -38.88 161.14 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.92 -0.488 . . . . 0.0 110.351 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 39.4 Cg_endo -64.91 -20.39 64.35 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.91 1.479 . . . . 0.0 110.878 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -143.66 84.4 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.026 HD11 HD13 ' A' ' 52' ' ' LEU . 18.3 mt -68.37 -162.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 9.0 t70 -161.7 172.2 16.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 0.0 110.464 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 69.2 mt-30 -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.728 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 t -64.49 -28.31 69.57 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.233 -0.917 . . . . 0.0 110.062 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 39.1 mm-40 -65.33 -40.68 94.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 91.6 mt -65.29 -35.25 80.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.048 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.17 -36.39 51.51 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.9 mt -72.52 -50.67 24.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.179 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' OE1' ' HB2' ' A' ' 29' ' ' ARG . 5.8 mm-40 -63.72 -33.87 76.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.846 -1.159 . . . . 0.0 110.437 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -72.24 -46.73 54.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.394 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 32.2 mm-40 -66.55 -35.38 80.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.121 -0.987 . . . . 0.0 109.85 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.967 HG23 ' CG2' ' A' ' 28' ' ' ILE . 11.5 mm -76.71 -47.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.42 -0.8 . . . . 0.0 111.498 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.901 HD11 ' NH1' ' A' ' 29' ' ' ARG . 45.8 mt -67.78 -48.19 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.937 -1.102 . . . . 0.0 110.125 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.8 mm100 -62.16 -32.93 73.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.329 -0.857 . . . . 0.0 109.956 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -65.81 -46.93 76.78 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.207 -0.933 . . . . 0.0 110.97 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.3 -48.93 47.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.969 -1.082 . . . . 0.0 111.589 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.546 HD22 HH12 ' A' ' 18' ' ' ARG . 38.2 mt -58.3 -39.13 78.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 111.293 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 5.3 tt0 -71.28 -46.8 60.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.112 0.958 . . . . 0.0 109.411 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 8.6 t-20 -59.21 -36.89 76.2 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -74.94 -34.76 62.12 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.873 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.81 10.46 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -102.73 125.69 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 110.2 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -111.99 134.86 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 109.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 81' ' ' LYS . 3.0 t -66.54 124.93 22.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.066 -1.021 . . . . 0.0 109.785 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.2 -11.7 59.35 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.427 -0.796 . . . . 0.0 109.109 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 79' ' ' VAL 0.269 0.0 OUTLIER -138.16 145.37 41.45 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.633 -0.667 . . . . 0.0 110.74 -178.923 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.562 178.58 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.469 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.465 0.65 . . . . 0.0 109.594 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.754 ' N ' HD12 ' A' ' 8' ' ' LEU . 7.8 mp -90.63 129.38 36.76 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 110.243 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.523 ' CE2' ' ND2' ' A' ' 49' ' ' ASN . 1.6 t90 -124.57 123.56 40.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.524 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.477 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 26.3 m-85 -126.79 138.01 53.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.412 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.883 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.9 tp60 -121.99 159.99 25.84 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.221 -0.924 . . . . 0.0 110.224 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 m -133.36 -176.94 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.02 . . . . 0.0 110.609 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' SD ' ' A' ' 14' ' ' MET . 5.6 pt-20 -138.41 56.04 1.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.545 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 4.5 mmt -137.05 149.49 66.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.553 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.911 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -70.84 -167.21 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.035 1.545 . . . . 0.0 113.13 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.22 -25.76 67.83 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.8 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.83 -45.54 89.77 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.264 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.545 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 2.8 mtp180 -89.76 -23.65 21.71 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.944 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 15' ' ' PRO . 24.4 t -47.95 -38.41 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.525 -0.734 . . . . 0.0 110.012 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 25.1 t-20 -53.36 -29.12 32.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.166 -0.959 . . . . 0.0 109.066 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.588 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 32.9 t0 -59.89 -42.39 93.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 19' ' ' VAL . 6.0 mp -58.32 -38.65 77.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.615 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.32 58.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -46.77 82.16 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.216 -0.927 . . . . 0.0 109.292 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.056 ' OE1' HG23 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -59.29 -48.12 82.82 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.85 0.833 . . . . 0.0 109.454 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.605 HD22 HG11 ' A' ' 35' ' ' VAL . 13.3 mt -53.95 -36.92 63.34 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.455 0.645 . . . . 0.0 110.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -35.6 74.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.602 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 15.9 mt -59.48 -32.52 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.041 . . . . 0.0 110.979 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.627 ' HG3' HG12 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -69.4 48.64 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.067 -1.021 . . . . 0.0 111.661 -178.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -25.59 25.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.435 -1.416 . . . . 0.0 109.851 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.384 -0.823 . . . . 0.0 111.14 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.001 HG21 HD11 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -83.46 142.78 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.12 . . . . 0.0 110.54 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.85 22.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 111.598 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.79 150.34 30.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.619 -1.301 . . . . 0.0 111.822 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.902 HG23 ' HB ' ' A' ' 50' ' ' ILE . 9.7 p -140.03 134.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.4 mtm -122.81 114.12 20.08 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.843 -1.16 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG13 HG22 ' A' ' 48' ' ' VAL . 4.8 t -116.43 132.15 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 109.925 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' HB ' ' CD ' ' A' ' 47' ' ' GLU . 11.2 t -118.81 157.08 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.607 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.11 154.95 21.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -73.91 -170.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.05 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -103.1 -2.13 27.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 111.031 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.578 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -152.25 -66.38 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -70.15 -158.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.469 1.247 . . . . 0.0 110.699 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.79 34.95 4.51 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 2.2 mtt180 -94.52 136.69 34.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -1.13 . . . . 0.0 109.815 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.629 ' OH ' HG21 ' A' ' 19' ' ' VAL . 32.7 m-85 -117.21 153.97 31.95 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.099 -1.0 . . . . 0.0 111.256 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' CD ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -103.67 110.82 23.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 67.5 t -89.41 124.66 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 111.686 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.523 ' ND2' ' CE2' ' A' ' 9' ' ' TRP . 5.6 m120 -131.01 101.18 5.5 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.001 HD11 HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -124.05 148.27 28.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 111.689 -178.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.52 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.2 p -105.68 151.28 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.695 -0.628 . . . . 0.0 109.758 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 52' ' ' LEU . 4.9 mp -132.88 -170.62 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.053 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 56' ' ' LEU . 15.7 m120 -43.44 161.3 0.2 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 110.456 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.42 -31.75 51.24 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.099 1.579 . . . . 0.0 110.838 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -113.3 70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' A' ' 52' ' ' LEU . 9.1 mt -62.85 -168.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 110.984 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 168.18 -175.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.62 0.724 . . . . 0.0 110.031 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.808 ' HA ' HD21 ' A' ' 61' ' ' LEU . 74.4 mt-30 -65.54 -32.44 74.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.06 -30.37 63.66 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 110.29 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.48 ' HG3' ' HA ' ' A' ' 56' ' ' LEU . 15.2 mm100 -73.84 -46.12 47.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.808 HD21 ' HA ' ' A' ' 58' ' ' GLN . 3.7 pp -68.0 -34.98 77.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 109.267 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.649 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -52.67 -35.6 55.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.67 ' O ' HG12 ' A' ' 67' ' ' ILE . 15.2 mt -70.92 -50.83 30.52 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.005 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 28.3 mm-40 -65.0 -41.84 95.02 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.37 -1.456 . . . . 0.0 109.397 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.22 -46.33 64.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.896 -1.127 . . . . 0.0 110.326 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 52.9 mm-40 -70.05 -39.75 75.52 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.891 -1.131 . . . . 0.0 110.106 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 63' ' ' LEU . 18.9 mm -77.54 -41.55 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.319 -0.863 . . . . 0.0 111.562 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.056 HG23 ' OE1' ' A' ' 25' ' ' GLU . 24.0 mt -70.74 -49.7 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.53 -1.356 . . . . 0.0 110.047 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 2.7 mt-30 -58.74 -34.09 70.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.243 -0.91 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' NH1' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -56.49 -47.63 78.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.84 -1.162 . . . . 0.0 109.868 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -71.93 -48.46 45.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 110.654 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.699 HD12 HG22 ' A' ' 68' ' ' ILE . 93.1 mt -58.2 -43.9 87.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 111.472 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.08 -44.26 69.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.163 -0.96 . . . . 0.0 109.468 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -59.67 -37.07 77.76 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.588 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -75.14 -26.18 58.97 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.644 -0.66 . . . . 0.0 110.117 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 14' ' ' MET . . . 109.92 -0.51 30.19 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -90.62 127.58 36.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.253 -1.145 . . . . 0.0 110.13 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.31 147.65 44.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 110.596 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.6 t -86.31 125.81 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -9.82 59.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.357 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 79' ' ' VAL 0.251 0.0 OUTLIER -133.58 150.0 51.63 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.615 -0.678 . . . . 0.0 110.776 -179.022 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.856 178.497 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.531 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 121.512 0.672 . . . . 0.0 109.831 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 ' CD1' ' A' ' 52' ' ' LEU . 2.9 mm? -103.47 126.19 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.395 -0.815 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.57 ' CE2' ' ND2' ' A' ' 49' ' ' ASN . 1.6 t90 -124.15 130.94 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.178 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -126.24 134.87 51.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.208 -0.932 . . . . 0.0 110.744 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.811 ' O ' HG13 ' A' ' 79' ' ' VAL . 54.8 tt0 -123.02 159.05 29.2 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.2 m -138.56 -176.74 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 110.643 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 5.0 tt0 -140.72 54.28 1.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 110.249 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.788 ' CE ' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -130.43 161.17 62.2 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.168 -0.958 . . . . 0.0 110.347 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -75.44 -178.42 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.934 1.492 . . . . 0.0 113.009 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.592 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -67.6 -24.6 65.5 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.409 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -59.72 -45.53 91.87 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.718 -0.614 . . . . 0.0 111.5 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.546 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 1.1 ptp180 -89.71 -10.22 46.54 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 111.466 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 22' ' ' LEU . 18.2 t -45.16 -36.16 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.115 -0.991 . . . . 0.0 110.42 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -51.53 -26.86 9.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 33.0 t0 -58.84 -45.76 89.29 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.498 -0.751 . . . . 0.0 110.046 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.788 HD11 ' CE ' ' A' ' 14' ' ' MET . 1.3 mp -57.92 -41.52 82.9 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.41 63.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.15 -0.969 . . . . 0.0 109.587 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -60.73 -46.77 89.14 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 2.7 tm-20 -60.98 -48.89 79.75 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 109.946 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.552 HD22 HG21 ' A' ' 35' ' ' VAL . 41.4 mt -54.28 -37.57 64.9 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.357 0.599 . . . . 0.0 110.268 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.609 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.063 -1.023 . . . . 0.0 110.357 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.609 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 7.7 mt -59.49 -44.77 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 121.013 -1.054 . . . . 0.0 110.374 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.72 65.46 5.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -53.95 -24.54 16.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.815 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -57.99 -13.12 4.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 110.16 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.77 HG23 HD11 ' A' ' 50' ' ' ILE . 1.8 p -78.54 126.65 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.147 -0.971 . . . . 0.0 110.1 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HG2' ' HB2' ' A' ' 34' ' ' ARG . 26.9 ttt180 -79.69 -44.95 19.89 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -151.71 122.97 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.733 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 50' ' ' ILE . 11.5 p -132.6 136.02 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.2 122.63 20.7 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.104 -0.997 . . . . 0.0 110.688 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.38 130.55 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 0.0 110.149 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.443 HG23 ' OE1' ' A' ' 47' ' ' GLU . 13.6 m -115.87 146.22 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.538 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.551 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.41 154.17 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.556 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -74.17 -170.22 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.3 p -103.31 -2.05 27.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 110.994 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -144.84 -67.15 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.0 110.616 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.0 Cg_endo -72.56 -168.29 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.353 1.186 . . . . 0.0 110.705 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -108.02 35.32 5.06 Favored Glycine 0 N--CA 1.479 1.5 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.3 mtp-105 -93.54 134.87 35.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.54 -0.977 . . . . 0.0 110.139 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 9.5 m-85 -119.31 154.3 33.74 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.876 0.846 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 38' ' ' VAL . 3.4 mt-10 -103.93 99.04 8.79 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 10' ' ' TYR . 47.0 t -79.15 124.41 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.773 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.57 ' ND2' ' CE2' ' A' ' 9' ' ' TRP . 34.4 m120 -131.29 100.92 5.35 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.77 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -119.19 138.91 48.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.515 -0.74 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 50' ' ' ILE . 4.0 p -96.59 151.14 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 109.324 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.028 ' HB2' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -114.11 173.91 6.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 111.503 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 65.2 m-80 -58.45 167.11 1.87 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.67 -0.644 . . . . 0.0 109.693 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.67 -15.17 44.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.6 1.316 . . . . 0.0 110.78 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -125.93 66.15 1.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.063 -1.023 . . . . 0.0 110.148 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.028 HD23 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -91.46 177.23 6.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.962 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 6.0 t70 -177.08 171.89 2.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.977 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.7 mt-30 -60.23 -33.23 71.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.597 -0.69 . . . . 0.0 110.037 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -65.04 -45.01 87.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 8.5 mm-40 -64.46 -44.32 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.855 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.847 HD23 ' OE1' ' A' ' 64' ' ' GLU . 74.3 mt -64.82 -37.32 87.22 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.729 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.46 55.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.864 -1.148 . . . . 0.0 108.065 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 63' ' ' LEU 0.256 0.1 OUTLIER -70.49 -51.28 30.03 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.666 0.746 . . . . 0.0 108.987 178.564 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.847 ' OE1' HD23 ' A' ' 61' ' ' LEU . 3.7 pt-20 -66.94 -43.16 83.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.316 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.38 -41.45 93.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.327 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -34.71 73.71 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.608 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -75.25 -50.41 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.679 HG22 HD12 ' A' ' 72' ' ' LEU . 17.8 mt -59.71 -46.71 93.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 43.5 mt-30 -61.04 -47.28 87.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 109.749 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.68 -47.22 85.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 0.0 110.772 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB3' ' CG ' ' A' ' 25' ' ' GLU . . . -69.91 -48.81 57.14 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.975 -1.078 . . . . 0.0 110.307 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.679 HD12 HG22 ' A' ' 68' ' ' ILE . 44.4 mt -64.06 -35.07 79.54 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.38 -0.825 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 2.1 mm-40 -69.37 -45.24 69.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.53 -0.731 . . . . 0.0 109.176 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -62.6 -39.19 92.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.23 -37.34 61.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.267 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 115.52 20.8 5.32 Favored Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . . . -95.22 123.4 38.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.241 . . . . 0.0 110.123 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.12 134.11 55.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.2 t -89.73 123.13 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.41 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -81.78 -10.75 59.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.526 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.61 140.6 52.0 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.425 -0.797 . . . . 0.0 110.9 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 109.939 178.59 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.486 0.66 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.08 132.44 50.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.447 -0.783 . . . . 0.0 110.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -124.12 118.37 26.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.956 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.503 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 25.6 m-85 -126.93 134.66 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.493 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.639 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.7 tt0 -117.44 158.29 24.74 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 17.2 m -134.29 -177.43 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.97 -1.081 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -134.51 51.07 2.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.668 ' HE1' ' HB2' ' A' ' 77' ' ' ALA . 1.5 ptp -130.22 152.74 80.66 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.423 -0.798 . . . . 0.0 109.74 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -70.73 -165.69 0.19 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.755 1.397 . . . . 0.0 113.202 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.871 ' O ' HG23 ' A' ' 19' ' ' VAL . 19.6 tt0 -52.1 -24.83 7.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.865 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.426 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 12.0 t70 -56.78 -23.76 45.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.044 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' CZ ' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -70.04 -14.1 62.53 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.386 -0.821 . . . . 0.0 110.83 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 16' ' ' GLU . 98.0 t -51.82 -48.79 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.144 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -59.24 -30.9 68.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.812 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 27.1 t0 -68.21 -54.91 14.45 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.5 mm? -62.63 -36.88 84.2 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.967 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -62.73 -52.41 63.34 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.619 -0.676 . . . . 0.0 109.851 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.8 tpp85 -69.84 -41.4 74.94 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.007 -1.058 . . . . 0.0 109.447 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -56.29 -48.82 75.88 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.525 -0.734 . . . . 0.0 110.6 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.725 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -66.52 -37.04 84.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 110.411 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.458 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.28 -40.15 93.07 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.174 -0.954 . . . . 0.0 110.903 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.737 ' CG2' HG23 ' A' ' 67' ' ' ILE . 87.1 mt -61.13 -44.13 97.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.002 -1.061 . . . . 0.0 110.994 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.822 ' NH2' HG21 ' A' ' 35' ' ' VAL . 13.7 ptt180 -84.88 68.39 10.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.803 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -56.05 -27.3 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 109.875 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -59.09 -14.1 8.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' HD11 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -80.13 128.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.948 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -79.32 -45.69 19.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 111.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.71 123.8 7.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.607 -1.308 . . . . 0.0 111.915 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.822 HG21 ' NH2' ' A' ' 29' ' ' ARG . 5.9 p -126.0 133.98 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.549 -0.719 . . . . 0.0 109.358 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.3 mtp -128.74 114.84 17.1 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.933 -1.104 . . . . 0.0 110.84 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.51 131.63 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG2' ' CG ' ' A' ' 47' ' ' GLU . 3.5 m -119.79 152.9 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -83.82 153.65 23.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.87 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -166.47 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.365 -0.834 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -104.94 0.27 27.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 0.0 111.161 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m -148.83 -65.88 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.865 -1.147 . . . . 0.0 110.801 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 47.2 Cg_endo -71.72 -169.13 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.214 1.113 . . . . 0.0 110.577 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -108.74 32.17 7.16 Favored Glycine 0 N--CA 1.477 1.371 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.528 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 6.2 ptm180 -93.9 160.43 14.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.923 -1.34 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 35.1 m-85 -138.28 155.44 48.6 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.888 0.851 . . . . 0.0 111.059 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.543 ' CG ' ' CG2' ' A' ' 38' ' ' VAL . 2.9 pt-20 -100.71 96.07 7.08 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.1 t -78.15 116.47 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 111.484 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -131.58 100.74 5.24 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.817 ' HB ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -123.69 140.25 47.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.591 -0.693 . . . . 0.0 110.603 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 51' ' ' VAL . 5.3 p -100.13 144.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.882 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.017 ' HB2' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -122.87 -166.54 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 110.9 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 52' ' ' LEU . 40.3 m-80 -39.46 159.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.725 -0.609 . . . . 0.0 110.774 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.17 -15.52 50.63 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.126 1.593 . . . . 0.0 111.289 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -140.11 73.11 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.813 -1.179 . . . . 0.0 111.162 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LEU . 13.0 mt -66.32 -164.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.853 -1.155 . . . . 0.0 110.354 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.9 t70 177.92 172.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.522 -0.736 . . . . 0.0 109.721 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.412 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.4 mm-40 -62.58 -34.89 77.88 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -71.29 -28.78 64.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.341 -0.85 . . . . 0.0 110.575 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -73.82 -39.99 63.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.065 -1.022 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 35.2 mt -66.32 -37.07 84.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.112 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.62 -38.07 59.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.636 ' C ' HD12 ' A' ' 63' ' ' LEU 0.259 0.2 OUTLIER -71.93 -51.42 22.2 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.893 0.854 . . . . 0.0 108.81 178.013 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 68' ' ' ILE . 60.7 mm-40 -61.9 -38.5 88.59 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 -47.22 78.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.207 -0.933 . . . . 0.0 111.308 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 6.3 pt-20 -62.88 -27.21 69.2 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 120.573 -1.329 . . . . 0.0 109.261 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.737 HG23 ' CG2' ' A' ' 28' ' ' ILE . 2.8 mm -76.81 -55.77 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.627 -0.67 . . . . 0.0 110.061 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 72' ' ' LEU . 8.8 mt -62.27 -42.69 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.339 -0.85 . . . . 0.0 109.891 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 38.2 mm-40 -63.12 -40.82 98.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -57.97 -47.3 83.37 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.237 -0.914 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.69 -48.45 59.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.147 -0.971 . . . . 0.0 109.81 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 68' ' ' ILE . 83.1 mt -64.01 -36.19 83.16 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.458 -0.776 . . . . 0.0 110.108 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 6.7 mm-40 -70.49 -45.89 64.8 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.552 -0.717 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -61.82 -38.71 89.17 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -75.65 -17.9 59.83 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.92 51.9 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.668 ' HB2' ' HE1' ' A' ' 14' ' ' MET . . . -87.63 129.2 35.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.147 -1.208 . . . . 0.0 110.055 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 119.6 34.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 110.342 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.7 t -77.19 120.77 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 109.932 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.19 -8.79 59.66 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HD2' ' HA ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -130.0 134.27 47.31 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.402 -0.811 . . . . 0.0 110.482 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 82' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 120.812 -1.18 . . . . 0.0 110.651 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 121.26 0.552 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 8' ' ' LEU . 1.7 mm? -84.67 138.99 32.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.237 -0.915 . . . . 0.0 109.915 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.418 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -108.75 118.96 38.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 0.0 110.585 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 48' ' ' VAL . 28.6 m-85 -127.23 115.45 19.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.161 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.919 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.1 tt0 -95.35 160.37 14.57 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.183 -0.948 . . . . 0.0 110.402 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 46' ' ' TYR . 30.7 m -130.41 179.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.517 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -135.55 53.0 1.98 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.414 -0.804 . . . . 0.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.662 ' SD ' ' HB2' ' A' ' 77' ' ' ALA . 4.2 ptt? -133.33 153.32 80.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.91 -163.96 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.13 1.595 . . . . 0.0 112.417 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.925 ' O ' HG23 ' A' ' 19' ' ' VAL . 3.9 tm-20 -50.27 -26.75 5.09 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.98 -17.33 16.53 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.772 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.556 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.76 -13.85 47.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 16' ' ' GLU . 93.3 t -53.1 -42.92 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.48 -0.763 . . . . 0.0 110.239 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.45 -34.98 76.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.946 . . . . 0.0 109.826 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.728 ' OD2' ' HB3' ' A' ' 77' ' ' ALA . 9.2 t0 -70.71 -54.43 11.82 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.647 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.2 mm? -64.17 -36.25 83.45 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 19' ' ' VAL . . . -60.5 -52.75 63.86 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.356 -0.84 . . . . 0.0 109.286 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 28' ' ' ILE . 5.6 mtt180 -70.08 -46.71 64.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 2.7 tm-20 -56.33 -45.73 80.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.808 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 35' ' ' VAL . 74.1 mt -62.81 -38.65 91.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.862 . . . . 0.0 110.302 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -45.66 93.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.819 ' CG2' HG23 ' A' ' 67' ' ' ILE . 13.4 mt -65.18 -42.96 95.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.769 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -70.43 55.22 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 110.67 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 15.4 p-10 -72.14 -30.07 64.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -61.24 -12.9 14.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.59 -0.694 . . . . 0.0 109.978 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 29' ' ' ARG . 3.9 p -79.09 137.55 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.361 -0.837 . . . . 0.0 110.437 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -42.68 25.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 110.813 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -148.06 122.71 9.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.043 -1.035 . . . . 0.0 111.06 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.875 HG12 HG13 ' A' ' 50' ' ' ILE . 22.5 m -117.67 135.16 58.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.328 -0.858 . . . . 0.0 110.423 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.66 116.12 10.09 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 22' ' ' LEU . 57.4 t -111.27 131.92 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.38 152.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.558 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.03 154.6 21.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.195 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -73.19 172.77 10.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.74 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.479 ' H ' HG22 ' A' ' 41' ' ' THR . 5.3 t -89.73 1.08 56.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.937 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.564 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.67 -64.61 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.028 -1.045 . . . . 0.0 110.48 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.9 Cg_endo -70.84 -159.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.532 1.28 . . . . 0.0 110.77 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.16 36.53 4.16 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 5.7 mtt180 -93.13 135.19 34.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.53 -0.982 . . . . 0.0 110.397 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.588 ' H ' HG22 ' A' ' 12' ' ' VAL . 25.5 m-85 -119.76 154.86 33.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.353 -0.842 . . . . 0.0 110.397 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -102.99 116.53 32.71 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -94.47 112.21 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 110.515 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.583 ' O ' HD12 ' A' ' 50' ' ' ILE . 64.3 m-80 -131.04 100.7 5.32 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.875 HG13 HG12 ' A' ' 35' ' ' VAL . 1.1 mp -115.28 140.04 38.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 121.738 0.78 . . . . 0.0 111.24 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.61 149.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 53' ' ' ASN . 6.3 mt -118.7 -170.23 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.627 -1.296 . . . . 0.0 112.062 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.8 m120 -42.34 170.74 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.635 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 36.3 Cg_endo -59.66 -12.72 18.73 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.648 1.341 . . . . 0.0 111.04 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -142.11 87.43 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.087 . . . . 0.0 110.436 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -60.74 -178.09 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.744 -1.222 . . . . 0.0 109.942 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.669 ' O ' HD12 ' A' ' 61' ' ' LEU . 12.4 t70 -175.24 171.67 2.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.047 . . . . 0.0 110.764 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.432 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 65.8 mt-30 -61.71 -40.55 95.42 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.549 -0.719 . . . . 0.0 110.514 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -29.57 68.81 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.222 -0.924 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.52 -45.11 69.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 110.158 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -66.19 -34.37 77.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.98 -38.8 62.55 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 67' ' ' ILE . 40.9 mt -71.64 -51.01 25.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' O ' HD12 ' A' ' 68' ' ' ILE . 3.5 mt-10 -60.06 -40.9 91.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.887 -1.133 . . . . 0.0 110.061 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -72.66 -46.46 53.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.045 -1.034 . . . . 0.0 109.634 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 6.8 mm-40 -69.58 -38.86 77.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 110.016 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.819 HG23 ' CG2' ' A' ' 28' ' ' ILE . 16.0 mm -76.43 -38.17 31.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.296 -0.878 . . . . 0.0 111.257 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 64' ' ' GLU . 57.7 mt -69.53 -48.28 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.778 -1.201 . . . . 0.0 110.053 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 4.9 pt20 -61.52 -38.86 88.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.184 -0.948 . . . . 0.0 110.02 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.17 -45.98 86.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.14 -0.975 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.3 59.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.081 -1.012 . . . . 0.0 110.836 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.518 HD23 ' CG ' ' A' ' 21' ' ' ASP . 79.2 mt -58.76 -43.03 90.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.267 -0.896 . . . . 0.0 110.661 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.44 -45.4 62.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 0.0 109.622 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.429 ' ND2' ' HD3' ' A' ' 70' ' ' ARG . 62.8 m-20 -62.61 -36.89 84.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.35 -35.29 58.78 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.312 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.29 18.28 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.728 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . . . -109.66 136.87 48.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.29 . . . . 0.0 110.224 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' NH1' ' HG2' ' A' ' 73' ' ' GLU . 2.1 tpt180 -119.69 133.53 55.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 110.326 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 11' ' ' GLN . 4.6 t -75.73 124.87 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.011 -1.055 . . . . 0.0 109.533 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.76 -8.0 59.62 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.73 156.31 47.27 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.501 -0.749 . . . . 0.0 111.608 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 82' ' ' VAL . 7.1 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.437 -0.789 . . . . 0.0 109.416 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.95 ' O ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.24 0.543 . . . . 0.0 110.029 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.027 HD11 HD11 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -138.41 131.86 30.5 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.344 -0.847 . . . . 0.0 109.78 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.541 ' CE2' ' ND2' ' A' ' 49' ' ' ASN . 1.2 t90 -126.81 127.44 45.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 28.9 m-85 -126.24 115.08 19.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.852 ' O ' HG13 ' A' ' 79' ' ' VAL . 4.4 tt0 -107.5 149.23 28.2 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.544 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.6 m -126.75 -176.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 111.026 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 1.9 tt0 -146.72 59.91 1.2 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.343 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.535 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.75 148.69 66.04 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 37.3 Cg_endo -71.78 -165.82 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.135 1.597 . . . . 0.0 113.573 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.822 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -62.98 -23.06 67.26 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.039 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.69 -48.15 67.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.738 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.535 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.5 OUTLIER -90.86 -14.22 32.2 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.116 -0.99 . . . . 0.0 111.219 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 16' ' ' GLU . 14.5 p -45.88 -37.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.261 -0.899 . . . . 0.0 109.784 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.575 ' N ' HG13 ' A' ' 19' ' ' VAL . 62.1 m-80 -53.32 -28.31 27.78 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.474 -0.767 . . . . 0.0 109.304 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 28.7 t0 -58.36 -32.5 68.61 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.545 -0.722 . . . . 0.0 110.129 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.61 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.3 mm? -59.0 -37.32 76.6 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.17 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -58.54 -51.22 70.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.28 -46.95 65.97 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.18 -0.95 . . . . 0.0 110.089 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' CD ' HD11 ' A' ' 72' ' ' LEU . 2.6 tt0 -56.32 -48.38 76.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.725 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -67.22 -37.22 83.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.854 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.36 -38.78 78.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.737 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.669 HD13 HG22 ' A' ' 67' ' ' ILE . 9.5 mt -59.06 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.148 -0.97 . . . . 0.0 110.703 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 13.1 ptm180 -74.4 56.53 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.12 -25.47 62.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.0 110.296 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -58.66 -17.18 20.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.88 162.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -0.824 . . . . 0.0 109.965 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -44.18 22.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.976 . . . . 0.0 111.945 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.82 146.58 26.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.741 -1.224 . . . . 0.0 111.655 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.637 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 6.9 t -132.32 127.48 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 tpt -140.41 115.55 9.83 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.488 -0.758 . . . . 0.0 109.69 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 88.9 t -114.81 131.9 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.0 110.981 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.65 HG22 ' HB2' ' A' ' 47' ' ' GLU . 7.8 m -101.97 140.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 110.035 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -81.46 153.07 27.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.19 152.73 39.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.848 . . . . 0.0 110.014 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.2 p -75.34 -11.56 60.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -0.926 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -141.41 -67.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.117 -0.99 . . . . 0.0 110.496 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.3 Cg_endo -70.68 -176.11 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.323 1.17 . . . . 0.0 110.562 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 33.29 6.65 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.9 mtt180 -93.2 135.44 34.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.008 . . . . 0.0 110.021 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 30.0 m-85 -117.93 154.93 31.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.296 -0.878 . . . . 0.0 110.568 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.65 ' HB2' HG22 ' A' ' 38' ' ' VAL . 33.9 mt-10 -103.5 95.08 5.83 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.748 -0.595 . . . . 0.0 109.683 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 10' ' ' TYR . 89.4 t -78.77 115.13 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.553 ' O ' HD12 ' A' ' 50' ' ' ILE . 32.1 m120 -131.65 102.0 5.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.035 HG21 HG21 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -111.82 142.26 24.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.749 0.785 . . . . 0.0 110.691 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.8 p -92.32 133.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.415 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.027 HD11 HD11 ' A' ' 8' ' ' LEU . 30.5 mt -90.04 174.37 7.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 0.0 110.549 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.96 ' OD1' HD11 ' A' ' 56' ' ' LEU . 2.1 m120 -62.24 -153.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.697 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.74 -35.4 28.16 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 CA-C-N 119.122 0.722 . . . . 0.0 111.439 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 55' ' ' ASN . 8.1 t30 -162.87 76.25 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.802 -1.186 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.96 HD11 ' OD1' ' A' ' 53' ' ' ASN . 16.8 mt -74.7 -161.04 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 110.419 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 1.004 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.1 t0 -171.92 -164.09 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.496 -0.752 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -64.77 -32.87 74.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.557 -0.715 . . . . 0.0 111.177 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -35.06 78.74 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.4 mm-40 -73.72 -42.9 60.54 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.414 -0.804 . . . . 0.0 109.954 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.004 HD12 ' O ' ' A' ' 57' ' ' ASP . 1.2 mt -64.87 -34.46 78.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.39 -33.65 44.48 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.562 ' O ' HG13 ' A' ' 67' ' ' ILE . 18.3 mt -64.38 -51.05 65.23 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.461 -0.895 . . . . 0.0 108.618 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 2.5 mt-10 -72.19 -43.09 65.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.232 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -62.51 -34.86 77.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.533 -0.729 . . . . 0.0 110.443 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.7 -48.9 70.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.826 -1.171 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.669 HG22 HD13 ' A' ' 28' ' ' ILE . 4.3 mt -78.98 -41.17 23.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.493 -0.754 . . . . 0.0 111.155 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 40.9 mt -59.01 -49.5 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.049 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.8 mt-30 -58.61 -48.91 79.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.393 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -66.15 -47.21 74.79 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 110.877 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -65.01 -48.25 74.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.907 -1.121 . . . . 0.0 110.182 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.48 HD12 ' CG2' ' A' ' 68' ' ' ILE . 32.8 mt -65.57 -35.33 80.52 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 110.026 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 1.0 OUTLIER -70.34 -45.31 66.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.44 -0.788 . . . . 0.0 109.487 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -63.16 -36.31 83.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.57 -38.9 62.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.562 -0.712 . . . . 0.0 110.604 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.3 21.65 5.12 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.13 123.76 46.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -1.221 . . . . 0.0 109.797 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -119.77 122.41 41.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 110.581 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.3 t -81.34 128.99 38.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.079 -1.013 . . . . 0.0 109.59 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.34 -17.68 48.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 108.467 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 10' ' ' TYR 0.255 0.0 OUTLIER -128.78 129.42 45.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.806 -0.559 . . . . 0.0 110.171 -179.533 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.489 1.51 0 O-C-N 120.677 -1.264 . . . . 0.0 110.692 179.335 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.88 ' O ' HD23 ' A' ' 8' ' ' LEU . 26.2 t80 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.11 0.481 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.971 ' CD2' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -141.93 124.75 16.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.767 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -127.77 119.86 26.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.118 -0.989 . . . . 0.0 109.972 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.975 ' O ' HG22 ' A' ' 48' ' ' VAL . 76.9 m-85 -126.54 137.79 53.4 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.152 -0.968 . . . . 0.0 111.104 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.781 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.2 tp60 -120.43 160.66 22.65 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.348 -0.845 . . . . 0.0 109.228 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 21.0 m -130.57 -178.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.03 -1.044 . . . . 0.0 110.687 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.39 57.17 1.59 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.638 -0.664 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.582 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -135.35 155.28 78.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.42 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 37.2 Cg_endo -73.0 -167.79 0.37 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.925 1.487 . . . . 0.0 113.05 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.591 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 15.3 tt0 -66.09 -25.53 67.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.038 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 13.3 t0 -59.87 -40.71 89.55 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.364 0.602 . . . . 0.0 111.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.582 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.1 OUTLIER -88.95 -14.56 36.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.271 -0.893 . . . . 0.0 110.125 -179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.591 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 15.1 t -47.19 -37.47 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -29.36 22.05 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.612 ' OD2' HD23 ' A' ' 72' ' ' LEU . 33.1 t0 -59.87 -39.57 85.71 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.481 -0.762 . . . . 0.0 109.199 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.588 HD12 HG11 ' A' ' 37' ' ' VAL . 4.4 mm? -58.94 -42.75 90.54 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.92 -51.77 66.45 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -46.68 78.69 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.575 -0.703 . . . . 0.0 109.257 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.4 -48.53 76.72 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.43 -0.794 . . . . 0.0 109.306 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.713 HD21 ' CG2' ' A' ' 37' ' ' VAL . 89.4 mt -60.33 -39.53 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -70.24 -38.64 75.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.528 -0.732 . . . . 0.0 109.274 179.344 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 67' ' ' ILE . 1.2 mm -58.96 -37.77 69.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.827 0.822 . . . . 0.0 108.855 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.873 ' O ' HG12 ' A' ' 32' ' ' VAL . 10.5 mtp180 -69.68 64.05 0.19 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.75 -0.594 . . . . 0.0 110.228 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -37.52 70.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -65.32 -14.01 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 110.021 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.873 HG12 ' O ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -79.93 138.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.374 -0.829 . . . . 0.0 110.384 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.7 mmt-85 -79.25 -45.49 19.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.068 -1.02 . . . . 0.0 110.913 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.63 123.15 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.204 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 50' ' ' ILE . 2.8 p -130.12 133.61 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.517 -0.74 . . . . 0.0 109.605 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -128.04 118.25 23.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.124 -0.985 . . . . 0.0 110.75 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.115 HG13 HG12 ' A' ' 48' ' ' VAL . 19.4 t -115.06 131.98 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.616 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.494 HG23 ' OE2' ' A' ' 47' ' ' GLU . 4.1 m -121.28 159.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.59 154.17 22.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.401 -0.812 . . . . 0.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.36 176.74 5.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.292 -0.88 . . . . 0.0 109.57 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.4 p -93.34 -3.98 52.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 110.73 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -148.02 -67.77 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.023 -1.048 . . . . 0.0 110.467 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 49.7 Cg_endo -72.53 -168.94 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.303 1.159 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.8 32.88 6.84 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.0 mtt180 -94.26 134.88 36.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -1.068 . . . . 0.0 109.323 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.577 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 7.8 m-85 -116.81 150.18 38.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.871 -1.143 . . . . 0.0 111.427 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.494 ' OE2' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -106.41 90.53 3.37 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.166 178.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.115 HG12 HG13 ' A' ' 37' ' ' VAL . 22.0 m -82.42 125.28 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.549 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -122.51 101.62 7.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.801 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -111.96 142.38 24.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 121.561 0.696 . . . . 0.0 111.437 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.657 ' N ' HD13 ' A' ' 50' ' ' ILE . 7.3 p -108.61 119.94 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.685 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.6 mt -86.81 177.21 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.967 . . . . 0.0 110.581 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.521 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.2 m-80 -42.96 167.19 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.9 Cg_endo -63.84 -15.0 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.673 1.354 . . . . 0.0 110.24 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 24.2 t-20 -133.28 63.54 1.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.893 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.794 ' C ' HD12 ' A' ' 56' ' ' LEU . 3.1 pp -61.78 176.55 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.041 -1.037 . . . . 0.0 110.414 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 61' ' ' LEU . 2.5 m-20 -168.29 178.31 4.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 110.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.73 -36.32 83.25 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.537 -0.727 . . . . 0.0 110.461 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 t -69.29 -30.6 68.71 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.255 -0.903 . . . . 0.0 110.3 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 22.1 mm-40 -73.12 -45.91 54.22 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.971 HD21 ' CD2' ' A' ' 8' ' ' LEU . 1.6 mp -66.86 -36.14 81.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 109.366 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 66' ' ' GLU . . . -53.45 -33.87 55.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.552 ' O ' HG13 ' A' ' 67' ' ' ILE . 13.7 mt -69.46 -50.38 46.13 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.248 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.4 mm-40 -71.53 -42.75 67.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -65.55 -30.84 71.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.186 -0.946 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 2.0 mm-40 -69.43 -48.92 59.45 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.865 -1.147 . . . . 0.0 110.355 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.596 HG21 HG23 ' A' ' 28' ' ' ILE . 4.7 mt -78.6 -38.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.302 -0.873 . . . . 0.0 111.063 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 53.4 mt -60.37 -48.95 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.993 -1.067 . . . . 0.0 110.391 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 1.6 pp0? -63.55 -41.63 98.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.0 109.809 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.55 -46.52 66.25 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.37 -0.832 . . . . 0.0 110.388 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.88 83.39 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.08 -1.013 . . . . 0.0 109.777 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.612 HD23 ' OD2' ' A' ' 21' ' ' ASP . 97.3 mt -65.5 -35.46 80.95 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.8 OUTLIER -67.0 -45.27 78.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.457 -0.777 . . . . 0.0 109.005 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -61.12 -36.55 80.03 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -74.88 -41.87 58.94 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.74 -0.6 . . . . 0.0 110.327 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.45 23.35 4.47 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -112.54 125.23 54.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.262 -1.14 . . . . 0.0 109.762 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.47 148.91 42.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 110.757 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 11' ' ' GLN . 1.9 t -95.79 114.59 32.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 108.773 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -82.07 -5.47 58.42 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.774 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -138.41 150.32 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.274 -0.891 . . . . 0.0 111.736 -178.354 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 82' ' ' VAL . 3.0 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.787 ' C ' HD13 ' A' ' 8' ' ' LEU . 4.4 p90 . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 121.164 0.507 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.787 HD13 ' C ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -119.52 125.06 47.95 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.227 -0.92 . . . . 0.0 111.245 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -126.58 116.55 21.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.848 ' CD2' HG21 ' A' ' 79' ' ' VAL . 1.4 m-85 -126.96 139.48 53.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 111.062 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.722 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.46 159.86 24.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 26.5 m -133.8 173.97 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.946 -1.096 . . . . 0.0 111.239 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.98 54.25 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.736 -0.603 . . . . 0.0 109.961 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.515 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 50.3 mmm -129.83 156.74 78.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.64 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.85 -167.02 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.825 1.434 . . . . 0.0 113.124 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.573 ' HA ' HG23 ' A' ' 19' ' ' VAL . 17.6 tp10 -63.79 -28.38 69.83 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.407 -1.269 . . . . 0.0 107.796 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -18.6 40.59 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.539 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.902 ' NH1' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -87.57 -23.71 24.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.593 -0.692 . . . . 0.0 110.095 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 16' ' ' GLU . 77.3 t -48.3 -42.71 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.469 -0.77 . . . . 0.0 110.309 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -58.92 -29.97 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.15 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.514 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.7 t0 -61.71 -50.84 70.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.144 -0.972 . . . . 0.0 109.964 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.644 HD11 HH11 ' A' ' 18' ' ' ARG . 8.3 mp -59.89 -43.11 94.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.666 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.5 79.64 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.229 -0.92 . . . . 0.0 109.656 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -68.73 -46.42 68.95 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.393 -0.817 . . . . 0.0 109.266 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.869 ' OE1' ' HB2' ' A' ' 71' ' ' ALA . 9.7 tp10 -60.38 -47.64 85.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.418 -0.801 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.928 HD22 HG11 ' A' ' 35' ' ' VAL . 29.6 mt -53.08 -38.66 62.73 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.579 0.704 . . . . 0.0 109.512 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 4.4 tpt180 -64.11 -34.5 78.18 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 110.549 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.697 HD12 ' OE1' ' A' ' 25' ' ' GLU . 5.4 mt -62.12 -44.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.898 -1.126 . . . . 0.0 109.808 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.626 ' NH1' HD23 ' A' ' 26' ' ' LEU . 11.6 mtp180 -70.05 76.45 0.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.697 -0.627 . . . . 0.0 110.311 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.62 -36.61 84.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.251 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -61.75 -12.89 18.98 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.977 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.019 HG22 HD11 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -79.03 123.73 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.719 . . . . 0.0 110.141 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -47.32 15.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 112.186 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.539 ' CG ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -153.55 139.18 17.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.562 -1.336 . . . . 0.0 110.851 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.928 HG11 HD22 ' A' ' 26' ' ' LEU . 13.3 p -135.63 135.85 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.455 -0.778 . . . . 0.0 110.002 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.488 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 42.0 mtp -117.44 115.48 25.28 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.227 -0.921 . . . . 0.0 109.846 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.9 t -114.67 128.55 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 110.572 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 38' ' ' VAL . 4.8 m -115.09 134.41 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.549 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.14 153.72 23.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.534 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.1 m -73.86 150.64 40.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.885 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.2 p -76.5 3.0 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.589 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -148.99 -66.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -72.37 178.59 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.366 1.193 . . . . 0.0 110.541 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -101.31 33.01 6.82 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 4.8 mtt180 -93.78 134.74 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.439 -1.036 . . . . 0.0 110.275 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.549 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 34.4 m-85 -120.56 151.51 39.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -106.51 99.03 8.63 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.911 -0.493 . . . . 0.0 110.186 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' TYR . 16.9 m -86.53 122.17 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.01 -1.056 . . . . 0.0 110.686 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 36' ' ' MET . 2.4 p30 -131.16 102.71 6.12 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.19 140.76 30.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 O-C-N 121.433 -0.792 . . . . 0.0 111.552 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.681 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.4 p -114.87 150.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.92 ' HB2' HD11 ' A' ' 56' ' ' LEU . 2.3 mp -139.48 -157.41 0.76 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.769 -1.207 . . . . 0.0 111.928 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 52' ' ' LEU . 14.5 m120 -37.86 161.47 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.561 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -64.67 -17.4 59.4 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.012 1.533 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -146.78 79.78 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.764 -1.21 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.92 HD11 ' HB2' ' A' ' 52' ' ' LEU . 16.2 mt -67.64 -164.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 110.586 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 3.3 t70 -177.08 171.6 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 110.68 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.1 mt-30 -54.63 -35.53 63.56 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.573 -0.704 . . . . 0.0 110.433 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 m -67.85 -40.6 83.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.177 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -70.77 -44.56 66.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.321 -0.862 . . . . 0.0 109.989 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 2.5 mm? -66.44 -34.83 78.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.91 -35.3 45.07 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.3 mt -72.12 -49.67 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.215 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 8.2 mt-10 -67.31 -35.88 80.34 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.533 -1.354 . . . . 0.0 109.915 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.24 -45.27 56.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 75.2 mt-10 -70.2 -38.5 75.34 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.096 -1.002 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 63' ' ' LEU . 43.9 mm -76.9 -38.75 29.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.329 -0.857 . . . . 0.0 111.192 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 62.4 mt -69.39 -46.88 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.884 -1.135 . . . . 0.0 110.125 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 20.0 mt-30 -59.71 -38.8 82.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.901 . . . . 0.0 110.165 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -44.66 91.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.196 -0.94 . . . . 0.0 110.894 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.869 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . . . -68.27 -48.64 64.51 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.997 -1.064 . . . . 0.0 110.522 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.902 HD23 ' NH1' ' A' ' 18' ' ' ARG . 20.3 mt -58.71 -39.93 82.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.39 -0.819 . . . . 0.0 110.547 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -71.2 -45.56 63.13 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.445 -0.784 . . . . 0.0 109.61 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.3 -38.47 86.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -75.79 -32.13 59.75 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.064 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.11 17.55 10.04 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.521 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . . . -102.36 124.36 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.0 110.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -119.0 124.1 46.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.848 HG21 ' CD2' ' A' ' 10' ' ' TYR . 3.8 t -67.6 125.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.983 -1.073 . . . . 0.0 109.884 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -10.28 59.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.69 152.99 52.02 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.315 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 1.028 ' C ' HD13 ' A' ' 8' ' ' LEU . 23.2 t80 . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 121.143 0.497 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.028 HD13 ' C ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -133.32 123.25 25.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.314 -1.491 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 1.4 t90 -128.69 118.42 22.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.667 -0.645 . . . . 0.0 109.481 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -127.2 137.45 52.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.018 -1.051 . . . . 0.0 110.995 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.882 ' O ' HG13 ' A' ' 79' ' ' VAL . 21.7 tt0 -109.32 160.27 16.29 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.282 -0.886 . . . . 0.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.603 HG21 HH21 ' A' ' 18' ' ' ARG . 15.9 m -129.02 -177.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.923 -1.111 . . . . 0.0 111.024 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 1.2 tp10 -140.22 59.68 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.833 0.825 . . . . 0.0 108.971 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.564 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 4.0 tpt -137.07 146.13 53.28 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.601 -0.687 . . . . 0.0 109.216 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' ' HG3' ' A' ' 14' ' ' MET . 33.2 Cg_endo -65.39 -166.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.651 1.342 . . . . 0.0 113.361 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 19' ' ' VAL . 24.5 tt0 -62.07 -27.02 68.61 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.272 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 34.9 t70 -57.65 -20.86 36.37 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.139 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.618 ' CZ ' ' CG ' ' A' ' 46' ' ' TYR . 4.4 ppt_? -88.41 -12.69 42.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 111.063 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 16' ' ' GLU . 56.0 t -46.78 -44.52 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.403 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.526 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.6 m-20 -57.19 -30.45 64.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 109.536 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 36.0 t0 -62.95 -46.75 86.27 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.299 -0.875 . . . . 0.0 110.221 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 37' ' ' VAL . 3.3 mm? -59.02 -43.02 91.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.488 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.08 -48.78 80.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -40.85 84.87 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.561 ' CD ' HG23 ' A' ' 68' ' ' ILE . 28.6 tt0 -56.37 -49.28 74.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.484 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.944 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -69.16 -37.08 78.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.138 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.2 tmm_? -65.66 -37.66 87.13 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.284 -0.885 . . . . 0.0 111.489 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.594 ' CG2' HG22 ' A' ' 67' ' ' ILE . 3.5 tt -58.61 -45.03 90.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.014 -1.054 . . . . 0.0 111.728 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.555 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -86.36 109.21 18.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.984 -1.073 . . . . 0.0 111.206 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -30.65 62.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.893 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 33.9 p30 -59.21 -13.42 7.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.78 . . . . 0.0 110.386 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.975 HG22 ' CD1' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -78.88 122.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.824 . . . . 0.0 110.485 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -79.76 -45.69 18.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 111.01 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -153.38 139.98 18.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.815 -1.178 . . . . 0.0 110.963 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.944 HG11 ' HB2' ' A' ' 26' ' ' LEU . 7.8 p -137.1 132.21 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 0.0 110.409 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.9 tpt -140.88 113.46 8.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.056 -1.027 . . . . 0.0 110.122 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 48' ' ' VAL . 23.3 t -116.92 132.25 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -0.821 . . . . 0.0 110.53 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' ' CD ' ' A' ' 47' ' ' GLU . 32.7 m -105.26 148.83 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.003 -1.06 . . . . 0.0 110.43 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -77.61 154.82 31.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.368 -0.832 . . . . 0.0 110.704 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 p -72.64 -176.68 2.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -101.57 5.71 41.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.086 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -153.11 -66.5 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.4 Cg_endo -72.78 -165.34 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.425 1.224 . . . . 0.0 110.567 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.29 35.4 4.77 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.4 mtt180 -94.04 138.5 32.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.456 -1.026 . . . . 0.0 110.216 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.618 ' CG ' ' CZ ' ' A' ' 18' ' ' ARG . 10.0 m-85 -125.52 154.82 41.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 110.307 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 47' ' ' GLU . 10.0 pt-20 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.435 0.636 . . . . 0.0 109.566 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.74 ' HA ' HG22 ' A' ' 37' ' ' VAL . 44.6 t -88.04 115.92 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 110.836 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.92 101.33 5.59 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.975 ' CD1' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -117.87 131.64 70.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.593 -178.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.723 ' N ' HD13 ' A' ' 50' ' ' ILE . 9.8 p -95.55 151.25 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.046 ' HB2' HD11 ' A' ' 56' ' ' LEU . 4.4 mp -138.6 -157.11 0.74 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 110.923 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 52' ' ' LEU . 14.9 m120 -34.85 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 121.056 0.455 . . . . 0.0 111.115 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.83 -27.94 59.22 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.144 1.602 . . . . 0.0 111.15 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -131.11 81.32 1.98 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 110.161 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.046 HD11 ' HB2' ' A' ' 52' ' ' LEU . 13.8 mt -74.03 -165.36 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 172.63 -171.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.597 0.713 . . . . 0.0 110.371 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -65.36 -33.13 75.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 110.852 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.9 t -68.27 -34.46 76.23 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HB3' HD22 ' A' ' 56' ' ' LEU . 21.5 mm-40 -71.19 -42.13 69.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 110.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 8' ' ' LEU . 9.3 mt -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.07 -36.59 60.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.928 -1.107 . . . . 0.0 108.086 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.7 mt -71.5 -49.87 36.98 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.807 0.813 . . . . 0.0 109.272 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.842 ' OE2' HD23 ' A' ' 61' ' ' LEU . 8.6 pt-20 -67.1 -39.76 86.78 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.585 -1.322 . . . . 0.0 109.94 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -71.87 -41.51 67.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.864 -1.148 . . . . 0.0 110.488 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.5 mt-10 -75.38 -41.07 57.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.701 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 63' ' ' LEU . 17.9 mm -78.92 -36.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 112.219 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 96.7 mt -70.41 -44.58 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.329 -1.482 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 26.1 mm-40 -55.79 -39.2 70.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -57.61 -48.12 80.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 111.374 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -72.23 -48.77 40.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.971 -1.08 . . . . 0.0 111.578 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 25.1 mt -60.1 -42.71 95.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 111.331 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.17 -43.39 70.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.014 -1.053 . . . . 0.0 109.182 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 34.1 t-20 -59.65 -37.12 77.85 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.578 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -74.49 -29.27 61.36 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.259 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.59 5.28 27.91 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -99.66 118.45 36.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -1.149 . . . . 0.0 110.462 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -118.6 137.18 53.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.647 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.3 t -75.98 119.52 24.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.88 -5.63 59.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.571 -0.706 . . . . 0.0 109.213 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.574 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.69 160.81 35.66 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.282 -0.886 . . . . 0.0 111.591 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 82' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.032 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.931 ' C ' HD12 ' A' ' 8' ' ' LEU . 57.6 m-85 . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 121.101 0.477 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.931 HD12 ' C ' ' A' ' 7' ' ' PHE . 5.3 mp -135.51 127.86 30.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 110.543 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.507 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -97.14 127.86 43.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.7 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.811 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -127.14 120.62 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.55 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 9.4 tt0 -112.35 159.7 18.42 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 10' ' ' TYR . 16.4 m -135.73 178.36 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.073 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -132.45 56.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.576 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.91 152.4 72.14 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 110.595 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.4 Cg_endo -72.23 -167.67 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.977 1.514 . . . . 0.0 112.809 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.528 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 2.4 tt0 -65.52 -25.37 67.42 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.854 178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.92 -41.46 91.81 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.873 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.62 -16.3 30.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.278 -0.889 . . . . 0.0 110.688 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 15' ' ' PRO . 20.6 t -47.36 -37.75 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.43 -0.794 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -53.59 -29.34 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.553 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 36.5 t0 -59.74 -39.47 84.86 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.399 -0.813 . . . . 0.0 110.338 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.4 mm? -59.07 -41.42 87.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 110.088 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.53 63.75 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.415 ' O ' HG13 ' A' ' 28' ' ' ILE . 2.1 ttp180 -68.93 -41.72 77.71 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.598 ' CD ' HG23 ' A' ' 68' ' ' ILE . 3.9 tt0 -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.196 -0.94 . . . . 0.0 109.946 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.766 HD22 ' CG2' ' A' ' 35' ' ' VAL . 14.1 mt -66.09 -38.63 88.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.772 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.54 ' NH1' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.81 -37.47 82.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.179 -0.95 . . . . 0.0 111.176 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.684 ' CG2' HG23 ' A' ' 67' ' ' ILE . 55.1 mt -61.75 -44.23 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.82 -1.175 . . . . 0.0 110.56 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.546 ' O ' HG12 ' A' ' 32' ' ' VAL . 9.4 ptp85 -75.06 59.6 0.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.124 -0.985 . . . . 0.0 110.282 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.49 -25.32 16.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.187 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -58.41 -17.08 17.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.3 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.09 HG23 HD11 ' A' ' 50' ' ' ILE . 4.3 p -80.68 137.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 110.302 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -79.18 -46.05 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.978 . . . . 0.0 110.758 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' O ' HG12 ' A' ' 50' ' ' ILE . 4.8 tpt180 -152.79 121.96 6.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.832 -1.167 . . . . 0.0 110.987 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.009 HG12 HG13 ' A' ' 50' ' ' ILE . 3.1 m -109.74 135.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.9 ttp -124.77 116.13 21.82 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.059 -1.026 . . . . 0.0 110.802 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.72 HG22 HG22 ' A' ' 48' ' ' VAL . 19.4 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.078 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 12.0 m -114.29 135.11 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.659 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.66 154.28 22.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -172.56 1.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 41' ' ' THR . 8.8 t -101.53 8.41 41.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.173 -0.954 . . . . 0.0 110.595 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.56 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.74 -63.75 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.978 . . . . 0.0 110.421 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.8 Cg_endo -69.56 -176.51 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.537 1.283 . . . . 0.0 110.845 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.36 32.74 6.9 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 17.5 mtt180 -96.21 143.12 27.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.395 -1.062 . . . . 0.0 109.92 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.645 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 12.1 m-85 -125.51 152.99 44.26 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.05 -1.031 . . . . 0.0 111.529 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.3 mp0 -105.05 92.83 4.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.72 HG22 HG22 ' A' ' 37' ' ' VAL . 21.7 t -80.69 125.41 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 111.84 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 47' ' ' GLU . 1.5 m-80 -130.31 101.08 5.61 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.09 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.98 146.38 33.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 119.746 -0.781 . . . . 0.0 111.876 -177.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' N ' HD13 ' A' ' 50' ' ' ILE . 14.3 p -111.79 151.66 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 56' ' ' LEU . 3.9 mp -118.17 -158.69 0.72 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.515 -1.366 . . . . 0.0 111.83 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' O ' ' O ' ' A' ' 52' ' ' LEU . 19.7 m120 -37.36 163.52 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.737 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.9 Cg_endo -63.73 -15.95 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.934 1.492 . . . . 0.0 110.759 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.434 ' C ' ' OD1' ' A' ' 55' ' ' ASN . 8.9 t-20 -151.84 90.54 1.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 110.201 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 52' ' ' LEU . 10.7 mt -76.83 -173.54 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.822 -1.173 . . . . 0.0 111.81 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.73 179.04 6.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.404 0.621 . . . . 0.0 109.536 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 61' ' ' LEU . 41.2 mt-30 -66.13 -43.17 87.88 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.425 -0.797 . . . . 0.0 111.009 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -65.41 -33.22 75.44 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.284 -0.885 . . . . 0.0 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 11.0 mm-40 -62.28 -38.28 88.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 110.359 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 58' ' ' GLN . 5.3 mt -59.99 -33.18 71.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.01 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.82 -34.48 40.53 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.652 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.1 mt -71.18 -51.8 22.74 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.957 0.884 . . . . 0.0 108.706 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -61.7 -41.39 97.53 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.859 -1.151 . . . . 0.0 109.735 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.522 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -72.72 -46.37 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 110.573 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 72.5 mt-10 -68.85 -37.57 79.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.87 -1.144 . . . . 0.0 109.686 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.684 HG23 ' CG2' ' A' ' 28' ' ' ILE . 19.2 mm -77.74 -45.5 28.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 111.84 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 ' CD ' ' A' ' 25' ' ' GLU . 58.2 mt -70.04 -42.01 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.76 -1.213 . . . . 0.0 110.214 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.9 pt20 -64.37 -40.74 96.43 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 11.2 ttt180 -58.38 -46.16 86.88 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.366 -0.834 . . . . 0.0 110.989 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.87 -48.76 57.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.902 -1.124 . . . . 0.0 110.636 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.632 HD13 ' OH ' ' A' ' 10' ' ' TYR . 83.8 mt -63.98 -36.24 83.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.336 -0.852 . . . . 0.0 110.641 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -69.82 -44.88 69.09 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.39 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -65.44 -37.04 85.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -75.72 -39.82 56.65 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.485 -0.759 . . . . 0.0 110.459 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.41 29.63 2.67 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.37 130.23 55.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.356 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.34 134.98 54.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.105 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.811 HG22 ' CE2' ' A' ' 10' ' ' TYR . 2.1 t -79.4 122.4 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.831 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.95 -10.98 59.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.63 145.03 50.33 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.537 -0.727 . . . . 0.0 111.023 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.034 179.172 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -148.88 124.54 10.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.15 -0.969 . . . . 0.0 111.413 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.458 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 1.3 t-105 -114.26 119.67 37.79 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.689 ' CD2' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -125.09 129.86 51.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.053 -1.029 . . . . 0.0 111.023 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.765 ' O ' HG13 ' A' ' 79' ' ' VAL . 14.2 tt0 -122.66 151.15 41.79 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.336 -0.852 . . . . 0.0 109.27 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.76 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 2.0 m -126.18 -174.98 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' O ' ' SD ' ' A' ' 14' ' ' MET . 4.3 pt-20 -138.78 49.93 1.86 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.286 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.597 ' HE3' ' HD2' ' A' ' 18' ' ' ARG . 30.3 mmm -123.46 155.63 65.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 1.006 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -70.52 -172.4 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.045 1.55 . . . . 0.0 112.82 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 1.1 tt0 -64.03 -27.04 68.84 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.536 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.36 -45.89 87.33 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.54 0.686 . . . . 0.0 109.82 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.597 ' HD2' ' HE3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.81 -33.1 16.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.555 -0.715 . . . . 0.0 110.197 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.006 HG23 ' O ' ' A' ' 15' ' ' PRO . 77.5 t -48.05 -40.56 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -54.88 -28.42 50.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.843 . . . . 0.0 109.019 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.595 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 26.0 t0 -58.92 -35.4 73.03 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.357 0.598 . . . . 0.0 110.609 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.576 HD21 ' OH ' ' A' ' 46' ' ' TYR . 4.2 mm? -55.87 -41.94 75.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.288 -0.965 . . . . 0.0 108.931 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.76 72.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.59 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -68.54 -46.05 70.56 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.365 -0.835 . . . . 0.0 109.511 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.696 ' CD ' ' HB1' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -65.0 -33.52 76.26 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.521 -0.737 . . . . 0.0 110.235 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.126 HD22 HG21 ' A' ' 35' ' ' VAL . 27.2 mt -69.42 -37.14 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 110.783 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' CD ' ' HA ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -68.09 -35.31 77.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.935 -1.103 . . . . 0.0 112.736 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.768 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.41 -35.52 67.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 120.423 -1.423 . . . . 0.0 111.43 -178.492 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.591 ' NE ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -79.9 61.58 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.751 -1.218 . . . . 0.0 109.873 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.94 -23.08 42.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.451 -0.781 . . . . 0.0 111.494 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 21.4 t-20 -56.62 -28.1 59.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.085 -1.009 . . . . 0.0 111.526 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.038 ' CG1' HD11 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -82.36 155.98 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.693 -1.254 . . . . 0.0 110.523 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -47.13 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 112.259 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' ILE . 1.2 ttt180 -154.28 156.95 37.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.65 -1.282 . . . . 0.0 112.149 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.126 HG21 HD22 ' A' ' 26' ' ' LEU . 9.9 p -141.22 135.82 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.4 117.84 23.77 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.511 HG21 HD11 ' A' ' 26' ' ' LEU . 25.8 t -115.16 132.01 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 110.966 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 5.4 m -114.3 126.32 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.185 -0.947 . . . . 0.0 110.0 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -80.65 152.58 28.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.287 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 13.6 p -76.42 -168.27 0.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.523 -0.736 . . . . 0.0 110.02 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 t -107.85 -32.61 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.774 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m -110.09 -67.12 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.078 -1.014 . . . . 0.0 111.136 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 48.2 Cg_endo -72.19 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.177 1.093 . . . . 0.0 110.628 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.36 31.83 5.28 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.556 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 6.7 mtt180 -94.68 135.71 35.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.997 . . . . 0.0 110.389 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.76 ' CZ ' HG21 ' A' ' 12' ' ' VAL . 9.4 p90 -135.65 154.01 51.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.738 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -91.88 96.24 10.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.891 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.593 HG23 ' CD1' ' A' ' 46' ' ' TYR . 24.2 t -77.06 124.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.405 -0.81 . . . . 0.0 110.261 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -130.73 102.3 6.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.038 HD11 ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.7 138.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.176 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.61 ' N ' HD13 ' A' ' 50' ' ' ILE . 7.6 p -94.55 151.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.562 -0.712 . . . . 0.0 110.202 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -97.41 179.67 4.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 110.844 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.571 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -49.26 -178.01 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.068 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.0 Cg_endo -63.92 -15.07 46.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.585 1.308 . . . . 0.0 110.068 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -143.7 84.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.297 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.541 ' HB3' ' CB ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -66.23 -176.99 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.074 -1.016 . . . . 0.0 111.389 -178.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.483 ' HB3' ' HG3' ' A' ' 60' ' ' GLN . 5.7 t70 174.61 172.28 0.22 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.416 0.627 . . . . 0.0 109.417 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.76 ' HA ' HD21 ' A' ' 61' ' ' LEU . 9.0 mt-30 -63.21 -41.02 99.09 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.158 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 -31.92 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' A' ' 57' ' ' ASP . 3.6 mm100 -74.15 -46.16 44.11 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 110.397 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.822 HD12 ' N ' ' A' ' 62' ' ' ALA . 4.4 pp -68.03 -35.19 77.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.817 -1.177 . . . . 0.0 109.368 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.822 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -51.8 -33.4 35.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.739 HD23 ' OE2' ' A' ' 66' ' ' GLU . 17.7 mt -71.27 -50.9 27.93 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.628 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.85 ' HG2' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -71.39 -35.49 71.06 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.401 -1.437 . . . . 0.0 109.885 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -74.15 -39.68 63.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.739 ' OE2' HD23 ' A' ' 63' ' ' LEU . 13.3 pt-20 -73.81 -37.85 64.76 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.753 -1.217 . . . . 0.0 109.982 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 63' ' ' LEU . 24.0 mm -77.89 -38.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.348 -0.845 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 46.1 mt -68.35 -42.03 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.9 -1.125 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 22.9 mt-30 -64.33 -48.16 76.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -40.41 95.35 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.22 -0.925 . . . . 0.0 110.593 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.696 ' HB1' ' CD ' ' A' ' 25' ' ' GLU . . . -66.47 -48.55 69.52 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.193 -0.942 . . . . 0.0 109.962 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 72' ' ' LEU . 47.9 mt -66.17 -35.53 80.7 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.313 -0.867 . . . . 0.0 110.017 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 9.0 mm-40 -70.03 -42.86 72.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -0.818 . . . . 0.0 109.086 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -58.78 -36.02 73.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.18 -31.47 62.69 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.581 -0.699 . . . . 0.0 110.559 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.41 1.5 21.75 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.3 124.77 39.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -1.188 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 5.0 ttm180 -120.37 150.89 40.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.1 t -92.67 118.83 39.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.134 -0.979 . . . . 0.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -4.9 57.91 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.545 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.79 144.46 51.09 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.388 -0.82 . . . . 0.0 110.894 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 109.087 178.76 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.825 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.124 0.488 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 7' ' ' PHE . 3.1 mm? -116.79 144.71 44.15 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 110.616 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.592 ' CE2' ' HE3' ' A' ' 81' ' ' LYS . 5.8 t90 -124.52 118.41 26.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.559 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.699 ' CD2' HG11 ' A' ' 79' ' ' VAL . 9.1 m-85 -127.61 131.11 49.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.896 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.9 tt0 -101.96 159.58 15.23 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.946 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 3.6 m -129.74 -175.34 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.39 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' SD ' ' A' ' 14' ' ' MET . 0.6 OUTLIER -141.13 54.2 1.56 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.755 -0.591 . . . . 0.0 109.843 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -121.32 152.19 57.19 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.427 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.6 Cg_endo -70.88 -162.9 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.207 1.635 . . . . 0.0 112.385 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.83 -26.45 2.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 15' ' ' PRO . 41.8 t0 -57.73 -15.38 7.79 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.957 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.585 ' HD3' ' CE1' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -71.74 -17.07 62.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.411 -0.805 . . . . 0.0 110.552 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.19 -48.59 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.549 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 20.0 m-80 -64.82 -30.32 71.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.094 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 26.4 t0 -65.16 -54.66 26.38 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.631 HD21 ' OH ' ' A' ' 46' ' ' TYR . 3.9 mm? -59.16 -36.87 76.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.173 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.48 -52.24 65.46 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.589 -0.695 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -47.12 80.25 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.378 -0.826 . . . . 0.0 109.585 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.65 -43.79 95.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.487 -0.758 . . . . 0.0 110.007 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.677 ' CD2' HG11 ' A' ' 35' ' ' VAL . 19.2 mt -54.94 -40.16 69.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 109.968 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -37.71 68.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.562 HG21 ' CG2' ' A' ' 67' ' ' ILE . 2.5 mt -59.64 -44.53 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.265 -0.897 . . . . 0.0 110.617 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.946 ' O ' HG12 ' A' ' 32' ' ' VAL . 13.8 ptt85 -69.52 62.99 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.457 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' ILE . 1.8 m-20 -74.44 -39.76 62.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -62.83 -15.01 52.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.212 -0.93 . . . . 0.0 111.112 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.129 HG21 ' CD1' ' A' ' 50' ' ' ILE . 6.1 p -80.76 151.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.901 -1.124 . . . . 0.0 111.424 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -45.39 17.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 111.254 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.433 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.22 155.7 38.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.926 -1.109 . . . . 0.0 111.313 -179.004 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 50' ' ' ILE . 14.9 p -137.67 136.15 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 110.061 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.14 118.25 26.46 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 131.92 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.823 . . . . 0.0 110.574 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 4.6 m -117.75 127.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.136 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -79.86 153.56 28.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.333 -0.854 . . . . 0.0 110.631 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.499 ' OG ' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -74.75 179.41 4.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.205 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -103.5 12.96 34.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.28 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 110.014 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.6 Cg_endo -70.24 -170.69 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.687 1.362 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 21.68 26.22 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 8.2 ptp180 -94.79 162.54 13.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.544 -0.974 . . . . 0.0 110.32 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.946 ' CZ ' HG21 ' A' ' 12' ' ' VAL . 2.1 p90 -152.8 154.7 35.7 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.797 0.808 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.554 ' HG3' ' CD1' ' A' ' 9' ' ' TRP . 2.4 tt0 -92.71 97.33 10.71 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.351 0.596 . . . . 0.0 109.662 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 46' ' ' TYR . 39.2 t -77.42 119.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.419 -0.801 . . . . 0.0 110.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.22 100.96 5.58 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.129 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -121.06 147.62 24.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 121.427 0.632 . . . . 0.0 110.602 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 7' ' ' PHE . 12.0 p -126.09 148.22 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.054 ' HG ' HG23 ' A' ' 32' ' ' VAL . 2.1 mp -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.13 -0.981 . . . . 0.0 110.174 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.53 ' N ' HD21 ' A' ' 56' ' ' LEU . 21.2 m120 -36.75 159.48 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.812 -0.555 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.52 -20.75 66.04 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.983 1.517 . . . . 0.0 111.498 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -127.98 77.67 1.78 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.057 . . . . 0.0 109.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 52' ' ' LEU . 6.4 mt -73.3 -173.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.384 1.088 . . . . 0.0 112.531 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.508 ' OD1' ' HG3' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -168.43 170.63 9.67 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.606 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.58 -32.22 73.17 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.958 -1.088 . . . . 0.0 110.813 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -38.39 76.05 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.508 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 8.7 mm-40 -68.57 -43.9 75.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 21.2 mt -65.15 -35.36 80.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.018 -1.051 . . . . 0.0 109.702 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 66' ' ' GLU . . . -52.83 -33.25 48.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 24.9 mt -66.17 -50.48 63.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' OE1' HD11 ' A' ' 52' ' ' LEU . 18.0 pt-20 -74.84 -41.14 60.44 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.847 -1.158 . . . . 0.0 109.513 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 4.0 mptp? -67.98 -32.92 73.66 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.41 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 11.1 pt-20 -69.88 -46.35 65.66 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.41 -1.431 . . . . 0.0 109.945 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.562 ' CG2' HG21 ' A' ' 28' ' ' ILE . 4.4 mt -78.3 -40.72 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.066 . . . . 0.0 111.136 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 68.1 mt -60.49 -49.85 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 70' ' ' ARG . 2.9 pt20 -60.85 -44.12 97.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 17.2 mtp-105 -68.6 -47.11 67.54 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.503 -0.748 . . . . 0.0 110.765 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -62.28 -47.83 82.6 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.053 -1.03 . . . . 0.0 110.077 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD2' ' OD2' ' A' ' 21' ' ' ASP . 91.3 mt -63.13 -38.01 89.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.354 -0.842 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.02 -45.34 64.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.398 -0.814 . . . . 0.0 109.595 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -61.63 -36.47 80.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.562 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.47 -17.94 60.0 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.467 -0.771 . . . . 0.0 110.406 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.15 2.86 48.38 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' CB ' ' OD2' ' A' ' 21' ' ' ASP . . . -98.36 111.78 24.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -1.187 . . . . 0.0 110.099 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -118.05 144.75 45.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.1 t -88.95 125.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 120.922 -1.111 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 -5.63 58.76 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -130.38 149.96 51.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 111.579 -178.468 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.506 HG12 ' CE2' ' A' ' 10' ' ' TYR . 1.2 m . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 109.125 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.456 ' C ' HD12 ' A' ' 8' ' ' LEU . 17.5 m-85 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.325 0.584 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.659 HD21 HD23 ' A' ' 61' ' ' LEU . 4.1 mp -144.34 124.17 13.44 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.34 -0.85 . . . . 0.0 110.645 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -123.15 118.21 27.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD2' HG11 ' A' ' 79' ' ' VAL . 3.1 m-85 -126.57 135.08 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 110.89 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.797 ' O ' HG13 ' A' ' 79' ' ' VAL . 2.3 tt0 -119.42 159.57 23.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 18.9 m -130.27 179.88 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 110.747 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -137.04 60.41 1.66 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.588 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 1.3 ptm -134.48 147.91 65.36 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.501 -0.749 . . . . 0.0 110.999 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 Cg_endo -73.37 -166.73 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.216 1.64 . . . . 0.0 112.452 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.579 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 22.7 tt0 -65.24 -25.42 67.66 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.203 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.01 -42.19 93.77 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.836 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -90.23 -14.34 33.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.33 -0.856 . . . . 0.0 110.322 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 7.2 t -46.52 -36.74 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.515 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.8 t30 -52.25 -27.89 16.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.364 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 42.3 t0 -59.14 -44.43 92.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.0 mm? -59.04 -39.62 82.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.84 . . . . 0.0 109.171 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -56.61 -53.12 61.32 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.439 -0.788 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -42.89 93.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.553 ' OE2' ' HB3' ' A' ' 71' ' ' ALA . 1.1 tt0 -57.69 -47.57 81.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.739 HD23 ' CG1' ' A' ' 35' ' ' VAL . 6.7 mt -54.69 -40.14 68.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -36.13 74.24 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -63.28 -43.93 98.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 32' ' ' VAL . 8.7 mtm180 -70.47 54.82 0.15 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.563 -0.71 . . . . 0.0 110.359 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -74.09 -40.66 62.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -61.03 -16.18 40.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.573 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.089 HG21 ' CD1' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -81.31 158.49 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 110.093 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.481 ' HD2' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -79.15 -46.81 17.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 111.229 -179.366 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.66 149.93 28.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 111.097 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.739 ' CG1' HD23 ' A' ' 26' ' ' LEU . 7.4 p -139.85 133.79 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.9 mtm -129.91 115.16 16.79 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.059 -1.026 . . . . 0.0 110.968 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.1 t -115.19 130.32 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 109.816 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -116.76 156.51 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.002 -1.061 . . . . 0.0 110.944 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.92 153.42 22.21 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.384 0.611 . . . . 0.0 110.456 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -76.83 -177.35 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.427 179.211 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -98.37 -47.85 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.303 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -100.59 -66.99 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 110.803 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.9 Cg_endo -72.1 -161.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.335 1.176 . . . . 0.0 110.776 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -116.19 40.49 2.39 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.6 mtt180 -93.3 135.41 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -1.081 . . . . 0.0 110.258 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.579 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 32.7 m-85 -115.05 154.98 27.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 111.034 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 5.3 mm-40 -100.52 114.99 29.06 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.925 -0.484 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 72.4 t -92.46 111.54 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 110.39 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.81 101.07 5.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.089 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -124.83 149.07 29.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 121.681 0.753 . . . . 0.0 111.553 -178.638 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 32' ' ' VAL . 6.5 p -98.72 151.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.739 -0.601 . . . . 0.0 109.682 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.499 HD13 HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -95.49 176.26 6.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.368 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.503 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 4.0 m-20 -48.48 179.23 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.403 -0.811 . . . . 0.0 109.794 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.8 -19.74 69.34 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.458 1.241 . . . . 0.0 109.266 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -142.1 84.92 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.919 HD12 ' N ' ' A' ' 57' ' ' ASP . 3.8 pp -71.13 -172.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.004 . . . . 0.0 110.812 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.919 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.8 t70 173.07 171.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.386 0.612 . . . . 0.0 109.782 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.446 ' HG3' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -53.86 -54.39 39.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -0.819 . . . . 0.0 110.868 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -32.48 72.24 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.918 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.0 mm-40 -67.17 -44.77 78.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.848 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.659 HD23 HD21 ' A' ' 8' ' ' LEU . 5.8 mp -65.05 -34.36 78.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.014 -1.054 . . . . 0.0 109.676 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 66' ' ' GLU . . . -52.28 -33.85 43.88 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.659 ' O ' HG12 ' A' ' 67' ' ' ILE . 32.9 mt -68.16 -50.03 57.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.87 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.8 ' OE2' HG23 ' A' ' 32' ' ' VAL . 90.8 mt-10 -70.62 -35.6 73.04 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.243 -1.536 . . . . 0.0 109.381 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.48 -43.87 59.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 110.646 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 67' ' ' ILE . 10.0 pt-20 -72.62 -37.82 67.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.891 -1.13 . . . . 0.0 109.893 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 63' ' ' LEU . 40.1 mm -77.25 -39.73 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 111.154 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 64' ' ' GLU . 87.8 mt -70.28 -47.0 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.867 -1.146 . . . . 0.0 110.043 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 12.0 mm-40 -61.49 -33.83 74.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 110.541 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -67.42 -41.9 84.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.098 -1.002 . . . . 0.0 111.235 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' OE2' ' A' ' 25' ' ' GLU . . . -70.44 -48.41 56.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 111.323 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HG ' ' OE1' ' A' ' 25' ' ' GLU . 29.3 mt -58.59 -36.47 74.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 111.211 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.252 4.0 tt0 -71.53 -47.57 54.35 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.147 0.975 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -61.54 -39.38 90.89 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.116 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.68 -35.73 60.26 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.65 24.82 4.2 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -107.3 127.05 53.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.861 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -118.77 137.69 53.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 110.426 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 11' ' ' GLN . 1.7 t -90.29 117.16 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -82.42 -6.82 59.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 109.452 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.571 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -134.94 136.13 42.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.302 -0.874 . . . . 0.0 111.525 -178.767 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 82' ' ' VAL . 2.7 p . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.169 0.509 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.055 ' CD2' HD22 ' A' ' 61' ' ' LEU . 6.4 mp -105.27 125.33 50.86 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.688 ' CE2' ' ND2' ' A' ' 49' ' ' ASN . 1.1 t90 -124.48 126.72 46.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.356 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.481 ' OH ' HD23 ' A' ' 8' ' ' LEU . 80.1 m-85 -122.94 122.1 37.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.921 . . . . 0.0 110.689 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.972 ' O ' HG13 ' A' ' 79' ' ' VAL . 11.8 tt0 -111.29 159.84 17.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.303 -0.873 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.8 m -136.86 -176.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.832 -1.168 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 15.1 tt0 -145.76 53.38 1.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.574 -0.704 . . . . 0.0 110.338 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.558 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -128.77 153.01 79.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.73 -166.53 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.952 1.501 . . . . 0.0 113.574 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HA ' HG23 ' A' ' 19' ' ' VAL . 3.0 tm-20 -60.72 -26.61 67.3 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.918 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.33 -27.28 62.09 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.908 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.616 ' NH1' ' CZ ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -88.44 -13.74 39.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.999 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.69 HG23 ' HA ' ' A' ' 16' ' ' GLU . 79.2 t -47.76 -40.99 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.0 109.968 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.8 m-20 -61.77 -29.68 70.29 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.772 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.733 ' OD2' HD23 ' A' ' 72' ' ' LEU . 39.5 t0 -60.85 -47.54 85.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.341 -0.85 . . . . 0.0 110.386 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.4 mm? -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.847 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.01 -47.29 78.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.06 -44.14 73.2 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.386 -0.821 . . . . 0.0 110.003 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.484 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.07 -47.95 82.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -63.06 -37.25 86.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.044 -1.035 . . . . 0.0 110.593 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.464 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.01 -42.38 63.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.849 -1.157 . . . . 0.0 110.454 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -61.93 -43.22 97.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.376 -0.828 . . . . 0.0 111.761 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -70.63 67.42 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.087 -1.008 . . . . 0.0 110.812 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.7 m-20 -64.59 -25.08 67.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.516 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 24.5 p30 -64.86 -25.79 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.299 -0.875 . . . . 0.0 111.57 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.653 HG22 ' CD1' ' A' ' 50' ' ' ILE . 0.5 OUTLIER -80.62 148.9 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.808 -1.182 . . . . 0.0 110.162 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -47.4 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 111.994 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -154.46 138.52 16.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.193 . . . . 0.0 111.243 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 50' ' ' ILE . 2.1 t -125.83 132.54 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.335 -0.853 . . . . 0.0 110.131 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 ttm -119.92 115.49 23.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.219 -0.926 . . . . 0.0 109.96 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.89 130.68 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.811 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 1.4 m -123.25 129.07 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.706 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -76.66 153.92 34.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -168.2 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.505 -0.747 . . . . 0.0 109.826 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.0 t -109.21 11.82 25.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.977 . . . . 0.0 110.79 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.574 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.36 -65.11 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 50.5 Cg_endo -72.62 -170.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.465 1.245 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -110.37 34.03 5.63 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.9 mtt180 -94.14 141.19 28.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -1.012 . . . . 0.0 110.04 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.706 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 17.4 m-85 -124.91 154.19 41.49 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.976 0.893 . . . . 0.0 110.729 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 24.8 mt-10 -103.05 92.5 4.57 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 80.7 t -77.49 124.74 36.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.688 ' ND2' ' CE2' ' A' ' 9' ' ' TRP . 32.8 m120 -128.32 100.83 5.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.709 HD13 ' N ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -113.49 130.03 68.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 121.216 0.531 . . . . 0.0 110.408 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.709 ' N ' HD13 ' A' ' 50' ' ' ILE . 8.4 p -91.97 150.25 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.84 HD22 HD12 ' A' ' 56' ' ' LEU . 12.5 mt -92.94 167.67 11.66 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 111.217 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.698 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 1.7 m-20 -65.1 -147.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.56 -35.14 30.71 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 CA-C-N 119.426 0.831 . . . . 0.0 111.64 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -162.97 79.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.74 -1.225 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.84 HD12 HD22 ' A' ' 52' ' ' LEU . 16.8 mt -80.4 -165.82 0.94 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.134 -0.979 . . . . 0.0 111.3 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.514 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER 177.72 -162.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.664 -0.647 . . . . 0.0 110.273 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.601 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 24.3 mt-30 -64.67 -30.16 71.17 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 111.132 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -71.25 -44.23 65.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 2.7 mm-40 -73.64 -44.09 57.81 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.487 -0.758 . . . . 0.0 109.682 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.055 HD22 ' CD2' ' A' ' 8' ' ' LEU . 30.7 mt -66.58 -33.28 75.32 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 58' ' ' GLN . . . -51.76 -32.91 32.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 67' ' ' ILE . 88.6 mt -71.18 -50.4 33.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.634 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.562 ' CD ' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -70.49 -32.21 69.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.453 -1.404 . . . . 0.0 109.56 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.556 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -73.37 -45.19 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 44.8 mt-10 -64.84 -38.3 90.53 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.121 -0.987 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 63' ' ' LEU . 7.1 mm -78.39 -43.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.538 -0.727 . . . . 0.0 111.458 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.562 HD12 ' CD ' ' A' ' 64' ' ' GLU . 10.4 mt -64.29 -41.3 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.0 110.7 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.91 -37.44 82.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.097 -1.002 . . . . 0.0 110.429 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -69.31 -45.43 69.55 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.222 -0.923 . . . . 0.0 111.103 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -48.82 72.27 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.008 -1.058 . . . . 0.0 110.253 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.733 HD23 ' OD2' ' A' ' 21' ' ' ASP . 36.1 mt -63.8 -35.68 81.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.958 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' CA ' ' OE1' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -70.35 -45.55 65.91 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.543 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -60.3 -37.23 79.88 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.36 -25.72 57.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.495 -0.753 . . . . 0.0 110.326 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.11 11.32 32.23 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -95.05 126.58 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -1.106 . . . . 0.0 110.2 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -119.49 131.71 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.972 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.4 t -85.84 124.6 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.01 -9.11 59.66 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -131.57 130.82 42.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.368 -0.832 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 82' ' ' VAL . 8.9 p . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.094 . . . . 0.0 110.57 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.976 ' C ' HD23 ' A' ' 8' ' ' LEU . 85.6 t80 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.221 0.534 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.976 HD23 ' C ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -153.51 123.97 7.12 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 120.962 -1.086 . . . . 0.0 111.939 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.407 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 7.3 t90 -128.11 118.83 24.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.503 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 62.0 m-85 -127.54 145.19 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.874 -1.141 . . . . 0.0 111.753 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 81' ' ' LYS . 23.2 tt0 -122.91 159.6 27.91 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.367 -0.833 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.54 -177.43 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.938 -1.102 . . . . 0.0 110.726 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 6.7 tt0 -135.58 50.18 2.12 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.693 0.759 . . . . 0.0 109.748 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' GLY . 16.6 mmt -128.59 148.7 69.42 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.81 -166.58 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.768 1.404 . . . . 0.0 113.412 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -52.58 -24.84 9.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.713 178.153 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.46 ' C ' ' HH ' ' A' ' 75' ' ' TYR . 35.8 t0 -58.22 -13.1 4.34 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.329 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -71.42 -13.3 61.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.234 -0.916 . . . . 0.0 111.027 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 16' ' ' GLU . 54.7 t -49.76 -46.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.34 -0.85 . . . . 0.0 110.068 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -30.87 69.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.168 -0.958 . . . . 0.0 109.58 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.652 ' OD2' ' HB3' ' A' ' 77' ' ' ALA . 16.3 t0 -69.48 -54.93 11.83 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.334 -0.854 . . . . 0.0 109.931 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.3 mm? -61.64 -38.13 86.55 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.85 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.81 -52.02 66.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.433 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.481 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -70.35 -46.83 63.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.187 -0.946 . . . . 0.0 109.769 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.949 ' OE2' HG23 ' A' ' 68' ' ' ILE . 50.5 tt0 -56.51 -49.63 74.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 110.919 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.737 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -63.76 -36.4 83.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.504 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.95 -41.98 97.35 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.194 -0.942 . . . . 0.0 111.313 -179.187 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.623 HG21 HG23 ' A' ' 67' ' ' ILE . 23.2 mt -67.57 -40.96 85.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.782 -1.199 . . . . 0.0 109.834 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 32' ' ' VAL . 36.7 mtp180 -74.39 64.53 1.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.546 -0.721 . . . . 0.0 110.373 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -29.62 70.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.942 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -62.14 -13.75 30.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.439 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.713 HG23 HD11 ' A' ' 50' ' ' ILE . 1.8 p -79.91 126.2 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.108 -0.995 . . . . 0.0 110.597 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -80.38 -44.59 19.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 110.69 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -151.72 123.72 8.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 0.0 111.486 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.499 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 3.7 p -129.94 128.16 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.708 . . . . 0.0 109.155 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.4 tpp -116.26 115.79 26.6 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.069 -1.02 . . . . 0.0 111.065 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG21 HD12 ' A' ' 22' ' ' LEU . 16.8 t -115.25 125.23 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.78 160.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.069 -1.019 . . . . 0.0 110.734 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -79.69 154.4 28.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.411 -0.806 . . . . 0.0 110.364 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.432 ' CB ' ' HG2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -74.11 -170.69 0.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.927 . . . . 0.0 110.105 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.407 ' H ' HG22 ' A' ' 41' ' ' THR . 8.8 t -98.69 1.71 46.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.629 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -160.53 -64.55 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.012 -1.055 . . . . 0.0 110.625 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 41.2 Cg_endo -67.66 -168.79 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.596 1.314 . . . . 0.0 110.782 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -107.11 29.17 11.04 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.6 ptt180 -94.19 160.61 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.845 -1.386 . . . . 0.0 110.393 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HG2' ' A' ' 18' ' ' ARG . 60.3 m-85 -132.48 155.26 48.87 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 121.956 0.884 . . . . 0.0 111.018 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.94 96.87 8.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 43.5 t -79.61 118.99 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.883 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -131.19 101.16 5.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.812 HD13 ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -117.36 146.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.912 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.812 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.7 p -107.05 120.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.621 HD12 HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.52 179.74 6.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 111.175 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.563 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 3.5 m-20 -45.33 174.04 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.766 -0.584 . . . . 0.0 110.359 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.2 Cg_endo -63.23 -15.13 46.19 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.594 1.313 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -140.36 73.71 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.96 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -63.03 165.19 7.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -165.42 168.67 16.45 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 110.82 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -54.68 -38.2 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.316 -0.865 . . . . 0.0 110.111 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -45.4 87.5 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.459 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm100 -69.7 -41.48 75.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.386 -0.822 . . . . 0.0 109.255 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.739 HD21 HD22 ' A' ' 8' ' ' LEU . 10.5 mt -63.26 -35.01 78.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.787 . . . . 0.0 109.957 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.541 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.22 -43.9 64.51 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 67' ' ' ILE . 66.9 mt -64.75 -48.38 74.77 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.702 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -65.26 -44.74 87.11 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.356 -1.465 . . . . 0.0 110.819 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 62' ' ' ALA . 5.0 ptmt -74.52 -35.16 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.471 -1.393 . . . . 0.0 110.433 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 86.9 mt-10 -77.23 -40.41 45.01 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.892 -1.13 . . . . 0.0 109.881 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 63' ' ' LEU . 8.7 mm -76.99 -35.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.173 -0.954 . . . . 0.0 110.946 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.949 HG23 ' OE2' ' A' ' 25' ' ' GLU . 69.1 mt -69.09 -45.27 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 0.0 109.48 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 32.0 mt-30 -60.3 -48.52 81.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.285 -0.885 . . . . 0.0 110.005 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -60.36 -44.24 95.77 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.435 -0.791 . . . . 0.0 111.082 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -65.5 -48.76 71.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.875 -1.14 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.602 HD23 ' CG ' ' A' ' 21' ' ' ASP . 32.0 mt -65.49 -38.15 88.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 12.9 mm-40 -70.88 -44.85 65.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 31.2 t-20 -60.75 -37.02 80.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 t80 -75.71 -33.47 60.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.241 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.49 11.35 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.652 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . . . -103.84 129.41 51.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.24 . . . . 0.0 109.802 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.15 137.57 52.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.131 -0.981 . . . . 0.0 110.547 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.1 t -79.29 115.65 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.596 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.78 -4.67 58.28 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.527 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -130.28 155.01 47.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.226 -0.922 . . . . 0.0 111.889 -178.568 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.967 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.429 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.738 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.7 mm? -90.79 148.45 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.155 -0.966 . . . . 0.0 111.521 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 3.5 t90 -127.36 119.61 26.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.787 . . . . 0.0 109.356 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.907 ' HD1' HG11 ' A' ' 79' ' ' VAL . 42.5 m-85 -123.27 143.74 49.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.93 -1.106 . . . . 0.0 111.163 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 79' ' ' VAL . 5.9 tt0 -121.05 160.33 23.84 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.406 -0.809 . . . . 0.0 109.597 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.85 -177.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 110.515 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 33.7 tt0 -143.32 53.47 1.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.234 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.559 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -122.1 148.93 53.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.256 -0.903 . . . . 0.0 109.876 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 36.2 Cg_endo -69.36 -167.31 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.992 1.522 . . . . 0.0 113.491 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.81 ' O ' HG12 ' A' ' 19' ' ' VAL . 3.0 tm-20 -65.52 -23.72 66.95 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.267 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.83 -39.49 79.97 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.615 -0.678 . . . . 0.0 111.966 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.3 OUTLIER -90.69 -16.76 27.98 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.056 -1.027 . . . . 0.0 110.869 -178.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.81 HG12 ' O ' ' A' ' 16' ' ' GLU . 7.4 p -46.54 -36.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.514 -0.741 . . . . 0.0 110.413 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.532 ' N ' HG13 ' A' ' 19' ' ' VAL . 2.2 t30 -52.21 -28.16 17.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.454 -0.779 . . . . 0.0 109.682 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.589 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 39.7 t0 -58.8 -38.12 77.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.365 -0.834 . . . . 0.0 109.834 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.586 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 2.9 mp -58.52 -41.66 85.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.526 -0.734 . . . . 0.0 109.349 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.38 -50.6 71.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.403 -0.811 . . . . 0.0 109.517 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -68.55 -41.03 80.39 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.83 . . . . 0.0 109.694 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 28' ' ' ILE . 1.1 tp10 -59.78 -48.8 80.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.348 -0.845 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -60.89 -37.26 81.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.051 . . . . 0.0 109.055 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.38 -38.96 81.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.436 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.583 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.5 OUTLIER -58.86 -44.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.273 -0.892 . . . . 0.0 110.534 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.819 ' O ' HG12 ' A' ' 32' ' ' VAL . 11.6 ptp180 -78.61 52.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.71 -27.91 69.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.107 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 29.8 p-10 -58.88 -17.85 27.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 109.94 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.143 HG21 ' CD1' ' A' ' 50' ' ' ILE . 3.4 p -80.9 154.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.45 -0.781 . . . . 0.0 110.522 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -79.17 -45.53 19.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 111.058 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.5 mtt-85 -152.14 135.62 16.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.992 -1.067 . . . . 0.0 110.899 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.514 ' CA ' HG13 ' A' ' 50' ' ' ILE . 8.8 p -133.87 133.67 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.82 119.26 12.24 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.189 -0.945 . . . . 0.0 110.793 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 48' ' ' VAL . 58.5 t -114.54 130.67 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.984 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 16.2 m -111.28 145.13 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.685 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.09 153.87 23.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.422 -0.799 . . . . 0.0 110.687 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.53 -173.82 1.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -105.24 -16.91 14.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.087 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -124.31 -67.95 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -71.52 -168.79 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.105 1.055 . . . . 0.0 110.791 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -110.48 31.62 7.23 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.527 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 1.4 ptm180 -94.54 160.74 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -1.183 . . . . 0.0 110.486 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 45' ' ' ARG . 19.9 m-85 -132.2 154.35 49.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.846 0.831 . . . . 0.0 110.836 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 20.2 mt-10 -103.85 93.19 4.75 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 37' ' ' VAL . 65.4 t -79.5 123.13 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.0 111.603 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' ND2' ' CE2' ' A' ' 9' ' ' TRP . 29.4 m120 -130.91 100.76 5.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.143 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -136.52 147.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.634 0.731 . . . . 0.0 111.432 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.51 ' N ' HG12 ' A' ' 50' ' ' ILE . 9.9 p -124.81 149.92 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.617 -0.677 . . . . 0.0 109.232 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.98 ' HG ' HG23 ' A' ' 32' ' ' VAL . 6.1 mp -105.41 -158.56 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 52' ' ' LEU . 11.5 m-20 -39.44 163.8 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.85 -0.531 . . . . 0.0 110.425 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.13 -15.71 50.9 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.0 1.526 . . . . 0.0 110.877 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -139.05 75.88 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 110.117 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.956 HD11 HD13 ' A' ' 52' ' ' LEU . 8.7 mt -61.76 -174.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.975 -1.078 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.79 -174.25 0.35 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.465 0.65 . . . . 0.0 109.724 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -65.82 -40.01 91.42 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 111.119 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.1 m -66.19 -36.12 82.24 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 0.0 110.56 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.26 -44.53 68.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 110.45 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 71.4 mt -64.67 -33.18 75.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.529 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.42 -35.66 52.52 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 67' ' ' ILE . 47.4 mt -71.55 -49.72 38.03 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.873 0.844 . . . . 0.0 109.145 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.686 ' OE1' HD11 ' A' ' 52' ' ' LEU . 4.6 mt-10 -67.32 -38.39 84.85 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.624 -1.297 . . . . 0.0 109.987 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.881 -1.137 . . . . 0.0 110.756 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 10.9 mm-40 -75.48 -39.41 58.65 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.725 -1.234 . . . . 0.0 109.628 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 63' ' ' LEU . 23.6 mm -78.17 -40.87 26.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.496 -0.753 . . . . 0.0 111.868 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 89.0 mt -71.32 -41.66 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.322 -1.487 . . . . 0.0 110.294 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 1.4 pp0? -64.35 -34.64 78.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -0.847 . . . . 0.0 110.761 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -69.06 -41.52 77.48 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.01 -1.056 . . . . 0.0 110.977 -179.394 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.02 -48.55 62.67 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.09 -1.006 . . . . 0.0 110.709 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 77' ' ' ALA . 61.6 mt -60.71 -38.2 84.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.192 -0.943 . . . . 0.0 110.606 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -72.04 -45.9 59.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.367 -0.833 . . . . 0.0 109.563 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 14.1 t-20 -60.9 -40.46 93.18 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.32 -43.75 39.89 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.574 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.72 34.23 1.44 Allowed Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -113.01 127.3 56.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -1.155 . . . . 0.0 109.534 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -120.7 129.29 53.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 110.612 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.907 HG11 ' HD1' ' A' ' 10' ' ' TYR . 2.3 t -75.13 119.66 23.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.087 -1.008 . . . . 0.0 109.407 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -82.32 -7.06 59.63 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.9 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -132.98 149.71 52.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.329 -0.857 . . . . 0.0 111.559 -178.397 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 178.169 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' H2 ' ' HD2' ' A' ' 3' ' ' PRO . 11.6 mtt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.372 0.606 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.654 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 3.0 t70 -76.4 -37.1 1.92 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 0.0 111.574 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.8 Cg_endo -83.04 8.67 4.47 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.314 1.165 . . . . 0.0 110.339 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.755 ' NE2' HG22 ' A' ' 51' ' ' VAL . 8.3 pt20 -165.21 -167.31 1.15 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.887 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.659 ' C ' HD21 ' A' ' 56' ' ' LEU . . . -140.66 54.55 0.64 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.59 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . 3.3 p90 -63.28 130.82 46.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.59 -1.535 . . . . 0.0 109.402 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.75 ' H ' HD22 ' A' ' 8' ' ' LEU . 1.7 m-85 -164.68 47.85 0.1 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.979 -1.076 . . . . 0.0 110.531 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.75 HD22 ' H ' ' A' ' 7' ' ' PHE . 1.6 mm? -104.67 124.32 49.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.16 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.502 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 1.7 t90 -115.79 119.63 36.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.741 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CA ' ' HD2' ' A' ' 81' ' ' LYS . 27.0 m-85 -126.84 137.37 53.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.761 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.553 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 10.7 tt0 -122.82 159.46 28.08 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.376 -0.827 . . . . 0.0 109.42 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 11.4 m -136.03 -177.51 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.003 -1.061 . . . . 0.0 110.667 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -146.54 56.22 1.15 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.481 0.657 . . . . 0.0 109.651 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.543 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 10.2 mmt -131.12 149.05 72.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.402 -0.811 . . . . 0.0 109.209 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.95 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.2 Cg_endo -68.63 -168.4 0.22 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.774 1.408 . . . . 0.0 112.823 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.57 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -61.12 -46.55 90.13 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.543 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.0 -28.73 20.0 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.275 -0.89 . . . . 0.0 110.214 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 15' ' ' PRO . 43.0 t -47.99 -37.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.571 -0.706 . . . . 0.0 110.791 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -53.64 -29.0 36.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.984 -1.073 . . . . 0.0 109.739 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 24.6 t0 -59.99 -36.58 77.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 110.655 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.628 HD13 ' HA ' ' A' ' 19' ' ' VAL . 6.8 mp -57.97 -39.35 77.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.54 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -61.37 -52.82 63.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.838 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.36 -42.39 75.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.246 -0.909 . . . . 0.0 110.383 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.588 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -56.02 -49.05 74.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 110.407 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.38 -36.98 85.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.504 -0.748 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.6 -38.63 88.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.151 -0.968 . . . . 0.0 110.781 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.802 ' CG2' HG21 ' A' ' 67' ' ' ILE . 55.8 mt -61.6 -47.44 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 120.927 -1.108 . . . . 0.0 110.567 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 2.9 ptt180 -72.66 67.47 0.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.94 -25.48 29.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -57.9 -14.98 7.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.102 -0.999 . . . . 0.0 110.154 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.9 ' CG2' HD11 ' A' ' 50' ' ' ILE . 1.7 p -80.35 132.08 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 110.311 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -80.04 -46.49 16.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.518 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttp85 -152.7 123.3 7.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.9 -1.125 . . . . 0.0 111.135 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 26' ' ' LEU . 7.2 p -127.18 136.18 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.465 -0.772 . . . . 0.0 109.75 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.97 120.72 17.38 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.04 -1.038 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.735 HG12 ' HB3' ' A' ' 46' ' ' TYR . 20.0 t -114.94 130.41 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.736 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 18.9 t -104.43 161.15 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.049 -1.032 . . . . 0.0 110.862 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.11 154.59 23.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.545 -0.722 . . . . 0.0 110.317 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 7.7 p -73.2 -172.58 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 41' ' ' THR . 8.5 t -94.66 -1.91 52.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.11 -64.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.043 -1.036 . . . . 0.0 110.786 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.5 Cg_endo -69.18 -160.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.556 1.292 . . . . 0.0 111.226 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.1 37.37 3.85 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.7 mtp180 -93.95 146.89 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.477 -1.014 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.735 ' HB3' HG12 ' A' ' 37' ' ' VAL . 41.2 m-85 -131.7 154.73 48.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.147 -0.971 . . . . 0.0 110.942 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.495 ' CG ' ' HB ' ' A' ' 38' ' ' VAL . 2.6 pt-20 -101.64 104.48 15.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 48.5 t -83.71 116.9 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 111.642 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -131.17 100.53 5.24 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.9 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -117.25 144.85 24.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.903 -178.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG22 ' NE2' ' A' ' 4' ' ' GLN . 9.4 p -96.18 147.39 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 109.429 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.615 ' HB2' HD23 ' A' ' 56' ' ' LEU . 19.8 mt -107.25 -178.28 3.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.711 -1.243 . . . . 0.0 111.625 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.545 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -64.86 179.32 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.767 -0.583 . . . . 0.0 110.523 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 38.4 Cg_endo -63.97 -15.99 52.31 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.861 1.453 . . . . 0.0 110.788 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -141.07 87.35 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.659 HD21 ' C ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER -95.33 173.76 7.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.02 -1.05 . . . . 0.0 111.162 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 173.72 -167.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.527 -0.733 . . . . 0.0 110.133 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.554 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.69 76.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 7.7 mm-40 -67.86 -45.11 75.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 52' ' ' LEU . 79.4 mt -64.61 -35.11 79.94 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 109.811 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.74 -33.89 50.2 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.048 . . . . 0.0 108.342 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' O ' HG13 ' A' ' 67' ' ' ILE . 15.2 mt -70.94 -49.39 46.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' OE1' HD21 ' A' ' 52' ' ' LEU . 38.5 mt-10 -68.51 -43.36 77.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 109.316 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.7 mmtp -60.73 -36.2 78.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 110.408 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.6 mm-40 -65.75 -48.84 70.53 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.841 -1.162 . . . . 0.0 110.061 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.802 HG21 ' CG2' ' A' ' 28' ' ' ILE . 4.6 mt -77.77 -41.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.392 -0.817 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 27.4 mt -59.46 -50.49 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 30.0 mt-30 -64.36 -47.06 80.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.2 -0.938 . . . . 0.0 108.897 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -58.13 -47.11 84.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.509 -0.745 . . . . 0.0 110.81 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -68.76 -48.51 63.53 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.864 -1.148 . . . . 0.0 110.449 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.496 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 76.1 mt -65.7 -35.55 81.09 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.326 -0.858 . . . . 0.0 110.455 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 69' ' ' GLN . 1.4 mm-40 -71.33 -44.91 64.21 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 109.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.9 m-80 -64.29 -36.6 84.64 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.011 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.03 -37.65 61.67 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.628 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.27 23.95 4.32 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HA ' ' HG3' ' A' ' 14' ' ' MET . . . -108.31 131.32 54.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.26 -1.141 . . . . 0.0 109.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 146.19 46.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.9 t -87.85 122.24 39.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.046 -1.034 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.01 -7.46 59.56 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.077 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -137.55 152.98 50.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 111.525 -178.738 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.94 108.36 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.628 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -127.28 107.79 10.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.072 -1.017 . . . . 0.0 111.068 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.643 ' C ' HD12 ' A' ' 85' ' ' LEU . 1.2 tt0 -99.55 110.27 22.73 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.364 -0.835 . . . . 0.0 109.978 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 84' ' ' GLU . 5.0 mp -145.29 176.26 9.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.059 -1.026 . . . . 0.0 110.95 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 5' ' ' GLY . . . 74.63 56.36 5.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.43 67.43 9.43 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.123 -1.222 . . . . 0.0 110.55 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HB2' ' HA3' ' A' ' 5' ' ' GLY . 15.2 mmt180 -100.66 151.49 21.57 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.112 -0.993 . . . . 0.0 110.547 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.437 ' HG3' ' C ' ' A' ' 88' ' ' ARG . 14.1 mtm180 -141.58 39.6 1.7 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.904 0.859 . . . . 0.0 109.763 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -76.24 119.47 20.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.329 0.585 . . . . 0.0 110.566 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.72 83.86 1.95 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.377 -0.827 . . . . 0.0 110.027 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.62 168.78 7.46 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.234 -0.916 . . . . 0.0 110.37 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.24 58.11 4.24 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.974 1.512 . . . . 0.0 110.569 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.89 117.99 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.046 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.67 135.83 33.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.307 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 pttm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.153 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.506 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 3.5 tpp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.276 0.56 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.649 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 37.3 t70 -62.37 -38.08 42.89 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.386 -0.821 . . . . 0.0 111.116 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.2 Cg_endo -83.02 2.94 8.17 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.467 1.246 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 18.7 pt20 -148.46 -149.48 0.3 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 88' ' ' ARG . . . -169.08 45.06 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.241 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.906 ' CE1' HD13 ' A' ' 8' ' ' LEU . 25.6 t80 -81.67 135.05 35.53 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.93 -1.335 . . . . 0.0 110.224 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.971 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -160.8 100.94 1.29 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.547 -0.72 . . . . 0.0 109.643 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.971 HD12 ' C ' ' A' ' 7' ' ' PHE . 6.7 mp -138.46 125.28 21.06 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.825 . . . . 0.0 110.847 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.562 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -99.57 132.41 44.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.975 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -128.12 128.51 44.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.45 157.33 29.57 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.833 -1.167 . . . . 0.0 110.519 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.743 HG21 ' CD ' ' A' ' 18' ' ' ARG . 26.6 m -130.36 179.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.75 51.54 2.12 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.58 -0.7 . . . . 0.0 109.84 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.586 ' CB ' ' HB3' ' A' ' 18' ' ' ARG . 70.4 mmm -133.96 151.82 77.46 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 109.535 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 36.0 Cg_endo -71.15 -167.57 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.835 1.44 . . . . 0.0 113.24 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 19' ' ' VAL . 37.7 tt0 -53.23 -25.51 14.41 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.528 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 26.9 t0 -57.58 -23.34 50.23 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.864 ' NH1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -88.09 -13.49 41.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 16' ' ' GLU . 70.3 t -48.26 -44.6 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.52 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 4.6 m-20 -57.9 -29.07 64.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.764 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.2 t0 -59.64 -45.33 92.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.864 HD21 ' NH1' ' A' ' 18' ' ' ARG . 2.0 mm? -59.71 -36.65 76.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.26 74.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.173 -0.954 . . . . 0.0 110.533 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.3 mmt-85 -60.05 -46.64 88.87 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.5 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 tm-20 -68.67 -40.99 79.89 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 0.0 109.65 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.537 ' CD2' ' HB ' ' A' ' 35' ' ' VAL . 18.2 mt -55.28 -38.03 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.997 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 9.0 tpt180 -70.64 -40.94 72.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.468 -0.77 . . . . 0.0 110.596 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.974 ' CG2' HG21 ' A' ' 67' ' ' ILE . 56.5 mt -67.51 -44.94 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.989 -1.07 . . . . 0.0 110.743 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.912 ' HD3' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.51 57.44 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -73.75 -25.67 60.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 110.569 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -66.36 -20.46 66.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.098 -1.001 . . . . 0.0 110.427 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.034 HG21 HD11 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.5 154.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.913 . . . . 0.0 110.271 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -79.51 -47.02 16.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 111.41 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.446 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.96 146.27 23.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.764 -1.21 . . . . 0.0 111.939 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.912 HG21 ' HD3' ' A' ' 29' ' ' ARG . 2.1 t -135.56 135.96 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.459 -0.776 . . . . 0.0 109.11 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.472 ' HB3' ' OD1' ' A' ' 49' ' ' ASN . 2.5 tpt -131.71 117.42 18.6 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.968 -1.083 . . . . 0.0 110.692 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.798 HG13 ' CG2' ' A' ' 48' ' ' VAL . 4.4 t -114.59 129.8 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.307 -0.87 . . . . 0.0 109.849 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 47' ' ' GLU . 3.2 m -115.54 135.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 110.402 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.551 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -78.28 154.03 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.467 -0.77 . . . . 0.0 110.503 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 161.23 30.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -83.08 6.49 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 110.648 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.91 -65.07 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.334 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 44.0 Cg_endo -70.95 -176.68 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.562 1.296 . . . . 0.0 110.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.97 28.02 17.81 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 14.8 mtt180 -93.92 138.93 31.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.387 -1.066 . . . . 0.0 109.972 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 18' ' ' ARG . 7.0 m-85 -119.22 153.89 34.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.056 0.931 . . . . 0.0 110.949 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.686 ' HB2' HG23 ' A' ' 38' ' ' VAL . 4.0 mt-10 -104.31 95.83 6.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.798 ' CG2' HG13 ' A' ' 37' ' ' VAL . 5.1 t -88.1 122.72 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.852 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 36' ' ' MET . 0.8 OUTLIER -130.68 101.14 5.56 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.288 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.034 HD11 HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -117.78 149.8 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.447 0.641 . . . . 0.0 111.262 -178.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.418 ' N ' HG12 ' A' ' 50' ' ' ILE . 5.5 p -112.86 152.86 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.71 -0.619 . . . . 0.0 109.786 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.587 ' HB2' ' CD2' ' A' ' 6' ' ' TYR . 3.4 mt -100.36 -165.03 1.17 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.054 -1.029 . . . . 0.0 110.924 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -68.69 -178.83 0.45 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.641 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -63.87 -15.04 46.72 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.758 1.399 . . . . 0.0 110.486 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.06 77.71 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.65 173.2 6.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.73 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.983 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.9 t70 178.81 171.05 0.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 5.1 mt-30 -57.8 -38.14 75.0 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.707 . . . . 0.0 110.294 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 -31.59 69.02 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.334 -0.854 . . . . 0.0 109.95 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.9 mm100 -74.3 -45.77 45.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.983 HD12 ' O ' ' A' ' 57' ' ' ASP . 1.6 mp -67.69 -36.0 79.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.993 -1.067 . . . . 0.0 109.514 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.84 -33.7 57.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' ILE . 20.2 mt -69.14 -50.31 49.05 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.271 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 29' ' ' ARG . 78.7 mm-40 -71.54 -42.06 68.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -67.34 -30.5 70.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.472 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 1.8 mm-40 -69.14 -48.34 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.761 -1.212 . . . . 0.0 109.91 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.974 HG21 ' CG2' ' A' ' 28' ' ' ILE . 6.3 mt -77.38 -42.4 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.4 -0.812 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.5 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 85.6 mt -59.47 -46.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.104 -0.998 . . . . 0.0 109.91 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 5.2 mt-30 -64.16 -44.13 93.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -68.41 -43.44 77.23 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.403 -0.811 . . . . 0.0 111.147 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 25' ' ' GLU . . . -65.07 -48.48 73.6 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.886 -1.134 . . . . 0.0 110.499 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.975 HD13 ' CZ ' ' A' ' 10' ' ' TYR . 96.6 mt -63.92 -35.19 79.84 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 69' ' ' GLN 0.258 2.0 tt0 -69.93 -45.85 66.63 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 108.988 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -58.24 -37.07 74.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.15 -26.53 60.36 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.893 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.24 28.74 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.61 121.92 41.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.24 . . . . 0.0 110.282 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.35 162.57 18.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.908 HG22 ' CE2' ' A' ' 10' ' ' TYR . 1.5 t -87.6 118.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -12.88 58.26 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.876 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.562 ' CE ' ' O ' ' A' ' 9' ' ' TRP 0.254 0.0 OUTLIER -131.57 157.24 44.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.494 -0.754 . . . . 0.0 111.015 -178.78 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.436 ' C ' ' HG2' ' A' ' 83' ' ' GLU . 32.6 t -141.3 108.62 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.641 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' C ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -127.11 109.49 11.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.995 -1.065 . . . . 0.0 111.076 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -97.72 121.18 39.33 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.282 -0.886 . . . . 0.0 109.873 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mp -81.03 -9.41 59.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 0.0 110.18 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.47 105.45 0.44 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -50.16 154.02 1.29 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.245 -1.15 . . . . 0.0 110.311 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.557 ' CB ' ' HA3' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -105.64 158.97 16.33 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 110.429 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 8.5 ptm180 -105.94 109.33 21.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.675 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 3' ' ' PRO . 1.7 pp -61.92 128.37 35.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 110.474 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.08 -51.14 5.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.34 131.15 83.26 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.288 -0.883 . . . . 0.0 110.171 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.52 154.18 44.79 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.959 1.505 . . . . 0.0 110.267 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.706 ' O ' HG23 ' A' ' 94' ' ' ILE . 9.1 tp -78.69 114.32 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.25 78.15 1.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -0.878 . . . . 0.0 110.254 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.114 -0.991 . . . . 0.0 110.228 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' GLN . 1.9 tmt? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.319 0.581 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.62 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 5.3 t70 -76.62 -39.5 2.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 111.476 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.5 Cg_endo -79.5 4.94 6.2 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.297 1.156 . . . . 0.0 110.777 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 5.1 pt20 179.7 -155.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.534 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 64.56 -79.16 0.06 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.673 ' HB2' HG23 ' A' ' 51' ' ' VAL . 1.1 t80 -64.81 98.25 0.26 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.412 -1.052 . . . . 0.0 111.225 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.987 ' CB ' HD13 ' A' ' 85' ' ' LEU . 1.5 m-85 -165.77 25.42 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.095 -1.003 . . . . 0.0 110.257 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 61' ' ' LEU . 9.6 mp -96.15 132.35 41.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.262 -0.899 . . . . 0.0 110.523 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -122.86 118.24 27.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.095 -1.003 . . . . 0.0 109.892 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.662 ' O ' HG22 ' A' ' 48' ' ' VAL . 36.2 m-85 -127.78 119.15 25.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 0.0 110.906 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.944 ' O ' HG13 ' A' ' 79' ' ' VAL . 34.7 tt0 -107.27 155.6 19.77 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.2 -0.937 . . . . 0.0 109.689 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' CG2' ' CD2' ' A' ' 46' ' ' TYR . 4.0 m -129.53 -178.38 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.865 -1.147 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' SD ' ' A' ' 14' ' ' MET . 3.5 pt-20 -133.06 48.87 2.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.537 0.684 . . . . 0.0 109.866 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.536 ' HB2' ' HB3' ' A' ' 18' ' ' ARG . 78.3 mmm -126.01 155.0 73.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 109.485 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.3 Cg_endo -72.67 -166.83 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.811 1.427 . . . . 0.0 113.014 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' HG12 ' A' ' 19' ' ' VAL . 42.4 tt0 -56.38 -26.85 54.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.48 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 29.8 t0 -58.13 -16.13 12.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.059 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.572 ' CD ' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -75.09 -16.57 60.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 110.18 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.588 HG13 ' N ' ' A' ' 20' ' ' ASN . 8.0 p -49.31 -43.68 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.416 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.588 ' N ' HG13 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -64.72 -30.05 71.05 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.104 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 41.1 t0 -65.6 -53.48 41.21 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.556 -0.715 . . . . 0.0 110.07 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.91 ' O ' HD12 ' A' ' 26' ' ' LEU . 4.7 mp -58.86 -37.11 75.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.136 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.11 -52.71 63.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.158 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -63.32 -46.26 87.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -56.91 -44.51 82.47 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.454 -0.779 . . . . 0.0 110.17 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.91 HD12 ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -66.94 -40.07 87.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.506 -0.746 . . . . 0.0 111.221 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.552 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.69 -37.36 83.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.915 -1.116 . . . . 0.0 110.355 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.955 ' CG2' HG23 ' A' ' 67' ' ' ILE . 14.8 mt -68.18 -44.56 84.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.727 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -81.4 69.26 8.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.403 -0.81 . . . . 0.0 110.297 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 37.7 p-10 -73.49 -25.96 60.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 6.1 t30 -58.82 -13.88 7.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.407 -0.808 . . . . 0.0 110.575 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.038 HG23 HD11 ' A' ' 50' ' ' ILE . 8.0 p -79.63 141.41 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 111.037 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -46.64 15.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 111.253 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttt180 -152.98 123.79 7.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 111.201 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.847 HG22 HG13 ' A' ' 50' ' ' ILE . 11.3 t -108.5 135.46 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 110.035 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 115.76 19.98 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.176 -0.953 . . . . 0.0 110.335 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.076 HG13 HG12 ' A' ' 48' ' ' VAL . 48.7 t -114.82 132.04 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.558 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 47' ' ' GLU . 3.9 m -113.22 130.79 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.371 -0.831 . . . . 0.0 110.018 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.654 ' HA ' ' CD1' ' A' ' 46' ' ' TYR . . . -77.62 153.67 32.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.519 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.59 166.33 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 109.445 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -83.51 2.83 35.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 0.0 110.848 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.42 -64.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.009 -1.057 . . . . 0.0 110.458 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.6 Cg_endo -70.55 -171.06 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.568 1.299 . . . . 0.0 111.072 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.24 26.42 18.8 Favored Glycine 0 N--CA 1.479 1.563 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -93.45 135.7 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 108.64 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.654 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 11.1 m-85 -128.73 151.29 49.71 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.763 -1.211 . . . . 0.0 112.379 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 mt-10 -105.03 90.63 3.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.098 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.076 HG12 HG13 ' A' ' 37' ' ' VAL . 16.0 m -86.92 125.24 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.486 ' HB3' ' OH ' ' A' ' 6' ' ' TYR . 13.5 m120 -123.63 100.74 6.94 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.038 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.13 147.77 16.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.447 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.76 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.7 p -102.82 129.76 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.12 -0.988 . . . . 0.0 111.296 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.781 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -93.58 -168.29 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.904 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 2.8 m120 -50.93 172.91 0.12 Allowed Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.0 109.505 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.8 Cg_endo -63.22 -14.66 43.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.548 1.289 . . . . 0.0 110.849 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 4.2 t30 -146.19 86.77 1.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.106 -0.996 . . . . 0.0 110.696 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.781 HD21 ' CB ' ' A' ' 52' ' ' LEU . 8.7 mt -61.17 -171.41 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 111.068 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.8 t70 172.94 172.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.483 0.659 . . . . 0.0 110.103 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 11.7 mt-30 -56.37 -34.31 66.55 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -34.22 75.15 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -72.05 -44.32 63.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 110.099 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 55.5 mt -63.37 -34.26 77.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 109.935 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.75 -40.36 63.03 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.62 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.1 mt -71.54 -49.99 35.5 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 79.1 mm-40 -58.34 -41.94 85.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.737 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HZ2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -70.79 -46.9 62.03 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.263 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -71.4 -37.66 71.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.85 -1.156 . . . . 0.0 109.834 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.955 HG23 ' CG2' ' A' ' 28' ' ' ILE . 11.0 mm -76.49 -41.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 56.2 mt -70.26 -49.73 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.714 -1.242 . . . . 0.0 109.786 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 25.7 mm-40 -59.17 -38.74 80.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.883 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -57.74 -48.08 80.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.264 -0.898 . . . . 0.0 111.128 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 25' ' ' GLU . . . -70.95 -48.52 52.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.907 -1.121 . . . . 0.0 110.099 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 20.3 mt -63.71 -35.41 80.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.604 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 4.8 mm-40 -69.57 -45.08 69.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.427 -0.795 . . . . 0.0 109.283 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.48 -40.24 90.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.74 -29.17 58.78 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.528 -0.733 . . . . 0.0 110.0 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . 101.06 18.34 20.11 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -93.6 127.12 39.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -1.086 . . . . 0.0 110.483 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.8 141.32 48.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 109.874 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.9 t -94.17 125.37 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.66 -10.29 58.29 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -131.56 133.4 44.99 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 82' ' ' VAL . 2.1 p -141.34 106.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.321 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -128.45 105.87 8.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.96 -1.087 . . . . 0.0 110.548 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' OE1' ' CE ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -101.84 122.84 44.74 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.768 179.176 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.987 HD13 ' CB ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -76.65 -26.16 54.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.858 -1.151 . . . . 0.0 109.736 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . 65.81 -168.68 31.84 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.457 ' HG ' ' OD1' ' A' ' 55' ' ' ASN . 1.6 tt -60.47 73.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.25 -1.147 . . . . 0.0 110.224 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 86' ' ' GLY . 51.3 ttt85 -117.46 143.3 46.18 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.172 -0.955 . . . . 0.0 110.377 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 12.7 mtt85 -103.0 133.95 47.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 110.081 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -171.88 91.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.657 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.88 -176.5 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.139 -0.976 . . . . 0.0 109.891 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -103.73 139.02 19.71 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.538 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.66 -3.06 12.82 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.186 1.624 . . . . 0.0 110.636 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.15 114.32 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.101 -0.999 . . . . 0.0 110.286 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 96' ' ' LYS . . . -132.63 153.8 50.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.207 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.5 ' CA ' ' HA ' ' A' ' 54' ' ' PRO . 1.2 tmm? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.395 0.617 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.601 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 15.9 t0 -76.65 -43.7 3.13 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.908 . . . . 0.0 110.579 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 2' ' ' ASP . 48.5 Cg_endo -77.3 4.25 6.04 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.512 1.27 . . . . 0.0 110.429 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' TYR . 8.6 pt20 -178.68 -139.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.896 . . . . 0.0 110.083 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.943 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 59.32 -80.8 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.889 ' HB3' HG23 ' A' ' 51' ' ' VAL . 1.4 p90 -66.38 121.55 15.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -1.166 . . . . 0.0 110.772 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -169.49 42.9 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.676 HD22 ' HA ' ' A' ' 84' ' ' GLU . 10.9 mt -126.04 125.01 41.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.468 -0.77 . . . . 0.0 110.35 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.481 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -116.54 119.16 34.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.823 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' OH ' ' CG ' ' A' ' 84' ' ' GLU . 22.0 m-85 -124.19 118.11 26.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.607 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.805 ' O ' HG13 ' A' ' 79' ' ' VAL . 7.4 tt0 -110.82 147.14 35.15 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.405 -0.809 . . . . 0.0 109.452 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.506 HG21 ' HD3' ' A' ' 18' ' ' ARG . 8.4 m -126.65 -179.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.837 -1.164 . . . . 0.0 111.433 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -129.65 45.3 2.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.737 0.779 . . . . 0.0 109.033 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.561 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 60.6 mmm -120.29 145.99 41.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.77 -0.581 . . . . 0.0 109.563 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 33.4 Cg_endo -67.99 -166.57 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.77 1.405 . . . . 0.0 113.518 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -27.57 65.75 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.237 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.527 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -59.53 -22.27 61.42 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.021 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.614 ' NH1' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -83.54 -13.47 54.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.227 -0.921 . . . . 0.0 110.378 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -48.0 -46.62 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.585 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -57.8 -29.96 65.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.604 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.4 t0 -61.15 -50.77 71.82 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.435 -0.791 . . . . 0.0 109.928 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.678 HD12 HG21 ' A' ' 37' ' ' VAL . 3.9 mm? -59.62 -41.45 90.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.116 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.21 -52.37 64.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.179 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.18 -42.35 89.01 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.33 -0.856 . . . . 0.0 109.608 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.813 ' OE2' HG23 ' A' ' 68' ' ' ILE . 19.0 tt0 -56.89 -48.77 77.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 110.903 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.72 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -69.02 -37.56 78.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 110.812 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.94 -36.11 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.01 -1.056 . . . . 0.0 111.395 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.85 ' CG2' HG23 ' A' ' 67' ' ' ILE . 73.1 mt -62.93 -44.83 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.951 -1.093 . . . . 0.0 111.378 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HB3' HG21 ' A' ' 67' ' ' ILE . 5.9 ptt180 -83.83 93.15 7.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.061 . . . . 0.0 110.788 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -73.43 -24.82 60.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 23.6 p30 -58.56 -15.12 9.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.645 HG21 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.61 134.36 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.399 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.436 ' HD2' ' CE ' ' A' ' 1' ' ' MET . 3.1 ttm-85 -79.47 -45.65 18.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 111.043 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -152.7 134.54 14.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.805 -1.184 . . . . 0.0 111.087 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.872 HG23 HD11 ' A' ' 50' ' ' ILE . 2.2 p -125.86 131.31 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.339 -0.851 . . . . 0.0 110.547 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.3 ttt -140.42 116.02 10.14 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.611 -0.68 . . . . 0.0 109.538 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.678 HG21 HD12 ' A' ' 22' ' ' LEU . 33.2 t -111.88 131.93 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 110.829 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 38' ' ' VAL . 33.5 m -105.59 142.11 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.458 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.03 154.67 23.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.357 -0.839 . . . . 0.0 110.517 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' NH2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -74.04 -176.12 2.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.089 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -103.06 9.89 38.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.169 -0.957 . . . . 0.0 110.82 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -155.93 -65.1 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.15 -0.969 . . . . 0.0 109.797 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.1 Cg_endo -71.43 -178.94 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.536 1.282 . . . . 0.0 110.334 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -105.13 30.17 10.42 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 3.0 ptt-85 -93.49 160.6 14.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.02 -1.282 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.614 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 78.6 m-85 -134.42 154.38 51.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.089 0.947 . . . . 0.0 111.358 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.55 95.05 7.02 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 15.2 t -78.18 112.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 111.07 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.624 ' O ' HD12 ' A' ' 50' ' ' ILE . 35.8 m120 -131.29 100.81 5.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -116.11 146.2 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' A' ' 6' ' ' TYR . 8.4 p -105.85 122.83 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.95 ' HB2' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.13 -168.5 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.5 m120 -41.77 165.17 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.46 -0.775 . . . . 0.0 110.07 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -64.4 -27.06 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.762 1.401 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 12.7 t-20 -127.75 78.36 1.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 52' ' ' LEU . 10.8 mt -62.28 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.226 -0.921 . . . . 0.0 111.011 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 58' ' ' GLN . 5.4 t0 174.59 172.09 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.441 0.638 . . . . 0.0 109.829 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.472 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.3 mm-40 -60.38 -31.4 70.32 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 110.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.422 ' HB2' ' OD2' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -70.05 -40.75 74.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.323 -0.861 . . . . 0.0 110.113 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 4.6 mm-40 -66.44 -42.77 87.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 109.942 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.524 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 15.1 mt -63.92 -33.5 75.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 109.732 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.74 -37.05 49.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.658 ' O ' HG12 ' A' ' 67' ' ' ILE . 62.5 mt -72.19 -51.36 21.5 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.3 mm-40 -61.64 -36.75 81.68 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.813 -1.179 . . . . 0.0 110.205 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.524 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -72.21 -47.05 53.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.976 -1.078 . . . . 0.0 110.232 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.488 ' OE2' HD23 ' A' ' 63' ' ' LEU . 23.7 pt-20 -71.21 -34.65 71.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.1 -1.0 . . . . 0.0 109.318 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.85 HG23 ' CG2' ' A' ' 28' ' ' ILE . 21.4 mm -77.03 -43.51 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.544 -0.722 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.813 HG23 ' OE2' ' A' ' 25' ' ' GLU . 49.6 mt -69.75 -46.01 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 110.259 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.09 -34.08 77.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.183 -0.948 . . . . 0.0 110.157 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 2.0 ttt-85 -64.42 -46.21 84.23 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.136 -0.978 . . . . 0.0 110.328 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -67.69 -48.61 66.11 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 110.21 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.506 HD23 ' OD2' ' A' ' 21' ' ' ASP . 86.9 mt -64.63 -36.07 83.07 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 38.3 mm-40 -70.05 -45.05 67.93 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.623 0.725 . . . . 0.0 109.247 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.51 -37.12 84.83 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.87 -41.08 60.48 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.564 -0.71 . . . . 0.0 110.049 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.15 23.6 4.48 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.52 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -98.7 138.23 36.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.218 . . . . 0.0 110.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -119.32 121.95 40.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.142 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.1 t -83.25 126.68 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.185 -0.947 . . . . 0.0 110.037 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.12 -15.01 54.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.63 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -130.66 129.65 42.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.682 -0.636 . . . . 0.0 110.454 -179.264 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.65 108.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.906 -1.121 . . . . 0.0 110.887 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 34.2 mp0 -127.45 105.7 8.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.982 . . . . 0.0 110.117 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.676 ' HA ' HD22 ' A' ' 8' ' ' LEU . 2.1 mp0 -101.88 104.9 15.66 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.263 -0.898 . . . . 0.0 110.353 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 16.6 mt -105.74 -67.82 0.9 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.051 -1.03 . . . . 0.0 109.812 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 87' ' ' LEU . . . 55.15 46.57 78.11 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.809 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.5 pp 179.65 45.19 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.422 -1.046 . . . . 0.0 110.059 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HB2' ' CD2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -121.36 121.16 37.01 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.503 -0.748 . . . . 0.0 110.241 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -93.52 109.51 21.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 110.508 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.731 ' C ' HD12 ' A' ' 90' ' ' LEU . 3.7 pp -85.12 150.96 24.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 110.01 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.1 -92.36 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 110.334 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -92.03 154.95 43.42 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.206 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.07 83.98 1.37 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.962 1.506 . . . . 0.0 110.384 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.577 ' O ' HG23 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -103.34 122.19 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.027 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.515 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -106.04 167.6 9.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 110.152 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 pptp? . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.104 179.909 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 6.6 mtm . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.12 0.486 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.614 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -62.59 -38.02 41.05 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.32 -0.863 . . . . 0.0 111.543 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 46.7 Cg_endo -78.58 1.84 8.68 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.289 1.152 . . . . 0.0 110.181 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER 179.75 116.99 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 110.198 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.686 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 122.28 -82.42 0.35 Allowed Glycine 0 N--CA 1.487 2.076 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.977 ' CD1' HG23 ' A' ' 51' ' ' VAL . 10.2 p90 -110.92 147.97 33.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -1.173 . . . . 0.0 111.879 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -158.0 51.49 0.43 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HG ' ' C ' ' A' ' 7' ' ' PHE . 1.4 mp -129.02 136.73 50.69 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.774 0.797 . . . . 0.0 111.886 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 3.7 t90 -125.59 119.01 26.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.554 ' CE2' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -123.59 140.36 53.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 111.383 -178.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.563 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 38.8 tt0 -122.76 158.14 30.82 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.506 -0.746 . . . . 0.0 109.513 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.586 HG11 HH11 ' A' ' 18' ' ' ARG . 13.6 m -130.76 177.59 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.046 . . . . 0.0 110.507 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -131.2 51.99 2.1 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.513 0.673 . . . . 0.0 109.979 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.56 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 54.2 mmm -132.98 153.54 81.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.303 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -71.02 -167.54 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.703 1.37 . . . . 0.0 113.487 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.6 tt0 -58.27 -27.27 63.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.709 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -59.16 -21.71 59.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.319 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.586 HH11 HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -87.78 -16.87 32.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.788 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 16' ' ' GLU . 40.5 t -48.76 -45.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 109.934 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.496 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.2 t-20 -54.96 -29.24 56.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.769 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 38.3 t0 -60.34 -48.88 79.84 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.422 -0.799 . . . . 0.0 110.017 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 22' ' ' LEU . 3.9 mm? -58.84 -36.74 75.04 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.475 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -56.8 -52.77 63.78 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.316 -0.865 . . . . 0.0 109.237 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 42.1 mtt180 -66.09 -44.09 85.43 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.429 -0.795 . . . . 0.0 109.331 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.642 ' OE2' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.7 -44.19 77.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.535 ' CD2' HG11 ' A' ' 35' ' ' VAL . 16.0 mt -65.44 -38.96 91.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.668 -0.645 . . . . 0.0 110.46 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.55 ' HG3' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -66.14 -36.24 82.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.207 -0.933 . . . . 0.0 111.756 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.967 ' CG2' HG23 ' A' ' 67' ' ' ILE . 49.0 mt -65.1 -45.7 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.609 -1.307 . . . . 0.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.901 ' NH1' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.29 79.56 9.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.042 . . . . 0.0 110.679 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.28 -25.47 62.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.998 . . . . 0.0 110.245 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.19 -14.47 10.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.748 ' CG2' HD11 ' A' ' 50' ' ' ILE . 2.2 p -79.68 133.65 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.197 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -80.09 -45.87 17.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 111.765 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.2 mtt85 -152.34 130.39 11.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.738 -1.226 . . . . 0.0 111.598 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.898 HG13 ' HB ' ' A' ' 50' ' ' ILE . 2.8 t -122.85 135.68 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.725 . . . . 0.0 109.209 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 115.71 23.01 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.019 -1.051 . . . . 0.0 110.715 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.498 HG11 ' HG ' ' A' ' 22' ' ' LEU . 15.7 t -114.87 129.09 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.298 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 3.6 m -119.81 125.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -82.36 153.99 25.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 p -74.31 -178.93 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.001 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -105.09 5.98 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -149.43 -66.34 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.963 . . . . 0.0 110.21 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.0 Cg_endo -71.59 -164.54 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.334 1.176 . . . . 0.0 110.13 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.29 34.36 4.32 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.1 mtt180 -97.33 134.71 40.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -1.101 . . . . 0.0 110.331 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.628 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 8.1 m-85 -117.88 155.44 30.15 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.288 -0.882 . . . . 0.0 110.438 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.8 mp0 -102.52 98.32 8.41 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 10' ' ' TYR . 66.9 t -78.45 111.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 111.356 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -131.13 101.94 5.8 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.898 ' HB ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.16 146.91 17.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.728 -177.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.977 HG23 ' CD1' ' A' ' 6' ' ' TYR . 11.7 p -119.36 146.92 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.432 -0.792 . . . . 0.0 110.2 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.026 HD13 HD11 ' A' ' 56' ' ' LEU . 1.5 mp -135.06 -160.94 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.615 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' LEU . 14.2 m120 -38.88 161.14 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.92 -0.488 . . . . 0.0 110.351 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 39.4 Cg_endo -64.91 -20.39 64.35 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.91 1.479 . . . . 0.0 110.878 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -143.66 84.4 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.026 HD11 HD13 ' A' ' 52' ' ' LEU . 18.3 mt -68.37 -162.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 9.0 t70 -161.7 172.2 16.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 0.0 110.464 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 69.2 mt-30 -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.728 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 t -64.49 -28.31 69.57 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.233 -0.917 . . . . 0.0 110.062 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 39.1 mm-40 -65.33 -40.68 94.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 91.6 mt -65.29 -35.25 80.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.048 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.17 -36.39 51.51 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.9 mt -72.52 -50.67 24.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.179 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' OE1' ' HB2' ' A' ' 29' ' ' ARG . 5.8 mm-40 -63.72 -33.87 76.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.846 -1.159 . . . . 0.0 110.437 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -72.24 -46.73 54.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.394 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 32.2 mm-40 -66.55 -35.38 80.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.121 -0.987 . . . . 0.0 109.85 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.967 HG23 ' CG2' ' A' ' 28' ' ' ILE . 11.5 mm -76.71 -47.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.42 -0.8 . . . . 0.0 111.498 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.901 HD11 ' NH1' ' A' ' 29' ' ' ARG . 45.8 mt -67.78 -48.19 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.937 -1.102 . . . . 0.0 110.125 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.8 mm100 -62.16 -32.93 73.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.329 -0.857 . . . . 0.0 109.956 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -65.81 -46.93 76.78 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.207 -0.933 . . . . 0.0 110.97 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.3 -48.93 47.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.969 -1.082 . . . . 0.0 111.589 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.546 HD22 HH12 ' A' ' 18' ' ' ARG . 38.2 mt -58.3 -39.13 78.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 111.293 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 5.3 tt0 -71.28 -46.8 60.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.112 0.958 . . . . 0.0 109.411 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 8.6 t-20 -59.21 -36.89 76.2 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -74.94 -34.76 62.12 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.873 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.81 10.46 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -102.73 125.69 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 110.2 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -111.99 134.86 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 109.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 81' ' ' LYS . 3.0 t -66.54 124.93 22.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.066 -1.021 . . . . 0.0 109.785 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.2 -11.7 59.35 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.427 -0.796 . . . . 0.0 109.109 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 79' ' ' VAL 0.269 0.0 OUTLIER -138.16 145.37 41.45 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.633 -0.667 . . . . 0.0 110.74 -178.923 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.67 105.26 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.562 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -130.06 108.13 9.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 111.046 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.38 100.78 11.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 109.578 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' CB ' ' CD2' ' A' ' 7' ' ' PHE . 13.6 mt -75.32 -0.53 20.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.045 -1.034 . . . . 0.0 110.304 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.18 119.94 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 87' ' ' LEU . 1.5 pp -44.79 134.93 5.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 110.421 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.4 OUTLIER -93.34 164.41 13.23 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.191 -0.943 . . . . 0.0 110.691 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 6.0 ptm180 -126.32 111.71 14.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.172 -0.955 . . . . 0.0 109.986 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 90' ' ' LEU . 26.0 tp -94.79 72.28 3.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -0.982 . . . . 0.0 109.968 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.72 97.42 4.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.247 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -97.92 137.53 20.92 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 110.204 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 154.24 54.07 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.043 1.549 . . . . 0.0 110.457 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.84 114.71 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.394 -0.816 . . . . 0.0 110.019 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.53 131.84 34.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.928 . . . . 0.0 110.55 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.141 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' H2 ' ' HD2' ' A' ' 3' ' ' PRO . 2.8 mmm . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.342 0.591 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.63 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 36.2 t0 -65.17 -37.79 23.26 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.3 -0.875 . . . . 0.0 111.394 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 47.5 Cg_endo -90.7 24.0 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.342 1.18 . . . . 0.0 109.981 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 86.0 mt-30 -125.77 -157.02 0.77 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.351 -0.843 . . . . 0.0 110.665 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.543 ' O ' HD12 ' A' ' 56' ' ' LEU . . . -102.87 0.85 48.29 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.984 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -61.61 98.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.928 -1.337 . . . . 0.0 110.526 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.549 ' HB2' ' HA3' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -163.42 25.18 0.08 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.512 -0.743 . . . . 0.0 109.594 178.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.754 ' N ' HD12 ' A' ' 8' ' ' LEU . 7.8 mp -90.63 129.38 36.76 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 110.243 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.523 ' CE2' ' ND2' ' A' ' 49' ' ' ASN . 1.6 t90 -124.57 123.56 40.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.524 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.477 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 26.3 m-85 -126.79 138.01 53.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.412 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.883 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.9 tp60 -121.99 159.99 25.84 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.221 -0.924 . . . . 0.0 110.224 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 m -133.36 -176.94 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.02 . . . . 0.0 110.609 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' SD ' ' A' ' 14' ' ' MET . 5.6 pt-20 -138.41 56.04 1.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.545 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 4.5 mmt -137.05 149.49 66.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.553 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.911 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -70.84 -167.21 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.035 1.545 . . . . 0.0 113.13 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.22 -25.76 67.83 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.8 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.83 -45.54 89.77 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.264 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.545 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 2.8 mtp180 -89.76 -23.65 21.71 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.944 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 15' ' ' PRO . 24.4 t -47.95 -38.41 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.525 -0.734 . . . . 0.0 110.012 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 25.1 t-20 -53.36 -29.12 32.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.166 -0.959 . . . . 0.0 109.066 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.588 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 32.9 t0 -59.89 -42.39 93.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 19' ' ' VAL . 6.0 mp -58.32 -38.65 77.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.615 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.32 58.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -46.77 82.16 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.216 -0.927 . . . . 0.0 109.292 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.056 ' OE1' HG23 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -59.29 -48.12 82.82 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.85 0.833 . . . . 0.0 109.454 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.605 HD22 HG11 ' A' ' 35' ' ' VAL . 13.3 mt -53.95 -36.92 63.34 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.455 0.645 . . . . 0.0 110.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -35.6 74.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.602 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 15.9 mt -59.48 -32.52 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.041 . . . . 0.0 110.979 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.627 ' HG3' HG12 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -69.4 48.64 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.067 -1.021 . . . . 0.0 111.661 -178.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -25.59 25.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.435 -1.416 . . . . 0.0 109.851 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.384 -0.823 . . . . 0.0 111.14 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.001 HG21 HD11 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -83.46 142.78 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.12 . . . . 0.0 110.54 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.85 22.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 111.598 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.79 150.34 30.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.619 -1.301 . . . . 0.0 111.822 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.902 HG23 ' HB ' ' A' ' 50' ' ' ILE . 9.7 p -140.03 134.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.4 mtm -122.81 114.12 20.08 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.843 -1.16 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG13 HG22 ' A' ' 48' ' ' VAL . 4.8 t -116.43 132.15 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 109.925 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' HB ' ' CD ' ' A' ' 47' ' ' GLU . 11.2 t -118.81 157.08 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.607 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.11 154.95 21.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -73.91 -170.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.05 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -103.1 -2.13 27.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 111.031 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.578 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -152.25 -66.38 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -70.15 -158.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.469 1.247 . . . . 0.0 110.699 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.79 34.95 4.51 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 2.2 mtt180 -94.52 136.69 34.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -1.13 . . . . 0.0 109.815 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.629 ' OH ' HG21 ' A' ' 19' ' ' VAL . 32.7 m-85 -117.21 153.97 31.95 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.099 -1.0 . . . . 0.0 111.256 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' CD ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -103.67 110.82 23.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 67.5 t -89.41 124.66 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 111.686 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' ND2' ' CE2' ' A' ' 9' ' ' TRP . 5.6 m120 -131.01 101.18 5.5 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.001 HD11 HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -124.05 148.27 28.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 111.689 -178.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.984 HG23 ' HB2' ' A' ' 6' ' ' TYR . 7.2 p -105.68 151.28 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.695 -0.628 . . . . 0.0 109.758 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 52' ' ' LEU . 4.9 mp -132.88 -170.62 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.053 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 56' ' ' LEU . 15.7 m120 -43.44 161.3 0.2 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 110.456 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.401 ' CB ' ' O ' ' A' ' 90' ' ' LEU . 39.7 Cg_endo -65.42 -31.75 51.24 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.099 1.579 . . . . 0.0 110.838 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 35.8 t-20 -113.3 70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' A' ' 52' ' ' LEU . 9.1 mt -62.85 -168.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 110.984 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 168.18 -175.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.62 0.724 . . . . 0.0 110.031 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.808 ' HA ' HD21 ' A' ' 61' ' ' LEU . 74.4 mt-30 -65.54 -32.44 74.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.06 -30.37 63.66 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 110.29 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.48 ' HG3' ' HA ' ' A' ' 56' ' ' LEU . 15.2 mm100 -73.84 -46.12 47.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.808 HD21 ' HA ' ' A' ' 58' ' ' GLN . 3.7 pp -68.0 -34.98 77.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 109.267 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.649 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -52.67 -35.6 55.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.67 ' O ' HG12 ' A' ' 67' ' ' ILE . 15.2 mt -70.92 -50.83 30.52 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.005 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 28.3 mm-40 -65.0 -41.84 95.02 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.37 -1.456 . . . . 0.0 109.397 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.22 -46.33 64.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.896 -1.127 . . . . 0.0 110.326 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 52.9 mm-40 -70.05 -39.75 75.52 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.891 -1.131 . . . . 0.0 110.106 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 63' ' ' LEU . 18.9 mm -77.54 -41.55 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.319 -0.863 . . . . 0.0 111.562 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.056 HG23 ' OE1' ' A' ' 25' ' ' GLU . 24.0 mt -70.74 -49.7 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.53 -1.356 . . . . 0.0 110.047 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 2.7 mt-30 -58.74 -34.09 70.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.243 -0.91 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' NH1' ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -56.49 -47.63 78.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.84 -1.162 . . . . 0.0 109.868 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -71.93 -48.46 45.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 110.654 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.699 HD12 HG22 ' A' ' 68' ' ' ILE . 93.1 mt -58.2 -43.9 87.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 111.472 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.08 -44.26 69.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.163 -0.96 . . . . 0.0 109.468 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -59.67 -37.07 77.76 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.588 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -75.14 -26.18 58.97 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.644 -0.66 . . . . 0.0 110.117 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 14' ' ' MET . . . 109.92 -0.51 30.19 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -90.62 127.58 36.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.253 -1.145 . . . . 0.0 110.13 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.31 147.65 44.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 110.596 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.6 t -86.31 125.81 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -9.82 59.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.357 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 79' ' ' VAL 0.251 0.0 OUTLIER -133.58 150.0 51.63 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.615 -0.678 . . . . 0.0 110.776 -179.022 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.68 107.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.856 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -128.4 106.86 9.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.996 -1.065 . . . . 0.0 111.118 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -100.22 90.23 4.28 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mt -111.79 177.99 4.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.959 . . . . 0.0 110.191 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.549 ' HA3' ' HB2' ' A' ' 7' ' ' PHE . . . 76.01 137.08 0.66 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.652 ' C ' HD12 ' A' ' 87' ' ' LEU . 2.5 pp 179.8 41.92 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.552 -0.969 . . . . 0.0 109.315 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -82.17 176.11 9.76 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.723 -0.611 . . . . 0.0 110.257 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -128.7 99.62 5.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 110.32 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -120.34 92.9 3.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.046 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.24 175.78 8.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.847 . . . . 0.0 110.198 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -90.81 154.46 45.59 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.038 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.84 54.79 2.64 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.002 1.527 . . . . 0.0 110.672 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.681 HD13 ' C ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -125.28 121.99 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.892 . . . . 0.0 110.424 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.676 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -43.63 -70.13 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.469 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' C ' HD12 ' A' ' 94' ' ' ILE . 6.9 ttpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.287 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' GLN . 4.8 tmm? . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.221 0.534 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.596 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 13.9 t0 -73.58 -43.53 6.92 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.007 . . . . 0.0 110.466 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.2 Cg_endo -82.18 10.12 3.68 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.61 1.321 . . . . 0.0 110.193 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -170.73 -160.35 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.632 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.873 ' C ' HD21 ' A' ' 56' ' ' LEU . . . -120.42 43.15 1.59 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.749 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -62.94 98.71 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -1.23 . . . . 0.0 110.262 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.626 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -146.15 34.51 0.99 Allowed 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.27 -0.894 . . . . 0.0 109.831 179.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 ' CD1' ' A' ' 52' ' ' LEU . 2.9 mm? -103.47 126.19 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.395 -0.815 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.57 ' CE2' ' ND2' ' A' ' 49' ' ' ASN . 1.6 t90 -124.15 130.94 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.178 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -126.24 134.87 51.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.208 -0.932 . . . . 0.0 110.744 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.811 ' O ' HG13 ' A' ' 79' ' ' VAL . 54.8 tt0 -123.02 159.05 29.2 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.2 m -138.56 -176.74 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 110.643 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 5.0 tt0 -140.72 54.28 1.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 110.249 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.788 ' CE ' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -130.43 161.17 62.2 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.168 -0.958 . . . . 0.0 110.347 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -75.44 -178.42 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.934 1.492 . . . . 0.0 113.009 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -67.6 -24.6 65.5 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.409 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -59.72 -45.53 91.87 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.718 -0.614 . . . . 0.0 111.5 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.546 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 1.1 ptp180 -89.71 -10.22 46.54 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 111.466 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 22' ' ' LEU . 18.2 t -45.16 -36.16 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.115 -0.991 . . . . 0.0 110.42 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -51.53 -26.86 9.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 33.0 t0 -58.84 -45.76 89.29 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.498 -0.751 . . . . 0.0 110.046 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.788 HD11 ' CE ' ' A' ' 14' ' ' MET . 1.3 mp -57.92 -41.52 82.9 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.41 63.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.15 -0.969 . . . . 0.0 109.587 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -60.73 -46.77 89.14 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 2.7 tm-20 -60.98 -48.89 79.75 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 109.946 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.552 HD22 HG21 ' A' ' 35' ' ' VAL . 41.4 mt -54.28 -37.57 64.9 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.357 0.599 . . . . 0.0 110.268 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.609 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.063 -1.023 . . . . 0.0 110.357 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.609 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 7.7 mt -59.49 -44.77 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 121.013 -1.054 . . . . 0.0 110.374 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.72 65.46 5.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -53.95 -24.54 16.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.815 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -57.99 -13.12 4.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 110.16 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.77 HG23 HD11 ' A' ' 50' ' ' ILE . 1.8 p -78.54 126.65 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.147 -0.971 . . . . 0.0 110.1 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HG2' ' HB2' ' A' ' 34' ' ' ARG . 26.9 ttt180 -79.69 -44.95 19.89 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -151.71 122.97 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.733 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 50' ' ' ILE . 11.5 p -132.6 136.02 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.2 122.63 20.7 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.104 -0.997 . . . . 0.0 110.688 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.38 130.55 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 0.0 110.149 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.443 HG23 ' OE1' ' A' ' 47' ' ' GLU . 13.6 m -115.87 146.22 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.538 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.551 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.41 154.17 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.556 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -74.17 -170.22 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.3 p -103.31 -2.05 27.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 110.994 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -144.84 -67.15 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.0 110.616 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.0 Cg_endo -72.56 -168.29 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.353 1.186 . . . . 0.0 110.705 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -108.02 35.32 5.06 Favored Glycine 0 N--CA 1.479 1.5 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.3 mtp-105 -93.54 134.87 35.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.54 -0.977 . . . . 0.0 110.139 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 9.5 m-85 -119.31 154.3 33.74 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.876 0.846 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 38' ' ' VAL . 3.4 mt-10 -103.93 99.04 8.79 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 10' ' ' TYR . 47.0 t -79.15 124.41 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.773 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.57 ' ND2' ' CE2' ' A' ' 9' ' ' TRP . 34.4 m120 -131.29 100.92 5.35 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.77 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -119.19 138.91 48.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.515 -0.74 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 6' ' ' TYR . 4.0 p -96.59 151.14 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 109.324 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.028 ' HB2' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -114.11 173.91 6.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 111.503 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 65.2 m-80 -58.45 167.11 1.87 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.67 -0.644 . . . . 0.0 109.693 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.67 -15.17 44.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.6 1.316 . . . . 0.0 110.78 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -125.93 66.15 1.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.063 -1.023 . . . . 0.0 110.148 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.028 HD23 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -91.46 177.23 6.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.962 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' HA ' HD21 ' A' ' 87' ' ' LEU . 6.0 t70 -177.08 171.89 2.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.977 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.7 mt-30 -60.23 -33.23 71.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.597 -0.69 . . . . 0.0 110.037 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -65.04 -45.01 87.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 8.5 mm-40 -64.46 -44.32 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.855 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.847 HD23 ' OE1' ' A' ' 64' ' ' GLU . 74.3 mt -64.82 -37.32 87.22 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.729 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.46 55.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.864 -1.148 . . . . 0.0 108.065 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 63' ' ' LEU 0.256 0.1 OUTLIER -70.49 -51.28 30.03 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.666 0.746 . . . . 0.0 108.987 178.564 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.847 ' OE1' HD23 ' A' ' 61' ' ' LEU . 3.7 pt-20 -66.94 -43.16 83.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.316 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.38 -41.45 93.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.327 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -34.71 73.71 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.608 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -75.25 -50.41 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.679 HG22 HD12 ' A' ' 72' ' ' LEU . 17.8 mt -59.71 -46.71 93.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 43.5 mt-30 -61.04 -47.28 87.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 109.749 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.68 -47.22 85.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 0.0 110.772 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB3' ' CG ' ' A' ' 25' ' ' GLU . . . -69.91 -48.81 57.14 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.975 -1.078 . . . . 0.0 110.307 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.679 HD12 HG22 ' A' ' 68' ' ' ILE . 44.4 mt -64.06 -35.07 79.54 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.38 -0.825 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 2.1 mm-40 -69.37 -45.24 69.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.53 -0.731 . . . . 0.0 109.176 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -62.6 -39.19 92.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.23 -37.34 61.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.267 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 115.52 20.8 5.32 Favored Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . . . -95.22 123.4 38.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.241 . . . . 0.0 110.123 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.12 134.11 55.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.2 t -89.73 123.13 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.41 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -81.78 -10.75 59.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.526 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.61 140.6 52.0 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.425 -0.797 . . . . 0.0 110.9 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -140.86 105.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 109.939 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' HG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -130.12 107.42 9.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 0.0 110.462 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.826 ' C ' HD23 ' A' ' 85' ' ' LEU . 39.2 mt-10 -100.3 90.89 4.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.997 -1.065 . . . . 0.0 110.389 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.826 HD23 ' C ' ' A' ' 84' ' ' GLU . 5.0 mt -116.7 178.77 4.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 109.928 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 7' ' ' PHE . . . 90.6 143.08 10.51 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.592 HD21 ' HA ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER 179.84 46.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.462 -1.022 . . . . 0.0 109.511 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -84.09 170.02 14.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.552 -0.717 . . . . 0.0 111.071 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mtp-105 -144.62 39.81 1.28 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.942 0.877 . . . . 0.0 109.582 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.46 115.05 27.57 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.267 0.556 . . . . 0.0 110.446 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . . . -155.97 52.74 0.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 109.986 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -92.39 160.41 34.99 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 110.411 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.12 166.84 28.92 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.009 1.531 . . . . 0.0 110.261 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 84.6 mt -91.25 129.97 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.93 9.12 7.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.899 . . . . 0.0 110.028 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.1 tptp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.224 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.163 0.506 . . . . 0.0 110.197 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.637 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.9 t70 -77.49 -38.14 1.76 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.493 -0.755 . . . . 0.0 111.715 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 52.8 Cg_endo -90.15 11.71 2.69 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.412 1.217 . . . . 0.0 109.142 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.566 ' HG3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -58.27 -139.6 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.426 0.632 . . . . 0.0 111.086 -179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.549 ' HA3' ' HB2' ' A' ' 56' ' ' LEU . . . -34.95 -27.01 0.01 OUTLIER Glycine 0 N--CA 1.494 2.503 0 O-C-N 121.744 -0.598 . . . . 0.0 111.834 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.781 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -61.22 97.16 0.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.288 -1.713 . . . . 0.0 109.674 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -167.96 42.57 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.736 179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 84' ' ' GLU . 12.8 mt -104.08 132.44 50.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.447 -0.783 . . . . 0.0 110.436 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -124.12 118.37 26.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.956 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.503 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 25.6 m-85 -126.93 134.66 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.493 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.639 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.7 tt0 -117.44 158.29 24.74 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 17.2 m -134.29 -177.43 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.97 -1.081 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -134.51 51.07 2.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.668 ' HE1' ' HB2' ' A' ' 77' ' ' ALA . 1.5 ptp -130.22 152.74 80.66 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.423 -0.798 . . . . 0.0 109.74 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -70.73 -165.69 0.19 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.755 1.397 . . . . 0.0 113.202 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.871 ' O ' HG23 ' A' ' 19' ' ' VAL . 19.6 tt0 -52.1 -24.83 7.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.865 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.426 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 12.0 t70 -56.78 -23.76 45.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.044 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' CZ ' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -70.04 -14.1 62.53 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.386 -0.821 . . . . 0.0 110.83 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 16' ' ' GLU . 98.0 t -51.82 -48.79 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.144 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -59.24 -30.9 68.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.812 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 27.1 t0 -68.21 -54.91 14.45 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.5 mm? -62.63 -36.88 84.2 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.967 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -62.73 -52.41 63.34 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.619 -0.676 . . . . 0.0 109.851 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.8 tpp85 -69.84 -41.4 74.94 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.007 -1.058 . . . . 0.0 109.447 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -56.29 -48.82 75.88 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.525 -0.734 . . . . 0.0 110.6 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.725 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -66.52 -37.04 84.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 110.411 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.458 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.28 -40.15 93.07 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.174 -0.954 . . . . 0.0 110.903 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.737 ' CG2' HG23 ' A' ' 67' ' ' ILE . 87.1 mt -61.13 -44.13 97.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.002 -1.061 . . . . 0.0 110.994 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.822 ' NH2' HG21 ' A' ' 35' ' ' VAL . 13.7 ptt180 -84.88 68.39 10.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.803 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -56.05 -27.3 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 109.875 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -59.09 -14.1 8.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' HD11 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -80.13 128.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.948 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -79.32 -45.69 19.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 111.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.71 123.8 7.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.607 -1.308 . . . . 0.0 111.915 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.822 HG21 ' NH2' ' A' ' 29' ' ' ARG . 5.9 p -126.0 133.98 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.549 -0.719 . . . . 0.0 109.358 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.3 mtp -128.74 114.84 17.1 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.933 -1.104 . . . . 0.0 110.84 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.51 131.63 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG2' ' CG ' ' A' ' 47' ' ' GLU . 3.5 m -119.79 152.9 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -83.82 153.65 23.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.87 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -166.47 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.365 -0.834 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -104.94 0.27 27.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 0.0 111.161 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m -148.83 -65.88 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.865 -1.147 . . . . 0.0 110.801 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 47.2 Cg_endo -71.72 -169.13 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.214 1.113 . . . . 0.0 110.577 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -108.74 32.17 7.16 Favored Glycine 0 N--CA 1.477 1.371 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.528 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 6.2 ptm180 -93.9 160.43 14.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.923 -1.34 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 35.1 m-85 -138.28 155.44 48.6 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.888 0.851 . . . . 0.0 111.059 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.543 ' CG ' ' CG2' ' A' ' 38' ' ' VAL . 2.9 pt-20 -100.71 96.07 7.08 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.1 t -78.15 116.47 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 111.484 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -131.58 100.74 5.24 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.817 ' HB ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -123.69 140.25 47.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.591 -0.693 . . . . 0.0 110.603 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.781 HG23 ' HB2' ' A' ' 6' ' ' TYR . 5.3 p -100.13 144.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.882 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.017 ' HB2' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -122.87 -166.54 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 110.9 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 52' ' ' LEU . 40.3 m-80 -39.46 159.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.725 -0.609 . . . . 0.0 110.774 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 39.7 Cg_endo -65.17 -15.52 50.63 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.126 1.593 . . . . 0.0 111.289 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -140.11 73.11 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.813 -1.179 . . . . 0.0 111.162 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LEU . 13.0 mt -66.32 -164.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.853 -1.155 . . . . 0.0 110.354 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.9 t70 177.92 172.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.522 -0.736 . . . . 0.0 109.721 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.412 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.4 mm-40 -62.58 -34.89 77.88 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -71.29 -28.78 64.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.341 -0.85 . . . . 0.0 110.575 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -73.82 -39.99 63.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.065 -1.022 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 35.2 mt -66.32 -37.07 84.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.112 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.62 -38.07 59.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.636 ' C ' HD12 ' A' ' 63' ' ' LEU 0.259 0.2 OUTLIER -71.93 -51.42 22.2 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.893 0.854 . . . . 0.0 108.81 178.013 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 68' ' ' ILE . 60.7 mm-40 -61.9 -38.5 88.59 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 -47.22 78.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.207 -0.933 . . . . 0.0 111.308 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 6.3 pt-20 -62.88 -27.21 69.2 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 120.573 -1.329 . . . . 0.0 109.261 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.737 HG23 ' CG2' ' A' ' 28' ' ' ILE . 2.8 mm -76.81 -55.77 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.627 -0.67 . . . . 0.0 110.061 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 72' ' ' LEU . 8.8 mt -62.27 -42.69 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.339 -0.85 . . . . 0.0 109.891 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 38.2 mm-40 -63.12 -40.82 98.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -57.97 -47.3 83.37 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.237 -0.914 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.69 -48.45 59.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.147 -0.971 . . . . 0.0 109.81 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 68' ' ' ILE . 83.1 mt -64.01 -36.19 83.16 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.458 -0.776 . . . . 0.0 110.108 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 6.7 mm-40 -70.49 -45.89 64.8 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.552 -0.717 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -61.82 -38.71 89.17 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -75.65 -17.9 59.83 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.92 51.9 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.668 ' HB2' ' HE1' ' A' ' 14' ' ' MET . . . -87.63 129.2 35.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.147 -1.208 . . . . 0.0 110.055 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 119.6 34.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 110.342 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.7 t -77.19 120.77 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 109.932 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.19 -8.79 59.66 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HD2' ' HA ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -130.0 134.27 47.31 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.402 -0.811 . . . . 0.0 110.482 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 82' ' ' VAL . 9.9 p -141.07 107.68 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.812 -1.18 . . . . 0.0 110.651 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -127.96 106.94 9.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.164 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 8' ' ' LEU . 3.4 mt-10 -100.25 110.09 22.32 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.266 -0.896 . . . . 0.0 110.546 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 85' ' ' LEU . 3.7 mm? -75.55 -16.37 60.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 110.044 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . 61.41 -172.09 7.89 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 tp -55.44 79.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.657 -0.908 . . . . 0.0 111.036 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 86' ' ' GLY . 19.1 tpt180 -80.52 157.13 26.21 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.185 -0.947 . . . . 0.0 110.022 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 2.5 ptm180 -127.78 116.14 19.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.091 -1.006 . . . . 0.0 110.168 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 90' ' ' LEU . 2.4 tp -71.91 104.5 3.51 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.247 -0.908 . . . . 0.0 110.021 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -168.69 -39.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 109.914 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -105.79 162.33 20.06 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 109.989 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.45 176.54 8.56 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.906 1.477 . . . . 0.0 110.551 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.703 HD13 ' C ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.08 119.52 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.181 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.629 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -159.65 56.99 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 0.0 110.19 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.2 tptt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.269 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.223 0.535 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.596 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 10.9 t70 -58.48 -49.75 91.83 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.902 . . . . 0.0 110.763 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 2' ' ' ASP . 44.3 Cg_endo -69.87 60.09 1.72 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 N-CA-C 109.221 -1.107 . . . . 0.0 109.221 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.551 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 3.4 pm0 -13.52 -53.52 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 3' ' ' PRO . . . -172.98 32.27 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 118.191 -1.957 . . . . 0.0 112.04 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.019 ' CZ ' HD12 ' A' ' 52' ' ' LEU . 3.4 t80 -86.49 118.05 25.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.214 -1.756 . . . . 0.0 109.504 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 6' ' ' TYR . 15.9 m-85 -163.21 64.5 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.203 -0.936 . . . . 0.0 110.489 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 8' ' ' LEU . 1.7 mm? -84.67 138.99 32.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.237 -0.915 . . . . 0.0 109.915 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.418 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -108.75 118.96 38.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 0.0 110.585 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 48' ' ' VAL . 28.6 m-85 -127.23 115.45 19.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.161 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.919 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.1 tt0 -95.35 160.37 14.57 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.183 -0.948 . . . . 0.0 110.402 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 46' ' ' TYR . 30.7 m -130.41 179.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.517 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -135.55 53.0 1.98 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.414 -0.804 . . . . 0.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.662 ' SD ' ' HB2' ' A' ' 77' ' ' ALA . 4.2 ptt? -133.33 153.32 80.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.91 -163.96 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.13 1.595 . . . . 0.0 112.417 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.925 ' O ' HG23 ' A' ' 19' ' ' VAL . 3.9 tm-20 -50.27 -26.75 5.09 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.98 -17.33 16.53 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.772 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.556 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.76 -13.85 47.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 16' ' ' GLU . 93.3 t -53.1 -42.92 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.48 -0.763 . . . . 0.0 110.239 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.45 -34.98 76.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.946 . . . . 0.0 109.826 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.728 ' OD2' ' HB3' ' A' ' 77' ' ' ALA . 9.2 t0 -70.71 -54.43 11.82 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.647 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.2 mm? -64.17 -36.25 83.45 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 19' ' ' VAL . . . -60.5 -52.75 63.86 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.356 -0.84 . . . . 0.0 109.286 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 28' ' ' ILE . 5.6 mtt180 -70.08 -46.71 64.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 2.7 tm-20 -56.33 -45.73 80.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.808 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 35' ' ' VAL . 74.1 mt -62.81 -38.65 91.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.862 . . . . 0.0 110.302 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -45.66 93.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.819 ' CG2' HG23 ' A' ' 67' ' ' ILE . 13.4 mt -65.18 -42.96 95.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.769 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -70.43 55.22 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 110.67 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 15.4 p-10 -72.14 -30.07 64.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -61.24 -12.9 14.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.59 -0.694 . . . . 0.0 109.978 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 29' ' ' ARG . 3.9 p -79.09 137.55 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.361 -0.837 . . . . 0.0 110.437 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -42.68 25.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 110.813 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -148.06 122.71 9.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.043 -1.035 . . . . 0.0 111.06 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.875 HG12 HG13 ' A' ' 50' ' ' ILE . 22.5 m -117.67 135.16 58.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.328 -0.858 . . . . 0.0 110.423 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.66 116.12 10.09 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 22' ' ' LEU . 57.4 t -111.27 131.92 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.38 152.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.558 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.03 154.6 21.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.195 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -73.19 172.77 10.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.74 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.479 ' H ' HG22 ' A' ' 41' ' ' THR . 5.3 t -89.73 1.08 56.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.937 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.564 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.67 -64.61 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.028 -1.045 . . . . 0.0 110.48 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.9 Cg_endo -70.84 -159.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.532 1.28 . . . . 0.0 110.77 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.16 36.53 4.16 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 5.7 mtt180 -93.13 135.19 34.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.53 -0.982 . . . . 0.0 110.397 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.588 ' H ' HG22 ' A' ' 12' ' ' VAL . 25.5 m-85 -119.76 154.86 33.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.353 -0.842 . . . . 0.0 110.397 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -102.99 116.53 32.71 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -94.47 112.21 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 110.515 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.583 ' O ' HD12 ' A' ' 50' ' ' ILE . 64.3 m-80 -131.04 100.7 5.32 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.875 HG13 HG12 ' A' ' 35' ' ' VAL . 1.1 mp -115.28 140.04 38.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 121.738 0.78 . . . . 0.0 111.24 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.583 HG13 ' HB3' ' A' ' 3' ' ' PRO . 0.9 OUTLIER -101.61 149.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.019 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 6.3 mt -118.7 -170.23 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.627 -1.296 . . . . 0.0 112.062 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.8 m120 -42.34 170.74 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.635 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 36.3 Cg_endo -59.66 -12.72 18.73 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.648 1.341 . . . . 0.0 111.04 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.496 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 20.9 t30 -142.11 87.43 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.087 . . . . 0.0 110.436 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -60.74 -178.09 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.744 -1.222 . . . . 0.0 109.942 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.669 ' O ' HD12 ' A' ' 61' ' ' LEU . 12.4 t70 -175.24 171.67 2.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.047 . . . . 0.0 110.764 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.432 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 65.8 mt-30 -61.71 -40.55 95.42 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.549 -0.719 . . . . 0.0 110.514 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -29.57 68.81 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.222 -0.924 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.52 -45.11 69.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 110.158 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -66.19 -34.37 77.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.98 -38.8 62.55 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 67' ' ' ILE . 40.9 mt -71.64 -51.01 25.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' O ' HD12 ' A' ' 68' ' ' ILE . 3.5 mt-10 -60.06 -40.9 91.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.887 -1.133 . . . . 0.0 110.061 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -72.66 -46.46 53.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.045 -1.034 . . . . 0.0 109.634 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 6.8 mm-40 -69.58 -38.86 77.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 110.016 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.819 HG23 ' CG2' ' A' ' 28' ' ' ILE . 16.0 mm -76.43 -38.17 31.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.296 -0.878 . . . . 0.0 111.257 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 64' ' ' GLU . 57.7 mt -69.53 -48.28 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.778 -1.201 . . . . 0.0 110.053 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 4.9 pt20 -61.52 -38.86 88.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.184 -0.948 . . . . 0.0 110.02 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.17 -45.98 86.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.14 -0.975 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.3 59.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.081 -1.012 . . . . 0.0 110.836 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.518 HD23 ' CG ' ' A' ' 21' ' ' ASP . 79.2 mt -58.76 -43.03 90.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.267 -0.896 . . . . 0.0 110.661 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.44 -45.4 62.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 0.0 109.622 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.429 ' ND2' ' HD3' ' A' ' 70' ' ' ARG . 62.8 m-20 -62.61 -36.89 84.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.35 -35.29 58.78 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.312 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.29 18.28 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.728 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . . . -109.66 136.87 48.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.29 . . . . 0.0 110.224 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' NH1' ' HG2' ' A' ' 73' ' ' GLU . 2.1 tpt180 -119.69 133.53 55.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 110.326 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 11' ' ' GLN . 4.6 t -75.73 124.87 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.011 -1.055 . . . . 0.0 109.533 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.76 -8.0 59.62 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.73 156.31 47.27 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.501 -0.749 . . . . 0.0 111.608 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 82' ' ' VAL . 7.1 p -141.56 106.62 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.437 -0.789 . . . . 0.0 109.416 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.67 108.84 10.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.078 -1.014 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.664 ' HA ' HD12 ' A' ' 8' ' ' LEU . 16.4 tt0 -99.02 89.87 4.42 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.187 -0.945 . . . . 0.0 109.858 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -112.61 177.39 4.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.2 -0.937 . . . . 0.0 109.794 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.619 ' O ' HD22 ' A' ' 87' ' ' LEU . . . 62.13 119.24 0.01 OUTLIER Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.619 HD22 ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -168.49 66.09 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.502 -0.999 . . . . 0.0 109.137 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.499 ' O ' HD11 ' A' ' 56' ' ' LEU . 12.2 mmt180 -117.04 -178.89 3.54 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.429 -0.794 . . . . 0.0 110.659 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 5.8 mtt180 -146.8 113.6 6.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.887 . . . . 0.0 110.408 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.03 127.97 31.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 109.88 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.09 -67.07 0.05 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 110.591 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . 19.0 m-85 -108.12 167.32 9.45 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.128 -0.983 . . . . 0.0 110.471 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 92' ' ' TYR . 46.9 Cg_endo -74.16 93.51 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.046 1.551 . . . . 0.0 110.276 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -106.92 123.67 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.104 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.606 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -163.8 157.54 19.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.176 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.201 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 20.0 mtp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.119 0.485 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.639 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 24.5 t0 -58.24 -37.66 57.54 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 111.012 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 51.2 Cg_endo -88.9 18.09 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.415 1.218 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 88' ' ' ARG . 14.2 mt-30 -118.76 -155.42 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.854 . . . . 0.0 110.621 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.804 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -74.17 8.74 11.44 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.112 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.697 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -70.39 98.86 1.48 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.593 -1.534 . . . . 0.0 109.656 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.95 ' O ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -163.61 59.08 0.17 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.118 -0.989 . . . . 0.0 110.029 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.027 HD11 HD11 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -138.41 131.86 30.5 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.344 -0.847 . . . . 0.0 109.78 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.541 ' CE2' ' ND2' ' A' ' 49' ' ' ASN . 1.2 t90 -126.81 127.44 45.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 28.9 m-85 -126.24 115.08 19.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.852 ' O ' HG13 ' A' ' 79' ' ' VAL . 4.4 tt0 -107.5 149.23 28.2 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.544 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.6 m -126.75 -176.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 111.026 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 1.9 tt0 -146.72 59.91 1.2 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.343 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.535 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.75 148.69 66.04 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 37.3 Cg_endo -71.78 -165.82 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.135 1.597 . . . . 0.0 113.573 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.822 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -62.98 -23.06 67.26 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.039 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.69 -48.15 67.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.738 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.5 OUTLIER -90.86 -14.22 32.2 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.116 -0.99 . . . . 0.0 111.219 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 16' ' ' GLU . 14.5 p -45.88 -37.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.261 -0.899 . . . . 0.0 109.784 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.575 ' N ' HG13 ' A' ' 19' ' ' VAL . 62.1 m-80 -53.32 -28.31 27.78 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.474 -0.767 . . . . 0.0 109.304 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 28.7 t0 -58.36 -32.5 68.61 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.545 -0.722 . . . . 0.0 110.129 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.61 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.3 mm? -59.0 -37.32 76.6 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.17 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -58.54 -51.22 70.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.28 -46.95 65.97 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.18 -0.95 . . . . 0.0 110.089 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' CD ' HD11 ' A' ' 72' ' ' LEU . 2.6 tt0 -56.32 -48.38 76.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.725 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -67.22 -37.22 83.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.854 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.36 -38.78 78.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.737 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.669 HD13 HG22 ' A' ' 67' ' ' ILE . 9.5 mt -59.06 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.148 -0.97 . . . . 0.0 110.703 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 13.1 ptm180 -74.4 56.53 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.12 -25.47 62.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.0 110.296 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -58.66 -17.18 20.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.88 162.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -0.824 . . . . 0.0 109.965 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -44.18 22.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.976 . . . . 0.0 111.945 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.82 146.58 26.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.741 -1.224 . . . . 0.0 111.655 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.637 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 6.9 t -132.32 127.48 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 tpt -140.41 115.55 9.83 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.488 -0.758 . . . . 0.0 109.69 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 88.9 t -114.81 131.9 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.0 110.981 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.65 HG22 ' HB2' ' A' ' 47' ' ' GLU . 7.8 m -101.97 140.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 110.035 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -81.46 153.07 27.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.19 152.73 39.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.848 . . . . 0.0 110.014 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.2 p -75.34 -11.56 60.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -0.926 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -141.41 -67.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.117 -0.99 . . . . 0.0 110.496 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.3 Cg_endo -70.68 -176.11 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.323 1.17 . . . . 0.0 110.562 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 33.29 6.65 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.9 mtt180 -93.2 135.44 34.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.008 . . . . 0.0 110.021 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 30.0 m-85 -117.93 154.93 31.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.296 -0.878 . . . . 0.0 110.568 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.65 ' HB2' HG22 ' A' ' 38' ' ' VAL . 33.9 mt-10 -103.5 95.08 5.83 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.748 -0.595 . . . . 0.0 109.683 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 10' ' ' TYR . 89.4 t -78.77 115.13 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.553 ' O ' HD12 ' A' ' 50' ' ' ILE . 32.1 m120 -131.65 102.0 5.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.035 HG21 HG21 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -111.82 142.26 24.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.749 0.785 . . . . 0.0 110.691 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 6' ' ' TYR . 7.8 p -92.32 133.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.415 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.027 HD11 HD11 ' A' ' 8' ' ' LEU . 30.5 mt -90.04 174.37 7.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 0.0 110.549 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.96 ' OD1' HD11 ' A' ' 56' ' ' LEU . 2.1 m120 -62.24 -153.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.697 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.74 -35.4 28.16 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 CA-C-N 119.122 0.722 . . . . 0.0 111.439 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.48 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 8.1 t30 -162.87 76.25 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.802 -1.186 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.96 HD11 ' OD1' ' A' ' 53' ' ' ASN . 16.8 mt -74.7 -161.04 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 110.419 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 1.004 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.1 t0 -171.92 -164.09 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.496 -0.752 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.457 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 2.4 mm-40 -64.77 -32.87 74.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.557 -0.715 . . . . 0.0 111.177 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -35.06 78.74 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.4 mm-40 -73.72 -42.9 60.54 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.414 -0.804 . . . . 0.0 109.954 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.004 HD12 ' O ' ' A' ' 57' ' ' ASP . 1.2 mt -64.87 -34.46 78.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.39 -33.65 44.48 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.562 ' O ' HG13 ' A' ' 67' ' ' ILE . 18.3 mt -64.38 -51.05 65.23 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.461 -0.895 . . . . 0.0 108.618 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 2.5 mt-10 -72.19 -43.09 65.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.232 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -62.51 -34.86 77.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.533 -0.729 . . . . 0.0 110.443 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.7 -48.9 70.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.826 -1.171 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.669 HG22 HD13 ' A' ' 28' ' ' ILE . 4.3 mt -78.98 -41.17 23.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.493 -0.754 . . . . 0.0 111.155 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 40.9 mt -59.01 -49.5 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.049 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.8 mt-30 -58.61 -48.91 79.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.393 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -66.15 -47.21 74.79 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 110.877 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -65.01 -48.25 74.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.907 -1.121 . . . . 0.0 110.182 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.48 HD12 ' CG2' ' A' ' 68' ' ' ILE . 32.8 mt -65.57 -35.33 80.52 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 110.026 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 1.0 OUTLIER -70.34 -45.31 66.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.44 -0.788 . . . . 0.0 109.487 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -63.16 -36.31 83.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.57 -38.9 62.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.562 -0.712 . . . . 0.0 110.604 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.3 21.65 5.12 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.13 123.76 46.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -1.221 . . . . 0.0 109.797 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -119.77 122.41 41.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 110.581 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.3 t -81.34 128.99 38.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.079 -1.013 . . . . 0.0 109.59 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.34 -17.68 48.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 108.467 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 10' ' ' TYR 0.255 0.0 OUTLIER -128.78 129.42 45.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.806 -0.559 . . . . 0.0 110.171 -179.533 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 t -141.86 106.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.677 -1.264 . . . . 0.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.95 106.8 8.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 110.055 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.633 ' HB2' HD13 ' A' ' 61' ' ' LEU . 1.4 pt-20 -100.46 90.57 4.34 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.791 HD12 ' N ' ' A' ' 85' ' ' LEU . 5.8 mp -97.1 -83.97 0.38 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.21 -0.931 . . . . 0.0 109.888 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 5' ' ' GLY . . . 47.05 100.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -170.07 47.38 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.256 -1.143 . . . . 0.0 109.966 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 12.7 ttt180 -115.16 159.92 20.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.461 -0.774 . . . . 0.0 110.371 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.48 ' HG2' ' HB2' ' A' ' 55' ' ' ASN . 12.6 mtm180 -143.45 110.05 5.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 0.0 110.517 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 3' ' ' PRO . 18.0 tp -178.97 81.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.354 -0.841 . . . . 0.0 110.161 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.49 -167.09 2.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -72.13 140.41 82.89 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 110.145 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.67 92.75 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.078 1.567 . . . . 0.0 110.441 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 96' ' ' LYS . 8.1 mm -101.14 118.55 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 109.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.6 -11.25 43.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.32 -0.862 . . . . 0.0 110.141 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 94' ' ' ILE . 2.3 tttt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.245 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' O ' ' O ' ' A' ' 4' ' ' GLN . 23.7 mtt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.194 0.521 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.647 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 49.9 t0 -74.5 -36.7 2.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.023 -1.048 . . . . 0.0 111.393 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.9 Cg_endo -91.15 13.65 2.08 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.329 1.173 . . . . 0.0 109.674 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 24.9 pt20 -175.16 156.17 2.06 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.317 -0.864 . . . . 0.0 110.464 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.831 ' O ' HD23 ' A' ' 56' ' ' LEU . . . 84.61 -57.67 5.01 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.886 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -63.61 98.94 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.711 -1.464 . . . . 0.0 111.073 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.88 ' O ' HD23 ' A' ' 8' ' ' LEU . 26.2 t80 -153.33 36.34 0.47 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.843 -1.16 . . . . 0.0 109.828 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.971 ' CD2' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -141.93 124.75 16.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.767 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.709 ' HB2' HD23 ' A' ' 85' ' ' LEU . 6.2 t90 -127.77 119.86 26.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.118 -0.989 . . . . 0.0 109.972 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.975 ' O ' HG22 ' A' ' 48' ' ' VAL . 76.9 m-85 -126.54 137.79 53.4 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.152 -0.968 . . . . 0.0 111.104 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.781 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.2 tp60 -120.43 160.66 22.65 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.348 -0.845 . . . . 0.0 109.228 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 21.0 m -130.57 -178.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.03 -1.044 . . . . 0.0 110.687 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.39 57.17 1.59 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.638 -0.664 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.582 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -135.35 155.28 78.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.42 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 37.2 Cg_endo -73.0 -167.79 0.37 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.925 1.487 . . . . 0.0 113.05 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.591 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 15.3 tt0 -66.09 -25.53 67.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.038 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 13.3 t0 -59.87 -40.71 89.55 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.364 0.602 . . . . 0.0 111.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.582 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.1 OUTLIER -88.95 -14.56 36.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.271 -0.893 . . . . 0.0 110.125 -179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.591 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 15.1 t -47.19 -37.47 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -29.36 22.05 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.612 ' OD2' HD23 ' A' ' 72' ' ' LEU . 33.1 t0 -59.87 -39.57 85.71 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.481 -0.762 . . . . 0.0 109.199 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.588 HD12 HG11 ' A' ' 37' ' ' VAL . 4.4 mm? -58.94 -42.75 90.54 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.92 -51.77 66.45 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -46.68 78.69 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.575 -0.703 . . . . 0.0 109.257 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.4 -48.53 76.72 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.43 -0.794 . . . . 0.0 109.306 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.713 HD21 ' CG2' ' A' ' 37' ' ' VAL . 89.4 mt -60.33 -39.53 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -70.24 -38.64 75.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.528 -0.732 . . . . 0.0 109.274 179.344 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 67' ' ' ILE . 1.2 mm -58.96 -37.77 69.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.827 0.822 . . . . 0.0 108.855 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.873 ' O ' HG12 ' A' ' 32' ' ' VAL . 10.5 mtp180 -69.68 64.05 0.19 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.75 -0.594 . . . . 0.0 110.228 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -37.52 70.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -65.32 -14.01 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 110.021 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.873 HG12 ' O ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -79.93 138.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.374 -0.829 . . . . 0.0 110.384 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.7 mmt-85 -79.25 -45.49 19.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.068 -1.02 . . . . 0.0 110.913 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.63 123.15 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.204 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 50' ' ' ILE . 2.8 p -130.12 133.61 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.517 -0.74 . . . . 0.0 109.605 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -128.04 118.25 23.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.124 -0.985 . . . . 0.0 110.75 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.115 HG13 HG12 ' A' ' 48' ' ' VAL . 19.4 t -115.06 131.98 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.616 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.494 HG23 ' OE2' ' A' ' 47' ' ' GLU . 4.1 m -121.28 159.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.59 154.17 22.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.401 -0.812 . . . . 0.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.36 176.74 5.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.292 -0.88 . . . . 0.0 109.57 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.4 p -93.34 -3.98 52.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 110.73 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -148.02 -67.77 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.023 -1.048 . . . . 0.0 110.467 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 49.7 Cg_endo -72.53 -168.94 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.303 1.159 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.8 32.88 6.84 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.0 mtt180 -94.26 134.88 36.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -1.068 . . . . 0.0 109.323 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.577 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 7.8 m-85 -116.81 150.18 38.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.871 -1.143 . . . . 0.0 111.427 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.494 ' OE2' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -106.41 90.53 3.37 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.166 178.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.115 HG12 HG13 ' A' ' 37' ' ' VAL . 22.0 m -82.42 125.28 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.549 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -122.51 101.62 7.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.801 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -111.96 142.38 24.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 121.561 0.696 . . . . 0.0 111.437 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.657 ' N ' HD13 ' A' ' 50' ' ' ILE . 7.3 p -108.61 119.94 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.685 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.6 mt -86.81 177.21 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.967 . . . . 0.0 110.581 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.521 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.2 m-80 -42.96 167.19 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.9 Cg_endo -63.84 -15.0 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.673 1.354 . . . . 0.0 110.24 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 24.2 t-20 -133.28 63.54 1.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.893 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 5' ' ' GLY . 3.1 pp -61.78 176.55 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.041 -1.037 . . . . 0.0 110.414 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 61' ' ' LEU . 2.5 m-20 -168.29 178.31 4.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 110.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.73 -36.32 83.25 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.537 -0.727 . . . . 0.0 110.461 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 t -69.29 -30.6 68.71 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.255 -0.903 . . . . 0.0 110.3 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 22.1 mm-40 -73.12 -45.91 54.22 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.971 HD21 ' CD2' ' A' ' 8' ' ' LEU . 1.6 mp -66.86 -36.14 81.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 109.366 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 66' ' ' GLU . . . -53.45 -33.87 55.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.552 ' O ' HG13 ' A' ' 67' ' ' ILE . 13.7 mt -69.46 -50.38 46.13 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.248 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.4 mm-40 -71.53 -42.75 67.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -65.55 -30.84 71.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.186 -0.946 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 2.0 mm-40 -69.43 -48.92 59.45 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.865 -1.147 . . . . 0.0 110.355 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.596 HG21 HG23 ' A' ' 28' ' ' ILE . 4.7 mt -78.6 -38.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.302 -0.873 . . . . 0.0 111.063 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 53.4 mt -60.37 -48.95 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.993 -1.067 . . . . 0.0 110.391 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 1.6 pp0? -63.55 -41.63 98.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.0 109.809 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.55 -46.52 66.25 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.37 -0.832 . . . . 0.0 110.388 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.88 83.39 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.08 -1.013 . . . . 0.0 109.777 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.612 HD23 ' OD2' ' A' ' 21' ' ' ASP . 97.3 mt -65.5 -35.46 80.95 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.8 OUTLIER -67.0 -45.27 78.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.457 -0.777 . . . . 0.0 109.005 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -61.12 -36.55 80.03 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -74.88 -41.87 58.94 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.74 -0.6 . . . . 0.0 110.327 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.45 23.35 4.47 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -112.54 125.23 54.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.262 -1.14 . . . . 0.0 109.762 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.47 148.91 42.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 110.757 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 11' ' ' GLN . 1.9 t -95.79 114.59 32.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 108.773 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -82.07 -5.47 58.42 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.774 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -138.41 150.32 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.274 -0.891 . . . . 0.0 111.736 -178.354 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 82' ' ' VAL . 3.0 p -141.56 107.15 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' TRP . 6.8 tp10 -128.6 122.48 31.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.125 -0.985 . . . . 0.0 111.062 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.572 ' O ' ' CE1' ' A' ' 7' ' ' PHE . 42.3 mt-10 -94.21 115.25 27.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 9' ' ' TRP . 2.8 pp -124.33 121.22 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.92 -1.112 . . . . 0.0 112.129 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA3' ' CZ ' ' A' ' 6' ' ' TYR . . . 98.76 45.83 2.21 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 88' ' ' ARG . 19.2 tp -45.91 165.78 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.282 -1.128 . . . . 0.0 109.516 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -79.02 121.07 24.49 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.962 -1.086 . . . . 0.0 110.477 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -157.89 28.59 0.27 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.013 . . . . 0.0 110.27 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.878 HD22 ' N ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -77.78 128.25 33.72 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.836 179.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.878 ' N ' HD22 ' A' ' 90' ' ' LEU . . . -122.52 -135.95 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 18.5 p90 -100.99 148.51 35.18 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 110.814 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.43 -90.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.012 1.533 . . . . 0.0 110.472 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 94' ' ' ILE . 1.8 tt -99.65 128.41 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.873 . . . . 0.0 110.265 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -165.89 -38.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 110.061 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.267 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.239 0.542 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.616 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 16.7 t70 -68.66 -40.31 17.75 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 111.199 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 53.8 Cg_endo -84.16 41.52 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.432 1.227 . . . . 0.0 110.334 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' C ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -23.65 140.9 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.213 0.53 . . . . 0.0 111.146 -179.197 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.702 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 85.46 -25.93 6.07 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.556 ' HB2' HG23 ' A' ' 51' ' ' VAL . 2.1 t80 -90.47 98.25 11.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.913 -1.345 . . . . 0.0 111.582 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.821 ' H ' HD22 ' A' ' 8' ' ' LEU . 4.4 p90 -149.94 31.55 0.7 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.169 -0.957 . . . . 0.0 109.734 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.821 HD22 ' H ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -119.52 125.06 47.95 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.227 -0.92 . . . . 0.0 111.245 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -126.58 116.55 21.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.848 ' CD2' HG21 ' A' ' 79' ' ' VAL . 1.4 m-85 -126.96 139.48 53.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 111.062 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.722 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.46 159.86 24.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 26.5 m -133.8 173.97 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.946 -1.096 . . . . 0.0 111.239 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.98 54.25 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.736 -0.603 . . . . 0.0 109.961 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.515 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 50.3 mmm -129.83 156.74 78.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.64 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.85 -167.02 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.825 1.434 . . . . 0.0 113.124 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.573 ' HA ' HG23 ' A' ' 19' ' ' VAL . 17.6 tp10 -63.79 -28.38 69.83 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.407 -1.269 . . . . 0.0 107.796 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -18.6 40.59 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.539 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.902 ' NH1' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -87.57 -23.71 24.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.593 -0.692 . . . . 0.0 110.095 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 16' ' ' GLU . 77.3 t -48.3 -42.71 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.469 -0.77 . . . . 0.0 110.309 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -58.92 -29.97 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.15 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.514 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.7 t0 -61.71 -50.84 70.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.144 -0.972 . . . . 0.0 109.964 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.644 HD11 HH11 ' A' ' 18' ' ' ARG . 8.3 mp -59.89 -43.11 94.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.666 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.5 79.64 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.229 -0.92 . . . . 0.0 109.656 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -68.73 -46.42 68.95 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.393 -0.817 . . . . 0.0 109.266 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.869 ' OE1' ' HB2' ' A' ' 71' ' ' ALA . 9.7 tp10 -60.38 -47.64 85.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.418 -0.801 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.928 HD22 HG11 ' A' ' 35' ' ' VAL . 29.6 mt -53.08 -38.66 62.73 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.579 0.704 . . . . 0.0 109.512 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 27' ' ' ARG . 4.4 tpt180 -64.11 -34.5 78.18 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 110.549 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.697 HD12 ' OE1' ' A' ' 25' ' ' GLU . 5.4 mt -62.12 -44.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.898 -1.126 . . . . 0.0 109.808 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.626 ' NH1' HD23 ' A' ' 26' ' ' LEU . 11.6 mtp180 -70.05 76.45 0.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.697 -0.627 . . . . 0.0 110.311 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.62 -36.61 84.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.251 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -61.75 -12.89 18.98 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.977 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.019 HG22 HD11 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -79.03 123.73 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.719 . . . . 0.0 110.141 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -47.32 15.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 112.186 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.539 ' CG ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -153.55 139.18 17.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.562 -1.336 . . . . 0.0 110.851 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.928 HG11 HD22 ' A' ' 26' ' ' LEU . 13.3 p -135.63 135.85 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.455 -0.778 . . . . 0.0 110.002 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.488 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 42.0 mtp -117.44 115.48 25.28 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.227 -0.921 . . . . 0.0 109.846 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.9 t -114.67 128.55 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 110.572 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 38' ' ' VAL . 4.8 m -115.09 134.41 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.14 153.72 23.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.534 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.1 m -73.86 150.64 40.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.885 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.2 p -76.5 3.0 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.589 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -148.99 -66.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -72.37 178.59 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.366 1.193 . . . . 0.0 110.541 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -101.31 33.01 6.82 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 4.8 mtt180 -93.78 134.74 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.439 -1.036 . . . . 0.0 110.275 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.549 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 34.4 m-85 -120.56 151.51 39.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -106.51 99.03 8.63 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.911 -0.493 . . . . 0.0 110.186 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' TYR . 16.9 m -86.53 122.17 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.01 -1.056 . . . . 0.0 110.686 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 36' ' ' MET . 2.4 p30 -131.16 102.71 6.12 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.19 140.76 30.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 O-C-N 121.433 -0.792 . . . . 0.0 111.552 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.681 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.4 p -114.87 150.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.92 ' HB2' HD11 ' A' ' 56' ' ' LEU . 2.3 mp -139.48 -157.41 0.76 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.769 -1.207 . . . . 0.0 111.928 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 52' ' ' LEU . 14.5 m120 -37.86 161.47 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.561 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 38.4 Cg_endo -64.67 -17.4 59.4 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.012 1.533 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -146.78 79.78 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.764 -1.21 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.92 HD11 ' HB2' ' A' ' 52' ' ' LEU . 16.2 mt -67.64 -164.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 110.586 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 3.3 t70 -177.08 171.6 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 110.68 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.1 mt-30 -54.63 -35.53 63.56 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.573 -0.704 . . . . 0.0 110.433 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 m -67.85 -40.6 83.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.177 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -70.77 -44.56 66.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.321 -0.862 . . . . 0.0 109.989 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 2.5 mm? -66.44 -34.83 78.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.91 -35.3 45.07 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.3 mt -72.12 -49.67 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.215 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 8.2 mt-10 -67.31 -35.88 80.34 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.533 -1.354 . . . . 0.0 109.915 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.24 -45.27 56.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 75.2 mt-10 -70.2 -38.5 75.34 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.096 -1.002 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 63' ' ' LEU . 43.9 mm -76.9 -38.75 29.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.329 -0.857 . . . . 0.0 111.192 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 62.4 mt -69.39 -46.88 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.884 -1.135 . . . . 0.0 110.125 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 20.0 mt-30 -59.71 -38.8 82.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.901 . . . . 0.0 110.165 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -44.66 91.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.196 -0.94 . . . . 0.0 110.894 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.869 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . . . -68.27 -48.64 64.51 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.997 -1.064 . . . . 0.0 110.522 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.902 HD23 ' NH1' ' A' ' 18' ' ' ARG . 20.3 mt -58.71 -39.93 82.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.39 -0.819 . . . . 0.0 110.547 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -71.2 -45.56 63.13 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.445 -0.784 . . . . 0.0 109.61 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.3 -38.47 86.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -75.79 -32.13 59.75 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.064 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.11 17.55 10.04 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.521 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . . . -102.36 124.36 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.0 110.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -119.0 124.1 46.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.848 HG21 ' CD2' ' A' ' 10' ' ' TYR . 3.8 t -67.6 125.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.983 -1.073 . . . . 0.0 109.884 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -10.28 59.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.69 152.99 52.02 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 t -141.76 106.82 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -128.28 109.54 11.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.065 -1.022 . . . . 0.0 111.305 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.65 120.13 33.53 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.168 -0.958 . . . . 0.0 109.496 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 7' ' ' PHE . 64.4 mt -75.28 0.56 16.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.997 -1.064 . . . . 0.0 110.491 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.16 116.57 0.24 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 56' ' ' LEU . 18.2 tp -52.44 114.39 1.35 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.386 -1.067 . . . . 0.0 109.986 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -114.54 151.3 33.58 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.004 -1.06 . . . . 0.0 110.233 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.26 103.61 8.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.917 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.509 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -131.4 81.48 1.99 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.437 -0.79 . . . . 0.0 110.066 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -161.53 -156.55 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.898 . . . . 0.0 110.056 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -105.13 153.9 39.18 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.108 -0.995 . . . . 0.0 110.377 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.8 102.16 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.091 1.574 . . . . 0.0 110.317 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.7 mt -87.31 133.19 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.395 -0.816 . . . . 0.0 110.342 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.42 -14.68 10.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.075 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.153 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.555 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 4.0 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.291 0.567 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.662 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 8.7 t70 -75.76 -34.67 1.57 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 111.496 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.4 Cg_endo -89.28 11.02 3.05 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.281 1.148 . . . . 0.0 109.634 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 3.8 pt20 -175.68 147.62 0.83 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.481 -0.762 . . . . 0.0 110.054 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 1.081 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 94.47 -56.99 1.99 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.74 ' HB3' HG23 ' A' ' 51' ' ' VAL . 3.9 p90 -61.85 129.96 43.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.997 -1.296 . . . . 0.0 109.706 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 1.028 ' C ' HD13 ' A' ' 8' ' ' LEU . 23.2 t80 -170.07 21.09 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.242 -0.911 . . . . 0.0 110.846 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.028 HD13 ' C ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -133.32 123.25 25.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.314 -1.491 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.496 ' CE3' ' CD2' ' A' ' 85' ' ' LEU . 1.4 t90 -128.69 118.42 22.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.667 -0.645 . . . . 0.0 109.481 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -127.2 137.45 52.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.018 -1.051 . . . . 0.0 110.995 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.882 ' O ' HG13 ' A' ' 79' ' ' VAL . 21.7 tt0 -109.32 160.27 16.29 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.282 -0.886 . . . . 0.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.603 HG21 HH21 ' A' ' 18' ' ' ARG . 15.9 m -129.02 -177.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.923 -1.111 . . . . 0.0 111.024 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 1.2 tp10 -140.22 59.68 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.833 0.825 . . . . 0.0 108.971 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.564 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 4.0 tpt -137.07 146.13 53.28 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.601 -0.687 . . . . 0.0 109.216 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' ' HG3' ' A' ' 14' ' ' MET . 33.2 Cg_endo -65.39 -166.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.651 1.342 . . . . 0.0 113.361 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 19' ' ' VAL . 24.5 tt0 -62.07 -27.02 68.61 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.272 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 34.9 t70 -57.65 -20.86 36.37 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.139 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.618 ' CZ ' ' CG ' ' A' ' 46' ' ' TYR . 4.4 ppt_? -88.41 -12.69 42.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 111.063 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 16' ' ' GLU . 56.0 t -46.78 -44.52 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.403 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.526 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.6 m-20 -57.19 -30.45 64.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 109.536 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 36.0 t0 -62.95 -46.75 86.27 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.299 -0.875 . . . . 0.0 110.221 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 37' ' ' VAL . 3.3 mm? -59.02 -43.02 91.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.488 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.08 -48.78 80.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -40.85 84.87 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.561 ' CD ' HG23 ' A' ' 68' ' ' ILE . 28.6 tt0 -56.37 -49.28 74.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.484 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.944 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -69.16 -37.08 78.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.138 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.2 tmm_? -65.66 -37.66 87.13 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.284 -0.885 . . . . 0.0 111.489 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.594 ' CG2' HG22 ' A' ' 67' ' ' ILE . 3.5 tt -58.61 -45.03 90.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.014 -1.054 . . . . 0.0 111.728 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.555 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -86.36 109.21 18.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.984 -1.073 . . . . 0.0 111.206 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -30.65 62.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.893 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 33.9 p30 -59.21 -13.42 7.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.78 . . . . 0.0 110.386 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.975 HG22 ' CD1' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -78.88 122.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.824 . . . . 0.0 110.485 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -79.76 -45.69 18.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 111.01 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -153.38 139.98 18.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.815 -1.178 . . . . 0.0 110.963 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.944 HG11 ' HB2' ' A' ' 26' ' ' LEU . 7.8 p -137.1 132.21 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 0.0 110.409 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.9 tpt -140.88 113.46 8.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.056 -1.027 . . . . 0.0 110.122 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 48' ' ' VAL . 23.3 t -116.92 132.25 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -0.821 . . . . 0.0 110.53 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' ' CD ' ' A' ' 47' ' ' GLU . 32.7 m -105.26 148.83 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.003 -1.06 . . . . 0.0 110.43 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -77.61 154.82 31.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.368 -0.832 . . . . 0.0 110.704 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 p -72.64 -176.68 2.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -101.57 5.71 41.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.086 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -153.11 -66.5 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.4 Cg_endo -72.78 -165.34 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.425 1.224 . . . . 0.0 110.567 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.29 35.4 4.77 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.4 mtt180 -94.04 138.5 32.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.456 -1.026 . . . . 0.0 110.216 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.618 ' CG ' ' CZ ' ' A' ' 18' ' ' ARG . 10.0 m-85 -125.52 154.82 41.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 110.307 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 47' ' ' GLU . 10.0 pt-20 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.435 0.636 . . . . 0.0 109.566 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.74 ' HA ' HG22 ' A' ' 37' ' ' VAL . 44.6 t -88.04 115.92 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 110.836 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.447 ' CB ' HD11 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -130.92 101.33 5.59 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.975 ' CD1' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -117.87 131.64 70.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.593 -178.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 6' ' ' TYR . 9.8 p -95.55 151.25 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.046 ' HB2' HD11 ' A' ' 56' ' ' LEU . 4.4 mp -138.6 -157.11 0.74 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 110.923 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 52' ' ' LEU . 14.9 m120 -34.85 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 121.056 0.455 . . . . 0.0 111.115 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.83 -27.94 59.22 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.144 1.602 . . . . 0.0 111.15 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.46 ' OD1' ' NH2' ' A' ' 88' ' ' ARG . 8.0 t30 -131.11 81.32 1.98 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 110.161 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.081 HD12 ' O ' ' A' ' 5' ' ' GLY . 13.8 mt -74.03 -165.36 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 172.63 -171.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.597 0.713 . . . . 0.0 110.371 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -65.36 -33.13 75.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 110.852 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.9 t -68.27 -34.46 76.23 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HB3' HD22 ' A' ' 56' ' ' LEU . 21.5 mm-40 -71.19 -42.13 69.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 110.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 8' ' ' LEU . 9.3 mt -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.07 -36.59 60.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.928 -1.107 . . . . 0.0 108.086 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.7 mt -71.5 -49.87 36.98 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.807 0.813 . . . . 0.0 109.272 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.842 ' OE2' HD23 ' A' ' 61' ' ' LEU . 8.6 pt-20 -67.1 -39.76 86.78 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.585 -1.322 . . . . 0.0 109.94 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -71.87 -41.51 67.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.864 -1.148 . . . . 0.0 110.488 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.5 mt-10 -75.38 -41.07 57.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.701 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 63' ' ' LEU . 17.9 mm -78.92 -36.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 112.219 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 96.7 mt -70.41 -44.58 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.329 -1.482 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 26.1 mm-40 -55.79 -39.2 70.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -57.61 -48.12 80.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 111.374 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -72.23 -48.77 40.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.971 -1.08 . . . . 0.0 111.578 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 25.1 mt -60.1 -42.71 95.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 111.331 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.17 -43.39 70.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.014 -1.053 . . . . 0.0 109.182 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 34.1 t-20 -59.65 -37.12 77.85 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.578 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -74.49 -29.27 61.36 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.259 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.59 5.28 27.91 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -99.66 118.45 36.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -1.149 . . . . 0.0 110.462 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -118.6 137.18 53.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.647 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.3 t -75.98 119.52 24.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.88 -5.63 59.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.571 -0.706 . . . . 0.0 109.213 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.574 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.69 160.81 35.66 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.282 -0.886 . . . . 0.0 111.591 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 82' ' ' VAL . 2.1 p -136.06 107.6 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.032 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.77 132.06 49.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.098 -1.001 . . . . 0.0 111.276 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 7' ' ' PHE . 1.9 mp0 -85.92 124.81 32.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.528 -0.733 . . . . 0.0 109.881 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 2.3 mt -76.3 29.79 0.12 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.084 -1.01 . . . . 0.0 111.671 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' TYR . . . 80.41 111.98 0.29 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.493 ' O ' ' O ' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -51.81 -170.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -1.104 . . . . 0.0 110.286 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -78.44 131.09 36.76 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.941 -1.099 . . . . 0.0 110.212 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -115.43 37.88 3.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.544 ' HG ' ' NE2' ' A' ' 4' ' ' GLN . 0.5 OUTLIER -43.78 116.34 0.96 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.305 0.574 . . . . 0.0 110.487 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.42 -44.26 4.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 109.556 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -105.65 144.65 29.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.63 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.53 -56.76 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.919 1.484 . . . . 0.0 111.093 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.2 mt -119.86 120.73 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.032 -1.043 . . . . 0.0 110.585 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.12 -63.02 1.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.139 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HG3' ' OXT' ' A' ' 96' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.185 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.585 ' HG2' ' CA ' ' A' ' 5' ' ' GLY . 2.5 ptp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.477 0.656 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.641 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 26.3 t0 -78.09 -26.53 0.51 Allowed Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 45.9 Cg_endo -85.5 -5.67 9.13 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 N-CA-C 109.844 -0.868 . . . . 0.0 109.844 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.512 ' NE2' ' OD1' ' A' ' 55' ' ' ASN . 1.0 OUTLIER 178.15 -100.54 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.476 -0.765 . . . . 0.0 109.989 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.585 ' CA ' ' HG2' ' A' ' 1' ' ' MET . . . 121.2 94.03 1.32 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.118 ' CB ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -84.66 145.98 27.7 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.095 -1.239 . . . . 0.0 110.499 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.931 ' C ' HD12 ' A' ' 8' ' ' LEU . 57.6 m-85 -145.98 124.71 12.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.541 -0.725 . . . . 0.0 109.733 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.931 HD12 ' C ' ' A' ' 7' ' ' PHE . 5.3 mp -135.51 127.86 30.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 110.543 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.507 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -97.14 127.86 43.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.7 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.811 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -127.14 120.62 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.55 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 9.4 tt0 -112.35 159.7 18.42 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 10' ' ' TYR . 16.4 m -135.73 178.36 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.073 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -132.45 56.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.576 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.91 152.4 72.14 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 110.595 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.4 Cg_endo -72.23 -167.67 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.977 1.514 . . . . 0.0 112.809 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.528 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 2.4 tt0 -65.52 -25.37 67.42 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.854 178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.92 -41.46 91.81 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.873 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.62 -16.3 30.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.278 -0.889 . . . . 0.0 110.688 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 15' ' ' PRO . 20.6 t -47.36 -37.75 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.43 -0.794 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -53.59 -29.34 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 36.5 t0 -59.74 -39.47 84.86 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.399 -0.813 . . . . 0.0 110.338 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.4 mm? -59.07 -41.42 87.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 110.088 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.53 63.75 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' O ' HG13 ' A' ' 28' ' ' ILE . 2.1 ttp180 -68.93 -41.72 77.71 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.598 ' CD ' HG23 ' A' ' 68' ' ' ILE . 3.9 tt0 -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.196 -0.94 . . . . 0.0 109.946 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.766 HD22 ' CG2' ' A' ' 35' ' ' VAL . 14.1 mt -66.09 -38.63 88.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.772 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.54 ' NH1' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.81 -37.47 82.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.179 -0.95 . . . . 0.0 111.176 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.684 ' CG2' HG23 ' A' ' 67' ' ' ILE . 55.1 mt -61.75 -44.23 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.82 -1.175 . . . . 0.0 110.56 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.546 ' O ' HG12 ' A' ' 32' ' ' VAL . 9.4 ptp85 -75.06 59.6 0.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.124 -0.985 . . . . 0.0 110.282 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.49 -25.32 16.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.187 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -58.41 -17.08 17.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.3 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.09 HG23 HD11 ' A' ' 50' ' ' ILE . 4.3 p -80.68 137.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 110.302 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -79.18 -46.05 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.978 . . . . 0.0 110.758 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' O ' HG12 ' A' ' 50' ' ' ILE . 4.8 tpt180 -152.79 121.96 6.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.832 -1.167 . . . . 0.0 110.987 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.009 HG12 HG13 ' A' ' 50' ' ' ILE . 3.1 m -109.74 135.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.9 ttp -124.77 116.13 21.82 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.059 -1.026 . . . . 0.0 110.802 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.72 HG22 HG22 ' A' ' 48' ' ' VAL . 19.4 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.078 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 12.0 m -114.29 135.11 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.659 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.66 154.28 22.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -172.56 1.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 41' ' ' THR . 8.8 t -101.53 8.41 41.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.173 -0.954 . . . . 0.0 110.595 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.56 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.74 -63.75 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.978 . . . . 0.0 110.421 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.8 Cg_endo -69.56 -176.51 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.537 1.283 . . . . 0.0 110.845 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.36 32.74 6.9 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 17.5 mtt180 -96.21 143.12 27.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.395 -1.062 . . . . 0.0 109.92 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.645 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 12.1 m-85 -125.51 152.99 44.26 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.05 -1.031 . . . . 0.0 111.529 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.3 mp0 -105.05 92.83 4.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.72 HG22 HG22 ' A' ' 37' ' ' VAL . 21.7 t -80.69 125.41 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 111.84 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 47' ' ' GLU . 1.5 m-80 -130.31 101.08 5.61 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.09 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.98 146.38 33.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 119.746 -0.781 . . . . 0.0 111.876 -177.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' N ' HD13 ' A' ' 50' ' ' ILE . 14.3 p -111.79 151.66 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 56' ' ' LEU . 3.9 mp -118.17 -158.69 0.72 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.515 -1.366 . . . . 0.0 111.83 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.52 ' O ' ' O ' ' A' ' 52' ' ' LEU . 19.7 m120 -37.36 163.52 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.737 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 37.9 Cg_endo -63.73 -15.95 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.934 1.492 . . . . 0.0 110.759 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.512 ' OD1' ' NE2' ' A' ' 4' ' ' GLN . 8.9 t-20 -151.84 90.54 1.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 110.201 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.118 HD12 ' CB ' ' A' ' 6' ' ' TYR . 10.7 mt -76.83 -173.54 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.822 -1.173 . . . . 0.0 111.81 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.73 179.04 6.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.404 0.621 . . . . 0.0 109.536 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 61' ' ' LEU . 41.2 mt-30 -66.13 -43.17 87.88 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.425 -0.797 . . . . 0.0 111.009 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -65.41 -33.22 75.44 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.284 -0.885 . . . . 0.0 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 11.0 mm-40 -62.28 -38.28 88.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 110.359 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 58' ' ' GLN . 5.3 mt -59.99 -33.18 71.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.01 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.82 -34.48 40.53 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.652 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.1 mt -71.18 -51.8 22.74 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.957 0.884 . . . . 0.0 108.706 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -61.7 -41.39 97.53 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.859 -1.151 . . . . 0.0 109.735 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.522 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -72.72 -46.37 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 110.573 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 72.5 mt-10 -68.85 -37.57 79.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.87 -1.144 . . . . 0.0 109.686 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.684 HG23 ' CG2' ' A' ' 28' ' ' ILE . 19.2 mm -77.74 -45.5 28.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 111.84 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 ' CD ' ' A' ' 25' ' ' GLU . 58.2 mt -70.04 -42.01 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.76 -1.213 . . . . 0.0 110.214 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.9 pt20 -64.37 -40.74 96.43 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 11.2 ttt180 -58.38 -46.16 86.88 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.366 -0.834 . . . . 0.0 110.989 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.87 -48.76 57.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.902 -1.124 . . . . 0.0 110.636 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.632 HD13 ' OH ' ' A' ' 10' ' ' TYR . 83.8 mt -63.98 -36.24 83.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.336 -0.852 . . . . 0.0 110.641 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -69.82 -44.88 69.09 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.39 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -65.44 -37.04 85.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -75.72 -39.82 56.65 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.485 -0.759 . . . . 0.0 110.459 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.41 29.63 2.67 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.37 130.23 55.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.356 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.34 134.98 54.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.105 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.811 HG22 ' CE2' ' A' ' 10' ' ' TYR . 2.1 t -79.4 122.4 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.831 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.95 -10.98 59.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.63 145.03 50.33 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.537 -0.727 . . . . 0.0 111.023 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t -141.7 108.28 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.034 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.15 109.09 11.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.013 -1.054 . . . . 0.0 110.586 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' OE2' ' NZ ' ' A' ' 65' ' ' LYS . 29.8 mm-40 -98.61 104.45 16.49 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.214 -0.929 . . . . 0.0 110.508 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.851 HD13 ' O ' ' A' ' 7' ' ' PHE . 2.0 mp -74.95 -24.54 58.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.999 -1.063 . . . . 0.0 110.22 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.514 ' HA2' ' CZ ' ' A' ' 6' ' ' TYR . . . 64.64 169.3 1.91 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.639 ' N ' ' CE1' ' A' ' 6' ' ' TYR . 7.6 tt -42.64 110.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -1.07 . . . . 0.0 110.661 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 14.9 mmm180 -88.57 178.2 6.58 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.224 -0.923 . . . . 0.0 110.283 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 124.37 36.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 0.0 110.089 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.72 140.97 9.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 110.446 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.82 -90.45 0.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -112.76 155.33 44.16 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.0 110.138 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.93 -92.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.073 1.565 . . . . 0.0 110.749 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 94' ' ' ILE . 4.4 tt -107.24 121.11 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.052 -1.03 . . . . 0.0 110.372 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.11 -76.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.162 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.23 0.538 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.612 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 6.7 t70 -75.95 -42.13 3.52 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 49.8 Cg_endo -82.96 8.82 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.612 1.322 . . . . 0.0 109.803 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.521 ' HB2' ' HG ' ' A' ' 56' ' ' LEU . 1.5 pt20 -178.4 -132.88 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 88' ' ' ARG . . . 168.79 80.43 0.04 OUTLIER Glycine 0 N--CA 1.485 1.938 0 C-N-CA 119.172 -1.49 . . . . 0.0 110.136 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.676 ' CD2' HG23 ' A' ' 51' ' ' VAL . 16.2 p90 -62.12 138.48 58.4 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.146 -1.208 . . . . 0.0 109.794 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CD1' ' HB2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -145.86 86.06 1.71 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.287 -0.883 . . . . 0.0 109.646 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -148.88 124.54 10.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.15 -0.969 . . . . 0.0 111.413 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.458 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 1.3 t-105 -114.26 119.67 37.79 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.689 ' CD2' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -125.09 129.86 51.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.053 -1.029 . . . . 0.0 111.023 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.765 ' O ' HG13 ' A' ' 79' ' ' VAL . 14.2 tt0 -122.66 151.15 41.79 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.336 -0.852 . . . . 0.0 109.27 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.76 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 2.0 m -126.18 -174.98 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' O ' ' SD ' ' A' ' 14' ' ' MET . 4.3 pt-20 -138.78 49.93 1.86 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.286 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.597 ' HE3' ' HD2' ' A' ' 18' ' ' ARG . 30.3 mmm -123.46 155.63 65.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 1.006 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -70.52 -172.4 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.045 1.55 . . . . 0.0 112.82 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 1.1 tt0 -64.03 -27.04 68.84 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.536 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.36 -45.89 87.33 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.54 0.686 . . . . 0.0 109.82 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.597 ' HD2' ' HE3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.81 -33.1 16.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.555 -0.715 . . . . 0.0 110.197 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.006 HG23 ' O ' ' A' ' 15' ' ' PRO . 77.5 t -48.05 -40.56 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -54.88 -28.42 50.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.843 . . . . 0.0 109.019 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.595 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 26.0 t0 -58.92 -35.4 73.03 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.357 0.598 . . . . 0.0 110.609 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD21 ' OH ' ' A' ' 46' ' ' TYR . 4.2 mm? -55.87 -41.94 75.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.288 -0.965 . . . . 0.0 108.931 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.76 72.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.59 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -68.54 -46.05 70.56 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.365 -0.835 . . . . 0.0 109.511 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.696 ' CD ' ' HB1' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -65.0 -33.52 76.26 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.521 -0.737 . . . . 0.0 110.235 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.126 HD22 HG21 ' A' ' 35' ' ' VAL . 27.2 mt -69.42 -37.14 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 110.783 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' CD ' ' HA ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -68.09 -35.31 77.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.935 -1.103 . . . . 0.0 112.736 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.768 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.41 -35.52 67.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 120.423 -1.423 . . . . 0.0 111.43 -178.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.591 ' NE ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -79.9 61.58 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.751 -1.218 . . . . 0.0 109.873 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.94 -23.08 42.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.451 -0.781 . . . . 0.0 111.494 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 21.4 t-20 -56.62 -28.1 59.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.085 -1.009 . . . . 0.0 111.526 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.038 ' CG1' HD11 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -82.36 155.98 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.693 -1.254 . . . . 0.0 110.523 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -47.13 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 112.259 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' ILE . 1.2 ttt180 -154.28 156.95 37.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.65 -1.282 . . . . 0.0 112.149 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.126 HG21 HD22 ' A' ' 26' ' ' LEU . 9.9 p -141.22 135.82 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.4 117.84 23.77 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.511 HG21 HD11 ' A' ' 26' ' ' LEU . 25.8 t -115.16 132.01 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 110.966 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 5.4 m -114.3 126.32 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.185 -0.947 . . . . 0.0 110.0 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -80.65 152.58 28.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.287 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 13.6 p -76.42 -168.27 0.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.523 -0.736 . . . . 0.0 110.02 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 t -107.85 -32.61 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.774 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m -110.09 -67.12 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.078 -1.014 . . . . 0.0 111.136 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 48.2 Cg_endo -72.19 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.177 1.093 . . . . 0.0 110.628 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.36 31.83 5.28 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.556 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 6.7 mtt180 -94.68 135.71 35.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.997 . . . . 0.0 110.389 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.76 ' CZ ' HG21 ' A' ' 12' ' ' VAL . 9.4 p90 -135.65 154.01 51.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.738 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -91.88 96.24 10.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.891 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.593 HG23 ' CD1' ' A' ' 46' ' ' TYR . 24.2 t -77.06 124.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.405 -0.81 . . . . 0.0 110.261 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -130.73 102.3 6.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.038 HD11 ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.7 138.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.176 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG23 ' CD2' ' A' ' 6' ' ' TYR . 7.6 p -94.55 151.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.562 -0.712 . . . . 0.0 110.202 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -97.41 179.67 4.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 110.844 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.571 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -49.26 -178.01 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.068 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.0 Cg_endo -63.92 -15.07 46.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.585 1.308 . . . . 0.0 110.068 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.503 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 31.1 t-20 -143.7 84.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.297 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.541 ' HB3' ' CB ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -66.23 -176.99 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.074 -1.016 . . . . 0.0 111.389 -178.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.483 ' HB3' ' HG3' ' A' ' 60' ' ' GLN . 5.7 t70 174.61 172.28 0.22 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.416 0.627 . . . . 0.0 109.417 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.76 ' HA ' HD21 ' A' ' 61' ' ' LEU . 9.0 mt-30 -63.21 -41.02 99.09 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.158 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 -31.92 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' A' ' 57' ' ' ASP . 3.6 mm100 -74.15 -46.16 44.11 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 110.397 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.822 HD12 ' N ' ' A' ' 62' ' ' ALA . 4.4 pp -68.03 -35.19 77.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.817 -1.177 . . . . 0.0 109.368 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.822 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -51.8 -33.4 35.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.739 HD23 ' OE2' ' A' ' 66' ' ' GLU . 17.7 mt -71.27 -50.9 27.93 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.628 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.85 ' HG2' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -71.39 -35.49 71.06 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.401 -1.437 . . . . 0.0 109.885 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -74.15 -39.68 63.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.739 ' OE2' HD23 ' A' ' 63' ' ' LEU . 13.3 pt-20 -73.81 -37.85 64.76 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.753 -1.217 . . . . 0.0 109.982 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 63' ' ' LEU . 24.0 mm -77.89 -38.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.348 -0.845 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 46.1 mt -68.35 -42.03 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.9 -1.125 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 22.9 mt-30 -64.33 -48.16 76.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -40.41 95.35 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.22 -0.925 . . . . 0.0 110.593 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.696 ' HB1' ' CD ' ' A' ' 25' ' ' GLU . . . -66.47 -48.55 69.52 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.193 -0.942 . . . . 0.0 109.962 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 72' ' ' LEU . 47.9 mt -66.17 -35.53 80.7 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.313 -0.867 . . . . 0.0 110.017 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 9.0 mm-40 -70.03 -42.86 72.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -0.818 . . . . 0.0 109.086 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -58.78 -36.02 73.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.18 -31.47 62.69 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.581 -0.699 . . . . 0.0 110.559 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.41 1.5 21.75 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.3 124.77 39.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -1.188 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 5.0 ttm180 -120.37 150.89 40.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.1 t -92.67 118.83 39.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.134 -0.979 . . . . 0.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -4.9 57.91 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.545 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.79 144.46 51.09 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.388 -0.82 . . . . 0.0 110.894 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.0 t -139.32 106.68 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 109.087 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.26 108.42 10.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 111.315 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -99.07 111.02 23.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.611 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -80.08 12.74 2.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.036 -1.04 . . . . 0.0 110.578 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.34 121.09 0.08 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.86 159.94 15.65 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.262 -1.14 . . . . 0.0 109.912 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.514 ' HB2' ' HA3' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -124.72 153.28 42.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.148 -0.97 . . . . 0.0 110.766 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -142.12 110.66 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 109.785 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.02 146.52 49.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.146 -0.972 . . . . 0.0 110.149 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.02 -140.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.95 . . . . 0.0 110.19 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -80.94 152.71 72.03 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.29 179.21 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.059 1.557 . . . . 0.0 110.301 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.36 114.53 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.37 179.95 4.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.927 . . . . 0.0 110.357 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.137 180.0 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.61 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.713 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 6.3 t0 -74.3 -22.72 0.48 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.081 . . . . 0.0 112.676 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 43.8 Cg_endo -86.79 -10.81 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 N-CA-C 109.302 -1.076 . . . . 0.0 109.302 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 87' ' ' LEU . 1.5 pm0 178.89 173.82 0.72 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.664 -0.648 . . . . 0.0 109.616 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.597 ' HA2' ' HG ' ' A' ' 56' ' ' LEU . . . -44.01 142.16 2.73 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.825 ' CD2' HD11 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -105.04 108.03 19.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.39 -1.065 . . . . 0.0 110.26 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.825 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.94 122.36 33.55 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.256 -0.903 . . . . 0.0 110.228 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 7' ' ' PHE . 3.1 mm? -116.79 144.71 44.15 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 110.616 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.592 ' CE2' ' HE3' ' A' ' 81' ' ' LYS . 5.8 t90 -124.52 118.41 26.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.559 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.699 ' CD2' HG11 ' A' ' 79' ' ' VAL . 9.1 m-85 -127.61 131.11 49.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.896 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.9 tt0 -101.96 159.58 15.23 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.946 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 3.6 m -129.74 -175.34 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.39 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' SD ' ' A' ' 14' ' ' MET . 0.6 OUTLIER -141.13 54.2 1.56 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.755 -0.591 . . . . 0.0 109.843 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -121.32 152.19 57.19 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.427 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.6 Cg_endo -70.88 -162.9 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.207 1.635 . . . . 0.0 112.385 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.83 -26.45 2.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 15' ' ' PRO . 41.8 t0 -57.73 -15.38 7.79 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.957 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.585 ' HD3' ' CE1' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -71.74 -17.07 62.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.411 -0.805 . . . . 0.0 110.552 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.19 -48.59 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.549 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 20.0 m-80 -64.82 -30.32 71.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.094 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 26.4 t0 -65.16 -54.66 26.38 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.631 HD21 ' OH ' ' A' ' 46' ' ' TYR . 3.9 mm? -59.16 -36.87 76.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.173 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.48 -52.24 65.46 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.589 -0.695 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -47.12 80.25 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.378 -0.826 . . . . 0.0 109.585 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.65 -43.79 95.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.487 -0.758 . . . . 0.0 110.007 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.677 ' CD2' HG11 ' A' ' 35' ' ' VAL . 19.2 mt -54.94 -40.16 69.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 109.968 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -37.71 68.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.562 HG21 ' CG2' ' A' ' 67' ' ' ILE . 2.5 mt -59.64 -44.53 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.265 -0.897 . . . . 0.0 110.617 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.946 ' O ' HG12 ' A' ' 32' ' ' VAL . 13.8 ptt85 -69.52 62.99 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.457 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' ILE . 1.8 m-20 -74.44 -39.76 62.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -62.83 -15.01 52.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.212 -0.93 . . . . 0.0 111.112 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.129 HG21 ' CD1' ' A' ' 50' ' ' ILE . 6.1 p -80.76 151.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.901 -1.124 . . . . 0.0 111.424 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -45.39 17.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 111.254 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.433 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.22 155.7 38.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.926 -1.109 . . . . 0.0 111.313 -179.004 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 50' ' ' ILE . 14.9 p -137.67 136.15 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 110.061 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.14 118.25 26.46 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 131.92 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.823 . . . . 0.0 110.574 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 4.6 m -117.75 127.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.136 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -79.86 153.56 28.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.333 -0.854 . . . . 0.0 110.631 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.499 ' OG ' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -74.75 179.41 4.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.205 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -103.5 12.96 34.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.28 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 110.014 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.6 Cg_endo -70.24 -170.69 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.687 1.362 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 21.68 26.22 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 8.2 ptp180 -94.79 162.54 13.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.544 -0.974 . . . . 0.0 110.32 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.946 ' CZ ' HG21 ' A' ' 12' ' ' VAL . 2.1 p90 -152.8 154.7 35.7 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.797 0.808 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.554 ' HG3' ' CD1' ' A' ' 9' ' ' TRP . 2.4 tt0 -92.71 97.33 10.71 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.351 0.596 . . . . 0.0 109.662 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 46' ' ' TYR . 39.2 t -77.42 119.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.419 -0.801 . . . . 0.0 110.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.22 100.96 5.58 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.129 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -121.06 147.62 24.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 121.427 0.632 . . . . 0.0 110.602 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 7' ' ' PHE . 12.0 p -126.09 148.22 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.054 ' HG ' HG23 ' A' ' 32' ' ' VAL . 2.1 mp -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.13 -0.981 . . . . 0.0 110.174 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.53 ' N ' HD21 ' A' ' 56' ' ' LEU . 21.2 m120 -36.75 159.48 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.812 -0.555 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 38.9 Cg_endo -64.52 -20.75 66.04 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.983 1.517 . . . . 0.0 111.498 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -127.98 77.67 1.78 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.057 . . . . 0.0 109.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 52' ' ' LEU . 6.4 mt -73.3 -173.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.384 1.088 . . . . 0.0 112.531 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.508 ' OD1' ' HG3' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -168.43 170.63 9.67 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.606 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.58 -32.22 73.17 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.958 -1.088 . . . . 0.0 110.813 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -38.39 76.05 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.508 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 8.7 mm-40 -68.57 -43.9 75.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.825 HD11 ' CD2' ' A' ' 6' ' ' TYR . 21.2 mt -65.15 -35.36 80.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.018 -1.051 . . . . 0.0 109.702 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 66' ' ' GLU . . . -52.83 -33.25 48.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 24.9 mt -66.17 -50.48 63.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' OE1' HD11 ' A' ' 52' ' ' LEU . 18.0 pt-20 -74.84 -41.14 60.44 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.847 -1.158 . . . . 0.0 109.513 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 4.0 mptp? -67.98 -32.92 73.66 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.41 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 11.1 pt-20 -69.88 -46.35 65.66 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.41 -1.431 . . . . 0.0 109.945 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.562 ' CG2' HG21 ' A' ' 28' ' ' ILE . 4.4 mt -78.3 -40.72 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.066 . . . . 0.0 111.136 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 68.1 mt -60.49 -49.85 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 70' ' ' ARG . 2.9 pt20 -60.85 -44.12 97.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 17.2 mtp-105 -68.6 -47.11 67.54 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.503 -0.748 . . . . 0.0 110.765 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -62.28 -47.83 82.6 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.053 -1.03 . . . . 0.0 110.077 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD2' ' OD2' ' A' ' 21' ' ' ASP . 91.3 mt -63.13 -38.01 89.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.354 -0.842 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.02 -45.34 64.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.398 -0.814 . . . . 0.0 109.595 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -61.63 -36.47 80.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.562 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.47 -17.94 60.0 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.467 -0.771 . . . . 0.0 110.406 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.15 2.86 48.38 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' CB ' ' OD2' ' A' ' 21' ' ' ASP . . . -98.36 111.78 24.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -1.187 . . . . 0.0 110.099 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -118.05 144.75 45.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.1 t -88.95 125.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 120.922 -1.111 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 -5.63 58.76 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -130.38 149.96 51.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 111.579 -178.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.506 HG12 ' CE2' ' A' ' 10' ' ' TYR . 1.2 m -137.5 106.92 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 109.125 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -128.87 123.04 31.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.446 -0.784 . . . . 0.0 111.109 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.483 ' O ' HD23 ' A' ' 85' ' ' LEU . 88.4 mt-10 -97.33 90.45 5.09 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.297 -0.877 . . . . 0.0 109.251 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 84' ' ' GLU . 12.9 mt -125.66 -172.76 2.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.932 . . . . 0.0 110.476 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 87' ' ' LEU . . . 56.53 162.44 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.7 pp -179.8 130.65 0.1 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.19 -1.182 . . . . 0.0 110.848 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.487 ' HB3' ' HA3' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -83.46 120.91 26.49 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.349 -0.844 . . . . 0.0 109.659 179.287 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 6.5 mtp180 -94.09 128.85 40.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.112 -0.992 . . . . 0.0 110.736 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -178.38 80.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 110.266 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -104.03 91.57 4.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 110.037 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.95 160.99 59.43 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -76.7 -74.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.064 1.56 . . . . 0.0 110.773 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.54 138.16 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 110.178 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.86 114.33 24.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.9 tttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.222 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.524 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.23 0.538 . . . . 0.0 110.094 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.588 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 30.9 t0 -77.67 -43.12 2.42 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 111.173 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.5 Cg_endo -79.18 0.37 10.08 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.439 1.231 . . . . 0.0 110.059 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 pt20 -174.43 -149.79 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.342 -0.848 . . . . 0.0 110.064 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.61 76.66 0.18 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 118.951 -1.595 . . . . 0.0 111.033 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' CG ' ' HA ' ' A' ' 51' ' ' VAL . 2.7 p90 -63.4 134.72 56.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.915 -1.344 . . . . 0.0 109.725 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.568 ' H ' HD12 ' A' ' 8' ' ' LEU . 17.5 m-85 -152.44 82.74 1.24 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 110.14 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD21 HD23 ' A' ' 61' ' ' LEU . 4.1 mp -144.34 124.17 13.44 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.34 -0.85 . . . . 0.0 110.645 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -123.15 118.21 27.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD2' HG11 ' A' ' 79' ' ' VAL . 3.1 m-85 -126.57 135.08 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 110.89 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.797 ' O ' HG13 ' A' ' 79' ' ' VAL . 2.3 tt0 -119.42 159.57 23.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 18.9 m -130.27 179.88 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 110.747 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -137.04 60.41 1.66 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.588 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 1.3 ptm -134.48 147.91 65.36 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.501 -0.749 . . . . 0.0 110.999 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 Cg_endo -73.37 -166.73 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.216 1.64 . . . . 0.0 112.452 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.579 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 22.7 tt0 -65.24 -25.42 67.66 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.203 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.01 -42.19 93.77 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.836 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -90.23 -14.34 33.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.33 -0.856 . . . . 0.0 110.322 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 7.2 t -46.52 -36.74 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.515 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.8 t30 -52.25 -27.89 16.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.364 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 42.3 t0 -59.14 -44.43 92.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.0 mm? -59.04 -39.62 82.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.84 . . . . 0.0 109.171 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -56.61 -53.12 61.32 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.439 -0.788 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -42.89 93.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.553 ' OE2' ' HB3' ' A' ' 71' ' ' ALA . 1.1 tt0 -57.69 -47.57 81.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.739 HD23 ' CG1' ' A' ' 35' ' ' VAL . 6.7 mt -54.69 -40.14 68.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -36.13 74.24 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -63.28 -43.93 98.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 32' ' ' VAL . 8.7 mtm180 -70.47 54.82 0.15 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.563 -0.71 . . . . 0.0 110.359 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -74.09 -40.66 62.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -61.03 -16.18 40.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.573 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.089 HG21 ' CD1' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -81.31 158.49 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 110.093 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.481 ' HD2' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -79.15 -46.81 17.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 111.229 -179.366 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.66 149.93 28.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 111.097 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.739 ' CG1' HD23 ' A' ' 26' ' ' LEU . 7.4 p -139.85 133.79 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.9 mtm -129.91 115.16 16.79 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.059 -1.026 . . . . 0.0 110.968 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.1 t -115.19 130.32 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 109.816 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -116.76 156.51 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.002 -1.061 . . . . 0.0 110.944 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.92 153.42 22.21 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.384 0.611 . . . . 0.0 110.456 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -76.83 -177.35 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.427 179.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -98.37 -47.85 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.303 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -100.59 -66.99 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 110.803 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.9 Cg_endo -72.1 -161.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.335 1.176 . . . . 0.0 110.776 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -116.19 40.49 2.39 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.6 mtt180 -93.3 135.41 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -1.081 . . . . 0.0 110.258 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.579 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 32.7 m-85 -115.05 154.98 27.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 111.034 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 5.3 mm-40 -100.52 114.99 29.06 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.925 -0.484 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 72.4 t -92.46 111.54 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 110.39 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.81 101.07 5.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.089 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -124.83 149.07 29.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 121.681 0.753 . . . . 0.0 111.553 -178.638 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 32' ' ' VAL . 6.5 p -98.72 151.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.739 -0.601 . . . . 0.0 109.682 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.499 HD13 HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -95.49 176.26 6.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.368 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.503 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 4.0 m-20 -48.48 179.23 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.403 -0.811 . . . . 0.0 109.794 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.8 -19.74 69.34 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.458 1.241 . . . . 0.0 109.266 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 9.6 t-20 -142.1 84.92 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.919 HD12 ' N ' ' A' ' 57' ' ' ASP . 3.8 pp -71.13 -172.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.004 . . . . 0.0 110.812 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.919 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.8 t70 173.07 171.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.386 0.612 . . . . 0.0 109.782 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.446 ' HG3' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -53.86 -54.39 39.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -0.819 . . . . 0.0 110.868 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -32.48 72.24 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.918 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.0 mm-40 -67.17 -44.77 78.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.848 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.659 HD23 HD21 ' A' ' 8' ' ' LEU . 5.8 mp -65.05 -34.36 78.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.014 -1.054 . . . . 0.0 109.676 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 66' ' ' GLU . . . -52.28 -33.85 43.88 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.659 ' O ' HG12 ' A' ' 67' ' ' ILE . 32.9 mt -68.16 -50.03 57.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.87 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.8 ' OE2' HG23 ' A' ' 32' ' ' VAL . 90.8 mt-10 -70.62 -35.6 73.04 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.243 -1.536 . . . . 0.0 109.381 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.48 -43.87 59.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 110.646 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 67' ' ' ILE . 10.0 pt-20 -72.62 -37.82 67.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.891 -1.13 . . . . 0.0 109.893 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 63' ' ' LEU . 40.1 mm -77.25 -39.73 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 111.154 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 64' ' ' GLU . 87.8 mt -70.28 -47.0 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.867 -1.146 . . . . 0.0 110.043 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 12.0 mm-40 -61.49 -33.83 74.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 110.541 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -67.42 -41.9 84.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.098 -1.002 . . . . 0.0 111.235 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' OE2' ' A' ' 25' ' ' GLU . . . -70.44 -48.41 56.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 111.323 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HG ' ' OE1' ' A' ' 25' ' ' GLU . 29.3 mt -58.59 -36.47 74.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 111.211 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.252 4.0 tt0 -71.53 -47.57 54.35 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.147 0.975 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -61.54 -39.38 90.89 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.116 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.68 -35.73 60.26 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.65 24.82 4.2 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -107.3 127.05 53.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.861 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -118.77 137.69 53.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 110.426 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 11' ' ' GLN . 1.7 t -90.29 117.16 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -82.42 -6.82 59.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 109.452 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.571 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -134.94 136.13 42.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.302 -0.874 . . . . 0.0 111.525 -178.767 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 82' ' ' VAL . 2.7 p -141.2 108.5 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 85' ' ' LEU . 1.7 tt0 -127.35 109.63 11.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.005 -1.059 . . . . 0.0 111.656 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.79 113.1 17.69 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.189 -0.945 . . . . 0.0 109.171 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 2.3 mp -85.92 30.76 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.988 -1.07 . . . . 0.0 111.385 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 7' ' ' PHE . . . 96.15 -168.63 25.92 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.811 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -140.06 -161.79 1.25 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.61 -0.936 . . . . 0.0 110.387 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.56 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 3.6 ppt_? -78.57 135.48 37.29 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.514 -0.742 . . . . 0.0 110.776 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -135.09 40.21 2.9 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.947 0.879 . . . . 0.0 109.731 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 tt -44.86 106.93 0.08 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.184 0.516 . . . . 0.0 110.395 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.88 158.87 43.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.158 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.77 131.21 26.12 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.23 88.3 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.924 1.486 . . . . 0.0 110.412 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 94' ' ' ILE . 40.2 pt -93.26 138.51 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.915 . . . . 0.0 110.111 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.15 107.14 10.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.201 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.632 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 19.8 ttm . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.142 0.496 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.714 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.0 p30 -75.18 -22.81 0.46 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 112.065 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.9 Cg_endo -88.41 44.32 0.87 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 122.769 0.878 . . . . 0.0 110.148 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.632 ' NE2' ' O ' ' A' ' 1' ' ' MET . 2.9 mp0 -42.54 -69.12 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.508 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 88' ' ' ARG . . . -105.42 24.85 26.42 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.835 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -63.26 97.3 0.12 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.835 -1.391 . . . . 0.0 108.944 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.984 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -156.5 31.47 0.32 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.906 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.055 ' CD2' HD22 ' A' ' 61' ' ' LEU . 6.4 mp -105.27 125.33 50.86 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.688 ' CE2' ' ND2' ' A' ' 49' ' ' ASN . 1.1 t90 -124.48 126.72 46.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.356 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.481 ' OH ' HD23 ' A' ' 8' ' ' LEU . 80.1 m-85 -122.94 122.1 37.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.921 . . . . 0.0 110.689 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.972 ' O ' HG13 ' A' ' 79' ' ' VAL . 11.8 tt0 -111.29 159.84 17.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.303 -0.873 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.8 m -136.86 -176.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.832 -1.168 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 15.1 tt0 -145.76 53.38 1.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.574 -0.704 . . . . 0.0 110.338 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.558 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -128.77 153.01 79.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.73 -166.53 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.952 1.501 . . . . 0.0 113.574 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HA ' HG23 ' A' ' 19' ' ' VAL . 3.0 tm-20 -60.72 -26.61 67.3 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.918 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.33 -27.28 62.09 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.908 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.616 ' NH1' ' CZ ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -88.44 -13.74 39.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.999 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.69 HG23 ' HA ' ' A' ' 16' ' ' GLU . 79.2 t -47.76 -40.99 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.0 109.968 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.8 m-20 -61.77 -29.68 70.29 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.772 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.733 ' OD2' HD23 ' A' ' 72' ' ' LEU . 39.5 t0 -60.85 -47.54 85.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.341 -0.85 . . . . 0.0 110.386 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.4 mm? -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.847 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.01 -47.29 78.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.06 -44.14 73.2 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.386 -0.821 . . . . 0.0 110.003 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.484 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.07 -47.95 82.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -63.06 -37.25 86.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.044 -1.035 . . . . 0.0 110.593 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.464 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.01 -42.38 63.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.849 -1.157 . . . . 0.0 110.454 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -61.93 -43.22 97.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.376 -0.828 . . . . 0.0 111.761 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -70.63 67.42 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.087 -1.008 . . . . 0.0 110.812 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 3.7 m-20 -64.59 -25.08 67.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.516 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 24.5 p30 -64.86 -25.79 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.299 -0.875 . . . . 0.0 111.57 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.653 HG22 ' CD1' ' A' ' 50' ' ' ILE . 0.5 OUTLIER -80.62 148.9 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.808 -1.182 . . . . 0.0 110.162 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -47.4 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 111.994 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -154.46 138.52 16.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.193 . . . . 0.0 111.243 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 50' ' ' ILE . 2.1 t -125.83 132.54 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.335 -0.853 . . . . 0.0 110.131 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 ttm -119.92 115.49 23.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.219 -0.926 . . . . 0.0 109.96 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.89 130.68 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.811 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 1.4 m -123.25 129.07 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.706 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -76.66 153.92 34.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -168.2 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.505 -0.747 . . . . 0.0 109.826 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.0 t -109.21 11.82 25.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.977 . . . . 0.0 110.79 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.574 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.36 -65.11 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 50.5 Cg_endo -72.62 -170.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.465 1.245 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -110.37 34.03 5.63 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.9 mtt180 -94.14 141.19 28.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -1.012 . . . . 0.0 110.04 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.706 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 17.4 m-85 -124.91 154.19 41.49 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.976 0.893 . . . . 0.0 110.729 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 24.8 mt-10 -103.05 92.5 4.57 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 80.7 t -77.49 124.74 36.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.688 ' ND2' ' CE2' ' A' ' 9' ' ' TRP . 32.8 m120 -128.32 100.83 5.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.709 HD13 ' N ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -113.49 130.03 68.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 121.216 0.531 . . . . 0.0 110.408 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 6' ' ' TYR . 8.4 p -91.97 150.25 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.84 HD22 HD12 ' A' ' 56' ' ' LEU . 12.5 mt -92.94 167.67 11.66 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 111.217 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.698 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 1.7 m-20 -65.1 -147.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.56 -35.14 30.71 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 CA-C-N 119.426 0.831 . . . . 0.0 111.64 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -162.97 79.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.74 -1.225 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.84 HD12 HD22 ' A' ' 52' ' ' LEU . 16.8 mt -80.4 -165.82 0.94 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.134 -0.979 . . . . 0.0 111.3 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.514 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER 177.72 -162.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.664 -0.647 . . . . 0.0 110.273 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.601 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 24.3 mt-30 -64.67 -30.16 71.17 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 111.132 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -71.25 -44.23 65.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 2.7 mm-40 -73.64 -44.09 57.81 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.487 -0.758 . . . . 0.0 109.682 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.055 HD22 ' CD2' ' A' ' 8' ' ' LEU . 30.7 mt -66.58 -33.28 75.32 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 58' ' ' GLN . . . -51.76 -32.91 32.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 67' ' ' ILE . 88.6 mt -71.18 -50.4 33.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.634 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.562 ' CD ' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -70.49 -32.21 69.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.453 -1.404 . . . . 0.0 109.56 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -73.37 -45.19 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 44.8 mt-10 -64.84 -38.3 90.53 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.121 -0.987 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 63' ' ' LEU . 7.1 mm -78.39 -43.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.538 -0.727 . . . . 0.0 111.458 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.562 HD12 ' CD ' ' A' ' 64' ' ' GLU . 10.4 mt -64.29 -41.3 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.0 110.7 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.91 -37.44 82.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.097 -1.002 . . . . 0.0 110.429 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -69.31 -45.43 69.55 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.222 -0.923 . . . . 0.0 111.103 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -48.82 72.27 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.008 -1.058 . . . . 0.0 110.253 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.733 HD23 ' OD2' ' A' ' 21' ' ' ASP . 36.1 mt -63.8 -35.68 81.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.958 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' OE1' ' CA ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -70.35 -45.55 65.91 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.543 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -60.3 -37.23 79.88 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.36 -25.72 57.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.495 -0.753 . . . . 0.0 110.326 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.11 11.32 32.23 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -95.05 126.58 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -1.106 . . . . 0.0 110.2 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -119.49 131.71 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.972 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.4 t -85.84 124.6 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.01 -9.11 59.66 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -131.57 130.82 42.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.368 -0.832 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 82' ' ' VAL . 8.9 p -141.2 108.63 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.094 . . . . 0.0 110.57 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HG3' HD11 ' A' ' 85' ' ' LEU . 3.5 tp10 -127.38 107.91 10.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.994 -1.067 . . . . 0.0 109.876 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' C ' HD12 ' A' ' 85' ' ' LEU . 10.4 pt-20 -99.56 118.22 35.64 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.312 -0.868 . . . . 0.0 111.319 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.984 HD13 ' O ' ' A' ' 7' ' ' PHE . 6.0 mp -113.64 -69.81 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.487 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.685 ' HA2' HD12 ' A' ' 52' ' ' LEU . . . 38.73 72.42 0.2 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.2 pp 179.55 45.58 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.211 -1.17 . . . . 0.0 110.287 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -121.78 140.49 52.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 110.494 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -130.85 121.46 25.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.878 . . . . 0.0 109.965 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.45 88.27 2.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.428 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.24 -32.77 3.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 110.075 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.558 ' CG ' ' HD2' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -101.03 149.55 36.33 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.096 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 92' ' ' TYR . 48.2 Cg_endo -74.89 55.26 3.83 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.983 1.517 . . . . 0.0 110.741 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.443 HG12 ' HB3' ' A' ' 92' ' ' TYR . 25.6 mm -82.05 124.9 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.042 -1.036 . . . . 0.0 110.067 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.71 -156.74 0.75 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 110.316 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.192 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.698 ' O ' HD23 ' A' ' 90' ' ' LEU . 1.4 mpp? . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.31 0.576 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.607 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 30.4 t0 -62.74 -40.3 62.57 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 111.301 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 47.7 Cg_endo -84.93 15.76 2.13 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.423 1.223 . . . . 0.0 110.373 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.876 ' HB3' HD23 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -44.04 123.37 3.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.462 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.979 ' O ' HD23 ' A' ' 56' ' ' LEU . . . 104.19 -37.58 3.7 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.15 -1.5 . . . . 0.0 109.902 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -66.79 117.42 8.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.062 -1.257 . . . . 0.0 109.701 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.976 ' C ' HD23 ' A' ' 8' ' ' LEU . 85.6 t80 -168.08 27.55 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.34 -0.85 . . . . 0.0 109.786 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.976 HD23 ' C ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -153.51 123.97 7.12 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 120.962 -1.086 . . . . 0.0 111.939 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.82 ' HB2' HD21 ' A' ' 85' ' ' LEU . 7.3 t90 -128.11 118.83 24.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.503 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 62.0 m-85 -127.54 145.19 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.874 -1.141 . . . . 0.0 111.753 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 81' ' ' LYS . 23.2 tt0 -122.91 159.6 27.91 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.367 -0.833 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.54 -177.43 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.938 -1.102 . . . . 0.0 110.726 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 13' ' ' GLU . 6.7 tt0 -135.58 50.18 2.12 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.693 0.759 . . . . 0.0 109.748 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' GLY . 16.6 mmt -128.59 148.7 69.42 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.81 -166.58 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.768 1.404 . . . . 0.0 113.412 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -52.58 -24.84 9.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.713 178.153 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.46 ' C ' ' HH ' ' A' ' 75' ' ' TYR . 35.8 t0 -58.22 -13.1 4.34 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.329 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -71.42 -13.3 61.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.234 -0.916 . . . . 0.0 111.027 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 16' ' ' GLU . 54.7 t -49.76 -46.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.34 -0.85 . . . . 0.0 110.068 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -30.87 69.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.168 -0.958 . . . . 0.0 109.58 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.652 ' OD2' ' HB3' ' A' ' 77' ' ' ALA . 16.3 t0 -69.48 -54.93 11.83 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.334 -0.854 . . . . 0.0 109.931 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.3 mm? -61.64 -38.13 86.55 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.85 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.81 -52.02 66.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.433 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.481 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -70.35 -46.83 63.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.187 -0.946 . . . . 0.0 109.769 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.949 ' OE2' HG23 ' A' ' 68' ' ' ILE . 50.5 tt0 -56.51 -49.63 74.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 110.919 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.737 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -63.76 -36.4 83.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.504 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.95 -41.98 97.35 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.194 -0.942 . . . . 0.0 111.313 -179.187 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.623 HG21 HG23 ' A' ' 67' ' ' ILE . 23.2 mt -67.57 -40.96 85.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.782 -1.199 . . . . 0.0 109.834 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 32' ' ' VAL . 36.7 mtp180 -74.39 64.53 1.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.546 -0.721 . . . . 0.0 110.373 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -29.62 70.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.942 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -62.14 -13.75 30.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.439 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.713 HG23 HD11 ' A' ' 50' ' ' ILE . 1.8 p -79.91 126.2 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.108 -0.995 . . . . 0.0 110.597 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -80.38 -44.59 19.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 110.69 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -151.72 123.72 8.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 0.0 111.486 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.499 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 3.7 p -129.94 128.16 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.708 . . . . 0.0 109.155 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.4 tpp -116.26 115.79 26.6 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.069 -1.02 . . . . 0.0 111.065 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG21 HD12 ' A' ' 22' ' ' LEU . 16.8 t -115.25 125.23 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.78 160.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.069 -1.019 . . . . 0.0 110.734 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -79.69 154.4 28.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.411 -0.806 . . . . 0.0 110.364 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.432 ' CB ' ' HG2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -74.11 -170.69 0.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.927 . . . . 0.0 110.105 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.407 ' H ' HG22 ' A' ' 41' ' ' THR . 8.8 t -98.69 1.71 46.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.629 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -160.53 -64.55 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.012 -1.055 . . . . 0.0 110.625 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 41.2 Cg_endo -67.66 -168.79 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.596 1.314 . . . . 0.0 110.782 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -107.11 29.17 11.04 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.6 ptt180 -94.19 160.61 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.845 -1.386 . . . . 0.0 110.393 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HG2' ' A' ' 18' ' ' ARG . 60.3 m-85 -132.48 155.26 48.87 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 121.956 0.884 . . . . 0.0 111.018 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.94 96.87 8.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 43.5 t -79.61 118.99 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.883 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -131.19 101.16 5.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.812 HD13 ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -117.36 146.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.912 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.812 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.7 p -107.05 120.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.621 HD12 HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.52 179.74 6.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 111.175 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.563 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 3.5 m-20 -45.33 174.04 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.766 -0.584 . . . . 0.0 110.359 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HA ' ' CG ' ' A' ' 4' ' ' GLN . 37.2 Cg_endo -63.23 -15.13 46.19 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.594 1.313 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' OD1' ' NH1' ' A' ' 88' ' ' ARG . 19.0 t-20 -140.36 73.71 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.96 . . . . 0.0 110.449 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.979 HD23 ' O ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -63.03 165.19 7.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -165.42 168.67 16.45 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 110.82 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -54.68 -38.2 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.316 -0.865 . . . . 0.0 110.111 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -45.4 87.5 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.459 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm100 -69.7 -41.48 75.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.386 -0.822 . . . . 0.0 109.255 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.739 HD21 HD22 ' A' ' 8' ' ' LEU . 10.5 mt -63.26 -35.01 78.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.787 . . . . 0.0 109.957 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.541 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.22 -43.9 64.51 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 67' ' ' ILE . 66.9 mt -64.75 -48.38 74.77 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.702 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -65.26 -44.74 87.11 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.356 -1.465 . . . . 0.0 110.819 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 62' ' ' ALA . 5.0 ptmt -74.52 -35.16 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.471 -1.393 . . . . 0.0 110.433 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 86.9 mt-10 -77.23 -40.41 45.01 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.892 -1.13 . . . . 0.0 109.881 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 63' ' ' LEU . 8.7 mm -76.99 -35.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.173 -0.954 . . . . 0.0 110.946 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.949 HG23 ' OE2' ' A' ' 25' ' ' GLU . 69.1 mt -69.09 -45.27 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 0.0 109.48 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 32.0 mt-30 -60.3 -48.52 81.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.285 -0.885 . . . . 0.0 110.005 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -60.36 -44.24 95.77 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.435 -0.791 . . . . 0.0 111.082 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -65.5 -48.76 71.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.875 -1.14 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.602 HD23 ' CG ' ' A' ' 21' ' ' ASP . 32.0 mt -65.49 -38.15 88.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 12.9 mm-40 -70.88 -44.85 65.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 31.2 t-20 -60.75 -37.02 80.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 t80 -75.71 -33.47 60.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.241 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.49 11.35 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.652 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . . . -103.84 129.41 51.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.24 . . . . 0.0 109.802 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.15 137.57 52.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.131 -0.981 . . . . 0.0 110.547 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.1 t -79.29 115.65 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.596 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.78 -4.67 58.28 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.527 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -130.28 155.01 47.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.226 -0.922 . . . . 0.0 111.889 -178.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -140.99 107.82 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -127.62 111.07 13.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.096 -1.003 . . . . 0.0 111.367 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 6.9 pm0 -95.54 89.49 5.4 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.269 -0.894 . . . . 0.0 109.153 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 9' ' ' TRP . 0.6 OUTLIER -107.94 -135.78 0.36 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.178 -0.951 . . . . 0.0 109.977 -179.601 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 85' ' ' LEU . . . 43.99 -171.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 87' ' ' LEU . 2.7 pp 179.68 124.3 0.07 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.239 -1.154 . . . . 0.0 110.482 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -77.84 128.94 34.78 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.312 -0.868 . . . . 0.0 110.545 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.461 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -141.25 26.64 1.98 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 110.045 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.876 HD23 ' HB3' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -82.33 51.18 1.76 Allowed 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.15 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.96 165.26 24.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 110.288 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.33 165.63 37.38 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 0.0 110.431 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.22 151.74 49.4 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.106 1.582 . . . . 0.0 110.495 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 87.6 mt -122.52 115.24 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.195 -0.94 . . . . 0.0 110.131 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.28 47.21 0.88 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.373 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.297 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.257 0.551 . . . . 0.0 110.026 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.692 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 26.6 t0 -77.61 -23.86 0.44 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 113.0 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 49.3 Cg_endo -82.57 -5.33 11.68 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 122.699 0.842 . . . . 0.0 110.106 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER 179.57 -170.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.818 . . . . 0.0 110.828 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.553 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -68.18 126.23 22.62 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.774 ' CB ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -80.48 132.27 35.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.611 -0.935 . . . . 0.0 110.591 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -101.84 93.92 5.55 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.271 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.738 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.7 mm? -90.79 148.45 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.155 -0.966 . . . . 0.0 111.521 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 3.5 t90 -127.36 119.61 26.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.787 . . . . 0.0 109.356 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.907 ' HD1' HG11 ' A' ' 79' ' ' VAL . 42.5 m-85 -123.27 143.74 49.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.93 -1.106 . . . . 0.0 111.163 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 79' ' ' VAL . 5.9 tt0 -121.05 160.33 23.84 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.406 -0.809 . . . . 0.0 109.597 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.85 -177.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 110.515 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 13' ' ' GLU . 33.7 tt0 -143.32 53.47 1.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.234 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.559 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -122.1 148.93 53.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.256 -0.903 . . . . 0.0 109.876 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 36.2 Cg_endo -69.36 -167.31 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.992 1.522 . . . . 0.0 113.491 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.81 ' O ' HG12 ' A' ' 19' ' ' VAL . 3.0 tm-20 -65.52 -23.72 66.95 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.267 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.83 -39.49 79.97 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.615 -0.678 . . . . 0.0 111.966 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.3 OUTLIER -90.69 -16.76 27.98 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.056 -1.027 . . . . 0.0 110.869 -178.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.81 HG12 ' O ' ' A' ' 16' ' ' GLU . 7.4 p -46.54 -36.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.514 -0.741 . . . . 0.0 110.413 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.532 ' N ' HG13 ' A' ' 19' ' ' VAL . 2.2 t30 -52.21 -28.16 17.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.454 -0.779 . . . . 0.0 109.682 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.589 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 39.7 t0 -58.8 -38.12 77.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.365 -0.834 . . . . 0.0 109.834 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.586 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 2.9 mp -58.52 -41.66 85.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.526 -0.734 . . . . 0.0 109.349 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.38 -50.6 71.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.403 -0.811 . . . . 0.0 109.517 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -68.55 -41.03 80.39 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.83 . . . . 0.0 109.694 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 28' ' ' ILE . 1.1 tp10 -59.78 -48.8 80.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.348 -0.845 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -60.89 -37.26 81.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.051 . . . . 0.0 109.055 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.38 -38.96 81.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.436 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.583 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.5 OUTLIER -58.86 -44.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.273 -0.892 . . . . 0.0 110.534 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.819 ' O ' HG12 ' A' ' 32' ' ' VAL . 11.6 ptp180 -78.61 52.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.71 -27.91 69.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.107 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 29.8 p-10 -58.88 -17.85 27.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 109.94 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.143 HG21 ' CD1' ' A' ' 50' ' ' ILE . 3.4 p -80.9 154.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.45 -0.781 . . . . 0.0 110.522 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -79.17 -45.53 19.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 111.058 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.5 mtt-85 -152.14 135.62 16.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.992 -1.067 . . . . 0.0 110.899 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.514 ' CA ' HG13 ' A' ' 50' ' ' ILE . 8.8 p -133.87 133.67 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.82 119.26 12.24 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.189 -0.945 . . . . 0.0 110.793 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 48' ' ' VAL . 58.5 t -114.54 130.67 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.984 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 16.2 m -111.28 145.13 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.685 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.09 153.87 23.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.422 -0.799 . . . . 0.0 110.687 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.53 -173.82 1.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -105.24 -16.91 14.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.087 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -124.31 -67.95 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -71.52 -168.79 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.105 1.055 . . . . 0.0 110.791 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -110.48 31.62 7.23 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.527 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 1.4 ptm180 -94.54 160.74 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -1.183 . . . . 0.0 110.486 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 45' ' ' ARG . 19.9 m-85 -132.2 154.35 49.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.846 0.831 . . . . 0.0 110.836 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 20.2 mt-10 -103.85 93.19 4.75 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 37' ' ' VAL . 65.4 t -79.5 123.13 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.0 111.603 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' ND2' ' CE2' ' A' ' 9' ' ' TRP . 29.4 m120 -130.91 100.76 5.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.143 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -136.52 147.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.634 0.731 . . . . 0.0 111.432 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 88' ' ' ARG . 9.9 p -124.81 149.92 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.617 -0.677 . . . . 0.0 109.232 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.98 ' HG ' HG23 ' A' ' 32' ' ' VAL . 6.1 mp -105.41 -158.56 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 52' ' ' LEU . 11.5 m-20 -39.44 163.8 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.85 -0.531 . . . . 0.0 110.425 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 38.5 Cg_endo -64.13 -15.71 50.9 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.0 1.526 . . . . 0.0 110.877 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.607 ' HB2' HD13 ' A' ' 90' ' ' LEU . 66.9 t30 -139.05 75.88 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 110.117 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.956 HD11 HD13 ' A' ' 52' ' ' LEU . 8.7 mt -61.76 -174.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.975 -1.078 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD2' ' OD1' ' A' ' 2' ' ' ASP . 0.5 OUTLIER -178.79 -174.25 0.35 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.465 0.65 . . . . 0.0 109.724 179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -65.82 -40.01 91.42 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 111.119 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.1 m -66.19 -36.12 82.24 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 0.0 110.56 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.26 -44.53 68.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 110.45 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 71.4 mt -64.67 -33.18 75.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.529 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.42 -35.66 52.52 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 67' ' ' ILE . 47.4 mt -71.55 -49.72 38.03 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.873 0.844 . . . . 0.0 109.145 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.686 ' OE1' HD11 ' A' ' 52' ' ' LEU . 4.6 mt-10 -67.32 -38.39 84.85 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.624 -1.297 . . . . 0.0 109.987 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.881 -1.137 . . . . 0.0 110.756 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 10.9 mm-40 -75.48 -39.41 58.65 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.725 -1.234 . . . . 0.0 109.628 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 63' ' ' LEU . 23.6 mm -78.17 -40.87 26.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.496 -0.753 . . . . 0.0 111.868 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 89.0 mt -71.32 -41.66 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.322 -1.487 . . . . 0.0 110.294 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 1.4 pp0? -64.35 -34.64 78.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -0.847 . . . . 0.0 110.761 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -69.06 -41.52 77.48 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.01 -1.056 . . . . 0.0 110.977 -179.394 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.02 -48.55 62.67 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.09 -1.006 . . . . 0.0 110.709 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 77' ' ' ALA . 61.6 mt -60.71 -38.2 84.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.192 -0.943 . . . . 0.0 110.606 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -72.04 -45.9 59.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.367 -0.833 . . . . 0.0 109.563 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 14.1 t-20 -60.9 -40.46 93.18 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.32 -43.75 39.89 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.574 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.72 34.23 1.44 Allowed Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -113.01 127.3 56.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -1.155 . . . . 0.0 109.534 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -120.7 129.29 53.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 110.612 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.907 HG11 ' HD1' ' A' ' 10' ' ' TYR . 2.3 t -75.13 119.66 23.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.087 -1.008 . . . . 0.0 109.407 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -82.32 -7.06 59.63 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.9 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -132.98 149.71 52.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.329 -0.857 . . . . 0.0 111.559 -178.397 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 t -141.51 105.21 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -129.95 115.81 17.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 110.652 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' HB3' ' OH ' ' A' ' 6' ' ' TYR . 10.0 mt-10 -98.18 89.7 4.6 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.979 -1.076 . . . . 0.0 109.974 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -131.77 -165.24 1.55 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.389 -0.819 . . . . 0.0 110.06 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 87' ' ' LEU . . . 61.12 163.34 0.19 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 87' ' ' LEU . 3.5 pp -178.41 137.43 0.17 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.311 -1.111 . . . . 0.0 110.258 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.601 ' CG ' HG21 ' A' ' 51' ' ' VAL . 20.2 mmm-85 -80.12 171.33 15.22 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.178 -0.951 . . . . 0.0 110.197 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -113.57 102.57 10.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.274 -0.891 . . . . 0.0 110.598 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -77.69 138.36 39.02 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.93 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.13 -36.22 4.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.221 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.91 144.27 47.61 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 110.309 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.79 -90.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.055 1.555 . . . . 0.0 110.296 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.83 117.24 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 110.102 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.96 149.39 28.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.384 -0.822 . . . . 0.0 110.282 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.276 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.412 ' N ' HD22 ' A' ' 8' ' ' LEU . 1.7 m-85 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.195 0.522 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 8' ' ' LEU . 1.6 mm? -104.67 124.32 49.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.16 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.502 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 1.7 t90 -115.79 119.63 36.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.741 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CA ' ' HD2' ' A' ' 81' ' ' LYS . 27.0 m-85 -126.84 137.37 53.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.761 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.553 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 10.7 tt0 -122.82 159.46 28.08 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.376 -0.827 . . . . 0.0 109.42 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 11.4 m -136.03 -177.51 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.003 -1.061 . . . . 0.0 110.667 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -146.54 56.22 1.15 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.481 0.657 . . . . 0.0 109.651 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.543 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 10.2 mmt -131.12 149.05 72.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.402 -0.811 . . . . 0.0 109.209 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.95 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.2 Cg_endo -68.63 -168.4 0.22 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.774 1.408 . . . . 0.0 112.823 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.57 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -61.12 -46.55 90.13 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.543 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.0 -28.73 20.0 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.275 -0.89 . . . . 0.0 110.214 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 15' ' ' PRO . 43.0 t -47.99 -37.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.571 -0.706 . . . . 0.0 110.791 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -53.64 -29.0 36.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.984 -1.073 . . . . 0.0 109.739 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.573 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 24.6 t0 -59.99 -36.58 77.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 110.655 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.628 HD13 ' HA ' ' A' ' 19' ' ' VAL . 6.8 mp -57.97 -39.35 77.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.54 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -61.37 -52.82 63.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.838 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.36 -42.39 75.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.246 -0.909 . . . . 0.0 110.383 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.588 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -56.02 -49.05 74.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 110.407 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.721 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.38 -36.98 85.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.504 -0.748 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.6 -38.63 88.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.151 -0.968 . . . . 0.0 110.781 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.802 ' CG2' HG21 ' A' ' 67' ' ' ILE . 55.8 mt -61.6 -47.44 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 120.927 -1.108 . . . . 0.0 110.567 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 2.9 ptt180 -72.66 67.47 0.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.94 -25.48 29.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -57.9 -14.98 7.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.102 -0.999 . . . . 0.0 110.154 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.9 ' CG2' HD11 ' A' ' 50' ' ' ILE . 1.7 p -80.35 132.08 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 110.311 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -80.04 -46.49 16.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.518 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttp85 -152.7 123.3 7.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.9 -1.125 . . . . 0.0 111.135 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 26' ' ' LEU . 7.2 p -127.18 136.18 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.465 -0.772 . . . . 0.0 109.75 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.97 120.72 17.38 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.04 -1.038 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.735 HG12 ' HB3' ' A' ' 46' ' ' TYR . 20.0 t -114.94 130.41 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.736 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 18.9 t -104.43 161.15 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.049 -1.032 . . . . 0.0 110.862 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.11 154.59 23.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.545 -0.722 . . . . 0.0 110.317 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 7.7 p -73.2 -172.58 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 41' ' ' THR . 8.5 t -94.66 -1.91 52.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.11 -64.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.043 -1.036 . . . . 0.0 110.786 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.5 Cg_endo -69.18 -160.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.556 1.292 . . . . 0.0 111.226 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.1 37.37 3.85 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.7 mtp180 -93.95 146.89 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.477 -1.014 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.735 ' HB3' HG12 ' A' ' 37' ' ' VAL . 41.2 m-85 -131.7 154.73 48.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.147 -0.971 . . . . 0.0 110.942 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.495 ' CG ' ' HB ' ' A' ' 38' ' ' VAL . 2.6 pt-20 -101.64 104.48 15.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 48.5 t -83.71 116.9 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 111.642 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -131.17 100.53 5.24 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.9 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -117.25 144.85 24.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.903 -178.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 50' ' ' ILE . 9.4 p -96.18 147.39 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 109.429 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.615 ' HB2' HD23 ' A' ' 56' ' ' LEU . 19.8 mt -107.25 -178.28 3.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.711 -1.243 . . . . 0.0 111.625 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.545 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -64.86 179.32 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.767 -0.583 . . . . 0.0 110.523 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -63.97 -15.99 52.31 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.861 1.453 . . . . 0.0 110.788 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -141.07 87.35 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.33 173.76 7.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.02 -1.05 . . . . 0.0 111.162 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 173.72 -167.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.527 -0.733 . . . . 0.0 110.133 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.554 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.69 76.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 1.9 mm100 -67.86 -45.11 75.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 52' ' ' LEU . 79.4 mt -64.61 -35.11 79.94 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 109.811 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.74 -33.89 50.2 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.048 . . . . 0.0 108.342 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.558 ' O ' HG13 ' A' ' 67' ' ' ILE . 15.2 mt -70.94 -49.39 46.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' OE1' HD21 ' A' ' 52' ' ' LEU . 38.5 mt-10 -68.51 -43.36 77.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 109.316 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.7 mmtp -60.73 -36.2 78.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 110.408 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.6 mm-40 -65.75 -48.84 70.53 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.841 -1.162 . . . . 0.0 110.061 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.802 HG21 ' CG2' ' A' ' 28' ' ' ILE . 4.6 mt -77.77 -41.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.392 -0.817 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 27.4 mt -59.46 -50.49 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 87.0 mt-30 -64.36 -47.06 80.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.2 -0.938 . . . . 0.0 108.897 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -58.13 -47.11 84.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.509 -0.745 . . . . 0.0 110.81 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -68.76 -48.51 63.53 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.864 -1.148 . . . . 0.0 110.449 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.496 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 76.1 mt -65.7 -35.55 81.09 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.326 -0.858 . . . . 0.0 110.455 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 69' ' ' GLN . 1.4 mm-40 -71.33 -44.91 64.21 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 109.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.9 m-80 -64.29 -36.6 84.64 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.011 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.03 -37.65 61.67 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.628 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.27 23.95 4.32 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HA ' ' HG3' ' A' ' 14' ' ' MET . . . -108.31 131.32 54.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.26 -1.141 . . . . 0.0 109.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 146.19 46.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.9 t -87.85 122.24 39.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.046 -1.034 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.01 -7.46 59.56 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.077 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -137.55 152.98 50.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 111.525 -178.738 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.628 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.971 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.332 0.587 . . . . 0.0 109.643 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.971 HD12 ' C ' ' A' ' 7' ' ' PHE . 6.7 mp -138.46 125.28 21.06 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.825 . . . . 0.0 110.847 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.562 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -99.57 132.41 44.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.975 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -128.12 128.51 44.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.45 157.33 29.57 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.833 -1.167 . . . . 0.0 110.519 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.743 HG21 ' CD ' ' A' ' 18' ' ' ARG . 26.6 m -130.36 179.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.75 51.54 2.12 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.58 -0.7 . . . . 0.0 109.84 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.586 ' CB ' ' HB3' ' A' ' 18' ' ' ARG . 70.4 mmm -133.96 151.82 77.46 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 109.535 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 36.0 Cg_endo -71.15 -167.57 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.835 1.44 . . . . 0.0 113.24 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 19' ' ' VAL . 37.7 tt0 -53.23 -25.51 14.41 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.528 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 26.9 t0 -57.58 -23.34 50.23 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.864 ' NH1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -88.09 -13.49 41.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 16' ' ' GLU . 70.3 t -48.26 -44.6 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.52 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -57.9 -29.07 64.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.764 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.2 t0 -59.64 -45.33 92.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.864 HD21 ' NH1' ' A' ' 18' ' ' ARG . 2.0 mm? -59.71 -36.65 76.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.26 74.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.173 -0.954 . . . . 0.0 110.533 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.3 mmt-85 -60.05 -46.64 88.87 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.5 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 tm-20 -68.67 -40.99 79.89 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 0.0 109.65 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.537 ' CD2' ' HB ' ' A' ' 35' ' ' VAL . 18.2 mt -55.28 -38.03 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.997 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.446 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 9.0 tpt180 -70.64 -40.94 72.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.468 -0.77 . . . . 0.0 110.596 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.974 ' CG2' HG21 ' A' ' 67' ' ' ILE . 56.5 mt -67.51 -44.94 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.989 -1.07 . . . . 0.0 110.743 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.912 ' HD3' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.51 57.44 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -73.75 -25.67 60.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 110.569 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -66.36 -20.46 66.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.098 -1.001 . . . . 0.0 110.427 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.034 HG21 HD11 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.5 154.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.913 . . . . 0.0 110.271 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -79.51 -47.02 16.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 111.41 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.446 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.96 146.27 23.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.764 -1.21 . . . . 0.0 111.939 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.912 HG21 ' HD3' ' A' ' 29' ' ' ARG . 2.1 t -135.56 135.96 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.459 -0.776 . . . . 0.0 109.11 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.472 ' HB3' ' OD1' ' A' ' 49' ' ' ASN . 2.5 tpt -131.71 117.42 18.6 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.968 -1.083 . . . . 0.0 110.692 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.798 HG13 ' CG2' ' A' ' 48' ' ' VAL . 4.4 t -114.59 129.8 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.307 -0.87 . . . . 0.0 109.849 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 47' ' ' GLU . 3.2 m -115.54 135.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 110.402 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.551 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -78.28 154.03 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.467 -0.77 . . . . 0.0 110.503 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 161.23 30.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -83.08 6.49 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 110.648 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.91 -65.07 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.334 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 44.0 Cg_endo -70.95 -176.68 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.562 1.296 . . . . 0.0 110.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.97 28.02 17.81 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 14.8 mtt180 -93.92 138.93 31.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.387 -1.066 . . . . 0.0 109.972 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 18' ' ' ARG . 7.0 m-85 -119.22 153.89 34.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.056 0.931 . . . . 0.0 110.949 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.686 ' HB2' HG23 ' A' ' 38' ' ' VAL . 4.0 mt-10 -104.31 95.83 6.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.798 ' CG2' HG13 ' A' ' 37' ' ' VAL . 5.1 t -88.1 122.72 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.852 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 36' ' ' MET . 0.8 OUTLIER -130.68 101.14 5.56 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.288 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.034 HD11 HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -117.78 149.8 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.447 0.641 . . . . 0.0 111.262 -178.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.418 ' N ' HG12 ' A' ' 50' ' ' ILE . 5.5 p -112.86 152.86 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.71 -0.619 . . . . 0.0 109.786 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 52' ' ' LEU . 3.4 mt -100.36 -165.03 1.17 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.054 -1.029 . . . . 0.0 110.924 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -68.69 -178.83 0.45 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.641 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -63.87 -15.04 46.72 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.758 1.399 . . . . 0.0 110.486 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.06 77.71 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.65 173.2 6.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.73 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.983 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.9 t70 178.81 171.05 0.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 5.1 mt-30 -57.8 -38.14 75.0 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.707 . . . . 0.0 110.294 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 -31.59 69.02 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.334 -0.854 . . . . 0.0 109.95 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.9 mm100 -74.3 -45.77 45.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.983 HD12 ' O ' ' A' ' 57' ' ' ASP . 1.6 mp -67.69 -36.0 79.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.993 -1.067 . . . . 0.0 109.514 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.84 -33.7 57.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' ILE . 20.2 mt -69.14 -50.31 49.05 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.271 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 29' ' ' ARG . 78.7 mm-40 -71.54 -42.06 68.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -67.34 -30.5 70.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.472 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 1.8 mm-40 -69.14 -48.34 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.761 -1.212 . . . . 0.0 109.91 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.974 HG21 ' CG2' ' A' ' 28' ' ' ILE . 6.3 mt -77.38 -42.4 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.4 -0.812 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.5 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 85.6 mt -59.47 -46.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.104 -0.998 . . . . 0.0 109.91 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 5.2 mt-30 -64.16 -44.13 93.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -68.41 -43.44 77.23 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.403 -0.811 . . . . 0.0 111.147 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 25' ' ' GLU . . . -65.07 -48.48 73.6 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.886 -1.134 . . . . 0.0 110.499 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.975 HD13 ' CZ ' ' A' ' 10' ' ' TYR . 96.6 mt -63.92 -35.19 79.84 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 69' ' ' GLN 0.258 2.0 tt0 -69.93 -45.85 66.63 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 108.988 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -58.24 -37.07 74.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.15 -26.53 60.36 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.893 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.24 28.74 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.61 121.92 41.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.24 . . . . 0.0 110.282 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.35 162.57 18.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.908 HG22 ' CE2' ' A' ' 10' ' ' TYR . 1.5 t -87.6 118.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -12.88 58.26 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.876 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.562 ' CE ' ' O ' ' A' ' 9' ' ' TRP 0.254 0.0 OUTLIER -131.57 157.24 44.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.494 -0.754 . . . . 0.0 111.015 -178.78 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.641 179.186 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.437 0.637 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 61' ' ' LEU . 9.6 mp -96.15 132.35 41.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.262 -0.899 . . . . 0.0 110.523 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -122.86 118.24 27.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.095 -1.003 . . . . 0.0 109.892 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.662 ' O ' HG22 ' A' ' 48' ' ' VAL . 36.2 m-85 -127.78 119.15 25.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 0.0 110.906 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.944 ' O ' HG13 ' A' ' 79' ' ' VAL . 34.7 tt0 -107.27 155.6 19.77 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.2 -0.937 . . . . 0.0 109.689 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.528 ' CG2' ' CD2' ' A' ' 46' ' ' TYR . 4.0 m -129.53 -178.38 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.865 -1.147 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' SD ' ' A' ' 14' ' ' MET . 3.5 pt-20 -133.06 48.87 2.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.537 0.684 . . . . 0.0 109.866 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.536 ' HB2' ' HB3' ' A' ' 18' ' ' ARG . 78.3 mmm -126.01 155.0 73.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 109.485 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.3 Cg_endo -72.67 -166.83 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.811 1.427 . . . . 0.0 113.014 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' HG12 ' A' ' 19' ' ' VAL . 42.4 tt0 -56.38 -26.85 54.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.48 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 29.8 t0 -58.13 -16.13 12.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.059 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.572 ' CD ' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -75.09 -16.57 60.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 110.18 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.588 HG13 ' N ' ' A' ' 20' ' ' ASN . 8.0 p -49.31 -43.68 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.416 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.588 ' N ' HG13 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -64.72 -30.05 71.05 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 41.1 t0 -65.6 -53.48 41.21 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.556 -0.715 . . . . 0.0 110.07 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.91 ' O ' HD12 ' A' ' 26' ' ' LEU . 4.7 mp -58.86 -37.11 75.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.136 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.11 -52.71 63.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.158 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -63.32 -46.26 87.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -56.91 -44.51 82.47 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.454 -0.779 . . . . 0.0 110.17 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.91 HD12 ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -66.94 -40.07 87.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.506 -0.746 . . . . 0.0 111.221 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.552 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.69 -37.36 83.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.915 -1.116 . . . . 0.0 110.355 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.955 ' CG2' HG23 ' A' ' 67' ' ' ILE . 14.8 mt -68.18 -44.56 84.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.727 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -81.4 69.26 8.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.403 -0.81 . . . . 0.0 110.297 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 37.7 p-10 -73.49 -25.96 60.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 6.1 t30 -58.82 -13.88 7.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.407 -0.808 . . . . 0.0 110.575 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.038 HG23 HD11 ' A' ' 50' ' ' ILE . 8.0 p -79.63 141.41 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 111.037 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -46.64 15.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 111.253 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttt180 -152.98 123.79 7.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 111.201 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.847 HG22 HG13 ' A' ' 50' ' ' ILE . 11.3 t -108.5 135.46 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 110.035 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 115.76 19.98 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.176 -0.953 . . . . 0.0 110.335 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.076 HG13 HG12 ' A' ' 48' ' ' VAL . 48.7 t -114.82 132.04 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.558 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 47' ' ' GLU . 3.9 m -113.22 130.79 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.371 -0.831 . . . . 0.0 110.018 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.654 ' HA ' ' CD1' ' A' ' 46' ' ' TYR . . . -77.62 153.67 32.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.519 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.59 166.33 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 109.445 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -83.51 2.83 35.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 0.0 110.848 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.42 -64.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.009 -1.057 . . . . 0.0 110.458 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.6 Cg_endo -70.55 -171.06 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.568 1.299 . . . . 0.0 111.072 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.24 26.42 18.8 Favored Glycine 0 N--CA 1.479 1.563 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -93.45 135.7 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 108.64 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.654 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 11.1 m-85 -128.73 151.29 49.71 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.763 -1.211 . . . . 0.0 112.379 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 mt-10 -105.03 90.63 3.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.098 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.076 HG12 HG13 ' A' ' 37' ' ' VAL . 16.0 m -86.92 125.24 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -123.63 100.74 6.94 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.038 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.13 147.77 16.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.447 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.76 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.7 p -102.82 129.76 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.12 -0.988 . . . . 0.0 111.296 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.781 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -93.58 -168.29 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.904 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.2 m-80 -50.93 172.91 0.12 Allowed Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.0 109.505 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.8 Cg_endo -63.22 -14.66 43.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.548 1.289 . . . . 0.0 110.849 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 4.2 t30 -146.19 86.77 1.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.106 -0.996 . . . . 0.0 110.696 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.781 HD21 ' CB ' ' A' ' 52' ' ' LEU . 8.7 mt -61.17 -171.41 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 111.068 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.8 t70 172.94 172.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.483 0.659 . . . . 0.0 110.103 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 11.7 mt-30 -56.37 -34.31 66.55 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -34.22 75.15 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -72.05 -44.32 63.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 110.099 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 8' ' ' LEU . 55.5 mt -63.37 -34.26 77.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 109.935 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.75 -40.36 63.03 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.62 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.1 mt -71.54 -49.99 35.5 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 79.1 mm-40 -58.34 -41.94 85.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.737 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -70.79 -46.9 62.03 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.263 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -71.4 -37.66 71.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.85 -1.156 . . . . 0.0 109.834 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.955 HG23 ' CG2' ' A' ' 28' ' ' ILE . 11.0 mm -76.49 -41.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 56.2 mt -70.26 -49.73 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.714 -1.242 . . . . 0.0 109.786 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 25.7 mm-40 -59.17 -38.74 80.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.883 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -57.74 -48.08 80.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.264 -0.898 . . . . 0.0 111.128 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 25' ' ' GLU . . . -70.95 -48.52 52.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.907 -1.121 . . . . 0.0 110.099 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 20.3 mt -63.71 -35.41 80.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.604 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 4.8 mm-40 -69.57 -45.08 69.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.427 -0.795 . . . . 0.0 109.283 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.48 -40.24 90.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.74 -29.17 58.78 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.528 -0.733 . . . . 0.0 110.0 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . 101.06 18.34 20.11 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -93.6 127.12 39.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -1.086 . . . . 0.0 110.483 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.8 141.32 48.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 109.874 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.9 t -94.17 125.37 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.66 -10.29 58.29 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -131.56 133.4 44.99 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 82' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.321 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 121.438 0.637 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 7' ' ' PHE . 10.9 mt -126.04 125.01 41.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.468 -0.77 . . . . 0.0 110.35 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.481 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -116.54 119.16 34.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.823 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB2' ' HB ' ' A' ' 48' ' ' VAL . 22.0 m-85 -124.19 118.11 26.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.607 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.805 ' O ' HG13 ' A' ' 79' ' ' VAL . 31.6 tt0 -110.82 147.14 35.15 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.405 -0.809 . . . . 0.0 109.452 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.506 HG21 ' HD3' ' A' ' 18' ' ' ARG . 8.4 m -126.65 -179.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.837 -1.164 . . . . 0.0 111.433 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -129.65 45.3 2.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.737 0.779 . . . . 0.0 109.033 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.561 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 60.6 mmm -120.29 145.99 41.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.77 -0.581 . . . . 0.0 109.563 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 33.4 Cg_endo -67.99 -166.57 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.77 1.405 . . . . 0.0 113.518 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -27.57 65.75 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.237 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.527 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -59.53 -22.27 61.42 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.021 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.614 ' NH1' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -83.54 -13.47 54.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.227 -0.921 . . . . 0.0 110.378 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -48.0 -46.62 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.585 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -57.8 -29.96 65.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.604 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.4 t0 -61.15 -50.77 71.82 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.435 -0.791 . . . . 0.0 109.928 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.678 HD12 HG21 ' A' ' 37' ' ' VAL . 3.9 mm? -59.62 -41.45 90.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.116 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.21 -52.37 64.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.179 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.18 -42.35 89.01 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.33 -0.856 . . . . 0.0 109.608 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.813 ' OE2' HG23 ' A' ' 68' ' ' ILE . 19.0 tt0 -56.89 -48.77 77.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 110.903 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.72 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -69.02 -37.56 78.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 110.812 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.94 -36.11 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.01 -1.056 . . . . 0.0 111.395 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.85 ' CG2' HG23 ' A' ' 67' ' ' ILE . 73.1 mt -62.93 -44.83 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.951 -1.093 . . . . 0.0 111.378 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HB3' HG21 ' A' ' 67' ' ' ILE . 5.9 ptt180 -83.83 93.15 7.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.061 . . . . 0.0 110.788 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -73.43 -24.82 60.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 23.6 p30 -58.56 -15.12 9.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.645 HG21 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.61 134.36 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.399 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -79.47 -45.65 18.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 111.043 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -152.7 134.54 14.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.805 -1.184 . . . . 0.0 111.087 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.872 HG23 HD11 ' A' ' 50' ' ' ILE . 2.2 p -125.86 131.31 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.339 -0.851 . . . . 0.0 110.547 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.3 ttt -140.42 116.02 10.14 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.611 -0.68 . . . . 0.0 109.538 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.678 HG21 HD12 ' A' ' 22' ' ' LEU . 33.2 t -111.88 131.93 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 110.829 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 38' ' ' VAL . 33.5 m -105.59 142.11 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.458 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.03 154.67 23.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.357 -0.839 . . . . 0.0 110.517 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' NH2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -74.04 -176.12 2.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.089 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -103.06 9.89 38.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.169 -0.957 . . . . 0.0 110.82 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -155.93 -65.1 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.15 -0.969 . . . . 0.0 109.797 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.1 Cg_endo -71.43 -178.94 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.536 1.282 . . . . 0.0 110.334 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -105.13 30.17 10.42 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 3.0 ptt-85 -93.49 160.6 14.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.02 -1.282 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.614 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 78.6 m-85 -134.42 154.38 51.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.089 0.947 . . . . 0.0 111.358 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.55 95.05 7.02 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 15.2 t -78.18 112.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 111.07 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.624 ' O ' HD12 ' A' ' 50' ' ' ILE . 69.1 m-80 -131.29 100.81 5.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -116.11 146.2 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.4 p -105.85 122.83 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.95 ' HB2' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.13 -168.5 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.5 m120 -41.77 165.17 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.46 -0.775 . . . . 0.0 110.07 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -64.4 -27.06 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.762 1.401 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 12.7 t-20 -127.75 78.36 1.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 52' ' ' LEU . 10.8 mt -62.28 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.226 -0.921 . . . . 0.0 111.011 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 58' ' ' GLN . 5.4 t0 174.59 172.09 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.441 0.638 . . . . 0.0 109.829 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.472 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.3 mm-40 -60.38 -31.4 70.32 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 110.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.422 ' HB2' ' OD2' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -70.05 -40.75 74.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.323 -0.861 . . . . 0.0 110.113 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 4.6 mm-40 -66.44 -42.77 87.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 109.942 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.524 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 15.1 mt -63.92 -33.5 75.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 109.732 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.74 -37.05 49.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.658 ' O ' HG12 ' A' ' 67' ' ' ILE . 62.5 mt -72.19 -51.36 21.5 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.3 mm-40 -61.64 -36.75 81.68 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.813 -1.179 . . . . 0.0 110.205 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.524 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -72.21 -47.05 53.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.976 -1.078 . . . . 0.0 110.232 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.488 ' OE2' HD23 ' A' ' 63' ' ' LEU . 23.7 pt-20 -71.21 -34.65 71.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.1 -1.0 . . . . 0.0 109.318 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.85 HG23 ' CG2' ' A' ' 28' ' ' ILE . 21.4 mm -77.03 -43.51 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.544 -0.722 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.813 HG23 ' OE2' ' A' ' 25' ' ' GLU . 49.6 mt -69.75 -46.01 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 110.259 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.09 -34.08 77.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.183 -0.948 . . . . 0.0 110.157 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 2.0 ttt-85 -64.42 -46.21 84.23 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.136 -0.978 . . . . 0.0 110.328 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -67.69 -48.61 66.11 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 110.21 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.506 HD23 ' OD2' ' A' ' 21' ' ' ASP . 86.9 mt -64.63 -36.07 83.07 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 38.3 mm-40 -70.05 -45.05 67.93 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.623 0.725 . . . . 0.0 109.247 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.51 -37.12 84.83 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.87 -41.08 60.48 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.564 -0.71 . . . . 0.0 110.049 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.15 23.6 4.48 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.52 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -98.7 138.23 36.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.218 . . . . 0.0 110.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -119.32 121.95 40.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.142 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.1 t -83.25 126.68 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.185 -0.947 . . . . 0.0 110.037 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.12 -15.01 54.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.63 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -130.66 129.65 42.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.682 -0.636 . . . . 0.0 110.454 -179.264 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.489 1.49 0 O-C-N 120.906 -1.121 . . . . 0.0 110.887 179.8 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.414 ' C ' ' HG ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HG ' ' C ' ' A' ' 7' ' ' PHE . 1.4 mp -129.02 136.73 50.69 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.774 0.797 . . . . 0.0 111.886 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 3.7 t90 -125.59 119.01 26.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.554 ' CE2' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -123.59 140.36 53.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 111.383 -178.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.563 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 38.8 tt0 -122.76 158.14 30.82 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.506 -0.746 . . . . 0.0 109.513 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.586 HG11 HH11 ' A' ' 18' ' ' ARG . 13.6 m -130.76 177.59 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.046 . . . . 0.0 110.507 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -131.2 51.99 2.1 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.513 0.673 . . . . 0.0 109.979 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.56 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 54.2 mmm -132.98 153.54 81.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.303 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -71.02 -167.54 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.703 1.37 . . . . 0.0 113.487 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.6 tt0 -58.27 -27.27 63.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.709 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -59.16 -21.71 59.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.319 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.586 HH11 HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -87.78 -16.87 32.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.788 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 16' ' ' GLU . 40.5 t -48.76 -45.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 109.934 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.496 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.2 t-20 -54.96 -29.24 56.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.769 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 38.3 t0 -60.34 -48.88 79.84 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.422 -0.799 . . . . 0.0 110.017 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.9 mm? -58.84 -36.74 75.04 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.475 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -56.8 -52.77 63.78 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.316 -0.865 . . . . 0.0 109.237 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 42.1 mtt180 -66.09 -44.09 85.43 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.429 -0.795 . . . . 0.0 109.331 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.642 ' OE2' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.7 -44.19 77.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.535 ' CD2' HG11 ' A' ' 35' ' ' VAL . 16.0 mt -65.44 -38.96 91.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.668 -0.645 . . . . 0.0 110.46 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.55 ' HG3' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -66.14 -36.24 82.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.207 -0.933 . . . . 0.0 111.756 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.967 ' CG2' HG23 ' A' ' 67' ' ' ILE . 49.0 mt -65.1 -45.7 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.609 -1.307 . . . . 0.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.901 ' NH1' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.29 79.56 9.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.042 . . . . 0.0 110.679 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.28 -25.47 62.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.998 . . . . 0.0 110.245 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.19 -14.47 10.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.748 ' CG2' HD11 ' A' ' 50' ' ' ILE . 2.2 p -79.68 133.65 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.197 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -80.09 -45.87 17.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 111.765 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.2 mtt85 -152.34 130.39 11.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.738 -1.226 . . . . 0.0 111.598 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.898 HG13 ' HB ' ' A' ' 50' ' ' ILE . 2.8 t -122.85 135.68 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.725 . . . . 0.0 109.209 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 115.71 23.01 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.019 -1.051 . . . . 0.0 110.715 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.498 HG11 ' HG ' ' A' ' 22' ' ' LEU . 15.7 t -114.87 129.09 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.298 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 3.6 m -119.81 125.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -82.36 153.99 25.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 p -74.31 -178.93 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.001 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -105.09 5.98 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -149.43 -66.34 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.963 . . . . 0.0 110.21 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.0 Cg_endo -71.59 -164.54 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.334 1.176 . . . . 0.0 110.13 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.29 34.36 4.32 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.1 mtt180 -97.33 134.71 40.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -1.101 . . . . 0.0 110.331 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.628 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 8.1 m-85 -117.88 155.44 30.15 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.288 -0.882 . . . . 0.0 110.438 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.8 mp0 -102.52 98.32 8.41 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 10' ' ' TYR . 66.9 t -78.45 111.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 111.356 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -131.13 101.94 5.8 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.898 ' HB ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.16 146.91 17.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.728 -177.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.765 ' N ' HD13 ' A' ' 50' ' ' ILE . 11.7 p -119.36 146.92 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.432 -0.792 . . . . 0.0 110.2 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.026 HD13 HD11 ' A' ' 56' ' ' LEU . 1.5 mp -135.06 -160.94 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.615 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' LEU . 26.8 m-80 -38.88 161.14 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.92 -0.488 . . . . 0.0 110.351 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 39.4 Cg_endo -64.91 -20.39 64.35 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.91 1.479 . . . . 0.0 110.878 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -143.66 84.4 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.026 HD11 HD13 ' A' ' 52' ' ' LEU . 18.3 mt -68.37 -162.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 9.0 t70 -161.7 172.2 16.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 0.0 110.464 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 69.2 mt-30 -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.728 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 t -64.49 -28.31 69.57 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.233 -0.917 . . . . 0.0 110.062 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 39.1 mm-40 -65.33 -40.68 94.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 91.6 mt -65.29 -35.25 80.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.048 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.17 -36.39 51.51 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.9 mt -72.52 -50.67 24.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.179 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' OE1' ' HB2' ' A' ' 29' ' ' ARG . 5.8 mm-40 -63.72 -33.87 76.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.846 -1.159 . . . . 0.0 110.437 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -72.24 -46.73 54.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.394 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 32.2 mm-40 -66.55 -35.38 80.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.121 -0.987 . . . . 0.0 109.85 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.967 HG23 ' CG2' ' A' ' 28' ' ' ILE . 11.5 mm -76.71 -47.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.42 -0.8 . . . . 0.0 111.498 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.901 HD11 ' NH1' ' A' ' 29' ' ' ARG . 45.8 mt -67.78 -48.19 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.937 -1.102 . . . . 0.0 110.125 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.8 mm100 -62.16 -32.93 73.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.329 -0.857 . . . . 0.0 109.956 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -65.81 -46.93 76.78 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.207 -0.933 . . . . 0.0 110.97 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.3 -48.93 47.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.969 -1.082 . . . . 0.0 111.589 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.546 HD22 HH12 ' A' ' 18' ' ' ARG . 38.2 mt -58.3 -39.13 78.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 111.293 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 5.3 tt0 -71.28 -46.8 60.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.112 0.958 . . . . 0.0 109.411 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 8.6 t-20 -59.21 -36.89 76.2 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -74.94 -34.76 62.12 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.873 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.81 10.46 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -102.73 125.69 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 110.2 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -111.99 134.86 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 109.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 81' ' ' LYS . 3.0 t -66.54 124.93 22.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.066 -1.021 . . . . 0.0 109.785 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.2 -11.7 59.35 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.427 -0.796 . . . . 0.0 109.109 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 79' ' ' VAL 0.269 0.0 OUTLIER -138.16 145.37 41.45 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.633 -0.667 . . . . 0.0 110.74 -178.923 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.562 178.58 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.469 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.465 0.65 . . . . 0.0 109.594 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 8' ' ' LEU . 7.8 mp -90.63 129.38 36.76 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 110.243 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 1.6 t90 -124.57 123.56 40.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.524 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.477 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 26.3 m-85 -126.79 138.01 53.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.412 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.883 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.9 tp60 -121.99 159.99 25.84 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.221 -0.924 . . . . 0.0 110.224 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 m -133.36 -176.94 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.02 . . . . 0.0 110.609 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' SD ' ' A' ' 14' ' ' MET . 5.6 pt-20 -138.41 56.04 1.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.545 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 4.5 mmt -137.05 149.49 66.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.553 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.911 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -70.84 -167.21 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.035 1.545 . . . . 0.0 113.13 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.22 -25.76 67.83 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.8 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.83 -45.54 89.77 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.264 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.545 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 2.8 mtp180 -89.76 -23.65 21.71 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.944 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 15' ' ' PRO . 24.4 t -47.95 -38.41 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.525 -0.734 . . . . 0.0 110.012 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 25.1 t-20 -53.36 -29.12 32.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.166 -0.959 . . . . 0.0 109.066 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.588 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 32.9 t0 -59.89 -42.39 93.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 19' ' ' VAL . 6.0 mp -58.32 -38.65 77.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.615 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.32 58.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -46.77 82.16 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.216 -0.927 . . . . 0.0 109.292 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.056 ' OE1' HG23 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -59.29 -48.12 82.82 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.85 0.833 . . . . 0.0 109.454 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.605 HD22 HG11 ' A' ' 35' ' ' VAL . 13.3 mt -53.95 -36.92 63.34 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.455 0.645 . . . . 0.0 110.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -35.6 74.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.602 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 15.9 mt -59.48 -32.52 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.041 . . . . 0.0 110.979 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.627 ' HG3' HG12 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -69.4 48.64 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.067 -1.021 . . . . 0.0 111.661 -178.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -25.59 25.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.435 -1.416 . . . . 0.0 109.851 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.384 -0.823 . . . . 0.0 111.14 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.001 HG21 HD11 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -83.46 142.78 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.12 . . . . 0.0 110.54 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.85 22.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 111.598 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.79 150.34 30.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.619 -1.301 . . . . 0.0 111.822 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.902 HG23 ' HB ' ' A' ' 50' ' ' ILE . 9.7 p -140.03 134.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.4 mtm -122.81 114.12 20.08 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.843 -1.16 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG13 HG22 ' A' ' 48' ' ' VAL . 4.8 t -116.43 132.15 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 109.925 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' HB ' ' CD ' ' A' ' 47' ' ' GLU . 11.2 t -118.81 157.08 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.607 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.11 154.95 21.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -73.91 -170.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.05 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -103.1 -2.13 27.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 111.031 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.578 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -152.25 -66.38 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -70.15 -158.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.469 1.247 . . . . 0.0 110.699 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.79 34.95 4.51 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 2.2 mtt180 -94.52 136.69 34.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -1.13 . . . . 0.0 109.815 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.629 ' OH ' HG21 ' A' ' 19' ' ' VAL . 32.7 m-85 -117.21 153.97 31.95 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.099 -1.0 . . . . 0.0 111.256 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' CD ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -103.67 110.82 23.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 67.5 t -89.41 124.66 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 111.686 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.476 ' N ' ' ND2' ' A' ' 49' ' ' ASN . 1.4 m-80 -131.01 101.18 5.5 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.001 HD11 HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -124.05 148.27 28.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 111.689 -178.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.52 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.2 p -105.68 151.28 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.695 -0.628 . . . . 0.0 109.758 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.9 mp -132.88 -170.62 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.053 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 56' ' ' LEU . 39.2 m-80 -43.44 161.3 0.2 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 110.456 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.42 -31.75 51.24 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.099 1.579 . . . . 0.0 110.838 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -113.3 70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' A' ' 52' ' ' LEU . 9.1 mt -62.85 -168.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 110.984 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 168.18 -175.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.62 0.724 . . . . 0.0 110.031 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.808 ' HA ' HD21 ' A' ' 61' ' ' LEU . 74.4 mt-30 -65.54 -32.44 74.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.06 -30.37 63.66 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 110.29 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.48 ' HG3' ' HA ' ' A' ' 56' ' ' LEU . 15.2 mm100 -73.84 -46.12 47.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.808 HD21 ' HA ' ' A' ' 58' ' ' GLN . 3.7 pp -68.0 -34.98 77.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 109.267 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.649 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -52.67 -35.6 55.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.67 ' O ' HG12 ' A' ' 67' ' ' ILE . 15.2 mt -70.92 -50.83 30.52 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.005 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 28.3 mm-40 -65.0 -41.84 95.02 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.37 -1.456 . . . . 0.0 109.397 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.22 -46.33 64.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.896 -1.127 . . . . 0.0 110.326 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 52.9 mm-40 -70.05 -39.75 75.52 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.891 -1.131 . . . . 0.0 110.106 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 63' ' ' LEU . 18.9 mm -77.54 -41.55 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.319 -0.863 . . . . 0.0 111.562 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.056 HG23 ' OE1' ' A' ' 25' ' ' GLU . 24.0 mt -70.74 -49.7 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.53 -1.356 . . . . 0.0 110.047 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 2.7 mt-30 -58.74 -34.09 70.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.243 -0.91 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' HG2' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -56.49 -47.63 78.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.84 -1.162 . . . . 0.0 109.868 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -71.93 -48.46 45.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 110.654 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.699 HD12 HG22 ' A' ' 68' ' ' ILE . 93.1 mt -58.2 -43.9 87.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 111.472 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.08 -44.26 69.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.163 -0.96 . . . . 0.0 109.468 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -59.67 -37.07 77.76 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.588 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -75.14 -26.18 58.97 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.644 -0.66 . . . . 0.0 110.117 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 14' ' ' MET . . . 109.92 -0.51 30.19 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -90.62 127.58 36.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.253 -1.145 . . . . 0.0 110.13 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.31 147.65 44.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 110.596 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.6 t -86.31 125.81 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -9.82 59.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.357 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 79' ' ' VAL 0.251 0.0 OUTLIER -133.58 150.0 51.63 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.615 -0.678 . . . . 0.0 110.776 -179.022 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.856 178.497 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.531 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 121.512 0.672 . . . . 0.0 109.831 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 ' CD1' ' A' ' 52' ' ' LEU . 2.9 mm? -103.47 126.19 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.395 -0.815 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CE2' ' OD1' ' A' ' 49' ' ' ASN . 1.6 t90 -124.15 130.94 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.178 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -126.24 134.87 51.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.208 -0.932 . . . . 0.0 110.744 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.811 ' O ' HG13 ' A' ' 79' ' ' VAL . 54.8 tt0 -123.02 159.05 29.2 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.2 m -138.56 -176.74 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 110.643 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 13' ' ' GLU . 5.0 tt0 -140.72 54.28 1.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 110.249 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.788 ' CE ' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -130.43 161.17 62.2 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.168 -0.958 . . . . 0.0 110.347 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -75.44 -178.42 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.934 1.492 . . . . 0.0 113.009 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.592 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -67.6 -24.6 65.5 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.409 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -59.72 -45.53 91.87 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.718 -0.614 . . . . 0.0 111.5 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.546 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 1.1 ptp180 -89.71 -10.22 46.54 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 111.466 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 22' ' ' LEU . 18.2 t -45.16 -36.16 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.115 -0.991 . . . . 0.0 110.42 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -51.53 -26.86 9.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 33.0 t0 -58.84 -45.76 89.29 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.498 -0.751 . . . . 0.0 110.046 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.788 HD11 ' CE ' ' A' ' 14' ' ' MET . 1.3 mp -57.92 -41.52 82.9 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.41 63.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.15 -0.969 . . . . 0.0 109.587 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -60.73 -46.77 89.14 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 2.7 tm-20 -60.98 -48.89 79.75 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 109.946 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.552 HD22 HG21 ' A' ' 35' ' ' VAL . 41.4 mt -54.28 -37.57 64.9 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.357 0.599 . . . . 0.0 110.268 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.609 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.063 -1.023 . . . . 0.0 110.357 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.609 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 7.7 mt -59.49 -44.77 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 121.013 -1.054 . . . . 0.0 110.374 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.72 65.46 5.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -53.95 -24.54 16.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.815 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -57.99 -13.12 4.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 110.16 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.77 HG23 HD11 ' A' ' 50' ' ' ILE . 1.8 p -78.54 126.65 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.147 -0.971 . . . . 0.0 110.1 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HG2' ' HB2' ' A' ' 34' ' ' ARG . 26.9 ttt180 -79.69 -44.95 19.89 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -151.71 122.97 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.733 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 50' ' ' ILE . 11.5 p -132.6 136.02 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.2 122.63 20.7 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.104 -0.997 . . . . 0.0 110.688 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.38 130.55 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 0.0 110.149 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.443 HG23 ' OE1' ' A' ' 47' ' ' GLU . 13.6 m -115.87 146.22 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.538 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.551 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.41 154.17 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.556 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -74.17 -170.22 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.3 p -103.31 -2.05 27.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 110.994 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -144.84 -67.15 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.0 110.616 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.0 Cg_endo -72.56 -168.29 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.353 1.186 . . . . 0.0 110.705 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -108.02 35.32 5.06 Favored Glycine 0 N--CA 1.479 1.5 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.3 mtp-105 -93.54 134.87 35.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.54 -0.977 . . . . 0.0 110.139 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 9.5 m-85 -119.31 154.3 33.74 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.876 0.846 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 38' ' ' VAL . 3.4 mt-10 -103.93 99.04 8.79 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 10' ' ' TYR . 47.0 t -79.15 124.41 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.773 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 71.4 m-80 -131.29 100.92 5.35 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.77 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -119.19 138.91 48.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.515 -0.74 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 50' ' ' ILE . 4.0 p -96.59 151.14 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 109.324 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.028 ' HB2' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -114.11 173.91 6.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 111.503 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 65.2 m-80 -58.45 167.11 1.87 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.67 -0.644 . . . . 0.0 109.693 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.67 -15.17 44.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.6 1.316 . . . . 0.0 110.78 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -125.93 66.15 1.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.063 -1.023 . . . . 0.0 110.148 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.028 HD23 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -91.46 177.23 6.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.962 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 6.0 t70 -177.08 171.89 2.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.977 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -60.23 -33.23 71.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.597 -0.69 . . . . 0.0 110.037 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -65.04 -45.01 87.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 8.5 mm-40 -64.46 -44.32 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.855 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.847 HD23 ' OE1' ' A' ' 64' ' ' GLU . 74.3 mt -64.82 -37.32 87.22 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.729 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.46 55.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.864 -1.148 . . . . 0.0 108.065 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 63' ' ' LEU 0.256 0.1 OUTLIER -70.49 -51.28 30.03 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.666 0.746 . . . . 0.0 108.987 178.564 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.847 ' OE1' HD23 ' A' ' 61' ' ' LEU . 3.7 pt-20 -66.94 -43.16 83.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.316 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.38 -41.45 93.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.327 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -34.71 73.71 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.608 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -75.25 -50.41 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.679 HG22 HD12 ' A' ' 72' ' ' LEU . 17.8 mt -59.71 -46.71 93.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 43.5 mt-30 -61.04 -47.28 87.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 109.749 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.68 -47.22 85.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 0.0 110.772 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB3' ' CG ' ' A' ' 25' ' ' GLU . . . -69.91 -48.81 57.14 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.975 -1.078 . . . . 0.0 110.307 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.679 HD12 HG22 ' A' ' 68' ' ' ILE . 44.4 mt -64.06 -35.07 79.54 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.38 -0.825 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 2.1 mm-40 -69.37 -45.24 69.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.53 -0.731 . . . . 0.0 109.176 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -62.6 -39.19 92.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.23 -37.34 61.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.267 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 115.52 20.8 5.32 Favored Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . . . -95.22 123.4 38.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.241 . . . . 0.0 110.123 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.12 134.11 55.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.2 t -89.73 123.13 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.41 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -81.78 -10.75 59.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.526 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.61 140.6 52.0 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.425 -0.797 . . . . 0.0 110.9 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 109.939 178.59 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.486 0.66 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.08 132.44 50.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.447 -0.783 . . . . 0.0 110.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -124.12 118.37 26.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.956 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.503 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 25.6 m-85 -126.93 134.66 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.493 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.639 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.7 tt0 -117.44 158.29 24.74 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 17.2 m -134.29 -177.43 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.97 -1.081 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -134.51 51.07 2.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.668 ' HE1' ' HB2' ' A' ' 77' ' ' ALA . 1.5 ptp -130.22 152.74 80.66 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.423 -0.798 . . . . 0.0 109.74 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -70.73 -165.69 0.19 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.755 1.397 . . . . 0.0 113.202 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.871 ' O ' HG23 ' A' ' 19' ' ' VAL . 19.6 tt0 -52.1 -24.83 7.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.865 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.426 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 12.0 t70 -56.78 -23.76 45.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.044 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' CZ ' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -70.04 -14.1 62.53 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.386 -0.821 . . . . 0.0 110.83 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 16' ' ' GLU . 98.0 t -51.82 -48.79 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.144 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -59.24 -30.9 68.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.812 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 27.1 t0 -68.21 -54.91 14.45 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.5 mm? -62.63 -36.88 84.2 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.967 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -62.73 -52.41 63.34 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.619 -0.676 . . . . 0.0 109.851 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.8 tpp85 -69.84 -41.4 74.94 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.007 -1.058 . . . . 0.0 109.447 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -56.29 -48.82 75.88 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.525 -0.734 . . . . 0.0 110.6 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.725 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -66.52 -37.04 84.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 110.411 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.458 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.28 -40.15 93.07 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.174 -0.954 . . . . 0.0 110.903 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.737 ' CG2' HG23 ' A' ' 67' ' ' ILE . 87.1 mt -61.13 -44.13 97.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.002 -1.061 . . . . 0.0 110.994 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.822 ' NH2' HG21 ' A' ' 35' ' ' VAL . 13.7 ptt180 -84.88 68.39 10.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.803 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -56.05 -27.3 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 109.875 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -59.09 -14.1 8.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' HD11 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -80.13 128.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.948 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -79.32 -45.69 19.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 111.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.71 123.8 7.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.607 -1.308 . . . . 0.0 111.915 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.822 HG21 ' NH2' ' A' ' 29' ' ' ARG . 5.9 p -126.0 133.98 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.549 -0.719 . . . . 0.0 109.358 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.3 mtp -128.74 114.84 17.1 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.933 -1.104 . . . . 0.0 110.84 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.51 131.63 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG2' ' CG ' ' A' ' 47' ' ' GLU . 3.5 m -119.79 152.9 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -83.82 153.65 23.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.87 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -166.47 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.365 -0.834 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -104.94 0.27 27.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 0.0 111.161 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m -148.83 -65.88 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.865 -1.147 . . . . 0.0 110.801 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 47.2 Cg_endo -71.72 -169.13 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.214 1.113 . . . . 0.0 110.577 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -108.74 32.17 7.16 Favored Glycine 0 N--CA 1.477 1.371 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.528 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 6.2 ptm180 -93.9 160.43 14.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.923 -1.34 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 35.1 m-85 -138.28 155.44 48.6 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.888 0.851 . . . . 0.0 111.059 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.543 ' CG ' ' CG2' ' A' ' 38' ' ' VAL . 2.9 pt-20 -100.71 96.07 7.08 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.1 t -78.15 116.47 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 111.484 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -131.58 100.74 5.24 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.817 ' HB ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -123.69 140.25 47.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.591 -0.693 . . . . 0.0 110.603 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 51' ' ' VAL . 5.3 p -100.13 144.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.882 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.017 ' HB2' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -122.87 -166.54 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 110.9 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 52' ' ' LEU . 40.3 m-80 -39.46 159.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.725 -0.609 . . . . 0.0 110.774 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.17 -15.52 50.63 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.126 1.593 . . . . 0.0 111.289 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -140.11 73.11 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.813 -1.179 . . . . 0.0 111.162 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LEU . 13.0 mt -66.32 -164.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.853 -1.155 . . . . 0.0 110.354 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.9 t70 177.92 172.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.522 -0.736 . . . . 0.0 109.721 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.412 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.4 mm-40 -62.58 -34.89 77.88 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -71.29 -28.78 64.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.341 -0.85 . . . . 0.0 110.575 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -73.82 -39.99 63.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.065 -1.022 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 35.2 mt -66.32 -37.07 84.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.112 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.62 -38.07 59.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 63' ' ' LEU 0.259 0.2 OUTLIER -71.93 -51.42 22.2 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.893 0.854 . . . . 0.0 108.81 178.013 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 68' ' ' ILE . 60.7 mm-40 -61.9 -38.5 88.59 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 -47.22 78.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.207 -0.933 . . . . 0.0 111.308 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 6.3 pt-20 -62.88 -27.21 69.2 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 120.573 -1.329 . . . . 0.0 109.261 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.737 HG23 ' CG2' ' A' ' 28' ' ' ILE . 2.8 mm -76.81 -55.77 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.627 -0.67 . . . . 0.0 110.061 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 72' ' ' LEU . 8.8 mt -62.27 -42.69 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.339 -0.85 . . . . 0.0 109.891 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 38.2 mm-40 -63.12 -40.82 98.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -57.97 -47.3 83.37 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.237 -0.914 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.69 -48.45 59.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.147 -0.971 . . . . 0.0 109.81 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 68' ' ' ILE . 83.1 mt -64.01 -36.19 83.16 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.458 -0.776 . . . . 0.0 110.108 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 6.7 mm-40 -70.49 -45.89 64.8 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.552 -0.717 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -61.82 -38.71 89.17 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -75.65 -17.9 59.83 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.92 51.9 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.668 ' HB2' ' HE1' ' A' ' 14' ' ' MET . . . -87.63 129.2 35.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.147 -1.208 . . . . 0.0 110.055 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 119.6 34.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 110.342 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.7 t -77.19 120.77 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 109.932 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.19 -8.79 59.66 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HD2' ' HA ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -130.0 134.27 47.31 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.402 -0.811 . . . . 0.0 110.482 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 120.812 -1.18 . . . . 0.0 110.651 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 121.26 0.552 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 8' ' ' LEU . 1.7 mm? -84.67 138.99 32.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.237 -0.915 . . . . 0.0 109.915 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.418 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -108.75 118.96 38.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 0.0 110.585 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 48' ' ' VAL . 28.6 m-85 -127.23 115.45 19.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.161 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.919 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.1 tt0 -95.35 160.37 14.57 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.183 -0.948 . . . . 0.0 110.402 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 46' ' ' TYR . 30.7 m -130.41 179.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.517 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -135.55 53.0 1.98 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.414 -0.804 . . . . 0.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.662 ' SD ' ' HB2' ' A' ' 77' ' ' ALA . 4.2 ptt? -133.33 153.32 80.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.91 -163.96 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.13 1.595 . . . . 0.0 112.417 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.925 ' O ' HG23 ' A' ' 19' ' ' VAL . 3.9 tm-20 -50.27 -26.75 5.09 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.98 -17.33 16.53 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.772 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.556 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.76 -13.85 47.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 16' ' ' GLU . 93.3 t -53.1 -42.92 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.48 -0.763 . . . . 0.0 110.239 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.45 -34.98 76.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.946 . . . . 0.0 109.826 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.728 ' OD2' ' HB3' ' A' ' 77' ' ' ALA . 9.2 t0 -70.71 -54.43 11.82 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.2 mm? -64.17 -36.25 83.45 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 19' ' ' VAL . . . -60.5 -52.75 63.86 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.356 -0.84 . . . . 0.0 109.286 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 28' ' ' ILE . 5.6 mtt180 -70.08 -46.71 64.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 2.7 tm-20 -56.33 -45.73 80.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.808 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 35' ' ' VAL . 74.1 mt -62.81 -38.65 91.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.862 . . . . 0.0 110.302 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -45.66 93.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.819 ' CG2' HG23 ' A' ' 67' ' ' ILE . 13.4 mt -65.18 -42.96 95.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.769 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -70.43 55.22 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 110.67 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 15.4 p-10 -72.14 -30.07 64.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -61.24 -12.9 14.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.59 -0.694 . . . . 0.0 109.978 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 29' ' ' ARG . 3.9 p -79.09 137.55 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.361 -0.837 . . . . 0.0 110.437 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -42.68 25.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 110.813 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -148.06 122.71 9.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.043 -1.035 . . . . 0.0 111.06 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.875 HG12 HG13 ' A' ' 50' ' ' ILE . 22.5 m -117.67 135.16 58.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.328 -0.858 . . . . 0.0 110.423 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.66 116.12 10.09 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 22' ' ' LEU . 57.4 t -111.27 131.92 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.38 152.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.558 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.03 154.6 21.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.195 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -73.19 172.77 10.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.74 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.479 ' H ' HG22 ' A' ' 41' ' ' THR . 5.3 t -89.73 1.08 56.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.937 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.564 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.67 -64.61 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.028 -1.045 . . . . 0.0 110.48 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.9 Cg_endo -70.84 -159.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.532 1.28 . . . . 0.0 110.77 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.16 36.53 4.16 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 5.7 mtt180 -93.13 135.19 34.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.53 -0.982 . . . . 0.0 110.397 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.588 ' H ' HG22 ' A' ' 12' ' ' VAL . 25.5 m-85 -119.76 154.86 33.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.353 -0.842 . . . . 0.0 110.397 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -102.99 116.53 32.71 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -94.47 112.21 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 110.515 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.583 ' O ' HD12 ' A' ' 50' ' ' ILE . 64.3 m-80 -131.04 100.7 5.32 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.875 HG13 HG12 ' A' ' 35' ' ' VAL . 1.1 mp -115.28 140.04 38.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 121.738 0.78 . . . . 0.0 111.24 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.61 149.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 53' ' ' ASN . 6.3 mt -118.7 -170.23 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.627 -1.296 . . . . 0.0 112.062 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.8 m120 -42.34 170.74 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.635 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 36.3 Cg_endo -59.66 -12.72 18.73 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.648 1.341 . . . . 0.0 111.04 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -142.11 87.43 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.087 . . . . 0.0 110.436 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -60.74 -178.09 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.744 -1.222 . . . . 0.0 109.942 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.669 ' O ' HD12 ' A' ' 61' ' ' LEU . 12.4 t70 -175.24 171.67 2.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.047 . . . . 0.0 110.764 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.432 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 65.8 mt-30 -61.71 -40.55 95.42 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.549 -0.719 . . . . 0.0 110.514 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -29.57 68.81 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.222 -0.924 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.52 -45.11 69.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 110.158 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -66.19 -34.37 77.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.98 -38.8 62.55 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 67' ' ' ILE . 40.9 mt -71.64 -51.01 25.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' O ' HD12 ' A' ' 68' ' ' ILE . 3.5 mt-10 -60.06 -40.9 91.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.887 -1.133 . . . . 0.0 110.061 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -72.66 -46.46 53.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.045 -1.034 . . . . 0.0 109.634 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 6.8 mm-40 -69.58 -38.86 77.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 110.016 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.819 HG23 ' CG2' ' A' ' 28' ' ' ILE . 16.0 mm -76.43 -38.17 31.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.296 -0.878 . . . . 0.0 111.257 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 64' ' ' GLU . 57.7 mt -69.53 -48.28 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.778 -1.201 . . . . 0.0 110.053 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 4.9 pt20 -61.52 -38.86 88.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.184 -0.948 . . . . 0.0 110.02 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.17 -45.98 86.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.14 -0.975 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.3 59.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.081 -1.012 . . . . 0.0 110.836 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.518 HD23 ' CG ' ' A' ' 21' ' ' ASP . 79.2 mt -58.76 -43.03 90.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.267 -0.896 . . . . 0.0 110.661 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.44 -45.4 62.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 0.0 109.622 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.429 ' ND2' ' HD3' ' A' ' 70' ' ' ARG . 62.8 m-20 -62.61 -36.89 84.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.35 -35.29 58.78 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.312 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.29 18.28 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.728 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . . . -109.66 136.87 48.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.29 . . . . 0.0 110.224 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' NH1' ' HG2' ' A' ' 73' ' ' GLU . 2.1 tpt180 -119.69 133.53 55.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 110.326 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 11' ' ' GLN . 4.6 t -75.73 124.87 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.011 -1.055 . . . . 0.0 109.533 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.76 -8.0 59.62 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.73 156.31 47.27 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.501 -0.749 . . . . 0.0 111.608 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.693 ' O ' HG13 ' A' ' 82' ' ' VAL . 7.1 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.437 -0.789 . . . . 0.0 109.416 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.95 ' O ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.24 0.543 . . . . 0.0 110.029 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.027 HD11 HD11 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -138.41 131.86 30.5 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.344 -0.847 . . . . 0.0 109.78 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 81' ' ' LYS . 1.2 t90 -126.81 127.44 45.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 28.9 m-85 -126.24 115.08 19.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.852 ' O ' HG13 ' A' ' 79' ' ' VAL . 4.4 tt0 -107.5 149.23 28.2 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.544 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.6 m -126.75 -176.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 111.026 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 13' ' ' GLU . 1.9 tt0 -146.72 59.91 1.2 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.343 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.535 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.75 148.69 66.04 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 37.3 Cg_endo -71.78 -165.82 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.135 1.597 . . . . 0.0 113.573 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.822 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -62.98 -23.06 67.26 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.039 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.69 -48.15 67.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.738 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.535 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.5 OUTLIER -90.86 -14.22 32.2 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.116 -0.99 . . . . 0.0 111.219 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 16' ' ' GLU . 14.5 p -45.88 -37.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.261 -0.899 . . . . 0.0 109.784 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.575 ' N ' HG13 ' A' ' 19' ' ' VAL . 62.1 m-80 -53.32 -28.31 27.78 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.474 -0.767 . . . . 0.0 109.304 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 28.7 t0 -58.36 -32.5 68.61 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.545 -0.722 . . . . 0.0 110.129 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.3 mm? -59.0 -37.32 76.6 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.17 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -58.54 -51.22 70.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.28 -46.95 65.97 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.18 -0.95 . . . . 0.0 110.089 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' CD ' HD11 ' A' ' 72' ' ' LEU . 2.6 tt0 -56.32 -48.38 76.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.725 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -67.22 -37.22 83.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.854 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.36 -38.78 78.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.737 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.669 HD13 HG22 ' A' ' 67' ' ' ILE . 9.5 mt -59.06 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.148 -0.97 . . . . 0.0 110.703 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 13.1 ptm180 -74.4 56.53 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.12 -25.47 62.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.0 110.296 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -58.66 -17.18 20.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.88 162.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -0.824 . . . . 0.0 109.965 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -44.18 22.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.976 . . . . 0.0 111.945 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.82 146.58 26.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.741 -1.224 . . . . 0.0 111.655 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.637 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 6.9 t -132.32 127.48 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 tpt -140.41 115.55 9.83 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.488 -0.758 . . . . 0.0 109.69 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 88.9 t -114.81 131.9 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.0 110.981 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.65 HG22 ' HB2' ' A' ' 47' ' ' GLU . 7.8 m -101.97 140.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 110.035 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -81.46 153.07 27.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.19 152.73 39.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.848 . . . . 0.0 110.014 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.2 p -75.34 -11.56 60.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -0.926 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -141.41 -67.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.117 -0.99 . . . . 0.0 110.496 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.3 Cg_endo -70.68 -176.11 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.323 1.17 . . . . 0.0 110.562 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 33.29 6.65 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.9 mtt180 -93.2 135.44 34.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.008 . . . . 0.0 110.021 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 30.0 m-85 -117.93 154.93 31.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.296 -0.878 . . . . 0.0 110.568 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.65 ' HB2' HG22 ' A' ' 38' ' ' VAL . 33.9 mt-10 -103.5 95.08 5.83 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.748 -0.595 . . . . 0.0 109.683 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 10' ' ' TYR . 89.4 t -78.77 115.13 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.553 ' O ' HD12 ' A' ' 50' ' ' ILE . 70.7 m-80 -131.65 102.0 5.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.035 HG21 HG21 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -111.82 142.26 24.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.749 0.785 . . . . 0.0 110.691 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.8 p -92.32 133.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.415 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.027 HD11 HD11 ' A' ' 8' ' ' LEU . 30.5 mt -90.04 174.37 7.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 0.0 110.549 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.96 ' OD1' HD11 ' A' ' 56' ' ' LEU . 2.1 m120 -62.24 -153.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.697 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.74 -35.4 28.16 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 CA-C-N 119.122 0.722 . . . . 0.0 111.439 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 55' ' ' ASN . 8.1 t30 -162.87 76.25 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.802 -1.186 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.96 HD11 ' OD1' ' A' ' 53' ' ' ASN . 16.8 mt -74.7 -161.04 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 110.419 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 1.004 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.1 t0 -171.92 -164.09 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.496 -0.752 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -64.77 -32.87 74.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.557 -0.715 . . . . 0.0 111.177 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -35.06 78.74 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.4 mm-40 -73.72 -42.9 60.54 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.414 -0.804 . . . . 0.0 109.954 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.004 HD12 ' O ' ' A' ' 57' ' ' ASP . 1.2 mt -64.87 -34.46 78.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.39 -33.65 44.48 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.562 ' O ' HG13 ' A' ' 67' ' ' ILE . 18.3 mt -64.38 -51.05 65.23 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.461 -0.895 . . . . 0.0 108.618 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 2.5 mt-10 -72.19 -43.09 65.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.232 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -62.51 -34.86 77.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.533 -0.729 . . . . 0.0 110.443 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.7 -48.9 70.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.826 -1.171 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.669 HG22 HD13 ' A' ' 28' ' ' ILE . 4.3 mt -78.98 -41.17 23.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.493 -0.754 . . . . 0.0 111.155 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 40.9 mt -59.01 -49.5 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.049 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.8 mt-30 -58.61 -48.91 79.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.393 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -66.15 -47.21 74.79 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 110.877 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -65.01 -48.25 74.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.907 -1.121 . . . . 0.0 110.182 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.48 HD12 ' CG2' ' A' ' 68' ' ' ILE . 32.8 mt -65.57 -35.33 80.52 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 110.026 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 1.0 OUTLIER -70.34 -45.31 66.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.44 -0.788 . . . . 0.0 109.487 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -63.16 -36.31 83.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.57 -38.9 62.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.562 -0.712 . . . . 0.0 110.604 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.3 21.65 5.12 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.13 123.76 46.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -1.221 . . . . 0.0 109.797 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -119.77 122.41 41.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 110.581 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.3 t -81.34 128.99 38.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.079 -1.013 . . . . 0.0 109.59 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.34 -17.68 48.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 108.467 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 10' ' ' TYR 0.255 0.0 OUTLIER -128.78 129.42 45.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.806 -0.559 . . . . 0.0 110.171 -179.533 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.489 1.51 0 O-C-N 120.677 -1.264 . . . . 0.0 110.692 179.335 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.88 ' O ' HD23 ' A' ' 8' ' ' LEU . 26.2 t80 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.11 0.481 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.971 ' CD2' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -141.93 124.75 16.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.767 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -127.77 119.86 26.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.118 -0.989 . . . . 0.0 109.972 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.975 ' O ' HG22 ' A' ' 48' ' ' VAL . 76.9 m-85 -126.54 137.79 53.4 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.152 -0.968 . . . . 0.0 111.104 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.781 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.2 tp60 -120.43 160.66 22.65 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.348 -0.845 . . . . 0.0 109.228 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 21.0 m -130.57 -178.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.03 -1.044 . . . . 0.0 110.687 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.39 57.17 1.59 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.638 -0.664 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.582 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -135.35 155.28 78.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.42 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 37.2 Cg_endo -73.0 -167.79 0.37 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.925 1.487 . . . . 0.0 113.05 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.591 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 15.3 tt0 -66.09 -25.53 67.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.038 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 13.3 t0 -59.87 -40.71 89.55 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.364 0.602 . . . . 0.0 111.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.582 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.1 OUTLIER -88.95 -14.56 36.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.271 -0.893 . . . . 0.0 110.125 -179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.591 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 15.1 t -47.19 -37.47 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -29.36 22.05 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.612 ' OD2' HD23 ' A' ' 72' ' ' LEU . 33.1 t0 -59.87 -39.57 85.71 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.481 -0.762 . . . . 0.0 109.199 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.588 HD12 HG11 ' A' ' 37' ' ' VAL . 4.4 mm? -58.94 -42.75 90.54 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.92 -51.77 66.45 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -46.68 78.69 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.575 -0.703 . . . . 0.0 109.257 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.4 -48.53 76.72 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.43 -0.794 . . . . 0.0 109.306 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.713 HD21 ' CG2' ' A' ' 37' ' ' VAL . 89.4 mt -60.33 -39.53 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -70.24 -38.64 75.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.528 -0.732 . . . . 0.0 109.274 179.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 67' ' ' ILE . 1.2 mm -58.96 -37.77 69.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.827 0.822 . . . . 0.0 108.855 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.873 ' O ' HG12 ' A' ' 32' ' ' VAL . 10.5 mtp180 -69.68 64.05 0.19 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.75 -0.594 . . . . 0.0 110.228 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -37.52 70.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.32 -14.01 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 110.021 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.873 HG12 ' O ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -79.93 138.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.374 -0.829 . . . . 0.0 110.384 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.7 mmt-85 -79.25 -45.49 19.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.068 -1.02 . . . . 0.0 110.913 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.63 123.15 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.204 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 50' ' ' ILE . 2.8 p -130.12 133.61 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.517 -0.74 . . . . 0.0 109.605 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -128.04 118.25 23.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.124 -0.985 . . . . 0.0 110.75 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.115 HG13 HG12 ' A' ' 48' ' ' VAL . 19.4 t -115.06 131.98 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.616 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.494 HG23 ' OE2' ' A' ' 47' ' ' GLU . 4.1 m -121.28 159.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.59 154.17 22.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.401 -0.812 . . . . 0.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.36 176.74 5.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.292 -0.88 . . . . 0.0 109.57 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.4 p -93.34 -3.98 52.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 110.73 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -148.02 -67.77 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.023 -1.048 . . . . 0.0 110.467 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 49.7 Cg_endo -72.53 -168.94 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.303 1.159 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.8 32.88 6.84 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.0 mtt180 -94.26 134.88 36.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -1.068 . . . . 0.0 109.323 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.577 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 7.8 m-85 -116.81 150.18 38.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.871 -1.143 . . . . 0.0 111.427 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.494 ' OE2' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -106.41 90.53 3.37 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.166 178.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.115 HG12 HG13 ' A' ' 37' ' ' VAL . 22.0 m -82.42 125.28 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.549 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -122.51 101.62 7.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.801 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -111.96 142.38 24.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 121.561 0.696 . . . . 0.0 111.437 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.657 ' N ' HD13 ' A' ' 50' ' ' ILE . 7.3 p -108.61 119.94 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.685 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 52' ' ' LEU . 4.6 mt -86.81 177.21 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.967 . . . . 0.0 110.581 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.521 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.2 m-80 -42.96 167.19 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.9 Cg_endo -63.84 -15.0 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.673 1.354 . . . . 0.0 110.24 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 24.2 t-20 -133.28 63.54 1.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.893 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.794 ' C ' HD12 ' A' ' 56' ' ' LEU . 3.1 pp -61.78 176.55 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.041 -1.037 . . . . 0.0 110.414 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 61' ' ' LEU . 2.5 m-20 -168.29 178.31 4.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 110.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.73 -36.32 83.25 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.537 -0.727 . . . . 0.0 110.461 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 t -69.29 -30.6 68.71 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.255 -0.903 . . . . 0.0 110.3 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 22.1 mm-40 -73.12 -45.91 54.22 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.971 HD21 ' CD2' ' A' ' 8' ' ' LEU . 1.6 mp -66.86 -36.14 81.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 109.366 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 66' ' ' GLU . . . -53.45 -33.87 55.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.552 ' O ' HG13 ' A' ' 67' ' ' ILE . 13.7 mt -69.46 -50.38 46.13 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.248 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.4 mm-40 -71.53 -42.75 67.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -65.55 -30.84 71.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.186 -0.946 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 2.0 mm-40 -69.43 -48.92 59.45 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.865 -1.147 . . . . 0.0 110.355 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.596 HG21 HG23 ' A' ' 28' ' ' ILE . 4.7 mt -78.6 -38.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.302 -0.873 . . . . 0.0 111.063 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 53.4 mt -60.37 -48.95 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.993 -1.067 . . . . 0.0 110.391 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 1.6 pp0? -63.55 -41.63 98.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.0 109.809 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.55 -46.52 66.25 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.37 -0.832 . . . . 0.0 110.388 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.88 83.39 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.08 -1.013 . . . . 0.0 109.777 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.612 HD23 ' OD2' ' A' ' 21' ' ' ASP . 97.3 mt -65.5 -35.46 80.95 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.8 OUTLIER -67.0 -45.27 78.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.457 -0.777 . . . . 0.0 109.005 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -61.12 -36.55 80.03 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -74.88 -41.87 58.94 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.74 -0.6 . . . . 0.0 110.327 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.45 23.35 4.47 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -112.54 125.23 54.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.262 -1.14 . . . . 0.0 109.762 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.47 148.91 42.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 110.757 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 11' ' ' GLN . 1.9 t -95.79 114.59 32.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 108.773 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -82.07 -5.47 58.42 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.774 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -138.41 150.32 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.274 -0.891 . . . . 0.0 111.736 -178.354 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 82' ' ' VAL . 3.0 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.787 ' C ' HD13 ' A' ' 8' ' ' LEU . 4.4 p90 . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 121.164 0.507 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.787 HD13 ' C ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -119.52 125.06 47.95 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.227 -0.92 . . . . 0.0 111.245 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -126.58 116.55 21.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.848 ' CD2' HG21 ' A' ' 79' ' ' VAL . 1.4 m-85 -126.96 139.48 53.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 111.062 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.722 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.46 159.86 24.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 26.5 m -133.8 173.97 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.946 -1.096 . . . . 0.0 111.239 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.98 54.25 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.736 -0.603 . . . . 0.0 109.961 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.515 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 50.3 mmm -129.83 156.74 78.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.64 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.85 -167.02 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.825 1.434 . . . . 0.0 113.124 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.573 ' HA ' HG23 ' A' ' 19' ' ' VAL . 17.6 tp10 -63.79 -28.38 69.83 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.407 -1.269 . . . . 0.0 107.796 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -18.6 40.59 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.539 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.902 ' NH1' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -87.57 -23.71 24.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.593 -0.692 . . . . 0.0 110.095 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 16' ' ' GLU . 77.3 t -48.3 -42.71 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.469 -0.77 . . . . 0.0 110.309 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -58.92 -29.97 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.15 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.514 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.7 t0 -61.71 -50.84 70.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.144 -0.972 . . . . 0.0 109.964 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.644 HD11 HH11 ' A' ' 18' ' ' ARG . 8.3 mp -59.89 -43.11 94.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.666 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.5 79.64 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.229 -0.92 . . . . 0.0 109.656 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -68.73 -46.42 68.95 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.393 -0.817 . . . . 0.0 109.266 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.869 ' OE1' ' HB2' ' A' ' 71' ' ' ALA . 9.7 tp10 -60.38 -47.64 85.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.418 -0.801 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.928 HD22 HG11 ' A' ' 35' ' ' VAL . 29.6 mt -53.08 -38.66 62.73 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.579 0.704 . . . . 0.0 109.512 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 4.4 tpt180 -64.11 -34.5 78.18 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 110.549 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.697 HD12 ' OE1' ' A' ' 25' ' ' GLU . 5.4 mt -62.12 -44.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.898 -1.126 . . . . 0.0 109.808 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.626 ' NH1' HD23 ' A' ' 26' ' ' LEU . 11.6 mtp180 -70.05 76.45 0.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.697 -0.627 . . . . 0.0 110.311 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.62 -36.61 84.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.251 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -61.75 -12.89 18.98 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.977 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.019 HG22 HD11 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -79.03 123.73 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.719 . . . . 0.0 110.141 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -47.32 15.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 112.186 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.539 ' CG ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -153.55 139.18 17.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.562 -1.336 . . . . 0.0 110.851 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.928 HG11 HD22 ' A' ' 26' ' ' LEU . 13.3 p -135.63 135.85 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.455 -0.778 . . . . 0.0 110.002 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.488 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 42.0 mtp -117.44 115.48 25.28 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.227 -0.921 . . . . 0.0 109.846 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.9 t -114.67 128.55 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 110.572 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 38' ' ' VAL . 4.8 m -115.09 134.41 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.549 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.14 153.72 23.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.534 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.1 m -73.86 150.64 40.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.885 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.2 p -76.5 3.0 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.589 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -148.99 -66.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -72.37 178.59 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.366 1.193 . . . . 0.0 110.541 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -101.31 33.01 6.82 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 4.8 mtt180 -93.78 134.74 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.439 -1.036 . . . . 0.0 110.275 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.549 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 34.4 m-85 -120.56 151.51 39.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -106.51 99.03 8.63 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.911 -0.493 . . . . 0.0 110.186 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' TYR . 16.9 m -86.53 122.17 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.01 -1.056 . . . . 0.0 110.686 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 36' ' ' MET . 2.4 p30 -131.16 102.71 6.12 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.19 140.76 30.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 O-C-N 121.433 -0.792 . . . . 0.0 111.552 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.681 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.4 p -114.87 150.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.92 ' HB2' HD11 ' A' ' 56' ' ' LEU . 2.3 mp -139.48 -157.41 0.76 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.769 -1.207 . . . . 0.0 111.928 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 52' ' ' LEU . 27.6 m-80 -37.86 161.47 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.561 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -64.67 -17.4 59.4 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.012 1.533 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -146.78 79.78 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.764 -1.21 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.92 HD11 ' HB2' ' A' ' 52' ' ' LEU . 16.2 mt -67.64 -164.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 110.586 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 3.3 t70 -177.08 171.6 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 110.68 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.1 mt-30 -54.63 -35.53 63.56 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.573 -0.704 . . . . 0.0 110.433 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 m -67.85 -40.6 83.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.177 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -70.77 -44.56 66.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.321 -0.862 . . . . 0.0 109.989 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 2.5 mm? -66.44 -34.83 78.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.91 -35.3 45.07 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.3 mt -72.12 -49.67 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.215 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 8.2 mt-10 -67.31 -35.88 80.34 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.533 -1.354 . . . . 0.0 109.915 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.24 -45.27 56.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 75.2 mt-10 -70.2 -38.5 75.34 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.096 -1.002 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 63' ' ' LEU . 43.9 mm -76.9 -38.75 29.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.329 -0.857 . . . . 0.0 111.192 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 62.4 mt -69.39 -46.88 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.884 -1.135 . . . . 0.0 110.125 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 20.0 mt-30 -59.71 -38.8 82.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.901 . . . . 0.0 110.165 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -44.66 91.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.196 -0.94 . . . . 0.0 110.894 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.869 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . . . -68.27 -48.64 64.51 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.997 -1.064 . . . . 0.0 110.522 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.902 HD23 ' NH1' ' A' ' 18' ' ' ARG . 20.3 mt -58.71 -39.93 82.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.39 -0.819 . . . . 0.0 110.547 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -71.2 -45.56 63.13 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.445 -0.784 . . . . 0.0 109.61 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.3 -38.47 86.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -75.79 -32.13 59.75 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.064 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.11 17.55 10.04 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.521 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . . . -102.36 124.36 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.0 110.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -119.0 124.1 46.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.848 HG21 ' CD2' ' A' ' 10' ' ' TYR . 3.8 t -67.6 125.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.983 -1.073 . . . . 0.0 109.884 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -10.28 59.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.69 152.99 52.02 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.315 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 1.028 ' C ' HD13 ' A' ' 8' ' ' LEU . 23.2 t80 . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 121.143 0.497 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.028 HD13 ' C ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -133.32 123.25 25.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.314 -1.491 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 1.4 t90 -128.69 118.42 22.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.667 -0.645 . . . . 0.0 109.481 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -127.2 137.45 52.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.018 -1.051 . . . . 0.0 110.995 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.882 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.8 tt0 -109.32 160.27 16.29 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.282 -0.886 . . . . 0.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.603 HG21 HH21 ' A' ' 18' ' ' ARG . 15.9 m -129.02 -177.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.923 -1.111 . . . . 0.0 111.024 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 1.2 tp10 -140.22 59.68 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.833 0.825 . . . . 0.0 108.971 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.564 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 4.0 tpt -137.07 146.13 53.28 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.601 -0.687 . . . . 0.0 109.216 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' ' HG3' ' A' ' 14' ' ' MET . 33.2 Cg_endo -65.39 -166.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.651 1.342 . . . . 0.0 113.361 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 19' ' ' VAL . 24.5 tt0 -62.07 -27.02 68.61 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.272 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 34.9 t70 -57.65 -20.86 36.37 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.139 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.618 ' CZ ' ' CG ' ' A' ' 46' ' ' TYR . 4.4 ppt_? -88.41 -12.69 42.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 111.063 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 16' ' ' GLU . 56.0 t -46.78 -44.52 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.403 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.526 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.6 m-20 -57.19 -30.45 64.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 109.536 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 36.0 t0 -62.95 -46.75 86.27 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.299 -0.875 . . . . 0.0 110.221 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 37' ' ' VAL . 3.3 mm? -59.02 -43.02 91.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.488 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.08 -48.78 80.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -40.85 84.87 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.561 ' CD ' HG23 ' A' ' 68' ' ' ILE . 28.6 tt0 -56.37 -49.28 74.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.484 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.944 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -69.16 -37.08 78.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.138 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.2 tmm_? -65.66 -37.66 87.13 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.284 -0.885 . . . . 0.0 111.489 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.594 ' CG2' HG22 ' A' ' 67' ' ' ILE . 3.5 tt -58.61 -45.03 90.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.014 -1.054 . . . . 0.0 111.728 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.555 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -86.36 109.21 18.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.984 -1.073 . . . . 0.0 111.206 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -30.65 62.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.893 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 33.9 p30 -59.21 -13.42 7.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.78 . . . . 0.0 110.386 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.975 HG22 ' CD1' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -78.88 122.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.824 . . . . 0.0 110.485 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -79.76 -45.69 18.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 111.01 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -153.38 139.98 18.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.815 -1.178 . . . . 0.0 110.963 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.944 HG11 ' HB2' ' A' ' 26' ' ' LEU . 7.8 p -137.1 132.21 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 0.0 110.409 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.9 tpt -140.88 113.46 8.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.056 -1.027 . . . . 0.0 110.122 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 48' ' ' VAL . 23.3 t -116.92 132.25 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -0.821 . . . . 0.0 110.53 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' ' CD ' ' A' ' 47' ' ' GLU . 32.7 m -105.26 148.83 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.003 -1.06 . . . . 0.0 110.43 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -77.61 154.82 31.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.368 -0.832 . . . . 0.0 110.704 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 p -72.64 -176.68 2.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -101.57 5.71 41.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.086 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -153.11 -66.5 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.4 Cg_endo -72.78 -165.34 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.425 1.224 . . . . 0.0 110.567 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.29 35.4 4.77 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.4 mtt180 -94.04 138.5 32.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.456 -1.026 . . . . 0.0 110.216 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.618 ' CG ' ' CZ ' ' A' ' 18' ' ' ARG . 10.0 m-85 -125.52 154.82 41.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 110.307 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 47' ' ' GLU . 10.0 pt-20 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.435 0.636 . . . . 0.0 109.566 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.74 ' HA ' HG22 ' A' ' 37' ' ' VAL . 44.6 t -88.04 115.92 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 110.836 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.92 101.33 5.59 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.975 ' CD1' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -117.87 131.64 70.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.593 -178.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.723 ' N ' HD13 ' A' ' 50' ' ' ILE . 9.8 p -95.55 151.25 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.046 ' HB2' HD11 ' A' ' 56' ' ' LEU . 4.4 mp -138.6 -157.11 0.74 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 110.923 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 52' ' ' LEU . 28.2 m-80 -34.85 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 121.056 0.455 . . . . 0.0 111.115 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.83 -27.94 59.22 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.144 1.602 . . . . 0.0 111.15 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -131.11 81.32 1.98 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 110.161 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.046 HD11 ' HB2' ' A' ' 52' ' ' LEU . 13.8 mt -74.03 -165.36 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 172.63 -171.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.597 0.713 . . . . 0.0 110.371 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -65.36 -33.13 75.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 110.852 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.9 t -68.27 -34.46 76.23 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HB3' HD22 ' A' ' 56' ' ' LEU . 21.5 mm-40 -71.19 -42.13 69.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 110.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 8' ' ' LEU . 9.3 mt -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.07 -36.59 60.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.928 -1.107 . . . . 0.0 108.086 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.7 mt -71.5 -49.87 36.98 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.807 0.813 . . . . 0.0 109.272 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.842 ' OE2' HD23 ' A' ' 61' ' ' LEU . 8.6 pt-20 -67.1 -39.76 86.78 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.585 -1.322 . . . . 0.0 109.94 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -71.87 -41.51 67.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.864 -1.148 . . . . 0.0 110.488 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.5 mt-10 -75.38 -41.07 57.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.701 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 63' ' ' LEU . 17.9 mm -78.92 -36.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 112.219 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 96.7 mt -70.41 -44.58 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.329 -1.482 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.1 mm100 -55.79 -39.2 70.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -57.61 -48.12 80.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 111.374 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -72.23 -48.77 40.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.971 -1.08 . . . . 0.0 111.578 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 25.1 mt -60.1 -42.71 95.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 111.331 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.17 -43.39 70.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.014 -1.053 . . . . 0.0 109.182 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 34.1 t-20 -59.65 -37.12 77.85 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.578 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -74.49 -29.27 61.36 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.259 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.59 5.28 27.91 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -99.66 118.45 36.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -1.149 . . . . 0.0 110.462 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -118.6 137.18 53.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.647 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.3 t -75.98 119.52 24.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.88 -5.63 59.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.571 -0.706 . . . . 0.0 109.213 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.574 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.69 160.81 35.66 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.282 -0.886 . . . . 0.0 111.591 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 82' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.032 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.931 ' C ' HD12 ' A' ' 8' ' ' LEU . 57.6 m-85 . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 121.101 0.477 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.931 HD12 ' C ' ' A' ' 7' ' ' PHE . 5.3 mp -135.51 127.86 30.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 110.543 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.507 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -97.14 127.86 43.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.7 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.811 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -127.14 120.62 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.55 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 9.4 tt0 -112.35 159.7 18.42 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 10' ' ' TYR . 16.4 m -135.73 178.36 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.073 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -132.45 56.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.576 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.91 152.4 72.14 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 110.595 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.4 Cg_endo -72.23 -167.67 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.977 1.514 . . . . 0.0 112.809 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.528 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 2.4 tt0 -65.52 -25.37 67.42 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.854 178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.92 -41.46 91.81 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.873 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.62 -16.3 30.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.278 -0.889 . . . . 0.0 110.688 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 15' ' ' PRO . 20.6 t -47.36 -37.75 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.43 -0.794 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -53.59 -29.34 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.553 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 36.5 t0 -59.74 -39.47 84.86 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.399 -0.813 . . . . 0.0 110.338 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.4 mm? -59.07 -41.42 87.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 110.088 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.53 63.75 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.415 ' O ' HG13 ' A' ' 28' ' ' ILE . 2.1 ttp180 -68.93 -41.72 77.71 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.598 ' CD ' HG23 ' A' ' 68' ' ' ILE . 3.9 tt0 -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.196 -0.94 . . . . 0.0 109.946 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.766 HD22 ' CG2' ' A' ' 35' ' ' VAL . 14.1 mt -66.09 -38.63 88.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.772 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.54 ' NH1' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.81 -37.47 82.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.179 -0.95 . . . . 0.0 111.176 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.684 ' CG2' HG23 ' A' ' 67' ' ' ILE . 55.1 mt -61.75 -44.23 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.82 -1.175 . . . . 0.0 110.56 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.546 ' O ' HG12 ' A' ' 32' ' ' VAL . 9.4 ptp85 -75.06 59.6 0.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.124 -0.985 . . . . 0.0 110.282 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.49 -25.32 16.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.187 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -58.41 -17.08 17.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.3 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.09 HG23 HD11 ' A' ' 50' ' ' ILE . 4.3 p -80.68 137.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 110.302 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -79.18 -46.05 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.978 . . . . 0.0 110.758 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' O ' HG12 ' A' ' 50' ' ' ILE . 4.8 tpt180 -152.79 121.96 6.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.832 -1.167 . . . . 0.0 110.987 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.009 HG12 HG13 ' A' ' 50' ' ' ILE . 3.1 m -109.74 135.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.9 ttp -124.77 116.13 21.82 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.059 -1.026 . . . . 0.0 110.802 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.72 HG22 HG22 ' A' ' 48' ' ' VAL . 19.4 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.078 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 12.0 m -114.29 135.11 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.659 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.66 154.28 22.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -172.56 1.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 41' ' ' THR . 8.8 t -101.53 8.41 41.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.173 -0.954 . . . . 0.0 110.595 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.56 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.74 -63.75 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.978 . . . . 0.0 110.421 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.8 Cg_endo -69.56 -176.51 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.537 1.283 . . . . 0.0 110.845 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.36 32.74 6.9 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 17.5 mtt180 -96.21 143.12 27.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.395 -1.062 . . . . 0.0 109.92 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.645 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 12.1 m-85 -125.51 152.99 44.26 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.05 -1.031 . . . . 0.0 111.529 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.3 mp0 -105.05 92.83 4.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.72 HG22 HG22 ' A' ' 37' ' ' VAL . 21.7 t -80.69 125.41 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 111.84 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 47' ' ' GLU . 1.5 m-80 -130.31 101.08 5.61 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.09 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.98 146.38 33.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 119.746 -0.781 . . . . 0.0 111.876 -177.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' N ' HD13 ' A' ' 50' ' ' ILE . 14.3 p -111.79 151.66 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 56' ' ' LEU . 3.9 mp -118.17 -158.69 0.72 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.515 -1.366 . . . . 0.0 111.83 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' O ' ' O ' ' A' ' 52' ' ' LEU . 47.2 m-80 -37.36 163.52 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.737 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.9 Cg_endo -63.73 -15.95 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.934 1.492 . . . . 0.0 110.759 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.434 ' OD1' ' C ' ' A' ' 55' ' ' ASN . 8.9 t-20 -151.84 90.54 1.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 110.201 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 52' ' ' LEU . 10.7 mt -76.83 -173.54 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.822 -1.173 . . . . 0.0 111.81 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.73 179.04 6.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.404 0.621 . . . . 0.0 109.536 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 61' ' ' LEU . 41.2 mt-30 -66.13 -43.17 87.88 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.425 -0.797 . . . . 0.0 111.009 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -65.41 -33.22 75.44 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.284 -0.885 . . . . 0.0 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 11.0 mm-40 -62.28 -38.28 88.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 110.359 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 58' ' ' GLN . 5.3 mt -59.99 -33.18 71.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.01 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.82 -34.48 40.53 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.652 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.1 mt -71.18 -51.8 22.74 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.957 0.884 . . . . 0.0 108.706 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -61.7 -41.39 97.53 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.859 -1.151 . . . . 0.0 109.735 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.522 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -72.72 -46.37 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 110.573 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 72.5 mt-10 -68.85 -37.57 79.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.87 -1.144 . . . . 0.0 109.686 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.684 HG23 ' CG2' ' A' ' 28' ' ' ILE . 19.2 mm -77.74 -45.5 28.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 111.84 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 ' CD ' ' A' ' 25' ' ' GLU . 58.2 mt -70.04 -42.01 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.76 -1.213 . . . . 0.0 110.214 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.9 pt20 -64.37 -40.74 96.43 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 11.2 ttt180 -58.38 -46.16 86.88 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.366 -0.834 . . . . 0.0 110.989 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.87 -48.76 57.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.902 -1.124 . . . . 0.0 110.636 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.632 HD13 ' OH ' ' A' ' 10' ' ' TYR . 83.8 mt -63.98 -36.24 83.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.336 -0.852 . . . . 0.0 110.641 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -69.82 -44.88 69.09 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.39 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 70' ' ' ARG . 72.5 m-20 -65.44 -37.04 85.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -75.72 -39.82 56.65 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.485 -0.759 . . . . 0.0 110.459 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.41 29.63 2.67 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.37 130.23 55.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.356 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.34 134.98 54.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.105 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.811 HG22 ' CE2' ' A' ' 10' ' ' TYR . 2.1 t -79.4 122.4 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.831 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.95 -10.98 59.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.63 145.03 50.33 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.537 -0.727 . . . . 0.0 111.023 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.034 179.172 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -148.88 124.54 10.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.15 -0.969 . . . . 0.0 111.413 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.458 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 1.3 t-105 -114.26 119.67 37.79 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.689 ' CD2' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -125.09 129.86 51.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.053 -1.029 . . . . 0.0 111.023 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.765 ' O ' HG13 ' A' ' 79' ' ' VAL . 14.2 tt0 -122.66 151.15 41.79 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.336 -0.852 . . . . 0.0 109.27 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.76 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 2.0 m -126.18 -174.98 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' O ' ' SD ' ' A' ' 14' ' ' MET . 4.3 pt-20 -138.78 49.93 1.86 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.286 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.597 ' HE3' ' HD2' ' A' ' 18' ' ' ARG . 30.3 mmm -123.46 155.63 65.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 1.006 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -70.52 -172.4 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.045 1.55 . . . . 0.0 112.82 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 1.1 tt0 -64.03 -27.04 68.84 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.536 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.36 -45.89 87.33 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.54 0.686 . . . . 0.0 109.82 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.597 ' HD2' ' HE3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.81 -33.1 16.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.555 -0.715 . . . . 0.0 110.197 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.006 HG23 ' O ' ' A' ' 15' ' ' PRO . 77.5 t -48.05 -40.56 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -54.88 -28.42 50.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.843 . . . . 0.0 109.019 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.595 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 26.0 t0 -58.92 -35.4 73.03 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.357 0.598 . . . . 0.0 110.609 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.576 HD21 ' OH ' ' A' ' 46' ' ' TYR . 4.2 mm? -55.87 -41.94 75.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.288 -0.965 . . . . 0.0 108.931 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.76 72.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.59 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -68.54 -46.05 70.56 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.365 -0.835 . . . . 0.0 109.511 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.696 ' CD ' ' HB1' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -65.0 -33.52 76.26 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.521 -0.737 . . . . 0.0 110.235 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.126 HD22 HG21 ' A' ' 35' ' ' VAL . 27.2 mt -69.42 -37.14 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 110.783 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' CD ' ' HA ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -68.09 -35.31 77.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.935 -1.103 . . . . 0.0 112.736 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.768 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.41 -35.52 67.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 120.423 -1.423 . . . . 0.0 111.43 -178.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.591 ' NE ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -79.9 61.58 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.751 -1.218 . . . . 0.0 109.873 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.94 -23.08 42.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.451 -0.781 . . . . 0.0 111.494 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -56.62 -28.1 59.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.085 -1.009 . . . . 0.0 111.526 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.038 ' CG1' HD11 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -82.36 155.98 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.693 -1.254 . . . . 0.0 110.523 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -47.13 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 112.259 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' ILE . 1.2 ttt180 -154.28 156.95 37.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.65 -1.282 . . . . 0.0 112.149 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.126 HG21 HD22 ' A' ' 26' ' ' LEU . 9.9 p -141.22 135.82 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.4 117.84 23.77 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.511 HG21 HD11 ' A' ' 26' ' ' LEU . 25.8 t -115.16 132.01 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 110.966 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 5.4 m -114.3 126.32 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.185 -0.947 . . . . 0.0 110.0 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -80.65 152.58 28.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.287 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 13.6 p -76.42 -168.27 0.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.523 -0.736 . . . . 0.0 110.02 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 t -107.85 -32.61 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.774 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m -110.09 -67.12 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.078 -1.014 . . . . 0.0 111.136 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 48.2 Cg_endo -72.19 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.177 1.093 . . . . 0.0 110.628 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.36 31.83 5.28 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.556 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 6.7 mtt180 -94.68 135.71 35.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.997 . . . . 0.0 110.389 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.76 ' CZ ' HG21 ' A' ' 12' ' ' VAL . 9.4 p90 -135.65 154.01 51.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.738 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -91.88 96.24 10.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.891 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.593 HG23 ' CD1' ' A' ' 46' ' ' TYR . 24.2 t -77.06 124.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.405 -0.81 . . . . 0.0 110.261 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -130.73 102.3 6.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.038 HD11 ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.7 138.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.176 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.61 ' N ' HD13 ' A' ' 50' ' ' ILE . 7.6 p -94.55 151.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.562 -0.712 . . . . 0.0 110.202 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -97.41 179.67 4.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 110.844 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.571 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -49.26 -178.01 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.068 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.0 Cg_endo -63.92 -15.07 46.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.585 1.308 . . . . 0.0 110.068 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -143.7 84.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.297 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.541 ' HB3' ' CB ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -66.23 -176.99 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.074 -1.016 . . . . 0.0 111.389 -178.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.483 ' HB3' ' HG3' ' A' ' 60' ' ' GLN . 5.7 t70 174.61 172.28 0.22 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.416 0.627 . . . . 0.0 109.417 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.76 ' HA ' HD21 ' A' ' 61' ' ' LEU . 9.0 mt-30 -63.21 -41.02 99.09 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.158 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 -31.92 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' A' ' 57' ' ' ASP . 3.6 mm100 -74.15 -46.16 44.11 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 110.397 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.822 HD12 ' N ' ' A' ' 62' ' ' ALA . 4.4 pp -68.03 -35.19 77.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.817 -1.177 . . . . 0.0 109.368 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.822 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -51.8 -33.4 35.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.739 HD23 ' OE2' ' A' ' 66' ' ' GLU . 17.7 mt -71.27 -50.9 27.93 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.628 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.85 ' HG2' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -71.39 -35.49 71.06 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.401 -1.437 . . . . 0.0 109.885 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -74.15 -39.68 63.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.739 ' OE2' HD23 ' A' ' 63' ' ' LEU . 13.3 pt-20 -73.81 -37.85 64.76 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.753 -1.217 . . . . 0.0 109.982 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 63' ' ' LEU . 24.0 mm -77.89 -38.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.348 -0.845 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 46.1 mt -68.35 -42.03 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.9 -1.125 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 22.9 mt-30 -64.33 -48.16 76.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -40.41 95.35 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.22 -0.925 . . . . 0.0 110.593 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.696 ' HB1' ' CD ' ' A' ' 25' ' ' GLU . . . -66.47 -48.55 69.52 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.193 -0.942 . . . . 0.0 109.962 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 72' ' ' LEU . 47.9 mt -66.17 -35.53 80.7 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.313 -0.867 . . . . 0.0 110.017 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 9.0 mm-40 -70.03 -42.86 72.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -0.818 . . . . 0.0 109.086 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -58.78 -36.02 73.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.18 -31.47 62.69 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.581 -0.699 . . . . 0.0 110.559 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.41 1.5 21.75 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.3 124.77 39.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -1.188 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 5.0 ttm180 -120.37 150.89 40.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.1 t -92.67 118.83 39.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.134 -0.979 . . . . 0.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -4.9 57.91 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.545 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.79 144.46 51.09 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.388 -0.82 . . . . 0.0 110.894 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 109.087 178.76 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.825 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.124 0.488 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 7' ' ' PHE . 3.1 mm? -116.79 144.71 44.15 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 110.616 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.592 ' CE2' ' HE3' ' A' ' 81' ' ' LYS . 5.8 t90 -124.52 118.41 26.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.559 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.699 ' CD2' HG11 ' A' ' 79' ' ' VAL . 9.1 m-85 -127.61 131.11 49.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.896 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.9 tt0 -101.96 159.58 15.23 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.946 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 3.6 m -129.74 -175.34 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.39 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' SD ' ' A' ' 14' ' ' MET . 0.6 OUTLIER -141.13 54.2 1.56 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.755 -0.591 . . . . 0.0 109.843 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -121.32 152.19 57.19 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.427 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.6 Cg_endo -70.88 -162.9 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.207 1.635 . . . . 0.0 112.385 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.83 -26.45 2.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 15' ' ' PRO . 41.8 t0 -57.73 -15.38 7.79 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.957 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.585 ' HD3' ' CE1' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -71.74 -17.07 62.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.411 -0.805 . . . . 0.0 110.552 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.19 -48.59 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.549 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 20.0 m-80 -64.82 -30.32 71.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.094 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 26.4 t0 -65.16 -54.66 26.38 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.631 HD21 ' OH ' ' A' ' 46' ' ' TYR . 3.9 mm? -59.16 -36.87 76.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.173 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.48 -52.24 65.46 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.589 -0.695 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -47.12 80.25 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.378 -0.826 . . . . 0.0 109.585 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.65 -43.79 95.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.487 -0.758 . . . . 0.0 110.007 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.677 ' CD2' HG11 ' A' ' 35' ' ' VAL . 19.2 mt -54.94 -40.16 69.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 109.968 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -37.71 68.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.562 HG21 ' CG2' ' A' ' 67' ' ' ILE . 2.5 mt -59.64 -44.53 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.265 -0.897 . . . . 0.0 110.617 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.946 ' O ' HG12 ' A' ' 32' ' ' VAL . 13.8 ptt85 -69.52 62.99 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.457 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' ILE . 1.8 m-20 -74.44 -39.76 62.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -62.83 -15.01 52.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.212 -0.93 . . . . 0.0 111.112 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.129 HG21 ' CD1' ' A' ' 50' ' ' ILE . 6.1 p -80.76 151.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.901 -1.124 . . . . 0.0 111.424 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -45.39 17.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 111.254 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.433 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.22 155.7 38.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.926 -1.109 . . . . 0.0 111.313 -179.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 50' ' ' ILE . 14.9 p -137.67 136.15 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 110.061 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.14 118.25 26.46 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 131.92 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.823 . . . . 0.0 110.574 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 4.6 m -117.75 127.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.136 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -79.86 153.56 28.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.333 -0.854 . . . . 0.0 110.631 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.499 ' OG ' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -74.75 179.41 4.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.205 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -103.5 12.96 34.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.28 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 110.014 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.6 Cg_endo -70.24 -170.69 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.687 1.362 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 21.68 26.22 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 8.2 ptp180 -94.79 162.54 13.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.544 -0.974 . . . . 0.0 110.32 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.946 ' CZ ' HG21 ' A' ' 12' ' ' VAL . 2.1 p90 -152.8 154.7 35.7 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.797 0.808 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.554 ' HG3' ' CD1' ' A' ' 9' ' ' TRP . 2.4 tt0 -92.71 97.33 10.71 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.351 0.596 . . . . 0.0 109.662 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 46' ' ' TYR . 39.2 t -77.42 119.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.419 -0.801 . . . . 0.0 110.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.22 100.96 5.58 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.129 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -121.06 147.62 24.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 121.427 0.632 . . . . 0.0 110.602 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 7' ' ' PHE . 12.0 p -126.09 148.22 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.054 ' HG ' HG23 ' A' ' 32' ' ' VAL . 2.1 mp -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.13 -0.981 . . . . 0.0 110.174 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.53 ' N ' HD21 ' A' ' 56' ' ' LEU . 41.5 m-80 -36.75 159.48 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.812 -0.555 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.52 -20.75 66.04 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.983 1.517 . . . . 0.0 111.498 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -127.98 77.67 1.78 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.057 . . . . 0.0 109.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 52' ' ' LEU . 6.4 mt -73.3 -173.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.384 1.088 . . . . 0.0 112.531 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.508 ' OD1' ' HG3' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -168.43 170.63 9.67 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.606 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.58 -32.22 73.17 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.958 -1.088 . . . . 0.0 110.813 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -38.39 76.05 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.508 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 8.7 mm-40 -68.57 -43.9 75.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 21.2 mt -65.15 -35.36 80.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.018 -1.051 . . . . 0.0 109.702 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 66' ' ' GLU . . . -52.83 -33.25 48.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 24.9 mt -66.17 -50.48 63.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' OE1' HD11 ' A' ' 52' ' ' LEU . 18.0 pt-20 -74.84 -41.14 60.44 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.847 -1.158 . . . . 0.0 109.513 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 4.0 mptp? -67.98 -32.92 73.66 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.41 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 11.1 pt-20 -69.88 -46.35 65.66 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.41 -1.431 . . . . 0.0 109.945 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.562 ' CG2' HG21 ' A' ' 28' ' ' ILE . 4.4 mt -78.3 -40.72 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.066 . . . . 0.0 111.136 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 68.1 mt -60.49 -49.85 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 70' ' ' ARG . 2.9 pt20 -60.85 -44.12 97.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 17.2 mtp-105 -68.6 -47.11 67.54 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.503 -0.748 . . . . 0.0 110.765 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -62.28 -47.83 82.6 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.053 -1.03 . . . . 0.0 110.077 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD2' ' OD2' ' A' ' 21' ' ' ASP . 91.3 mt -63.13 -38.01 89.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.354 -0.842 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.02 -45.34 64.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.398 -0.814 . . . . 0.0 109.595 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -61.63 -36.47 80.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.562 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.47 -17.94 60.0 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.467 -0.771 . . . . 0.0 110.406 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.15 2.86 48.38 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' CB ' ' OD2' ' A' ' 21' ' ' ASP . . . -98.36 111.78 24.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -1.187 . . . . 0.0 110.099 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -118.05 144.75 45.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.1 t -88.95 125.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 120.922 -1.111 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 -5.63 58.76 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -130.38 149.96 51.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 111.579 -178.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.506 HG12 ' CE2' ' A' ' 10' ' ' TYR . 1.2 m . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 109.125 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.456 ' C ' HD12 ' A' ' 8' ' ' LEU . 17.5 m-85 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.325 0.584 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.659 HD21 HD23 ' A' ' 61' ' ' LEU . 4.1 mp -144.34 124.17 13.44 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.34 -0.85 . . . . 0.0 110.645 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -123.15 118.21 27.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD2' HG11 ' A' ' 79' ' ' VAL . 3.1 m-85 -126.57 135.08 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 110.89 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.797 ' O ' HG13 ' A' ' 79' ' ' VAL . 2.3 tt0 -119.42 159.57 23.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 18.9 m -130.27 179.88 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 110.747 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -137.04 60.41 1.66 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.588 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 1.3 ptm -134.48 147.91 65.36 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.501 -0.749 . . . . 0.0 110.999 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 Cg_endo -73.37 -166.73 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.216 1.64 . . . . 0.0 112.452 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.579 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 22.7 tt0 -65.24 -25.42 67.66 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.203 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.01 -42.19 93.77 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.836 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -90.23 -14.34 33.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.33 -0.856 . . . . 0.0 110.322 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 7.2 t -46.52 -36.74 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.515 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.8 t30 -52.25 -27.89 16.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.364 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 42.3 t0 -59.14 -44.43 92.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.0 mm? -59.04 -39.62 82.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.84 . . . . 0.0 109.171 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -56.61 -53.12 61.32 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.439 -0.788 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -42.89 93.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.553 ' OE2' ' HB3' ' A' ' 71' ' ' ALA . 1.1 tt0 -57.69 -47.57 81.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.739 HD23 ' CG1' ' A' ' 35' ' ' VAL . 6.7 mt -54.69 -40.14 68.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -36.13 74.24 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -63.28 -43.93 98.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 32' ' ' VAL . 8.7 mtm180 -70.47 54.82 0.15 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.563 -0.71 . . . . 0.0 110.359 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -74.09 -40.66 62.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.03 -16.18 40.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.573 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.089 HG21 ' CD1' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -81.31 158.49 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 110.093 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.481 ' HD2' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -79.15 -46.81 17.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 111.229 -179.366 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.66 149.93 28.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 111.097 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.739 ' CG1' HD23 ' A' ' 26' ' ' LEU . 7.4 p -139.85 133.79 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.9 mtm -129.91 115.16 16.79 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.059 -1.026 . . . . 0.0 110.968 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.1 t -115.19 130.32 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 109.816 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -116.76 156.51 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.002 -1.061 . . . . 0.0 110.944 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.92 153.42 22.21 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.384 0.611 . . . . 0.0 110.456 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -76.83 -177.35 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.427 179.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -98.37 -47.85 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.303 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -100.59 -66.99 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 110.803 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.9 Cg_endo -72.1 -161.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.335 1.176 . . . . 0.0 110.776 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -116.19 40.49 2.39 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.6 mtt180 -93.3 135.41 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -1.081 . . . . 0.0 110.258 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.579 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 32.7 m-85 -115.05 154.98 27.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 111.034 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 5.3 mm-40 -100.52 114.99 29.06 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.925 -0.484 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 72.4 t -92.46 111.54 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 110.39 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.81 101.07 5.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.089 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -124.83 149.07 29.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 121.681 0.753 . . . . 0.0 111.553 -178.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 32' ' ' VAL . 6.5 p -98.72 151.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.739 -0.601 . . . . 0.0 109.682 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.499 HD13 HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -95.49 176.26 6.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.368 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.503 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -48.48 179.23 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.403 -0.811 . . . . 0.0 109.794 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.8 -19.74 69.34 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.458 1.241 . . . . 0.0 109.266 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -142.1 84.92 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.919 HD12 ' N ' ' A' ' 57' ' ' ASP . 3.8 pp -71.13 -172.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.004 . . . . 0.0 110.812 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.919 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.8 t70 173.07 171.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.386 0.612 . . . . 0.0 109.782 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.446 ' HG3' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -53.86 -54.39 39.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -0.819 . . . . 0.0 110.868 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -32.48 72.24 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.918 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.0 mm-40 -67.17 -44.77 78.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.848 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.659 HD23 HD21 ' A' ' 8' ' ' LEU . 5.8 mp -65.05 -34.36 78.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.014 -1.054 . . . . 0.0 109.676 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 66' ' ' GLU . . . -52.28 -33.85 43.88 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.659 ' O ' HG12 ' A' ' 67' ' ' ILE . 32.9 mt -68.16 -50.03 57.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.87 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.8 ' OE2' HG23 ' A' ' 32' ' ' VAL . 90.8 mt-10 -70.62 -35.6 73.04 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.243 -1.536 . . . . 0.0 109.381 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.48 -43.87 59.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 110.646 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 67' ' ' ILE . 10.0 pt-20 -72.62 -37.82 67.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.891 -1.13 . . . . 0.0 109.893 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 63' ' ' LEU . 40.1 mm -77.25 -39.73 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 111.154 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 64' ' ' GLU . 87.8 mt -70.28 -47.0 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.867 -1.146 . . . . 0.0 110.043 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 12.0 mm-40 -61.49 -33.83 74.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 110.541 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -67.42 -41.9 84.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.098 -1.002 . . . . 0.0 111.235 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' OE2' ' A' ' 25' ' ' GLU . . . -70.44 -48.41 56.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 111.323 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HG ' ' OE1' ' A' ' 25' ' ' GLU . 29.3 mt -58.59 -36.47 74.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 111.211 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.252 4.0 tt0 -71.53 -47.57 54.35 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.147 0.975 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -61.54 -39.38 90.89 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.116 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.68 -35.73 60.26 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.65 24.82 4.2 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -107.3 127.05 53.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.861 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -118.77 137.69 53.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 110.426 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 11' ' ' GLN . 1.7 t -90.29 117.16 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -82.42 -6.82 59.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 109.452 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.571 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -134.94 136.13 42.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.302 -0.874 . . . . 0.0 111.525 -178.767 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.524 ' O ' HG13 ' A' ' 82' ' ' VAL . 2.7 p . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.169 0.509 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.055 ' CD2' HD22 ' A' ' 61' ' ' LEU . 6.4 mp -105.27 125.33 50.86 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.543 ' CE2' ' OD1' ' A' ' 49' ' ' ASN . 1.1 t90 -124.48 126.72 46.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.356 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.481 ' OH ' HD23 ' A' ' 8' ' ' LEU . 80.1 m-85 -122.94 122.1 37.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.921 . . . . 0.0 110.689 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.972 ' O ' HG13 ' A' ' 79' ' ' VAL . 11.8 tt0 -111.29 159.84 17.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.303 -0.873 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.8 m -136.86 -176.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.832 -1.168 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 15.1 tt0 -145.76 53.38 1.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.574 -0.704 . . . . 0.0 110.338 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.558 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -128.77 153.01 79.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.73 -166.53 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.952 1.501 . . . . 0.0 113.574 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HA ' HG23 ' A' ' 19' ' ' VAL . 3.0 tm-20 -60.72 -26.61 67.3 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.918 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.33 -27.28 62.09 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.908 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.616 ' NH1' ' CZ ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -88.44 -13.74 39.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.999 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.69 HG23 ' HA ' ' A' ' 16' ' ' GLU . 79.2 t -47.76 -40.99 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.0 109.968 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.8 m-20 -61.77 -29.68 70.29 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.772 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.733 ' OD2' HD23 ' A' ' 72' ' ' LEU . 39.5 t0 -60.85 -47.54 85.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.341 -0.85 . . . . 0.0 110.386 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.4 mm? -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.847 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.01 -47.29 78.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.06 -44.14 73.2 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.386 -0.821 . . . . 0.0 110.003 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.484 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.07 -47.95 82.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.739 HD12 ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -63.06 -37.25 86.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.044 -1.035 . . . . 0.0 110.593 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.464 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.01 -42.38 63.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.849 -1.157 . . . . 0.0 110.454 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -61.93 -43.22 97.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.376 -0.828 . . . . 0.0 111.761 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -70.63 67.42 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.087 -1.008 . . . . 0.0 110.812 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 3.7 m-20 -64.59 -25.08 67.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.516 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 24.5 p30 -64.86 -25.79 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.299 -0.875 . . . . 0.0 111.57 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.653 HG22 ' CD1' ' A' ' 50' ' ' ILE . 0.5 OUTLIER -80.62 148.9 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.808 -1.182 . . . . 0.0 110.162 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -47.4 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 111.994 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -154.46 138.52 16.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.193 . . . . 0.0 111.243 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 50' ' ' ILE . 2.1 t -125.83 132.54 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.335 -0.853 . . . . 0.0 110.131 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 ttm -119.92 115.49 23.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.219 -0.926 . . . . 0.0 109.96 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.89 130.68 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.811 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 1.4 m -123.25 129.07 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.706 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -76.66 153.92 34.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -168.2 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.505 -0.747 . . . . 0.0 109.826 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.0 t -109.21 11.82 25.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.977 . . . . 0.0 110.79 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.574 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.36 -65.11 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 50.5 Cg_endo -72.62 -170.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.465 1.245 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -110.37 34.03 5.63 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.9 mtt180 -94.14 141.19 28.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -1.012 . . . . 0.0 110.04 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.706 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 17.4 m-85 -124.91 154.19 41.49 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.976 0.893 . . . . 0.0 110.729 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 24.8 mt-10 -103.05 92.5 4.57 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 80.7 t -77.49 124.74 36.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.543 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 74.9 m-20 -128.32 100.83 5.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.709 HD13 ' N ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -113.49 130.03 68.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 121.216 0.531 . . . . 0.0 110.408 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.709 ' N ' HD13 ' A' ' 50' ' ' ILE . 8.4 p -91.97 150.25 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.84 HD22 HD12 ' A' ' 56' ' ' LEU . 12.5 mt -92.94 167.67 11.66 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 111.217 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.698 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 1.7 m-20 -65.1 -147.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.56 -35.14 30.71 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 CA-C-N 119.426 0.831 . . . . 0.0 111.64 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -162.97 79.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.74 -1.225 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.84 HD12 HD22 ' A' ' 52' ' ' LEU . 16.8 mt -80.4 -165.82 0.94 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.134 -0.979 . . . . 0.0 111.3 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.514 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER 177.72 -162.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.664 -0.647 . . . . 0.0 110.273 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.601 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 24.3 mt-30 -64.67 -30.16 71.17 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 111.132 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -71.25 -44.23 65.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.4 mm100 -73.64 -44.09 57.81 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.487 -0.758 . . . . 0.0 109.682 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.055 HD22 ' CD2' ' A' ' 8' ' ' LEU . 30.7 mt -66.58 -33.28 75.32 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 58' ' ' GLN . . . -51.76 -32.91 32.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 67' ' ' ILE . 88.6 mt -71.18 -50.4 33.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.634 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.562 ' CD ' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -70.49 -32.21 69.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.453 -1.404 . . . . 0.0 109.56 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.556 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -73.37 -45.19 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 44.8 mt-10 -64.84 -38.3 90.53 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.121 -0.987 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 63' ' ' LEU . 7.1 mm -78.39 -43.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.538 -0.727 . . . . 0.0 111.458 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.562 HD12 ' CD ' ' A' ' 64' ' ' GLU . 10.4 mt -64.29 -41.3 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.0 110.7 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.91 -37.44 82.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.097 -1.002 . . . . 0.0 110.429 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -69.31 -45.43 69.55 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.222 -0.923 . . . . 0.0 111.103 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -48.82 72.27 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.008 -1.058 . . . . 0.0 110.253 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.733 HD23 ' OD2' ' A' ' 21' ' ' ASP . 36.1 mt -63.8 -35.68 81.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.958 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' CA ' ' OE1' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -70.35 -45.55 65.91 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.543 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -60.3 -37.23 79.88 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.36 -25.72 57.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.495 -0.753 . . . . 0.0 110.326 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.11 11.32 32.23 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -95.05 126.58 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -1.106 . . . . 0.0 110.2 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -119.49 131.71 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.972 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.4 t -85.84 124.6 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.01 -9.11 59.66 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -131.57 130.82 42.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.368 -0.832 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.749 ' O ' HG13 ' A' ' 82' ' ' VAL . 8.9 p . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.094 . . . . 0.0 110.57 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.976 ' C ' HD23 ' A' ' 8' ' ' LEU . 85.6 t80 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.221 0.534 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.976 HD23 ' C ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -153.51 123.97 7.12 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 120.962 -1.086 . . . . 0.0 111.939 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.407 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 7.3 t90 -128.11 118.83 24.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.503 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 62.0 m-85 -127.54 145.19 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.874 -1.141 . . . . 0.0 111.753 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 81' ' ' LYS . 23.2 tt0 -122.91 159.6 27.91 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.367 -0.833 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.54 -177.43 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.938 -1.102 . . . . 0.0 110.726 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 13' ' ' GLU . 6.7 tt0 -135.58 50.18 2.12 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.693 0.759 . . . . 0.0 109.748 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' GLY . 16.6 mmt -128.59 148.7 69.42 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.81 -166.58 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.768 1.404 . . . . 0.0 113.412 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -52.58 -24.84 9.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.713 178.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.46 ' C ' ' HH ' ' A' ' 75' ' ' TYR . 35.8 t0 -58.22 -13.1 4.34 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.329 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -71.42 -13.3 61.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.234 -0.916 . . . . 0.0 111.027 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 16' ' ' GLU . 54.7 t -49.76 -46.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.34 -0.85 . . . . 0.0 110.068 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -30.87 69.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.168 -0.958 . . . . 0.0 109.58 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.652 ' OD2' ' HB3' ' A' ' 77' ' ' ALA . 16.3 t0 -69.48 -54.93 11.83 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.334 -0.854 . . . . 0.0 109.931 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.3 mm? -61.64 -38.13 86.55 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.85 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.81 -52.02 66.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.433 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.481 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -70.35 -46.83 63.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.187 -0.946 . . . . 0.0 109.769 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.949 ' OE2' HG23 ' A' ' 68' ' ' ILE . 50.5 tt0 -56.51 -49.63 74.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 110.919 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.737 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -63.76 -36.4 83.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.504 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.95 -41.98 97.35 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.194 -0.942 . . . . 0.0 111.313 -179.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.623 HG21 HG23 ' A' ' 67' ' ' ILE . 23.2 mt -67.57 -40.96 85.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.782 -1.199 . . . . 0.0 109.834 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 32' ' ' VAL . 36.7 mtp180 -74.39 64.53 1.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.546 -0.721 . . . . 0.0 110.373 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -29.62 70.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.942 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -62.14 -13.75 30.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.439 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.713 HG23 HD11 ' A' ' 50' ' ' ILE . 1.8 p -79.91 126.2 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.108 -0.995 . . . . 0.0 110.597 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -80.38 -44.59 19.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 110.69 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -151.72 123.72 8.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 0.0 111.486 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.499 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 3.7 p -129.94 128.16 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.708 . . . . 0.0 109.155 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.4 tpp -116.26 115.79 26.6 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.069 -1.02 . . . . 0.0 111.065 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG21 HD12 ' A' ' 22' ' ' LEU . 16.8 t -115.25 125.23 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.78 160.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.069 -1.019 . . . . 0.0 110.734 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -79.69 154.4 28.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.411 -0.806 . . . . 0.0 110.364 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.432 ' CB ' ' HG2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -74.11 -170.69 0.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.927 . . . . 0.0 110.105 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.407 ' H ' HG22 ' A' ' 41' ' ' THR . 8.8 t -98.69 1.71 46.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.629 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -160.53 -64.55 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.012 -1.055 . . . . 0.0 110.625 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 41.2 Cg_endo -67.66 -168.79 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.596 1.314 . . . . 0.0 110.782 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -107.11 29.17 11.04 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.6 ptt180 -94.19 160.61 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.845 -1.386 . . . . 0.0 110.393 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HG2' ' A' ' 18' ' ' ARG . 60.3 m-85 -132.48 155.26 48.87 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 121.956 0.884 . . . . 0.0 111.018 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.94 96.87 8.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 43.5 t -79.61 118.99 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.883 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -131.19 101.16 5.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.812 HD13 ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -117.36 146.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.912 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.812 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.7 p -107.05 120.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.621 HD12 HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.52 179.74 6.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 111.175 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.563 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.0 OUTLIER -45.33 174.04 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.766 -0.584 . . . . 0.0 110.359 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.2 Cg_endo -63.23 -15.13 46.19 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.594 1.313 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -140.36 73.71 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.96 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -63.03 165.19 7.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -165.42 168.67 16.45 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 110.82 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -54.68 -38.2 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.316 -0.865 . . . . 0.0 110.111 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -45.4 87.5 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.459 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm100 -69.7 -41.48 75.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.386 -0.822 . . . . 0.0 109.255 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.739 HD21 HD22 ' A' ' 8' ' ' LEU . 10.5 mt -63.26 -35.01 78.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.787 . . . . 0.0 109.957 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.541 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.22 -43.9 64.51 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 67' ' ' ILE . 66.9 mt -64.75 -48.38 74.77 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.702 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -65.26 -44.74 87.11 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.356 -1.465 . . . . 0.0 110.819 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 62' ' ' ALA . 5.0 ptmt -74.52 -35.16 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.471 -1.393 . . . . 0.0 110.433 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 86.9 mt-10 -77.23 -40.41 45.01 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.892 -1.13 . . . . 0.0 109.881 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 63' ' ' LEU . 8.7 mm -76.99 -35.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.173 -0.954 . . . . 0.0 110.946 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.949 HG23 ' OE2' ' A' ' 25' ' ' GLU . 69.1 mt -69.09 -45.27 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 0.0 109.48 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 32.0 mt-30 -60.3 -48.52 81.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.285 -0.885 . . . . 0.0 110.005 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -60.36 -44.24 95.77 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.435 -0.791 . . . . 0.0 111.082 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -65.5 -48.76 71.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.875 -1.14 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.602 HD23 ' CG ' ' A' ' 21' ' ' ASP . 32.0 mt -65.49 -38.15 88.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 12.9 mm-40 -70.88 -44.85 65.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 31.2 t-20 -60.75 -37.02 80.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 t80 -75.71 -33.47 60.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.241 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.49 11.35 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.652 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . . . -103.84 129.41 51.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.24 . . . . 0.0 109.802 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.15 137.57 52.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.131 -0.981 . . . . 0.0 110.547 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.1 t -79.29 115.65 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.596 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.78 -4.67 58.28 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.527 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -130.28 155.01 47.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.226 -0.922 . . . . 0.0 111.889 -178.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.967 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.429 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.738 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.7 mm? -90.79 148.45 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.155 -0.966 . . . . 0.0 111.521 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 3.5 t90 -127.36 119.61 26.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.787 . . . . 0.0 109.356 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.907 ' HD1' HG11 ' A' ' 79' ' ' VAL . 42.5 m-85 -123.27 143.74 49.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.93 -1.106 . . . . 0.0 111.163 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 79' ' ' VAL . 5.9 tt0 -121.05 160.33 23.84 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.406 -0.809 . . . . 0.0 109.597 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.85 -177.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 110.515 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 33.7 tt0 -143.32 53.47 1.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.234 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.559 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -122.1 148.93 53.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.256 -0.903 . . . . 0.0 109.876 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 36.2 Cg_endo -69.36 -167.31 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.992 1.522 . . . . 0.0 113.491 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.81 ' O ' HG12 ' A' ' 19' ' ' VAL . 3.0 tm-20 -65.52 -23.72 66.95 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.267 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.83 -39.49 79.97 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.615 -0.678 . . . . 0.0 111.966 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.3 OUTLIER -90.69 -16.76 27.98 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.056 -1.027 . . . . 0.0 110.869 -178.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.81 HG12 ' O ' ' A' ' 16' ' ' GLU . 7.4 p -46.54 -36.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.514 -0.741 . . . . 0.0 110.413 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.532 ' N ' HG13 ' A' ' 19' ' ' VAL . 2.2 t30 -52.21 -28.16 17.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.454 -0.779 . . . . 0.0 109.682 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.589 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 39.7 t0 -58.8 -38.12 77.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.365 -0.834 . . . . 0.0 109.834 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 2.9 mp -58.52 -41.66 85.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.526 -0.734 . . . . 0.0 109.349 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.38 -50.6 71.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.403 -0.811 . . . . 0.0 109.517 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -68.55 -41.03 80.39 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.83 . . . . 0.0 109.694 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 28' ' ' ILE . 1.1 tp10 -59.78 -48.8 80.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.348 -0.845 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.711 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -60.89 -37.26 81.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.051 . . . . 0.0 109.055 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.38 -38.96 81.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.436 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.583 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.5 OUTLIER -58.86 -44.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.273 -0.892 . . . . 0.0 110.534 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.819 ' O ' HG12 ' A' ' 32' ' ' VAL . 11.6 ptp180 -78.61 52.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.71 -27.91 69.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.107 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 29.8 p-10 -58.88 -17.85 27.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 109.94 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.143 HG21 ' CD1' ' A' ' 50' ' ' ILE . 3.4 p -80.9 154.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.45 -0.781 . . . . 0.0 110.522 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -79.17 -45.53 19.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 111.058 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.5 mtt-85 -152.14 135.62 16.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.992 -1.067 . . . . 0.0 110.899 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.514 ' CA ' HG13 ' A' ' 50' ' ' ILE . 8.8 p -133.87 133.67 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.82 119.26 12.24 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.189 -0.945 . . . . 0.0 110.793 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 48' ' ' VAL . 58.5 t -114.54 130.67 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.984 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 16.2 m -111.28 145.13 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.685 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.09 153.87 23.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.422 -0.799 . . . . 0.0 110.687 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.53 -173.82 1.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -105.24 -16.91 14.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.087 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -124.31 -67.95 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -71.52 -168.79 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.105 1.055 . . . . 0.0 110.791 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -110.48 31.62 7.23 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.527 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 1.4 ptm180 -94.54 160.74 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -1.183 . . . . 0.0 110.486 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 45' ' ' ARG . 19.9 m-85 -132.2 154.35 49.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.846 0.831 . . . . 0.0 110.836 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 20.2 mt-10 -103.85 93.19 4.75 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 37' ' ' VAL . 65.4 t -79.5 123.13 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.0 111.603 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 77.6 m-20 -130.91 100.76 5.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.143 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -136.52 147.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.634 0.731 . . . . 0.0 111.432 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.51 ' N ' HG12 ' A' ' 50' ' ' ILE . 9.9 p -124.81 149.92 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.617 -0.677 . . . . 0.0 109.232 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.98 ' HG ' HG23 ' A' ' 32' ' ' VAL . 6.1 mp -105.41 -158.56 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 52' ' ' LEU . 1.2 m-80 -39.44 163.8 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.85 -0.531 . . . . 0.0 110.425 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.13 -15.71 50.9 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.0 1.526 . . . . 0.0 110.877 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -139.05 75.88 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 110.117 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.956 HD11 HD13 ' A' ' 52' ' ' LEU . 8.7 mt -61.76 -174.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.975 -1.078 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.79 -174.25 0.35 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.465 0.65 . . . . 0.0 109.724 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -65.82 -40.01 91.42 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 111.119 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.1 m -66.19 -36.12 82.24 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 0.0 110.56 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.26 -44.53 68.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 110.45 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 71.4 mt -64.67 -33.18 75.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.529 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.42 -35.66 52.52 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 67' ' ' ILE . 47.4 mt -71.55 -49.72 38.03 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.873 0.844 . . . . 0.0 109.145 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.686 ' OE1' HD11 ' A' ' 52' ' ' LEU . 4.6 mt-10 -67.32 -38.39 84.85 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.624 -1.297 . . . . 0.0 109.987 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.881 -1.137 . . . . 0.0 110.756 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 10.9 mm-40 -75.48 -39.41 58.65 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.725 -1.234 . . . . 0.0 109.628 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 63' ' ' LEU . 23.6 mm -78.17 -40.87 26.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.496 -0.753 . . . . 0.0 111.868 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 89.0 mt -71.32 -41.66 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.322 -1.487 . . . . 0.0 110.294 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 1.4 pp0? -64.35 -34.64 78.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -0.847 . . . . 0.0 110.761 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -69.06 -41.52 77.48 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.01 -1.056 . . . . 0.0 110.977 -179.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.02 -48.55 62.67 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.09 -1.006 . . . . 0.0 110.709 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 77' ' ' ALA . 61.6 mt -60.71 -38.2 84.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.192 -0.943 . . . . 0.0 110.606 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -72.04 -45.9 59.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.367 -0.833 . . . . 0.0 109.563 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 14.1 t-20 -60.9 -40.46 93.18 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.32 -43.75 39.89 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.574 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.72 34.23 1.44 Allowed Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -113.01 127.3 56.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -1.155 . . . . 0.0 109.534 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -120.7 129.29 53.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 110.612 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.907 HG11 ' HD1' ' A' ' 10' ' ' TYR . 2.3 t -75.13 119.66 23.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.087 -1.008 . . . . 0.0 109.407 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -82.32 -7.06 59.63 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.9 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -132.98 149.71 52.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.329 -0.857 . . . . 0.0 111.559 -178.397 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 178.169 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' H2 ' ' HD2' ' A' ' 3' ' ' PRO . 11.6 mtt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.372 0.606 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.654 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 3.0 t70 -76.4 -37.1 1.92 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 0.0 111.574 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.8 Cg_endo -83.04 8.67 4.47 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.314 1.165 . . . . 0.0 110.339 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.605 ' OE1' HG22 ' A' ' 51' ' ' VAL . 2.9 pt20 -165.21 -167.31 1.15 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.887 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.659 ' C ' HD21 ' A' ' 56' ' ' LEU . . . -140.66 54.55 0.64 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.59 ' HB2' ' HA ' ' A' ' 51' ' ' VAL . 3.3 p90 -63.28 130.82 46.15 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.59 -1.535 . . . . 0.0 109.402 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.75 ' H ' HD22 ' A' ' 8' ' ' LEU . 1.7 m-85 -164.68 47.85 0.1 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.979 -1.076 . . . . 0.0 110.531 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.75 HD22 ' H ' ' A' ' 7' ' ' PHE . 1.6 mm? -104.67 124.32 49.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.16 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.502 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 1.7 t90 -115.79 119.63 36.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.741 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CA ' ' HD2' ' A' ' 81' ' ' LYS . 27.0 m-85 -126.84 137.37 53.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.761 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.553 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 10.7 tt0 -122.82 159.46 28.08 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.376 -0.827 . . . . 0.0 109.42 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 11.4 m -136.03 -177.51 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.003 -1.061 . . . . 0.0 110.667 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -146.54 56.22 1.15 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.481 0.657 . . . . 0.0 109.651 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.543 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 10.2 mmt -131.12 149.05 72.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.402 -0.811 . . . . 0.0 109.209 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.95 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.2 Cg_endo -68.63 -168.4 0.22 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.774 1.408 . . . . 0.0 112.823 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.57 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -61.12 -46.55 90.13 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.543 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.0 -28.73 20.0 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.275 -0.89 . . . . 0.0 110.214 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 15' ' ' PRO . 43.0 t -47.99 -37.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.571 -0.706 . . . . 0.0 110.791 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -53.64 -29.0 36.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.984 -1.073 . . . . 0.0 109.739 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 24.6 t0 -59.99 -36.58 77.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 110.655 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.628 HD13 ' HA ' ' A' ' 19' ' ' VAL . 6.8 mp -57.97 -39.35 77.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.54 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -61.37 -52.82 63.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.838 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.36 -42.39 75.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.246 -0.909 . . . . 0.0 110.383 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.588 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -56.02 -49.05 74.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 0.0 110.407 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.721 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.38 -36.98 85.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.504 -0.748 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.6 -38.63 88.3 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.151 -0.968 . . . . 0.0 110.781 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.802 ' CG2' HG21 ' A' ' 67' ' ' ILE . 55.8 mt -61.6 -47.44 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 O-C-N 120.927 -1.108 . . . . 0.0 110.567 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 2.9 ptt180 -72.66 67.47 0.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 109.785 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.94 -25.48 29.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.421 -0.799 . . . . 0.0 110.827 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -57.9 -14.98 7.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.102 -0.999 . . . . 0.0 110.154 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.9 ' CG2' HD11 ' A' ' 50' ' ' ILE . 1.7 p -80.35 132.08 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 110.311 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -80.04 -46.49 16.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 111.081 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.518 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttp85 -152.7 123.3 7.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.9 -1.125 . . . . 0.0 111.135 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 26' ' ' LEU . 7.2 p -127.18 136.18 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.465 -0.772 . . . . 0.0 109.75 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.97 120.72 17.38 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.04 -1.038 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.735 HG12 ' HB3' ' A' ' 46' ' ' TYR . 20.0 t -114.94 130.41 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.736 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 18.9 t -104.43 161.15 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.049 -1.032 . . . . 0.0 110.862 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.11 154.59 23.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.545 -0.722 . . . . 0.0 110.317 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 7.7 p -73.2 -172.58 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 41' ' ' THR . 8.5 t -94.66 -1.91 52.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.11 -64.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.043 -1.036 . . . . 0.0 110.786 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.5 Cg_endo -69.18 -160.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.556 1.292 . . . . 0.0 111.226 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.1 37.37 3.85 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.7 mtp180 -93.95 146.89 23.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.477 -1.014 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.735 ' HB3' HG12 ' A' ' 37' ' ' VAL . 41.2 m-85 -131.7 154.73 48.7 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.147 -0.971 . . . . 0.0 110.942 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.495 ' CG ' ' HB ' ' A' ' 38' ' ' VAL . 2.6 pt-20 -101.64 104.48 15.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 48.5 t -83.71 116.9 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 111.642 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -131.17 100.53 5.24 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.9 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -117.25 144.85 24.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.903 -178.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.605 HG22 ' OE1' ' A' ' 4' ' ' GLN . 9.4 p -96.18 147.39 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.169 -0.957 . . . . 0.0 109.429 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.615 ' HB2' HD23 ' A' ' 56' ' ' LEU . 19.8 mt -107.25 -178.28 3.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.711 -1.243 . . . . 0.0 111.625 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.545 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -64.86 179.32 0.4 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.767 -0.583 . . . . 0.0 110.523 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 38.4 Cg_endo -63.97 -15.99 52.31 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.861 1.453 . . . . 0.0 110.788 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -141.07 87.35 2.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.659 HD21 ' C ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER -95.33 173.76 7.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.02 -1.05 . . . . 0.0 111.162 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 173.72 -167.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.527 -0.733 . . . . 0.0 110.133 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.554 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -42.69 76.27 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 1.9 mm100 -67.86 -45.11 75.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 52' ' ' LEU . 79.4 mt -64.61 -35.11 79.94 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 109.811 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.74 -33.89 50.2 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.048 . . . . 0.0 108.342 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' O ' HG13 ' A' ' 67' ' ' ILE . 15.2 mt -70.94 -49.39 46.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' OE1' HD21 ' A' ' 52' ' ' LEU . 38.5 mt-10 -68.51 -43.36 77.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 109.316 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 12.7 mmtp -60.73 -36.2 78.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 110.408 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 1.6 mm-40 -65.75 -48.84 70.53 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 120.841 -1.162 . . . . 0.0 110.061 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.802 HG21 ' CG2' ' A' ' 28' ' ' ILE . 4.6 mt -77.77 -41.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.392 -0.817 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 27.4 mt -59.46 -50.49 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 87.0 mt-30 -64.36 -47.06 80.74 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.2 -0.938 . . . . 0.0 108.897 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -58.13 -47.11 84.29 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.509 -0.745 . . . . 0.0 110.81 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -68.76 -48.51 63.53 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.864 -1.148 . . . . 0.0 110.449 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.496 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 76.1 mt -65.7 -35.55 81.09 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.326 -0.858 . . . . 0.0 110.455 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 69' ' ' GLN . 1.4 mm-40 -71.33 -44.91 64.21 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.379 -0.826 . . . . 0.0 109.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.9 m-80 -64.29 -36.6 84.64 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.011 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.573 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.03 -37.65 61.67 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.628 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.27 23.95 4.32 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HA ' ' HG3' ' A' ' 14' ' ' MET . . . -108.31 131.32 54.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.26 -1.141 . . . . 0.0 109.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.89 146.19 46.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 2.9 t -87.85 122.24 39.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.046 -1.034 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.01 -7.46 59.56 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.251 -0.905 . . . . 0.0 110.077 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -137.55 152.98 50.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 111.525 -178.738 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.94 108.36 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.137 -0.977 . . . . 0.0 109.628 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG3' HD11 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -127.28 107.79 10.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.072 -1.017 . . . . 0.0 111.068 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.643 ' C ' HD12 ' A' ' 85' ' ' LEU . 1.2 tt0 -99.55 110.27 22.73 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.364 -0.835 . . . . 0.0 109.978 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 84' ' ' GLU . 5.0 mp -145.29 176.26 9.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.059 -1.026 . . . . 0.0 110.95 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 5' ' ' GLY . . . 74.63 56.36 5.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.43 67.43 9.43 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.123 -1.222 . . . . 0.0 110.55 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HB2' ' HA3' ' A' ' 5' ' ' GLY . 15.2 mmt180 -100.66 151.49 21.57 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.112 -0.993 . . . . 0.0 110.547 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.437 ' HG3' ' C ' ' A' ' 88' ' ' ARG . 14.1 mtm180 -141.58 39.6 1.7 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.904 0.859 . . . . 0.0 109.763 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -76.24 119.47 20.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.329 0.585 . . . . 0.0 110.566 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.72 83.86 1.95 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.377 -0.827 . . . . 0.0 110.027 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.62 168.78 7.46 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.234 -0.916 . . . . 0.0 110.37 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.24 58.11 4.24 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.974 1.512 . . . . 0.0 110.569 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.89 117.99 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.046 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.67 135.83 33.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.307 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 pttm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.153 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.506 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 3.5 tpp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.276 0.56 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.649 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 37.3 t70 -62.37 -38.08 42.89 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.386 -0.821 . . . . 0.0 111.116 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.2 Cg_endo -83.02 2.94 8.17 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.467 1.246 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 6.7 pt20 -148.46 -149.48 0.3 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 88' ' ' ARG . . . -169.08 45.06 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.241 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.906 ' CE1' HD13 ' A' ' 8' ' ' LEU . 25.6 t80 -81.67 135.05 35.53 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.93 -1.335 . . . . 0.0 110.224 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.971 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -160.8 100.94 1.29 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.547 -0.72 . . . . 0.0 109.643 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.971 HD12 ' C ' ' A' ' 7' ' ' PHE . 6.7 mp -138.46 125.28 21.06 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.825 . . . . 0.0 110.847 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.562 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -99.57 132.41 44.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 109.236 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.975 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -128.12 128.51 44.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.45 157.33 29.57 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.833 -1.167 . . . . 0.0 110.519 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.743 HG21 ' CD ' ' A' ' 18' ' ' ARG . 26.6 m -130.36 179.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.75 51.54 2.12 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.58 -0.7 . . . . 0.0 109.84 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.586 ' CB ' ' HB3' ' A' ' 18' ' ' ARG . 70.4 mmm -133.96 151.82 77.46 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 109.535 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 36.0 Cg_endo -71.15 -167.57 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.835 1.44 . . . . 0.0 113.24 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 19' ' ' VAL . 37.7 tt0 -53.23 -25.51 14.41 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.528 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 26.9 t0 -57.58 -23.34 50.23 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.864 ' NH1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -88.09 -13.49 41.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 16' ' ' GLU . 70.3 t -48.26 -44.6 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.52 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 0.7 OUTLIER -57.9 -29.07 64.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.764 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.2 t0 -59.64 -45.33 92.34 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.864 HD21 ' NH1' ' A' ' 18' ' ' ARG . 2.0 mm? -59.71 -36.65 76.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.26 74.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.173 -0.954 . . . . 0.0 110.533 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.3 mmt-85 -60.05 -46.64 88.87 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.5 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 tm-20 -68.67 -40.99 79.89 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 0.0 109.65 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.537 ' CD2' ' HB ' ' A' ' 35' ' ' VAL . 18.2 mt -55.28 -38.03 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.997 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.446 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 9.0 tpt180 -70.64 -40.94 72.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.468 -0.77 . . . . 0.0 110.596 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.974 ' CG2' HG21 ' A' ' 67' ' ' ILE . 56.5 mt -67.51 -44.94 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 120.989 -1.07 . . . . 0.0 110.743 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.912 ' HD3' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.51 57.44 0.08 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -73.75 -25.67 60.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 110.569 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -66.36 -20.46 66.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.098 -1.001 . . . . 0.0 110.427 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.034 HG21 HD11 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.5 154.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.24 -0.913 . . . . 0.0 110.271 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -79.51 -47.02 16.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 111.41 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.446 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.96 146.27 23.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.764 -1.21 . . . . 0.0 111.939 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.912 HG21 ' HD3' ' A' ' 29' ' ' ARG . 2.1 t -135.56 135.96 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.459 -0.776 . . . . 0.0 109.11 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.472 ' HB3' ' OD1' ' A' ' 49' ' ' ASN . 2.5 tpt -131.71 117.42 18.6 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.968 -1.083 . . . . 0.0 110.692 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.798 HG13 ' CG2' ' A' ' 48' ' ' VAL . 4.4 t -114.59 129.8 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.307 -0.87 . . . . 0.0 109.849 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 47' ' ' GLU . 3.2 m -115.54 135.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 110.402 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.551 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -78.28 154.03 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.467 -0.77 . . . . 0.0 110.503 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 161.23 30.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.895 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -83.08 6.49 18.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 110.648 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.91 -65.07 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.108 -0.995 . . . . 0.0 110.334 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 44.0 Cg_endo -70.95 -176.68 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.562 1.296 . . . . 0.0 110.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.97 28.02 17.81 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 14.8 mtt180 -93.92 138.93 31.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.387 -1.066 . . . . 0.0 109.972 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 18' ' ' ARG . 7.0 m-85 -119.22 153.89 34.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.056 0.931 . . . . 0.0 110.949 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.686 ' HB2' HG23 ' A' ' 38' ' ' VAL . 4.0 mt-10 -104.31 95.83 6.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.798 ' CG2' HG13 ' A' ' 37' ' ' VAL . 5.1 t -88.1 122.72 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.852 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 36' ' ' MET . 0.8 OUTLIER -130.68 101.14 5.56 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.288 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.034 HD11 HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -117.78 149.8 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.447 0.641 . . . . 0.0 111.262 -178.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.418 ' N ' HG12 ' A' ' 50' ' ' ILE . 5.5 p -112.86 152.86 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.71 -0.619 . . . . 0.0 109.786 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.587 ' HB2' ' CD2' ' A' ' 6' ' ' TYR . 3.4 mt -100.36 -165.03 1.17 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.054 -1.029 . . . . 0.0 110.924 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -68.69 -178.83 0.45 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.641 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -63.87 -15.04 46.72 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.758 1.399 . . . . 0.0 110.486 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.06 77.71 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.65 173.2 6.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.73 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.983 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.9 t70 178.81 171.05 0.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.44 -0.787 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 5.1 mt-30 -57.8 -38.14 75.0 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.707 . . . . 0.0 110.294 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.28 -31.59 69.02 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.334 -0.854 . . . . 0.0 109.95 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 25.9 mm100 -74.3 -45.77 45.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.983 HD12 ' O ' ' A' ' 57' ' ' ASP . 1.6 mp -67.69 -36.0 79.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.993 -1.067 . . . . 0.0 109.514 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.84 -33.7 57.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' ILE . 20.2 mt -69.14 -50.31 49.05 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.271 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 29' ' ' ARG . 78.7 mm-40 -71.54 -42.06 68.36 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -67.34 -30.5 70.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.472 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 1.8 mm-40 -69.14 -48.34 62.63 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 120.761 -1.212 . . . . 0.0 109.91 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.974 HG21 ' CG2' ' A' ' 28' ' ' ILE . 6.3 mt -77.38 -42.4 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.4 -0.812 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.5 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 85.6 mt -59.47 -46.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.104 -0.998 . . . . 0.0 109.91 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 5.2 mt-30 -64.16 -44.13 93.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.194 -0.941 . . . . 0.0 109.673 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -68.41 -43.44 77.23 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.403 -0.811 . . . . 0.0 111.147 -179.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 25' ' ' GLU . . . -65.07 -48.48 73.6 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.886 -1.134 . . . . 0.0 110.499 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.975 HD13 ' CZ ' ' A' ' 10' ' ' TYR . 96.6 mt -63.92 -35.19 79.84 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 110.451 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 69' ' ' GLN 0.258 2.0 tt0 -69.93 -45.85 66.63 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 108.988 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -58.24 -37.07 74.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.15 -26.53 60.36 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.893 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.24 28.74 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.61 121.92 41.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.24 . . . . 0.0 110.282 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.35 162.57 18.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.908 HG22 ' CE2' ' A' ' 10' ' ' TYR . 1.5 t -87.6 118.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.86 -12.88 58.26 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.876 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.562 ' CE ' ' O ' ' A' ' 9' ' ' TRP 0.254 0.0 OUTLIER -131.57 157.24 44.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.494 -0.754 . . . . 0.0 111.015 -178.78 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.436 ' C ' ' HG2' ' A' ' 83' ' ' GLU . 32.6 t -141.3 108.62 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.641 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' C ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -127.11 109.49 11.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.995 -1.065 . . . . 0.0 111.076 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -97.72 121.18 39.33 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.282 -0.886 . . . . 0.0 109.873 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mp -81.03 -9.41 59.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 0.0 110.18 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.47 105.45 0.44 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -50.16 154.02 1.29 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.245 -1.15 . . . . 0.0 110.311 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.557 ' CB ' ' HA3' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -105.64 158.97 16.33 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 110.429 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 89' ' ' ARG . 8.5 ptm180 -105.94 109.33 21.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.675 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 3' ' ' PRO . 1.7 pp -61.92 128.37 35.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 110.474 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.08 -51.14 5.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.34 131.15 83.26 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.288 -0.883 . . . . 0.0 110.171 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.52 154.18 44.79 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.959 1.505 . . . . 0.0 110.267 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 94' ' ' ILE . 9.1 tp -78.69 114.32 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.25 78.15 1.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -0.878 . . . . 0.0 110.254 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.114 -0.991 . . . . 0.0 110.228 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' GLN . 1.9 tmt? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.319 0.581 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.62 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 5.3 t70 -76.62 -39.5 2.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 111.476 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.5 Cg_endo -79.5 4.94 6.2 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.297 1.156 . . . . 0.0 110.777 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 5.1 pt20 179.7 -155.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.534 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 64.56 -79.16 0.06 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.673 ' HB2' HG23 ' A' ' 51' ' ' VAL . 1.1 t80 -64.81 98.25 0.26 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.412 -1.052 . . . . 0.0 111.225 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.987 ' CB ' HD13 ' A' ' 85' ' ' LEU . 1.5 m-85 -165.77 25.42 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.095 -1.003 . . . . 0.0 110.257 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 61' ' ' LEU . 9.6 mp -96.15 132.35 41.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.262 -0.899 . . . . 0.0 110.523 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -122.86 118.24 27.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.095 -1.003 . . . . 0.0 109.892 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.662 ' O ' HG22 ' A' ' 48' ' ' VAL . 36.2 m-85 -127.78 119.15 25.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 0.0 110.906 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.944 ' O ' HG13 ' A' ' 79' ' ' VAL . 34.7 tt0 -107.27 155.6 19.77 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.2 -0.937 . . . . 0.0 109.689 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' CG2' ' CD2' ' A' ' 46' ' ' TYR . 4.0 m -129.53 -178.38 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.865 -1.147 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' SD ' ' A' ' 14' ' ' MET . 3.5 pt-20 -133.06 48.87 2.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.537 0.684 . . . . 0.0 109.866 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.536 ' HB2' ' HB3' ' A' ' 18' ' ' ARG . 78.3 mmm -126.01 155.0 73.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.641 -0.662 . . . . 0.0 109.485 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.3 Cg_endo -72.67 -166.83 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.811 1.427 . . . . 0.0 113.014 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' O ' HG12 ' A' ' 19' ' ' VAL . 42.4 tt0 -56.38 -26.85 54.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.48 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 29.8 t0 -58.13 -16.13 12.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.059 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.572 ' CD ' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -75.09 -16.57 60.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.421 -0.799 . . . . 0.0 110.18 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.588 HG13 ' N ' ' A' ' 20' ' ' ASN . 8.0 p -49.31 -43.68 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.416 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.588 ' N ' HG13 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -64.72 -30.05 71.05 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 41.1 t0 -65.6 -53.48 41.21 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.556 -0.715 . . . . 0.0 110.07 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.91 ' O ' HD12 ' A' ' 26' ' ' LEU . 4.7 mp -58.86 -37.11 75.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.136 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.11 -52.71 63.34 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.445 -0.784 . . . . 0.0 109.158 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -63.32 -46.26 87.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -56.91 -44.51 82.47 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.454 -0.779 . . . . 0.0 110.17 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.91 HD12 ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -66.94 -40.07 87.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.506 -0.746 . . . . 0.0 111.221 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.552 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.69 -37.36 83.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.915 -1.116 . . . . 0.0 110.355 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.955 ' CG2' HG23 ' A' ' 67' ' ' ILE . 14.8 mt -68.18 -44.56 84.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.727 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -81.4 69.26 8.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.403 -0.81 . . . . 0.0 110.297 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 37.7 p-10 -73.49 -25.96 60.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 6.1 t30 -58.82 -13.88 7.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.407 -0.808 . . . . 0.0 110.575 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.038 HG23 HD11 ' A' ' 50' ' ' ILE . 8.0 p -79.63 141.41 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 111.037 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.83 -46.64 15.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 111.253 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.1 ttt180 -152.98 123.79 7.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 0.0 111.201 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.847 HG22 HG13 ' A' ' 50' ' ' ILE . 11.3 t -108.5 135.46 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 110.035 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 115.76 19.98 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.176 -0.953 . . . . 0.0 110.335 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.076 HG13 HG12 ' A' ' 48' ' ' VAL . 48.7 t -114.82 132.04 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.558 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 47' ' ' GLU . 3.9 m -113.22 130.79 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.371 -0.831 . . . . 0.0 110.018 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.654 ' HA ' ' CD1' ' A' ' 46' ' ' TYR . . . -77.62 153.67 32.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.519 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.59 166.33 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.058 -1.026 . . . . 0.0 109.445 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -83.51 2.83 35.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 0.0 110.848 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -161.42 -64.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.009 -1.057 . . . . 0.0 110.458 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.6 Cg_endo -70.55 -171.06 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.568 1.299 . . . . 0.0 111.072 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.24 26.42 18.8 Favored Glycine 0 N--CA 1.479 1.563 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -93.45 135.7 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 108.64 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.654 ' CD1' ' HA ' ' A' ' 39' ' ' ALA . 11.1 m-85 -128.73 151.29 49.71 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.763 -1.211 . . . . 0.0 112.379 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 mt-10 -105.03 90.63 3.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.098 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.076 HG12 HG13 ' A' ' 37' ' ' VAL . 16.0 m -86.92 125.24 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.486 ' HB3' ' OH ' ' A' ' 6' ' ' TYR . 21.6 m-80 -123.63 100.74 6.94 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.038 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.13 147.77 16.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.447 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.76 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.7 p -102.82 129.76 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.12 -0.988 . . . . 0.0 111.296 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.781 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -93.58 -168.29 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.904 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.2 m-80 -50.93 172.91 0.12 Allowed Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.0 109.505 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.8 Cg_endo -63.22 -14.66 43.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.548 1.289 . . . . 0.0 110.849 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 4.2 t30 -146.19 86.77 1.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.106 -0.996 . . . . 0.0 110.696 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.781 HD21 ' CB ' ' A' ' 52' ' ' LEU . 8.7 mt -61.17 -171.41 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 111.068 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.8 t70 172.94 172.49 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.483 0.659 . . . . 0.0 110.103 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.435 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 11.7 mt-30 -56.37 -34.31 66.55 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.81 -34.22 75.15 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.94 . . . . 0.0 110.064 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -72.05 -44.32 63.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 110.099 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HZ2' ' A' ' 65' ' ' LYS . 55.5 mt -63.37 -34.26 77.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 109.935 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.75 -40.36 63.03 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.62 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.1 mt -71.54 -49.99 35.5 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 79.1 mm-40 -58.34 -41.94 85.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.993 -1.067 . . . . 0.0 109.737 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HZ2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -70.79 -46.9 62.03 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.263 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -71.4 -37.66 71.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.85 -1.156 . . . . 0.0 109.834 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.955 HG23 ' CG2' ' A' ' 28' ' ' ILE . 11.0 mm -76.49 -41.28 35.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 25' ' ' GLU . 56.2 mt -70.26 -49.73 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.714 -1.242 . . . . 0.0 109.786 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 25.7 mm-40 -59.17 -38.74 80.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.883 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -57.74 -48.08 80.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.264 -0.898 . . . . 0.0 111.128 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 25' ' ' GLU . . . -70.95 -48.52 52.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.907 -1.121 . . . . 0.0 110.099 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 20.3 mt -63.71 -35.41 80.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.524 -0.735 . . . . 0.0 110.604 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 4.8 mm-40 -69.57 -45.08 69.53 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.427 -0.795 . . . . 0.0 109.283 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.48 -40.24 90.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.74 -29.17 58.78 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.528 -0.733 . . . . 0.0 110.0 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . 101.06 18.34 20.11 Favored Glycine 0 N--CA 1.48 1.59 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -93.6 127.12 39.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -1.086 . . . . 0.0 110.483 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.8 141.32 48.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 109.874 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.9 t -94.17 125.37 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.66 -10.29 58.29 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -131.56 133.4 44.99 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 82' ' ' VAL . 2.1 p -141.34 106.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.321 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -128.45 105.87 8.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.96 -1.087 . . . . 0.0 110.548 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' OE1' ' CE ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -101.84 122.84 44.74 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.768 179.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.987 HD13 ' CB ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -76.65 -26.16 54.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.858 -1.151 . . . . 0.0 109.736 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . 65.81 -168.68 31.84 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.457 ' HG ' ' OD1' ' A' ' 55' ' ' ASN . 1.6 tt -60.47 73.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.25 -1.147 . . . . 0.0 110.224 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 86' ' ' GLY . 51.3 ttt85 -117.46 143.3 46.18 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.172 -0.955 . . . . 0.0 110.377 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 12.7 mtt85 -103.0 133.95 47.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 110.081 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -171.88 91.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.657 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.88 -176.5 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.139 -0.976 . . . . 0.0 109.891 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -103.73 139.02 19.71 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.538 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.66 -3.06 12.82 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.186 1.624 . . . . 0.0 110.636 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.15 114.32 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.101 -0.999 . . . . 0.0 110.286 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 96' ' ' LYS . . . -132.63 153.8 50.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.207 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.5 ' CA ' ' HA ' ' A' ' 54' ' ' PRO . 1.2 tmm? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.395 0.617 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.601 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 15.9 t0 -76.65 -43.7 3.13 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.908 . . . . 0.0 110.579 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 2' ' ' ASP . 48.5 Cg_endo -77.3 4.25 6.04 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.512 1.27 . . . . 0.0 110.429 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' TYR . 9.7 pt20 -178.68 -139.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.896 . . . . 0.0 110.083 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.943 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 59.32 -80.8 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.889 ' HB3' HG23 ' A' ' 51' ' ' VAL . 1.4 p90 -66.38 121.55 15.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -1.166 . . . . 0.0 110.772 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -169.49 42.9 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.676 HD22 ' HA ' ' A' ' 84' ' ' GLU . 10.9 mt -126.04 125.01 41.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.468 -0.77 . . . . 0.0 110.35 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.481 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -116.54 119.16 34.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.823 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' OH ' ' CG ' ' A' ' 84' ' ' GLU . 22.0 m-85 -124.19 118.11 26.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.607 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.805 ' O ' HG13 ' A' ' 79' ' ' VAL . 31.6 tt0 -110.82 147.14 35.15 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.405 -0.809 . . . . 0.0 109.452 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.506 HG21 ' HD3' ' A' ' 18' ' ' ARG . 8.4 m -126.65 -179.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.837 -1.164 . . . . 0.0 111.433 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -129.65 45.3 2.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.737 0.779 . . . . 0.0 109.033 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.561 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 60.6 mmm -120.29 145.99 41.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.77 -0.581 . . . . 0.0 109.563 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 17' ' ' ASP . 33.4 Cg_endo -67.99 -166.57 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.77 1.405 . . . . 0.0 113.518 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -27.57 65.75 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.237 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.527 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -59.53 -22.27 61.42 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.021 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.614 ' NH1' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -83.54 -13.47 54.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.227 -0.921 . . . . 0.0 110.378 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.8 t -48.0 -46.62 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.585 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 0.6 OUTLIER -57.8 -29.96 65.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.604 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.4 t0 -61.15 -50.77 71.82 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.435 -0.791 . . . . 0.0 109.928 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.678 HD12 HG21 ' A' ' 37' ' ' VAL . 3.9 mm? -59.62 -41.45 90.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.116 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.21 -52.37 64.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.179 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.18 -42.35 89.01 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.33 -0.856 . . . . 0.0 109.608 179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.813 ' OE2' HG23 ' A' ' 68' ' ' ILE . 19.0 tt0 -56.89 -48.77 77.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 110.903 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.72 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -69.02 -37.56 78.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 110.812 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -61.94 -36.11 80.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.01 -1.056 . . . . 0.0 111.395 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.85 ' CG2' HG23 ' A' ' 67' ' ' ILE . 73.1 mt -62.93 -44.83 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.951 -1.093 . . . . 0.0 111.378 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HB3' HG21 ' A' ' 67' ' ' ILE . 5.9 ptt180 -83.83 93.15 7.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.003 -1.061 . . . . 0.0 110.788 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -73.43 -24.82 60.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 23.6 p30 -58.56 -15.12 9.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.645 HG21 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.61 134.36 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.399 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.436 ' HD2' ' CE ' ' A' ' 1' ' ' MET . 3.1 ttm-85 -79.47 -45.65 18.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 111.043 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -152.7 134.54 14.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.805 -1.184 . . . . 0.0 111.087 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.872 HG23 HD11 ' A' ' 50' ' ' ILE . 2.2 p -125.86 131.31 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.339 -0.851 . . . . 0.0 110.547 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.3 ttt -140.42 116.02 10.14 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.611 -0.68 . . . . 0.0 109.538 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.678 HG21 HD12 ' A' ' 22' ' ' LEU . 33.2 t -111.88 131.93 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 110.829 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 38' ' ' VAL . 33.5 m -105.59 142.11 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.458 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.03 154.67 23.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.357 -0.839 . . . . 0.0 110.517 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' NH2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -74.04 -176.12 2.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.089 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -103.06 9.89 38.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.169 -0.957 . . . . 0.0 110.82 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -155.93 -65.1 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.15 -0.969 . . . . 0.0 109.797 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.1 Cg_endo -71.43 -178.94 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.536 1.282 . . . . 0.0 110.334 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -105.13 30.17 10.42 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 3.0 ptt-85 -93.49 160.6 14.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.02 -1.282 . . . . 0.0 110.057 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.614 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 78.6 m-85 -134.42 154.38 51.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.089 0.947 . . . . 0.0 111.358 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.55 95.05 7.02 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 15.2 t -78.18 112.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 111.07 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.624 ' O ' HD12 ' A' ' 50' ' ' ILE . 69.1 m-80 -131.29 100.81 5.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -116.11 146.2 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' A' ' 6' ' ' TYR . 8.4 p -105.85 122.83 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.95 ' HB2' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.13 -168.5 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.5 m120 -41.77 165.17 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.46 -0.775 . . . . 0.0 110.07 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 38.3 Cg_endo -64.4 -27.06 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.762 1.401 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 12.7 t-20 -127.75 78.36 1.82 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 110.332 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.95 HD11 ' HB2' ' A' ' 52' ' ' LEU . 10.8 mt -62.28 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.226 -0.921 . . . . 0.0 111.011 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 58' ' ' GLN . 5.4 t0 174.59 172.09 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.441 0.638 . . . . 0.0 109.829 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.472 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.3 mm-40 -60.38 -31.4 70.32 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 110.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.422 ' HB2' ' OD2' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -70.05 -40.75 74.91 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.323 -0.861 . . . . 0.0 110.113 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 4.6 mm-40 -66.44 -42.77 87.18 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 109.942 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.524 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 15.1 mt -63.92 -33.5 75.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 109.732 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.74 -37.05 49.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.658 ' O ' HG12 ' A' ' 67' ' ' ILE . 62.5 mt -72.19 -51.36 21.5 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 1.3 mm-40 -61.64 -36.75 81.68 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.813 -1.179 . . . . 0.0 110.205 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.524 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -72.21 -47.05 53.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.976 -1.078 . . . . 0.0 110.232 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.488 ' OE2' HD23 ' A' ' 63' ' ' LEU . 23.7 pt-20 -71.21 -34.65 71.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.1 -1.0 . . . . 0.0 109.318 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.85 HG23 ' CG2' ' A' ' 28' ' ' ILE . 21.4 mm -77.03 -43.51 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.544 -0.722 . . . . 0.0 110.999 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.813 HG23 ' OE2' ' A' ' 25' ' ' GLU . 49.6 mt -69.75 -46.01 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.982 -1.074 . . . . 0.0 110.259 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.09 -34.08 77.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.183 -0.948 . . . . 0.0 110.157 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 2.0 ttt-85 -64.42 -46.21 84.23 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.136 -0.978 . . . . 0.0 110.328 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -67.69 -48.61 66.11 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.135 -0.978 . . . . 0.0 110.21 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.506 HD23 ' OD2' ' A' ' 21' ' ' ASP . 86.9 mt -64.63 -36.07 83.07 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 38.3 mm-40 -70.05 -45.05 67.93 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.623 0.725 . . . . 0.0 109.247 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.51 -37.12 84.83 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.604 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.87 -41.08 60.48 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.564 -0.71 . . . . 0.0 110.049 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.15 23.6 4.48 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.52 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -98.7 138.23 36.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -1.218 . . . . 0.0 110.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -119.32 121.95 40.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.142 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.1 t -83.25 126.68 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.185 -0.947 . . . . 0.0 110.037 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.12 -15.01 54.86 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.63 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -130.66 129.65 42.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.682 -0.636 . . . . 0.0 110.454 -179.264 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.65 108.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.906 -1.121 . . . . 0.0 110.887 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 34.2 mp0 -127.45 105.7 8.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.982 . . . . 0.0 110.117 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.676 ' HA ' HD22 ' A' ' 8' ' ' LEU . 2.1 mp0 -101.88 104.9 15.66 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.263 -0.898 . . . . 0.0 110.353 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 16.6 mt -105.74 -67.82 0.9 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.051 -1.03 . . . . 0.0 109.812 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 87' ' ' LEU . . . 55.15 46.57 78.11 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.809 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.5 pp 179.65 45.19 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.422 -1.046 . . . . 0.0 110.059 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HB2' ' CD2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -121.36 121.16 37.01 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.503 -0.748 . . . . 0.0 110.241 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -93.52 109.51 21.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 110.508 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.731 ' C ' HD12 ' A' ' 90' ' ' LEU . 3.7 pp -85.12 150.96 24.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 0.0 110.01 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.1 -92.36 0.52 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 110.334 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -92.03 154.95 43.42 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.206 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.07 83.98 1.37 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.962 1.506 . . . . 0.0 110.384 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -103.34 122.19 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.027 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.515 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -106.04 167.6 9.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 110.152 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 pptp? . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.104 179.909 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 6.6 mtm . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.12 0.486 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.614 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -62.59 -38.02 41.05 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.32 -0.863 . . . . 0.0 111.543 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 46.7 Cg_endo -78.58 1.84 8.68 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.289 1.152 . . . . 0.0 110.181 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER 179.75 116.99 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 110.198 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.686 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 122.28 -82.42 0.35 Allowed Glycine 0 N--CA 1.487 2.076 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.977 ' CD1' HG23 ' A' ' 51' ' ' VAL . 10.2 p90 -110.92 147.97 33.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -1.173 . . . . 0.0 111.879 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -158.0 51.49 0.43 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HG ' ' C ' ' A' ' 7' ' ' PHE . 1.4 mp -129.02 136.73 50.69 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.774 0.797 . . . . 0.0 111.886 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 3.7 t90 -125.59 119.01 26.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.554 ' CE2' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -123.59 140.36 53.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 111.383 -178.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.563 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 38.8 tt0 -122.76 158.14 30.82 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.506 -0.746 . . . . 0.0 109.513 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.586 HG11 HH11 ' A' ' 18' ' ' ARG . 13.6 m -130.76 177.59 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.046 . . . . 0.0 110.507 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -131.2 51.99 2.1 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.513 0.673 . . . . 0.0 109.979 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.56 ' HB2' ' CB ' ' A' ' 18' ' ' ARG . 54.2 mmm -132.98 153.54 81.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.303 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -71.02 -167.54 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.703 1.37 . . . . 0.0 113.487 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.6 tt0 -58.27 -27.27 63.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.709 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -59.16 -21.71 59.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.319 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.586 HH11 HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -87.78 -16.87 32.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.788 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 16' ' ' GLU . 40.5 t -48.76 -45.47 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 109.934 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.496 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.2 t-20 -54.96 -29.24 56.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.769 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 38.3 t0 -60.34 -48.88 79.84 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.422 -0.799 . . . . 0.0 110.017 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.9 mm? -58.84 -36.74 75.04 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.475 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -56.8 -52.77 63.78 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.316 -0.865 . . . . 0.0 109.237 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 42.1 mtt180 -66.09 -44.09 85.43 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.429 -0.795 . . . . 0.0 109.331 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.642 ' OE2' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.7 -44.19 77.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.535 ' CD2' HG11 ' A' ' 35' ' ' VAL . 16.0 mt -65.44 -38.96 91.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.668 -0.645 . . . . 0.0 110.46 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.55 ' HG3' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -66.14 -36.24 82.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.207 -0.933 . . . . 0.0 111.756 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.967 ' CG2' HG23 ' A' ' 67' ' ' ILE . 49.0 mt -65.1 -45.7 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.609 -1.307 . . . . 0.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.901 ' NH1' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.29 79.56 9.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.042 . . . . 0.0 110.679 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.28 -25.47 62.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.998 . . . . 0.0 110.245 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.19 -14.47 10.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.748 ' CG2' HD11 ' A' ' 50' ' ' ILE . 2.2 p -79.68 133.65 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.197 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -80.09 -45.87 17.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 111.765 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 3.2 mtt85 -152.34 130.39 11.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.738 -1.226 . . . . 0.0 111.598 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.898 HG13 ' HB ' ' A' ' 50' ' ' ILE . 2.8 t -122.85 135.68 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.725 . . . . 0.0 109.209 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.99 115.71 23.01 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.019 -1.051 . . . . 0.0 110.715 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.498 HG11 ' HG ' ' A' ' 22' ' ' LEU . 15.7 t -114.87 129.09 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 110.298 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 3.6 m -119.81 125.91 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -82.36 153.99 25.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 p -74.31 -178.93 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.001 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -105.09 5.98 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.591 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -149.43 -66.34 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.963 . . . . 0.0 110.21 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.0 Cg_endo -71.59 -164.54 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.334 1.176 . . . . 0.0 110.13 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.29 34.36 4.32 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.1 mtt180 -97.33 134.71 40.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -1.101 . . . . 0.0 110.331 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.628 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 8.1 m-85 -117.88 155.44 30.15 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.288 -0.882 . . . . 0.0 110.438 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.8 mp0 -102.52 98.32 8.41 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 10' ' ' TYR . 66.9 t -78.45 111.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 111.356 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -131.13 101.94 5.8 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.898 ' HB ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -113.16 146.91 17.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.728 -177.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.977 HG23 ' CD1' ' A' ' 6' ' ' TYR . 11.7 p -119.36 146.92 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.432 -0.792 . . . . 0.0 110.2 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.026 HD13 HD11 ' A' ' 56' ' ' LEU . 1.5 mp -135.06 -160.94 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.236 -0.915 . . . . 0.0 110.615 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' LEU . 26.8 m-80 -38.88 161.14 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.92 -0.488 . . . . 0.0 110.351 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.475 ' HA ' ' NE2' ' A' ' 4' ' ' GLN . 39.4 Cg_endo -64.91 -20.39 64.35 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.91 1.479 . . . . 0.0 110.878 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -143.66 84.4 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.026 HD11 HD13 ' A' ' 52' ' ' LEU . 18.3 mt -68.37 -162.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.545 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 9.0 t70 -161.7 172.2 16.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.568 -0.707 . . . . 0.0 110.464 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 69.2 mt-30 -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.728 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 t -64.49 -28.31 69.57 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.233 -0.917 . . . . 0.0 110.062 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 39.1 mm-40 -65.33 -40.68 94.0 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 91.6 mt -65.29 -35.25 80.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.048 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.17 -36.39 51.51 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.9 mt -72.52 -50.67 24.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.179 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' OE1' ' HB2' ' A' ' 29' ' ' ARG . 5.8 mm-40 -63.72 -33.87 76.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.846 -1.159 . . . . 0.0 110.437 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -72.24 -46.73 54.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.394 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 32.2 mm-40 -66.55 -35.38 80.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.121 -0.987 . . . . 0.0 109.85 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.967 HG23 ' CG2' ' A' ' 28' ' ' ILE . 11.5 mm -76.71 -47.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.42 -0.8 . . . . 0.0 111.498 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.901 HD11 ' NH1' ' A' ' 29' ' ' ARG . 45.8 mt -67.78 -48.19 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.937 -1.102 . . . . 0.0 110.125 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.8 mm100 -62.16 -32.93 73.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.329 -0.857 . . . . 0.0 109.956 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -65.81 -46.93 76.78 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.207 -0.933 . . . . 0.0 110.97 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.3 -48.93 47.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.969 -1.082 . . . . 0.0 111.589 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.546 HD22 HH12 ' A' ' 18' ' ' ARG . 38.2 mt -58.3 -39.13 78.53 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 111.293 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 5.3 tt0 -71.28 -46.8 60.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.112 0.958 . . . . 0.0 109.411 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 8.6 t-20 -59.21 -36.89 76.2 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -74.94 -34.76 62.12 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.873 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.21 13.81 10.46 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' CB ' ' HG3' ' A' ' 14' ' ' MET . . . -102.73 125.69 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -1.204 . . . . 0.0 110.2 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -111.99 134.86 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 109.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 81' ' ' LYS . 3.0 t -66.54 124.93 22.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.066 -1.021 . . . . 0.0 109.785 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -81.2 -11.7 59.35 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.427 -0.796 . . . . 0.0 109.109 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.627 ' O ' HG12 ' A' ' 79' ' ' VAL 0.269 0.0 OUTLIER -138.16 145.37 41.45 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.633 -0.667 . . . . 0.0 110.74 -178.923 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.67 105.26 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.562 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -130.06 108.13 9.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 111.046 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.38 100.78 11.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 109.578 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' CB ' ' CD2' ' A' ' 7' ' ' PHE . 13.6 mt -75.32 -0.53 20.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.045 -1.034 . . . . 0.0 110.304 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.18 119.94 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 87' ' ' LEU . 1.5 pp -44.79 134.93 5.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 110.421 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.4 OUTLIER -93.34 164.41 13.23 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.191 -0.943 . . . . 0.0 110.691 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 89' ' ' ARG . 6.0 ptm180 -126.32 111.71 14.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.172 -0.955 . . . . 0.0 109.986 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 26.0 tp -94.79 72.28 3.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -0.982 . . . . 0.0 109.968 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.72 97.42 4.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.247 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -97.92 137.53 20.92 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 110.204 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 154.24 54.07 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.043 1.549 . . . . 0.0 110.457 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.84 114.71 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.394 -0.816 . . . . 0.0 110.019 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.53 131.84 34.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.928 . . . . 0.0 110.55 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.141 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 2.8 mmm . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.342 0.591 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.63 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 36.2 t0 -65.17 -37.79 23.26 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.3 -0.875 . . . . 0.0 111.394 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 47.5 Cg_endo -90.7 24.0 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.342 1.18 . . . . 0.0 109.981 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 26.1 mt-30 -125.77 -157.02 0.77 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.351 -0.843 . . . . 0.0 110.665 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.543 ' O ' HD12 ' A' ' 56' ' ' LEU . . . -102.87 0.85 48.29 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.984 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -61.61 98.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.928 -1.337 . . . . 0.0 110.526 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.549 ' HB2' ' HA3' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -163.42 25.18 0.08 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.512 -0.743 . . . . 0.0 109.594 178.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 8' ' ' LEU . 7.8 mp -90.63 129.38 36.76 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 110.243 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 1.6 t90 -124.57 123.56 40.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.524 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.477 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 26.3 m-85 -126.79 138.01 53.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.412 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.883 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.9 tp60 -121.99 159.99 25.84 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.221 -0.924 . . . . 0.0 110.224 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 m -133.36 -176.94 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.02 . . . . 0.0 110.609 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' SD ' ' A' ' 14' ' ' MET . 5.6 pt-20 -138.41 56.04 1.73 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.657 -0.652 . . . . 0.0 110.295 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.545 ' HB3' ' CG ' ' A' ' 18' ' ' ARG . 4.5 mmt -137.05 149.49 66.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.553 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.911 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -70.84 -167.21 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.035 1.545 . . . . 0.0 113.13 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.22 -25.76 67.83 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.8 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.83 -45.54 89.77 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.264 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.545 ' CG ' ' HB3' ' A' ' 14' ' ' MET . 2.8 mtp180 -89.76 -23.65 21.71 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.944 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 15' ' ' PRO . 24.4 t -47.95 -38.41 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.525 -0.734 . . . . 0.0 110.012 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 25.1 t-20 -53.36 -29.12 32.59 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.166 -0.959 . . . . 0.0 109.066 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.588 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 32.9 t0 -59.89 -42.39 93.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 19' ' ' VAL . 6.0 mp -58.32 -38.65 77.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.843 . . . . 0.0 109.615 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.32 58.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.273 -0.892 . . . . 0.0 109.419 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -46.77 82.16 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.216 -0.927 . . . . 0.0 109.292 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.056 ' OE1' HG23 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -59.29 -48.12 82.82 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.85 0.833 . . . . 0.0 109.454 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.605 HD22 HG11 ' A' ' 35' ' ' VAL . 13.3 mt -53.95 -36.92 63.34 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.455 0.645 . . . . 0.0 110.085 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -35.6 74.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.562 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.602 ' CG2' ' CG2' ' A' ' 67' ' ' ILE . 15.9 mt -59.48 -32.52 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.041 . . . . 0.0 110.979 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.627 ' HG3' HG12 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -69.4 48.64 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.067 -1.021 . . . . 0.0 111.661 -178.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -25.59 25.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.435 -1.416 . . . . 0.0 109.851 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -71.55 -27.28 63.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.384 -0.823 . . . . 0.0 111.14 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.001 HG21 HD11 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -83.46 142.78 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.907 -1.12 . . . . 0.0 110.54 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.85 22.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 111.598 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.79 150.34 30.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.619 -1.301 . . . . 0.0 111.822 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.902 HG23 ' HB ' ' A' ' 50' ' ' ILE . 9.7 p -140.03 134.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.4 mtm -122.81 114.12 20.08 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.843 -1.16 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG13 HG22 ' A' ' 48' ' ' VAL . 4.8 t -116.43 132.15 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 109.925 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' HB ' ' CD ' ' A' ' 47' ' ' GLU . 11.2 t -118.81 157.08 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.607 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.11 154.95 21.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.482 -0.761 . . . . 0.0 110.681 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -73.91 -170.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.325 -0.859 . . . . 0.0 110.05 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -103.1 -2.13 27.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 111.031 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.578 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -152.25 -66.38 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.101 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -70.15 -158.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.469 1.247 . . . . 0.0 110.699 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.79 34.95 4.51 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 2.2 mtt180 -94.52 136.69 34.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -1.13 . . . . 0.0 109.815 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.629 ' OH ' HG21 ' A' ' 19' ' ' VAL . 32.7 m-85 -117.21 153.97 31.95 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.099 -1.0 . . . . 0.0 111.256 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' CD ' ' HB ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -103.67 110.82 23.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 9' ' ' TRP . 67.5 t -89.41 124.66 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 111.686 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.476 ' N ' ' ND2' ' A' ' 49' ' ' ASN . 1.4 m-80 -131.01 101.18 5.5 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.001 HD11 HG21 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -124.05 148.27 28.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 111.689 -178.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.984 HG23 ' HB2' ' A' ' 6' ' ' TYR . 7.2 p -105.68 151.28 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.695 -0.628 . . . . 0.0 109.758 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.9 mp -132.88 -170.62 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.053 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 56' ' ' LEU . 39.2 m-80 -43.44 161.3 0.2 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 110.456 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.401 ' CB ' ' O ' ' A' ' 90' ' ' LEU . 39.7 Cg_endo -65.42 -31.75 51.24 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.099 1.579 . . . . 0.0 110.838 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 35.8 t-20 -113.3 70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' A' ' 52' ' ' LEU . 9.1 mt -62.85 -168.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 110.984 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER 168.18 -175.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.62 0.724 . . . . 0.0 110.031 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.808 ' HA ' HD21 ' A' ' 61' ' ' LEU . 74.4 mt-30 -65.54 -32.44 74.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.06 -30.37 63.66 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 110.29 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.48 ' HG3' ' HA ' ' A' ' 56' ' ' LEU . 15.2 mm100 -73.84 -46.12 47.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.808 HD21 ' HA ' ' A' ' 58' ' ' GLN . 3.7 pp -68.0 -34.98 77.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 109.267 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.649 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -52.67 -35.6 55.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.67 ' O ' HG12 ' A' ' 67' ' ' ILE . 15.2 mt -70.92 -50.83 30.52 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.005 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 28.3 mm-40 -65.0 -41.84 95.02 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.37 -1.456 . . . . 0.0 109.397 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.22 -46.33 64.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.896 -1.127 . . . . 0.0 110.326 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 52.9 mm-40 -70.05 -39.75 75.52 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.891 -1.131 . . . . 0.0 110.106 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 63' ' ' LEU . 18.9 mm -77.54 -41.55 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.319 -0.863 . . . . 0.0 111.562 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.056 HG23 ' OE1' ' A' ' 25' ' ' GLU . 24.0 mt -70.74 -49.7 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.53 -1.356 . . . . 0.0 110.047 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 2.7 mt-30 -58.74 -34.09 70.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.243 -0.91 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' HG2' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -56.49 -47.63 78.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.84 -1.162 . . . . 0.0 109.868 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -71.93 -48.46 45.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 110.654 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.699 HD12 HG22 ' A' ' 68' ' ' ILE . 93.1 mt -58.2 -43.9 87.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 111.472 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.08 -44.26 69.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.163 -0.96 . . . . 0.0 109.468 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -59.67 -37.07 77.76 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.588 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -75.14 -26.18 58.97 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.644 -0.66 . . . . 0.0 110.117 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 14' ' ' MET . . . 109.92 -0.51 30.19 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -90.62 127.58 36.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.253 -1.145 . . . . 0.0 110.13 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.31 147.65 44.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 110.596 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.6 t -86.31 125.81 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.82 -9.82 59.5 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.357 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 79' ' ' VAL 0.251 0.0 OUTLIER -133.58 150.0 51.63 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.615 -0.678 . . . . 0.0 110.776 -179.022 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.68 107.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.856 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -128.4 106.86 9.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.996 -1.065 . . . . 0.0 111.118 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -100.22 90.23 4.28 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mt -111.79 177.99 4.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.959 . . . . 0.0 110.191 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.549 ' HA3' ' HB2' ' A' ' 7' ' ' PHE . . . 76.01 137.08 0.66 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.652 ' C ' HD12 ' A' ' 87' ' ' LEU . 2.5 pp 179.8 41.92 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.552 -0.969 . . . . 0.0 109.315 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -82.17 176.11 9.76 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.723 -0.611 . . . . 0.0 110.257 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -128.7 99.62 5.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 110.32 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -120.34 92.9 3.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.046 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.24 175.78 8.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.847 . . . . 0.0 110.198 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -90.81 154.46 45.59 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.038 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.84 54.79 2.64 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.002 1.527 . . . . 0.0 110.672 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.681 HD13 ' C ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -125.28 121.99 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.892 . . . . 0.0 110.424 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.676 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -43.63 -70.13 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.469 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' C ' HD12 ' A' ' 94' ' ' ILE . 6.9 ttpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.287 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' GLN . 4.8 tmm? . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.221 0.534 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.596 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 13.9 t0 -73.58 -43.53 6.92 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.007 . . . . 0.0 110.466 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.2 Cg_endo -82.18 10.12 3.68 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.61 1.321 . . . . 0.0 110.193 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -170.73 -160.35 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.632 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.873 ' C ' HD21 ' A' ' 56' ' ' LEU . . . -120.42 43.15 1.59 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.749 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -62.94 98.71 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -1.23 . . . . 0.0 110.262 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.626 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -146.15 34.51 0.99 Allowed 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.27 -0.894 . . . . 0.0 109.831 179.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 ' CD1' ' A' ' 52' ' ' LEU . 2.9 mm? -103.47 126.19 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.395 -0.815 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.438 ' CE2' ' OD1' ' A' ' 49' ' ' ASN . 1.6 t90 -124.15 130.94 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.178 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -126.24 134.87 51.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.208 -0.932 . . . . 0.0 110.744 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.811 ' O ' HG13 ' A' ' 79' ' ' VAL . 54.8 tt0 -123.02 159.05 29.2 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.249 -0.907 . . . . 0.0 109.614 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.2 m -138.56 -176.74 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 110.643 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 13' ' ' GLU . 5.0 tt0 -140.72 54.28 1.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 110.249 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.788 ' CE ' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -130.43 161.17 62.2 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.168 -0.958 . . . . 0.0 110.347 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -75.44 -178.42 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.934 1.492 . . . . 0.0 113.009 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -67.6 -24.6 65.5 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.409 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -59.72 -45.53 91.87 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.718 -0.614 . . . . 0.0 111.5 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.546 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 1.1 ptp180 -89.71 -10.22 46.54 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.886 . . . . 0.0 111.466 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 22' ' ' LEU . 18.2 t -45.16 -36.16 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.115 -0.991 . . . . 0.0 110.42 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -51.53 -26.86 9.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 33.0 t0 -58.84 -45.76 89.29 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.498 -0.751 . . . . 0.0 110.046 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.788 HD11 ' CE ' ' A' ' 14' ' ' MET . 1.3 mp -57.92 -41.52 82.9 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.41 63.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.15 -0.969 . . . . 0.0 109.587 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -60.73 -46.77 89.14 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.387 -0.821 . . . . 0.0 109.384 179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 2.7 tm-20 -60.98 -48.89 79.75 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 109.946 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.552 HD22 HG21 ' A' ' 35' ' ' VAL . 41.4 mt -54.28 -37.57 64.9 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.357 0.599 . . . . 0.0 110.268 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.609 ' HG2' ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.063 -1.023 . . . . 0.0 110.357 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.609 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 7.7 mt -59.49 -44.77 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 121.013 -1.054 . . . . 0.0 110.374 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.72 65.46 5.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -53.95 -24.54 16.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.815 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -57.99 -13.12 4.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.507 -0.746 . . . . 0.0 110.16 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.77 HG23 HD11 ' A' ' 50' ' ' ILE . 1.8 p -78.54 126.65 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.147 -0.971 . . . . 0.0 110.1 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HG2' ' HB2' ' A' ' 34' ' ' ARG . 26.9 ttt180 -79.69 -44.95 19.89 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.011 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -151.71 122.97 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.733 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 50' ' ' ILE . 11.5 p -132.6 136.02 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.2 122.63 20.7 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.104 -0.997 . . . . 0.0 110.688 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.38 130.55 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 0.0 110.149 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.443 HG23 ' OE1' ' A' ' 47' ' ' GLU . 13.6 m -115.87 146.22 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.538 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.551 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.41 154.17 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.556 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -74.17 -170.22 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.3 p -103.31 -2.05 27.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 110.994 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -144.84 -67.15 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.0 110.616 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.0 Cg_endo -72.56 -168.29 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.353 1.186 . . . . 0.0 110.705 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -108.02 35.32 5.06 Favored Glycine 0 N--CA 1.479 1.5 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 12' ' ' VAL . 4.3 mtp-105 -93.54 134.87 35.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.54 -0.977 . . . . 0.0 110.139 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 9.5 m-85 -119.31 154.3 33.74 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.876 0.846 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 38' ' ' VAL . 3.4 mt-10 -103.93 99.04 8.79 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 10' ' ' TYR . 47.0 t -79.15 124.41 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.773 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 71.4 m-80 -131.29 100.92 5.35 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.77 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -119.19 138.91 48.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.515 -0.74 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 6' ' ' TYR . 4.0 p -96.59 151.14 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 109.324 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.028 ' HB2' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -114.11 173.91 6.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 111.503 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 65.2 m-80 -58.45 167.11 1.87 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.67 -0.644 . . . . 0.0 109.693 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.67 -15.17 44.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.6 1.316 . . . . 0.0 110.78 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -125.93 66.15 1.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.063 -1.023 . . . . 0.0 110.148 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.028 HD23 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -91.46 177.23 6.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.962 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' HA ' HD21 ' A' ' 87' ' ' LEU . 6.0 t70 -177.08 171.89 2.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.977 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -60.23 -33.23 71.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.597 -0.69 . . . . 0.0 110.037 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -65.04 -45.01 87.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 8.5 mm-40 -64.46 -44.32 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.855 . . . . 0.0 110.079 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.847 HD23 ' OE1' ' A' ' 64' ' ' GLU . 74.3 mt -64.82 -37.32 87.22 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.729 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.9 -34.46 55.07 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.864 -1.148 . . . . 0.0 108.065 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 63' ' ' LEU 0.256 0.1 OUTLIER -70.49 -51.28 30.03 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.666 0.746 . . . . 0.0 108.987 178.564 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.847 ' OE1' HD23 ' A' ' 61' ' ' LEU . 3.7 pt-20 -66.94 -43.16 83.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.316 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.38 -41.45 93.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.327 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -34.71 73.71 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.608 ' CG2' ' CG2' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -75.25 -50.41 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.679 HG22 HD12 ' A' ' 72' ' ' LEU . 17.8 mt -59.71 -46.71 93.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 43.5 mt-30 -61.04 -47.28 87.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 109.749 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.68 -47.22 85.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 0.0 110.772 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB3' ' CG ' ' A' ' 25' ' ' GLU . . . -69.91 -48.81 57.14 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.975 -1.078 . . . . 0.0 110.307 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.679 HD12 HG22 ' A' ' 68' ' ' ILE . 44.4 mt -64.06 -35.07 79.54 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.38 -0.825 . . . . 0.0 110.133 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 2.1 mm-40 -69.37 -45.24 69.82 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.53 -0.731 . . . . 0.0 109.176 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -62.6 -39.19 92.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.23 -37.34 61.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.267 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 115.52 20.8 5.32 Favored Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . . . -95.22 123.4 38.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.241 . . . . 0.0 110.123 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.12 134.11 55.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.2 t -89.73 123.13 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.41 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -81.78 -10.75 59.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.526 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.61 140.6 52.0 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.425 -0.797 . . . . 0.0 110.9 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -140.86 105.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 109.939 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' HG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -130.12 107.42 9.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 0.0 110.462 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.826 ' C ' HD23 ' A' ' 85' ' ' LEU . 39.2 mt-10 -100.3 90.89 4.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.997 -1.065 . . . . 0.0 110.389 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.826 HD23 ' C ' ' A' ' 84' ' ' GLU . 5.0 mt -116.7 178.77 4.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 109.928 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 7' ' ' PHE . . . 90.6 143.08 10.51 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.592 HD21 ' HA ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER 179.84 46.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.462 -1.022 . . . . 0.0 109.511 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -84.09 170.02 14.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.552 -0.717 . . . . 0.0 111.071 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mtp-105 -144.62 39.81 1.28 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.942 0.877 . . . . 0.0 109.582 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.46 115.05 27.57 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.267 0.556 . . . . 0.0 110.446 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . . . -155.97 52.74 0.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 109.986 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -92.39 160.41 34.99 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 110.411 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.12 166.84 28.92 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.009 1.531 . . . . 0.0 110.261 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 84.6 mt -91.25 129.97 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.93 9.12 7.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.899 . . . . 0.0 110.028 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.1 tptp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.224 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.163 0.506 . . . . 0.0 110.197 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.637 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.9 t70 -77.49 -38.14 1.76 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.493 -0.755 . . . . 0.0 111.715 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 52.8 Cg_endo -90.15 11.71 2.69 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.412 1.217 . . . . 0.0 109.142 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.566 ' HG3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -58.27 -139.6 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.426 0.632 . . . . 0.0 111.086 -179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.549 ' HA3' ' HB2' ' A' ' 56' ' ' LEU . . . -34.95 -27.01 0.01 OUTLIER Glycine 0 N--CA 1.494 2.503 0 O-C-N 121.744 -0.598 . . . . 0.0 111.834 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.781 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -61.22 97.16 0.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.288 -1.713 . . . . 0.0 109.674 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -167.96 42.57 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.736 179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 84' ' ' GLU . 12.8 mt -104.08 132.44 50.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.447 -0.783 . . . . 0.0 110.436 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -124.12 118.37 26.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.956 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.503 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 25.6 m-85 -126.93 134.66 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.493 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.639 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.7 tt0 -117.44 158.29 24.74 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 17.2 m -134.29 -177.43 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.97 -1.081 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -134.51 51.07 2.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.668 ' HE1' ' HB2' ' A' ' 77' ' ' ALA . 1.5 ptp -130.22 152.74 80.66 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.423 -0.798 . . . . 0.0 109.74 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.5 Cg_endo -70.73 -165.69 0.19 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.755 1.397 . . . . 0.0 113.202 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.871 ' O ' HG23 ' A' ' 19' ' ' VAL . 19.6 tt0 -52.1 -24.83 7.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.865 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.426 ' O ' ' CE2' ' A' ' 75' ' ' TYR . 12.0 t70 -56.78 -23.76 45.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.044 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' CZ ' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -70.04 -14.1 62.53 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.386 -0.821 . . . . 0.0 110.83 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 16' ' ' GLU . 98.0 t -51.82 -48.79 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.144 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.567 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -59.24 -30.9 68.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.812 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 27.1 t0 -68.21 -54.91 14.45 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.5 mm? -62.63 -36.88 84.2 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.967 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -62.73 -52.41 63.34 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.619 -0.676 . . . . 0.0 109.851 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.8 tpp85 -69.84 -41.4 74.94 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.007 -1.058 . . . . 0.0 109.447 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -56.29 -48.82 75.88 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.525 -0.734 . . . . 0.0 110.6 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.725 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -66.52 -37.04 84.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 110.411 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.458 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.28 -40.15 93.07 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.174 -0.954 . . . . 0.0 110.903 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.737 ' CG2' HG23 ' A' ' 67' ' ' ILE . 87.1 mt -61.13 -44.13 97.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.002 -1.061 . . . . 0.0 110.994 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.822 ' NH2' HG21 ' A' ' 35' ' ' VAL . 13.7 ptt180 -84.88 68.39 10.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.803 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -56.05 -27.3 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 109.875 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -59.09 -14.1 8.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' HD11 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -80.13 128.42 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.948 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -79.32 -45.69 19.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 111.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.71 123.8 7.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.607 -1.308 . . . . 0.0 111.915 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.822 HG21 ' NH2' ' A' ' 29' ' ' ARG . 5.9 p -126.0 133.98 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.549 -0.719 . . . . 0.0 109.358 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.3 mtp -128.74 114.84 17.1 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.933 -1.104 . . . . 0.0 110.84 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.51 131.63 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG2' ' CG ' ' A' ' 47' ' ' GLU . 3.5 m -119.79 152.9 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -83.82 153.65 23.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.87 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -166.47 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.365 -0.834 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.3 t -104.94 0.27 27.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 0.0 111.161 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m -148.83 -65.88 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 120.865 -1.147 . . . . 0.0 110.801 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 47.2 Cg_endo -71.72 -169.13 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.214 1.113 . . . . 0.0 110.577 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -108.74 32.17 7.16 Favored Glycine 0 N--CA 1.477 1.371 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.528 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 6.2 ptm180 -93.9 160.43 14.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.923 -1.34 . . . . 0.0 110.508 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 35.1 m-85 -138.28 155.44 48.6 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.888 0.851 . . . . 0.0 111.059 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.543 ' CG ' ' CG2' ' A' ' 38' ' ' VAL . 2.9 pt-20 -100.71 96.07 7.08 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.1 t -78.15 116.47 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 111.484 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -131.58 100.74 5.24 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.817 ' HB ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -123.69 140.25 47.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.591 -0.693 . . . . 0.0 110.603 -179.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.781 HG23 ' HB2' ' A' ' 6' ' ' TYR . 5.3 p -100.13 144.4 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.882 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.017 ' HB2' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -122.87 -166.54 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 110.9 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 52' ' ' LEU . 40.3 m-80 -39.46 159.78 0.11 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.725 -0.609 . . . . 0.0 110.774 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 39.7 Cg_endo -65.17 -15.52 50.63 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.126 1.593 . . . . 0.0 111.289 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -140.11 73.11 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.813 -1.179 . . . . 0.0 111.162 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LEU . 13.0 mt -66.32 -164.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.853 -1.155 . . . . 0.0 110.354 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 11.9 t70 177.92 172.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.522 -0.736 . . . . 0.0 109.721 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.412 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.4 mm-40 -62.58 -34.89 77.88 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -71.29 -28.78 64.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.341 -0.85 . . . . 0.0 110.575 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -73.82 -39.99 63.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.065 -1.022 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 35.2 mt -66.32 -37.07 84.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 110.112 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.62 -38.07 59.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 63' ' ' LEU 0.259 0.2 OUTLIER -71.93 -51.42 22.2 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.893 0.854 . . . . 0.0 108.81 178.013 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 68' ' ' ILE . 60.7 mm-40 -61.9 -38.5 88.59 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.498 -0.751 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 -47.22 78.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.207 -0.933 . . . . 0.0 111.308 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 6.3 pt-20 -62.88 -27.21 69.2 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 120.573 -1.329 . . . . 0.0 109.261 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.737 HG23 ' CG2' ' A' ' 28' ' ' ILE . 2.8 mm -76.81 -55.77 9.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.627 -0.67 . . . . 0.0 110.061 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 72' ' ' LEU . 8.8 mt -62.27 -42.69 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.339 -0.85 . . . . 0.0 109.891 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 38.2 mm-40 -63.12 -40.82 98.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -57.97 -47.3 83.37 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.237 -0.914 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.69 -48.45 59.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.147 -0.971 . . . . 0.0 109.81 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 68' ' ' ILE . 83.1 mt -64.01 -36.19 83.16 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.458 -0.776 . . . . 0.0 110.108 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 6.7 mm-40 -70.49 -45.89 64.8 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.552 -0.717 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -61.82 -38.71 89.17 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -75.65 -17.9 59.83 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.92 51.9 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.668 ' HB2' ' HE1' ' A' ' 14' ' ' MET . . . -87.63 129.2 35.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.147 -1.208 . . . . 0.0 110.055 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 119.6 34.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 110.342 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.7 t -77.19 120.77 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 109.932 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.19 -8.79 59.66 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HD2' ' HA ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -130.0 134.27 47.31 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.402 -0.811 . . . . 0.0 110.482 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.9 p -141.07 107.68 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.812 -1.18 . . . . 0.0 110.651 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -127.96 106.94 9.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.164 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 8' ' ' LEU . 3.4 mt-10 -100.25 110.09 22.32 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.266 -0.896 . . . . 0.0 110.546 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 3.7 mm? -75.55 -16.37 60.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 110.044 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . 61.41 -172.09 7.89 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 tp -55.44 79.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.657 -0.908 . . . . 0.0 111.036 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 86' ' ' GLY . 19.1 tpt180 -80.52 157.13 26.21 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.185 -0.947 . . . . 0.0 110.022 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 89' ' ' ARG . 2.5 ptm180 -127.78 116.14 19.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.091 -1.006 . . . . 0.0 110.168 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 2.4 tp -71.91 104.5 3.51 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.247 -0.908 . . . . 0.0 110.021 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -168.69 -39.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 109.914 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -105.79 162.33 20.06 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 109.989 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.45 176.54 8.56 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.906 1.477 . . . . 0.0 110.551 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.703 HD13 ' C ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -95.08 119.52 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.181 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.629 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -159.65 56.99 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.328 -0.857 . . . . 0.0 110.19 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.2 tptt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.269 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.223 0.535 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.596 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 10.9 t70 -58.48 -49.75 91.83 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.902 . . . . 0.0 110.763 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 2' ' ' ASP . 44.3 Cg_endo -69.87 60.09 1.72 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 N-CA-C 109.221 -1.107 . . . . 0.0 109.221 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.551 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 3.4 pm0 -13.52 -53.52 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 3' ' ' PRO . . . -172.98 32.27 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 118.191 -1.957 . . . . 0.0 112.04 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.019 ' CZ ' HD12 ' A' ' 52' ' ' LEU . 3.4 t80 -86.49 118.05 25.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.214 -1.756 . . . . 0.0 109.504 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 6' ' ' TYR . 15.9 m-85 -163.21 64.5 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.203 -0.936 . . . . 0.0 110.489 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 8' ' ' LEU . 1.7 mm? -84.67 138.99 32.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.237 -0.915 . . . . 0.0 109.915 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.418 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -108.75 118.96 38.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.937 . . . . 0.0 110.585 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 48' ' ' VAL . 28.6 m-85 -127.23 115.45 19.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.161 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.919 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.1 tt0 -95.35 160.37 14.57 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.183 -0.948 . . . . 0.0 110.402 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.588 HG22 ' H ' ' A' ' 46' ' ' TYR . 30.7 m -130.41 179.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 110.517 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -135.55 53.0 1.98 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.414 -0.804 . . . . 0.0 110.606 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.662 ' SD ' ' HB2' ' A' ' 77' ' ' ALA . 4.2 ptt? -133.33 153.32 80.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.269 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.91 -163.96 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.13 1.595 . . . . 0.0 112.417 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.925 ' O ' HG23 ' A' ' 19' ' ' VAL . 3.9 tm-20 -50.27 -26.75 5.09 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.98 -17.33 16.53 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.772 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.556 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -63.76 -13.85 47.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 16' ' ' GLU . 93.3 t -53.1 -42.92 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.48 -0.763 . . . . 0.0 110.239 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.45 -34.98 76.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.946 . . . . 0.0 109.826 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.728 ' OD2' ' HB3' ' A' ' 77' ' ' ALA . 9.2 t0 -70.71 -54.43 11.82 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.2 mm? -64.17 -36.25 83.45 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 19' ' ' VAL . . . -60.5 -52.75 63.86 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.356 -0.84 . . . . 0.0 109.286 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 28' ' ' ILE . 5.6 mtt180 -70.08 -46.71 64.35 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.276 -0.89 . . . . 0.0 109.889 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 2.7 tm-20 -56.33 -45.73 80.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.808 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 35' ' ' VAL . 74.1 mt -62.81 -38.65 91.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.862 . . . . 0.0 110.302 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -45.66 93.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.819 ' CG2' HG23 ' A' ' 67' ' ' ILE . 13.4 mt -65.18 -42.96 95.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.769 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -70.43 55.22 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 110.67 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 15.4 p-10 -72.14 -30.07 64.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.58 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -61.24 -12.9 14.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.59 -0.694 . . . . 0.0 109.978 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 29' ' ' ARG . 3.9 p -79.09 137.55 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.361 -0.837 . . . . 0.0 110.437 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -42.68 25.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 110.813 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -148.06 122.71 9.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.043 -1.035 . . . . 0.0 111.06 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.875 HG12 HG13 ' A' ' 50' ' ' ILE . 22.5 m -117.67 135.16 58.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.328 -0.858 . . . . 0.0 110.423 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.66 116.12 10.09 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 22' ' ' LEU . 57.4 t -111.27 131.92 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.38 152.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.558 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.03 154.6 21.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.195 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -73.19 172.77 10.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.74 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.479 ' H ' HG22 ' A' ' 41' ' ' THR . 5.3 t -89.73 1.08 56.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.937 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.564 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.67 -64.61 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.028 -1.045 . . . . 0.0 110.48 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 45.9 Cg_endo -70.84 -159.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.532 1.28 . . . . 0.0 110.77 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.16 36.53 4.16 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 5.7 mtt180 -93.13 135.19 34.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.53 -0.982 . . . . 0.0 110.397 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.588 ' H ' HG22 ' A' ' 12' ' ' VAL . 25.5 m-85 -119.76 154.86 33.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.353 -0.842 . . . . 0.0 110.397 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -102.99 116.53 32.71 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -94.47 112.21 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 110.515 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.583 ' O ' HD12 ' A' ' 50' ' ' ILE . 64.3 m-80 -131.04 100.7 5.32 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.875 HG13 HG12 ' A' ' 35' ' ' VAL . 1.1 mp -115.28 140.04 38.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 121.738 0.78 . . . . 0.0 111.24 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.583 HG13 ' HB3' ' A' ' 3' ' ' PRO . 0.9 OUTLIER -101.61 149.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.019 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 6.3 mt -118.7 -170.23 1.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.627 -1.296 . . . . 0.0 112.062 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 6.8 m120 -42.34 170.74 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.635 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 53' ' ' ASN . 36.3 Cg_endo -59.66 -12.72 18.73 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.648 1.341 . . . . 0.0 111.04 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.496 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 3.3 t-20 -142.11 87.43 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.087 . . . . 0.0 110.436 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -60.74 -178.09 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.744 -1.222 . . . . 0.0 109.942 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.669 ' O ' HD12 ' A' ' 61' ' ' LEU . 12.4 t70 -175.24 171.67 2.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.047 . . . . 0.0 110.764 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.432 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 65.8 mt-30 -61.71 -40.55 95.42 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.549 -0.719 . . . . 0.0 110.514 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -29.57 68.81 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.222 -0.924 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.52 -45.11 69.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 110.158 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -66.19 -34.37 77.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.555 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.98 -38.8 62.55 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 67' ' ' ILE . 40.9 mt -71.64 -51.01 25.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' O ' HD12 ' A' ' 68' ' ' ILE . 3.5 mt-10 -60.06 -40.9 91.06 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.887 -1.133 . . . . 0.0 110.061 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -72.66 -46.46 53.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.045 -1.034 . . . . 0.0 109.634 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 6.8 mm-40 -69.58 -38.86 77.54 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 110.016 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.819 HG23 ' CG2' ' A' ' 28' ' ' ILE . 16.0 mm -76.43 -38.17 31.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.296 -0.878 . . . . 0.0 111.257 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 64' ' ' GLU . 57.7 mt -69.53 -48.28 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.778 -1.201 . . . . 0.0 110.053 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 4.9 pt20 -61.52 -38.86 88.94 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.184 -0.948 . . . . 0.0 110.02 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -58.17 -45.98 86.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.14 -0.975 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.3 59.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.081 -1.012 . . . . 0.0 110.836 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.518 HD23 ' CG ' ' A' ' 21' ' ' ASP . 79.2 mt -58.76 -43.03 90.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.267 -0.896 . . . . 0.0 110.661 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.44 -45.4 62.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.376 -0.828 . . . . 0.0 109.622 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.429 ' ND2' ' HD3' ' A' ' 70' ' ' ARG . 62.8 m-20 -62.61 -36.89 84.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.35 -35.29 58.78 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.312 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.29 18.28 6.31 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.728 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . . . -109.66 136.87 48.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.29 . . . . 0.0 110.224 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' NH1' ' HG2' ' A' ' 73' ' ' GLU . 2.1 tpt180 -119.69 133.53 55.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 110.326 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 11' ' ' GLN . 4.6 t -75.73 124.87 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.011 -1.055 . . . . 0.0 109.533 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.76 -8.0 59.62 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.73 156.31 47.27 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.501 -0.749 . . . . 0.0 111.608 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.693 ' O ' HG13 ' A' ' 82' ' ' VAL . 7.1 p -141.56 106.62 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.437 -0.789 . . . . 0.0 109.416 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.67 108.84 10.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.078 -1.014 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.664 ' HA ' HD12 ' A' ' 8' ' ' LEU . 16.4 tt0 -99.02 89.87 4.42 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.187 -0.945 . . . . 0.0 109.858 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -112.61 177.39 4.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.2 -0.937 . . . . 0.0 109.794 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.619 ' O ' HD22 ' A' ' 87' ' ' LEU . . . 62.13 119.24 0.01 OUTLIER Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.619 HD22 ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -168.49 66.09 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.502 -0.999 . . . . 0.0 109.137 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.499 ' O ' HD11 ' A' ' 56' ' ' LEU . 12.2 mmt180 -117.04 -178.89 3.54 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.429 -0.794 . . . . 0.0 110.659 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 5.8 mtt180 -146.8 113.6 6.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.887 . . . . 0.0 110.408 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.03 127.97 31.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 109.88 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.09 -67.07 0.05 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 110.591 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . 19.0 m-85 -108.12 167.32 9.45 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.128 -0.983 . . . . 0.0 110.471 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 92' ' ' TYR . 46.9 Cg_endo -74.16 93.51 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.046 1.551 . . . . 0.0 110.276 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -106.92 123.67 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.104 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.606 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -163.8 157.54 19.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.176 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.201 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 20.0 mtp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.119 0.485 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.639 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 24.5 t0 -58.24 -37.66 57.54 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 111.012 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 51.2 Cg_endo -88.9 18.09 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.415 1.218 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 88' ' ' ARG . 14.2 mt-30 -118.76 -155.42 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.854 . . . . 0.0 110.621 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.804 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -74.17 8.74 11.44 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.112 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.697 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -70.39 98.86 1.48 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.593 -1.534 . . . . 0.0 109.656 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.95 ' O ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -163.61 59.08 0.17 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.118 -0.989 . . . . 0.0 110.029 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.027 HD11 HD11 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -138.41 131.86 30.5 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.344 -0.847 . . . . 0.0 109.78 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 81' ' ' LYS . 1.2 t90 -126.81 127.44 45.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 28.9 m-85 -126.24 115.08 19.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.33 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.852 ' O ' HG13 ' A' ' 79' ' ' VAL . 4.4 tt0 -107.5 149.23 28.2 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.544 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.6 m -126.75 -176.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 111.026 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 13' ' ' GLU . 1.9 tt0 -146.72 59.91 1.2 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.343 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.535 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.75 148.69 66.04 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 37.3 Cg_endo -71.78 -165.82 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.135 1.597 . . . . 0.0 113.573 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.822 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -62.98 -23.06 67.26 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.039 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.69 -48.15 67.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.738 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.5 OUTLIER -90.86 -14.22 32.2 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.116 -0.99 . . . . 0.0 111.219 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 16' ' ' GLU . 14.5 p -45.88 -37.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.261 -0.899 . . . . 0.0 109.784 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.575 ' N ' HG13 ' A' ' 19' ' ' VAL . 62.1 m-80 -53.32 -28.31 27.78 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.474 -0.767 . . . . 0.0 109.304 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 28.7 t0 -58.36 -32.5 68.61 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.545 -0.722 . . . . 0.0 110.129 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.3 mm? -59.0 -37.32 76.6 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.17 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -58.54 -51.22 70.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.28 -46.95 65.97 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.18 -0.95 . . . . 0.0 110.089 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' CD ' HD11 ' A' ' 72' ' ' LEU . 2.6 tt0 -56.32 -48.38 76.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.725 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -67.22 -37.22 83.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.854 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.36 -38.78 78.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 109.737 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.669 HD13 HG22 ' A' ' 67' ' ' ILE . 9.5 mt -59.06 -45.87 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.148 -0.97 . . . . 0.0 110.703 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 26' ' ' LEU . 13.1 ptm180 -74.4 56.53 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 0.0 110.223 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.12 -25.47 62.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.0 110.296 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -58.66 -17.18 20.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.035 HG21 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -80.88 162.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.381 -0.824 . . . . 0.0 109.965 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -44.18 22.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.976 . . . . 0.0 111.945 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.82 146.58 26.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.741 -1.224 . . . . 0.0 111.655 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.637 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 6.9 t -132.32 127.48 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 tpt -140.41 115.55 9.83 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.488 -0.758 . . . . 0.0 109.69 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 46' ' ' TYR . 88.9 t -114.81 131.9 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.0 110.981 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.65 HG22 ' HB2' ' A' ' 47' ' ' GLU . 7.8 m -101.97 140.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 110.035 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -81.46 153.07 27.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.162 -0.961 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.19 152.73 39.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.848 . . . . 0.0 110.014 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.2 p -75.34 -11.56 60.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -0.926 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -141.41 -67.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.117 -0.99 . . . . 0.0 110.496 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.3 Cg_endo -70.68 -176.11 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.323 1.17 . . . . 0.0 110.562 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 33.29 6.65 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.9 mtt180 -93.2 135.44 34.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.008 . . . . 0.0 110.021 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 30.0 m-85 -117.93 154.93 31.09 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.296 -0.878 . . . . 0.0 110.568 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.65 ' HB2' HG22 ' A' ' 38' ' ' VAL . 33.9 mt-10 -103.5 95.08 5.83 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.748 -0.595 . . . . 0.0 109.683 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 10' ' ' TYR . 89.4 t -78.77 115.13 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 110.615 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.553 ' O ' HD12 ' A' ' 50' ' ' ILE . 70.7 m-80 -131.65 102.0 5.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.035 HG21 HG21 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -111.82 142.26 24.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.749 0.785 . . . . 0.0 110.691 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 6' ' ' TYR . 7.8 p -92.32 133.61 33.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.415 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.027 HD11 HD11 ' A' ' 8' ' ' LEU . 30.5 mt -90.04 174.37 7.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 0.0 110.549 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.96 ' OD1' HD11 ' A' ' 56' ' ' LEU . 2.1 m120 -62.24 -153.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.697 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.74 -35.4 28.16 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 CA-C-N 119.122 0.722 . . . . 0.0 111.439 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.48 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 8.1 t30 -162.87 76.25 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.802 -1.186 . . . . 0.0 111.327 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.96 HD11 ' OD1' ' A' ' 53' ' ' ASN . 16.8 mt -74.7 -161.04 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 110.419 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 1.004 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.1 t0 -171.92 -164.09 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.496 -0.752 . . . . 0.0 111.1 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.457 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 2.4 mm-40 -64.77 -32.87 74.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.557 -0.715 . . . . 0.0 111.177 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -35.06 78.74 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.4 mm-40 -73.72 -42.9 60.54 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.414 -0.804 . . . . 0.0 109.954 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.004 HD12 ' O ' ' A' ' 57' ' ' ASP . 1.2 mt -64.87 -34.46 78.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.39 -33.65 44.48 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.562 ' O ' HG13 ' A' ' 67' ' ' ILE . 18.3 mt -64.38 -51.05 65.23 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.461 -0.895 . . . . 0.0 108.618 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 2.5 mt-10 -72.19 -43.09 65.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.232 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -62.51 -34.86 77.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.533 -0.729 . . . . 0.0 110.443 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.7 -48.9 70.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.826 -1.171 . . . . 0.0 109.687 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.669 HG22 HD13 ' A' ' 28' ' ' ILE . 4.3 mt -78.98 -41.17 23.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.493 -0.754 . . . . 0.0 111.155 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 40.9 mt -59.01 -49.5 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.049 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.8 mt-30 -58.61 -48.91 79.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.393 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -66.15 -47.21 74.79 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 110.877 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -65.01 -48.25 74.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.907 -1.121 . . . . 0.0 110.182 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.48 HD12 ' CG2' ' A' ' 68' ' ' ILE . 32.8 mt -65.57 -35.33 80.52 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 110.026 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 1.0 OUTLIER -70.34 -45.31 66.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.44 -0.788 . . . . 0.0 109.487 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -63.16 -36.31 83.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -74.57 -38.9 62.55 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.562 -0.712 . . . . 0.0 110.604 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.3 21.65 5.12 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.13 123.76 46.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -1.221 . . . . 0.0 109.797 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -119.77 122.41 41.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 110.581 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.3 t -81.34 128.99 38.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.079 -1.013 . . . . 0.0 109.59 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.34 -17.68 48.32 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 108.467 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 10' ' ' TYR 0.255 0.0 OUTLIER -128.78 129.42 45.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.806 -0.559 . . . . 0.0 110.171 -179.533 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 t -141.86 106.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.677 -1.264 . . . . 0.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.95 106.8 8.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 110.055 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.633 ' HB2' HD13 ' A' ' 61' ' ' LEU . 1.4 pt-20 -100.46 90.57 4.34 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.791 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.8 mp -97.1 -83.97 0.38 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.21 -0.931 . . . . 0.0 109.888 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 5' ' ' GLY . . . 47.05 100.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -170.07 47.38 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.256 -1.143 . . . . 0.0 109.966 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 3' ' ' PRO . 12.7 ttt180 -115.16 159.92 20.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.461 -0.774 . . . . 0.0 110.371 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.48 ' HG2' ' HB2' ' A' ' 55' ' ' ASN . 12.6 mtm180 -143.45 110.05 5.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 0.0 110.517 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 3' ' ' PRO . 18.0 tp -178.97 81.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.354 -0.841 . . . . 0.0 110.161 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.49 -167.09 2.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -72.13 140.41 82.89 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 110.145 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.67 92.75 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.078 1.567 . . . . 0.0 110.441 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 96' ' ' LYS . 8.1 mm -101.14 118.55 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 109.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.6 -11.25 43.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.32 -0.862 . . . . 0.0 110.141 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 94' ' ' ILE . 2.3 tttt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.245 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.479 ' O ' ' O ' ' A' ' 4' ' ' GLN . 23.7 mtt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.194 0.521 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.647 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 49.9 t0 -74.5 -36.7 2.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.023 -1.048 . . . . 0.0 111.393 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.9 Cg_endo -91.15 13.65 2.08 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.329 1.173 . . . . 0.0 109.674 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 5.2 pt20 -175.16 156.17 2.06 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.317 -0.864 . . . . 0.0 110.464 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.831 ' O ' HD23 ' A' ' 56' ' ' LEU . . . 84.61 -57.67 5.01 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.886 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.648 ' O ' ' CG ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -63.61 98.94 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.711 -1.464 . . . . 0.0 111.073 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.88 ' O ' HD23 ' A' ' 8' ' ' LEU . 26.2 t80 -153.33 36.34 0.47 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.843 -1.16 . . . . 0.0 109.828 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.971 ' CD2' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -141.93 124.75 16.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.767 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.709 ' HB2' HD23 ' A' ' 85' ' ' LEU . 6.2 t90 -127.77 119.86 26.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.118 -0.989 . . . . 0.0 109.972 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.975 ' O ' HG22 ' A' ' 48' ' ' VAL . 76.9 m-85 -126.54 137.79 53.4 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.152 -0.968 . . . . 0.0 111.104 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.781 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.2 tp60 -120.43 160.66 22.65 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.348 -0.845 . . . . 0.0 109.228 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 21.0 m -130.57 -178.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.03 -1.044 . . . . 0.0 110.687 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.39 57.17 1.59 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.638 -0.664 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.582 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -135.35 155.28 78.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.42 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 37.2 Cg_endo -73.0 -167.79 0.37 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.925 1.487 . . . . 0.0 113.05 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.591 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 15.3 tt0 -66.09 -25.53 67.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.038 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 13.3 t0 -59.87 -40.71 89.55 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.364 0.602 . . . . 0.0 111.036 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.582 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.1 OUTLIER -88.95 -14.56 36.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.271 -0.893 . . . . 0.0 110.125 -179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.591 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 15.1 t -47.19 -37.47 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.764 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -29.36 22.05 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.612 ' OD2' HD23 ' A' ' 72' ' ' LEU . 33.1 t0 -59.87 -39.57 85.71 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.481 -0.762 . . . . 0.0 109.199 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.588 HD12 HG11 ' A' ' 37' ' ' VAL . 4.4 mm? -58.94 -42.75 90.54 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.92 -51.77 66.45 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -46.68 78.69 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.575 -0.703 . . . . 0.0 109.257 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.4 -48.53 76.72 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.43 -0.794 . . . . 0.0 109.306 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.713 HD21 ' CG2' ' A' ' 37' ' ' VAL . 89.4 mt -60.33 -39.53 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -70.24 -38.64 75.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.528 -0.732 . . . . 0.0 109.274 179.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 67' ' ' ILE . 1.2 mm -58.96 -37.77 69.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.827 0.822 . . . . 0.0 108.855 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.873 ' O ' HG12 ' A' ' 32' ' ' VAL . 10.5 mtp180 -69.68 64.05 0.19 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.75 -0.594 . . . . 0.0 110.228 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -37.52 70.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.32 -14.01 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 110.021 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.873 HG12 ' O ' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -79.93 138.66 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.374 -0.829 . . . . 0.0 110.384 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.7 mmt-85 -79.25 -45.49 19.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.068 -1.02 . . . . 0.0 110.913 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.63 123.15 7.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.933 -1.104 . . . . 0.0 111.204 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 50' ' ' ILE . 2.8 p -130.12 133.61 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.517 -0.74 . . . . 0.0 109.605 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -128.04 118.25 23.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.124 -0.985 . . . . 0.0 110.75 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.115 HG13 HG12 ' A' ' 48' ' ' VAL . 19.4 t -115.06 131.98 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.616 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.494 HG23 ' OE2' ' A' ' 47' ' ' GLU . 4.1 m -121.28 159.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 110.452 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.59 154.17 22.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.401 -0.812 . . . . 0.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.36 176.74 5.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.292 -0.88 . . . . 0.0 109.57 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.4 p -93.34 -3.98 52.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 110.73 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -148.02 -67.77 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.023 -1.048 . . . . 0.0 110.467 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 49.7 Cg_endo -72.53 -168.94 0.43 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.303 1.159 . . . . 0.0 110.915 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.8 32.88 6.84 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 8.0 mtt180 -94.26 134.88 36.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -1.068 . . . . 0.0 109.323 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.577 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 7.8 m-85 -116.81 150.18 38.76 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.871 -1.143 . . . . 0.0 111.427 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.494 ' OE2' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -106.41 90.53 3.37 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.166 178.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.115 HG12 HG13 ' A' ' 37' ' ' VAL . 22.0 m -82.42 125.28 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.549 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -122.51 101.62 7.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.801 HD11 ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -111.96 142.38 24.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 121.561 0.696 . . . . 0.0 111.437 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.657 ' N ' HD13 ' A' ' 50' ' ' ILE . 7.3 p -108.61 119.94 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.685 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 52' ' ' LEU . 4.6 mt -86.81 177.21 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.967 . . . . 0.0 110.581 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.521 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 70.2 m-80 -42.96 167.19 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' HB2' ' NE2' ' A' ' 4' ' ' GLN . 37.9 Cg_endo -63.84 -15.0 46.46 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.673 1.354 . . . . 0.0 110.24 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 24.2 t-20 -133.28 63.54 1.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.893 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 5' ' ' GLY . 3.1 pp -61.78 176.55 0.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.041 -1.037 . . . . 0.0 110.414 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 61' ' ' LEU . 2.5 m-20 -168.29 178.31 4.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 110.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -65.73 -36.32 83.25 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.537 -0.727 . . . . 0.0 110.461 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.4 t -69.29 -30.6 68.71 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.255 -0.903 . . . . 0.0 110.3 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 22.1 mm-40 -73.12 -45.91 54.22 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.971 HD21 ' CD2' ' A' ' 8' ' ' LEU . 1.6 mp -66.86 -36.14 81.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.983 -1.073 . . . . 0.0 109.366 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 66' ' ' GLU . . . -53.45 -33.87 55.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.552 ' O ' HG13 ' A' ' 67' ' ' ILE . 13.7 mt -69.46 -50.38 46.13 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.248 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' O ' ' HB ' ' A' ' 68' ' ' ILE . 4.4 mm-40 -71.53 -42.75 67.57 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -65.55 -30.84 71.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.186 -0.946 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 62' ' ' ALA . 2.0 mm-40 -69.43 -48.92 59.45 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.865 -1.147 . . . . 0.0 110.355 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.596 HG21 HG23 ' A' ' 28' ' ' ILE . 4.7 mt -78.6 -38.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.302 -0.873 . . . . 0.0 111.063 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 53.4 mt -60.37 -48.95 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.993 -1.067 . . . . 0.0 110.391 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.54 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 1.6 pp0? -63.55 -41.63 98.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.0 109.809 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.55 -46.52 66.25 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.37 -0.832 . . . . 0.0 110.388 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.88 83.39 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.08 -1.013 . . . . 0.0 109.777 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.612 HD23 ' OD2' ' A' ' 21' ' ' ASP . 97.3 mt -65.5 -35.46 80.95 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.8 OUTLIER -67.0 -45.27 78.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.457 -0.777 . . . . 0.0 109.005 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -61.12 -36.55 80.03 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -74.88 -41.87 58.94 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.74 -0.6 . . . . 0.0 110.327 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.45 23.35 4.47 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -112.54 125.23 54.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.262 -1.14 . . . . 0.0 109.762 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.47 148.91 42.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 110.757 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 11' ' ' GLN . 1.9 t -95.79 114.59 32.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 108.773 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -82.07 -5.47 58.42 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.774 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.257 0.0 OUTLIER -138.41 150.32 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.274 -0.891 . . . . 0.0 111.736 -178.354 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 82' ' ' VAL . 3.0 p -141.56 107.15 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.46 -0.775 . . . . 0.0 109.456 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' TRP . 6.8 tp10 -128.6 122.48 31.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.125 -0.985 . . . . 0.0 111.062 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.572 ' O ' ' CE1' ' A' ' 7' ' ' PHE . 42.3 mt-10 -94.21 115.25 27.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.709 HD23 ' HB2' ' A' ' 9' ' ' TRP . 2.8 pp -124.33 121.22 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.92 -1.112 . . . . 0.0 112.129 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA3' ' CZ ' ' A' ' 6' ' ' TYR . . . 98.76 45.83 2.21 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 88' ' ' ARG . 19.2 tp -45.91 165.78 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.282 -1.128 . . . . 0.0 109.516 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -79.02 121.07 24.49 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.962 -1.086 . . . . 0.0 110.477 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 18.5 mtt180 -157.89 28.59 0.27 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.013 . . . . 0.0 110.27 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.878 HD22 ' N ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -77.78 128.25 33.72 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.836 179.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.878 ' N ' HD22 ' A' ' 90' ' ' LEU . . . -122.52 -135.95 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 18.5 p90 -100.99 148.51 35.18 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 110.814 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.43 -90.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.012 1.533 . . . . 0.0 110.472 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 94' ' ' ILE . 1.8 tt -99.65 128.41 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.873 . . . . 0.0 110.265 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -165.89 -38.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 110.061 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.267 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.239 0.542 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.616 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 16.7 t70 -68.66 -40.31 17.75 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 111.199 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 53.8 Cg_endo -84.16 41.52 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.432 1.227 . . . . 0.0 110.334 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' C ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -23.65 140.9 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.213 0.53 . . . . 0.0 111.146 -179.197 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.702 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 85.46 -25.93 6.07 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.556 ' HB2' HG23 ' A' ' 51' ' ' VAL . 2.1 t80 -90.47 98.25 11.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.913 -1.345 . . . . 0.0 111.582 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.821 ' H ' HD22 ' A' ' 8' ' ' LEU . 4.4 p90 -149.94 31.55 0.7 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.169 -0.957 . . . . 0.0 109.734 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.821 HD22 ' H ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -119.52 125.06 47.95 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.227 -0.92 . . . . 0.0 111.245 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -126.58 116.55 21.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.848 ' CD2' HG21 ' A' ' 79' ' ' VAL . 1.4 m-85 -126.96 139.48 53.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 111.062 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.722 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -120.46 159.86 24.29 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 26.5 m -133.8 173.97 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.946 -1.096 . . . . 0.0 111.239 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.98 54.25 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.736 -0.603 . . . . 0.0 109.961 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.515 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 50.3 mmm -129.83 156.74 78.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.329 -0.857 . . . . 0.0 109.64 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -70.85 -167.02 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.825 1.434 . . . . 0.0 113.124 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.573 ' HA ' HG23 ' A' ' 19' ' ' VAL . 17.6 tp10 -63.79 -28.38 69.83 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.407 -1.269 . . . . 0.0 107.796 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -18.6 40.59 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.539 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.902 ' NH1' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -87.57 -23.71 24.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.593 -0.692 . . . . 0.0 110.095 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 16' ' ' GLU . 77.3 t -48.3 -42.71 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.469 -0.77 . . . . 0.0 110.309 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -58.92 -29.97 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.15 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.514 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 30.7 t0 -61.71 -50.84 70.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.144 -0.972 . . . . 0.0 109.964 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.644 HD11 HH11 ' A' ' 18' ' ' ARG . 8.3 mp -59.89 -43.11 94.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.381 -0.824 . . . . 0.0 109.666 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.5 79.64 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.229 -0.92 . . . . 0.0 109.656 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -68.73 -46.42 68.95 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.393 -0.817 . . . . 0.0 109.266 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.869 ' OE1' ' HB2' ' A' ' 71' ' ' ALA . 9.7 tp10 -60.38 -47.64 85.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.418 -0.801 . . . . 0.0 109.532 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.928 HD22 HG11 ' A' ' 35' ' ' VAL . 29.6 mt -53.08 -38.66 62.73 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.579 0.704 . . . . 0.0 109.512 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 4.4 tpt180 -64.11 -34.5 78.18 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 110.549 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.697 HD12 ' OE1' ' A' ' 25' ' ' GLU . 5.4 mt -62.12 -44.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.898 -1.126 . . . . 0.0 109.808 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.626 ' NH1' HD23 ' A' ' 26' ' ' LEU . 11.6 mtp180 -70.05 76.45 0.5 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.697 -0.627 . . . . 0.0 110.311 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.62 -36.61 84.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.251 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -61.75 -12.89 18.98 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.977 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.019 HG22 HD11 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -79.03 123.73 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.719 . . . . 0.0 110.141 -179.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -47.32 15.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 112.186 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.539 ' CG ' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -153.55 139.18 17.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.562 -1.336 . . . . 0.0 110.851 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.928 HG11 HD22 ' A' ' 26' ' ' LEU . 13.3 p -135.63 135.85 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.455 -0.778 . . . . 0.0 110.002 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.488 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 42.0 mtp -117.44 115.48 25.28 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.227 -0.921 . . . . 0.0 109.846 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.9 t -114.67 128.55 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 110.572 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 38' ' ' VAL . 4.8 m -115.09 134.41 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.14 153.72 23.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.534 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 1.1 m -73.86 150.64 40.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 0.0 109.885 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.2 p -76.5 3.0 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.589 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -148.99 -66.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 46.9 Cg_endo -72.37 178.59 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.366 1.193 . . . . 0.0 110.541 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -101.31 33.01 6.82 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 4.8 mtt180 -93.78 134.74 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.439 -1.036 . . . . 0.0 110.275 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.549 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 34.4 m-85 -120.56 151.51 39.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -106.51 99.03 8.63 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.911 -0.493 . . . . 0.0 110.186 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' TYR . 16.9 m -86.53 122.17 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.01 -1.056 . . . . 0.0 110.686 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 36' ' ' MET . 2.4 p30 -131.16 102.71 6.12 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.19 140.76 30.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 O-C-N 121.433 -0.792 . . . . 0.0 111.552 -178.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.681 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.4 p -114.87 150.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.92 ' HB2' HD11 ' A' ' 56' ' ' LEU . 2.3 mp -139.48 -157.41 0.76 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.769 -1.207 . . . . 0.0 111.928 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 52' ' ' LEU . 27.6 m-80 -37.86 161.47 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.561 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 38.4 Cg_endo -64.67 -17.4 59.4 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.012 1.533 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -146.78 79.78 1.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.764 -1.21 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.92 HD11 ' HB2' ' A' ' 52' ' ' LEU . 16.2 mt -67.64 -164.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.039 . . . . 0.0 110.586 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 58' ' ' GLN . 3.3 t70 -177.08 171.6 2.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 110.68 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' N ' ' CG ' ' A' ' 57' ' ' ASP . 2.1 mt-30 -54.63 -35.53 63.56 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.573 -0.704 . . . . 0.0 110.433 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 m -67.85 -40.6 83.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.177 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -70.77 -44.56 66.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.321 -0.862 . . . . 0.0 109.989 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 2.5 mm? -66.44 -34.83 78.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.733 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.91 -35.3 45.07 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 67' ' ' ILE . 22.3 mt -72.12 -49.67 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.215 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 8.2 mt-10 -67.31 -35.88 80.34 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.533 -1.354 . . . . 0.0 109.915 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.24 -45.27 56.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 75.2 mt-10 -70.2 -38.5 75.34 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.096 -1.002 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 63' ' ' LEU . 43.9 mm -76.9 -38.75 29.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.329 -0.857 . . . . 0.0 111.192 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 62.4 mt -69.39 -46.88 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.884 -1.135 . . . . 0.0 110.125 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 20.0 mt-30 -59.71 -38.8 82.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.259 -0.901 . . . . 0.0 110.165 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -44.66 91.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.196 -0.94 . . . . 0.0 110.894 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.869 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . . . -68.27 -48.64 64.51 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.997 -1.064 . . . . 0.0 110.522 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.902 HD23 ' NH1' ' A' ' 18' ' ' ARG . 20.3 mt -58.71 -39.93 82.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.39 -0.819 . . . . 0.0 110.547 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -71.2 -45.56 63.13 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.445 -0.784 . . . . 0.0 109.61 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -61.3 -38.47 86.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -75.79 -32.13 59.75 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.064 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.11 17.55 10.04 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.521 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . . . -102.36 124.36 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.0 110.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -119.0 124.1 46.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 109.796 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.848 HG21 ' CD2' ' A' ' 10' ' ' TYR . 3.8 t -67.6 125.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.983 -1.073 . . . . 0.0 109.884 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -10.28 59.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.69 152.99 52.02 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.281 -0.887 . . . . 0.0 111.716 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 t -141.76 106.82 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -128.28 109.54 11.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.065 -1.022 . . . . 0.0 111.305 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.65 120.13 33.53 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.168 -0.958 . . . . 0.0 109.496 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 7' ' ' PHE . 64.4 mt -75.28 0.56 16.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.997 -1.064 . . . . 0.0 110.491 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.16 116.57 0.24 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 56' ' ' LEU . 18.2 tp -52.44 114.39 1.35 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.386 -1.067 . . . . 0.0 109.986 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -114.54 151.3 33.58 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.004 -1.06 . . . . 0.0 110.233 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.26 103.61 8.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.917 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.509 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -131.4 81.48 1.99 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.437 -0.79 . . . . 0.0 110.066 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -161.53 -156.55 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.898 . . . . 0.0 110.056 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -105.13 153.9 39.18 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.108 -0.995 . . . . 0.0 110.377 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.8 102.16 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.091 1.574 . . . . 0.0 110.317 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.7 mt -87.31 133.19 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.395 -0.816 . . . . 0.0 110.342 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.42 -14.68 10.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.075 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.153 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.555 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 4.0 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.291 0.567 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.662 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 8.7 t70 -75.76 -34.67 1.57 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 111.496 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 48.4 Cg_endo -89.28 11.02 3.05 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.281 1.148 . . . . 0.0 109.634 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -175.68 147.62 0.83 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.481 -0.762 . . . . 0.0 110.054 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 1.081 ' O ' HD12 ' A' ' 56' ' ' LEU . . . 94.47 -56.99 1.99 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.74 ' HB3' HG23 ' A' ' 51' ' ' VAL . 3.9 p90 -61.85 129.96 43.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.997 -1.296 . . . . 0.0 109.706 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 1.028 ' C ' HD13 ' A' ' 8' ' ' LEU . 23.2 t80 -170.07 21.09 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.242 -0.911 . . . . 0.0 110.846 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.028 HD13 ' C ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -133.32 123.25 25.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.314 -1.491 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.496 ' CE3' ' CD2' ' A' ' 85' ' ' LEU . 1.4 t90 -128.69 118.42 22.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.667 -0.645 . . . . 0.0 109.481 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -127.2 137.45 52.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.018 -1.051 . . . . 0.0 110.995 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.882 ' O ' HG13 ' A' ' 79' ' ' VAL . 3.8 tt0 -109.32 160.27 16.29 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.282 -0.886 . . . . 0.0 109.189 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.603 HG21 HH21 ' A' ' 18' ' ' ARG . 15.9 m -129.02 -177.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.923 -1.111 . . . . 0.0 111.024 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 1.2 tp10 -140.22 59.68 1.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.833 0.825 . . . . 0.0 108.971 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.564 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 4.0 tpt -137.07 146.13 53.28 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.601 -0.687 . . . . 0.0 109.216 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' ' HG3' ' A' ' 14' ' ' MET . 33.2 Cg_endo -65.39 -166.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.651 1.342 . . . . 0.0 113.361 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 19' ' ' VAL . 24.5 tt0 -62.07 -27.02 68.61 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.272 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 34.9 t70 -57.65 -20.86 36.37 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.139 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.618 ' CZ ' ' CG ' ' A' ' 46' ' ' TYR . 4.4 ppt_? -88.41 -12.69 42.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 111.063 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 16' ' ' GLU . 56.0 t -46.78 -44.52 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.403 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.526 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.6 m-20 -57.19 -30.45 64.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.087 -1.008 . . . . 0.0 109.536 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 36.0 t0 -62.95 -46.75 86.27 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.299 -0.875 . . . . 0.0 110.221 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 37' ' ' VAL . 3.3 mm? -59.02 -43.02 91.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.488 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.08 -48.78 80.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -40.85 84.87 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.561 ' CD ' HG23 ' A' ' 68' ' ' ILE . 28.6 tt0 -56.37 -49.28 74.89 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.484 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.944 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -69.16 -37.08 78.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.138 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.2 tmm_? -65.66 -37.66 87.13 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.284 -0.885 . . . . 0.0 111.489 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.594 ' CG2' HG22 ' A' ' 67' ' ' ILE . 3.5 tt -58.61 -45.03 90.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.014 -1.054 . . . . 0.0 111.728 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.555 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -86.36 109.21 18.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.984 -1.073 . . . . 0.0 111.206 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -30.65 62.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 109.893 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 33.9 p30 -59.21 -13.42 7.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.78 . . . . 0.0 110.386 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.975 HG22 ' CD1' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -78.88 122.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.381 -0.824 . . . . 0.0 110.485 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -79.76 -45.69 18.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 111.01 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -153.38 139.98 18.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.815 -1.178 . . . . 0.0 110.963 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.944 HG11 ' HB2' ' A' ' 26' ' ' LEU . 7.8 p -137.1 132.21 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 0.0 110.409 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.9 tpt -140.88 113.46 8.15 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.056 -1.027 . . . . 0.0 110.122 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 48' ' ' VAL . 23.3 t -116.92 132.25 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -0.821 . . . . 0.0 110.53 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' CG2' ' CD ' ' A' ' 47' ' ' GLU . 32.7 m -105.26 148.83 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.003 -1.06 . . . . 0.0 110.43 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -77.61 154.82 31.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.368 -0.832 . . . . 0.0 110.704 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 p -72.64 -176.68 2.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -101.57 5.71 41.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.086 . . . . 0.0 110.918 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -153.11 -66.5 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.4 Cg_endo -72.78 -165.34 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.425 1.224 . . . . 0.0 110.567 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.29 35.4 4.77 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.4 mtt180 -94.04 138.5 32.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.456 -1.026 . . . . 0.0 110.216 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.618 ' CG ' ' CZ ' ' A' ' 18' ' ' ARG . 10.0 m-85 -125.52 154.82 41.53 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 110.307 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 47' ' ' GLU . 10.0 pt-20 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.435 0.636 . . . . 0.0 109.566 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.74 ' HA ' HG22 ' A' ' 37' ' ' VAL . 44.6 t -88.04 115.92 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 110.836 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.447 ' CB ' HD11 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -130.92 101.33 5.59 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.975 ' CD1' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -117.87 131.64 70.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.593 -178.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 6' ' ' TYR . 9.8 p -95.55 151.25 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.046 ' HB2' HD11 ' A' ' 56' ' ' LEU . 4.4 mp -138.6 -157.11 0.74 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.849 -1.157 . . . . 0.0 110.923 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 52' ' ' LEU . 28.2 m-80 -34.85 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 121.056 0.455 . . . . 0.0 111.115 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 39.4 Cg_endo -64.83 -27.94 59.22 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.144 1.602 . . . . 0.0 111.15 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.46 ' OD1' ' NH2' ' A' ' 88' ' ' ARG . 8.0 t30 -131.11 81.32 1.98 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 110.161 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.081 HD12 ' O ' ' A' ' 5' ' ' GLY . 13.8 mt -74.03 -165.36 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.972 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 172.63 -171.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.597 0.713 . . . . 0.0 110.371 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -65.36 -33.13 75.23 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 110.852 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.9 t -68.27 -34.46 76.23 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HB3' HD22 ' A' ' 56' ' ' LEU . 21.5 mm-40 -71.19 -42.13 69.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 110.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 8' ' ' LEU . 9.3 mt -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -53.07 -36.59 60.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.928 -1.107 . . . . 0.0 108.086 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.7 mt -71.5 -49.87 36.98 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.807 0.813 . . . . 0.0 109.272 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.842 ' OE2' HD23 ' A' ' 61' ' ' LEU . 8.6 pt-20 -67.1 -39.76 86.78 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.585 -1.322 . . . . 0.0 109.94 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -71.87 -41.51 67.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.864 -1.148 . . . . 0.0 110.488 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 1.5 mt-10 -75.38 -41.07 57.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.701 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 63' ' ' LEU . 17.9 mm -78.92 -36.84 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.324 -0.86 . . . . 0.0 112.219 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 96.7 mt -70.41 -44.58 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.329 -1.482 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.1 mm100 -55.79 -39.2 70.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -57.61 -48.12 80.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 111.374 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -72.23 -48.77 40.32 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.971 -1.08 . . . . 0.0 111.578 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 25.1 mt -60.1 -42.71 95.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 111.331 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.17 -43.39 70.93 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.014 -1.053 . . . . 0.0 109.182 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 34.1 t-20 -59.65 -37.12 77.85 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.578 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -74.49 -29.27 61.36 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.259 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.59 5.28 27.91 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -99.66 118.45 36.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -1.149 . . . . 0.0 110.462 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -118.6 137.18 53.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.647 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.3 t -75.98 119.52 24.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.124 -0.985 . . . . 0.0 110.603 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.88 -5.63 59.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.571 -0.706 . . . . 0.0 109.213 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.574 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -132.69 160.81 35.66 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.282 -0.886 . . . . 0.0 111.591 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 82' ' ' VAL . 2.1 p -136.06 107.6 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.032 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.77 132.06 49.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.098 -1.001 . . . . 0.0 111.276 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 7' ' ' PHE . 1.9 mp0 -85.92 124.81 32.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.528 -0.733 . . . . 0.0 109.881 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 2.3 mt -76.3 29.79 0.12 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.084 -1.01 . . . . 0.0 111.671 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 6' ' ' TYR . . . 80.41 111.98 0.29 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.493 ' O ' ' O ' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -51.81 -170.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -1.104 . . . . 0.0 110.286 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -78.44 131.09 36.76 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.941 -1.099 . . . . 0.0 110.212 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -115.43 37.88 3.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.78 116.34 0.96 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.305 0.574 . . . . 0.0 110.487 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.42 -44.26 4.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 109.556 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -105.65 144.65 29.28 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.63 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.53 -56.76 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.919 1.484 . . . . 0.0 111.093 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.2 mt -119.86 120.73 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.032 -1.043 . . . . 0.0 110.585 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.12 -63.02 1.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.139 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HG3' ' OXT' ' A' ' 96' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.185 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.585 ' HG2' ' CA ' ' A' ' 5' ' ' GLY . 2.5 ptp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.477 0.656 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.641 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 26.3 t0 -78.09 -26.53 0.51 Allowed Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 45.9 Cg_endo -85.5 -5.67 9.13 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 N-CA-C 109.844 -0.868 . . . . 0.0 109.844 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.512 ' NE2' ' OD1' ' A' ' 55' ' ' ASN . 1.0 OUTLIER 178.15 -100.54 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.476 -0.765 . . . . 0.0 109.989 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.585 ' CA ' ' HG2' ' A' ' 1' ' ' MET . . . 121.2 94.03 1.32 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.118 ' CB ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -84.66 145.98 27.7 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.095 -1.239 . . . . 0.0 110.499 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.931 ' C ' HD12 ' A' ' 8' ' ' LEU . 57.6 m-85 -145.98 124.71 12.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.541 -0.725 . . . . 0.0 109.733 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.931 HD12 ' C ' ' A' ' 7' ' ' PHE . 5.3 mp -135.51 127.86 30.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 110.543 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.507 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -97.14 127.86 43.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.7 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.811 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -127.14 120.62 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.55 ' CB ' ' HG2' ' A' ' 81' ' ' LYS . 9.4 tt0 -112.35 159.7 18.42 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 10' ' ' TYR . 16.4 m -135.73 178.36 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.137 -0.977 . . . . 0.0 111.073 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -132.45 56.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.576 ' HB2' ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.91 152.4 72.14 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 110.595 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.4 Cg_endo -72.23 -167.67 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.977 1.514 . . . . 0.0 112.809 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.528 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 2.4 tt0 -65.52 -25.37 67.42 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.207 -1.361 . . . . 0.0 108.854 178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.92 -41.46 91.81 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.873 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.62 -16.3 30.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.278 -0.889 . . . . 0.0 110.688 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 15' ' ' PRO . 20.6 t -47.36 -37.75 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.43 -0.794 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -53.59 -29.34 37.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' OD1' ' CD2' ' A' ' 75' ' ' TYR . 36.5 t0 -59.74 -39.47 84.86 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.399 -0.813 . . . . 0.0 110.338 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 22' ' ' LEU . 4.4 mm? -59.07 -41.42 87.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.817 . . . . 0.0 110.088 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.88 -52.53 63.75 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.179 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' O ' HG13 ' A' ' 28' ' ' ILE . 2.1 ttp180 -68.93 -41.72 77.71 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.3 -0.875 . . . . 0.0 109.802 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.598 ' CD ' HG23 ' A' ' 68' ' ' ILE . 3.9 tt0 -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.196 -0.94 . . . . 0.0 109.946 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.766 HD22 ' CG2' ' A' ' 35' ' ' VAL . 14.1 mt -66.09 -38.63 88.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.772 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.54 ' NH1' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.81 -37.47 82.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.179 -0.95 . . . . 0.0 111.176 -178.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.684 ' CG2' HG23 ' A' ' 67' ' ' ILE . 55.1 mt -61.75 -44.23 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.82 -1.175 . . . . 0.0 110.56 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.546 ' O ' HG12 ' A' ' 32' ' ' VAL . 9.4 ptp85 -75.06 59.6 0.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.124 -0.985 . . . . 0.0 110.282 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.49 -25.32 16.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.187 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -58.41 -17.08 17.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.3 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.09 HG23 HD11 ' A' ' 50' ' ' ILE . 4.3 p -80.68 137.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 110.302 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -79.18 -46.05 18.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.978 . . . . 0.0 110.758 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' O ' HG12 ' A' ' 50' ' ' ILE . 4.8 tpt180 -152.79 121.96 6.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.832 -1.167 . . . . 0.0 110.987 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.009 HG12 HG13 ' A' ' 50' ' ' ILE . 3.1 m -109.74 135.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.9 ttp -124.77 116.13 21.82 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.059 -1.026 . . . . 0.0 110.802 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.72 HG22 HG22 ' A' ' 48' ' ' VAL . 19.4 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.078 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 12.0 m -114.29 135.11 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.659 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -84.66 154.28 22.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.343 -0.848 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -172.56 1.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 41' ' ' THR . 8.8 t -101.53 8.41 41.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.173 -0.954 . . . . 0.0 110.595 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.56 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.74 -63.75 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.134 -0.978 . . . . 0.0 110.421 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 42.8 Cg_endo -69.56 -176.51 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.537 1.283 . . . . 0.0 110.845 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -107.36 32.74 6.9 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 17.5 mtt180 -96.21 143.12 27.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.395 -1.062 . . . . 0.0 109.92 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.645 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 12.1 m-85 -125.51 152.99 44.26 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.05 -1.031 . . . . 0.0 111.529 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 2.3 mp0 -105.05 92.83 4.39 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.72 HG22 HG22 ' A' ' 37' ' ' VAL . 21.7 t -80.69 125.41 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 111.84 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 47' ' ' GLU . 1.5 m-80 -130.31 101.08 5.61 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.09 HD11 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.98 146.38 33.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 C-N-CA 119.746 -0.781 . . . . 0.0 111.876 -177.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' N ' HD13 ' A' ' 50' ' ' ILE . 14.3 p -111.79 151.66 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 56' ' ' LEU . 3.9 mp -118.17 -158.69 0.72 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.515 -1.366 . . . . 0.0 111.83 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.52 ' O ' ' O ' ' A' ' 52' ' ' LEU . 47.2 m-80 -37.36 163.52 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.737 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 37.9 Cg_endo -63.73 -15.95 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.934 1.492 . . . . 0.0 110.759 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.512 ' OD1' ' NE2' ' A' ' 4' ' ' GLN . 8.9 t-20 -151.84 90.54 1.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 110.201 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.118 HD12 ' CB ' ' A' ' 6' ' ' TYR . 10.7 mt -76.83 -173.54 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.822 -1.173 . . . . 0.0 111.81 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.73 179.04 6.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.404 0.621 . . . . 0.0 109.536 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 61' ' ' LEU . 41.2 mt-30 -66.13 -43.17 87.88 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.425 -0.797 . . . . 0.0 111.009 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -65.41 -33.22 75.44 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.284 -0.885 . . . . 0.0 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 11.0 mm-40 -62.28 -38.28 88.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 110.359 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 58' ' ' GLN . 5.3 mt -59.99 -33.18 71.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.01 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -51.82 -34.48 40.53 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.652 ' O ' HG12 ' A' ' 67' ' ' ILE . 18.1 mt -71.18 -51.8 22.74 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.957 0.884 . . . . 0.0 108.706 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -61.7 -41.39 97.53 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.859 -1.151 . . . . 0.0 109.735 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.522 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -72.72 -46.37 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 110.573 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 72.5 mt-10 -68.85 -37.57 79.19 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.87 -1.144 . . . . 0.0 109.686 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.684 HG23 ' CG2' ' A' ' 28' ' ' ILE . 19.2 mm -77.74 -45.5 28.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.235 -0.916 . . . . 0.0 111.84 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 ' CD ' ' A' ' 25' ' ' GLU . 58.2 mt -70.04 -42.01 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.76 -1.213 . . . . 0.0 110.214 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.9 pt20 -64.37 -40.74 96.43 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 11.2 ttt180 -58.38 -46.16 86.88 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.366 -0.834 . . . . 0.0 110.989 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.87 -48.76 57.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.902 -1.124 . . . . 0.0 110.636 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.632 HD13 ' OH ' ' A' ' 10' ' ' TYR . 83.8 mt -63.98 -36.24 83.33 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.336 -0.852 . . . . 0.0 110.641 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -69.82 -44.88 69.09 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.39 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 70' ' ' ARG . 72.5 m-20 -65.44 -37.04 85.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -75.72 -39.82 56.65 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.485 -0.759 . . . . 0.0 110.459 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.41 29.63 2.67 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.37 130.23 55.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.356 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.34 134.98 54.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.105 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.811 HG22 ' CE2' ' A' ' 10' ' ' TYR . 2.1 t -79.4 122.4 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.831 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.95 -10.98 59.1 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.443 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.63 145.03 50.33 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.537 -0.727 . . . . 0.0 111.023 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t -141.7 108.28 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.93 . . . . 0.0 110.034 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.15 109.09 11.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.013 -1.054 . . . . 0.0 110.586 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' OE2' ' NZ ' ' A' ' 65' ' ' LYS . 29.8 mm-40 -98.61 104.45 16.49 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.214 -0.929 . . . . 0.0 110.508 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.851 HD13 ' O ' ' A' ' 7' ' ' PHE . 2.0 mp -74.95 -24.54 58.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.999 -1.063 . . . . 0.0 110.22 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.514 ' HA2' ' CZ ' ' A' ' 6' ' ' TYR . . . 64.64 169.3 1.91 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.639 ' N ' ' CE1' ' A' ' 6' ' ' TYR . 7.6 tt -42.64 110.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -1.07 . . . . 0.0 110.661 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 14.9 mmm180 -88.57 178.2 6.58 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.224 -0.923 . . . . 0.0 110.283 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 124.37 36.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 0.0 110.089 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.72 140.97 9.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 110.446 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.82 -90.45 0.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -112.76 155.33 44.16 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.0 110.138 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.93 -92.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.073 1.565 . . . . 0.0 110.749 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 94' ' ' ILE . 4.4 tt -107.24 121.11 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.052 -1.03 . . . . 0.0 110.372 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.11 -76.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.162 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.23 0.538 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.612 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 6.7 t70 -75.95 -42.13 3.52 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 49.8 Cg_endo -82.96 8.82 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.612 1.322 . . . . 0.0 109.803 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.521 ' HB2' ' HG ' ' A' ' 56' ' ' LEU . 1.5 pt20 -178.4 -132.88 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 88' ' ' ARG . . . 168.79 80.43 0.04 OUTLIER Glycine 0 N--CA 1.485 1.938 0 C-N-CA 119.172 -1.49 . . . . 0.0 110.136 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.676 ' CD2' HG23 ' A' ' 51' ' ' VAL . 16.2 p90 -62.12 138.48 58.4 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.146 -1.208 . . . . 0.0 109.794 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CD1' ' HB2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -145.86 86.06 1.71 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.287 -0.883 . . . . 0.0 109.646 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -148.88 124.54 10.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.15 -0.969 . . . . 0.0 111.413 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.458 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 1.3 t-105 -114.26 119.67 37.79 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.689 ' CD2' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -125.09 129.86 51.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.053 -1.029 . . . . 0.0 111.023 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.765 ' O ' HG13 ' A' ' 79' ' ' VAL . 14.2 tt0 -122.66 151.15 41.79 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.336 -0.852 . . . . 0.0 109.27 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.76 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 2.0 m -126.18 -174.98 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 110.405 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' O ' ' SD ' ' A' ' 14' ' ' MET . 4.3 pt-20 -138.78 49.93 1.86 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.286 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.597 ' HE3' ' HD2' ' A' ' 18' ' ' ARG . 30.3 mmm -123.46 155.63 65.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 1.006 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -70.52 -172.4 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.045 1.55 . . . . 0.0 112.82 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 1.1 tt0 -64.03 -27.04 68.84 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.536 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.36 -45.89 87.33 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.54 0.686 . . . . 0.0 109.82 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.597 ' HD2' ' HE3' ' A' ' 14' ' ' MET . 0.0 OUTLIER -89.81 -33.1 16.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.555 -0.715 . . . . 0.0 110.197 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.006 HG23 ' O ' ' A' ' 15' ' ' PRO . 77.5 t -48.05 -40.56 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -54.88 -28.42 50.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.843 . . . . 0.0 109.019 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.595 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 26.0 t0 -58.92 -35.4 73.03 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.357 0.598 . . . . 0.0 110.609 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD21 ' OH ' ' A' ' 46' ' ' TYR . 4.2 mm? -55.87 -41.94 75.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.288 -0.965 . . . . 0.0 108.931 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.76 72.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.59 ' HA ' ' CD ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -68.54 -46.05 70.56 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.365 -0.835 . . . . 0.0 109.511 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.696 ' CD ' ' HB1' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -65.0 -33.52 76.26 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.521 -0.737 . . . . 0.0 110.235 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.126 HD22 HG21 ' A' ' 35' ' ' VAL . 27.2 mt -69.42 -37.14 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 110.783 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' CD ' ' HA ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -68.09 -35.31 77.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.935 -1.103 . . . . 0.0 112.736 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.768 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.41 -35.52 67.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 120.423 -1.423 . . . . 0.0 111.43 -178.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.591 ' NE ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -79.9 61.58 3.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.751 -1.218 . . . . 0.0 109.873 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.94 -23.08 42.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.451 -0.781 . . . . 0.0 111.494 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -56.62 -28.1 59.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.085 -1.009 . . . . 0.0 111.526 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.038 ' CG1' HD11 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -82.36 155.98 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.693 -1.254 . . . . 0.0 110.523 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -47.13 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 112.259 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 50' ' ' ILE . 1.2 ttt180 -154.28 156.95 37.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.65 -1.282 . . . . 0.0 112.149 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.126 HG21 HD22 ' A' ' 26' ' ' LEU . 9.9 p -141.22 135.82 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.679 -0.638 . . . . 0.0 110.188 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.4 117.84 23.77 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.142 -0.974 . . . . 0.0 110.488 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.511 HG21 HD11 ' A' ' 26' ' ' LEU . 25.8 t -115.16 132.01 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 110.966 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 5.4 m -114.3 126.32 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.185 -0.947 . . . . 0.0 110.0 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -80.65 152.58 28.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.287 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 13.6 p -76.42 -168.27 0.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.523 -0.736 . . . . 0.0 110.02 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 t -107.85 -32.61 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.774 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m -110.09 -67.12 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.078 -1.014 . . . . 0.0 111.136 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 48.2 Cg_endo -72.19 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.177 1.093 . . . . 0.0 110.628 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.36 31.83 5.28 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.556 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 6.7 mtt180 -94.68 135.71 35.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.997 . . . . 0.0 110.389 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.76 ' CZ ' HG21 ' A' ' 12' ' ' VAL . 9.4 p90 -135.65 154.01 51.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.738 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -91.88 96.24 10.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.891 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.593 HG23 ' CD1' ' A' ' 46' ' ' TYR . 24.2 t -77.06 124.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.405 -0.81 . . . . 0.0 110.261 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -130.73 102.3 6.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.038 HD11 ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -112.7 138.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.176 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG23 ' CD2' ' A' ' 6' ' ' TYR . 7.6 p -94.55 151.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.562 -0.712 . . . . 0.0 110.202 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -97.41 179.67 4.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 110.844 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.571 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -49.26 -178.01 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.42 -0.8 . . . . 0.0 110.068 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.0 Cg_endo -63.92 -15.07 46.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.585 1.308 . . . . 0.0 110.068 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.503 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 31.1 t-20 -143.7 84.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.537 -0.727 . . . . 0.0 109.297 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.541 ' HB3' ' CB ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -66.23 -176.99 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.074 -1.016 . . . . 0.0 111.389 -178.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.483 ' HB3' ' HG3' ' A' ' 60' ' ' GLN . 5.7 t70 174.61 172.28 0.22 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.416 0.627 . . . . 0.0 109.417 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.76 ' HA ' HD21 ' A' ' 61' ' ' LEU . 9.0 mt-30 -63.21 -41.02 99.09 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.158 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 -31.92 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' A' ' 57' ' ' ASP . 3.6 mm100 -74.15 -46.16 44.11 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 110.397 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.822 HD12 ' N ' ' A' ' 62' ' ' ALA . 4.4 pp -68.03 -35.19 77.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.817 -1.177 . . . . 0.0 109.368 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.822 ' N ' HD12 ' A' ' 61' ' ' LEU . . . -51.8 -33.4 35.39 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.739 HD23 ' OE2' ' A' ' 66' ' ' GLU . 17.7 mt -71.27 -50.9 27.93 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.628 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.85 ' HG2' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -71.39 -35.49 71.06 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 120.401 -1.437 . . . . 0.0 109.885 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -74.15 -39.68 63.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.739 ' OE2' HD23 ' A' ' 63' ' ' LEU . 13.3 pt-20 -73.81 -37.85 64.76 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.753 -1.217 . . . . 0.0 109.982 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 63' ' ' LEU . 24.0 mm -77.89 -38.49 24.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.348 -0.845 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 46.1 mt -68.35 -42.03 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.9 -1.125 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 22.9 mt-30 -64.33 -48.16 76.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -40.41 95.35 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.22 -0.925 . . . . 0.0 110.593 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.696 ' HB1' ' CD ' ' A' ' 25' ' ' GLU . . . -66.47 -48.55 69.52 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.193 -0.942 . . . . 0.0 109.962 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 72' ' ' LEU . 47.9 mt -66.17 -35.53 80.7 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.313 -0.867 . . . . 0.0 110.017 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 9.0 mm-40 -70.03 -42.86 72.37 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.391 -0.818 . . . . 0.0 109.086 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -58.78 -36.02 73.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 21' ' ' ASP . 1.4 t80 -74.18 -31.47 62.69 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.581 -0.699 . . . . 0.0 110.559 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.41 1.5 21.75 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.3 124.77 39.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -1.188 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 5.0 ttm180 -120.37 150.89 40.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.1 t -92.67 118.83 39.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.134 -0.979 . . . . 0.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -4.9 57.91 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.545 ' HG2' ' CB ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.79 144.46 51.09 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.388 -0.82 . . . . 0.0 110.894 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.0 t -139.32 106.68 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 109.087 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.26 108.42 10.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 111.315 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -99.07 111.02 23.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.611 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -80.08 12.74 2.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.036 -1.04 . . . . 0.0 110.578 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.34 121.09 0.08 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.86 159.94 15.65 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.262 -1.14 . . . . 0.0 109.912 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.514 ' HB2' ' HA3' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -124.72 153.28 42.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.148 -0.97 . . . . 0.0 110.766 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -142.12 110.66 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 109.785 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.02 146.52 49.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.146 -0.972 . . . . 0.0 110.149 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.02 -140.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.95 . . . . 0.0 110.19 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -80.94 152.71 72.03 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.29 179.21 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.059 1.557 . . . . 0.0 110.301 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.36 114.53 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.37 179.95 4.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.927 . . . . 0.0 110.357 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.137 180.0 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.61 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.713 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 6.3 t0 -74.3 -22.72 0.48 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.081 . . . . 0.0 112.676 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 43.8 Cg_endo -86.79 -10.81 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 N-CA-C 109.302 -1.076 . . . . 0.0 109.302 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 87' ' ' LEU . 1.5 pm0 178.89 173.82 0.72 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.664 -0.648 . . . . 0.0 109.616 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.597 ' HA2' ' HG ' ' A' ' 56' ' ' LEU . . . -44.01 142.16 2.73 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.825 ' CD2' HD11 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -105.04 108.03 19.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.39 -1.065 . . . . 0.0 110.26 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.825 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.94 122.36 33.55 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.256 -0.903 . . . . 0.0 110.228 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 7' ' ' PHE . 3.1 mm? -116.79 144.71 44.15 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.143 -0.973 . . . . 0.0 110.616 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.592 ' CE2' ' HE3' ' A' ' 81' ' ' LYS . 5.8 t90 -124.52 118.41 26.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.559 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.699 ' CD2' HG11 ' A' ' 79' ' ' VAL . 9.1 m-85 -127.61 131.11 49.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.896 ' O ' HG13 ' A' ' 79' ' ' VAL . 1.9 tt0 -101.96 159.58 15.23 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.946 HG21 ' CZ ' ' A' ' 46' ' ' TYR . 3.6 m -129.74 -175.34 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.39 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' SD ' ' A' ' 14' ' ' MET . 0.6 OUTLIER -141.13 54.2 1.56 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.755 -0.591 . . . . 0.0 109.843 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -121.32 152.19 57.19 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 0.0 110.427 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 18' ' ' ARG . 36.6 Cg_endo -70.88 -162.9 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.207 1.635 . . . . 0.0 112.385 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.83 -26.45 2.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.436 ' N ' ' C ' ' A' ' 15' ' ' PRO . 41.8 t0 -57.73 -15.38 7.79 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.957 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.585 ' HD3' ' CE1' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -71.74 -17.07 62.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.411 -0.805 . . . . 0.0 110.552 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.19 -48.59 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.549 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 20.0 m-80 -64.82 -30.32 71.32 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.094 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB2' ' CD2' ' A' ' 75' ' ' TYR . 26.4 t0 -65.16 -54.66 26.38 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.631 HD21 ' OH ' ' A' ' 46' ' ' TYR . 3.9 mm? -59.16 -36.87 76.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.173 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.48 -52.24 65.46 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.589 -0.695 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -47.12 80.25 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.378 -0.826 . . . . 0.0 109.585 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.65 -43.79 95.73 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.487 -0.758 . . . . 0.0 110.007 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.677 ' CD2' HG11 ' A' ' 35' ' ' VAL . 19.2 mt -54.94 -40.16 69.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 109.968 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -37.71 68.62 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.562 HG21 ' CG2' ' A' ' 67' ' ' ILE . 2.5 mt -59.64 -44.53 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.265 -0.897 . . . . 0.0 110.617 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.946 ' O ' HG12 ' A' ' 32' ' ' VAL . 13.8 ptt85 -69.52 62.99 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.457 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 28' ' ' ILE . 1.8 m-20 -74.44 -39.76 62.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -62.83 -15.01 52.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.212 -0.93 . . . . 0.0 111.112 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.129 HG21 ' CD1' ' A' ' 50' ' ' ILE . 6.1 p -80.76 151.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.901 -1.124 . . . . 0.0 111.424 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -45.39 17.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 111.254 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.433 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.22 155.7 38.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.926 -1.109 . . . . 0.0 111.313 -179.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 50' ' ' ILE . 14.9 p -137.67 136.15 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 110.061 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.14 118.25 26.46 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 131.92 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.823 . . . . 0.0 110.574 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' TYR . 4.6 m -117.75 127.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.136 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 46' ' ' TYR . . . -79.86 153.56 28.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.333 -0.854 . . . . 0.0 110.631 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.499 ' OG ' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -74.75 179.41 4.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.205 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -103.5 12.96 34.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 110.303 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -159.28 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 110.014 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.6 Cg_endo -70.24 -170.69 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.687 1.362 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 21.68 26.22 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 8.2 ptp180 -94.79 162.54 13.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.544 -0.974 . . . . 0.0 110.32 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.946 ' CZ ' HG21 ' A' ' 12' ' ' VAL . 2.1 p90 -152.8 154.7 35.7 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.797 0.808 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.554 ' HG3' ' CD1' ' A' ' 9' ' ' TRP . 2.4 tt0 -92.71 97.33 10.71 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.351 0.596 . . . . 0.0 109.662 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 46' ' ' TYR . 39.2 t -77.42 119.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.419 -0.801 . . . . 0.0 110.059 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.22 100.96 5.58 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.129 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -121.06 147.62 24.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 121.427 0.632 . . . . 0.0 110.602 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 7' ' ' PHE . 12.0 p -126.09 148.22 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.054 ' HG ' HG23 ' A' ' 32' ' ' VAL . 2.1 mp -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.13 -0.981 . . . . 0.0 110.174 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.53 ' N ' HD21 ' A' ' 56' ' ' LEU . 41.5 m-80 -36.75 159.48 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.812 -0.555 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 38.9 Cg_endo -64.52 -20.75 66.04 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.983 1.517 . . . . 0.0 111.498 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -127.98 77.67 1.78 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.008 -1.057 . . . . 0.0 109.935 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 52' ' ' LEU . 6.4 mt -73.3 -173.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.384 1.088 . . . . 0.0 112.531 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.508 ' OD1' ' HG3' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -168.43 170.63 9.67 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.606 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.58 -32.22 73.17 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.958 -1.088 . . . . 0.0 110.813 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -38.39 76.05 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.102 -0.998 . . . . 0.0 110.52 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.508 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 8.7 mm-40 -68.57 -43.9 75.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.825 HD11 ' CD2' ' A' ' 6' ' ' TYR . 21.2 mt -65.15 -35.36 80.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.018 -1.051 . . . . 0.0 109.702 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 66' ' ' GLU . . . -52.83 -33.25 48.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' O ' ' HG2' ' A' ' 66' ' ' GLU . 24.9 mt -66.17 -50.48 63.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.614 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' OE1' HD11 ' A' ' 52' ' ' LEU . 18.0 pt-20 -74.84 -41.14 60.44 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 120.847 -1.158 . . . . 0.0 109.513 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 4.0 mptp? -67.98 -32.92 73.66 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.41 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 11.1 pt-20 -69.88 -46.35 65.66 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.41 -1.431 . . . . 0.0 109.945 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.562 ' CG2' HG21 ' A' ' 28' ' ' ILE . 4.4 mt -78.3 -40.72 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.066 . . . . 0.0 111.136 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 64' ' ' GLU . 68.1 mt -60.49 -49.85 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 0.0 110.106 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 70' ' ' ARG . 2.9 pt20 -60.85 -44.12 97.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.508 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.538 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 17.2 mtp-105 -68.6 -47.11 67.54 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.503 -0.748 . . . . 0.0 110.765 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -62.28 -47.83 82.6 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.053 -1.03 . . . . 0.0 110.077 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD2' ' OD2' ' A' ' 21' ' ' ASP . 91.3 mt -63.13 -38.01 89.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.354 -0.842 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -71.02 -45.34 64.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.398 -0.814 . . . . 0.0 109.595 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -61.63 -36.47 80.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.562 ' CD2' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.47 -17.94 60.0 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.467 -0.771 . . . . 0.0 110.406 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.15 2.86 48.38 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' CB ' ' OD2' ' A' ' 21' ' ' ASP . . . -98.36 111.78 24.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -1.187 . . . . 0.0 110.099 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -118.05 144.75 45.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.1 t -88.95 125.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 120.922 -1.111 . . . . 0.0 110.344 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 -5.63 58.76 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HE3' ' CE2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -130.38 149.96 51.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 111.579 -178.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.506 HG12 ' CE2' ' A' ' 10' ' ' TYR . 1.2 m -137.5 106.92 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 109.125 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -128.87 123.04 31.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.446 -0.784 . . . . 0.0 111.109 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.483 ' O ' HD23 ' A' ' 85' ' ' LEU . 88.4 mt-10 -97.33 90.45 5.09 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.297 -0.877 . . . . 0.0 109.251 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 84' ' ' GLU . 12.9 mt -125.66 -172.76 2.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.932 . . . . 0.0 110.476 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 87' ' ' LEU . . . 56.53 162.44 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.7 pp -179.8 130.65 0.1 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.19 -1.182 . . . . 0.0 110.848 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.487 ' HB3' ' HA3' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -83.46 120.91 26.49 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.349 -0.844 . . . . 0.0 109.659 179.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 6.5 mtp180 -94.09 128.85 40.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.112 -0.992 . . . . 0.0 110.736 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -178.38 80.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 110.266 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -104.03 91.57 4.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 110.037 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.95 160.99 59.43 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -76.7 -74.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.064 1.56 . . . . 0.0 110.773 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.54 138.16 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 110.178 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.86 114.33 24.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.9 tttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.222 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.524 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.23 0.538 . . . . 0.0 110.094 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.588 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 30.9 t0 -77.67 -43.12 2.42 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 111.173 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.5 Cg_endo -79.18 0.37 10.08 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.439 1.231 . . . . 0.0 110.059 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 pt20 -174.43 -149.79 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.342 -0.848 . . . . 0.0 110.064 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.61 76.66 0.18 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 118.951 -1.595 . . . . 0.0 111.033 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' CG ' ' HA ' ' A' ' 51' ' ' VAL . 2.7 p90 -63.4 134.72 56.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.915 -1.344 . . . . 0.0 109.725 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.568 ' H ' HD12 ' A' ' 8' ' ' LEU . 17.5 m-85 -152.44 82.74 1.24 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 110.14 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD21 HD23 ' A' ' 61' ' ' LEU . 4.1 mp -144.34 124.17 13.44 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.34 -0.85 . . . . 0.0 110.645 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -123.15 118.21 27.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD2' HG11 ' A' ' 79' ' ' VAL . 3.1 m-85 -126.57 135.08 50.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 110.89 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.797 ' O ' HG13 ' A' ' 79' ' ' VAL . 2.3 tt0 -119.42 159.57 23.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 18.9 m -130.27 179.88 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 110.747 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -137.04 60.41 1.66 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.588 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 1.3 ptm -134.48 147.91 65.36 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.501 -0.749 . . . . 0.0 110.999 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 Cg_endo -73.37 -166.73 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.216 1.64 . . . . 0.0 112.452 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.579 ' HA ' ' CG2' ' A' ' 19' ' ' VAL . 22.7 tt0 -65.24 -25.42 67.66 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.203 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -60.01 -42.19 93.77 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.836 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -90.23 -14.34 33.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.33 -0.856 . . . . 0.0 110.322 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 7.2 t -46.52 -36.74 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.515 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 1.8 t30 -52.25 -27.89 16.64 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.853 . . . . 0.0 109.364 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 42.3 t0 -59.14 -44.43 92.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.0 mm? -59.04 -39.62 82.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.84 . . . . 0.0 109.171 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -56.61 -53.12 61.32 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.439 -0.788 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -42.89 93.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.553 ' OE2' ' HB3' ' A' ' 71' ' ' ALA . 1.1 tt0 -57.69 -47.57 81.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.739 HD23 ' CG1' ' A' ' 35' ' ' VAL . 6.7 mt -54.69 -40.14 68.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -36.13 74.24 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.529 -0.732 . . . . 0.0 109.879 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -63.28 -43.93 98.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.266 -0.896 . . . . 0.0 109.687 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 32' ' ' VAL . 8.7 mtm180 -70.47 54.82 0.15 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.563 -0.71 . . . . 0.0 110.359 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -74.09 -40.66 62.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.03 -16.18 40.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.573 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.089 HG21 ' CD1' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -81.31 158.49 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 110.093 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.481 ' HD2' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -79.15 -46.81 17.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 111.229 -179.366 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.529 ' O ' ' CG1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -153.66 149.93 28.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 111.097 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.739 ' CG1' HD23 ' A' ' 26' ' ' LEU . 7.4 p -139.85 133.79 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.514 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.9 mtm -129.91 115.16 16.79 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.059 -1.026 . . . . 0.0 110.968 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.1 t -115.19 130.32 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 109.816 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -116.76 156.51 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.002 -1.061 . . . . 0.0 110.944 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -85.92 153.42 22.21 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.384 0.611 . . . . 0.0 110.456 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -76.83 -177.35 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.418 -0.801 . . . . 0.0 109.427 179.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.2 p -98.37 -47.85 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.303 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.579 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -100.59 -66.99 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.134 -0.979 . . . . 0.0 110.803 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 48.9 Cg_endo -72.1 -161.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.335 1.176 . . . . 0.0 110.776 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 46' ' ' TYR . . . -116.19 40.49 2.39 Favored Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 14.6 mtt180 -93.3 135.41 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -1.081 . . . . 0.0 110.258 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.579 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 32.7 m-85 -115.05 154.98 27.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 111.034 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 5.3 mm-40 -100.52 114.99 29.06 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.925 -0.484 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 72.4 t -92.46 111.54 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 110.39 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -130.81 101.07 5.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.089 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -124.83 149.07 29.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 121.681 0.753 . . . . 0.0 111.553 -178.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 32' ' ' VAL . 6.5 p -98.72 151.82 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.739 -0.601 . . . . 0.0 109.682 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.499 HD13 HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -95.49 176.26 6.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 0.0 110.368 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.503 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -48.48 179.23 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.403 -0.811 . . . . 0.0 109.794 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 37.5 Cg_endo -62.8 -19.74 69.34 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.458 1.241 . . . . 0.0 109.266 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 4' ' ' GLN . 9.6 t-20 -142.1 84.92 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.919 HD12 ' N ' ' A' ' 57' ' ' ASP . 3.8 pp -71.13 -172.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.094 -1.004 . . . . 0.0 110.812 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.919 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.8 t70 173.07 171.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.386 0.612 . . . . 0.0 109.782 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.446 ' HG3' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -53.86 -54.39 39.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -0.819 . . . . 0.0 110.868 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -32.48 72.24 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.918 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.0 mm-40 -67.17 -44.77 78.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.848 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.659 HD23 HD21 ' A' ' 8' ' ' LEU . 5.8 mp -65.05 -34.36 78.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.014 -1.054 . . . . 0.0 109.676 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 66' ' ' GLU . . . -52.28 -33.85 43.88 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.659 ' O ' HG12 ' A' ' 67' ' ' ILE . 32.9 mt -68.16 -50.03 57.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.87 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.8 ' OE2' HG23 ' A' ' 32' ' ' VAL . 90.8 mt-10 -70.62 -35.6 73.04 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.243 -1.536 . . . . 0.0 109.381 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -73.48 -43.87 59.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 110.646 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 67' ' ' ILE . 10.0 pt-20 -72.62 -37.82 67.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.891 -1.13 . . . . 0.0 109.893 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 63' ' ' LEU . 40.1 mm -77.25 -39.73 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 111.154 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 64' ' ' GLU . 87.8 mt -70.28 -47.0 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.867 -1.146 . . . . 0.0 110.043 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 12.0 mm-40 -61.49 -33.83 74.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 110.541 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -67.42 -41.9 84.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.098 -1.002 . . . . 0.0 111.235 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' OE2' ' A' ' 25' ' ' GLU . . . -70.44 -48.41 56.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 111.323 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HG ' ' OE1' ' A' ' 25' ' ' GLU . 29.3 mt -58.59 -36.47 74.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 111.211 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.252 4.0 tt0 -71.53 -47.57 54.35 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.147 0.975 . . . . 0.0 109.536 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -61.54 -39.38 90.89 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.116 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.68 -35.73 60.26 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.555 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.65 24.82 4.2 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -107.3 127.05 53.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.861 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -118.77 137.69 53.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 110.426 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 11' ' ' GLN . 1.7 t -90.29 117.16 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.207 -0.933 . . . . 0.0 109.212 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -82.42 -6.82 59.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 109.452 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.571 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -134.94 136.13 42.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.302 -0.874 . . . . 0.0 111.525 -178.767 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.524 ' O ' HG13 ' A' ' 82' ' ' VAL . 2.7 p -141.2 108.5 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' HD12 ' A' ' 85' ' ' LEU . 1.7 tt0 -127.35 109.63 11.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.005 -1.059 . . . . 0.0 111.656 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.79 113.1 17.69 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.189 -0.945 . . . . 0.0 109.171 178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 2.3 mp -85.92 30.76 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.988 -1.07 . . . . 0.0 111.385 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 7' ' ' PHE . . . 96.15 -168.63 25.92 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.811 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -140.06 -161.79 1.25 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.61 -0.936 . . . . 0.0 110.387 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.56 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 3.6 ppt_? -78.57 135.48 37.29 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.514 -0.742 . . . . 0.0 110.776 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -135.09 40.21 2.9 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.947 0.879 . . . . 0.0 109.731 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 tt -44.86 106.93 0.08 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.184 0.516 . . . . 0.0 110.395 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.88 158.87 43.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.158 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.77 131.21 26.12 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.23 88.3 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.924 1.486 . . . . 0.0 110.412 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 94' ' ' ILE . 40.2 pt -93.26 138.51 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.915 . . . . 0.0 110.111 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.15 107.14 10.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.201 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.531 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 19.8 ttm . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.142 0.496 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.714 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.0 p30 -75.18 -22.81 0.46 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 112.065 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 50.9 Cg_endo -88.41 44.32 0.87 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 122.769 0.878 . . . . 0.0 110.148 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.556 ' CG ' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -42.54 -69.12 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.508 -179.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 88' ' ' ARG . . . -105.42 24.85 26.42 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.835 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -63.26 97.3 0.12 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.835 -1.391 . . . . 0.0 108.944 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.984 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -156.5 31.47 0.32 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.906 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.055 ' CD2' HD22 ' A' ' 61' ' ' LEU . 6.4 mp -105.27 125.33 50.86 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.159 -0.963 . . . . 0.0 110.242 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.543 ' CE2' ' OD1' ' A' ' 49' ' ' ASN . 1.1 t90 -124.48 126.72 46.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.356 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.481 ' OH ' HD23 ' A' ' 8' ' ' LEU . 80.1 m-85 -122.94 122.1 37.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.227 -0.921 . . . . 0.0 110.689 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.972 ' O ' HG13 ' A' ' 79' ' ' VAL . 11.8 tt0 -111.29 159.84 17.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.303 -0.873 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' CG ' ' A' ' 45' ' ' ARG . 6.8 m -136.86 -176.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.832 -1.168 . . . . 0.0 110.625 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 15.1 tt0 -145.76 53.38 1.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.574 -0.704 . . . . 0.0 110.338 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.558 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -128.77 153.01 79.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.73 -166.53 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.952 1.501 . . . . 0.0 113.574 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HA ' HG23 ' A' ' 19' ' ' VAL . 3.0 tm-20 -60.72 -26.61 67.3 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.918 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.33 -27.28 62.09 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.908 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.616 ' NH1' ' CZ ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -88.44 -13.74 39.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.999 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.69 HG23 ' HA ' ' A' ' 16' ' ' GLU . 79.2 t -47.76 -40.99 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.0 109.968 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' CB ' ' OH ' ' A' ' 75' ' ' TYR . 1.8 m-20 -61.77 -29.68 70.29 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.772 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.733 ' OD2' HD23 ' A' ' 72' ' ' LEU . 39.5 t0 -60.85 -47.54 85.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.341 -0.85 . . . . 0.0 110.386 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.4 mm? -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.847 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.01 -47.29 78.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -69.06 -44.14 73.2 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.386 -0.821 . . . . 0.0 110.003 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.484 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -62.07 -47.95 82.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -63.06 -37.25 86.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.044 -1.035 . . . . 0.0 110.593 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.464 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.01 -42.38 63.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.849 -1.157 . . . . 0.0 110.454 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -61.93 -43.22 97.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.376 -0.828 . . . . 0.0 111.761 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HD2' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -70.63 67.42 0.36 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.087 -1.008 . . . . 0.0 110.812 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 3.7 m-20 -64.59 -25.08 67.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.516 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 32' ' ' VAL . 24.5 p30 -64.86 -25.79 68.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.299 -0.875 . . . . 0.0 111.57 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.653 HG22 ' CD1' ' A' ' 50' ' ' ILE . 0.5 OUTLIER -80.62 148.9 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.808 -1.182 . . . . 0.0 110.162 -179.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -47.4 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -0.904 . . . . 0.0 111.994 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -154.46 138.52 16.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.193 . . . . 0.0 111.243 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 50' ' ' ILE . 2.1 t -125.83 132.54 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.335 -0.853 . . . . 0.0 110.131 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 ttm -119.92 115.49 23.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.219 -0.926 . . . . 0.0 109.96 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.8 t -114.89 130.68 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.811 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 1.4 m -123.25 129.07 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 109.736 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.706 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . . . -76.66 153.92 34.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 110.702 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -168.2 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.505 -0.747 . . . . 0.0 109.826 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.0 t -109.21 11.82 25.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.136 -0.977 . . . . 0.0 110.79 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.574 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -157.36 -65.11 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 50.5 Cg_endo -72.62 -170.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.465 1.245 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 14' ' ' MET . . . -110.37 34.03 5.63 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 12' ' ' VAL . 3.9 mtt180 -94.14 141.19 28.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -1.012 . . . . 0.0 110.04 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.706 ' CE2' ' HB2' ' A' ' 39' ' ' ALA . 17.4 m-85 -124.91 154.19 41.49 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.976 0.893 . . . . 0.0 110.729 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 24.8 mt-10 -103.05 92.5 4.57 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 80.7 t -77.49 124.74 36.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.543 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 74.9 m-20 -128.32 100.83 5.97 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.709 HD13 ' N ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -113.49 130.03 68.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 121.216 0.531 . . . . 0.0 110.408 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 6' ' ' TYR . 8.4 p -91.97 150.25 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.84 HD22 HD12 ' A' ' 56' ' ' LEU . 12.5 mt -92.94 167.67 11.66 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 111.217 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.698 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 1.7 m-20 -65.1 -147.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HD2' ' CB ' ' A' ' 53' ' ' ASN . 38.4 Cg_endo -66.56 -35.14 30.71 Favored 'Trans proline' 0 N--CA 1.486 1.077 0 CA-C-N 119.426 0.831 . . . . 0.0 111.64 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -162.97 79.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.74 -1.225 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.84 HD12 HD22 ' A' ' 52' ' ' LEU . 16.8 mt -80.4 -165.82 0.94 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.134 -0.979 . . . . 0.0 111.3 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.514 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER 177.72 -162.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.664 -0.647 . . . . 0.0 110.273 -179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.601 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 24.3 mt-30 -64.67 -30.16 71.17 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.288 -0.883 . . . . 0.0 111.132 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -71.25 -44.23 65.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 9.4 mm100 -73.64 -44.09 57.81 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.487 -0.758 . . . . 0.0 109.682 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.055 HD22 ' CD2' ' A' ' 8' ' ' LEU . 30.7 mt -66.58 -33.28 75.32 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 58' ' ' GLN . . . -51.76 -32.91 32.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 67' ' ' ILE . 88.6 mt -71.18 -50.4 33.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.634 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.562 ' CD ' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -70.49 -32.21 69.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.453 -1.404 . . . . 0.0 109.56 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' CD ' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -73.37 -45.19 56.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 44.8 mt-10 -64.84 -38.3 90.53 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.121 -0.987 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 63' ' ' LEU . 7.1 mm -78.39 -43.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.538 -0.727 . . . . 0.0 111.458 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.562 HD12 ' CD ' ' A' ' 64' ' ' GLU . 10.4 mt -64.29 -41.3 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.0 110.7 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -60.91 -37.44 82.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.097 -1.002 . . . . 0.0 110.429 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -69.31 -45.43 69.55 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.222 -0.923 . . . . 0.0 111.103 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -48.82 72.27 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.008 -1.058 . . . . 0.0 110.253 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.733 HD23 ' OD2' ' A' ' 21' ' ' ASP . 36.1 mt -63.8 -35.68 81.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.3 -0.875 . . . . 0.0 109.958 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' OE1' ' CA ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -70.35 -45.55 65.91 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.507 -0.746 . . . . 0.0 109.543 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -60.3 -37.23 79.88 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -75.36 -25.72 57.94 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.495 -0.753 . . . . 0.0 110.326 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' O ' ' SD ' ' A' ' 14' ' ' MET . . . 104.11 11.32 32.23 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 72' ' ' LEU . . . -95.05 126.58 40.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.321 -1.106 . . . . 0.0 110.2 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -119.49 131.71 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.972 HG13 ' O ' ' A' ' 11' ' ' GLN . 3.4 t -85.84 124.6 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.01 -9.11 59.66 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -131.57 130.82 42.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.368 -0.832 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 82' ' ' VAL . 8.9 p -141.2 108.63 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.95 -1.094 . . . . 0.0 110.57 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HG3' HD11 ' A' ' 85' ' ' LEU . 3.5 tp10 -127.38 107.91 10.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.994 -1.067 . . . . 0.0 109.876 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' C ' HD12 ' A' ' 85' ' ' LEU . 10.4 pt-20 -99.56 118.22 35.64 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.312 -0.868 . . . . 0.0 111.319 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.984 HD13 ' O ' ' A' ' 7' ' ' PHE . 6.0 mp -113.64 -69.81 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.487 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.685 ' HA2' HD12 ' A' ' 52' ' ' LEU . . . 38.73 72.42 0.2 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.2 pp 179.55 45.58 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.211 -1.17 . . . . 0.0 110.287 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -121.78 140.49 52.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 110.494 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -130.85 121.46 25.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.878 . . . . 0.0 109.965 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.45 88.27 2.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 110.428 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.24 -32.77 3.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 110.075 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.558 ' CG ' ' HD2' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -101.03 149.55 36.33 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.096 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 92' ' ' TYR . 48.2 Cg_endo -74.89 55.26 3.83 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.983 1.517 . . . . 0.0 110.741 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.443 HG12 ' HB3' ' A' ' 92' ' ' TYR . 25.6 mm -82.05 124.9 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.042 -1.036 . . . . 0.0 110.067 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.71 -156.74 0.75 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 110.316 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.192 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.698 ' O ' HD23 ' A' ' 90' ' ' LEU . 1.4 mpp? . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.31 0.576 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.607 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 30.4 t0 -62.74 -40.3 62.57 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 111.301 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 47.7 Cg_endo -84.93 15.76 2.13 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.423 1.223 . . . . 0.0 110.373 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.876 ' HB3' HD23 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -44.04 123.37 3.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.462 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.979 ' O ' HD23 ' A' ' 56' ' ' LEU . . . 104.19 -37.58 3.7 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.15 -1.5 . . . . 0.0 109.902 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -66.79 117.42 8.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.062 -1.257 . . . . 0.0 109.701 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.976 ' C ' HD23 ' A' ' 8' ' ' LEU . 85.6 t80 -168.08 27.55 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.34 -0.85 . . . . 0.0 109.786 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.976 HD23 ' C ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -153.51 123.97 7.12 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 120.962 -1.086 . . . . 0.0 111.939 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.82 ' HB2' HD21 ' A' ' 85' ' ' LEU . 7.3 t90 -128.11 118.83 24.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.503 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 62.0 m-85 -127.54 145.19 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.874 -1.141 . . . . 0.0 111.753 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 81' ' ' LYS . 23.2 tt0 -122.91 159.6 27.91 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.367 -0.833 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.54 -177.43 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.938 -1.102 . . . . 0.0 110.726 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 13' ' ' GLU . 6.7 tt0 -135.58 50.18 2.12 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.693 0.759 . . . . 0.0 109.748 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' GLY . 16.6 mmt -128.59 148.7 69.42 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.81 -166.58 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.768 1.404 . . . . 0.0 113.412 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -52.58 -24.84 9.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.713 178.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.46 ' C ' ' HH ' ' A' ' 75' ' ' TYR . 35.8 t0 -58.22 -13.1 4.34 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.329 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -71.42 -13.3 61.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.234 -0.916 . . . . 0.0 111.027 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 16' ' ' GLU . 54.7 t -49.76 -46.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.34 -0.85 . . . . 0.0 110.068 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -30.87 69.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.168 -0.958 . . . . 0.0 109.58 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.652 ' OD2' ' HB3' ' A' ' 77' ' ' ALA . 16.3 t0 -69.48 -54.93 11.83 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.334 -0.854 . . . . 0.0 109.931 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.3 mm? -61.64 -38.13 86.55 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.686 -0.806 . . . . 0.0 108.85 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -60.81 -52.02 66.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.433 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.481 ' O ' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -70.35 -46.83 63.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.187 -0.946 . . . . 0.0 109.769 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.949 ' OE2' HG23 ' A' ' 68' ' ' ILE . 50.5 tt0 -56.51 -49.63 74.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 110.919 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.737 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -63.76 -36.4 83.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 110.504 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.95 -41.98 97.35 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.194 -0.942 . . . . 0.0 111.313 -179.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.623 HG21 HG23 ' A' ' 67' ' ' ILE . 23.2 mt -67.57 -40.96 85.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.782 -1.199 . . . . 0.0 109.834 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 32' ' ' VAL . 36.7 mtp180 -74.39 64.53 1.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.546 -0.721 . . . . 0.0 110.373 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -29.62 70.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.942 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -62.14 -13.75 30.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.439 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.713 HG23 HD11 ' A' ' 50' ' ' ILE . 1.8 p -79.91 126.2 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.108 -0.995 . . . . 0.0 110.597 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -80.38 -44.59 19.15 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 110.69 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -151.72 123.72 8.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 0.0 111.486 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.499 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 3.7 p -129.94 128.16 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.708 . . . . 0.0 109.155 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.4 tpp -116.26 115.79 26.6 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.069 -1.02 . . . . 0.0 111.065 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG21 HD12 ' A' ' 22' ' ' LEU . 16.8 t -115.25 125.23 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.78 160.01 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.069 -1.019 . . . . 0.0 110.734 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -79.69 154.4 28.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.411 -0.806 . . . . 0.0 110.364 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.432 ' CB ' ' HG2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -74.11 -170.69 0.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.927 . . . . 0.0 110.105 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.407 ' H ' HG22 ' A' ' 41' ' ' THR . 8.8 t -98.69 1.71 46.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.629 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.58 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 m -160.53 -64.55 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.012 -1.055 . . . . 0.0 110.625 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 41.2 Cg_endo -67.66 -168.79 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.596 1.314 . . . . 0.0 110.782 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -107.11 29.17 11.04 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.6 ptt180 -94.19 160.61 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.845 -1.386 . . . . 0.0 110.393 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HG2' ' A' ' 18' ' ' ARG . 60.3 m-85 -132.48 155.26 48.87 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 121.956 0.884 . . . . 0.0 111.018 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.94 96.87 8.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 10' ' ' TYR . 43.5 t -79.61 118.99 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.883 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -131.19 101.16 5.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.812 HD13 ' N ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -117.36 146.13 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.912 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.812 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.7 p -107.05 120.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.621 HD12 HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.52 179.74 6.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 111.175 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.563 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.0 OUTLIER -45.33 174.04 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.766 -0.584 . . . . 0.0 110.359 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HA ' ' CG ' ' A' ' 4' ' ' GLN . 37.2 Cg_endo -63.23 -15.13 46.19 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.594 1.313 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' OD1' ' NH1' ' A' ' 88' ' ' ARG . 19.0 t-20 -140.36 73.71 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.163 -0.96 . . . . 0.0 110.449 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.979 HD23 ' O ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER -63.03 165.19 7.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -165.42 168.67 16.45 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 110.82 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -54.68 -38.2 66.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.316 -0.865 . . . . 0.0 110.111 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -45.4 87.5 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.459 ' HB2' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm100 -69.7 -41.48 75.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.386 -0.822 . . . . 0.0 109.255 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.739 HD21 HD22 ' A' ' 8' ' ' LEU . 10.5 mt -63.26 -35.01 78.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.787 . . . . 0.0 109.957 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.541 ' O ' ' CG ' ' A' ' 66' ' ' GLU . . . -52.22 -43.9 64.51 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.665 ' O ' HG12 ' A' ' 67' ' ' ILE . 66.9 mt -64.75 -48.38 74.77 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.702 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -65.26 -44.74 87.11 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.356 -1.465 . . . . 0.0 110.819 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 62' ' ' ALA . 5.0 ptmt -74.52 -35.16 63.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.471 -1.393 . . . . 0.0 110.433 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 62' ' ' ALA . 86.9 mt-10 -77.23 -40.41 45.01 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.892 -1.13 . . . . 0.0 109.881 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 63' ' ' LEU . 8.7 mm -76.99 -35.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.173 -0.954 . . . . 0.0 110.946 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.949 HG23 ' OE2' ' A' ' 25' ' ' GLU . 69.1 mt -69.09 -45.27 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 0.0 109.48 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 32.0 mt-30 -60.3 -48.52 81.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.285 -0.885 . . . . 0.0 110.005 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -60.36 -44.24 95.77 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.435 -0.791 . . . . 0.0 111.082 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.49 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . . . -65.5 -48.76 71.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 120.875 -1.14 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.602 HD23 ' CG ' ' A' ' 21' ' ' ASP . 32.0 mt -65.49 -38.15 88.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 12.9 mm-40 -70.88 -44.85 65.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 31.2 t-20 -60.75 -37.02 80.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 t80 -75.71 -33.47 60.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.241 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 116.52 9.49 11.35 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.652 ' HB3' ' OD2' ' A' ' 21' ' ' ASP . . . -103.84 129.41 51.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.092 -1.24 . . . . 0.0 109.802 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.15 137.57 52.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.131 -0.981 . . . . 0.0 110.547 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 11' ' ' GLN . 2.1 t -79.29 115.65 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.596 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -82.78 -4.67 58.28 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.527 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -130.28 155.01 47.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.226 -0.922 . . . . 0.0 111.889 -178.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -140.99 107.82 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -127.62 111.07 13.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.096 -1.003 . . . . 0.0 111.367 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 6.9 pm0 -95.54 89.49 5.4 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.269 -0.894 . . . . 0.0 109.153 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 9' ' ' TRP . 0.6 OUTLIER -107.94 -135.78 0.36 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.178 -0.951 . . . . 0.0 109.977 -179.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 85' ' ' LEU . . . 43.99 -171.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 87' ' ' LEU . 2.7 pp 179.68 124.3 0.07 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.239 -1.154 . . . . 0.0 110.482 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -77.84 128.94 34.78 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.312 -0.868 . . . . 0.0 110.545 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.461 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -141.25 26.64 1.98 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 110.045 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.876 HD23 ' HB3' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -82.33 51.18 1.76 Allowed 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.15 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.96 165.26 24.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 110.288 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.33 165.63 37.38 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 0.0 110.431 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.22 151.74 49.4 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.106 1.582 . . . . 0.0 110.495 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 87.6 mt -122.52 115.24 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.195 -0.94 . . . . 0.0 110.131 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.28 47.21 0.88 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.373 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.297 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.257 0.551 . . . . 0.0 110.026 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.692 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 26.6 t0 -77.61 -23.86 0.44 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 113.0 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 49.3 Cg_endo -82.57 -5.33 11.68 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 122.699 0.842 . . . . 0.0 110.106 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER 179.57 -170.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.818 . . . . 0.0 110.828 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.553 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -68.18 126.23 22.62 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.774 ' CB ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -80.48 132.27 35.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.611 -0.935 . . . . 0.0 110.591 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -101.84 93.92 5.55 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.738 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.7 mm? -90.79 148.45 22.53 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.155 -0.966 . . . . 0.0 111.521 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 48' ' ' VAL . 3.5 t90 -127.36 119.61 26.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.787 . . . . 0.0 109.356 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.907 ' HD1' HG11 ' A' ' 79' ' ' VAL . 42.5 m-85 -123.27 143.74 49.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.93 -1.106 . . . . 0.0 111.163 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.654 ' O ' HG13 ' A' ' 79' ' ' VAL . 5.9 tt0 -121.05 160.33 23.84 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.406 -0.809 . . . . 0.0 109.597 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.85 -177.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 110.515 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 33.7 tt0 -143.32 53.47 1.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.234 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.559 ' HB2' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -122.1 148.93 53.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.256 -0.903 . . . . 0.0 109.876 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 18' ' ' ARG . 36.2 Cg_endo -69.36 -167.31 0.2 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.992 1.522 . . . . 0.0 113.491 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.81 ' O ' HG12 ' A' ' 19' ' ' VAL . 3.0 tm-20 -65.52 -23.72 66.95 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.267 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.83 -39.49 79.97 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.615 -0.678 . . . . 0.0 111.966 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 14' ' ' MET . 0.3 OUTLIER -90.69 -16.76 27.98 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.056 -1.027 . . . . 0.0 110.869 -178.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.81 HG12 ' O ' ' A' ' 16' ' ' GLU . 7.4 p -46.54 -36.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.514 -0.741 . . . . 0.0 110.413 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.532 ' N ' HG13 ' A' ' 19' ' ' VAL . 2.2 t30 -52.21 -28.16 17.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.454 -0.779 . . . . 0.0 109.682 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.589 ' HB2' ' CD1' ' A' ' 75' ' ' TYR . 39.7 t0 -58.8 -38.12 77.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.365 -0.834 . . . . 0.0 109.834 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 2.9 mp -58.52 -41.66 85.97 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.526 -0.734 . . . . 0.0 109.349 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -56.38 -50.6 71.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.403 -0.811 . . . . 0.0 109.517 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -68.55 -41.03 80.39 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.83 . . . . 0.0 109.694 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 28' ' ' ILE . 1.1 tp10 -59.78 -48.8 80.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.348 -0.845 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.711 HD12 ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -60.89 -37.26 81.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.051 . . . . 0.0 109.055 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.38 -38.96 81.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.436 179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.583 ' CG2' HG22 ' A' ' 67' ' ' ILE . 0.5 OUTLIER -58.86 -44.66 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.273 -0.892 . . . . 0.0 110.534 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.819 ' O ' HG12 ' A' ' 32' ' ' VAL . 11.6 ptp180 -78.61 52.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 110.521 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.71 -27.91 69.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.107 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 29.8 p-10 -58.88 -17.85 27.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 109.94 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.143 HG21 ' CD1' ' A' ' 50' ' ' ILE . 3.4 p -80.9 154.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.45 -0.781 . . . . 0.0 110.522 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -79.17 -45.53 19.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 111.058 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.5 mtt-85 -152.14 135.62 16.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.992 -1.067 . . . . 0.0 110.899 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.514 ' CA ' HG13 ' A' ' 50' ' ' ILE . 8.8 p -133.87 133.67 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.82 119.26 12.24 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.189 -0.945 . . . . 0.0 110.793 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 48' ' ' VAL . 58.5 t -114.54 130.67 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.984 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 47' ' ' GLU . 16.2 m -111.28 145.13 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.685 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 46' ' ' TYR . . . -84.09 153.87 23.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.422 -0.799 . . . . 0.0 110.687 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.53 -173.82 1.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -105.24 -16.91 14.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 110.087 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m -124.31 -67.95 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 42' ' ' THR . 43.9 Cg_endo -71.52 -168.79 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.105 1.055 . . . . 0.0 110.791 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' MET . . . -110.48 31.62 7.23 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.527 ' CD ' ' HG2' ' A' ' 43' ' ' PRO . 1.4 ptm180 -94.54 160.74 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -1.183 . . . . 0.0 110.486 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 45' ' ' ARG . 19.9 m-85 -132.2 154.35 49.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.846 0.831 . . . . 0.0 110.836 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . 20.2 mt-10 -103.85 93.19 4.75 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 37' ' ' VAL . 65.4 t -79.5 123.13 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.0 111.603 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 9' ' ' TRP . 77.6 m-20 -130.91 100.76 5.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.143 ' CD1' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -136.52 147.88 27.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.634 0.731 . . . . 0.0 111.432 -178.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 88' ' ' ARG . 9.9 p -124.81 149.92 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.617 -0.677 . . . . 0.0 109.232 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.98 ' HG ' HG23 ' A' ' 32' ' ' VAL . 6.1 mp -105.41 -158.56 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 52' ' ' LEU . 1.2 m-80 -39.44 163.8 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.85 -0.531 . . . . 0.0 110.425 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 38.5 Cg_endo -64.13 -15.71 50.9 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 124.0 1.526 . . . . 0.0 110.877 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.607 ' HB2' HD13 ' A' ' 90' ' ' LEU . 66.9 t30 -139.05 75.88 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 110.117 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.956 HD11 HD13 ' A' ' 52' ' ' LEU . 8.7 mt -61.76 -174.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.975 -1.078 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD2' ' OD1' ' A' ' 2' ' ' ASP . 0.5 OUTLIER -178.79 -174.25 0.35 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.465 0.65 . . . . 0.0 109.724 179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -65.82 -40.01 91.42 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 111.119 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.1 m -66.19 -36.12 82.24 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.251 -0.906 . . . . 0.0 110.56 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.26 -44.53 68.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 110.45 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 71.4 mt -64.67 -33.18 75.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.529 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 66' ' ' GLU . . . -52.42 -35.66 52.52 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 67' ' ' ILE . 47.4 mt -71.55 -49.72 38.03 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.873 0.844 . . . . 0.0 109.145 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.686 ' OE1' HD11 ' A' ' 52' ' ' LEU . 4.6 mt-10 -67.32 -38.39 84.85 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.624 -1.297 . . . . 0.0 109.987 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.67 -42.15 67.83 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.881 -1.137 . . . . 0.0 110.756 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 10.9 mm-40 -75.48 -39.41 58.65 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.725 -1.234 . . . . 0.0 109.628 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 63' ' ' LEU . 23.6 mm -78.17 -40.87 26.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.496 -0.753 . . . . 0.0 111.868 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 64' ' ' GLU . 89.0 mt -71.32 -41.66 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.322 -1.487 . . . . 0.0 110.294 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 1.4 pp0? -64.35 -34.64 78.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -0.847 . . . . 0.0 110.761 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -69.06 -41.52 77.48 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.01 -1.056 . . . . 0.0 110.977 -179.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' TYR . . . -69.02 -48.55 62.67 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.09 -1.006 . . . . 0.0 110.709 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 77' ' ' ALA . 61.6 mt -60.71 -38.2 84.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.192 -0.943 . . . . 0.0 110.606 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -72.04 -45.9 59.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.367 -0.833 . . . . 0.0 109.563 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 14.1 t-20 -60.9 -40.46 93.18 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.32 -43.75 39.89 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.574 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.72 34.23 1.44 Allowed Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . . . -113.01 127.3 56.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -1.155 . . . . 0.0 109.534 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -120.7 129.29 53.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 110.612 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.907 HG11 ' HD1' ' A' ' 10' ' ' TYR . 2.3 t -75.13 119.66 23.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.087 -1.008 . . . . 0.0 109.407 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -82.32 -7.06 59.63 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.9 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HG2' ' CB ' ' A' ' 11' ' ' GLN 0.251 0.0 OUTLIER -132.98 149.71 52.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.329 -0.857 . . . . 0.0 111.559 -178.397 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 t -141.51 105.21 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.798 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -129.95 115.81 17.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 110.652 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' HB3' ' OH ' ' A' ' 6' ' ' TYR . 10.0 mt-10 -98.18 89.7 4.6 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.979 -1.076 . . . . 0.0 109.974 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -131.77 -165.24 1.55 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.389 -0.819 . . . . 0.0 110.06 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 87' ' ' LEU . . . 61.12 163.34 0.19 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 87' ' ' LEU . 3.5 pp -178.41 137.43 0.17 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.311 -1.111 . . . . 0.0 110.258 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.601 ' CG ' HG21 ' A' ' 51' ' ' VAL . 20.2 mmm-85 -80.12 171.33 15.22 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.178 -0.951 . . . . 0.0 110.197 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -113.57 102.57 10.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.274 -0.891 . . . . 0.0 110.598 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -77.69 138.36 39.02 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.93 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.13 -36.22 4.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.221 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.91 144.27 47.61 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 110.309 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.79 -90.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.055 1.555 . . . . 0.0 110.296 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.83 117.24 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 110.102 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.96 149.39 28.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.384 -0.822 . . . . 0.0 110.282 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.276 -179.935 . . . . . . . . 0 0 . 1 stop_ save_